data_2hpu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hpu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 85.6 tttt . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.552 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -143.56 144.17 31.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.413 0.149 . . . . 0.0 110.823 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 29.0 pt20 -149.01 134.7 18.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.148 0.499 . . . . 0.0 110.767 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.641 HG21 ' HB ' ' A' ' 71' ' ' ILE . 37.6 pt -115.92 129.18 72.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.657 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -98.87 116.47 31.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.597 HD23 ' HB2' ' A' ' 66' ' ' ALA . 8.5 mp -91.85 142.72 27.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.873 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.915 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 34.4 tt0 -74.26 125.06 27.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.603 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.93 -23.74 33.0 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.731 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.501 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 39.7 t -88.49 129.41 49.31 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.4 Cg_exo -77.58 -3.35 13.51 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.897 2.398 . . . . 0.0 112.323 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.25 139.69 32.36 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.813 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.76 149.47 8.53 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.596 2.197 . . . . 0.0 112.167 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 10.3 tt -89.07 111.57 22.34 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -124.11 135.95 53.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.204 0.526 . . . . 0.0 111.623 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -146.82 162.65 38.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.567 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 30.2 t -72.46 -41.89 65.56 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.913 ' HG2' ' HB2' ' A' ' 83' ' ' TRP . 37.9 mt-30 -65.65 113.08 3.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.485 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.552 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 4.5 t -72.66 -52.03 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.23 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.498 ' HA ' HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -52.09 -35.71 48.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.444 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 51' ' ' GLN . 29.1 t70 -76.05 -51.9 11.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.577 0.227 . . . . 0.0 110.999 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.89 94.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.36 . . . . 0.0 111.394 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.806 HD12 ' HB1' ' A' ' 114' ' ' ALA . 23.9 pt -66.91 -30.56 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.691 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.24 97.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.663 0.268 . . . . 0.0 110.663 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.65 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 16.6 m-85 -63.05 -34.02 76.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.364 . . . . 0.0 110.785 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.621 ' HB2' HG22 ' A' ' 38' ' ' ILE . . . -69.68 -16.81 63.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.557 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.489 HH12 ' HG2' ' A' ' 112' ' ' PRO . 49.9 mtm180 -102.52 -0.7 31.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.049 -175.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -154.57 -73.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.998 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.65 ' HD2' ' HA ' ' A' ' 58' ' ' TYR . 76.2 Cg_exo -55.65 0.32 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.085 3.19 . . . . 0.0 115.095 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -79.78 9.09 5.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.935 0.397 . . . . 0.0 111.142 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 84.3 mm-40 -62.64 -18.01 61.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.89 0.376 . . . . 0.0 111.452 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.4 tp -70.49 -45.01 76.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.697 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.597 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -152.13 140.68 13.65 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.915 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 64.7 Cg_endo -68.31 143.76 59.62 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 122.244 1.963 . . . . 0.0 112.021 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.8 pt -74.07 113.11 11.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.229 0.538 . . . . 0.0 110.333 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.6 -50.8 10.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.8 p -161.2 140.45 2.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.227 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.641 ' HB ' HG21 ' A' ' 38' ' ' ILE . 2.7 tt -112.99 131.9 63.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.628 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -111.84 135.51 52.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.429 HG22 HG13 ' A' ' 92' ' ' ILE . 27.8 m -131.59 140.82 47.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.445 0.64 . . . . 0.0 111.161 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.502 ' HB3' ' HE1' ' A' ' 76' ' ' MET . 13.0 m120 -90.28 99.9 12.83 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -54.63 104.67 0.12 Allowed 'General case' 0 C--O 1.239 0.529 0 O-C-N 124.485 1.116 . . . . 0.0 111.025 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.635 ' O ' ' HD2' ' A' ' 86' ' ' PRO . 64.8 mtt -144.61 52.55 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.414 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.05 -52.56 4.51 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.338 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 67.12 -84.36 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.255 0.622 . . . . 0.0 112.221 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.71 -15.99 15.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.824 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.51 -43.25 96.88 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.64 ' CB ' ' HD3' ' A' ' 86' ' ' PRO . . . -95.02 -154.79 0.44 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.374 173.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.0 p -103.6 177.76 4.75 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.864 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.913 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 3.3 p90 -55.49 -13.27 1.43 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 172.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.61 -35.61 39.27 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 71.74 150.13 0.13 Allowed Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.38 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.64 ' HD3' ' CB ' ' A' ' 81' ' ' ALA . 48.2 Cg_endo -72.89 -61.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.455 2.104 . . . . 0.0 113.1 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.51 -179.21 39.65 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.372 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.14 136.82 42.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.196 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.3 -113.18 1.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.834 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -100.51 152.02 20.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.515 0.198 . . . . 0.0 111.053 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -105.25 124.94 50.39 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 168.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 1.005 HG21 ' HB2' ' A' ' 118' ' ' SER . 8.8 pt -145.81 164.48 10.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.87 107.22 19.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.578 ' HB3' ' HE1' ' A' ' 99' ' ' TYR . . . -57.64 -33.14 67.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 111.188 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.814 ' HA ' HD12 ' A' ' 137' ' ' LEU . 9.1 t70 -62.12 -28.17 69.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.033 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -114.65 33.44 5.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.201 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -138.24 -175.07 3.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.739 0.304 . . . . 0.0 110.902 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -91.34 138.98 31.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.497 0.665 . . . . 0.0 110.61 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.578 ' HE1' ' HB3' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -120.52 135.03 55.2 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.565 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.905 HG13 HG13 ' A' ' 115' ' ' VAL . 1.1 p -118.57 124.63 73.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.604 0.716 . . . . 0.0 109.752 169.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 145' ' ' VAL . 65.3 t -101.65 117.82 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.149 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.702 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -77.87 125.82 7.42 Favored Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.452 -171.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -91.88 -36.71 13.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 110.909 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.11 -43.65 23.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.37 . . . . 0.0 111.138 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.534 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 71.4 mtp180 -131.02 96.97 4.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.543 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.794 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 2.8 tpp180 172.82 175.32 0.1 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.663 0.602 . . . . 0.0 109.905 173.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.1 70.4 3.15 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.366 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.19 -42.68 98.73 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.358 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.6 mtm -109.55 16.52 22.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.275 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -139.21 -122.33 1.98 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.475 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.36 92.83 4.24 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 110.915 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.561 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 73.9 Cg_endo -77.3 135.34 14.95 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.61 2.207 . . . . 0.0 112.958 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.794 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 30.9 mt-10 -115.13 146.45 41.34 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.029 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.806 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -118.42 133.14 56.11 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.738 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.905 HG13 HG13 ' A' ' 100' ' ' VAL . 0.5 OUTLIER -101.86 105.69 43.03 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.685 171.047 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 6.6 Cg_exo -81.99 123.8 4.21 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 124.425 3.416 . . . . 0.0 111.77 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.723 ' HD1' ' H ' ' A' ' 119' ' ' SER . 1.2 t80 -135.16 149.59 49.99 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.988 0.423 . . . . 0.0 110.154 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 1.005 ' HB2' HG21 ' A' ' 92' ' ' ILE . 29.2 t -78.34 -34.68 48.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.615 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.723 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 8.0 m -91.34 116.93 29.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.211 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -58.14 -44.56 87.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.965 0.412 . . . . 0.0 111.495 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -61.63 -31.56 71.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.099 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -67.48 -41.52 84.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.655 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.39 83.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.128 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.25 92.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.774 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.16 86.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.101 0.477 . . . . 0.0 110.567 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -62.0 -38.71 89.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.84 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.599 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 48.2 t -65.99 -42.8 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.903 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.2 mt -53.96 -35.36 61.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.643 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.01 -46.6 11.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.0 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -159.07 -34.58 0.06 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.702 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -50.43 157.86 1.98 Allowed Glycine 0 C--N 1.32 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.024 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -101.27 -68.5 0.83 Allowed Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.74 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.441 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.2 140.96 50.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.741 0.305 . . . . 0.0 110.831 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 89.0 t -98.38 112.87 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.284 0.564 . . . . 0.0 109.664 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -137.58 144.88 42.23 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.766 -178.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.96 157.59 37.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.814 HD12 ' HA ' ' A' ' 95' ' ' ASP . 4.5 tt -63.32 -28.85 70.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.418 0.628 . . . . 0.0 109.673 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.32 -9.56 53.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.425 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -123.45 18.1 9.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.09 0.472 . . . . 0.0 110.539 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.815 HD11 HD11 ' A' ' 135' ' ' LEU . 38.2 mm -71.78 121.65 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.197 0.522 . . . . 0.0 110.387 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 1.001 HG22 ' HA ' ' A' ' 156' ' ' ARG . 2.9 t -111.47 148.24 33.57 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.722 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.486 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.3 p-10 -69.27 -22.31 63.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.681 0.277 . . . . 0.0 110.656 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.27 -33.41 74.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.936 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 1.024 ' HA ' ' HE1' ' A' ' 144' ' ' MET . 7.2 mmt -87.26 -30.14 21.14 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.806 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 141' ' ' THR . 5.0 t -80.53 -22.91 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.991 0.424 . . . . 0.0 110.746 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.6 pp -154.47 134.26 12.93 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.372 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.9 p -116.39 149.37 43.55 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.162 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -58.99 -58.05 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.476 2.117 . . . . 0.0 109.621 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.517 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 25.7 t -127.56 -72.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 165.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 149' ' ' VAL . 7.5 mt-10 165.2 -77.03 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.438 1.495 . . . . 0.0 108.493 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.7 t 46.18 28.99 0.73 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.504 1.122 . . . . 0.0 113.129 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 74.92 64.36 2.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.286 -176.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.6 t -89.93 162.08 15.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.922 0.392 . . . . 0.0 110.873 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -88.69 150.97 47.12 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.108 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.681 ' HA ' ' SD ' ' A' ' 144' ' ' MET . 60.3 Cg_endo -73.12 -136.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.991 2.461 . . . . 0.0 113.125 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 1.001 ' HA ' HG22 ' A' ' 141' ' ' THR . 0.0 OUTLIER -57.21 -29.14 63.49 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -174.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -179.49 20.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.371 0.419 . . . . 0.0 110.638 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.1 t70 48.49 70.52 0.44 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.684 0.754 . . . . 0.0 109.133 -169.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.488 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 14.3 t70 -145.14 -42.18 0.23 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.53 -167.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 C--O 1.247 0.963 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.691 -179.787 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.93 ' H ' ' HB2' ' A' ' 74' ' ' ASN . 16.5 ttmm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.557 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -133.14 141.88 48.37 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.84 175.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 9.4 pt20 -149.65 132.66 16.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.828 174.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.582 HG23 ' HB2' ' A' ' 59' ' ' ALA . 28.6 pt -115.95 133.68 61.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.3 0.571 . . . . 0.0 111.458 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -103.81 119.51 39.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.739 HD22 ' HB2' ' A' ' 66' ' ' ALA . 11.1 mp -89.63 153.95 20.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.276 0.56 . . . . 0.0 111.503 -174.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.586 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 29.7 tt0 -71.68 125.54 27.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.635 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.31 -27.36 5.7 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.199 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.504 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.9 t -87.98 128.38 54.14 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 8.9 Cg_endo -87.29 -1.35 7.74 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.122 2.548 . . . . 0.0 112.612 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.23 132.98 21.83 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.828 0.347 . . . . 0.0 111.053 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -87.77 124.57 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.675 2.25 . . . . 0.0 112.036 174.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 7.2 tt -80.56 109.0 14.67 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -108.84 143.13 38.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.988 0.423 . . . . 0.0 110.831 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.539 ' HD1' ' H ' ' A' ' 51' ' ' GLN . 1.9 t80 -144.66 145.24 31.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.696 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.7 m -63.97 -34.95 79.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.194 0.521 . . . . 0.0 110.201 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.618 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 76.1 mt-30 -83.38 105.96 14.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.051 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.557 HG12 ' HB1' ' A' ' 36' ' ' ALA . 8.6 t -56.37 -51.46 63.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.285 0.564 . . . . 0.0 109.57 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -55.5 -32.84 63.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.682 -1.145 . . . . 0.0 113.205 -178.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.536 ' HB2' HH11 ' A' ' 53' ' ' ARG . 22.8 t70 -76.28 -50.08 15.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.013 0.435 . . . . 0.0 110.839 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.47 93.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.276 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.713 HD12 ' HB1' ' A' ' 114' ' ' ALA . 16.2 pt -70.16 -30.53 43.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.625 0.25 . . . . 0.0 110.628 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.07 82.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.141 0.496 . . . . 0.0 110.075 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -62.01 -34.91 77.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.13 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.65 ' HB3' HD11 ' A' ' 68' ' ' ILE . . . -72.89 -18.17 61.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.993 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -96.52 12.47 31.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -172.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.32 -61.51 0.1 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.521 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.35 22.43 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.145 2.563 . . . . 0.0 114.8 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.65 74.09 9.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.134 0.968 . . . . 0.0 110.376 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.448 ' O ' HG22 ' A' ' 65' ' ' ILE . 14.0 mt-30 -79.09 145.82 33.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.25 -172.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 64' ' ' GLN . 1.9 tp 72.74 -38.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.91 1.284 . . . . 0.0 112.345 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.739 ' HB2' HD22 ' A' ' 40' ' ' LEU . . . -133.44 139.57 34.35 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 122.007 -0.433 . . . . 0.0 110.413 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 96.2 Cg_endo -85.59 159.97 10.8 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.95 2.434 . . . . 0.0 112.061 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 59' ' ' ALA . 28.0 pt -77.08 113.35 16.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.31 0.576 . . . . 0.0 110.465 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -77.54 -46.81 21.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.7 p -158.28 138.82 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.395 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.586 HD12 HG23 ' A' ' 56' ' ' ILE . 2.6 tt -116.94 134.35 60.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.027 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.94 128.78 56.26 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 94' ' ' ALA . 29.0 m -126.96 151.93 34.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.26 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.93 ' HB2' ' H ' ' A' ' 35' ' ' LYS . 16.5 m120 -91.49 105.65 17.91 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.54 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.575 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 18.3 t70 -48.26 134.02 15.04 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 125.928 2.018 . . . . 0.0 110.844 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.497 ' SD ' ' HD2' ' A' ' 86' ' ' PRO . 23.9 mmt -127.04 176.55 7.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -167.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.95 -19.38 56.37 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.73 173.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 83.47 -45.16 0.11 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.16 0.584 . . . . 0.0 112.33 168.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.54 -44.22 76.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.061 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.03 -87.1 0.78 Allowed Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.506 173.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 53.73 26.16 5.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.52 0.676 . . . . 0.0 111.699 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.0 p -83.67 179.16 7.68 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.983 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.618 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 48.6 p90 -59.5 -24.2 63.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.733 0.301 . . . . 0.0 111.267 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -81.37 -35.29 30.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.824 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 68.74 140.22 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.668 174.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.497 ' HD2' ' SD ' ' A' ' 76' ' ' MET . 96.5 Cg_endo -85.14 31.71 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.36 2.04 . . . . 0.0 113.577 -173.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 118.01 -171.83 14.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.125 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.4 147.22 36.14 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.493 0.317 . . . . 0.0 110.728 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -141.58 -158.06 7.4 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.169 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.597 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 41.9 m-80 -100.17 150.44 22.51 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 40.8 p-90 -98.56 130.28 45.11 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.444 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.745 HG23 ' HB2' ' A' ' 118' ' ' SER . 14.1 pt -143.97 160.6 15.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.601 -173.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.68 101.16 9.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.108 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.551 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -62.11 -38.95 90.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.349 -172.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.658 ' HA ' HD12 ' A' ' 137' ' ' LEU . 14.0 t70 -58.85 -30.43 67.69 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.666 0.746 . . . . 0.0 110.301 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -107.96 25.73 11.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.123 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.13 -177.21 3.79 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.847 0.356 . . . . 0.0 110.485 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -97.79 136.81 37.59 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.527 0.68 . . . . 0.0 110.475 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.503 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 7.6 m-85 -120.5 136.18 54.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.88 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.682 HG13 ' HB ' ' A' ' 115' ' ' VAL . 3.2 p -114.77 127.89 72.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.423 0.63 . . . . 0.0 109.762 174.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.573 HG11 ' HA ' ' A' ' 145' ' ' VAL . 96.4 t -101.46 103.49 14.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.49 123.16 5.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.555 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.8 t -92.51 -29.54 16.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.587 0.232 . . . . 0.0 110.756 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.18 60.74 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -171.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -139.19 101.53 4.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.421 173.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.946 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 19.4 tpp180 -175.06 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.845 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.65 42.09 0.15 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.113 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.97 -34.38 89.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.266 -0.968 . . . . 0.0 111.715 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.0 ttt -109.5 2.23 20.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.096 0.474 . . . . 0.0 110.326 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -136.56 -123.52 2.26 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.72 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.8 99.08 12.61 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.977 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 72.1 Cg_endo -79.18 151.38 23.44 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.143 2.562 . . . . 0.0 113.696 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.946 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 25.9 mt-10 -128.82 146.52 50.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.603 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.713 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -93.79 130.93 39.62 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.945 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.682 ' HB ' HG13 ' A' ' 100' ' ' VAL . 55.4 t -101.28 106.4 45.13 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 6.1 Cg_exo -86.26 132.52 3.79 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.656 2.904 . . . . 0.0 112.305 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.744 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.8 t80 -137.66 149.43 46.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.745 ' HB2' HG23 ' A' ' 92' ' ' ILE . 35.5 t -77.97 -37.88 46.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.846 0.355 . . . . 0.0 111.148 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.744 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 17.8 m -95.75 129.74 42.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.826 0.346 . . . . 0.0 110.645 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -65.92 -49.72 66.97 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.229 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -63.18 -29.65 70.95 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.554 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -65.73 -42.92 90.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.554 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.7 -36.95 73.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.229 0.538 . . . . 0.0 110.035 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.03 -34.56 71.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.846 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.69 81.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.036 0.446 . . . . 0.0 110.356 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -62.43 -37.59 86.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.751 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.644 HG21 ' H ' ' A' ' 132' ' ' GLY . 93.2 t -70.95 -38.13 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.974 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.1 mt -53.24 -50.95 63.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.368 0.604 . . . . 0.0 110.11 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.59 78.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.133 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.749 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.3 pt-20 -165.55 -82.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.58 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.749 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 39.6 -132.79 2.15 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 123.915 0.759 . . . . 0.0 114.45 175.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.644 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -171.23 -93.37 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.77 139.66 51.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.711 0.291 . . . . 0.0 110.715 174.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.406 HG22 HG22 ' A' ' 127' ' ' VAL . 99.4 t -97.43 123.17 49.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.378 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.844 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -147.02 164.38 33.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.563 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.14 164.38 15.04 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.658 HD12 ' HA ' ' A' ' 95' ' ' ASP . 4.1 tt -61.44 -40.05 93.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.97 -8.62 38.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.592 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -124.67 17.96 8.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.248 0.547 . . . . 0.0 110.748 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.844 HD11 HD12 ' A' ' 135' ' ' LEU . 26.1 mm -71.78 121.92 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -116.86 146.0 43.2 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.96 -30.73 68.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.717 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.76 -28.78 68.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.923 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.6 mmt -77.62 -41.21 39.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.783 0.325 . . . . 0.0 110.953 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.573 ' HA ' HG11 ' A' ' 101' ' ' VAL . 3.0 t -81.52 -23.79 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.393 . . . . 0.0 111.217 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -156.62 159.33 38.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.552 -175.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.433 ' HB ' ' HG2' ' A' ' 150' ' ' GLU . 3.4 p -100.02 120.35 57.11 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.657 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.26 -69.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.1 2.533 . . . . 0.0 112.406 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 149' ' ' VAL . 10.6 t -129.69 0.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.288 0.566 . . . . 0.0 109.646 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.433 ' HG2' ' HB ' ' A' ' 147' ' ' THR . 40.1 mt-10 57.36 55.8 5.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.422 -175.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 t -90.94 -6.84 53.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.055 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 82.42 26.57 46.78 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.535 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 p -84.41 161.93 20.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.667 0.27 . . . . 0.0 110.646 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.831 ' HB3' ' H ' ' A' ' 158' ' ' ASP . 43.3 mp0 -61.38 131.96 92.58 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.59 -24.68 25.61 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.698 2.265 . . . . 0.0 113.253 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.513 ' HD2' ' HB1' ' A' ' 157' ' ' ALA . 5.8 ppt_? -155.13 -39.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.14 0.495 . . . . 0.0 110.527 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' A' ' 156' ' ' ARG . . . 179.33 53.89 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.831 ' H ' ' HB3' ' A' ' 154' ' ' GLU . 13.5 t70 63.38 -144.9 0.34 Allowed 'General case' 0 C--O 1.237 0.424 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 -156.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -154.17 161.49 41.82 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 119.662 1.119 . . . . 0.0 112.408 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 C--O 1.248 0.975 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.343 -173.281 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 28.7 tttm . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.778 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -135.91 143.71 45.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.541 0.21 . . . . 0.0 111.099 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -149.35 139.55 22.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.645 0.26 . . . . 0.0 110.417 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.417 HG21 ' HB ' ' A' ' 71' ' ' ILE . 32.5 pt -116.01 136.1 54.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.992 0.425 . . . . 0.0 111.429 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -104.87 123.71 48.2 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 66' ' ' ALA . 8.9 mp -97.74 148.99 22.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.187 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.783 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 40.6 tt0 -74.04 125.5 28.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.616 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.03 -29.28 10.23 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.592 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 37.1 t -92.4 124.98 57.79 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.1 Cg_exo -81.26 -7.39 12.94 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.878 2.385 . . . . 0.0 111.958 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.71 133.95 22.14 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.632 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -91.01 143.24 3.25 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.084 2.523 . . . . 0.0 112.656 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.2 tt -89.41 121.41 31.63 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -107.85 147.22 31.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 111.527 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 1.5 m-85 -143.12 141.94 31.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.146 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.5 m -72.42 -28.73 63.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.0 109.487 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.52 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 17.1 mt-30 -86.84 109.39 19.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.92 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.778 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 17.2 t -63.54 -51.17 73.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.294 0.569 . . . . 0.0 109.909 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.645 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.33 -29.07 60.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.111 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.645 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 8.8 t70 -76.21 -47.27 24.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.532 -176.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -72.31 -36.08 68.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.485 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.505 ' CD1' ' HB1' ' A' ' 114' ' ' ALA . 22.8 pt -68.23 -35.24 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.436 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.31 -40.96 81.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.03 0.443 . . . . 0.0 110.338 172.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.479 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 33.2 t80 -62.29 -28.31 69.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.686 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.1 -15.9 61.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.288 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.6 mtp-105 -98.19 11.71 36.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -172.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.96 -60.97 0.09 OUTLIER Glycine 0 CA--C 1.52 0.404 0 C-N-CA 119.274 -1.441 . . . . 0.0 114.469 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 58' ' ' TYR . 37.5 Cg_exo -59.81 -7.6 6.24 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.265 2.643 . . . . 0.0 115.149 -176.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.852 ' HG3' HG23 ' A' ' 68' ' ' ILE . 3.2 pm0 -77.41 89.61 3.8 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.41 1.1 . . . . 0.0 109.604 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -106.78 -24.64 12.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.045 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.2 tp -68.6 -40.21 81.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.275 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.545 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -152.24 152.65 29.8 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.538 177.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.783 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 59.8 Cg_endo -72.65 160.03 47.37 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.259 1.973 . . . . 0.0 111.447 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.852 HG23 ' HG3' ' A' ' 63' ' ' GLU . 29.1 pt -80.35 132.52 31.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.05 0.452 . . . . 0.0 111.035 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.08 -51.89 3.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -161.23 138.56 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.469 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.524 HG23 ' HB2' ' A' ' 95' ' ' ASP . 2.7 tt -108.15 134.64 49.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.153 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -111.88 130.07 55.95 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.95 145.61 27.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.026 0.441 . . . . 0.0 109.877 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 17.0 m120 -85.56 100.87 12.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.246 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -56.24 109.21 0.56 Allowed 'General case' 0 C--O 1.238 0.48 0 O-C-N 125.292 1.62 . . . . 0.0 110.136 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.496 ' SD ' ' HG2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -159.73 107.23 1.7 Allowed 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.291 -179.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.21 -68.3 2.05 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.399 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.553 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . 67.42 -50.85 0.5 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.72 0.808 . . . . 0.0 112.51 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.85 -36.3 69.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.066 0.46 . . . . 0.0 110.547 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.31 -71.3 1.16 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . 51.41 54.49 11.0 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 124.176 0.574 . . . . 0.0 112.052 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.5 p -83.82 175.94 9.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.52 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 28.0 p-90 -66.53 -20.0 65.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.152 0.501 . . . . 0.0 110.254 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -84.76 -26.28 27.69 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.655 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 63.76 171.49 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.604 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.951 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.496 ' HG2' ' SD ' ' A' ' 76' ' ' MET . 38.4 Cg_endo -92.16 0.77 4.16 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.636 1.557 . . . . 0.0 112.06 172.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.3 -168.55 20.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.869 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.16 146.45 37.09 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.22 -166.55 12.15 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.159 -1.019 . . . . 0.0 113.277 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.3 t-20 -77.65 152.34 33.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.133 -0.534 . . . . 0.0 110.087 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -98.05 128.7 44.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.436 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.562 HD11 ' HG ' ' A' ' 118' ' ' SER . 44.3 pt -140.57 143.59 28.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.77 -175.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.92 102.44 4.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.177 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.91 78.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.237 0.542 . . . . 0.0 111.066 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.673 ' HA ' HD12 ' A' ' 137' ' ' LEU . 21.8 t70 -61.85 -24.63 67.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.64 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -115.97 27.56 9.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.995 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.35 178.84 5.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.651 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -92.67 136.02 33.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.431 0.634 . . . . 0.0 110.592 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.56 ' HH ' HD13 ' A' ' 137' ' ' LEU . 8.7 m-85 -120.54 136.22 54.85 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.739 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.726 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.7 p -113.9 125.98 71.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 CA-C-O 121.835 0.826 . . . . 0.0 110.423 173.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.656 ' HA ' HH11 ' A' ' 106' ' ' ARG . 40.8 t -102.03 113.4 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.461 174.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.66 122.57 7.2 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 119.975 -1.107 . . . . 0.0 111.553 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t -89.03 -28.46 20.15 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.34 -44.25 12.98 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.861 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.667 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 60.9 mtp180 -146.01 127.16 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.322 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.656 HH11 ' HA ' ' A' ' 101' ' ' VAL . 7.6 ttt180 -176.58 -53.37 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.626 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 151.39 26.33 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.28 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.26 -38.15 92.86 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.919 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 67.4 mtt -109.36 21.34 17.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.73 0.3 . . . . 0.0 110.637 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.55 -125.5 0.93 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.816 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.32 101.7 24.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.942 0.401 . . . . 0.0 110.375 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.585 ' HA ' ' HA3' ' A' ' 107' ' ' GLY . 43.0 Cg_endo -66.94 123.4 10.93 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 123.229 2.619 . . . . 0.0 113.301 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.38 131.13 56.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.79 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.591 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -98.13 131.77 44.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.85 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.726 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 93.3 t -98.04 104.54 22.87 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.826 174.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.0 Cg_endo -96.53 127.18 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.975 3.117 . . . . 0.0 112.064 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.514 ' CE2' ' HG3' ' A' ' 122' ' ' GLU . 1.1 t80 -147.06 148.78 32.0 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.562 ' HG ' HD11 ' A' ' 92' ' ' ILE . 16.4 m -86.87 -17.54 33.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.938 0.399 . . . . 0.0 110.759 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.465 ' H ' ' HD2' ' A' ' 117' ' ' PHE . 43.9 m -92.3 107.56 19.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.922 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.5 -44.62 72.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.782 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -63.42 -28.03 69.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.311 -173.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.514 ' HG3' ' CE2' ' A' ' 117' ' ' PHE . 40.9 mm-40 -66.4 -44.64 82.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.067 0.46 . . . . 0.0 110.242 174.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.05 77.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.364 0.602 . . . . 0.0 109.707 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.67 95.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.571 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.8 -33.85 72.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.295 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -64.37 -43.75 93.54 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.649 HG21 ' H ' ' A' ' 132' ' ' GLY . 40.5 t -72.95 -28.62 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.277 0.561 . . . . 0.0 110.397 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.3 tp -57.6 -38.64 75.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.921 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.02 -46.46 11.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.419 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.733 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.5 pt-20 -156.58 -80.05 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.621 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.733 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.36 -133.43 10.85 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 114.249 0.46 . . . . 0.0 114.249 174.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.649 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -178.39 -85.47 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.485 ' HG3' ' SD ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -130.16 139.5 50.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.629 0.252 . . . . 0.0 110.975 178.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.2 t -103.72 112.85 38.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.522 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.775 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -139.7 165.5 27.1 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.016 -175.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.81 161.29 14.92 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 95' ' ' ASP . 1.6 tt -60.77 -31.03 70.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.188 0.518 . . . . 0.0 110.086 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.59 -22.91 67.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.645 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.28 26.01 9.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.043 -174.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.775 HD11 HD12 ' A' ' 135' ' ' LEU . 31.1 mm -71.69 119.48 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.479 ' CG2' ' HG2' ' A' ' 144' ' ' MET . 5.6 t -119.49 149.48 41.82 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.068 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 15.7 p-10 -68.99 -27.45 65.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.93 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.67 70.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.667 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.485 ' SD ' ' HG3' ' A' ' 133' ' ' GLN . 12.8 mmt -75.73 -37.66 59.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.968 0.413 . . . . 0.0 110.699 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.69 -23.44 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.48 -171.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.5 pp -153.0 142.42 21.69 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.209 -174.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.4 p -122.75 150.33 58.26 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.589 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.07 -59.75 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.293 1.995 . . . . 0.0 109.592 171.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.599 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 28.7 t -119.73 -71.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 166.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.599 ' HG3' ' O ' ' A' ' 149' ' ' VAL . 11.4 mt-10 172.28 -76.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.625 1.57 . . . . 0.0 107.569 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 150' ' ' GLU . 0.6 OUTLIER 64.35 -31.17 0.12 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.878 1.271 . . . . 0.0 113.973 173.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . 97.41 54.99 1.2 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -175.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.2 t -102.66 144.68 30.74 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.638 ' HG2' ' HB3' ' A' ' 158' ' ' ASP . 2.2 mp0 -57.71 126.26 75.43 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 110.66 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 157' ' ' ALA . 59.8 Cg_endo -73.85 -85.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.029 2.486 . . . . 0.0 113.236 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.405 ' HD2' ' HB3' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -75.5 -27.23 58.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.419 1.104 . . . . 0.0 108.089 174.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.527 ' O ' ' HD2' ' A' ' 155' ' ' PRO . . . 165.73 -162.9 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 112.563 -2.108 . . . . 0.0 105.448 -170.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.638 ' HB3' ' HG2' ' A' ' 154' ' ' GLU . 4.0 p30 -106.26 17.45 23.44 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 36.1 t70 -66.26 -83.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.475 -1.238 . . . . 0.0 111.358 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.558 176.557 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 50' ' ' SER . 88.0 tttt . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.553 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . . . -132.89 145.05 50.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.713 0.292 . . . . 0.0 111.226 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 10.4 pt20 -149.13 134.55 18.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.413 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.632 HG22 ' HB2' ' A' ' 59' ' ' ALA . 22.3 pt -115.58 135.69 54.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.183 0.516 . . . . 0.0 110.923 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -104.73 119.64 39.47 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.528 HD23 ' HB2' ' A' ' 66' ' ' ALA . 10.5 mp -81.16 151.66 28.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.38 -175.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.34 125.53 28.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.374 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.7 -36.75 3.22 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.634 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 41.5 t -81.6 125.45 78.36 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.932 0.396 . . . . 0.0 110.359 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.5 Cg_exo -78.74 -1.42 11.58 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.179 2.586 . . . . 0.0 112.289 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -114.63 134.01 22.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.69 0.281 . . . . 0.0 111.106 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -93.37 162.25 2.45 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.331 2.687 . . . . 0.0 112.69 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.5 tt -115.21 116.27 28.07 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 20.6 p90 -119.62 146.04 45.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.286 0.565 . . . . 0.0 111.732 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -149.96 143.84 25.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.068 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 16.4 m -60.24 -45.61 92.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.096 0.475 . . . . 0.0 110.76 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.585 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 66.8 mt-30 -69.7 111.1 5.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.493 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.52 HG21 ' H ' ' A' ' 35' ' ' LYS . 8.9 t -61.95 -52.42 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.948 0.404 . . . . 0.0 110.456 -177.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.552 HH11 ' HB2' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.86 -29.9 56.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.411 178.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.552 ' HB2' HH11 ' A' ' 53' ' ' ARG . 29.0 t70 -76.16 -51.56 11.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.953 0.406 . . . . 0.0 110.234 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.732 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -68.02 -38.3 82.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.676 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.436 ' CD1' ' HB1' ' A' ' 114' ' ' ALA . 28.3 pt -65.82 -30.24 49.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.66 96.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.678 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.732 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 70.2 m-85 -60.4 -44.97 95.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.712 0.292 . . . . 0.0 110.847 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.632 ' HB2' HG22 ' A' ' 38' ' ' ILE . . . -61.01 -18.18 56.25 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -105.05 12.5 32.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.824 0.345 . . . . 0.0 111.396 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.91 -85.4 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.34 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -48.05 -55.3 4.15 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.672 2.914 . . . . 0.0 113.858 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 57.21 -89.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.775 0.672 . . . . 0.0 110.43 -173.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HB3' HD22 ' A' ' 40' ' ' LEU . 58.7 tt0 -178.97 -59.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tp -165.87 -40.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.048 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.528 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -94.12 152.16 40.15 Favored Pre-proline 0 N--CA 1.446 -0.675 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.007 173.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.59 161.38 46.25 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.768 1.645 . . . . 0.0 111.305 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.5 pt -73.79 136.98 24.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.196 0.522 . . . . 0.0 110.786 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tt -98.37 -47.89 5.25 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.01 138.75 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.8 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.536 HG22 ' HB3' ' A' ' 95' ' ' ASP . 2.8 tt -111.08 133.23 57.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.079 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -112.86 145.06 41.35 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 36' ' ' ALA . 18.8 m -136.35 155.88 35.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.231 0.538 . . . . 0.0 110.912 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -91.21 102.65 15.37 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -57.0 108.53 0.52 Allowed 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 125.034 1.459 . . . . 0.0 111.252 -175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.584 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 1.6 mmt -161.12 62.02 0.29 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.555 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.913 ' HA2' ' HB3' ' A' ' 81' ' ' ALA . . . -100.15 27.02 22.28 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.78 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.44 97.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.94 0.435 . . . . 0.0 111.067 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 56.4 33.97 23.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.398 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.56 -59.7 0.22 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 119.148 -1.501 . . . . 0.0 114.566 176.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.913 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . 60.64 56.55 2.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.364 0.602 . . . . 0.0 110.375 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.6 p -83.99 177.18 8.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.069 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.585 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 24.5 p90 -66.71 -24.21 66.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.267 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.85 -31.89 27.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 66.59 157.36 0.13 Allowed Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.059 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 76' ' ' MET . 21.8 Cg_exo -70.76 -22.02 28.05 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.532 2.155 . . . . 0.0 111.1 170.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . 146.87 -162.99 28.61 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.515 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.74 141.95 42.51 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.412 ' HA3' ' HG2' ' A' ' 76' ' ' MET . . . -131.11 -156.14 8.42 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.484 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -96.66 155.72 16.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.442 -175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -97.53 127.39 43.45 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.694 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.786 HD13 ' HB2' ' A' ' 118' ' ' SER . 26.6 pt -145.3 166.97 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.33 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.73 117.32 29.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.452 ' HB3' HG12 ' A' ' 73' ' ' VAL . . . -69.86 -35.54 74.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.737 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -70.63 -18.22 62.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.932 0.872 . . . . 0.0 109.718 -178.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.459 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 41.1 mmtm -107.12 21.06 18.12 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.678 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.21 177.59 4.83 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.797 0.332 . . . . 0.0 110.87 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -92.02 133.36 35.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.966 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -120.66 135.76 55.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.465 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.437 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.7 p -112.16 127.84 69.11 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-O 121.695 0.759 . . . . 0.0 110.422 174.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.521 ' HA ' HH11 ' A' ' 106' ' ' ARG . 43.8 t -102.89 103.92 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.119 174.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.441 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -70.35 125.02 14.01 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.453 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.6 m -92.21 -14.42 29.04 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.186 0.517 . . . . 0.0 110.032 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -91.88 -43.57 9.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.008 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.656 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 54.1 mtp180 -121.41 -107.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 119.292 -0.385 . . . . 0.0 109.988 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.521 HH11 ' HA ' ' A' ' 101' ' ' VAL . 5.0 tpt180 68.26 -60.66 0.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 176.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.657 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . -178.62 -61.11 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 58.56 -94.34 0.05 OUTLIER Glycine 0 C--N 1.332 0.319 0 O-C-N 123.92 0.424 . . . . 0.0 113.159 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -83.05 -3.97 57.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.986 0.422 . . . . 0.0 110.94 -178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.98 -135.89 5.24 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.418 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -102.36 108.16 56.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.803 0.301 . . . . 0.0 110.342 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.657 ' HA ' ' HA3' ' A' ' 107' ' ' GLY . 18.4 Cg_endo -59.88 128.06 25.49 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 123.185 2.59 . . . . 0.0 112.99 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.421 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 43.1 mt-10 -114.52 135.35 54.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.904 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.552 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.77 131.62 38.95 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.827 -174.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.437 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 8.8 t -101.31 105.39 39.38 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.625 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.4 Cg_exo -86.97 136.84 4.33 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.713 2.942 . . . . 0.0 112.341 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -129.27 149.01 51.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.049 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.786 ' HB2' HD13 ' A' ' 92' ' ' ILE . 30.9 t -85.2 -35.61 21.53 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.9 m -91.59 118.7 30.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.763 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -59.74 -42.55 93.42 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.429 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -65.9 -31.7 72.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.892 -173.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -64.55 -40.44 95.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.746 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.03 -42.54 84.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.51 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.26 -41.19 99.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.855 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.42 -31.27 72.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.91 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -64.95 -36.52 84.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.902 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 62.1 t -73.02 -27.83 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.649 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mp -61.73 -46.23 90.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.086 0.469 . . . . 0.0 110.809 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.91 -49.92 26.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.485 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.702 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 0.7 OUTLIER -145.96 -86.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.757 178.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.902 ' HA3' ' HA ' ' A' ' 127' ' ' VAL . . . 50.44 -148.68 6.94 Favored Glycine 0 N--CA 1.444 -0.792 0 O-C-N 123.642 0.588 . . . . 0.0 113.702 172.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.538 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -179.96 -84.77 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -130.22 141.17 50.66 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 38.4 t -104.63 113.96 43.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.643 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.738 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.28 164.17 29.92 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.699 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.72 166.3 17.13 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.71 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 4.7 tt -62.22 -33.44 74.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.351 0.596 . . . . 0.0 109.611 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.02 60.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.168 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -117.44 17.47 14.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.292 0.568 . . . . 0.0 110.073 -176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.738 HD11 HD12 ' A' ' 135' ' ' LEU . 31.9 mm -71.93 120.28 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.312 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.6 t -119.1 147.82 43.73 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.978 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -69.26 -31.32 69.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.891 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.77 -28.82 66.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.798 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.979 ' HE2' ' HA ' ' A' ' 144' ' ' MET . 8.2 mmt -87.18 -26.45 23.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.494 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.4 t -85.56 -24.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.207 0.527 . . . . 0.0 110.521 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -160.3 151.88 19.75 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.566 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.419 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 4.0 p -94.59 120.06 65.43 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 120.829 0.347 . . . . 0.0 111.214 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.444 ' HG2' ' H ' ' A' ' 149' ' ' VAL . 36.8 Cg_endo -66.6 -67.57 0.04 OUTLIER 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.73 2.287 . . . . 0.0 111.511 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.444 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 2.4 t -118.66 5.39 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 152' ' ' GLY . 22.4 mt-10 66.58 -81.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.699 -170.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.1 t 43.31 -59.99 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.134 1.774 . . . . 0.0 114.999 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 150' ' ' GLU . . . 118.34 63.37 0.3 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -175.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.1 m -116.91 161.58 19.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.545 0.212 . . . . 0.0 110.467 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 158' ' ' ASP . 1.6 mp0 -66.54 135.17 94.53 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.712 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.494 ' HB3' ' HE1' ' A' ' 144' ' ' MET . 74.1 Cg_endo -81.21 -89.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 123.037 2.491 . . . . 0.0 114.583 -169.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.415 ' HD2' ' HB3' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -66.21 -25.71 67.04 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.001 0.429 . . . . 0.0 111.393 -173.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -171.03 -82.34 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 6.3 p-10 -171.18 20.67 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.415 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 30.5 t70 -78.11 -83.02 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.339 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.186 173.73 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.621 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 22.1 ttmm . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -131.4 148.48 52.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.83 0.286 . . . . 0.0 111.275 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 1.7 pt20 -149.04 134.47 18.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 36.1 pt -115.94 137.82 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.821 -0.549 . . . . 0.0 110.892 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -108.95 126.52 53.18 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.638 HD22 ' HB2' ' A' ' 66' ' ' ALA . 10.8 mp -97.51 150.52 21.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.931 0.396 . . . . 0.0 111.502 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.701 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 38.2 tt0 -74.15 129.15 37.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.591 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.34 -34.7 4.05 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.842 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 33.2 t -81.9 129.99 62.49 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.1 Cg_endo -85.44 2.36 7.78 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.966 2.444 . . . . 0.0 112.439 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -122.43 134.54 24.93 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 120.845 0.355 . . . . 0.0 111.41 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 10.3 Cg_endo -91.1 145.05 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.488 2.792 . . . . 0.0 112.051 174.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 2.8 tm? -93.21 114.53 27.03 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -95.49 135.37 37.23 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.445 ' HB3' ' HB2' ' A' ' 55' ' ' ALA . 5.6 t80 -147.26 131.24 17.19 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.621 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 70.1 m -57.82 -49.02 78.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.056 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -71.21 108.47 4.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.575 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 10.6 t -56.53 -50.18 74.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.658 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.88 -33.56 66.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.785 -177.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.658 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 11.8 t70 -76.52 -43.01 41.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.901 0.381 . . . . 0.0 110.848 -175.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 36' ' ' ALA . . . -72.8 -39.51 66.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.277 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.535 HG23 HD12 ' A' ' 71' ' ' ILE . 12.0 pt -65.36 -29.95 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.942 0.401 . . . . 0.0 110.014 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.563 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -63.32 -41.79 98.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.823 173.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 55' ' ' ALA . 21.1 m-30 -55.66 -43.8 76.61 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.126 0.489 . . . . 0.0 110.469 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.411 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -61.2 -17.11 51.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.824 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 60' ' ' ARG . 37.5 mtp180 -101.62 12.06 37.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.98 -60.33 0.36 Allowed Glycine 0 CA--C 1.518 0.239 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.549 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 33.4 Cg_exo -63.36 51.18 0.14 Allowed 'Trans proline' 0 N--CA 1.48 0.694 0 C-N-CA 123.874 3.049 . . . . 0.0 114.242 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -104.1 -175.34 2.77 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 173.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -106.52 -161.76 0.81 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.103 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -53.42 -34.85 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.671 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.638 ' HB2' HD22 ' A' ' 40' ' ' LEU . . . -85.06 140.49 37.06 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.668 0.27 . . . . 0.0 110.53 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.701 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 73.9 Cg_endo -78.17 159.68 29.96 Favored 'Trans proline' 0 CA--C 1.521 -0.137 0 C-N-CA 122.975 2.45 . . . . 0.0 112.559 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 59' ' ' ALA . 45.1 pt -74.29 131.94 34.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 41' ' ' GLU . 6.1 tt -97.91 -49.5 4.77 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -161.15 138.03 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.876 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.535 HD12 HG23 ' A' ' 56' ' ' ILE . 2.8 tt -108.33 133.41 53.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.661 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.452 ' HB2' ' HG3' ' A' ' 37' ' ' GLN . 93.9 m-85 -113.7 143.21 44.99 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 94' ' ' ALA . 20.6 m -133.31 156.93 42.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.584 0.707 . . . . 0.0 110.392 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.56 ' HB3' ' HE2' ' A' ' 76' ' ' MET . 11.3 m120 -93.67 106.16 18.14 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 171.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 90' ' ' ASN . 18.2 t70 -46.37 97.75 0.01 OUTLIER 'General case' 0 C--O 1.233 0.232 0 O-C-N 125.384 1.677 . . . . 0.0 110.719 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.572 ' HB3' ' HG2' ' A' ' 86' ' ' PRO . 65.5 mtt -147.86 51.2 1.04 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.19 -174.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 80' ' ' GLY . . . -91.86 27.07 10.52 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.035 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . . . -71.42 96.82 1.53 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -175.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 68.98 22.93 6.8 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.93 0.769 . . . . 0.0 110.515 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.499 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . 146.66 -116.6 0.87 Allowed Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 175.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 80' ' ' GLY . . . 158.21 62.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -171.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.0 p -83.64 175.37 9.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.572 -169.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.414 ' H ' ' HD1' ' A' ' 83' ' ' TRP . 1.4 p-90 -71.55 -30.41 65.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.452 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -84.88 -24.33 28.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.316 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 69.03 154.39 0.14 Allowed Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.508 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.572 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 14.9 Cg_exo -50.04 -38.2 48.99 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.173 1.916 . . . . 0.0 112.132 171.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.25 -84.51 0.33 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.351 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.59 148.61 35.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.4 157.51 29.87 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.784 -1.198 . . . . 0.0 113.741 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 14.9 m-80 -92.58 151.84 19.93 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 25.1 p-90 -98.6 128.61 44.97 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 118.917 -1.113 . . . . 0.0 109.891 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.833 HG21 ' HB2' ' A' ' 118' ' ' SER . 23.3 pt -145.6 167.03 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.291 -176.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.83 116.04 23.84 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.509 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -69.92 -42.26 73.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -171.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.697 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -67.87 -23.11 65.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.777 0.798 . . . . 0.0 109.684 -177.027 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -101.06 32.55 3.18 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.816 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.41 178.47 7.04 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.662 -172.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -92.64 135.11 34.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.271 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.729 ' HH ' HD13 ' A' ' 137' ' ' LEU . 7.2 m-85 -120.73 135.9 55.01 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.417 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.887 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.4 p -114.96 120.32 64.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.639 0.733 . . . . 0.0 109.869 171.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.796 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 95.5 t -101.95 119.05 49.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.584 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.487 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -82.62 121.1 5.34 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.412 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.4 m -92.59 -28.92 16.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.003 0.43 . . . . 0.0 110.231 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.91 -44.16 64.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.158 -176.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 70.6 mtt180 -138.07 118.11 13.43 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.674 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 1.3 tpp180 175.27 -170.65 0.06 Allowed 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.499 0.499 . . . . 0.0 109.682 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.465 ' H ' ' HG3' ' A' ' 106' ' ' ARG . . . -51.83 -70.8 0.78 Allowed Glycine 0 C--N 1.335 0.527 0 O-C-N 123.623 0.577 . . . . 0.0 112.883 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.95 -78.16 0.65 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.138 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -89.91 -4.23 57.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.187 0.518 . . . . 0.0 110.076 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -121.55 -128.67 3.53 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.381 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.458 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -102.94 99.27 13.39 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.93 0.395 . . . . 0.0 111.163 177.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 35.6 Cg_endo -64.66 151.64 84.88 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 123.191 2.594 . . . . 0.0 112.229 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.674 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 41.3 mt-10 -118.21 146.36 44.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.42 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.516 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -106.63 130.91 54.3 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.031 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.887 ' HB ' HG13 ' A' ' 100' ' ' VAL . 57.3 t -98.05 105.19 26.47 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.9 Cg_exo -86.76 132.52 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.751 2.967 . . . . 0.0 112.989 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -136.51 149.47 48.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.714 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.833 ' HB2' HG21 ' A' ' 92' ' ' ILE . 42.0 t -84.54 -19.75 32.68 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 170.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.436 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 15.7 m -105.59 115.51 30.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.3 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -44.78 80.96 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.158 0.504 . . . . 0.0 110.979 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.436 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 20.4 p-10 -62.46 -29.34 70.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.121 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -71.29 -40.41 70.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.688 175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.63 -37.38 84.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.143 0.497 . . . . 0.0 109.986 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.31 -35.11 78.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.659 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.419 ' HA ' HD13 ' A' ' 128' ' ' LEU . . . -63.93 -34.81 78.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.776 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -63.18 -36.46 83.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.799 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.64 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 44.4 t -71.91 -31.75 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.486 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 125' ' ' ALA . 67.7 mt -60.54 -35.39 75.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.726 176.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.24 -50.22 7.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.815 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.8 pt-20 -148.32 -85.18 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.842 175.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.815 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 52.05 -146.84 13.54 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 170.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.554 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -171.33 -89.06 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.796 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.29 160.1 34.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 175.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.37 113.32 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.182 0.515 . . . . 0.0 110.246 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.895 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -134.57 165.13 25.92 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.902 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -86.67 160.86 18.73 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.729 HD13 ' HH ' ' A' ' 99' ' ' TYR . 6.7 tt -61.66 -42.85 99.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.274 0.559 . . . . 0.0 109.624 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.59 -18.51 62.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.943 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.26 20.71 13.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.576 -172.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.895 HD11 HD12 ' A' ' 135' ' ' LEU . 22.6 mm -71.87 120.86 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.896 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 t -107.05 147.7 29.64 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.433 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.19 -33.27 73.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.467 ' HB2' ' HB2' ' A' ' 153' ' ' SER . . . -60.65 -28.79 68.84 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.744 0.653 . . . . 0.0 112.07 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.892 ' HE3' ' HB3' ' A' ' 155' ' ' PRO . 11.9 mmt -82.94 -26.84 31.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.769 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.447 ' HA ' HG11 ' A' ' 101' ' ' VAL . 2.2 t -92.68 -23.01 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 -175.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.6 pp -170.04 164.79 9.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.131 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.435 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 19.6 p -113.66 118.66 42.82 Favored Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.622 174.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 32.9 Cg_endo -65.92 -82.44 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.747 2.298 . . . . 0.0 112.287 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.687 ' HB ' ' OG1' ' A' ' 151' ' ' THR . 5.2 t -109.64 -6.58 11.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 37.9 mt-10 89.69 -73.52 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.687 ' OG1' ' HB ' ' A' ' 149' ' ' VAL . 44.4 m 53.79 21.9 2.95 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 163.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.4 50.65 58.3 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.56 -175.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 143' ' ' ALA . 9.7 p -64.11 125.45 24.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.207 0.527 . . . . 0.0 111.731 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -93.73 153.94 41.04 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.81 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.892 ' HB3' ' HE3' ' A' ' 144' ' ' MET . 6.2 Cg_exo -64.65 -163.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.205 1.937 . . . . 0.0 111.975 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -32.23 50.51 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -175.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.45 37.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.589 ' HA ' ' HG2' ' A' ' 155' ' ' PRO . 34.8 t0 59.0 72.49 0.53 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.862 -167.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.461 ' H ' ' HG2' ' A' ' 155' ' ' PRO . 12.2 t70 -168.95 -143.11 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -172.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.426 ' H ' ' CG ' ' A' ' 159' ' ' ASP . 56.1 mm-40 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.351 172.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 37.2 ttpt . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.589 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . . . -137.07 144.38 43.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 4.4 pt20 -147.11 132.17 18.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 110.665 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.674 HG23 ' HB2' ' A' ' 59' ' ' ALA . 30.1 pt -116.13 136.34 53.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.15 0.5 . . . . 0.0 110.985 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -105.2 132.17 51.75 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.443 ' CD2' ' HB2' ' A' ' 64' ' ' GLN . 11.1 mp -99.37 157.08 16.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.173 0.511 . . . . 0.0 111.527 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 26.4 tt0 -74.22 124.32 26.16 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.224 175.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.85 -42.64 3.12 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.244 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 15.7 t -82.13 123.83 79.22 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.0 Cg_exo -79.46 -11.6 14.3 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.983 2.455 . . . . 0.0 112.628 -176.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -97.98 131.97 25.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.981 0.419 . . . . 0.0 110.881 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 59.7 Cg_endo -93.37 137.45 1.33 Allowed 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 123.184 2.589 . . . . 0.0 112.355 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 8.1 tt -88.06 119.68 28.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -129.68 135.63 48.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.138 0.494 . . . . 0.0 111.42 -177.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.512 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 44.2 m-85 -142.04 153.2 44.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.038 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 t -64.51 -49.32 71.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.082 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 24.3 mt-30 -67.79 119.27 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.778 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.861 HG23 ' HB3' ' A' ' 81' ' ' ALA . 60.1 t -71.98 -50.23 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.641 ' HB3' ' HG3' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -53.99 -30.01 45.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.156 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.466 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 33.8 t70 -76.05 -50.08 15.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.7 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 36' ' ' ALA . . . -68.77 -39.25 80.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.585 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.627 HD12 ' HB1' ' A' ' 114' ' ' ALA . 11.1 pt -68.11 -31.47 51.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.795 0.331 . . . . 0.0 110.283 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.1 91.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.32 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -57.6 -41.9 82.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.747 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.674 ' HB2' HG23 ' A' ' 38' ' ' ILE . . . -61.16 -17.44 52.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.096 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 45.5 mtm180 -102.79 7.39 39.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.414 -175.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.86 -82.47 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.081 -1.057 . . . . 0.0 112.77 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -50.49 -56.83 2.71 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.361 2.708 . . . . 0.0 113.56 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 52.22 -102.97 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.045 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.443 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 74.3 mt-30 -152.6 -86.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 tt -142.93 4.58 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 122.028 0.918 . . . . 0.0 109.346 174.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -138.29 161.65 58.03 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.143 -173.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.431 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 72.0 Cg_endo -76.77 157.4 35.36 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.273 1.982 . . . . 0.0 111.714 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.1 pt -74.05 151.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.095 0.474 . . . . 0.0 111.357 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.44 -48.1 3.04 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.07 143.96 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.415 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.532 HD12 HG23 ' A' ' 56' ' ' ILE . 3.3 tt -123.48 131.98 72.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.055 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -111.65 132.06 54.85 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.603 HG23 HG13 ' A' ' 92' ' ' ILE . 17.1 m -126.25 140.89 47.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 121.499 0.666 . . . . 0.0 110.63 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -95.56 110.46 22.54 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -67.54 79.87 0.17 Allowed 'General case' 0 C--O 1.222 -0.374 0 O-C-N 124.367 1.042 . . . . 0.0 108.737 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.881 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 23.7 ptm 178.76 179.53 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.255 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.724 ' HA3' ' HB2' ' A' ' 81' ' ' ALA . . . 140.34 -33.59 2.06 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.416 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.441 ' C ' ' H ' ' A' ' 80' ' ' GLY . . . 48.11 78.86 0.07 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.822 0.449 . . . . 0.0 111.26 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 73.78 -28.89 0.19 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.36 0.664 . . . . 0.0 111.819 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 78' ' ' ALA . . . -78.17 -5.54 87.31 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.884 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.861 ' HB3' HG23 ' A' ' 52' ' ' VAL . . . -113.22 -74.43 0.63 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.281 0.562 . . . . 0.0 110.274 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.44 ' H ' ' HB1' ' A' ' 81' ' ' ALA . 7.3 p -104.26 152.56 22.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 169.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -76.1 -25.29 55.3 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.261 0.553 . . . . 0.0 110.188 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.05 -13.95 51.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.426 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 38.8 mt-30 72.16 139.29 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 113.826 -1.533 . . . . 0.0 112.337 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 85' ' ' GLN . 28.9 Cg_endo -86.78 -83.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.196 2.597 . . . . 0.0 113.007 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.31 -137.21 4.57 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.385 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.99 136.84 38.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.58 0.352 . . . . 0.0 111.459 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.881 ' HA2' ' HB3' ' A' ' 76' ' ' MET . . . -66.39 87.52 0.12 Allowed Glycine 0 C--N 1.333 0.408 0 O-C-N 124.091 0.869 . . . . 0.0 115.205 -168.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -100.59 146.76 26.74 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -99.6 130.51 45.84 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.472 -0.768 . . . . 0.0 109.891 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.603 HG13 HG23 ' A' ' 73' ' ' VAL . 2.5 pt -145.28 158.27 13.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.187 0.518 . . . . 0.0 112.316 -177.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.03 117.66 25.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 170.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.572 ' HB3' HG13 ' A' ' 73' ' ' VAL . . . -65.77 -39.63 91.21 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -169.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.682 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -68.69 -24.36 64.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.724 0.773 . . . . 0.0 109.393 -177.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -100.83 26.36 6.97 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.522 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.46 176.48 7.43 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.363 -0.21 . . . . 0.0 110.474 -173.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -94.54 135.79 35.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.414 0.626 . . . . 0.0 110.418 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.629 ' HH ' HD13 ' A' ' 137' ' ' LEU . 8.1 m-85 -120.55 136.23 54.85 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.228 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.528 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -113.22 128.55 69.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.381 0.61 . . . . 0.0 110.112 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.0 t -101.68 109.24 25.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.404 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.521 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -80.68 126.21 7.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.643 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.3 m -92.54 -30.98 15.38 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.461 ' HB2' ' HB2' ' A' ' 130' ' ' GLU . . . -80.5 -47.02 14.89 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -163.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -129.12 12.59 6.12 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.022 -0.424 . . . . 0.0 111.281 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.655 ' HD3' ' HB3' ' A' ' 113' ' ' GLU . 1.4 tpm_? -89.5 -91.68 0.13 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.95 -169.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -170.93 40.25 0.19 Allowed Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.502 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -65.37 -29.88 76.31 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.908 -1.139 . . . . 0.0 111.174 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 88.4 mmm -109.12 20.87 17.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.395 -0.402 . . . . 0.0 110.692 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -160.32 -124.22 0.72 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.401 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.98 100.98 18.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 110.844 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.4 146.41 50.24 Favored 'Trans proline' 0 C--N 1.331 -0.382 0 C-N-CA 123.61 2.874 . . . . 0.0 113.407 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.655 ' HB3' ' HD3' ' A' ' 106' ' ' ARG . 27.5 tt0 -114.88 127.48 55.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.75 172.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.627 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -93.91 129.99 40.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.528 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 48.8 t -102.16 105.29 41.81 Favored Pre-proline 0 C--N 1.321 -0.671 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.312 174.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -89.35 110.98 0.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.821 3.014 . . . . 0.0 111.218 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.67 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.6 t80 -119.62 149.03 42.62 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.503 ' HB2' HD11 ' A' ' 92' ' ' ILE . 44.1 t -71.6 -32.77 68.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.925 0.393 . . . . 0.0 111.06 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.67 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 66.9 m -99.24 124.16 44.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.848 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.91 -45.41 82.06 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -65.58 -28.7 69.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.349 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -68.8 -42.08 77.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.465 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.09 79.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.305 0.574 . . . . 0.0 110.1 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.65 -32.31 69.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.744 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -65.19 -32.38 74.03 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.077 0.465 . . . . 0.0 110.703 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -61.71 -39.61 92.09 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.714 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 42.1 t -73.14 -28.82 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.658 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 6.7 tp -56.32 -43.99 79.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.957 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.64 -50.75 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.255 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.915 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.5 pt-20 -152.7 -76.16 0.13 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.486 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.915 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.48 -130.87 11.69 Favored Glycine 0 C--N 1.334 0.424 0 O-C-N 123.543 0.527 . . . . 0.0 112.974 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.641 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -179.84 -89.64 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.36 139.47 50.66 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 177.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.73 119.66 51.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.742 HD12 HD12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -147.04 165.65 29.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.111 -177.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.05 162.73 15.2 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.775 ' HA ' HG12 ' A' ' 140' ' ' ILE . 1.1 tt -62.59 -32.64 73.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.133 0.492 . . . . 0.0 109.675 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.8 -11.65 58.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.252 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -125.53 21.5 7.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.775 HG12 ' HA ' ' A' ' 137' ' ' LEU . 30.4 mm -71.63 118.18 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -119.28 147.68 44.01 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.238 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.548 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 13.4 p-10 -69.37 -26.92 64.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.72 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.83 -28.74 69.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.772 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.4 mmt -83.9 -26.2 29.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.412 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.3 -22.8 5.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.357 -172.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.4 pp -143.61 142.81 31.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.581 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 32.4 p -113.12 122.8 34.86 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.093 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -64.81 -75.75 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.314 2.009 . . . . 0.0 111.51 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.37 11.23 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 152' ' ' GLY . 37.6 mt-10 67.51 -79.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.326 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.4 t 43.76 -62.57 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.931 1.692 . . . . 0.0 113.928 -171.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 150' ' ' GLU . . . 150.28 55.25 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.3 t -89.95 148.68 22.97 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 157' ' ' ALA . 20.4 mm-40 -71.06 136.01 84.9 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.213 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.526 ' HD2' ' O ' ' A' ' 157' ' ' ALA . 98.3 Cg_endo -78.36 -118.29 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.819 2.346 . . . . 0.0 112.239 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.445 ' H ' ' HB2' ' A' ' 155' ' ' PRO . 0.0 OUTLIER -60.46 -27.19 67.34 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.052 0.453 . . . . 0.0 109.784 177.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.526 ' O ' ' HD2' ' A' ' 155' ' ' PRO . . . -179.84 -118.26 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.808 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -123.55 14.87 9.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.543 1.163 . . . . 0.0 108.564 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.29 30.89 1.82 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.251 -167.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.203 -177.806 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.589 ' H ' ' HB2' ' A' ' 74' ' ' ASN . 37.2 ttmt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.401 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . . . -144.55 144.29 31.24 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 112.024 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -149.17 135.28 19.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.101 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.582 HG22 ' HB2' ' A' ' 59' ' ' ALA . 33.7 pt -115.93 138.84 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.024 0.44 . . . . 0.0 111.103 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -107.57 121.15 44.07 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 66' ' ' ALA . 10.5 mp -87.58 147.86 25.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.006 0.432 . . . . 0.0 110.912 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 27.6 tt0 -74.06 124.3 26.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.659 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.03 -38.4 3.2 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.884 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 28.0 t -82.1 125.06 78.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.2 Cg_exo -80.44 1.77 9.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.998 2.465 . . . . 0.0 112.786 -176.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -107.28 132.86 20.63 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 9.4 Cg_endo -92.66 115.76 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.611 2.874 . . . . 0.0 111.702 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.61 108.33 7.3 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -113.23 137.97 50.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.19 0.519 . . . . 0.0 111.318 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.546 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 36.6 m-85 -139.58 143.95 37.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.223 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 33.9 m -56.37 -54.43 45.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 83' ' ' TRP . 48.4 mt-30 -63.62 125.58 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.148 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 56' ' ' ILE . 18.5 t -65.28 -50.62 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.621 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -58.1 -28.27 64.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.376 -178.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.621 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 11.5 t70 -75.95 -51.6 12.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 110.184 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -64.93 -39.93 94.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.336 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 28.7 pt -69.31 -31.88 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.951 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.05 82.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 0.0 110.791 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -62.3 -32.04 72.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.481 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 38' ' ' ILE . . . -70.75 -18.27 62.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 23.9 mtm180 -94.41 3.73 54.78 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.43 -60.49 0.23 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 119.412 -1.375 . . . . 0.0 114.414 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -40.47 -44.25 4.3 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.799 2.999 . . . . 0.0 114.781 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -82.26 99.7 9.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.148 0.499 . . . . 0.0 111.364 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -106.45 111.06 23.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -176.68 -42.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.079 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.582 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -151.78 151.25 28.01 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.503 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.5 Cg_endo -72.22 158.12 52.48 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.056 1.837 . . . . 0.0 111.741 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.0 pt -81.54 117.59 27.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.067 0.461 . . . . 0.0 110.434 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 tt -77.82 -48.05 17.44 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.19 138.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.218 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.567 HG22 ' HB3' ' A' ' 95' ' ' ASP . 3.6 tt -107.99 129.76 61.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.947 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.528 ' HA ' ' O ' ' A' ' 92' ' ' ILE . 79.6 m-85 -111.71 127.25 55.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.55 HG21 ' HB3' ' A' ' 94' ' ' ALA . 27.7 m -123.03 151.7 27.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.045 0.45 . . . . 0.0 110.061 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.589 ' HB2' ' H ' ' A' ' 35' ' ' LYS . 15.6 m120 -86.03 97.03 10.05 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 76' ' ' MET . 10.3 t70 -45.08 106.6 0.08 Allowed 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 125.581 1.801 . . . . 0.0 110.449 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -179.71 87.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 O-C-N 125.46 1.725 . . . . 0.0 109.16 178.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.593 ' HA3' HG11 ' A' ' 115' ' ' VAL . . . -126.93 28.94 4.51 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.541 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.524 ' H ' ' HG3' ' A' ' 86' ' ' PRO . . . -79.55 43.76 0.58 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.427 0.632 . . . . 0.0 110.509 -174.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -175.05 9.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.194 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.68 7.32 55.71 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.038 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 55.3 53.1 10.43 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 110.047 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.613 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 26.4 p -83.67 177.55 8.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.625 -169.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.534 ' HA ' ' HG2' ' A' ' 51' ' ' GLN . 35.5 p90 -66.39 -25.05 66.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.189 0.519 . . . . 0.0 110.149 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -82.91 -35.14 26.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.702 176.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 82' ' ' THR . 0.9 OUTLIER 66.75 165.24 0.12 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.49 175.054 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.524 ' HG3' ' H ' ' A' ' 78' ' ' ALA . 87.6 Cg_endo -90.31 5.66 4.3 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.054 1.836 . . . . 0.0 111.997 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.94 -179.68 16.05 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.038 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.96 146.12 51.36 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.64 -172.81 13.17 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.205 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 36.8 m-80 -95.18 151.6 19.08 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -97.51 129.75 44.65 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.076 -1.015 . . . . 0.0 111.121 -170.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.705 HD11 ' HB2' ' A' ' 118' ' ' SER . 24.9 pt -144.0 166.2 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.594 -173.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.09 106.3 14.78 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.55 ' HB3' HG21 ' A' ' 73' ' ' VAL . . . -69.84 -32.5 70.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.923 -173.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.777 ' HA ' HD12 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -71.45 -23.87 61.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.72 0.771 . . . . 0.0 109.889 -177.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -99.45 29.6 3.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.07 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.21 -176.37 4.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -95.72 138.05 33.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.546 0.689 . . . . 0.0 110.621 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.531 ' CE1' HD13 ' A' ' 137' ' ' LEU . 2.3 m-85 -120.53 136.62 54.72 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.028 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.78 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -114.46 123.14 69.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.438 0.637 . . . . 0.0 110.41 173.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.8 t -101.56 127.6 54.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.427 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -86.71 121.37 5.75 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.116 -173.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.4 m -92.48 -37.15 12.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.688 0.28 . . . . 0.0 110.79 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.14 -44.71 16.11 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.042 0.449 . . . . 0.0 110.9 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 50.8 mtp180 -134.62 121.6 21.11 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.541 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 165.55 -175.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.542 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -79.23 42.3 2.35 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.066 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.78 -24.69 70.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.6 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.8 ttp -103.57 -3.49 25.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.853 0.359 . . . . 0.0 110.474 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -153.91 -110.14 0.39 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.972 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.542 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.47 99.32 14.84 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.676 0.274 . . . . 0.0 111.208 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.68 147.01 75.04 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.64 2.893 . . . . 0.0 113.659 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.541 ' CD ' ' HE ' ' A' ' 106' ' ' ARG . 1.6 mp0 -114.68 142.34 46.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.536 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -107.68 130.8 54.89 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.613 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.78 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 96.5 t -100.97 105.55 39.17 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 120.969 0.414 . . . . 0.0 110.38 175.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.3 Cg_exo -87.91 127.52 2.23 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.645 2.897 . . . . 0.0 112.387 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -134.07 148.82 51.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.487 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.705 ' HB2' HD11 ' A' ' 92' ' ' ILE . 33.0 t -80.48 -16.73 53.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.139 0.495 . . . . 0.0 109.947 174.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.8 m -108.58 131.9 54.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.523 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.15 -48.67 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.073 0.463 . . . . 0.0 110.921 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -63.64 -28.5 69.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.888 -173.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.59 -40.2 76.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.385 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.37 -35.78 71.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 110.121 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.96 88.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.785 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.508 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -63.28 -30.07 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.001 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -66.06 -40.45 90.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.712 HG21 ' H ' ' A' ' 132' ' ' GLY . 59.5 t -72.25 -29.11 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.415 0.626 . . . . 0.0 110.395 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 7.7 tp -58.04 -43.7 86.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.122 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.83 -50.97 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.666 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.715 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.8 pt-20 -141.6 -92.91 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.468 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.715 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 47.98 -145.41 5.58 Favored Glycine 0 C--N 1.333 0.398 0 O-C-N 123.517 0.511 . . . . 0.0 113.984 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.712 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -172.62 -81.49 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.06 139.27 51.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.847 0.356 . . . . 0.0 110.793 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.13 115.21 43.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.215 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.76 HD12 HD11 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -140.04 159.82 41.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.786 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.66 157.48 24.64 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 95' ' ' ASP . 6.3 tt -60.95 -34.95 75.53 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.35 -13.8 59.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.759 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -127.66 29.64 5.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.126 0.488 . . . . 0.0 110.635 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.76 HD11 HD12 ' A' ' 135' ' ' LEU . 36.1 mm -71.58 121.42 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.5 t -108.95 147.87 31.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.154 177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.428 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.6 p-10 -69.27 -32.84 72.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.67 -29.77 66.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.019 -175.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.906 ' HA ' ' HE1' ' A' ' 144' ' ' MET . 6.2 mmt -87.19 -33.86 19.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.457 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.9 t -78.99 -23.51 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.359 0.599 . . . . 0.0 109.915 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 1.8 pp -150.18 106.76 3.51 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.77 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 23.7 p -80.06 120.1 78.68 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.555 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 9.8 Cg_endo -55.76 -72.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.768 2.312 . . . . 0.0 111.671 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.7 t -129.27 10.25 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 151' ' ' THR . 42.4 mt-10 67.47 -77.92 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.326 -173.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 150' ' ' GLU . 5.8 t 53.07 -41.4 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.899 1.679 . . . . 0.0 114.936 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.37 15.6 4.09 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.3 p -70.55 142.37 51.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.598 0.237 . . . . 0.0 111.264 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.57 ' HG2' ' HB2' ' A' ' 158' ' ' ASP . 2.8 mp0 -56.61 126.07 69.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.274 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.404 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 27.1 Cg_endo -62.85 -86.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.334 2.689 . . . . 0.0 113.601 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -28.36 15.92 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.029 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 177.2 19.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.344 0.402 . . . . 0.0 111.385 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.57 ' HB2' ' HG2' ' A' ' 154' ' ' GLU . 32.2 t70 53.42 84.9 0.05 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.398 0.618 . . . . 0.0 109.571 -171.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -163.91 -43.31 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.582 -165.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.815 179.735 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.67 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 69.6 tttt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.702 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -143.78 143.77 31.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.027 -175.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 3.4 pt20 -149.31 129.64 13.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.586 174.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.465 HG21 ' CG1' ' A' ' 71' ' ' ILE . 29.9 pt -116.11 135.29 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -103.24 121.45 42.73 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 10.4 mp -86.1 141.28 29.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.088 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.638 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 32.7 tt0 -74.0 124.35 26.05 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.599 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.18 -14.21 64.24 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.269 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 34.7 t -105.86 125.47 33.13 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.6 Cg_exo -78.0 5.99 4.95 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.944 2.429 . . . . 0.0 112.733 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -129.69 132.74 24.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.321 . . . . 0.0 111.182 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 7.6 Cg_endo -89.92 165.45 4.88 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.593 2.862 . . . . 0.0 112.133 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 7.1 tt -107.68 118.71 37.46 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -101.91 134.69 44.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.24 146.83 27.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.155 0.502 . . . . 0.0 110.85 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -69.27 -36.36 77.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.298 0.57 . . . . 0.0 110.63 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.888 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 51.8 mt-30 -84.94 122.7 29.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.834 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.702 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 2.6 t -67.6 -51.7 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.587 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -52.62 -41.17 63.48 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.179 -178.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.587 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 29.8 t0 -76.34 -43.05 42.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.754 0.311 . . . . 0.0 111.105 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.2 -37.66 75.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.704 0.288 . . . . 0.0 111.443 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.711 HD12 ' HB1' ' A' ' 114' ' ' ALA . 24.4 pt -68.19 -31.29 51.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.37 -42.44 96.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.295 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -57.17 -37.75 72.57 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.155 0.502 . . . . 0.0 110.438 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.563 ' HB3' HD11 ' A' ' 68' ' ' ILE . . . -64.63 -18.89 65.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.111 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -94.66 -6.69 42.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -179.48 -58.98 0.08 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.998 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -65.56 46.3 0.18 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.527 2.818 . . . . 0.0 114.555 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -96.26 165.7 12.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.711 ' HG3' HG22 ' A' ' 65' ' ' ILE . 10.4 pt20 -92.86 -18.85 22.32 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -169.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.711 HG22 ' HG3' ' A' ' 64' ' ' GLN . 6.5 tt 179.32 -39.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.382 . . . . 0.0 111.976 -174.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 40' ' ' LEU . . . -104.99 146.76 33.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.58 -171.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 55.9 Cg_endo -71.8 163.77 37.81 Favored 'Trans proline' 0 C--O 1.224 -0.183 0 C-N-CA 123.159 2.573 . . . . 0.0 111.73 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 59' ' ' ALA . 27.6 pt -79.3 127.19 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.149 0.499 . . . . 0.0 110.737 177.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 tt -91.78 -48.13 6.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -159.17 138.75 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.84 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.465 ' CG1' HG21 ' A' ' 38' ' ' ILE . 3.0 tt -117.07 131.53 69.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.215 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -111.85 128.34 56.1 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.475 HG21 ' HB1' ' A' ' 94' ' ' ALA . 29.6 m -127.83 139.49 51.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 120.834 0.35 . . . . 0.0 110.096 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.67 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 2.2 m-20 -84.64 107.04 16.64 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -69.6 142.35 53.55 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 124.371 1.045 . . . . 0.0 109.494 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.777 ' O ' ' HG2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER 168.28 -29.13 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 124.511 1.132 . . . . 0.0 109.039 -170.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 81' ' ' ALA . . . -69.47 68.49 0.54 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.622 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.97 106.78 2.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.445 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.22 26.49 15.94 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.539 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.9 -72.38 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.73 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.527 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . . . 57.19 52.35 9.05 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.309 0.576 . . . . 0.0 110.338 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.46 175.75 9.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.178 -173.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.888 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 31.7 p90 -68.8 -20.68 64.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.369 0.604 . . . . 0.0 110.162 175.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.85 -31.8 31.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.838 173.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 62.36 171.38 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.353 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.777 ' HG2' ' O ' ' A' ' 76' ' ' MET . 5.7 Cg_exo -83.88 -5.06 10.62 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.929 1.753 . . . . 0.0 110.372 166.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.09 174.06 13.22 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -174.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -77.14 146.07 37.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.607 0.704 . . . . 0.0 109.468 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.4 ' HA3' ' HG2' ' A' ' 76' ' ' MET . . . -136.91 -140.18 4.05 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.655 -175.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 19.2 m120 -100.31 145.44 28.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 74' ' ' ASN . 37.3 p90 -98.52 130.94 45.1 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.549 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.695 HD11 ' HB2' ' A' ' 118' ' ' SER . 1.8 pt -133.6 151.92 34.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.656 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.85 102.67 4.13 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . . . -61.02 -31.59 71.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.153 0.501 . . . . 0.0 110.935 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.605 ' HA ' HD12 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -58.03 -31.05 66.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.165 176.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -111.39 27.7 9.43 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.868 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -122.52 178.59 4.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.529 0.204 . . . . 0.0 110.775 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -92.74 131.61 37.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.251 0.548 . . . . 0.0 110.779 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -120.49 136.12 54.86 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.338 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.454 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 4.2 p -113.71 129.48 69.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-O 121.866 0.841 . . . . 0.0 110.571 172.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.522 ' HA ' HH11 ' A' ' 106' ' ' ARG . 38.1 t -104.01 111.84 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.282 172.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.679 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -74.67 124.07 7.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.314 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 p -86.71 -31.23 21.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.957 0.408 . . . . 0.0 110.564 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -78.41 -35.04 47.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.714 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.609 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 60.2 mtp180 -121.13 -140.84 0.33 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.369 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.522 HH11 ' HA ' ' A' ' 101' ' ' VAL . 22.4 ttt180 72.25 176.57 0.27 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.467 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -71.94 -48.96 24.52 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.096 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.08 -96.89 0.33 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.339 -0.934 . . . . 0.0 110.832 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.0 mtt -99.48 -3.8 32.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.281 0.562 . . . . 0.0 109.735 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.78 -123.37 2.72 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.717 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.467 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.19 94.66 5.84 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 117.077 0.439 . . . . 0.0 110.663 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.92 113.18 3.15 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.74 2.293 . . . . 0.0 113.125 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -114.65 130.53 56.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.836 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.711 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -100.16 132.8 45.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.456 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.454 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 14.3 t -99.38 105.87 35.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.674 176.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -90.73 131.45 1.58 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 124.2 3.267 . . . . 0.0 112.329 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -128.82 153.27 47.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.695 ' HB2' HD11 ' A' ' 92' ' ' ILE . 38.4 t -85.08 -27.76 26.08 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 170.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.4 m -96.02 115.99 28.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.142 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -57.8 -45.75 85.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.315 0.578 . . . . 0.0 111.139 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -63.38 -28.54 70.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.368 -172.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -64.48 -42.45 95.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.075 0.464 . . . . 0.0 110.296 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -68.45 -37.34 80.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.283 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.3 98.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.709 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.42 83.6 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.12 0.486 . . . . 0.0 110.447 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -61.88 -40.7 96.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.762 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.622 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 78.6 t -66.19 -40.17 86.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.017 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 66.4 mt -56.86 -34.62 68.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.599 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.04 -41.86 13.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.231 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.609 ' OE1' ' HD3' ' A' ' 105' ' ' ARG . 7.6 pt-20 -161.12 -35.18 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -172.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.679 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -53.61 163.88 2.59 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.232 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -111.41 -66.26 0.52 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.705 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.433 HE21 ' HB3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -130.13 141.56 50.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.829 0.347 . . . . 0.0 110.675 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.3 t -103.34 113.75 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.188 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.689 HD12 HD11 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -138.65 164.87 28.39 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.987 -176.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.27 170.07 13.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 95' ' ' ASP . 3.6 tt -66.36 -30.52 70.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.304 0.573 . . . . 0.0 109.629 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.22 -12.1 60.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.587 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -109.43 12.82 24.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.689 HD11 HD12 ' A' ' 135' ' ' LEU . 41.8 mm -71.88 119.12 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.082 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.3 t -119.37 147.12 44.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.849 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.413 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.1 p-10 -69.41 -25.49 64.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.053 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.27 -28.8 69.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.669 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.965 ' HE2' ' HA ' ' A' ' 144' ' ' MET . 3.9 mmt -87.1 -28.96 22.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.037 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 141' ' ' THR . 8.6 t -79.16 -23.56 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.263 0.554 . . . . 0.0 110.476 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.2 pp -155.9 139.75 16.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.77 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.1 p -95.97 120.58 62.73 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.832 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.36 -78.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.175 1.917 . . . . 0.0 111.285 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.62 6.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 65.91 -74.94 0.05 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.308 -167.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.0 t 43.32 31.06 0.35 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.626 1.17 . . . . 0.0 114.062 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 71.97 23.59 77.78 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.012 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.3 t -96.38 124.51 40.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.018 0.437 . . . . 0.0 109.824 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -80.0 149.62 70.43 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.333 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.601 ' HB3' ' HE1' ' A' ' 144' ' ' MET . 10.8 Cg_endo -55.82 -33.53 88.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.164 2.576 . . . . 0.0 112.445 -176.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.561 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 3.3 ptp85 -155.35 -69.25 0.12 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.318 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.561 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -145.93 69.65 1.22 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.23 31.66 0.39 Allowed 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.31 1.006 . . . . 0.0 111.81 -175.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 160' ' ' GLU . 11.9 t70 -130.49 -166.02 1.63 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.412 ' H ' ' CG ' ' A' ' 159' ' ' ASP . 7.1 mm-40 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.731 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 40.1 ttmt . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.57 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -126.54 144.35 50.9 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.448 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . 11.7 pt20 -148.84 136.76 20.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.963 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.677 HG23 ' HB2' ' A' ' 59' ' ' ALA . 30.3 pt -115.9 134.82 57.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.103 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -98.83 116.9 32.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.564 HD23 ' HB2' ' A' ' 66' ' ' ALA . 3.0 mp -92.26 142.34 27.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.964 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.757 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 34.7 tt0 -74.0 132.43 42.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.23 -36.46 3.19 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.5 -175.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.507 ' HB2' ' CB ' ' A' ' 40' ' ' LEU . 68.8 m -82.14 124.5 78.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.014 0.435 . . . . 0.0 110.332 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 2.5 Cg_endo -82.86 -3.47 11.16 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.134 2.556 . . . . 0.0 112.884 -176.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -125.39 133.98 25.37 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.719 -177.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 5.9 Cg_exo -79.1 141.88 16.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.999 2.466 . . . . 0.0 111.847 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.501 ' HB3' HG12 ' A' ' 38' ' ' ILE . 6.3 tt -91.48 107.23 19.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . 38.4 p90 -116.81 137.68 52.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.173 0.511 . . . . 0.0 111.14 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -138.58 143.15 39.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.513 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 5.3 p -55.69 -40.7 72.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.224 0.535 . . . . 0.0 110.982 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.514 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 68.4 mt-30 -82.1 114.85 20.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.396 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.621 HG21 HE22 ' A' ' 85' ' ' GLN . 45.4 t -58.53 -47.89 87.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.298 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -58.68 -28.43 65.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.626 -178.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.468 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 22.5 t70 -75.99 -51.12 13.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.022 0.439 . . . . 0.0 110.257 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.71 95.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.344 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.703 HG23 HD12 ' A' ' 71' ' ' ILE . 28.4 pt -69.08 -31.92 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.316 . . . . 0.0 110.546 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.95 82.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.707 0.289 . . . . 0.0 110.339 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 62' ' ' PRO . 10.1 m-85 -62.12 -35.63 79.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.244 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.677 ' HB2' HG23 ' A' ' 38' ' ' ILE . . . -63.19 -18.1 63.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.707 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -81.71 -3.26 53.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.72 -42.64 0.96 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 119.63 -1.272 . . . . 0.0 114.68 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.486 ' HB2' ' HA ' ' A' ' 58' ' ' TYR . 93.2 Cg_exo -49.32 -16.68 1.21 Allowed 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 123.515 2.81 . . . . 0.0 115.367 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -68.38 -30.84 69.87 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.522 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 41.9 35.41 0.53 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.826 1.25 . . . . 0.0 114.059 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 tt -132.51 -47.55 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.564 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -152.2 151.84 28.37 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.623 0.249 . . . . 0.0 110.917 -175.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.757 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 74.5 Cg_endo -70.35 148.88 62.2 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.366 2.044 . . . . 0.0 111.805 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 68' ' ' ILE . 27.5 pt -84.4 105.33 13.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.394 0.616 . . . . 0.0 110.335 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.8 tt -67.27 -47.36 70.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -161.16 138.38 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.119 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.703 HD12 HG23 ' A' ' 56' ' ' ILE . 2.8 tt -108.34 131.13 59.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.76 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -112.03 128.21 56.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.228 0.537 . . . . 0.0 110.007 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.482 HG21 ' HB1' ' A' ' 94' ' ' ALA . 30.7 m -126.21 136.64 60.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.069 0.461 . . . . 0.0 109.839 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 91' ' ' TRP . 0.2 OUTLIER -83.72 101.04 11.28 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.279 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.432 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 61.1 t0 -55.92 103.73 0.11 Allowed 'General case' 0 C--O 1.236 0.386 0 O-C-N 124.774 1.296 . . . . 0.0 110.058 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.842 ' O ' ' HG2' ' A' ' 86' ' ' PRO . 52.6 mtt -127.64 -26.21 3.02 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.07 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.725 ' HA3' ' HB3' ' A' ' 81' ' ' ALA . . . -70.66 58.07 0.94 Allowed Glycine 0 C--O 1.226 -0.348 0 O-C-N 123.951 0.782 . . . . 0.0 115.015 -165.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.38 33.9 0.69 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.381 0.61 . . . . 0.0 109.846 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -171.53 8.54 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.548 -171.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.416 ' HA2' ' HZ ' ' A' ' 126' ' ' PHE . . . 127.02 -26.13 5.1 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.568 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.725 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . . . 67.68 70.06 0.35 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.399 0.619 . . . . 0.0 110.315 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.2 p -83.97 175.06 9.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.359 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.514 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 21.1 p-90 -70.2 -20.86 63.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.213 0.53 . . . . 0.0 110.321 174.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -83.08 -35.88 25.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.005 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.621 HE22 HG21 ' A' ' 52' ' ' VAL . 0.6 OUTLIER 68.1 140.74 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.144 173.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.842 ' HG2' ' O ' ' A' ' 76' ' ' MET . 52.1 Cg_exo -57.46 -48.38 17.62 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.925 2.416 . . . . 0.0 113.032 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.99 -141.65 8.32 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.682 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -67.1 139.67 57.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.973 0.415 . . . . 0.0 111.521 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -150.99 -165.05 12.47 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -100.15 138.45 37.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 117.08 0.44 . . . . 0.0 110.116 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 74' ' ' ASN . 15.4 p-90 -98.61 131.08 45.09 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.416 -177.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.468 HD13 ' CA ' ' A' ' 118' ' ' SER . 3.7 pt -141.88 163.19 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.247 -170.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.39 107.31 10.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.384 171.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB1' HG21 ' A' ' 73' ' ' VAL . . . -62.61 -35.28 79.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.004 0.43 . . . . 0.0 111.229 -176.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.752 ' HA ' HD12 ' A' ' 137' ' ' LEU . 8.9 t70 -59.78 -26.82 66.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.88 0.848 . . . . 0.0 110.27 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -116.4 36.06 4.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.646 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.27 178.96 6.5 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.796 0.331 . . . . 0.0 110.55 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -97.51 138.11 35.44 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.426 0.631 . . . . 0.0 109.924 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.404 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 5.6 m-85 -120.09 135.65 54.87 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.029 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.939 HG13 HG12 ' A' ' 115' ' ' VAL . 2.2 p -115.3 120.6 65.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.717 0.77 . . . . 0.0 109.473 170.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 64.4 t -101.74 115.94 44.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.57 -1.196 . . . . 0.0 108.58 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.469 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -77.61 120.87 5.64 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.263 -176.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 m -92.5 -29.16 16.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.926 0.394 . . . . 0.0 110.382 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.98 -43.97 17.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.133 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 46.6 mtp180 -130.93 121.19 24.72 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.557 HH22 ' HZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER 172.84 175.21 0.1 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.804 0.69 . . . . 0.0 109.863 177.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.88 -78.47 0.09 OUTLIER Glycine 0 C--N 1.337 0.587 0 O-C-N 123.363 0.414 . . . . 0.0 113.402 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.37 -76.9 0.76 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.329 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -83.63 -3.67 57.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.155 0.503 . . . . 0.0 110.749 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -130.55 -124.0 2.56 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.403 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.42 96.99 9.36 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 28.3 Cg_endo -64.5 147.64 90.45 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.765 2.31 . . . . 0.0 112.695 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.495 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 1.6 mp0 -115.0 121.83 44.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.709 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.08 131.51 39.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.939 HG12 HG13 ' A' ' 100' ' ' VAL . 1.4 p -108.8 106.77 59.35 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.783 0.802 . . . . 0.0 110.352 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 7.6 Cg_exo -81.86 119.99 3.35 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 124.414 3.409 . . . . 0.0 112.65 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -108.05 153.39 23.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.956 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.468 ' CA ' HD13 ' A' ' 92' ' ' ILE . 48.1 t -81.01 -43.06 20.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.184 174.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.6 m -100.65 131.09 46.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.292 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.568 ' HD2' ' N ' ' A' ' 121' ' ' ASP . 0.0 OUTLIER -65.32 -33.71 76.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.347 -177.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.568 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 10.8 p-10 -68.17 -28.51 67.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.196 0.522 . . . . 0.0 110.072 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -69.41 -39.28 78.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.788 173.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.6 82.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.49 94.28 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.687 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.07 73.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.031 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.557 ' HZ ' HH22 ' A' ' 106' ' ' ARG . 44.6 t80 -66.02 -40.34 90.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.07 177.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.665 HG21 ' H ' ' A' ' 132' ' ' GLY . 65.0 t -73.05 -29.07 27.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.452 0.644 . . . . 0.0 110.255 176.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.36 -36.23 81.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.929 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.19 -50.6 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.627 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.779 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 1.9 pt-20 -146.64 -88.92 0.09 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.298 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.779 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 49.85 -142.9 11.81 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 123.412 0.445 . . . . 0.0 113.794 174.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.665 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -175.62 -82.86 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.0 139.44 51.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 176.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.8 t -101.1 113.95 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.955 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.63 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -139.85 165.7 26.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.068 -176.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -88.68 168.2 12.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 95' ' ' ASP . 3.6 tt -63.4 -32.46 73.9 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.83 -16.07 63.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.028 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -111.88 12.39 20.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.488 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.63 HD11 HD12 ' A' ' 135' ' ' LEU . 16.4 mm -71.87 119.71 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.2 t -119.29 145.5 46.07 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.958 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -69.57 -27.52 65.2 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.082 0.239 . . . . 0.0 110.406 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.64 -28.98 68.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.885 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.713 ' HG2' ' HB3' ' A' ' 155' ' ' PRO . 3.9 mmt -84.72 -33.97 23.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.728 0.299 . . . . 0.0 111.425 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.5 t -79.81 -23.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.341 0.591 . . . . 0.0 110.275 -177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.8 pp -159.88 143.3 14.15 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.773 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.604 ' HB ' ' HA ' ' A' ' 150' ' ' GLU . 16.7 p -106.51 120.42 48.55 Favored Pre-proline 0 C--N 1.318 -0.774 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.887 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 14.7 Cg_endo -58.9 -53.17 4.02 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.676 2.251 . . . . 0.0 111.83 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.417 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 1.4 t -135.62 20.28 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.604 ' HA ' ' HB ' ' A' ' 147' ' ' THR . 5.2 mm-40 64.81 -83.6 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.3 -168.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 t 44.83 7.45 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 57.38 46.36 91.93 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.297 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 25.4 m -71.08 144.75 50.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.776 0.288 . . . . 0.0 110.563 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 158' ' ' ASP . 45.2 mt-10 -75.8 122.88 87.91 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.713 ' HB3' ' HG2' ' A' ' 144' ' ' MET . 6.8 Cg_endo -48.53 -85.4 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 124.228 3.286 . . . . 0.0 114.299 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.93 -22.3 12.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.216 0.532 . . . . 0.0 109.904 175.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -175.9 21.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.241 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 29.8 t0 53.81 71.88 0.48 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.307 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.65 -39.83 1.97 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.323 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 1.7 pm0 . . . . . 0 C--O 1.25 1.079 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.503 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -132.45 144.12 50.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.68 0.276 . . . . 0.0 110.645 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 20.3 pt20 -149.16 131.63 15.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.092 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.736 HG21 ' HB ' ' A' ' 71' ' ' ILE . 29.8 pt -115.78 133.23 62.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.148 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -103.99 123.9 48.04 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.551 ' CB ' ' HB2' ' A' ' 43' ' ' SER . 6.4 mp -90.35 148.52 22.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.33 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.616 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 35.7 tt0 -74.16 124.06 25.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.31 -28.8 4.57 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.066 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.551 ' HB2' ' CB ' ' A' ' 40' ' ' LEU . 59.7 m -81.72 124.51 79.57 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.923 0.392 . . . . 0.0 110.347 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 4.2 Cg_exo -78.12 -13.34 15.6 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.373 2.715 . . . . 0.0 113.298 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.63 133.62 24.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.369 . . . . 0.0 111.266 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HG2' ' CE2' ' A' ' 48' ' ' PHE . 96.8 Cg_endo -85.98 168.51 9.26 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.873 2.382 . . . . 0.0 112.472 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 8.0 tt -111.75 116.21 30.34 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.419 ' CE2' ' HG2' ' A' ' 46' ' ' PRO . 98.6 m-85 -96.08 136.19 36.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.355 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.01 133.15 18.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.2 m -66.23 -40.48 90.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.395 0.617 . . . . 0.0 109.613 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.818 ' HG2' ' HB2' ' A' ' 83' ' ' TRP . 50.3 mt-30 -77.31 102.22 6.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.316 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.651 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 13.8 t -56.73 -50.05 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.177 0.513 . . . . 0.0 110.129 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.562 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -55.44 -33.89 64.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.812 -1.086 . . . . 0.0 112.782 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.436 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 7.8 t70 -76.34 -43.55 40.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.138 0.494 . . . . 0.0 110.084 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.52 -34.75 70.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.746 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.562 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 10.4 pt -68.56 -31.67 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.76 88.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.542 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -60.29 -44.89 94.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.97 0.414 . . . . 0.0 111.356 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.46 -17.88 63.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.478 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -105.04 12.63 31.99 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 179.21 -71.94 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.118 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -65.74 37.94 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.829 0 C-N-CA 124.189 3.26 . . . . 0.0 114.994 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -68.57 144.14 54.65 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 173.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -53.83 -82.25 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -169.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.8 tt -137.5 4.3 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.065 0.936 . . . . 0.0 109.559 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 41' ' ' GLU . . . -141.33 156.45 67.33 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.52 -174.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.616 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.6 Cg_endo -72.62 160.26 46.91 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.184 1.923 . . . . 0.0 111.045 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.7 pt -77.19 134.81 27.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.333 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.4 tt -89.98 -52.64 4.87 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 p -161.34 141.26 3.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.761 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.736 ' HB ' HG21 ' A' ' 38' ' ' ILE . 1.7 tt -107.72 134.08 50.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.606 174.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.84 145.42 39.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.638 HG21 ' HB2' ' A' ' 94' ' ' ALA . 31.1 m -137.77 143.21 34.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.392 0.615 . . . . 0.0 110.642 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.655 ' O ' ' HG3' ' A' ' 76' ' ' MET . 93.3 m-20 -78.39 105.46 9.66 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 168.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 1.054 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 31.5 t0 -58.78 121.46 11.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.368 -175.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.84 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -154.37 48.59 0.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.622 -179.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.806 ' HA2' ' HB3' ' A' ' 81' ' ' ALA . . . -101.25 49.49 1.05 Allowed Glycine 0 C--N 1.314 -0.694 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.507 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.04 79.15 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.765 0.317 . . . . 0.0 110.561 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 57.94 25.7 12.49 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.763 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.6 -74.25 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.049 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.806 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . 59.33 62.17 1.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.406 0.622 . . . . 0.0 110.869 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 77.6 p -83.82 176.14 9.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.882 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.818 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 46.6 p90 -69.25 -22.58 63.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 0.0 110.496 177.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -85.19 -24.59 27.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.616 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 71.68 158.86 0.16 Allowed Pre-proline 0 N--CA 1.468 0.471 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.433 173.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.84 ' HD2' ' HB2' ' A' ' 76' ' ' MET . 19.6 Cg_endo -88.16 8.16 4.22 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.801 2.334 . . . . 0.0 111.476 169.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.66 130.8 6.23 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.797 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -72.44 126.79 30.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.732 0.266 . . . . 0.0 110.457 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.49 -65.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.505 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 1.054 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 61.9 t30 -85.6 153.17 22.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -122.57 128.8 51.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.941 HG21 ' HB2' ' A' ' 118' ' ' SER . 21.7 pt -145.64 166.14 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.282 0.563 . . . . 0.0 112.354 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.24 101.59 12.64 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.217 -0.902 . . . . 0.0 108.852 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.687 ' O ' ' HG ' ' A' ' 137' ' ' LEU . . . -59.03 -40.01 83.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.029 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.709 ' HB2' HG22 ' A' ' 71' ' ' ILE . 24.0 t70 -63.3 -11.05 19.02 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.458 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -130.35 50.7 2.17 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.594 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -149.5 -169.2 3.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.469 0.176 . . . . 0.0 110.709 -173.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -94.82 142.25 27.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.52 0.676 . . . . 0.0 111.147 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.5 135.7 54.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.853 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.602 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.2 p -115.16 124.01 71.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.622 0.725 . . . . 0.0 110.007 169.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.557 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 43.8 t -101.65 106.92 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.753 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.87 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -72.62 141.16 30.35 Favored Glycine 0 C--O 1.223 -0.536 0 CA-C-N 116.057 -0.52 . . . . 0.0 114.219 -170.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.3 m -92.13 -32.77 15.0 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.625 -0.338 . . . . 0.0 111.207 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.648 ' HB1' ' HB2' ' A' ' 130' ' ' GLU . . . -88.29 -46.18 9.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.615 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 35.7 mtp-105 -104.73 -92.64 0.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.145 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 145' ' ' VAL . 37.2 ttp85 51.41 -87.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.78 23.75 0.02 OUTLIER Glycine 0 C--O 1.222 -0.652 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.207 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -57.78 -26.82 58.28 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.283 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 70.7 mtm -105.68 15.98 26.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.66 0.267 . . . . 0.0 110.553 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.52 -120.92 0.54 Allowed Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.47 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.3 104.33 40.33 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.621 0.211 . . . . 0.0 110.743 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 6.8 Cg_endo -51.28 124.1 13.39 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.544 2.829 . . . . 0.0 113.124 177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.73 146.14 41.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.962 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.524 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -125.05 132.82 53.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.916 -175.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.693 HG22 ' HB2' ' A' ' 81' ' ' ALA . 67.6 t -96.7 106.36 29.6 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.879 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 1.2 Cg_endo -90.44 105.75 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.702 2.935 . . . . 0.0 111.056 175.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.861 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.2 t80 -117.95 149.07 41.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.911 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.941 ' HB2' HG21 ' A' ' 92' ' ' ILE . 47.9 t -71.01 -35.73 72.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.915 0.388 . . . . 0.0 110.488 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.861 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 7.3 m -97.85 127.14 43.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.764 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -43.16 98.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.155 0.502 . . . . 0.0 110.584 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.75 -32.63 71.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.856 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -74.66 -37.99 62.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.733 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.36 76.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.21 0.528 . . . . 0.0 110.12 176.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.86 -32.18 70.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.832 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.2 89.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.042 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.96 -40.27 94.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.694 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.658 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 93.0 t -63.55 -38.2 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.695 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.38 -36.85 74.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.575 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.71 -45.75 16.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.254 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.648 ' HB2' ' HB1' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -161.4 -36.03 0.05 OUTLIER 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.87 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -46.71 163.09 0.17 Allowed Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.075 -0.966 . . . . 0.0 114.034 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.94 -72.63 0.71 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.82 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.574 ' HB3' ' CB ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -124.73 144.47 50.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.821 0.343 . . . . 0.0 111.078 -178.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.32 113.47 42.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.379 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -134.86 148.91 50.24 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.782 -179.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.85 161.02 23.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.614 0.245 . . . . 0.0 110.456 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -57.92 -27.29 63.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.037 -178.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.03 -16.06 60.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.779 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -123.7 20.48 9.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.945 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.723 HD11 HD11 ' A' ' 135' ' ' LEU . 19.6 mm -71.76 121.52 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.518 HG23 ' HG2' ' A' ' 144' ' ' MET . 4.0 t -114.68 145.77 41.65 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.538 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.2 p-10 -69.75 -24.48 63.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.381 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.02 68.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.795 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.633 ' SD ' ' HB3' ' A' ' 155' ' ' PRO . 19.9 mmt -77.96 -40.28 39.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.952 0.406 . . . . 0.0 110.794 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.411 ' O ' ' NH1' ' A' ' 106' ' ' ARG . 2.4 t -85.73 -21.31 7.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.173 0.511 . . . . 0.0 111.33 -174.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.0 pp -144.56 127.67 16.6 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.343 0.592 . . . . 0.0 110.543 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 21.2 p -102.73 120.45 52.72 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.486 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.35 -58.39 1.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.799 2.333 . . . . 0.0 112.354 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.96 3.68 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.009 0.433 . . . . 0.0 110.209 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.453 ' O ' HG23 ' A' ' 151' ' ' THR . 35.8 mt-10 65.95 -73.42 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.211 -166.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 150' ' ' GLU . 0.6 OUTLIER 57.8 -4.52 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.974 1.309 . . . . 0.0 114.181 172.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 92.36 25.58 20.87 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.005 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 56.3 p -97.16 125.36 41.62 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.65 145.41 95.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.633 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 37.4 Cg_exo -35.1 -58.67 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.998 3.132 . . . . 0.0 113.495 -176.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -141.81 -42.55 0.35 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.66 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -165.22 25.81 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.825 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.4 t0 53.91 77.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -165.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -136.96 24.25 3.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.563 -167.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.574 ' CB ' ' HB3' ' A' ' 133' ' ' GLN . 2.8 pt-20 . . . . . 0 C--O 1.246 0.918 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.269 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.604 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -126.96 143.88 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.21 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 1.7 pm0 -149.06 136.28 20.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.934 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.867 HG23 ' HB2' ' A' ' 59' ' ' ALA . 37.1 pt -115.82 132.67 64.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.114 0.483 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -99.19 126.36 44.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 66' ' ' ALA . 9.0 mp -91.75 151.98 20.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.006 -175.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.538 ' HA ' HD12 ' A' ' 69' ' ' LEU . 26.9 tt0 -74.01 125.44 28.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.958 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.62 -30.9 5.12 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.213 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 14.7 t -92.16 124.23 60.39 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -84.73 19.62 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.168 2.579 . . . . 0.0 112.109 -178.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.91 133.58 24.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.527 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -91.51 138.08 2.1 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.659 2.239 . . . . 0.0 112.732 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.447 ' HB3' HG12 ' A' ' 38' ' ' ILE . 3.6 tt -89.28 104.16 16.73 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 47.3 p90 -113.21 151.06 31.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.335 -175.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -149.8 149.6 30.75 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.65 -59.47 4.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.122 0.487 . . . . 0.0 110.482 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.616 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 32.7 mt-30 -65.4 121.96 16.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.459 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.604 HG12 ' HB1' ' A' ' 36' ' ' ALA . 12.6 t -59.92 -49.99 81.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.579 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -55.06 -30.28 59.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.482 179.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.616 ' HB2' ' HB2' ' A' ' 51' ' ' GLN . 5.2 t0 -76.13 -51.17 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.843 0.354 . . . . 0.0 110.805 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.74 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -67.89 -35.54 78.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.456 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.757 HG23 HD12 ' A' ' 71' ' ' ILE . 20.9 pt -67.79 -31.68 53.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.305 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.17 95.08 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.411 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.806 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 36.1 m-85 -57.97 -42.23 84.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.198 0.523 . . . . 0.0 110.77 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.867 ' HB2' HG23 ' A' ' 38' ' ' ILE . . . -63.36 -19.79 64.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.387 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -105.26 12.23 32.04 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.863 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.41 -72.59 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.656 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.806 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 25.9 Cg_exo -67.79 47.61 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.823 3.015 . . . . 0.0 113.606 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.552 ' OE1' ' HA ' ' A' ' 67' ' ' PRO . 9.4 pt-20 -81.37 -3.27 52.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.268 0.556 . . . . 0.0 110.217 177.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 72.45 -78.67 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.844 171.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -129.67 -52.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -171.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -97.31 148.49 34.49 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.432 0.158 . . . . 0.0 110.713 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.552 ' HA ' ' OE1' ' A' ' 63' ' ' GLU . 59.4 Cg_endo -71.81 157.72 54.59 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.447 2.098 . . . . 0.0 111.936 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 68' ' ' ILE . 47.5 pt -75.1 122.16 28.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.263 0.554 . . . . 0.0 110.261 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 41' ' ' GLU . 5.6 tt -88.22 -47.96 8.05 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.46 138.72 2.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.547 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.757 HD12 HG23 ' A' ' 56' ' ' ILE . 2.6 tt -110.19 131.58 60.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.315 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -111.94 142.16 44.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.881 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.66 143.66 31.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.968 0.414 . . . . 0.0 110.773 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.465 HD22 ' HA ' ' A' ' 88' ' ' ASP . 33.7 t30 -79.57 101.11 8.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 167.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 76' ' ' MET . 54.5 t0 -63.63 106.99 1.05 Allowed 'General case' 0 C--O 1.242 0.707 0 O-C-N 124.47 1.107 . . . . 0.0 110.628 -174.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.601 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 3.6 mmt -152.29 58.95 0.83 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 113.442 -1.708 . . . . 0.0 107.86 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.28 26.46 21.2 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.042 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.15 39.45 0.82 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.979 0.419 . . . . 0.0 110.953 -172.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -179.43 -11.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.238 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.14 -4.32 7.82 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.997 -177.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.27 65.39 1.09 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.622 0.725 . . . . 0.0 109.956 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.7 p -83.81 177.1 8.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.419 -171.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 68.8 t90 -59.43 -40.6 87.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.075 0.464 . . . . 0.0 110.026 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.32 -34.15 48.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.089 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.08 159.79 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.983 1.313 . . . . 0.0 112.935 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.545 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 8.2 Cg_exo -58.47 -25.93 75.97 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.67 1.58 . . . . 0.0 112.188 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.601 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . 135.39 -149.51 19.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.966 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.465 ' HA ' HD22 ' A' ' 74' ' ' ASN . 7.6 p-10 -77.55 137.52 38.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.999 0.428 . . . . 0.0 110.285 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.81 -141.85 3.99 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.549 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -100.6 133.65 44.73 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -98.16 130.25 44.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.13 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.693 HD12 ' HB2' ' A' ' 118' ' ' SER . 6.9 pt -145.04 166.42 11.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.934 -173.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.26 107.16 15.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.05 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . . . -62.1 -27.78 69.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.136 0.493 . . . . 0.0 110.479 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.741 ' HA ' HD12 ' A' ' 137' ' ' LEU . 22.7 t70 -59.54 -25.19 64.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.413 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -123.65 43.14 3.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.384 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -139.86 -177.93 5.2 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -173.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -97.95 138.04 35.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.394 0.616 . . . . 0.0 110.646 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 116' ' ' PRO . 3.1 m-85 -120.46 135.33 55.09 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.104 -177.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.674 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.9 p -113.66 124.82 70.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.514 0.673 . . . . 0.0 109.816 173.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.59 113.87 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.419 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -79.44 121.84 5.63 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.011 -1.09 . . . . 0.0 112.774 -172.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.8 m -92.68 -41.02 10.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.854 0.359 . . . . 0.0 110.313 175.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.21 -43.84 63.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 -174.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -133.84 114.72 13.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.454 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 176.0 -168.88 0.05 Allowed 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.554 0.534 . . . . 0.0 110.086 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.466 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -65.56 -50.99 51.73 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.925 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.06 -102.15 0.68 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.272 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.3 mmt -86.46 -3.92 59.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 110.757 174.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.49 -124.53 5.08 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.466 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.35 96.13 8.01 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.56 0.18 . . . . 0.0 111.084 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.37 141.89 70.15 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.552 2.168 . . . . 0.0 111.9 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 36.5 mt-10 -125.94 140.63 52.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.605 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.75 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -105.95 131.47 53.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.859 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.674 ' HB ' HG13 ' A' ' 100' ' ' VAL . 59.4 t -100.59 106.14 41.37 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.6 Cg_endo -87.75 122.92 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.695 2.93 . . . . 0.0 111.552 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.58 ' HD1' ' H ' ' A' ' 119' ' ' SER . 3.6 t80 -130.43 151.11 51.27 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.693 ' HB2' HD12 ' A' ' 92' ' ' ILE . 33.8 t -73.47 -35.79 65.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.58 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 15.2 m -105.96 128.83 54.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.798 0.332 . . . . 0.0 110.846 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -49.85 57.9 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.787 -176.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -67.14 -28.38 68.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.29 0.567 . . . . 0.0 109.74 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 66.3 mm-40 -71.46 -34.84 70.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.594 172.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.64 -35.09 76.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.338 0.59 . . . . 0.0 109.69 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.43 75.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.695 173.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.1 -32.3 73.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.39 . . . . 0.0 110.444 175.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -63.79 -37.49 87.58 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.624 HG21 ' H ' ' A' ' 132' ' ' GLY . 58.9 t -69.57 -30.48 45.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.447 176.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 tp -59.5 -39.6 84.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.949 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.44 -47.85 13.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.686 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.809 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.6 pt-20 -149.94 -89.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.459 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.809 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 44.88 -143.33 2.95 Favored Glycine 0 C--N 1.334 0.453 0 O-C-N 123.588 0.555 . . . . 0.0 114.297 174.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.624 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -176.08 -81.26 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.437 HE21 ' HB3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -130.21 145.97 51.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.586 0.231 . . . . 0.0 110.568 175.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.21 116.31 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.149 0.499 . . . . 0.0 110.682 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.841 HD11 HD11 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -141.0 164.13 31.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.955 -178.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.31 163.3 18.68 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 95' ' ' ASP . 0.6 OUTLIER -66.4 -31.57 72.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.399 0.618 . . . . 0.0 109.505 178.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.87 -9.12 58.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.878 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.27 17.9 11.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.23 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.841 HD11 HD11 ' A' ' 135' ' ' LEU . 26.3 mm -71.87 121.99 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.147 0.499 . . . . 0.0 110.627 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -112.23 149.56 32.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.261 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 2.2 p-10 -68.92 -29.86 68.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.556 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.43 68.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.66 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.536 ' HE3' ' HA ' ' A' ' 160' ' ' GLU . 13.4 mmt -87.11 -36.95 17.81 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.16 -22.73 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 121.09 0.471 . . . . 0.0 110.672 -174.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.3 pp -148.64 141.25 24.44 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.014 -177.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.3 p -126.0 135.55 27.24 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.053 0.454 . . . . 0.0 111.132 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.8 -49.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.822 2.348 . . . . 0.0 111.809 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 151' ' ' THR . 8.0 t -159.23 85.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -176.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -50.82 74.6 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.226 168.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 149' ' ' VAL . 10.2 t -106.92 21.21 17.9 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.756 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.73 78.0 0.8 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.132 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.2 m -129.96 139.33 51.1 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.54 125.67 92.12 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.726 0.298 . . . . 0.0 110.294 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.55 -73.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.85 2.367 . . . . 0.0 112.253 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.609 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -108.67 -54.07 2.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.786 176.633 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.609 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -151.84 37.76 0.58 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -174.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 157' ' ' ALA . 32.9 t70 73.74 -30.01 0.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.235 -175.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 157' ' ' ALA . 6.2 t70 -73.72 -168.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.362 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.536 ' HA ' ' HE3' ' A' ' 144' ' ' MET . 39.2 mt-10 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.595 -0.717 . . . . 0.0 109.926 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.549 ' H ' ' HB3' ' A' ' 74' ' ' ASN . 26.9 ttpp . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.602 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -126.71 142.54 51.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 9.0 pt20 -149.39 133.66 17.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.474 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.527 HG21 ' HB2' ' A' ' 59' ' ' ALA . 39.0 pt -115.63 136.21 53.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.957 0.408 . . . . 0.0 110.946 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -105.77 131.84 52.63 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.888 HD21 ' HB3' ' A' ' 64' ' ' GLN . 8.7 mp -89.19 152.57 21.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.113 0.482 . . . . 0.0 111.672 -173.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.844 ' HG3' HD11 ' A' ' 69' ' ' LEU . 32.0 tt0 -74.22 124.78 27.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.62 -41.1 2.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.238 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.446 ' HB3' ' CB ' ' A' ' 40' ' ' LEU . 31.2 t -81.92 123.96 79.6 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.038 0.447 . . . . 0.0 110.446 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.0 Cg_exo -81.74 5.63 6.18 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.322 2.682 . . . . 0.0 112.455 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -100.37 131.18 24.35 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.574 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 97.8 Cg_endo -101.41 161.08 0.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.573 2.848 . . . . 0.0 112.984 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.437 ' HB3' HG12 ' A' ' 38' ' ' ILE . 7.6 tt -117.73 114.93 24.05 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -118.24 135.77 54.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.61 0.719 . . . . 0.0 111.582 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.42 135.17 31.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.624 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.9 m -63.93 -29.49 70.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.579 0.704 . . . . 0.0 109.171 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.606 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 14.3 mt-30 -75.97 95.98 3.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.702 175.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.602 HG12 ' HB1' ' A' ' 36' ' ' ALA . 10.8 t -57.65 -52.03 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.058 0.456 . . . . 0.0 111.019 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.53 ' HA ' HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -54.15 -30.11 47.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.364 -178.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.524 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 1.2 m-20 -73.98 -53.47 9.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.761 0.315 . . . . 0.0 111.189 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.404 ' HB1' ' CB ' ' A' ' 36' ' ' ALA . . . -67.21 -35.97 80.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.256 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.648 HD12 ' HB1' ' A' ' 114' ' ' ALA . 17.7 pt -70.35 -32.52 50.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.521 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.17 -44.97 74.74 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.567 174.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.468 ' HD1' ' HG2' ' A' ' 62' ' ' PRO . 22.1 m-85 -62.39 -35.11 78.18 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.527 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -61.04 -17.8 54.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 112.017 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -84.8 -15.57 44.43 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.35 -73.02 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.264 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.468 ' HG2' ' HD1' ' A' ' 58' ' ' TYR . 84.8 Cg_exo -48.67 -47.01 22.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.329 2.686 . . . . 0.0 113.205 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 54.76 -91.08 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.564 0.746 . . . . 0.0 111.723 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.888 ' HB3' HD21 ' A' ' 40' ' ' LEU . 5.7 tp-100 -174.27 -61.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.186 0.517 . . . . 0.0 109.672 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.0 tt -168.42 -38.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.603 ' HB2' HD22 ' A' ' 40' ' ' LEU . . . -106.63 165.3 13.17 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.493 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 73.0 Cg_endo -74.53 156.59 45.14 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.649 1.566 . . . . 0.0 111.628 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.3 pt -69.87 128.15 32.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.219 0.533 . . . . 0.0 110.909 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.844 HD11 ' HG3' ' A' ' 41' ' ' GLU . 42.6 tp -89.32 -48.95 7.01 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.99 138.45 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.631 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.569 HD12 HG23 ' A' ' 56' ' ' ILE . 2.7 tt -110.89 135.42 50.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.429 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -112.91 138.81 49.2 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.559 HG22 ' HB1' ' A' ' 94' ' ' ALA . 19.7 m -128.94 137.88 56.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.289 0.566 . . . . 0.0 110.551 175.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.549 ' HB3' ' H ' ' A' ' 35' ' ' LYS . 27.9 t-20 -78.63 104.17 9.07 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -72.49 121.54 19.79 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 124.256 0.973 . . . . 0.0 109.73 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.535 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -151.84 92.37 1.73 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.611 -176.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.7 -56.84 3.84 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.886 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 81' ' ' ALA . . . 70.99 -52.07 0.68 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.984 0.914 . . . . 0.0 112.49 175.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.91 -34.07 58.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.99 0.424 . . . . 0.0 110.791 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -97.29 -65.33 0.9 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . 44.06 64.54 1.26 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.59 0.756 . . . . 0.0 112.908 175.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.9 p -84.0 176.14 9.05 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.606 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 26.1 p90 -73.32 -12.83 60.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.164 0.507 . . . . 0.0 110.287 175.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.82 -35.15 22.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 68.02 161.04 0.14 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.768 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 76' ' ' MET . 69.9 Cg_endo -93.52 29.35 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.195 1.93 . . . . 0.0 111.634 176.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.15 161.92 18.64 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.721 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -77.35 123.23 26.22 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -106.56 -139.18 9.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.145 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -100.04 149.45 23.47 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 67.2 p-90 -98.44 134.72 41.03 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.232 0.539 . . . . 0.0 110.639 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 118' ' ' SER . 4.3 pt -133.78 151.91 33.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.543 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.04 102.54 4.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.559 ' HB1' HG22 ' A' ' 73' ' ' VAL . . . -61.16 -34.81 75.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.337 -176.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.643 ' HA ' HD12 ' A' ' 137' ' ' LEU . 16.7 t70 -57.81 -30.34 65.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.707 0.765 . . . . 0.0 110.354 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -111.24 26.79 10.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.826 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.17 177.39 5.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.718 0.294 . . . . 0.0 111.06 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -90.44 131.34 36.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.453 0.644 . . . . 0.0 110.535 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.62 135.33 55.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.071 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.685 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.8 p -112.82 125.46 70.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.745 0.783 . . . . 0.0 110.334 174.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.673 ' HA ' HH11 ' A' ' 106' ' ' ARG . 47.9 t -101.81 107.87 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.998 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.44 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -69.6 124.27 15.11 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.547 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.4 m -88.6 -31.01 18.81 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.77 -44.33 11.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.738 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -133.59 109.52 9.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.755 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.746 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 13.7 ttt180 -168.64 -72.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.601 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.67 46.04 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.523 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -61.8 -39.49 97.54 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.699 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 45.2 tpp -109.39 -4.21 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.559 0.695 . . . . 0.0 110.1 174.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.88 -132.87 5.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.208 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.3 102.6 29.96 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.74 129.47 24.95 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.253 2.636 . . . . 0.0 114.01 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.746 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 47.9 mm-40 -114.21 129.33 56.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.364 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.648 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -102.22 131.06 49.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.824 -0.171 . . . . 0.0 111.263 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.685 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 85.7 t -101.61 105.74 42.41 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.772 173.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -90.09 127.04 1.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.762 2.975 . . . . 0.0 111.795 175.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.26 149.81 52.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.195 -176.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.737 ' HB2' HD12 ' A' ' 92' ' ' ILE . 47.9 t -79.1 -18.25 53.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.893 0.378 . . . . 0.0 110.758 176.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.7 m -119.85 134.24 55.31 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.77 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -67.48 -49.52 63.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -60.13 -28.99 68.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.452 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -70.23 -43.28 70.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.268 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.7 -30.2 69.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.148 176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.1 -38.09 72.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.639 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.57 74.79 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.264 0.554 . . . . 0.0 110.272 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.69 -39.64 92.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.847 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.821 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 94.6 t -70.78 -34.81 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.929 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 67.6 mt -56.36 -40.94 75.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.62 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.53 -48.97 11.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.699 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.766 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.5 pt-20 -145.4 -82.72 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.101 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.821 ' HA3' ' HA ' ' A' ' 127' ' ' VAL . . . 38.23 -142.24 0.35 Allowed Glycine 0 C--N 1.337 0.606 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.757 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -179.73 -87.28 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.454 HE21 ' HB ' ' A' ' 101' ' ' VAL . 1.9 pm0 -129.86 141.46 50.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.675 0.274 . . . . 0.0 110.863 175.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.48 113.22 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.04 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.709 HD12 HD12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.41 165.05 27.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.656 -178.239 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.31 161.79 19.36 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.675 ' HA ' HG12 ' A' ' 140' ' ' ILE . 5.9 tt -61.75 -36.78 82.0 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.85 -11.48 27.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.487 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -126.0 23.15 7.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.012 0.434 . . . . 0.0 110.895 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.709 HD12 HD12 ' A' ' 135' ' ' LEU . 34.4 mm -71.82 119.12 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 145' ' ' VAL . 14.1 t -119.26 148.65 42.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.681 -176.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.522 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 1.5 p30 -66.07 -41.73 90.35 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -171.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 155' ' ' PRO . . . -57.03 -28.6 62.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.501 ' SD ' ' HB2' ' A' ' 155' ' ' PRO . 19.2 mmt -82.19 -26.83 33.0 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 141' ' ' THR . 10.9 t -97.88 -23.19 4.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -170.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.6 pp -136.33 156.4 48.69 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.969 -172.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.5 p -111.99 119.52 44.08 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.044 0.449 . . . . 0.0 110.779 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.19 -81.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.581 2.187 . . . . 0.0 111.976 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.564 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 4.1 t -129.35 -2.48 2.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 15.0 mm-40 87.83 -77.78 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -169.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.555 ' OG1' ' HB ' ' A' ' 149' ' ' VAL . 13.0 m 68.46 -42.33 0.47 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 163.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.83 20.91 5.88 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.9 m -84.02 126.55 33.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.585 0.231 . . . . 0.0 110.438 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.702 ' HB3' ' HB2' ' A' ' 158' ' ' ASP . 4.3 mp0 -71.14 126.57 91.98 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.157 177.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.501 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 61.8 Cg_endo -72.94 126.94 11.7 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.633 2.222 . . . . 0.0 111.325 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 155' ' ' PRO . 18.5 tpp85 69.66 -63.07 0.4 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.527 0.517 . . . . 0.0 110.471 -175.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -179.07 13.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.275 0.63 . . . . 0.0 109.92 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.702 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 14.0 t70 57.59 30.88 19.49 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -169.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.01 -68.22 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.679 -172.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.751 179.643 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.566 ' HB3' ' OD1' ' A' ' 74' ' ' ASN . 43.7 tttp . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.715 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -144.72 144.75 31.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.763 0.316 . . . . 0.0 111.671 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 22.3 pt20 -145.56 134.8 22.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.874 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.686 HG12 ' HB3' ' A' ' 47' ' ' LEU . 3.9 pt -119.81 143.24 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.248 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -116.82 127.88 54.74 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.711 HD21 ' HB2' ' A' ' 66' ' ' ALA . 10.3 mp -92.07 142.42 27.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.068 0.461 . . . . 0.0 111.082 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.75 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 44.8 tt0 -73.83 124.69 26.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.866 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.05 -27.29 11.58 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.146 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.3 t -92.0 125.56 56.45 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.1 Cg_exo -80.5 12.12 2.67 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.132 2.554 . . . . 0.0 112.833 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.45 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -130.15 133.25 24.73 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.876 0.369 . . . . 0.0 110.961 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 55.6 Cg_endo -97.42 170.83 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.388 2.725 . . . . 0.0 112.782 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.686 ' HB3' HG12 ' A' ' 38' ' ' ILE . 14.4 tp -107.04 130.64 54.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.94 177.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -114.45 134.47 54.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.1 147.6 27.97 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 110.688 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 55.3 m -70.38 -52.58 21.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.143 173.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.479 HE21 ' HB3' ' A' ' 83' ' ' TRP . 39.8 mt-30 -67.37 113.09 4.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.718 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.715 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 6.2 t -60.48 -50.48 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.565 0.697 . . . . 0.0 109.444 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.646 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -60.21 -28.79 68.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.548 -176.765 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.646 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 14.2 t70 -76.14 -45.5 33.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.781 0.324 . . . . 0.0 110.482 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.52 72.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.275 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.572 ' CD1' ' HB1' ' A' ' 114' ' ' ALA . 16.4 pt -71.19 -32.51 47.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 0.0 110.179 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.26 -36.34 79.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.16 0.505 . . . . 0.0 110.302 172.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.444 ' CD1' HD21 ' A' ' 47' ' ' LEU . 33.8 t80 -60.62 -33.23 72.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.279 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.636 ' HB3' HD11 ' A' ' 68' ' ' ILE . . . -72.37 -18.1 61.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.605 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.542 ' NH2' ' HG ' ' A' ' 137' ' ' LEU . 75.1 mtt85 -105.62 13.14 30.33 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.36 -78.63 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.538 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -43.37 -35.54 5.71 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 124.041 3.161 . . . . 0.0 114.774 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -67.61 128.66 37.28 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.759 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -169.68 -36.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.122 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.9 -27.46 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.542 0.687 . . . . 0.0 109.644 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.711 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -152.1 141.2 14.08 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.309 175.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.75 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 70.4 Cg_endo -74.23 155.12 46.81 Favored 'Trans proline' 0 CA--C 1.52 -0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.282 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.636 HD11 ' HB3' ' A' ' 59' ' ' ALA . 27.5 pt -75.74 116.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.373 0.606 . . . . 0.0 110.484 174.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -79.12 -47.84 15.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 p -161.08 150.16 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.775 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.568 HD12 HG23 ' A' ' 56' ' ' ILE . 5.7 tt -128.0 128.61 69.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.448 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -111.99 133.46 54.15 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.421 HG21 ' HB2' ' A' ' 94' ' ' ALA . 34.6 m -132.2 156.6 42.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.108 0.48 . . . . 0.0 110.668 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 12.3 m120 -92.34 104.56 16.89 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.442 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 10.3 t0 -49.56 103.9 0.06 Allowed 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 125.35 1.656 . . . . 0.0 109.525 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.553 ' SD ' ' HB3' ' A' ' 85' ' ' GLN . 3.3 ttm -144.69 41.04 1.31 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.038 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 79' ' ' ALA . . . -89.62 18.1 48.53 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.644 -175.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.06 22.17 0.11 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.216 0.532 . . . . 0.0 111.474 -175.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -172.89 20.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.493 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.51 -2.29 77.32 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.347 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.443 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . 60.47 66.82 0.89 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.688 0.756 . . . . 0.0 110.315 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 p -83.73 175.59 9.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.445 -176.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.479 ' HB3' HE21 ' A' ' 51' ' ' GLN . 59.8 p-90 -67.26 -23.92 65.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.981 0.42 . . . . 0.0 110.767 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.03 -35.55 42.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.553 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 24.2 mt-30 66.8 142.97 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.578 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -57.61 -42.22 62.76 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.015 1.81 . . . . 0.0 112.07 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.2 -64.56 0.6 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.247 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.32 131.79 38.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.7 0.286 . . . . 0.0 110.619 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 75' ' ' ASP . . . -147.47 139.74 8.04 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.401 -177.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.3 t30 -100.13 149.14 23.83 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -98.48 129.74 45.08 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.705 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.733 HG21 ' HB2' ' A' ' 118' ' ' SER . 20.3 pt -145.02 166.17 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.967 -174.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.69 114.1 23.1 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 73' ' ' VAL . . . -69.46 -38.07 77.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.036 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.743 ' HA ' HD12 ' A' ' 137' ' ' LEU . 0.6 OUTLIER -68.03 -25.24 65.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.738 0.78 . . . . 0.0 109.752 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -98.9 37.35 1.53 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.262 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.48 179.24 7.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.35 -171.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -93.59 141.8 28.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.304 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -120.67 137.08 54.64 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.558 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.827 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -115.16 123.21 70.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.504 0.669 . . . . 0.0 109.368 172.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.475 ' HB ' ' HG2' ' A' ' 133' ' ' GLN . 56.4 t -101.53 107.13 20.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.31 123.25 7.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.793 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.4 t -92.42 -35.4 13.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.893 0.378 . . . . 0.0 110.146 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.39 -45.08 20.21 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.943 0.401 . . . . 0.0 111.568 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.434 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 48.9 mtp180 -129.58 111.72 13.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.617 ' NE ' ' HA ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -177.81 -170.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -54.54 -37.56 61.01 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.67 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.45 -105.26 1.09 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.041 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 86.7 mtp -92.94 -4.0 53.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.979 0.419 . . . . 0.0 110.374 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -95.15 -129.51 5.8 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.782 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.423 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.27 96.58 8.52 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 176.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 18.1 Cg_endo -59.72 151.51 69.78 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.401 2.734 . . . . 0.0 113.314 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.465 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 2.5 mp0 -117.1 146.13 43.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.54 175.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.572 ' HB1' ' CD1' ' A' ' 56' ' ' ILE . . . -103.98 131.13 51.53 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.827 ' HB ' HG13 ' A' ' 100' ' ' VAL . 5.7 t -99.19 105.22 31.07 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.3 Cg_exo -87.07 133.35 3.4 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.556 2.837 . . . . 0.0 112.89 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -129.26 149.67 50.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.46 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.733 ' HB2' HG21 ' A' ' 92' ' ' ILE . 32.5 t -78.05 -38.19 45.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.064 0.459 . . . . 0.0 109.837 172.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 m -96.28 135.33 38.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.818 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -46.2 84.85 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -64.73 -28.46 69.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.875 -172.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -64.98 -38.66 91.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.95 0.405 . . . . 0.0 110.677 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.481 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -73.02 -36.16 66.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.077 176.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.0 -44.99 83.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.065 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.65 -34.14 75.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 110.9 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -62.78 -40.51 97.53 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.806 HG21 ' H ' ' A' ' 132' ' ' GLY . 91.7 t -72.43 -32.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.603 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.4 tp -57.75 -43.67 85.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.1 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.44 -44.64 15.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.164 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.675 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.2 pt-20 -150.69 -93.29 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.403 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.675 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.27 -138.12 7.73 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 114.438 0.535 . . . . 0.0 114.438 173.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.806 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -176.95 -83.09 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.475 ' HG2' ' HB ' ' A' ' 101' ' ' VAL . 13.2 pm0 -130.07 142.16 50.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.645 0.259 . . . . 0.0 110.937 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.5 t -109.45 120.14 60.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.046 0.451 . . . . 0.0 110.729 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.841 HD12 HD13 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -147.2 165.69 29.25 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.547 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.91 164.05 18.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 95' ' ' ASP . 8.6 tt -63.88 -35.52 80.91 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.02 -10.14 59.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.975 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -117.85 20.27 13.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.493 0.663 . . . . 0.0 110.043 -174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.841 HD13 HD12 ' A' ' 135' ' ' LEU . 35.8 mm -76.58 121.69 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.895 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.488 HG21 ' HB2' ' A' ' 144' ' ' MET . 0.5 OUTLIER -106.08 145.85 30.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.858 171.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -69.96 -33.17 71.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.018 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.19 -27.37 68.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.406 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.488 ' HB2' HG21 ' A' ' 141' ' ' THR . 1.7 mmt -73.45 -38.8 65.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.871 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.9 t -83.67 -22.61 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.275 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 pp -151.08 133.44 15.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.594 -0.443 . . . . 0.0 111.406 -174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.8 p -125.93 120.85 24.15 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.305 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.4 -59.59 0.41 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.898 2.399 . . . . 0.0 113.392 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.3 t -125.21 6.62 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.93 0.395 . . . . 0.0 110.68 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 60.91 47.62 7.46 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.82 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 t -71.9 -3.33 21.87 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 82.8 28.92 36.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.868 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 p -70.49 141.08 52.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.661 0.267 . . . . 0.0 111.231 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.499 ' OE2' ' HB2' ' A' ' 158' ' ' ASP . 37.9 mt-10 -59.73 125.84 81.26 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.204 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.74 -72.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 123.146 2.564 . . . . 0.0 112.723 -176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -117.66 -33.57 4.5 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.476 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 159' ' ' ASP . . . -171.05 39.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.895 -173.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.499 ' HB2' ' OE2' ' A' ' 154' ' ' GLU . 14.6 t70 71.99 -37.26 0.38 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.292 0.637 . . . . 0.0 110.659 -174.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.9 t70 -65.24 -163.38 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.249 175.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.835 177.072 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.806 ' H ' ' HB2' ' A' ' 74' ' ' ASN . 36.6 ttpt . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.503 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -134.16 144.54 48.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.149 0.431 . . . . 0.0 111.859 -177.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 28.9 pt20 -147.02 136.83 23.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.872 174.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.611 HG21 ' HB ' ' A' ' 71' ' ' ILE . 35.5 pt -120.06 132.75 68.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.2 0.524 . . . . 0.0 111.495 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -105.75 119.06 38.2 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.464 HD21 ' HB2' ' A' ' 66' ' ' ALA . 9.9 mp -92.94 142.78 26.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.039 0.447 . . . . 0.0 110.738 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.676 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 31.4 tt0 -71.34 124.2 24.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.702 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.67 -17.16 58.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.594 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.429 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 37.5 t -92.38 125.96 54.29 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 1.4 Cg_endo -83.56 10.07 3.83 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.08 2.52 . . . . 0.0 112.678 -178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -134.3 134.2 22.45 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.786 0.327 . . . . 0.0 111.35 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 9.1 Cg_endo -89.2 125.36 1.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.484 2.789 . . . . 0.0 111.422 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.36 102.97 13.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 44.5 p90 -103.14 139.57 38.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.732 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -144.59 142.88 30.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.705 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.595 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 4.8 m -57.15 -44.1 83.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.077 0.465 . . . . 0.0 111.426 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.633 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 46.1 mt-30 -78.46 119.89 22.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.163 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.503 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 9.9 t -64.49 -50.39 76.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.599 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.01 -29.84 45.07 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.512 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.599 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 22.2 t70 -76.34 -51.55 11.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.828 0.347 . . . . 0.0 110.691 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.51 81.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.283 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.469 HD12 ' HB1' ' A' ' 114' ' ' ALA . 31.0 pt -67.6 -30.79 49.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.407 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -62.58 -46.11 89.83 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.547 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.402 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 30.1 m-85 -62.14 -40.88 97.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.888 0.375 . . . . 0.0 110.839 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.545 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -60.83 -20.67 62.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.732 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 48.6 mtm105 -95.43 12.36 29.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.18 -62.35 0.32 Allowed Glycine 0 C--O 1.226 -0.354 0 C-N-CA 119.779 -1.201 . . . . 0.0 113.645 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 18.1 Cg_exo -70.8 49.46 0.94 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.441 2.761 . . . . 0.0 114.323 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -84.26 -89.23 0.1 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.601 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.599 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 22.1 tp60 -164.23 -51.7 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.499 0.591 . . . . 0.0 112.018 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.504 HG22 ' HG3' ' A' ' 64' ' ' GLN . 14.6 tt 177.52 -27.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.258 0.551 . . . . 0.0 110.703 -170.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.464 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -99.41 144.56 28.51 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.455 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.676 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 53.5 Cg_endo -68.62 152.69 74.46 Favored 'Trans proline' 0 CA--C 1.517 -0.332 0 C-N-CA 122.383 2.055 . . . . 0.0 111.371 176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.545 HD13 ' O ' ' A' ' 59' ' ' ALA . 29.5 pt -81.58 107.17 13.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.498 0.666 . . . . 0.0 110.059 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -69.86 -49.42 52.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 p -161.22 138.94 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.927 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.611 ' HB ' HG21 ' A' ' 38' ' ' ILE . 2.6 tt -112.87 128.58 69.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.754 174.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -111.84 128.87 56.25 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 94' ' ' ALA . 35.4 m -128.28 153.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.212 0.529 . . . . 0.0 110.565 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.806 ' HB2' ' H ' ' A' ' 35' ' ' LYS . 15.2 m120 -87.65 103.88 16.0 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -47.36 113.99 0.79 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 125.684 1.865 . . . . 0.0 110.7 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.603 ' HG2' ' O ' ' A' ' 74' ' ' ASN . 11.6 ptp -158.97 117.58 2.94 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.794 0.684 . . . . 0.0 110.074 -176.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.768 ' HA3' ' CZ ' ' A' ' 117' ' ' PHE . . . -151.12 44.89 0.66 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.656 -1.259 . . . . 0.0 113.941 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -97.79 26.42 5.13 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -176.95 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.674 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.534 ' HA2' ' CG2' ' A' ' 115' ' ' VAL . . . 131.03 20.67 1.14 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.281 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 55.83 54.52 8.05 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.421 0.629 . . . . 0.0 110.908 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.7 p -83.57 176.6 8.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.196 -174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.633 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 44.5 p90 -64.66 -28.51 69.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.041 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -80.35 -33.07 37.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 70.37 138.1 0.06 OUTLIER Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.951 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.445 ' CG ' ' HB2' ' A' ' 76' ' ' MET . 36.5 Cg_endo -65.78 -60.08 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.292 1.995 . . . . 0.0 112.808 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.24 -38.21 0.41 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.794 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.504 ' O ' ' HB3' ' A' ' 76' ' ' MET . 10.9 p-10 -72.41 146.75 46.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 176.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.93 94.23 0.11 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.023 -1.085 . . . . 0.0 113.67 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 49.9 m-80 -100.29 151.83 21.02 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.5 p90 -98.13 126.95 43.81 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.268 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.875 HG22 ' HB2' ' A' ' 118' ' ' SER . 34.5 pt -145.62 166.73 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.083 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -95.12 103.5 15.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 172.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -63.59 -30.52 71.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.25 -175.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.731 ' HA ' HD12 ' A' ' 137' ' ' LEU . 21.8 t70 -59.43 -24.26 63.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.697 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -120.51 33.97 5.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.329 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.41 -177.64 4.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.293 -171.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.94 137.4 33.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.545 0.688 . . . . 0.0 110.422 -177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.441 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 6.0 m-85 -120.65 135.69 55.04 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.372 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.564 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 6.3 p -112.24 120.92 63.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.462 0.649 . . . . 0.0 109.643 170.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.432 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 96.9 t -101.61 107.35 21.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.442 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -70.25 122.33 11.03 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.389 -175.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 m -92.31 -20.55 20.99 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.737 0.303 . . . . 0.0 110.821 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.99 -19.08 19.02 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.27 0.557 . . . . 0.0 110.453 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 23.3 mmm-85 -112.53 -30.63 7.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.416 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.751 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 5.4 mpt_? -120.88 -161.71 0.91 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.512 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.834 ' HA2' ' HD3' ' A' ' 112' ' ' PRO . . . 70.11 51.02 25.08 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -171.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.45 -127.04 0.16 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 114.483 -0.858 . . . . 0.0 113.068 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 66.2 mtt -97.93 21.32 10.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.665 0.745 . . . . 0.0 109.493 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.22 -114.07 0.29 Allowed Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.167 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.524 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.19 115.91 63.17 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.878 ' HG2' ' HA ' ' A' ' 145' ' ' VAL . 1.9 Cg_endo -44.09 157.15 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.905 3.07 . . . . 0.0 113.212 164.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.751 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 43.3 mt-10 -113.47 125.97 54.81 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.469 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -93.76 131.97 38.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.873 -168.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.564 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 2.4 t -97.41 106.07 29.87 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 5.7 Cg_exo -85.91 131.07 3.72 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.225 2.617 . . . . 0.0 112.731 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.768 ' CZ ' ' HA3' ' A' ' 77' ' ' GLY . 81.6 m-85 -129.82 149.8 51.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.505 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.875 ' HB2' HG22 ' A' ' 92' ' ' ILE . 16.6 t -87.23 -26.56 23.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.4 m -91.98 110.62 21.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.929 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -58.77 -46.82 86.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.245 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -62.82 -28.74 70.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.214 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.61 -44.82 81.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.891 0.377 . . . . 0.0 110.225 174.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -65.85 -35.62 81.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.329 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.81 -41.49 62.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.477 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.0 -33.2 74.92 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.207 0.527 . . . . 0.0 110.529 177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -59.84 -38.41 81.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.576 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.628 HG21 ' H ' ' A' ' 132' ' ' GLY . 61.7 t -73.17 -30.91 32.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.098 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mp -56.82 -48.98 76.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.233 0.54 . . . . 0.0 110.72 176.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.73 -38.25 47.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.21 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.633 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.1 pt-20 -159.26 -90.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.708 -178.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.633 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 45.51 -139.05 6.0 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 123.827 0.704 . . . . 0.0 113.54 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.628 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -172.97 -89.54 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -128.44 139.15 52.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.809 0.337 . . . . 0.0 110.58 177.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 75.4 t -99.5 113.41 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.572 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.89 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.81 160.96 38.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.691 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.28 162.96 15.57 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.731 HD12 ' HA ' ' A' ' 95' ' ' ASP . 7.0 tt -64.3 -30.52 71.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.43 0.634 . . . . 0.0 109.495 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.91 -10.41 59.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.915 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -124.8 19.92 8.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.041 0.448 . . . . 0.0 110.407 -176.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.89 HD11 HD12 ' A' ' 135' ' ' LEU . 26.9 mm -72.1 119.76 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.491 ' O ' HG21 ' A' ' 145' ' ' VAL . 2.2 t -103.02 148.29 25.89 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.203 175.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.44 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 6.0 p-10 -68.94 -29.2 67.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.53 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.54 -32.29 66.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.453 ' HG3' ' HG3' ' A' ' 133' ' ' GLN . 18.0 mmt -86.99 -26.55 23.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.463 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.878 ' HA ' ' HG2' ' A' ' 112' ' ' PRO . 1.3 t -103.3 -3.22 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 111.405 -173.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.8 pp -169.64 132.87 1.23 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.822 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 1.8 p -94.0 118.69 67.26 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.245 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 24.0 Cg_endo -62.47 -68.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.953 2.435 . . . . 0.0 112.917 -177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 64.6 t -114.7 -27.56 2.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.043 -173.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 5.4 mm-40 68.99 46.15 0.86 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.977 0.894 . . . . 0.0 108.791 -166.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.4 t -75.72 -13.98 60.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.636 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.13 50.27 6.92 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.61 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.2 t -130.14 161.42 31.13 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -57.16 132.57 80.69 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.49 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.9 -72.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.536 2.824 . . . . 0.0 112.801 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.22 -44.83 3.21 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.263 173.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.28 44.35 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.384 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.0 t70 56.59 32.78 21.55 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.321 1.058 . . . . 0.0 109.637 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -142.07 -179.18 6.08 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 133' ' ' GLN . 9.9 mm-40 . . . . . 0 C--O 1.243 0.757 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.878 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 34.6 ttmt . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -139.21 144.92 38.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.153 0.433 . . . . 0.0 111.754 -176.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 13.8 pt20 -149.19 134.49 18.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 173.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.591 HG21 ' HB ' ' A' ' 71' ' ' ILE . 23.1 pt -115.8 132.91 63.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.135 0.493 . . . . 0.0 111.403 -177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -98.99 116.97 32.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 66' ' ' ALA . 9.5 mp -90.4 140.48 29.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.888 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.814 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 35.4 tt0 -71.91 124.9 25.88 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.317 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.35 -15.54 61.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.709 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 30.6 t -94.48 124.87 53.94 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.0 Cg_endo -81.47 2.95 8.2 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.091 2.527 . . . . 0.0 112.13 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -135.23 134.6 21.55 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.544 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 1.3 Cg_endo -83.68 147.63 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.21 2.607 . . . . 0.0 112.249 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 tt -99.15 112.58 24.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 33.9 p90 -108.62 143.85 37.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.984 0.421 . . . . 0.0 111.365 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -150.03 139.65 21.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.878 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 17.2 m -63.21 -29.98 71.22 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -176.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -90.3 113.69 25.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.673 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.779 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 17.1 t -64.33 -50.66 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.007 0.432 . . . . 0.0 110.889 -177.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.66 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.79 -29.46 62.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.931 -177.375 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.66 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 5.1 t70 -76.12 -47.9 22.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.193 0.52 . . . . 0.0 109.828 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.23 80.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.459 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.59 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 36.8 pt -69.16 -32.75 55.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.191 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.567 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . . . -68.22 -42.15 80.23 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 110.214 174.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.416 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 35.6 t80 -61.85 -31.31 71.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.721 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 68' ' ' ILE . . . -73.23 -17.0 61.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.152 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 38.2 mtm105 -97.72 8.26 44.99 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.76 -67.69 0.03 OUTLIER Glycine 0 C--N 1.322 -0.198 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.234 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 64' ' ' GLN . 75.0 Cg_exo -55.17 -0.85 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.844 3.03 . . . . 0.0 115.119 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.44 37.61 0.28 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.651 0.739 . . . . 0.0 110.595 174.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 62' ' ' PRO . 10.7 pt20 -79.91 -14.85 58.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.631 -175.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tp -90.55 -38.62 11.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.212 0.53 . . . . 0.0 110.164 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.684 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -148.01 139.7 13.98 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.814 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 73.0 Cg_endo -74.17 150.73 42.96 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.328 2.019 . . . . 0.0 112.039 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 59' ' ' ALA . 37.8 pt -74.79 123.71 30.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.168 0.509 . . . . 0.0 110.303 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -88.34 -53.07 4.86 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.8 142.36 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.287 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.591 ' HB ' HG21 ' A' ' 38' ' ' ILE . 2.6 tt -113.5 136.0 51.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.457 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -111.94 133.93 53.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.95 159.14 43.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.453 0.644 . . . . 0.0 111.72 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.66 ' HB2' ' H ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -95.52 106.98 19.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.141 171.197 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 90' ' ' ASN . 13.0 t70 -50.99 121.8 6.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 125.088 1.493 . . . . 0.0 109.816 175.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.832 ' HE1' ' HB3' ' A' ' 85' ' ' GLN . 29.4 mtp -124.21 49.36 1.79 Allowed 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -165.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.45 -30.53 0.84 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.818 169.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.937 ' HA ' HG12 ' A' ' 115' ' ' VAL . . . 87.79 -64.44 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.986 0.915 . . . . 0.0 111.801 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.13 -38.34 24.74 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.548 0.53 . . . . 0.0 111.794 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.5 -81.82 1.27 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.554 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.657 ' HA ' ' HE2' ' A' ' 76' ' ' MET . . . 56.41 22.32 6.32 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 176.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 36.1 p -84.38 175.44 9.36 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.478 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -63.26 -23.27 67.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.802 0.334 . . . . 0.0 110.546 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -81.75 -29.88 32.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.592 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.832 ' HB3' ' HE1' ' A' ' 76' ' ' MET . 0.0 OUTLIER 57.09 162.82 0.08 OUTLIER Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.782 1.233 . . . . 0.0 112.469 174.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.44 -9.96 16.1 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.36 1.374 . . . . 0.0 111.477 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 137.65 -177.57 19.8 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.11 140.14 40.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.438 0.619 . . . . 0.0 109.408 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.46 -126.74 2.87 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.989 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 35.4 m-80 -96.46 150.81 20.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.576 -173.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -99.0 126.14 44.63 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.466 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.721 HD11 ' HB2' ' A' ' 118' ' ' SER . 9.8 pt -145.72 166.54 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.137 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.58 106.44 18.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.75 -33.2 73.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.121 0.486 . . . . 0.0 110.76 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.546 ' HA ' HD12 ' A' ' 137' ' ' LEU . 20.9 t70 -59.63 -24.96 64.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.41 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -121.53 33.86 5.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.394 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -135.26 -172.77 3.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.318 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 97.8 m-85 -95.36 139.16 32.05 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.521 0.676 . . . . 0.0 111.041 -176.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.611 ' CE1' HG21 ' A' ' 101' ' ' VAL . 17.9 t80 -120.34 131.04 54.69 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.651 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.9 p -109.52 123.07 65.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.705 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.611 HG21 ' CE1' ' A' ' 99' ' ' TYR . 4.0 t -101.74 103.01 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.394 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.645 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -69.26 134.49 26.82 Favored Glycine 0 N--CA 1.45 -0.432 0 O-C-N 123.574 0.546 . . . . 0.0 113.524 -173.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -92.08 -36.98 13.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.652 0.263 . . . . 0.0 110.317 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.08 -43.74 17.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 0.0 110.385 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.569 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 41.3 mtp-105 -132.84 132.78 42.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.668 177.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.975 HH21 HG11 ' A' ' 145' ' ' VAL . 12.7 ttt85 -172.08 -62.63 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.814 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.83 -61.2 0.23 Allowed Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.83 -94.53 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.527 -0.368 . . . . 0.0 112.42 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.81 -4.49 59.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.981 0.42 . . . . 0.0 110.896 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -110.65 -129.84 5.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.623 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.17 102.2 26.91 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.718 0.259 . . . . 0.0 110.584 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 26.8 Cg_endo -61.86 128.06 23.26 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 123.745 2.964 . . . . 0.0 112.983 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 5.0 mm-40 -114.34 139.97 49.02 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.593 -177.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.551 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -123.59 134.59 53.79 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.64 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 78' ' ' ALA . 46.1 t -98.13 106.68 36.56 Favored Pre-proline 0 C--N 1.314 -0.973 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.983 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 5.3 Cg_exo -84.55 110.17 1.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.157 2.571 . . . . 0.0 111.283 173.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.714 ' HD1' ' H ' ' A' ' 119' ' ' SER . 4.1 t80 -120.06 151.03 39.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.971 -174.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.721 ' HB2' HD11 ' A' ' 92' ' ' ILE . 33.1 t -74.89 -37.26 62.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.778 0.323 . . . . 0.0 110.953 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.714 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 9.6 m -95.95 128.22 42.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.608 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 3.7 ttt180 -62.42 -48.97 77.33 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.133 0.492 . . . . 0.0 111.215 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -63.11 -31.59 72.76 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.786 -172.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -67.48 -40.44 85.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.731 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.17 -34.59 76.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.124 0.488 . . . . 0.0 109.747 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.09 74.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.865 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.35 97.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.142 0.496 . . . . 0.0 109.964 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -60.11 -38.74 83.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.836 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.68 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 60.8 t -64.57 -43.85 96.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.195 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.2 mt -52.46 -40.15 61.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.202 0.525 . . . . 0.0 110.678 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.86 -44.01 19.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.96 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.569 ' OE1' ' HD3' ' A' ' 105' ' ' ARG . 6.9 pt-20 -158.97 -33.49 0.06 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -172.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.68 ' CA ' ' HA ' ' A' ' 127' ' ' VAL . . . -52.76 167.01 1.12 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.257 -0.429 . . . . 0.0 113.907 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.64 -81.76 1.4 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.269 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.632 ' HG2' ' HG3' ' A' ' 144' ' ' MET . 2.1 pt20 -125.99 144.39 50.72 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.958 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.88 113.15 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.325 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.555 HD12 HD11 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -133.87 164.56 26.99 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.502 -178.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.86 163.84 22.01 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 95' ' ' ASP . 0.8 OUTLIER -62.61 -24.81 67.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.864 0.364 . . . . 0.0 110.691 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.29 -19.97 57.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.949 0.404 . . . . 0.0 111.151 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -104.35 19.33 20.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.852 -173.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 135' ' ' LEU . 48.8 mm -71.88 120.37 20.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.216 0.531 . . . . 0.0 111.084 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.766 HG21 ' HB2' ' A' ' 144' ' ' MET . 0.8 OUTLIER -99.42 145.99 26.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.131 177.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.79 -32.21 70.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.045 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.23 -29.2 67.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.504 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.851 ' HA ' ' HE3' ' A' ' 144' ' ' MET . 0.0 OUTLIER -78.94 -35.48 43.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.343 175.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.975 HG11 HH21 ' A' ' 106' ' ' ARG . 55.9 t -78.27 -25.36 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.382 -167.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -160.7 146.61 14.89 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.26 -174.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.4 p -109.01 119.15 49.66 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 121.057 0.456 . . . . 0.0 110.719 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.442 ' HG2' ' H ' ' A' ' 149' ' ' VAL . 38.1 Cg_endo -67.24 -67.86 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.913 2.408 . . . . 0.0 112.364 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.442 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 2.1 t -122.0 1.65 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.79 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 68.24 -76.73 0.05 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.341 -170.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.8 t 42.29 21.67 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.159 1.384 . . . . 0.0 114.643 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 66.29 26.91 72.69 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.885 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.9 m -76.33 152.67 36.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.052 0.426 . . . . 0.0 110.573 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.431 ' CG ' ' HB2' ' A' ' 158' ' ' ASP . 2.5 mp0 -70.63 142.32 88.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.698 ' HB2' ' HE2' ' A' ' 144' ' ' MET . 69.4 Cg_endo -80.55 19.91 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.72 2.28 . . . . 0.0 112.799 -172.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.402 ' HE ' ' CD ' ' A' ' 133' ' ' GLN . 11.9 ptp85 177.06 -45.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.423 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 162.54 -16.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.11 -161.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.431 ' HB2' ' CG ' ' A' ' 154' ' ' GLU . 25.1 t0 59.14 31.24 21.11 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.283 1.039 . . . . 0.0 108.761 -168.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.37 -49.58 22.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.665 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 5.0 pt-20 . . . . . 0 C--O 1.254 1.323 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.362 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 50' ' ' SER . 40.0 ttmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.677 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -132.19 144.21 50.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . 11.9 pt20 -145.06 144.71 31.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.967 0.413 . . . . 0.0 110.574 177.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.681 HG23 ' HB2' ' A' ' 59' ' ' ALA . 23.2 pt -115.94 134.24 59.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 120.969 0.414 . . . . 0.0 110.415 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -98.67 116.87 31.86 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 66' ' ' ALA . 9.3 mp -89.16 139.0 30.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.234 -174.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.842 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 40.8 tt0 -73.89 122.39 22.45 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.51 -4.18 66.43 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.568 -173.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 46.9 t -120.02 128.28 25.93 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.7 Cg_exo -79.1 -12.8 14.3 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.105 2.537 . . . . 0.0 111.704 176.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -115.39 133.8 22.69 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.62 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 2.2 Cg_endo -86.06 149.88 9.47 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.365 2.71 . . . . 0.0 112.149 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.9 tt -94.7 109.77 21.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.641 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . 31.1 p90 -115.54 147.87 40.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.374 0.607 . . . . 0.0 111.834 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -139.24 154.08 47.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.015 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 6.2 m -56.42 -50.98 70.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.155 0.502 . . . . 0.0 110.917 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -77.38 136.06 38.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.397 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.677 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 48.4 t -73.17 -50.7 29.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.467 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -52.78 -32.96 46.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.522 177.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.448 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 15.9 t70 -76.13 -50.0 15.8 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.864 0.364 . . . . 0.0 110.72 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 36' ' ' ALA . . . -67.93 -36.09 79.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.682 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.7 HG23 HD12 ' A' ' 71' ' ' ILE . 31.1 pt -66.02 -31.24 52.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.7 -0.4 . . . . 0.0 109.925 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.3 96.7 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.744 174.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.524 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 54.4 m-85 -58.1 -41.19 82.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.967 0.413 . . . . 0.0 111.046 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.681 ' HB2' HG23 ' A' ' 38' ' ' ILE . . . -63.61 -17.63 63.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.128 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.04 12.24 32.45 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.56 -68.22 0.09 OUTLIER Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.268 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -68.14 46.47 0.34 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.586 2.858 . . . . 0.0 113.642 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.96 172.96 13.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.752 0.311 . . . . 0.0 110.285 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 84.1 mm-40 -96.81 -164.58 1.16 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.843 0.354 . . . . 0.0 110.91 -176.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.3 tt -62.12 -19.4 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.379 0.609 . . . . 0.0 111.17 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.567 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -105.97 141.01 21.81 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.842 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 42.1 Cg_endo -69.36 162.79 40.46 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.967 2.445 . . . . 0.0 112.122 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.9 pt -84.38 116.57 28.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.1 0.476 . . . . 0.0 110.674 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 tt -84.08 -52.58 6.18 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.11 139.86 7.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.662 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.7 HD12 HG23 ' A' ' 56' ' ' ILE . 4.1 tt -108.92 126.89 65.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.133 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -111.55 128.76 56.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.954 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.581 HG22 HG13 ' A' ' 92' ' ' ILE . 31.2 m -123.43 134.25 66.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.118 0.485 . . . . 0.0 110.101 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -89.5 99.44 12.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.611 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 25.6 t70 -68.82 85.94 0.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.778 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.714 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 21.7 ptm -165.17 -168.12 1.33 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.349 0.595 . . . . 0.0 112.268 -174.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.26 -42.9 2.42 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.768 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . . . 51.88 28.33 5.01 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.111 0.536 . . . . 0.0 112.124 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.06 -62.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.97 -11.31 30.38 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.321 -0.942 . . . . 0.0 114.389 -170.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.473 ' HB3' HG21 ' A' ' 52' ' ' VAL . . . -61.38 -52.62 63.86 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.953 0.883 . . . . 0.0 109.325 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.0 p -129.62 152.75 48.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 114.001 -1.454 . . . . 0.0 107.497 168.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -72.22 -19.59 61.7 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.439 0.637 . . . . 0.0 110.054 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -85.14 -18.48 34.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.776 175.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 10.4 mt-30 69.75 141.35 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.358 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.768 ' HD2' ' HA ' ' A' ' 78' ' ' ALA . 73.7 Cg_endo -91.49 -82.17 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.918 2.412 . . . . 0.0 112.929 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.15 -126.2 1.67 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.378 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.68 146.62 48.11 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 122.013 0.125 . . . . 0.0 110.957 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.714 ' HA2' ' HB3' ' A' ' 76' ' ' MET . . . -70.78 90.01 0.39 Allowed Glycine 0 CA--C 1.518 0.278 0 O-C-N 123.66 0.6 . . . . 0.0 113.964 -175.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -100.16 149.5 23.47 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -100.17 127.8 46.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.581 HG13 HG22 ' A' ' 73' ' ' VAL . 1.4 pt -145.51 156.65 13.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.59 117.99 30.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 164.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.93 79.41 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -169.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.623 ' HA ' ' CB ' ' A' ' 137' ' ' LEU . 9.4 p-10 -66.9 -28.01 67.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.009 0.909 . . . . 0.0 109.789 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -105.32 33.33 3.74 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.177 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.58 171.48 12.55 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.215 -0.303 . . . . 0.0 110.351 -174.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -89.54 136.15 33.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.314 0.578 . . . . 0.0 110.013 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.527 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 7.6 m-85 -120.39 136.95 54.55 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.983 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.411 ' CG1' HG11 ' A' ' 115' ' ' VAL . 2.2 p -120.9 125.47 74.08 Favored 'Isoleucine or valine' 0 C--O 1.251 1.146 0 CA-C-O 121.691 0.758 . . . . 0.0 109.428 170.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.556 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 59.1 t -108.57 117.16 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.117 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -75.8 124.49 7.48 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.155 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.5 m -90.43 -23.45 21.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.013 0.435 . . . . 0.0 110.172 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 130' ' ' GLU . . . -82.35 -45.17 15.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.224 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.607 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 47.2 mtp180 -139.23 93.75 2.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.029 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 0.1 OUTLIER -147.84 169.45 19.77 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.451 176.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.602 ' H ' ' HA ' ' A' ' 112' ' ' PRO . . . -79.51 45.85 2.95 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.836 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.8 -25.26 63.51 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.502 171.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.8 ptm -108.36 21.21 17.64 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.746 -0.727 . . . . 0.0 110.213 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -176.3 -116.7 0.47 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.013 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.59 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.45 102.5 29.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.949 0.404 . . . . 0.0 111.378 177.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.602 ' HA ' ' H ' ' A' ' 107' ' ' GLY . 88.0 Cg_endo -74.54 151.83 42.45 Favored 'Trans proline' 0 N--CA 1.467 -0.078 0 C-N-CA 123.253 2.635 . . . . 0.0 111.948 177.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.532 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 1.7 tp10 -118.94 123.24 44.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.308 -177.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -99.88 121.43 41.3 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.51 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 6.4 p -110.81 106.63 57.77 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.235 176.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.527 ' HG3' ' CE2' ' A' ' 99' ' ' TYR . 5.1 Cg_exo -84.98 112.21 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.379 3.386 . . . . 0.0 111.872 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -103.98 149.42 25.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.337 0.589 . . . . 0.0 111.015 -177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -79.68 -43.78 22.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.3 m -83.61 111.31 19.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.087 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -56.93 -45.0 83.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.741 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.8 -28.17 69.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.973 -173.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -67.47 -43.99 79.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.338 . . . . 0.0 110.521 174.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.8 92.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.243 0.544 . . . . 0.0 110.208 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.16 74.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.107 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 128' ' ' LEU . . . -61.63 -39.9 92.94 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 111.186 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -57.63 -40.29 78.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.758 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.556 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 42.4 t -71.79 -28.39 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.843 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 54.2 mt -57.85 -49.82 75.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.451 175.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.55 -48.66 54.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.176 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.928 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.5 pt-20 -157.81 -75.97 0.08 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.566 175.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.928 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.0 -136.85 8.1 Favored Glycine 0 N--CA 1.448 -0.546 0 O-C-N 123.601 0.563 . . . . 0.0 112.914 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.536 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -166.31 -91.91 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.556 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.48 139.7 50.53 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 176.393 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.61 118.19 41.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.779 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.27 164.37 29.42 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.464 -176.727 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.02 165.57 13.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.675 ' HA ' HG12 ' A' ' 140' ' ' ILE . 4.2 tt -64.55 -30.15 71.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.122 0.486 . . . . 0.0 109.95 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.19 -10.68 59.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.011 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -118.99 15.59 13.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.41 0.624 . . . . 0.0 110.262 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.779 HD11 HD12 ' A' ' 135' ' ' LEU . 28.3 mm -72.07 121.52 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.923 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.466 HG21 ' HG2' ' A' ' 144' ' ' MET . 1.2 t -115.39 147.03 41.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -69.4 -31.71 70.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.947 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.93 -29.36 60.0 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.367 0.417 . . . . 0.0 112.076 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.553 ' HE1' ' HB2' ' A' ' 155' ' ' PRO . 12.5 mmt -75.74 -34.88 60.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.14 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.532 ' HB ' HD13 ' A' ' 146' ' ' LEU . 2.7 t -86.12 -25.28 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.049 -172.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.532 HD13 ' HB ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -179.65 149.2 0.36 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.444 -176.012 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.401 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 43.0 p -103.07 120.18 53.05 Favored Pre-proline 0 C--N 1.317 -0.842 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.557 -178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 37.3 Cg_endo -68.39 -77.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.499 2.133 . . . . 0.0 111.483 173.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.6 t -128.86 -27.44 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 73.45 31.54 1.33 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.268 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 t -86.27 16.28 4.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.791 0.805 . . . . 0.0 109.407 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -113.91 -149.04 10.07 Favored Glycine 0 N--CA 1.437 -1.259 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.716 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.1 m -99.89 162.66 12.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.275 -0.462 . . . . 0.0 110.351 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.31 143.43 85.25 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.553 ' HB2' ' HE1' ' A' ' 144' ' ' MET . 15.5 Cg_endo -56.9 -29.52 82.2 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.878 2.385 . . . . 0.0 113.213 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.566 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 3.2 ptp180 -166.25 -54.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.549 175.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.566 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -160.19 28.3 0.17 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.867 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.8 t70 55.0 75.66 0.3 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.962 0.887 . . . . 0.0 108.92 -168.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.434 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 26.0 t0 -128.97 25.13 5.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.739 1.257 . . . . 0.0 107.863 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.411 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 3.1 pt-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-N 113.221 -1.809 . . . . 0.0 111.137 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.574 ' HB3' ' OD1' ' A' ' 74' ' ' ASN . 30.0 ttpt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.588 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -139.99 142.64 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.34 . . . . 0.0 111.052 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 12.8 pt20 -149.58 137.45 20.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.599 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.431 HG23 ' HB ' ' A' ' 71' ' ' ILE . 23.9 pt -115.88 142.91 27.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 0.0 111.111 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -118.72 129.84 55.49 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 66' ' ' ALA . 10.3 mp -95.7 146.54 24.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.853 0.358 . . . . 0.0 111.167 -175.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.635 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 22.1 tt0 -74.05 125.37 28.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.722 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.09 -13.34 61.72 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.201 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 24.3 t -104.3 125.29 34.65 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 4.2 Cg_exo -80.83 10.47 3.34 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.057 2.505 . . . . 0.0 112.733 -177.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.15 133.23 24.52 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.812 0.339 . . . . 0.0 111.455 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -98.11 153.69 0.83 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.744 2.963 . . . . 0.0 112.382 173.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 3.0 tm? -110.76 105.54 14.43 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -112.61 136.77 51.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.16 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.434 ' HE2' HE21 ' A' ' 51' ' ' GLN . 10.7 t80 -149.98 154.97 39.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.144 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.6 m -64.04 -38.78 92.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.298 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.881 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 45.4 mt-30 -72.42 108.69 5.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.571 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.831 HG23 ' HE3' ' A' ' 76' ' ' MET . 12.3 t -62.55 -51.52 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.633 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -53.95 -34.53 59.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.577 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.633 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 28.3 t70 -76.31 -46.69 26.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.767 0.317 . . . . 0.0 110.6 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.803 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -71.23 -39.03 71.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.426 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.531 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 27.3 pt -63.75 -30.81 50.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.66 99.18 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 174.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.803 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 61.6 m-85 -56.91 -39.16 73.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.979 0.418 . . . . 0.0 110.799 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.86 -17.8 64.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.894 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 15.3 mtm180 -102.37 12.61 36.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.57 -60.31 0.19 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.303 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.468 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 23.6 Cg_exo -66.57 35.19 0.13 Allowed 'Trans proline' 0 N--CA 1.48 0.686 0 C-N-CA 123.774 2.983 . . . . 0.0 114.959 -177.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.437 ' OE2' ' HA ' ' A' ' 67' ' ' PRO . 4.6 pt-20 -83.42 128.03 34.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 170.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -47.58 -92.74 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -170.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -125.85 -5.49 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.077 0.941 . . . . 0.0 109.516 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 41' ' ' GLU . . . -113.13 141.92 26.48 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.988 -176.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.635 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.0 Cg_endo -70.1 155.06 65.71 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 C-N-CA 122.413 2.076 . . . . 0.0 111.786 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 68' ' ' ILE . 22.8 pt -71.08 109.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.17 0.51 . . . . 0.0 110.287 175.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -71.7 -52.01 19.98 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 p -161.23 138.81 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.443 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.531 HG22 ' HB2' ' A' ' 95' ' ' ASP . 1.4 tt -111.39 135.85 49.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.465 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 92' ' ' ILE . 87.0 m-85 -115.23 134.64 54.96 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.118 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 94' ' ' ALA . 27.1 m -126.53 150.11 32.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.92 0.39 . . . . 0.0 110.086 176.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.574 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 14.0 m120 -83.71 104.9 14.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.543 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 18.7 t70 -55.37 120.66 7.46 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 125.476 1.735 . . . . 0.0 110.29 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.831 ' HE3' HG23 ' A' ' 52' ' ' VAL . 22.3 mtm -128.63 -165.25 1.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.303 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.79 61.49 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 166.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' A' ' 115' ' ' VAL . . . 74.31 -32.27 0.23 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.789 0.836 . . . . 0.0 112.881 169.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.71 -32.9 63.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.047 0.451 . . . . 0.0 110.581 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.28 -68.47 1.17 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.234 172.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 53.14 34.87 18.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.265 0.555 . . . . 0.0 112.135 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.5 p -83.59 177.61 8.34 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.227 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.881 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 47.0 p90 -64.13 -24.83 67.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.174 0.511 . . . . 0.0 111.081 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.74 -27.24 27.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 64.55 173.79 0.07 OUTLIER Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.746 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 59.6 Cg_endo -97.04 6.08 1.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.399 2.066 . . . . 0.0 111.264 173.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.32 157.56 7.81 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.364 -175.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.94 126.71 31.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.842 0.353 . . . . 0.0 110.417 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -118.6 -159.13 11.03 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.487 -174.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 76.9 m-20 -81.39 151.98 27.67 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -98.08 129.83 44.9 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 121.318 -0.864 . . . . 0.0 110.209 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.71 HD11 ' HB2' ' A' ' 118' ' ' SER . 20.3 pt -138.54 161.23 30.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.985 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.25 100.57 7.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.431 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.516 ' HB3' HG21 ' A' ' 73' ' ' VAL . . . -66.28 -34.97 79.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.798 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.599 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 31.3 t70 -61.06 -24.88 66.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.618 0.723 . . . . 0.0 110.138 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -111.64 22.01 15.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.839 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.92 178.79 4.18 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.961 0.41 . . . . 0.0 111.156 -170.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -96.32 130.48 43.41 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.099 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.78 ' HH ' HD13 ' A' ' 137' ' ' LEU . 11.2 m-85 -120.48 136.56 54.72 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.918 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.823 HG13 ' HB ' ' A' ' 115' ' ' VAL . 1.5 p -121.06 125.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.216 0.531 . . . . 0.0 110.226 172.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.723 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 55.6 t -101.75 125.47 55.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.634 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -87.55 126.84 8.2 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.753 -174.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.7 m -92.66 -21.27 20.11 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.551 0.215 . . . . 0.0 111.084 177.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.636 ' HB1' ' HB2' ' A' ' 130' ' ' GLU . . . -89.02 -46.46 8.84 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -170.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -129.89 19.71 5.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.351 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.67 ' HG3' ' H ' ' A' ' 107' ' ' GLY . 8.9 tpp180 -112.0 -161.65 0.76 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.858 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.67 ' H ' ' HG3' ' A' ' 106' ' ' ARG . . . 66.58 46.17 78.78 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -163.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -56.95 -98.22 0.01 OUTLIER Glycine 0 CA--C 1.517 0.161 0 CA-C-N 113.78 -1.21 . . . . 0.0 115.771 -164.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.1 ttt -87.95 21.6 2.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.568 0.699 . . . . 0.0 110.957 -169.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 135.53 -57.69 0.68 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -177.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.438 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.29 122.68 44.36 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HA ' ' HA2' ' A' ' 107' ' ' GLY . 5.2 Cg_endo -47.42 152.35 2.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.884 2.389 . . . . 0.0 112.372 173.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.519 ' CB ' ' HD2' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -114.01 131.81 56.22 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -172.018 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.608 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.8 130.16 39.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.442 -174.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.823 ' HB ' HG13 ' A' ' 100' ' ' VAL . 93.1 t -94.85 103.94 13.1 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.4 Cg_exo -91.23 120.38 0.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.548 2.832 . . . . 0.0 112.171 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.36 148.81 50.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.375 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.71 ' HB2' HD11 ' A' ' 92' ' ' ILE . 42.2 t -80.26 -26.86 38.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 173.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.0 m -101.17 121.26 41.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.538 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -59.21 -46.66 87.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.618 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -62.76 -28.97 70.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.272 -173.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -69.63 -38.13 77.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.64 -36.93 81.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.302 0.572 . . . . 0.0 109.755 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.85 -35.85 82.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.573 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.73 78.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.443 ' HZ ' HH21 ' A' ' 106' ' ' ARG . 63.8 t80 -63.48 -41.01 98.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.789 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 41.3 t -72.95 -30.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.202 0.525 . . . . 0.0 110.251 177.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.2 -36.87 76.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.084 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.08 -50.94 7.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.15 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.899 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 1.3 pt-20 -146.94 -81.61 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.093 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.899 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 52.52 -146.82 15.46 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.669 173.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.53 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -172.53 -84.18 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.723 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.43 145.23 51.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.728 0.299 . . . . 0.0 110.509 174.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.7 t -101.23 113.3 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.267 0.556 . . . . 0.0 109.535 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.797 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -130.48 164.86 23.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.918 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.41 ' H ' ' HB3' ' A' ' 139' ' ' ASP . . . -90.66 166.18 13.3 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.78 HD13 ' HH ' ' A' ' 99' ' ' TYR . 5.8 tt -64.38 -38.64 91.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.76 -10.24 57.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.26 175.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 136' ' ' ALA . 31.3 t70 -120.24 18.58 12.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.413 0.625 . . . . 0.0 110.389 -175.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.797 HD11 HD12 ' A' ' 135' ' ' LEU . 25.2 mm -72.02 121.35 22.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 145' ' ' VAL . 2.5 t -116.67 148.88 40.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.093 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.526 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 4.3 p30 -68.96 -26.36 65.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.605 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.29 69.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.995 0.426 . . . . 0.0 111.324 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.563 ' HE3' ' HG3' ' A' ' 133' ' ' GLN . 11.5 mmt -86.96 -32.23 20.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.401 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 141' ' ' THR . 4.2 t -86.75 -23.7 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.13 0.49 . . . . 0.0 110.726 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.4 pp -153.4 125.5 7.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.324 -176.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.2 p -102.85 131.68 21.99 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.656 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.31 -99.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.661 2.241 . . . . 0.0 111.386 172.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.622 ' HB ' HG22 ' A' ' 151' ' ' THR . 4.8 t -115.21 -5.78 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 70.19 7.84 6.39 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.573 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.622 HG22 ' HB ' ' A' ' 149' ' ' VAL . 7.6 t -82.18 73.5 9.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 122.195 0.998 . . . . 0.0 109.035 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.83 -140.46 2.99 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.72 -173.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -102.34 161.32 13.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.06 132.08 93.72 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.534 ' HG2' ' OD2' ' A' ' 159' ' ' ASP . 14.3 Cg_exo -46.45 -75.67 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.641 2.894 . . . . 0.0 114.465 -167.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.603 ' HG3' ' OD1' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -92.87 -36.69 12.68 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.649 -176.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 173.16 38.95 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.8 t70 62.7 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -164.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.603 ' OD1' ' HG3' ' A' ' 156' ' ' ARG . 8.3 m-20 -63.55 161.36 14.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.386 -157.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 C--O 1.252 1.194 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.329 -176.292 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 28.6 ttpp . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -147.62 144.54 28.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.613 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 14.5 pt20 -147.31 126.82 13.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.898 0.38 . . . . 0.0 110.558 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.859 HG12 ' HB3' ' A' ' 47' ' ' LEU . 7.8 pt -117.3 138.13 48.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.12 0.486 . . . . 0.0 111.113 -176.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -103.95 126.97 51.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.518 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 66' ' ' ALA . 9.0 mp -92.18 139.87 30.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.068 0.461 . . . . 0.0 111.286 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.746 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 36.8 tt0 -74.54 124.33 26.43 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.429 176.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.0 -15.7 62.57 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.533 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.475 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 33.4 t -120.0 124.09 28.04 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 120.957 0.408 . . . . 0.0 110.202 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 2.8 Cg_exo -77.31 7.71 3.61 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.055 2.503 . . . . 0.0 112.487 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -102.56 131.2 22.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.871 0.367 . . . . 0.0 111.254 -178.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 37.5 Cg_endo -98.88 136.89 0.31 Allowed 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.803 3.002 . . . . 0.0 112.69 174.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.859 ' HB3' HG12 ' A' ' 38' ' ' ILE . 13.8 tp -82.99 129.84 35.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.701 176.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.422 ' HE1' ' HG2' ' A' ' 46' ' ' PRO . 51.6 m-85 -118.38 133.12 56.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.96 0.41 . . . . 0.0 111.162 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 11.4 m-85 -150.2 148.96 29.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.477 174.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 m -77.32 -32.04 54.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.056 0.455 . . . . 0.0 110.488 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.713 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 41.5 mt-30 -88.14 122.53 31.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.682 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 56' ' ' ILE . 6.2 t -63.77 -51.04 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.644 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -51.25 -36.44 42.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.867 179.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.644 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 36.0 t70 -76.39 -49.22 17.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.823 0.344 . . . . 0.0 110.604 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.563 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -62.53 -42.49 99.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.446 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.857 HD12 ' HB1' ' A' ' 114' ' ' ALA . 21.9 pt -65.42 -31.48 54.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.284 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.537 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . . . -60.87 -43.62 98.17 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 120.591 0.234 . . . . 0.0 110.487 174.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.657 ' HA ' ' HG2' ' A' ' 62' ' ' PRO . 11.8 m-85 -61.1 -40.11 92.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.285 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HB3' HG23 ' A' ' 68' ' ' ILE . . . -67.05 -27.03 67.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.432 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.537 ' HE ' ' HA ' ' A' ' 57' ' ' ALA . 83.4 mtm180 -88.57 -1.48 58.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.019 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.06 -75.75 0.03 OUTLIER Glycine 0 CA--C 1.52 0.348 0 C-N-CA 119.581 -1.295 . . . . 0.0 114.045 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.657 ' HG2' ' HA ' ' A' ' 58' ' ' TYR . 30.7 Cg_exo -37.96 -51.31 1.93 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 124.314 3.343 . . . . 0.0 114.665 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -76.94 98.34 4.89 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -117.09 -23.11 8.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.208 -173.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.5 tp -67.45 -29.32 45.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.009 0.433 . . . . 0.0 111.244 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.801 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -141.5 141.45 22.96 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.746 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 57.8 Cg_endo -73.38 163.21 38.36 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.43 2.086 . . . . 0.0 111.993 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.453 HG23 ' HB3' ' A' ' 59' ' ' ALA . 14.3 pt -85.49 121.02 36.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.337 0.589 . . . . 0.0 110.882 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.81 -59.43 2.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.252 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.16 138.54 20.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.203 0.525 . . . . 0.0 110.298 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.527 HG13 HG23 ' A' ' 38' ' ' ILE . 2.3 tt -122.52 129.25 75.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.399 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -111.73 130.69 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.4 m -127.4 139.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.77 0.795 . . . . 0.0 111.25 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -87.58 101.67 13.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 170.338 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.921 ' HB3' ' HB2' ' A' ' 90' ' ' ASN . 12.5 t0 -46.95 108.34 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.846 1.341 . . . . 0.0 109.267 175.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.568 ' C ' ' HG3' ' A' ' 86' ' ' PRO . 14.0 ttt -162.65 -101.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.591 -165.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.472 ' H ' ' HB3' ' A' ' 76' ' ' MET . . . -79.7 63.1 4.06 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-O 122.112 0.84 . . . . 0.0 111.978 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 115' ' ' VAL . . . -142.75 -55.05 0.42 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.176 -1.512 . . . . 0.0 107.018 174.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.81 -20.76 65.21 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.039 166.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.648 ' HA3' ' HD3' ' A' ' 86' ' ' PRO . . . -89.37 -96.65 1.07 Allowed Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.158 175.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -178.88 -51.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 85' ' ' GLN . 71.9 p -107.7 175.75 5.38 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.713 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 10.9 p90 -70.45 -31.13 68.16 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.273 0.559 . . . . 0.0 110.125 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.87 -28.69 25.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.036 -174.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.521 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.9 OUTLIER -61.71 -60.19 11.07 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -167.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.648 ' HD3' ' HA3' ' A' ' 80' ' ' GLY . 7.0 Cg_endo -44.75 -57.57 1.98 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.298 2.665 . . . . 0.0 113.523 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.49 -45.7 2.57 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.01 146.85 37.15 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.407 0.283 . . . . 0.0 110.474 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.96 100.65 0.29 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.857 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.921 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 91.7 m-20 -95.85 150.26 20.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 175.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -109.6 128.08 54.97 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.194 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.3 pt -145.52 163.45 11.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.635 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.7 109.13 21.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.62 -33.03 74.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.792 -174.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.857 ' HA ' HD12 ' A' ' 137' ' ' LEU . 12.7 t70 -58.66 -31.46 68.18 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.83 0.824 . . . . 0.0 110.566 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -111.31 38.29 2.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.207 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 117' ' ' PHE . . . -140.09 169.81 17.01 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.535 -168.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -90.25 143.28 26.91 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.096 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.466 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 3.2 m-85 -119.81 134.3 55.29 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.828 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.631 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.2 p -113.17 121.54 65.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.655 HG13 HH11 ' A' ' 106' ' ' ARG . 19.7 t -101.79 103.06 14.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.756 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -68.75 133.11 27.12 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.777 -173.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.9 t -92.11 -21.99 20.14 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.64 -43.81 68.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.608 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.511 ' HB2' ' OE1' ' A' ' 113' ' ' GLU . 77.1 mtt180 -100.97 -85.84 0.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.672 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.756 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 3.7 ttp180 58.42 -96.6 0.07 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.484 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.422 ' H ' ' HB3' ' A' ' 106' ' ' ARG . . . 167.6 -60.56 0.21 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -170.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 61.73 -84.83 0.03 OUTLIER Glycine 0 C--N 1.332 0.341 0 O-C-N 123.823 0.366 . . . . 0.0 113.034 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.2 tpt -82.99 -4.36 58.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.023 0.44 . . . . 0.0 110.381 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.79 -128.98 3.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.474 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.1 102.97 31.49 Favored Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 122.918 -0.166 . . . . 0.0 111.137 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 2.4 Cg_endo -47.31 150.51 3.36 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.413 3.409 . . . . 0.0 113.936 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.682 ' HB3' ' HA ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -114.42 138.11 50.98 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.293 -172.191 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.857 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -128.77 130.33 46.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.649 172.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.631 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 14.5 t -106.97 104.85 53.63 Favored Pre-proline 0 C--N 1.315 -0.933 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.553 172.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 2.7 Cg_exo -84.76 123.75 2.9 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.79 2.994 . . . . 0.0 112.697 178.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' A' ' 97' ' ' ALA . 43.1 m-85 -127.0 149.18 50.01 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.879 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.9 t -79.68 -26.63 40.92 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.569 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 19.3 m -100.51 124.11 45.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.957 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -37.24 84.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.283 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.569 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 19.5 p-10 -63.65 -32.37 73.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.661 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.49 ' HG2' ' HB2' ' A' ' 119' ' ' SER . 43.7 mm-40 -64.28 -42.7 96.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.998 0.428 . . . . 0.0 110.259 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.85 -37.88 79.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.718 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.86 94.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.67 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 128' ' ' LEU . . . -59.92 -35.65 75.36 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 110.943 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -65.24 -37.37 87.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.204 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.475 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 46.9 t -72.24 -32.21 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.561 178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 125' ' ' ALA . 69.5 mt -58.33 -40.38 81.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.84 -49.63 9.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.549 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.644 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.6 pt-20 -149.65 -90.14 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.944 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.644 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 51.4 -149.76 7.66 Favored Glycine 0 C--N 1.331 0.267 0 N-CA-C 114.203 0.441 . . . . 0.0 114.203 173.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -163.86 -96.73 0.11 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.53 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -123.32 144.33 49.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.941 0.37 . . . . 0.0 110.513 176.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.5 t -101.17 122.4 53.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.346 0.593 . . . . 0.0 110.646 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.577 HD21 ' HA ' ' A' ' 140' ' ' ILE . 0.4 OUTLIER -147.11 154.7 41.44 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.669 178.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.48 168.61 19.21 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' A' ' 95' ' ' ASP . 7.0 tt -67.71 -34.13 76.27 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.99 -15.33 60.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.254 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -111.23 0.69 16.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.24 0.543 . . . . 0.0 110.861 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.577 ' HA ' HD21 ' A' ' 135' ' ' LEU . 1.4 tt -71.64 144.79 12.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.514 0.673 . . . . 0.0 110.902 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.32 148.16 43.49 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.421 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -69.05 -30.41 68.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.006 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.825 ' HB1' ' HB3' ' A' ' 155' ' ' PRO . . . -65.29 -28.55 69.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.701 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.1 mmt -78.34 -26.23 46.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.672 0.272 . . . . 0.0 111.279 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.412 HG12 ' HD2' ' A' ' 60' ' ' ARG . 4.0 t -86.58 -23.54 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.059 0.457 . . . . 0.0 110.763 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 pp -157.04 132.42 9.17 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.18 -175.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.7 p -107.04 135.65 19.56 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.586 0.708 . . . . 0.0 111.642 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.468 ' HB2' ' H ' ' A' ' 149' ' ' VAL . 51.7 Cg_endo -93.04 -131.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.804 3.002 . . . . 0.0 111.47 175.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.468 ' H ' ' HB2' ' A' ' 148' ' ' PRO . 6.8 t -97.78 2.85 10.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.743 0.782 . . . . 0.0 109.123 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 42.0 mt-10 59.98 22.1 11.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.579 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.6 t -87.28 26.72 1.16 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.102 0.953 . . . . 0.0 109.03 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . -118.48 -124.46 3.36 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.273 -172.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.1 p -129.39 161.77 29.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.642 0.258 . . . . 0.0 110.651 -176.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.553 ' HB3' ' HA ' ' A' ' 158' ' ' ASP . 2.0 mp0 -71.6 139.96 84.01 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.727 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.825 ' HB3' ' HB1' ' A' ' 143' ' ' ALA . 52.6 Cg_endo -72.93 -29.91 11.64 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.816 2.344 . . . . 0.0 111.86 176.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.57 ' HG3' ' HA ' ' A' ' 159' ' ' ASP . 6.8 ptp180 -144.55 -141.72 0.12 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.614 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.417 ' H ' ' HB2' ' A' ' 156' ' ' ARG . . . -71.1 72.7 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 170.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.559 ' O ' ' HD2' ' A' ' 155' ' ' PRO . 9.8 t70 62.27 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -164.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.57 ' HA ' ' HG3' ' A' ' 156' ' ' ARG . 5.0 p-10 -171.81 -166.67 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.573 0.225 . . . . 0.0 110.552 167.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 C--O 1.251 1.182 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.845 -175.898 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 37.0 tttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.477 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -141.49 143.08 33.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.699 0.681 . . . . 0.0 112.135 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 10.7 pt20 -149.29 139.26 22.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.538 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.525 HG23 ' HB ' ' A' ' 71' ' ' ILE . 17.1 pt -122.33 138.14 53.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.163 0.506 . . . . 0.0 111.622 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -98.86 116.39 31.0 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 173.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.806 HD23 ' HB2' ' A' ' 66' ' ' ALA . 8.4 mp -92.17 134.24 35.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.98 0.419 . . . . 0.0 110.765 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.866 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 39.9 tt0 -71.75 125.82 28.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.516 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.67 -26.63 23.89 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 23.1 t -97.79 126.08 42.11 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.3 Cg_exo -74.2 -9.59 22.0 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.878 2.385 . . . . 0.0 113.177 -174.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.25 146.55 49.58 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.821 0.343 . . . . 0.0 111.587 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.24 151.45 26.58 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.824 2.349 . . . . 0.0 112.389 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tt -108.77 101.18 10.32 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 53.9 p90 -101.62 151.98 21.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.819 0.342 . . . . 0.0 110.592 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -148.04 149.74 32.65 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.656 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -64.28 -48.65 74.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.339 0.59 . . . . 0.0 110.764 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.708 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 35.0 mt-30 -78.63 113.99 17.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.391 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.493 ' O ' HG12 ' A' ' 56' ' ' ILE . 9.1 t -57.58 -48.83 82.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.642 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.34 -30.99 53.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.702 -178.409 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.642 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 14.1 t70 -76.37 -48.48 19.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.804 0.335 . . . . 0.0 110.683 -177.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.77 83.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.333 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.774 HD12 ' HB1' ' A' ' 114' ' ' ALA . 23.3 pt -67.47 -30.24 48.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.728 0.299 . . . . 0.0 110.676 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.07 88.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.861 0.362 . . . . 0.0 110.309 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -59.66 -37.32 78.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.434 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.693 ' HB3' HD11 ' A' ' 68' ' ' ILE . . . -70.58 -18.28 62.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.905 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.527 HH12 HG13 ' A' ' 145' ' ' VAL . 48.9 mtm180 -105.07 12.38 32.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.57 -72.42 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.317 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.24 -2.01 0.22 Allowed 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 123.905 3.07 . . . . 0.0 115.145 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.472 ' OE1' HG12 ' A' ' 68' ' ' ILE . 1.1 pt-20 -74.4 53.63 0.54 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.578 0.704 . . . . 0.0 110.033 171.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -92.33 -39.93 11.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.725 -176.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -75.79 -30.22 21.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.074 0.464 . . . . 0.0 110.545 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.806 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -152.06 140.41 13.45 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.347 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.866 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 80.4 Cg_endo -77.9 153.77 29.43 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.546 2.164 . . . . 0.0 112.134 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.693 HD11 ' HB3' ' A' ' 59' ' ' ALA . 46.6 pt -77.96 125.47 37.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.304 0.573 . . . . 0.0 110.188 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tt -86.0 -52.5 5.67 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -156.66 141.12 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.129 176.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.525 ' HB ' HG23 ' A' ' 38' ' ' ILE . 2.9 tt -114.6 129.19 71.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.322 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.443 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 87.1 m-85 -111.96 128.24 56.1 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' A' ' 94' ' ' ALA . 28.2 m -126.05 157.02 36.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.455 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -86.95 110.3 19.93 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 15.8 t70 -52.8 98.06 0.02 OUTLIER 'General case' 0 C--O 1.239 0.542 0 O-C-N 125.338 1.649 . . . . 0.0 109.503 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.607 ' SD ' ' HB2' ' A' ' 86' ' ' PRO . 2.0 mmt -179.71 87.74 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.548 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 79' ' ' ALA . . . -146.57 36.87 1.23 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 16.88 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -167.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.447 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -156.04 7.09 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.893 0.378 . . . . 0.0 110.537 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.41 ' HA3' ' NH1' ' A' ' 106' ' ' ARG . . . 130.0 -12.18 5.86 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.259 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.29 63.74 0.76 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.604 0.716 . . . . 0.0 109.945 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 46.3 p -83.81 176.71 8.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.409 -172.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.708 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 41.3 p-90 -66.62 -25.08 66.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.155 0.502 . . . . 0.0 110.275 172.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -77.5 -36.16 52.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.24 175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 67.93 150.64 0.12 Allowed Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.889 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.607 ' HB2' ' SD ' ' A' ' 76' ' ' MET . 17.1 Cg_exo -72.7 0.2 7.98 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.701 2.267 . . . . 0.0 111.568 169.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.46 176.26 15.64 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.055 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.34 135.76 38.4 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.77 -136.6 3.59 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.073 -174.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 53.7 t30 -89.91 151.34 21.78 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -173.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -98.8 128.91 45.16 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.896 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.696 HG22 ' HB2' ' A' ' 118' ' ' SER . 25.9 pt -145.17 162.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.185 -175.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.29 110.7 19.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.499 ' HB3' HG22 ' A' ' 73' ' ' VAL . . . -69.51 -35.25 75.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -172.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.69 ' HA ' HD12 ' A' ' 137' ' ' LEU . 0.2 OUTLIER -68.35 -22.73 64.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.797 0.808 . . . . 0.0 109.791 -178.394 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.412 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 43.2 mmtm -102.68 26.5 7.92 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.767 175.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.09 176.69 7.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.475 -171.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -91.36 134.48 34.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.035 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 7.8 m-85 -120.39 136.16 54.81 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.946 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.863 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.1 p -115.62 122.39 69.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.445 0.64 . . . . 0.0 109.639 173.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.645 HG23 HD11 ' A' ' 135' ' ' LEU . 48.1 t -101.59 109.78 26.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.742 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -69.69 125.05 16.15 Favored Glycine 0 N--CA 1.448 -0.531 0 O-C-N 123.986 0.804 . . . . 0.0 113.263 -173.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.0 t -90.13 -38.58 13.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.839 0.352 . . . . 0.0 110.227 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -80.29 -43.72 20.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 111.466 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.537 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 79.8 mtt180 -125.65 107.08 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.014 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.725 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 1.2 tpp180 173.93 -177.28 0.08 Allowed 'General case' 0 C--O 1.232 0.165 0 O-C-N 123.941 0.776 . . . . 0.0 109.68 171.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.02 -57.33 19.82 Favored Glycine 0 N--CA 1.451 -0.33 0 O-C-N 123.368 0.417 . . . . 0.0 113.615 -176.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.63 -98.26 0.59 Allowed Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.63 ' HE2' ' HA ' ' A' ' 148' ' ' PRO . 4.1 mmt -86.99 -3.35 59.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.952 0.406 . . . . 0.0 110.733 173.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.7 -127.93 6.12 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.24 96.17 7.9 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.787 0.327 . . . . 0.0 110.598 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.43 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 72.6 Cg_endo -76.51 147.64 28.72 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.384 2.056 . . . . 0.0 112.498 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.725 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 32.1 mt-10 -129.33 131.68 46.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.462 -176.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.774 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -93.87 131.1 39.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.499 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.863 ' HB ' HG13 ' A' ' 100' ' ' VAL . 87.0 t -95.94 106.28 26.96 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 120.89 0.376 . . . . 0.0 110.227 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.3 Cg_endo -91.55 123.68 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.586 2.857 . . . . 0.0 112.677 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -132.97 150.42 52.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.092 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.696 ' HB2' HG22 ' A' ' 92' ' ' ILE . 9.7 t -86.9 -21.92 26.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.1 m -93.77 119.48 32.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.873 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -61.62 -48.01 82.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.096 0.474 . . . . 0.0 111.202 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.59 -29.57 70.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.618 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -62.15 -41.58 98.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.578 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 100' ' ' VAL . . . -69.87 -37.02 75.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.131 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.68 86.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.048 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.95 82.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.105 0.479 . . . . 0.0 110.452 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -60.66 -42.86 97.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.736 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.62 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 55.1 t -61.97 -42.33 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.158 177.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tp -54.36 -36.16 63.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.784 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.06 -40.1 15.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.29 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -164.52 -35.13 0.03 OUTLIER 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.742 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -49.39 156.07 1.81 Allowed Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.45 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.449 ' N ' ' HA2' ' A' ' 102' ' ' GLY . . . -94.03 -82.67 1.56 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.949 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.581 HE21 HD22 ' A' ' 135' ' ' LEU . 12.6 pt20 -130.36 150.42 51.6 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.835 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.34 113.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.366 0.603 . . . . 0.0 110.214 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.645 HD11 HG23 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -133.89 159.97 39.07 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.759 -179.047 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.69 168.63 15.07 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.69 HD12 ' HA ' ' A' ' 95' ' ' ASP . 6.0 tt -65.2 -32.08 73.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.312 0.577 . . . . 0.0 109.497 178.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.91 -10.26 59.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.735 176.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -116.4 14.92 15.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.297 -174.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.536 HD11 HD12 ' A' ' 135' ' ' LEU . 36.6 mm -71.49 121.41 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.76 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 145' ' ' VAL . 1.5 t -108.36 147.82 30.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.126 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -69.41 -22.87 63.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.122 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' A' ' 155' ' ' PRO . . . -67.4 -30.07 69.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.654 -175.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.452 ' HG3' ' HG2' ' A' ' 133' ' ' GLN . 78.1 mmm -86.44 -37.78 17.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.832 0.348 . . . . 0.0 111.189 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.527 HG13 HH12 ' A' ' 60' ' ' ARG . 13.3 t -78.81 -21.86 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.522 0.677 . . . . 0.0 110.44 -174.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -147.31 104.82 3.68 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.119 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.496 ' HB ' ' OE2' ' A' ' 150' ' ' GLU . 20.0 p -102.06 123.91 41.86 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.613 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.63 ' HA ' ' HE2' ' A' ' 109' ' ' MET . 71.9 Cg_endo -74.51 44.42 1.07 Allowed 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.405 2.737 . . . . 0.0 112.251 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 149' ' ' VAL . 6.5 t 54.79 28.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 122.067 0.937 . . . . 0.0 109.869 -174.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.496 ' OE2' ' HB ' ' A' ' 147' ' ' THR . 1.8 mp0 59.28 23.06 11.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.214 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 148' ' ' PRO . 6.9 t -81.57 13.77 2.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.792 0.806 . . . . 0.0 109.539 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . -119.55 -142.59 6.78 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.788 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.4 t -96.61 163.23 13.11 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -57.11 151.88 32.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 11.4 Cg_endo -54.39 -22.99 29.06 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.07 2.513 . . . . 0.0 113.087 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.547 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 2.1 ptp180 -174.96 -54.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.256 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.547 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -163.21 30.39 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.761 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.5 t70 54.22 68.25 0.88 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.845 0.831 . . . . 0.0 109.465 -170.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -100.51 -6.14 25.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.397 -172.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.076 -179.608 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.951 ' H ' ' HB3' ' A' ' 74' ' ' ASN . 79.8 tttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.675 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -143.15 144.75 32.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.046 0.385 . . . . 0.0 111.401 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 3.9 pt20 -149.2 140.1 22.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.595 HG23 ' HB ' ' A' ' 71' ' ' ILE . 24.2 pt -115.77 131.15 69.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.112 0.482 . . . . 0.0 110.19 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -98.75 118.22 34.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.838 HD23 ' HB2' ' A' ' 66' ' ' ALA . 8.4 mp -84.04 153.24 23.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.375 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.515 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 28.9 tt0 -74.12 126.84 31.45 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.962 177.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.82 -41.46 3.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.561 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.9 t -81.93 125.28 77.97 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.1 Cg_exo -79.09 -3.97 13.53 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.14 2.56 . . . . 0.0 112.493 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -101.82 133.54 20.69 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.59 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 61.2 Cg_endo -92.03 133.44 1.31 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.01 2.473 . . . . 0.0 112.315 176.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.9 tt -86.96 105.62 17.25 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 40.2 p90 -111.79 143.73 42.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.183 0.516 . . . . 0.0 111.468 -175.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -150.01 138.92 20.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.1 m -58.91 -37.0 75.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.95 0.405 . . . . 0.0 111.342 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.503 ' HB3' ' HD2' ' A' ' 53' ' ' ARG . 51.2 mt-30 -81.86 109.29 16.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.432 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.675 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 39.8 t -59.31 -46.77 92.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.147 0.499 . . . . 0.0 110.661 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HG3' ' H ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -57.15 -30.29 64.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.469 -178.375 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -74.6 -48.64 25.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 110.28 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.81 90.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.75 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 pt -66.05 -31.74 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.545 0.212 . . . . 0.0 110.579 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.3 90.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.781 176.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.608 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 54.5 m-85 -62.74 -37.49 86.79 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 111.444 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.725 ' HB3' HD11 ' A' ' 68' ' ' ILE . . . -63.99 -17.87 63.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.229 -175.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 -100.31 12.66 36.61 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -173.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.48 -56.41 0.34 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.457 -1.354 . . . . 0.0 113.863 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.608 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 34.2 Cg_exo -60.62 6.53 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.346 2.698 . . . . 0.0 114.458 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -66.89 105.54 1.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 170.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -128.68 77.82 1.81 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.39 0.614 . . . . 0.0 110.864 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.443 HG21 ' N ' ' A' ' 66' ' ' ALA . 5.4 tp 177.42 -52.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.723 176.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.838 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -152.28 146.33 18.34 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.515 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 66.7 Cg_endo -72.41 156.71 54.23 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.109 1.873 . . . . 0.0 111.994 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.725 HD11 ' HB3' ' A' ' 59' ' ' ALA . 46.1 pt -73.47 129.94 36.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.08 0.467 . . . . 0.0 110.577 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tt -88.86 -49.67 6.67 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -160.46 139.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.067 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.595 ' HB ' HG23 ' A' ' 38' ' ' ILE . 4.4 tt -108.94 129.87 62.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 120.912 0.387 . . . . 0.0 110.115 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -111.84 127.29 55.78 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.401 HG11 HG12 ' A' ' 52' ' ' VAL . 27.6 m -124.63 153.72 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.007 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.951 ' HB3' ' H ' ' A' ' 35' ' ' LYS . 25.7 t-20 -80.17 102.0 9.15 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.773 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 25.5 t70 -49.66 107.1 0.13 Allowed 'General case' 0 C--O 1.243 0.72 0 O-C-N 125.808 1.943 . . . . 0.0 110.973 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.518 ' HG3' ' O ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -171.36 151.56 3.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.377 -179.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.5 50.3 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.598 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.68 88.83 3.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.19 32.04 20.72 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.485 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.15 -90.87 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.991 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' HB2' HG23 ' A' ' 115' ' ' VAL . . . 61.86 33.15 17.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.541 0.686 . . . . 0.0 110.278 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.534 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 20.4 p -83.74 177.08 8.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.721 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -55.51 -35.64 65.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.811 0.339 . . . . 0.0 111.288 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -77.24 -30.37 54.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' A' ' 82' ' ' THR . 22.8 mt-30 63.88 170.28 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.498 175.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -94.44 9.73 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.547 2.165 . . . . 0.0 111.468 171.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.24 130.08 5.97 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.018 -177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -64.65 135.09 55.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.696 0.284 . . . . 0.0 110.769 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.27 -79.0 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.172 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.773 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 43.9 t30 -100.07 153.49 19.18 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -120.02 131.35 55.11 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 121.691 -0.631 . . . . 0.0 110.676 173.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.762 HG21 ' HB2' ' A' ' 118' ' ' SER . 42.1 pt -141.98 167.37 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.839 -175.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 96' ' ' LYS . . . -84.64 116.99 23.49 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 171.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.18 -39.63 78.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.596 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.857 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 2.4 p-10 -78.13 0.58 24.29 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.939 0.876 . . . . 0.0 110.645 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.493 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . 40.3 mmtm -127.18 56.49 1.52 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.235 169.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.507 ' H ' HD22 ' A' ' 137' ' ' LEU . . . -156.76 -170.12 3.21 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 121.738 -0.601 . . . . 0.0 112.101 -172.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.97 140.96 31.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.023 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 2.2 m-85 -120.68 136.75 54.76 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.09 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.502 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.0 p -113.08 120.49 63.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.773 0.797 . . . . 0.0 109.614 168.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.56 ' HB ' HE21 ' A' ' 133' ' ' GLN . 99.7 t -101.87 106.77 20.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.556 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.7 130.74 28.48 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.745 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.2 t -92.37 -28.91 16.61 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -87.26 -45.46 10.6 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.973 0.416 . . . . 0.0 110.133 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -128.93 129.8 45.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.482 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 1.004 HH21 HG11 ' A' ' 145' ' ' VAL . 36.6 ttt85 -170.07 -64.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.085 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 164.26 -44.63 0.31 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -177.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.19 -111.41 4.08 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.318 -0.467 . . . . 0.0 111.995 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.6 mtp -86.22 -3.78 59.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.178 0.514 . . . . 0.0 110.198 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.43 -126.28 3.91 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.473 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.39 92.85 4.28 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.938 0.369 . . . . 0.0 111.03 175.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.24 121.89 10.31 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.228 2.619 . . . . 0.0 112.715 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.48 139.27 49.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.026 0.441 . . . . 0.0 110.576 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.581 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -120.46 133.89 55.35 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.238 -172.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.502 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 39.9 t -100.84 105.02 35.56 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.541 -0.464 . . . . 0.0 109.942 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.9 Cg_exo -89.1 124.82 1.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.758 2.972 . . . . 0.0 111.356 171.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.579 ' HD1' ' H ' ' A' ' 119' ' ' SER . 1.7 t80 -135.73 149.13 49.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -176.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.762 ' HB2' HG21 ' A' ' 92' ' ' ILE . 24.1 t -80.35 -31.11 38.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.258 0.551 . . . . 0.0 110.273 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.579 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 16.3 m -90.08 113.37 25.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.346 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -43.04 75.54 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.402 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -63.83 -31.51 72.72 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.682 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.485 ' HG3' ' CE1' ' A' ' 117' ' ' PHE . 43.3 mm-40 -66.23 -43.0 87.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.84 175.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.1 80.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.111 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.43 79.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.874 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -59.7 -31.36 69.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.251 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -62.68 -44.02 97.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.661 HG21 ' H ' ' A' ' 132' ' ' GLY . 56.5 t -72.91 -29.21 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.469 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 9.0 tp -58.22 -35.84 72.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.016 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.68 -50.11 7.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.988 175.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.785 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.9 pt-20 -156.26 -79.95 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.39 175.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . 0.785 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.55 -129.7 11.41 Favored Glycine 0 C--N 1.335 0.502 0 O-C-N 123.522 0.514 . . . . 0.0 112.753 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.661 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -174.67 -83.01 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.56 HE21 ' HB ' ' A' ' 101' ' ' VAL . 2.8 pm0 -130.22 139.28 50.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.819 0.342 . . . . 0.0 110.516 174.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 76.4 t -98.1 124.13 50.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.703 ' HB3' HH21 ' A' ' 156' ' ' ARG . 0.3 OUTLIER -146.99 152.52 38.74 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.815 -177.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.469 ' O ' HG12 ' A' ' 140' ' ' ILE . . . -92.47 173.3 7.86 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.568 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.857 ' HG ' ' O ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -48.4 -40.73 26.8 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.305 178.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.61 -29.76 67.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.676 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.52 3.9 53.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.309 0.576 . . . . 0.0 110.33 -175.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.62 HD12 HD12 ' A' ' 135' ' ' LEU . 26.2 mm -71.37 119.43 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.279 0.561 . . . . 0.0 109.842 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.5 t -119.39 148.43 43.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.003 173.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.436 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.1 p-10 -69.05 -25.81 64.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.729 0.3 . . . . 0.0 110.41 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.69 70.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.217 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.579 ' HE2' ' HG2' ' A' ' 156' ' ' ARG . 10.6 mmt -83.51 -34.11 25.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.07 0.462 . . . . 0.0 110.596 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 1.004 HG11 HH21 ' A' ' 106' ' ' ARG . 38.8 t -78.99 -25.21 13.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.488 -173.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.4 pp -158.07 151.82 23.76 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.276 -174.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . 0.413 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 16.0 p -101.87 120.08 55.07 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.663 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 19.9 Cg_endo -62.87 -71.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.364 2.043 . . . . 0.0 111.213 175.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.13 12.63 3.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.462 ' O ' HG21 ' A' ' 151' ' ' THR . 39.4 mt-10 65.84 -76.87 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.798 -169.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 150' ' ' GLU . 1.1 t 53.71 -0.94 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.986 1.314 . . . . 0.0 114.348 176.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . 71.86 30.24 66.14 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.027 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.6 p -86.05 141.62 29.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.82 0.31 . . . . 0.0 110.509 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.0 125.33 91.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.577 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.17 -95.38 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.062 2.508 . . . . 0.0 112.647 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.703 HH21 ' HB3' ' A' ' 135' ' ' LEU . 1.9 ptp180 -67.89 -32.4 72.86 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 172.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 156' ' ' ARG . . . 172.67 -175.1 0.05 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.981 -1.918 . . . . 0.0 106.483 -174.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -82.59 60.72 5.34 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 122.013 0.911 . . . . 0.0 109.368 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -99.19 -15.88 18.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.196 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--O 1.253 1.251 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.999 -176.791 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 85.6 tttt . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.552 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -143.56 144.17 31.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.413 0.149 . . . . 0.0 110.823 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 29.0 pt20 -149.01 134.7 18.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.148 0.499 . . . . 0.0 110.767 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.641 HG21 ' HB ' ' A' ' 71' ' ' ILE . 37.6 pt -115.92 129.18 72.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.657 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -98.87 116.47 31.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.597 HD23 ' HB2' ' A' ' 66' ' ' ALA . 8.5 mp -91.85 142.72 27.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.873 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.915 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 34.4 tt0 -74.26 125.06 27.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.603 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.93 -23.74 33.0 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.731 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.501 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 39.7 t -88.49 129.41 49.31 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.4 Cg_exo -77.58 -3.35 13.51 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.897 2.398 . . . . 0.0 112.323 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.25 139.69 32.36 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.813 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.76 149.47 8.53 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.596 2.197 . . . . 0.0 112.167 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.424 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 10.3 tt -89.07 111.57 22.34 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -124.11 135.95 53.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.204 0.526 . . . . 0.0 111.623 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -146.82 162.65 38.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.567 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 30.2 t -72.46 -41.89 65.56 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.913 ' HG2' ' HB2' ' A' ' 83' ' ' TRP . 37.9 mt-30 -65.65 113.08 3.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.485 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.552 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 4.5 t -72.66 -52.03 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.23 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.498 ' HA ' HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -52.09 -35.71 48.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.444 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 51' ' ' GLN . 29.1 t70 -76.05 -51.9 11.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.577 0.227 . . . . 0.0 110.999 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.89 94.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.36 . . . . 0.0 111.394 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.806 HD12 ' HB1' ' A' ' 114' ' ' ALA . 23.9 pt -66.91 -30.56 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.691 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.24 97.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.663 0.268 . . . . 0.0 110.663 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.65 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 16.6 m-85 -63.05 -34.02 76.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.364 . . . . 0.0 110.785 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.621 ' HB2' HG22 ' A' ' 38' ' ' ILE . . . -69.68 -16.81 63.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.557 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.489 HH12 ' HG2' ' A' ' 112' ' ' PRO . 49.9 mtm180 -102.52 -0.7 31.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.049 -175.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -154.57 -73.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.998 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.65 ' HD2' ' HA ' ' A' ' 58' ' ' TYR . 76.2 Cg_exo -55.65 0.32 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.085 3.19 . . . . 0.0 115.095 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -79.78 9.09 5.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.935 0.397 . . . . 0.0 111.142 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 84.3 mm-40 -62.64 -18.01 61.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.89 0.376 . . . . 0.0 111.452 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.4 tp -70.49 -45.01 76.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.697 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.597 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -152.13 140.68 13.65 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.915 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 64.7 Cg_endo -68.31 143.76 59.62 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 122.244 1.963 . . . . 0.0 112.021 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.8 pt -74.07 113.11 11.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.229 0.538 . . . . 0.0 110.333 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.6 -50.8 10.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.8 p -161.2 140.45 2.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.227 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.641 ' HB ' HG21 ' A' ' 38' ' ' ILE . 2.7 tt -112.99 131.9 63.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.628 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -111.84 135.51 52.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.429 HG22 HG13 ' A' ' 92' ' ' ILE . 27.8 m -131.59 140.82 47.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.445 0.64 . . . . 0.0 111.161 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.502 ' HB3' ' HE1' ' A' ' 76' ' ' MET . 13.0 m120 -90.28 99.9 12.83 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -54.63 104.67 0.12 Allowed 'General case' 0 C--O 1.239 0.529 0 O-C-N 124.485 1.116 . . . . 0.0 111.025 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.635 ' O ' ' HD2' ' A' ' 86' ' ' PRO . 64.8 mtt -144.61 52.55 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.414 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.05 -52.56 4.51 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.338 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 67.12 -84.36 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.255 0.622 . . . . 0.0 112.221 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.71 -15.99 15.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.824 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.51 -43.25 96.88 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.64 ' CB ' ' HD3' ' A' ' 86' ' ' PRO . . . -95.02 -154.79 0.44 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.374 173.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.0 p -103.6 177.76 4.75 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.864 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.913 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 3.3 p90 -55.49 -13.27 1.43 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 172.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.61 -35.61 39.27 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 71.74 150.13 0.13 Allowed Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.38 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.64 ' HD3' ' CB ' ' A' ' 81' ' ' ALA . 48.2 Cg_endo -72.89 -61.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.455 2.104 . . . . 0.0 113.1 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.51 -179.21 39.65 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.372 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.14 136.82 42.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.196 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.3 -113.18 1.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.834 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -100.51 152.02 20.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.515 0.198 . . . . 0.0 111.053 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -105.25 124.94 50.39 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 168.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 1.005 HG21 ' HB2' ' A' ' 118' ' ' SER . 8.8 pt -145.81 164.48 10.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.87 107.22 19.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.578 ' HB3' ' HE1' ' A' ' 99' ' ' TYR . . . -57.64 -33.14 67.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 111.188 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.814 ' HA ' HD12 ' A' ' 137' ' ' LEU . 9.1 t70 -62.12 -28.17 69.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.033 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -114.65 33.44 5.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.201 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -138.24 -175.07 3.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.739 0.304 . . . . 0.0 110.902 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -91.34 138.98 31.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.497 0.665 . . . . 0.0 110.61 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.578 ' HE1' ' HB3' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -120.52 135.03 55.2 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.565 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.905 HG13 HG13 ' A' ' 115' ' ' VAL . 1.1 p -118.57 124.63 73.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.604 0.716 . . . . 0.0 109.752 169.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 145' ' ' VAL . 65.3 t -101.65 117.82 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.149 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.702 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -77.87 125.82 7.42 Favored Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.452 -171.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -91.88 -36.71 13.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 110.909 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.11 -43.65 23.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.37 . . . . 0.0 111.138 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.534 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 71.4 mtp180 -131.02 96.97 4.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.543 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.794 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 2.8 tpp180 172.82 175.32 0.1 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.663 0.602 . . . . 0.0 109.905 173.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.1 70.4 3.15 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.366 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.19 -42.68 98.73 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.358 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.6 mtm -109.55 16.52 22.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.275 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -139.21 -122.33 1.98 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.475 -175.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.36 92.83 4.24 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 110.915 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.561 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 73.9 Cg_endo -77.3 135.34 14.95 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.61 2.207 . . . . 0.0 112.958 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.794 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 30.9 mt-10 -115.13 146.45 41.34 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.029 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.806 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -118.42 133.14 56.11 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.738 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.905 HG13 HG13 ' A' ' 100' ' ' VAL . 0.5 OUTLIER -101.86 105.69 43.03 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.685 171.047 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 6.6 Cg_exo -81.99 123.8 4.21 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 124.425 3.416 . . . . 0.0 111.77 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.723 ' HD1' ' H ' ' A' ' 119' ' ' SER . 1.2 t80 -135.16 149.59 49.99 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.988 0.423 . . . . 0.0 110.154 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 1.005 ' HB2' HG21 ' A' ' 92' ' ' ILE . 29.2 t -78.34 -34.68 48.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.615 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.723 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 8.0 m -91.34 116.93 29.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.211 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -58.14 -44.56 87.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.965 0.412 . . . . 0.0 111.495 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -61.63 -31.56 71.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.099 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -67.48 -41.52 84.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.655 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.39 83.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.128 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.25 92.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.774 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.16 86.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.101 0.477 . . . . 0.0 110.567 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -62.0 -38.71 89.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.84 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.599 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 48.2 t -65.99 -42.8 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.903 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.2 mt -53.96 -35.36 61.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.643 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.01 -46.6 11.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.0 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -159.07 -34.58 0.06 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.702 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -50.43 157.86 1.98 Allowed Glycine 0 C--N 1.32 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.024 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -101.27 -68.5 0.83 Allowed Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.74 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.441 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.2 140.96 50.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.741 0.305 . . . . 0.0 110.831 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 89.0 t -98.38 112.87 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.284 0.564 . . . . 0.0 109.664 172.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.815 HD11 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -137.58 144.88 42.23 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.766 -178.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.96 157.59 37.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.814 HD12 ' HA ' ' A' ' 95' ' ' ASP . 4.5 tt -63.32 -28.85 70.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.418 0.628 . . . . 0.0 109.673 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.32 -9.56 53.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.425 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -123.45 18.1 9.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.09 0.472 . . . . 0.0 110.539 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.815 HD11 HD11 ' A' ' 135' ' ' LEU . 38.2 mm -71.78 121.65 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.197 0.522 . . . . 0.0 110.387 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 1.001 HG22 ' HA ' ' A' ' 156' ' ' ARG . 2.9 t -111.47 148.24 33.57 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.722 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.486 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.3 p-10 -69.27 -22.31 63.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.681 0.277 . . . . 0.0 110.656 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.27 -33.41 74.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.936 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 1.024 ' HA ' ' HE1' ' A' ' 144' ' ' MET . 7.2 mmt -87.26 -30.14 21.14 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.806 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 141' ' ' THR . 5.0 t -80.53 -22.91 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.991 0.424 . . . . 0.0 110.746 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.6 pp -154.47 134.26 12.93 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.372 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.9 p -116.39 149.37 43.55 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.162 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -58.99 -58.05 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.476 2.117 . . . . 0.0 109.621 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.517 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 25.7 t -127.56 -72.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 165.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.517 ' HG3' ' O ' ' A' ' 149' ' ' VAL . 7.5 mt-10 165.2 -77.03 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.438 1.495 . . . . 0.0 108.493 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.7 t 46.18 28.99 0.73 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.504 1.122 . . . . 0.0 113.129 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 74.92 64.36 2.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.286 -176.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.6 t -89.93 162.08 15.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.922 0.392 . . . . 0.0 110.873 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -88.69 150.97 47.12 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.108 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.681 ' HA ' ' SD ' ' A' ' 144' ' ' MET . 60.3 Cg_endo -73.12 -136.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.991 2.461 . . . . 0.0 113.125 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.001 ' HA ' HG22 ' A' ' 141' ' ' THR . 0.0 OUTLIER -57.21 -29.14 63.49 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -174.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -179.49 20.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.371 0.419 . . . . 0.0 110.638 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.1 t70 48.49 70.52 0.44 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.684 0.754 . . . . 0.0 109.133 -169.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.488 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 14.3 t70 -145.14 -42.18 0.23 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.53 -167.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 C--O 1.247 0.963 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.691 -179.787 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.93 ' H ' ' HB2' ' A' ' 74' ' ' ASN . 16.5 ttmm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.557 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -133.14 141.88 48.37 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.84 175.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 9.4 pt20 -149.65 132.66 16.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.828 174.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.582 HG23 ' HB2' ' A' ' 59' ' ' ALA . 28.6 pt -115.95 133.68 61.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.3 0.571 . . . . 0.0 111.458 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -103.81 119.51 39.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.739 HD22 ' HB2' ' A' ' 66' ' ' ALA . 11.1 mp -89.63 153.95 20.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.276 0.56 . . . . 0.0 111.503 -174.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.586 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 29.7 tt0 -71.68 125.54 27.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.635 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.31 -27.36 5.7 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.199 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.504 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.9 t -87.98 128.38 54.14 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 8.9 Cg_endo -87.29 -1.35 7.74 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.122 2.548 . . . . 0.0 112.612 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.23 132.98 21.83 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.828 0.347 . . . . 0.0 111.053 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -87.77 124.57 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.675 2.25 . . . . 0.0 112.036 174.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 7.2 tt -80.56 109.0 14.67 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -108.84 143.13 38.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.988 0.423 . . . . 0.0 110.831 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.539 ' HD1' ' H ' ' A' ' 51' ' ' GLN . 1.9 t80 -144.66 145.24 31.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.696 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.7 m -63.97 -34.95 79.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.194 0.521 . . . . 0.0 110.201 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.618 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 76.1 mt-30 -83.38 105.96 14.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.051 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.557 HG12 ' HB1' ' A' ' 36' ' ' ALA . 8.6 t -56.37 -51.46 63.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.285 0.564 . . . . 0.0 109.57 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.635 ' HB3' ' HB3' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -55.5 -32.84 63.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.682 -1.145 . . . . 0.0 113.205 -178.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.536 ' HB2' HH11 ' A' ' 53' ' ' ARG . 22.8 t70 -76.28 -50.08 15.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.013 0.435 . . . . 0.0 110.839 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.47 93.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.276 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.713 HD12 ' HB1' ' A' ' 114' ' ' ALA . 16.2 pt -70.16 -30.53 43.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.625 0.25 . . . . 0.0 110.628 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.07 82.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.141 0.496 . . . . 0.0 110.075 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -62.01 -34.91 77.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.13 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.65 ' HB3' HD11 ' A' ' 68' ' ' ILE . . . -72.89 -18.17 61.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.993 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -96.52 12.47 31.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -172.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.32 -61.51 0.1 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.521 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.35 22.43 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.145 2.563 . . . . 0.0 114.8 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.65 74.09 9.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.134 0.968 . . . . 0.0 110.376 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.448 ' O ' HG22 ' A' ' 65' ' ' ILE . 14.0 mt-30 -79.09 145.82 33.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.25 -172.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 64' ' ' GLN . 1.9 tp 72.74 -38.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.91 1.284 . . . . 0.0 112.345 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.739 ' HB2' HD22 ' A' ' 40' ' ' LEU . . . -133.44 139.57 34.35 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 122.007 -0.433 . . . . 0.0 110.413 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.586 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 96.2 Cg_endo -85.59 159.97 10.8 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.95 2.434 . . . . 0.0 112.061 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 59' ' ' ALA . 28.0 pt -77.08 113.35 16.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.31 0.576 . . . . 0.0 110.465 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -77.54 -46.81 21.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.7 p -158.28 138.82 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.395 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.586 HD12 HG23 ' A' ' 56' ' ' ILE . 2.6 tt -116.94 134.35 60.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.027 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.94 128.78 56.26 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 94' ' ' ALA . 29.0 m -126.96 151.93 34.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.26 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.93 ' HB2' ' H ' ' A' ' 35' ' ' LYS . 16.5 m120 -91.49 105.65 17.91 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.54 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.575 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 18.3 t70 -48.26 134.02 15.04 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 125.928 2.018 . . . . 0.0 110.844 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.497 ' SD ' ' HD2' ' A' ' 86' ' ' PRO . 23.9 mmt -127.04 176.55 7.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -167.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.95 -19.38 56.37 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.73 173.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 83.47 -45.16 0.11 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.16 0.584 . . . . 0.0 112.33 168.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.54 -44.22 76.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.061 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.03 -87.1 0.78 Allowed Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.506 173.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 53.73 26.16 5.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.52 0.676 . . . . 0.0 111.699 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.0 p -83.67 179.16 7.68 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.983 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.618 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 48.6 p90 -59.5 -24.2 63.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.733 0.301 . . . . 0.0 111.267 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -81.37 -35.29 30.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.824 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 68.74 140.22 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.668 174.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.497 ' HD2' ' SD ' ' A' ' 76' ' ' MET . 96.5 Cg_endo -85.14 31.71 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.36 2.04 . . . . 0.0 113.577 -173.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 118.01 -171.83 14.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.125 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.4 147.22 36.14 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.493 0.317 . . . . 0.0 110.728 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -141.58 -158.06 7.4 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.169 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.597 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 41.9 m-80 -100.17 150.44 22.51 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 40.8 p-90 -98.56 130.28 45.11 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.444 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.745 HG23 ' HB2' ' A' ' 118' ' ' SER . 14.1 pt -143.97 160.6 15.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.601 -173.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.68 101.16 9.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.108 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.551 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -62.11 -38.95 90.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.349 -172.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.658 ' HA ' HD12 ' A' ' 137' ' ' LEU . 14.0 t70 -58.85 -30.43 67.69 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.666 0.746 . . . . 0.0 110.301 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -107.96 25.73 11.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.123 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.13 -177.21 3.79 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.847 0.356 . . . . 0.0 110.485 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -97.79 136.81 37.59 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.527 0.68 . . . . 0.0 110.475 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.503 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 7.6 m-85 -120.5 136.18 54.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.88 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.682 HG13 ' HB ' ' A' ' 115' ' ' VAL . 3.2 p -114.77 127.89 72.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.423 0.63 . . . . 0.0 109.762 174.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.573 HG11 ' HA ' ' A' ' 145' ' ' VAL . 96.4 t -101.46 103.49 14.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -80.49 123.16 5.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.555 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.8 t -92.51 -29.54 16.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.587 0.232 . . . . 0.0 110.756 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.18 60.74 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -171.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -139.19 101.53 4.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.421 173.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.946 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 19.4 tpp180 -175.06 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.845 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.65 42.09 0.15 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.113 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.97 -34.38 89.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.266 -0.968 . . . . 0.0 111.715 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.0 ttt -109.5 2.23 20.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.096 0.474 . . . . 0.0 110.326 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -136.56 -123.52 2.26 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.72 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.8 99.08 12.61 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.977 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 72.1 Cg_endo -79.18 151.38 23.44 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.143 2.562 . . . . 0.0 113.696 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.946 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 25.9 mt-10 -128.82 146.52 50.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.603 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.713 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -93.79 130.93 39.62 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.945 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.682 ' HB ' HG13 ' A' ' 100' ' ' VAL . 55.4 t -101.28 106.4 45.13 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 6.1 Cg_exo -86.26 132.52 3.79 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.656 2.904 . . . . 0.0 112.305 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.744 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.8 t80 -137.66 149.43 46.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.745 ' HB2' HG23 ' A' ' 92' ' ' ILE . 35.5 t -77.97 -37.88 46.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.846 0.355 . . . . 0.0 111.148 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.744 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 17.8 m -95.75 129.74 42.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.826 0.346 . . . . 0.0 110.645 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -65.92 -49.72 66.97 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.229 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -63.18 -29.65 70.95 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.554 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -65.73 -42.92 90.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.554 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.7 -36.95 73.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.229 0.538 . . . . 0.0 110.035 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.03 -34.56 71.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.846 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.69 81.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.036 0.446 . . . . 0.0 110.356 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -62.43 -37.59 86.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.751 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.644 HG21 ' H ' ' A' ' 132' ' ' GLY . 93.2 t -70.95 -38.13 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.974 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.1 mt -53.24 -50.95 63.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.368 0.604 . . . . 0.0 110.11 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.59 78.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.133 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.749 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.3 pt-20 -165.55 -82.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.58 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.749 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 39.6 -132.79 2.15 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 123.915 0.759 . . . . 0.0 114.45 175.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.644 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -171.23 -93.37 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.77 139.66 51.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.711 0.291 . . . . 0.0 110.715 174.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.406 HG22 HG22 ' A' ' 127' ' ' VAL . 99.4 t -97.43 123.17 49.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.378 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.844 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -147.02 164.38 33.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.563 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.14 164.38 15.04 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.658 HD12 ' HA ' ' A' ' 95' ' ' ASP . 4.1 tt -61.44 -40.05 93.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.97 -8.62 38.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.592 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -124.67 17.96 8.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.248 0.547 . . . . 0.0 110.748 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.844 HD11 HD12 ' A' ' 135' ' ' LEU . 26.1 mm -71.78 121.92 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -116.86 146.0 43.2 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.96 -30.73 68.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.717 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.76 -28.78 68.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.923 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.6 mmt -77.62 -41.21 39.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.783 0.325 . . . . 0.0 110.953 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.573 ' HA ' HG11 ' A' ' 101' ' ' VAL . 3.0 t -81.52 -23.79 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.393 . . . . 0.0 111.217 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -156.62 159.33 38.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.552 -175.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.433 ' HB ' ' HG2' ' A' ' 150' ' ' GLU . 3.4 p -100.02 120.35 57.11 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.657 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.26 -69.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.1 2.533 . . . . 0.0 112.406 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 149' ' ' VAL . 10.6 t -129.69 0.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.288 0.566 . . . . 0.0 109.646 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.433 ' HG2' ' HB ' ' A' ' 147' ' ' THR . 40.1 mt-10 57.36 55.8 5.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.422 -175.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 t -90.94 -6.84 53.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.055 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 82.42 26.57 46.78 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.535 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 p -84.41 161.93 20.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.667 0.27 . . . . 0.0 110.646 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.831 ' HB3' ' H ' ' A' ' 158' ' ' ASP . 43.3 mp0 -61.38 131.96 92.58 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.59 -24.68 25.61 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.698 2.265 . . . . 0.0 113.253 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.513 ' HD2' ' HB1' ' A' ' 157' ' ' ALA . 5.8 ppt_? -155.13 -39.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.14 0.495 . . . . 0.0 110.527 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.513 ' HB1' ' HD2' ' A' ' 156' ' ' ARG . . . 179.33 53.89 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.831 ' H ' ' HB3' ' A' ' 154' ' ' GLU . 13.5 t70 63.38 -144.9 0.34 Allowed 'General case' 0 C--O 1.237 0.424 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 -156.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -154.17 161.49 41.82 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 119.662 1.119 . . . . 0.0 112.408 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 C--O 1.248 0.975 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.343 -173.281 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 28.7 tttm . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.778 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -135.91 143.71 45.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.541 0.21 . . . . 0.0 111.099 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -149.35 139.55 22.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.645 0.26 . . . . 0.0 110.417 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.417 HG21 ' HB ' ' A' ' 71' ' ' ILE . 32.5 pt -116.01 136.1 54.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.992 0.425 . . . . 0.0 111.429 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -104.87 123.71 48.2 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 66' ' ' ALA . 8.9 mp -97.74 148.99 22.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.187 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.783 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 40.6 tt0 -74.04 125.5 28.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.616 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.03 -29.28 10.23 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.592 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 37.1 t -92.4 124.98 57.79 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.1 Cg_exo -81.26 -7.39 12.94 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.878 2.385 . . . . 0.0 111.958 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -113.71 133.95 22.14 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.632 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -91.01 143.24 3.25 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.084 2.523 . . . . 0.0 112.656 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.2 tt -89.41 121.41 31.63 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -107.85 147.22 31.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 111.527 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.495 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 1.5 m-85 -143.12 141.94 31.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.146 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.5 m -72.42 -28.73 63.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.0 109.487 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.52 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 17.1 mt-30 -86.84 109.39 19.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.92 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.778 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 17.2 t -63.54 -51.17 73.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.294 0.569 . . . . 0.0 109.909 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.645 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.33 -29.07 60.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.111 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.645 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 8.8 t70 -76.21 -47.27 24.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.532 -176.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -72.31 -36.08 68.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.485 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.505 ' CD1' ' HB1' ' A' ' 114' ' ' ALA . 22.8 pt -68.23 -35.24 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.436 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.31 -40.96 81.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.03 0.443 . . . . 0.0 110.338 172.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.479 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 33.2 t80 -62.29 -28.31 69.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.686 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.1 -15.9 61.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.288 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.6 mtp-105 -98.19 11.71 36.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -172.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.96 -60.97 0.09 OUTLIER Glycine 0 CA--C 1.52 0.404 0 C-N-CA 119.274 -1.441 . . . . 0.0 114.469 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 58' ' ' TYR . 37.5 Cg_exo -59.81 -7.6 6.24 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.265 2.643 . . . . 0.0 115.149 -176.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.852 ' HG3' HG23 ' A' ' 68' ' ' ILE . 3.2 pm0 -77.41 89.61 3.8 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.41 1.1 . . . . 0.0 109.604 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -106.78 -24.64 12.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.045 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.2 tp -68.6 -40.21 81.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.275 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.545 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -152.24 152.65 29.8 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.538 177.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.783 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 59.8 Cg_endo -72.65 160.03 47.37 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.259 1.973 . . . . 0.0 111.447 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.852 HG23 ' HG3' ' A' ' 63' ' ' GLU . 29.1 pt -80.35 132.52 31.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.05 0.452 . . . . 0.0 111.035 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.08 -51.89 3.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -161.23 138.56 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.469 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.524 HG23 ' HB2' ' A' ' 95' ' ' ASP . 2.7 tt -108.15 134.64 49.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.153 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -111.88 130.07 55.95 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.95 145.61 27.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.026 0.441 . . . . 0.0 109.877 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 17.0 m120 -85.56 100.87 12.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.246 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -56.24 109.21 0.56 Allowed 'General case' 0 C--O 1.238 0.48 0 O-C-N 125.292 1.62 . . . . 0.0 110.136 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.496 ' SD ' ' HG2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -159.73 107.23 1.7 Allowed 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.291 -179.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.21 -68.3 2.05 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.399 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.553 ' HB2' HG11 ' A' ' 115' ' ' VAL . . . 67.42 -50.85 0.5 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.72 0.808 . . . . 0.0 112.51 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.85 -36.3 69.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.066 0.46 . . . . 0.0 110.547 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.31 -71.3 1.16 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . 51.41 54.49 11.0 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 124.176 0.574 . . . . 0.0 112.052 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.5 p -83.82 175.94 9.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.52 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 28.0 p-90 -66.53 -20.0 65.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.152 0.501 . . . . 0.0 110.254 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -84.76 -26.28 27.69 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.655 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 63.76 171.49 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.604 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.951 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.496 ' HG2' ' SD ' ' A' ' 76' ' ' MET . 38.4 Cg_endo -92.16 0.77 4.16 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.636 1.557 . . . . 0.0 112.06 172.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.3 -168.55 20.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.869 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.16 146.45 37.09 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.22 -166.55 12.15 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.159 -1.019 . . . . 0.0 113.277 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.3 t-20 -77.65 152.34 33.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.133 -0.534 . . . . 0.0 110.087 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -98.05 128.7 44.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.436 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.562 HD11 ' HG ' ' A' ' 118' ' ' SER . 44.3 pt -140.57 143.59 28.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.77 -175.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.92 102.44 4.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.177 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.91 78.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.237 0.542 . . . . 0.0 111.066 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.673 ' HA ' HD12 ' A' ' 137' ' ' LEU . 21.8 t70 -61.85 -24.63 67.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.64 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -115.97 27.56 9.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.995 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.35 178.84 5.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.651 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -92.67 136.02 33.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.431 0.634 . . . . 0.0 110.592 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.56 ' HH ' HD13 ' A' ' 137' ' ' LEU . 8.7 m-85 -120.54 136.22 54.85 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.739 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.726 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.7 p -113.9 125.98 71.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 CA-C-O 121.835 0.826 . . . . 0.0 110.423 173.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.656 ' HA ' HH11 ' A' ' 106' ' ' ARG . 40.8 t -102.03 113.4 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.461 174.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.66 122.57 7.2 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 119.975 -1.107 . . . . 0.0 111.553 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t -89.03 -28.46 20.15 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.34 -44.25 12.98 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.861 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.667 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 60.9 mtp180 -146.01 127.16 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.322 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.656 HH11 ' HA ' ' A' ' 101' ' ' VAL . 7.6 ttt180 -176.58 -53.37 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.626 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 151.39 26.33 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.28 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.26 -38.15 92.86 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.919 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 67.4 mtt -109.36 21.34 17.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.73 0.3 . . . . 0.0 110.637 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.55 -125.5 0.93 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.816 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.32 101.7 24.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.942 0.401 . . . . 0.0 110.375 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.585 ' HA ' ' HA3' ' A' ' 107' ' ' GLY . 43.0 Cg_endo -66.94 123.4 10.93 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 123.229 2.619 . . . . 0.0 113.301 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.38 131.13 56.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.79 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.591 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -98.13 131.77 44.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.85 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.726 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 93.3 t -98.04 104.54 22.87 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.826 174.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.0 Cg_endo -96.53 127.18 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.975 3.117 . . . . 0.0 112.064 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.514 ' CE2' ' HG3' ' A' ' 122' ' ' GLU . 1.1 t80 -147.06 148.78 32.0 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.562 ' HG ' HD11 ' A' ' 92' ' ' ILE . 16.4 m -86.87 -17.54 33.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.938 0.399 . . . . 0.0 110.759 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.465 ' H ' ' HD2' ' A' ' 117' ' ' PHE . 43.9 m -92.3 107.56 19.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.922 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.5 -44.62 72.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.782 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -63.42 -28.03 69.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.311 -173.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.514 ' HG3' ' CE2' ' A' ' 117' ' ' PHE . 40.9 mm-40 -66.4 -44.64 82.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.067 0.46 . . . . 0.0 110.242 174.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.05 77.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.364 0.602 . . . . 0.0 109.707 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.67 95.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.571 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -59.8 -33.85 72.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.295 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -64.37 -43.75 93.54 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.649 HG21 ' H ' ' A' ' 132' ' ' GLY . 40.5 t -72.95 -28.62 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.277 0.561 . . . . 0.0 110.397 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.3 tp -57.6 -38.64 75.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.921 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.02 -46.46 11.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.419 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.733 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.5 pt-20 -156.58 -80.05 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.621 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.733 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.36 -133.43 10.85 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 114.249 0.46 . . . . 0.0 114.249 174.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.649 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -178.39 -85.47 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.485 ' HG3' ' SD ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -130.16 139.5 50.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.629 0.252 . . . . 0.0 110.975 178.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.2 t -103.72 112.85 38.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.522 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.775 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -139.7 165.5 27.1 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.016 -175.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.81 161.29 14.92 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 95' ' ' ASP . 1.6 tt -60.77 -31.03 70.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.188 0.518 . . . . 0.0 110.086 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.59 -22.91 67.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.645 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.28 26.01 9.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.043 -174.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.775 HD11 HD12 ' A' ' 135' ' ' LEU . 31.1 mm -71.69 119.48 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.479 ' CG2' ' HG2' ' A' ' 144' ' ' MET . 5.6 t -119.49 149.48 41.82 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.068 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.431 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 15.7 p-10 -68.99 -27.45 65.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.93 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.67 70.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.667 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.485 ' SD ' ' HG3' ' A' ' 133' ' ' GLN . 12.8 mmt -75.73 -37.66 59.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.968 0.413 . . . . 0.0 110.699 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.69 -23.44 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.48 -171.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.5 pp -153.0 142.42 21.69 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.209 -174.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.4 p -122.75 150.33 58.26 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.589 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.07 -59.75 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.293 1.995 . . . . 0.0 109.592 171.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.599 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 28.7 t -119.73 -71.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 166.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.599 ' HG3' ' O ' ' A' ' 149' ' ' VAL . 11.4 mt-10 172.28 -76.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.625 1.57 . . . . 0.0 107.569 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 150' ' ' GLU . 0.6 OUTLIER 64.35 -31.17 0.12 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.878 1.271 . . . . 0.0 113.973 173.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . 97.41 54.99 1.2 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -175.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.2 t -102.66 144.68 30.74 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.638 ' HG2' ' HB3' ' A' ' 158' ' ' ASP . 2.2 mp0 -57.71 126.26 75.43 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 110.66 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 157' ' ' ALA . 59.8 Cg_endo -73.85 -85.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.029 2.486 . . . . 0.0 113.236 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.405 ' HD2' ' HB3' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -75.5 -27.23 58.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.419 1.104 . . . . 0.0 108.089 174.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.527 ' O ' ' HD2' ' A' ' 155' ' ' PRO . . . 165.73 -162.9 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 112.563 -2.108 . . . . 0.0 105.448 -170.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.638 ' HB3' ' HG2' ' A' ' 154' ' ' GLU . 4.0 p30 -106.26 17.45 23.44 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 36.1 t70 -66.26 -83.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.475 -1.238 . . . . 0.0 111.358 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.558 176.557 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 50' ' ' SER . 88.0 tttt . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.553 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . . . -132.89 145.05 50.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.713 0.292 . . . . 0.0 111.226 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 10.4 pt20 -149.13 134.55 18.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.413 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.632 HG22 ' HB2' ' A' ' 59' ' ' ALA . 22.3 pt -115.58 135.69 54.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.183 0.516 . . . . 0.0 110.923 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -104.73 119.64 39.47 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.528 HD23 ' HB2' ' A' ' 66' ' ' ALA . 10.5 mp -81.16 151.66 28.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.38 -175.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.34 125.53 28.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.374 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.7 -36.75 3.22 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.634 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 41.5 t -81.6 125.45 78.36 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.932 0.396 . . . . 0.0 110.359 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.5 Cg_exo -78.74 -1.42 11.58 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.179 2.586 . . . . 0.0 112.289 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -114.63 134.01 22.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.69 0.281 . . . . 0.0 111.106 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -93.37 162.25 2.45 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.331 2.687 . . . . 0.0 112.69 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.5 tt -115.21 116.27 28.07 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 20.6 p90 -119.62 146.04 45.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.286 0.565 . . . . 0.0 111.732 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -149.96 143.84 25.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.068 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 16.4 m -60.24 -45.61 92.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.096 0.475 . . . . 0.0 110.76 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.585 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 66.8 mt-30 -69.7 111.1 5.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.493 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.52 HG21 ' H ' ' A' ' 35' ' ' LYS . 8.9 t -61.95 -52.42 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.948 0.404 . . . . 0.0 110.456 -177.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.552 HH11 ' HB2' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.86 -29.9 56.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.411 178.59 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.552 ' HB2' HH11 ' A' ' 53' ' ' ARG . 29.0 t70 -76.16 -51.56 11.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.953 0.406 . . . . 0.0 110.234 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.732 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -68.02 -38.3 82.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.676 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.436 ' CD1' ' HB1' ' A' ' 114' ' ' ALA . 28.3 pt -65.82 -30.24 49.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.66 96.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.678 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.732 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 70.2 m-85 -60.4 -44.97 95.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.712 0.292 . . . . 0.0 110.847 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.632 ' HB2' HG22 ' A' ' 38' ' ' ILE . . . -61.01 -18.18 56.25 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -105.05 12.5 32.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.824 0.345 . . . . 0.0 111.396 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.91 -85.4 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.34 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -48.05 -55.3 4.15 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.672 2.914 . . . . 0.0 113.858 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 57.21 -89.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.775 0.672 . . . . 0.0 110.43 -173.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HB3' HD22 ' A' ' 40' ' ' LEU . 58.7 tt0 -178.97 -59.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tp -165.87 -40.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.048 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.528 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -94.12 152.16 40.15 Favored Pre-proline 0 N--CA 1.446 -0.675 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.007 173.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.59 161.38 46.25 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.768 1.645 . . . . 0.0 111.305 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.5 pt -73.79 136.98 24.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.196 0.522 . . . . 0.0 110.786 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tt -98.37 -47.89 5.25 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.01 138.75 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.8 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.536 HG22 ' HB3' ' A' ' 95' ' ' ASP . 2.8 tt -111.08 133.23 57.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.079 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -112.86 145.06 41.35 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 36' ' ' ALA . 18.8 m -136.35 155.88 35.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.231 0.538 . . . . 0.0 110.912 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -91.21 102.65 15.37 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -57.0 108.53 0.52 Allowed 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 125.034 1.459 . . . . 0.0 111.252 -175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.584 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 1.6 mmt -161.12 62.02 0.29 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.555 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.913 ' HA2' ' HB3' ' A' ' 81' ' ' ALA . . . -100.15 27.02 22.28 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.78 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.44 97.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.94 0.435 . . . . 0.0 111.067 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 56.4 33.97 23.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.398 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.56 -59.7 0.22 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 119.148 -1.501 . . . . 0.0 114.566 176.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.913 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . 60.64 56.55 2.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.364 0.602 . . . . 0.0 110.375 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.6 p -83.99 177.18 8.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.069 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.585 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 24.5 p90 -66.71 -24.21 66.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.267 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.85 -31.89 27.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 66.59 157.36 0.13 Allowed Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.059 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.584 ' HD2' ' HB3' ' A' ' 76' ' ' MET . 21.8 Cg_exo -70.76 -22.02 28.05 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.532 2.155 . . . . 0.0 111.1 170.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . 146.87 -162.99 28.61 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.515 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.74 141.95 42.51 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.412 ' HA3' ' HG2' ' A' ' 76' ' ' MET . . . -131.11 -156.14 8.42 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.484 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -96.66 155.72 16.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.442 -175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -97.53 127.39 43.45 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.694 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.786 HD13 ' HB2' ' A' ' 118' ' ' SER . 26.6 pt -145.3 166.97 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.33 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.73 117.32 29.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.452 ' HB3' HG12 ' A' ' 73' ' ' VAL . . . -69.86 -35.54 74.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.737 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -70.63 -18.22 62.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.932 0.872 . . . . 0.0 109.718 -178.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.459 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 41.1 mmtm -107.12 21.06 18.12 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.678 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.21 177.59 4.83 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.797 0.332 . . . . 0.0 110.87 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -92.02 133.36 35.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.966 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -120.66 135.76 55.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.465 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.437 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.7 p -112.16 127.84 69.11 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-O 121.695 0.759 . . . . 0.0 110.422 174.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.521 ' HA ' HH11 ' A' ' 106' ' ' ARG . 43.8 t -102.89 103.92 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.119 174.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.441 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -70.35 125.02 14.01 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.453 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.6 m -92.21 -14.42 29.04 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.186 0.517 . . . . 0.0 110.032 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.451 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -91.88 -43.57 9.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.008 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.656 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 54.1 mtp180 -121.41 -107.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 119.292 -0.385 . . . . 0.0 109.988 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.521 HH11 ' HA ' ' A' ' 101' ' ' VAL . 5.0 tpt180 68.26 -60.66 0.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 176.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.657 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . -178.62 -61.11 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 58.56 -94.34 0.05 OUTLIER Glycine 0 C--N 1.332 0.319 0 O-C-N 123.92 0.424 . . . . 0.0 113.159 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -83.05 -3.97 57.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.986 0.422 . . . . 0.0 110.94 -178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.98 -135.89 5.24 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.418 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -102.36 108.16 56.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.803 0.301 . . . . 0.0 110.342 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.657 ' HA ' ' HA3' ' A' ' 107' ' ' GLY . 18.4 Cg_endo -59.88 128.06 25.49 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 123.185 2.59 . . . . 0.0 112.99 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.421 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 43.1 mt-10 -114.52 135.35 54.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.904 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.552 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.77 131.62 38.95 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.827 -174.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.437 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 8.8 t -101.31 105.39 39.38 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.625 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.4 Cg_exo -86.97 136.84 4.33 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.713 2.942 . . . . 0.0 112.341 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -129.27 149.01 51.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.049 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.786 ' HB2' HD13 ' A' ' 92' ' ' ILE . 30.9 t -85.2 -35.61 21.53 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.9 m -91.59 118.7 30.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.763 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -59.74 -42.55 93.42 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.429 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -65.9 -31.7 72.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.892 -173.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -64.55 -40.44 95.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.746 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.03 -42.54 84.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.51 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.26 -41.19 99.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.855 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.42 -31.27 72.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.91 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -64.95 -36.52 84.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.902 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 62.1 t -73.02 -27.83 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.649 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mp -61.73 -46.23 90.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.086 0.469 . . . . 0.0 110.809 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.91 -49.92 26.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.485 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.702 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 0.7 OUTLIER -145.96 -86.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.757 178.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.902 ' HA3' ' HA ' ' A' ' 127' ' ' VAL . . . 50.44 -148.68 6.94 Favored Glycine 0 N--CA 1.444 -0.792 0 O-C-N 123.642 0.588 . . . . 0.0 113.702 172.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.538 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -179.96 -84.77 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -130.22 141.17 50.66 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 38.4 t -104.63 113.96 43.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.643 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.738 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.28 164.17 29.92 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.699 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.72 166.3 17.13 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.71 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 4.7 tt -62.22 -33.44 74.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.351 0.596 . . . . 0.0 109.611 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.02 60.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.168 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -117.44 17.47 14.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.292 0.568 . . . . 0.0 110.073 -176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.738 HD11 HD12 ' A' ' 135' ' ' LEU . 31.9 mm -71.93 120.28 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.312 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.6 t -119.1 147.82 43.73 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.978 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -69.26 -31.32 69.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.891 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.77 -28.82 66.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.798 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.979 ' HE2' ' HA ' ' A' ' 144' ' ' MET . 8.2 mmt -87.18 -26.45 23.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.494 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.4 t -85.56 -24.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.207 0.527 . . . . 0.0 110.521 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -160.3 151.88 19.75 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.566 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.419 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 4.0 p -94.59 120.06 65.43 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 120.829 0.347 . . . . 0.0 111.214 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.444 ' HG2' ' H ' ' A' ' 149' ' ' VAL . 36.8 Cg_endo -66.6 -67.57 0.04 OUTLIER 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.73 2.287 . . . . 0.0 111.511 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.444 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 2.4 t -118.66 5.39 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 152' ' ' GLY . 22.4 mt-10 66.58 -81.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.699 -170.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.1 t 43.31 -59.99 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.134 1.774 . . . . 0.0 114.999 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 150' ' ' GLU . . . 118.34 63.37 0.3 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -175.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.1 m -116.91 161.58 19.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.545 0.212 . . . . 0.0 110.467 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 158' ' ' ASP . 1.6 mp0 -66.54 135.17 94.53 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.712 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.494 ' HB3' ' HE1' ' A' ' 144' ' ' MET . 74.1 Cg_endo -81.21 -89.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 123.037 2.491 . . . . 0.0 114.583 -169.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.415 ' HD2' ' HB3' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -66.21 -25.71 67.04 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.001 0.429 . . . . 0.0 111.393 -173.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -171.03 -82.34 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.519 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 6.3 p-10 -171.18 20.67 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.415 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 30.5 t70 -78.11 -83.02 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.339 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.186 173.73 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.621 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 22.1 ttmm . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.575 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -131.4 148.48 52.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.83 0.286 . . . . 0.0 111.275 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 1.7 pt20 -149.04 134.47 18.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 36.1 pt -115.94 137.82 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.821 -0.549 . . . . 0.0 110.892 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -108.95 126.52 53.18 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.638 HD22 ' HB2' ' A' ' 66' ' ' ALA . 10.8 mp -97.51 150.52 21.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.931 0.396 . . . . 0.0 111.502 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.701 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 38.2 tt0 -74.15 129.15 37.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.591 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.34 -34.7 4.05 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.842 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 33.2 t -81.9 129.99 62.49 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.1 Cg_endo -85.44 2.36 7.78 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.966 2.444 . . . . 0.0 112.439 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -122.43 134.54 24.93 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 120.845 0.355 . . . . 0.0 111.41 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 10.3 Cg_endo -91.1 145.05 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.488 2.792 . . . . 0.0 112.051 174.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.534 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 2.8 tm? -93.21 114.53 27.03 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -95.49 135.37 37.23 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.445 ' HB3' ' HB2' ' A' ' 55' ' ' ALA . 5.6 t80 -147.26 131.24 17.19 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.621 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 70.1 m -57.82 -49.02 78.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.056 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -71.21 108.47 4.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.575 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 10.6 t -56.53 -50.18 74.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.658 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.88 -33.56 66.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.785 -177.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.658 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 11.8 t70 -76.52 -43.01 41.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.901 0.381 . . . . 0.0 110.848 -175.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HB1' ' HB3' ' A' ' 36' ' ' ALA . . . -72.8 -39.51 66.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.277 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.535 HG23 HD12 ' A' ' 71' ' ' ILE . 12.0 pt -65.36 -29.95 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.942 0.401 . . . . 0.0 110.014 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.563 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -63.32 -41.79 98.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.823 173.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 55' ' ' ALA . 21.1 m-30 -55.66 -43.8 76.61 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.126 0.489 . . . . 0.0 110.469 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.411 ' HA ' HG22 ' A' ' 68' ' ' ILE . . . -61.2 -17.11 51.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.824 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 60' ' ' ARG . 37.5 mtp180 -101.62 12.06 37.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.98 -60.33 0.36 Allowed Glycine 0 CA--C 1.518 0.239 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.549 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.563 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 33.4 Cg_exo -63.36 51.18 0.14 Allowed 'Trans proline' 0 N--CA 1.48 0.694 0 C-N-CA 123.874 3.049 . . . . 0.0 114.242 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -104.1 -175.34 2.77 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 173.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -106.52 -161.76 0.81 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.103 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -53.42 -34.85 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.671 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.638 ' HB2' HD22 ' A' ' 40' ' ' LEU . . . -85.06 140.49 37.06 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.668 0.27 . . . . 0.0 110.53 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.701 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 73.9 Cg_endo -78.17 159.68 29.96 Favored 'Trans proline' 0 CA--C 1.521 -0.137 0 C-N-CA 122.975 2.45 . . . . 0.0 112.559 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 59' ' ' ALA . 45.1 pt -74.29 131.94 34.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 41' ' ' GLU . 6.1 tt -97.91 -49.5 4.77 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -161.15 138.03 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.876 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.535 HD12 HG23 ' A' ' 56' ' ' ILE . 2.8 tt -108.33 133.41 53.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.661 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.452 ' HB2' ' HG3' ' A' ' 37' ' ' GLN . 93.9 m-85 -113.7 143.21 44.99 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 94' ' ' ALA . 20.6 m -133.31 156.93 42.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.584 0.707 . . . . 0.0 110.392 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.56 ' HB3' ' HE2' ' A' ' 76' ' ' MET . 11.3 m120 -93.67 106.16 18.14 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 171.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 90' ' ' ASN . 18.2 t70 -46.37 97.75 0.01 OUTLIER 'General case' 0 C--O 1.233 0.232 0 O-C-N 125.384 1.677 . . . . 0.0 110.719 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.572 ' HB3' ' HG2' ' A' ' 86' ' ' PRO . 65.5 mtt -147.86 51.2 1.04 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.19 -174.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 80' ' ' GLY . . . -91.86 27.07 10.52 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.035 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . . . -71.42 96.82 1.53 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -175.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 68.98 22.93 6.8 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.93 0.769 . . . . 0.0 110.515 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.499 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . 146.66 -116.6 0.87 Allowed Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 175.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 80' ' ' GLY . . . 158.21 62.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -171.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.0 p -83.64 175.37 9.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.572 -169.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.414 ' H ' ' HD1' ' A' ' 83' ' ' TRP . 1.4 p-90 -71.55 -30.41 65.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.452 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -84.88 -24.33 28.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.316 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 69.03 154.39 0.14 Allowed Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.508 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.572 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 14.9 Cg_exo -50.04 -38.2 48.99 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.173 1.916 . . . . 0.0 112.132 171.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.25 -84.51 0.33 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.351 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.59 148.61 35.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.4 157.51 29.87 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.784 -1.198 . . . . 0.0 113.741 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 14.9 m-80 -92.58 151.84 19.93 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 25.1 p-90 -98.6 128.61 44.97 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 118.917 -1.113 . . . . 0.0 109.891 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.833 HG21 ' HB2' ' A' ' 118' ' ' SER . 23.3 pt -145.6 167.03 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.291 -176.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.83 116.04 23.84 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.509 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -69.92 -42.26 73.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -171.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.697 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -67.87 -23.11 65.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.777 0.798 . . . . 0.0 109.684 -177.027 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -101.06 32.55 3.18 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.816 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.41 178.47 7.04 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.662 -172.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -92.64 135.11 34.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.271 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.729 ' HH ' HD13 ' A' ' 137' ' ' LEU . 7.2 m-85 -120.73 135.9 55.01 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.417 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.887 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.4 p -114.96 120.32 64.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.639 0.733 . . . . 0.0 109.869 171.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.796 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 95.5 t -101.95 119.05 49.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.584 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.487 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -82.62 121.1 5.34 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.412 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.4 m -92.59 -28.92 16.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.003 0.43 . . . . 0.0 110.231 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.91 -44.16 64.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.158 -176.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 70.6 mtt180 -138.07 118.11 13.43 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.674 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 1.3 tpp180 175.27 -170.65 0.06 Allowed 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.499 0.499 . . . . 0.0 109.682 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.465 ' H ' ' HG3' ' A' ' 106' ' ' ARG . . . -51.83 -70.8 0.78 Allowed Glycine 0 C--N 1.335 0.527 0 O-C-N 123.623 0.577 . . . . 0.0 112.883 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.95 -78.16 0.65 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.138 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -89.91 -4.23 57.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.187 0.518 . . . . 0.0 110.076 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -121.55 -128.67 3.53 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.381 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.458 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -102.94 99.27 13.39 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.93 0.395 . . . . 0.0 111.163 177.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 35.6 Cg_endo -64.66 151.64 84.88 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 123.191 2.594 . . . . 0.0 112.229 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.674 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 41.3 mt-10 -118.21 146.36 44.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.42 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.516 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -106.63 130.91 54.3 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.031 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.887 ' HB ' HG13 ' A' ' 100' ' ' VAL . 57.3 t -98.05 105.19 26.47 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.9 Cg_exo -86.76 132.52 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.751 2.967 . . . . 0.0 112.989 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -136.51 149.47 48.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.714 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.833 ' HB2' HG21 ' A' ' 92' ' ' ILE . 42.0 t -84.54 -19.75 32.68 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 170.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.436 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 15.7 m -105.59 115.51 30.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.3 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -44.78 80.96 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.158 0.504 . . . . 0.0 110.979 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.436 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 20.4 p-10 -62.46 -29.34 70.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.121 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -71.29 -40.41 70.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.688 175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.63 -37.38 84.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.143 0.497 . . . . 0.0 109.986 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.31 -35.11 78.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.659 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.419 ' HA ' HD13 ' A' ' 128' ' ' LEU . . . -63.93 -34.81 78.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.776 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -63.18 -36.46 83.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.799 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.64 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 44.4 t -71.91 -31.75 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.486 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 125' ' ' ALA . 67.7 mt -60.54 -35.39 75.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.726 176.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.24 -50.22 7.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.815 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.8 pt-20 -148.32 -85.18 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.842 175.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.815 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 52.05 -146.84 13.54 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 170.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.554 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -171.33 -89.06 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.796 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.29 160.1 34.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 175.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.37 113.32 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.182 0.515 . . . . 0.0 110.246 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.895 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -134.57 165.13 25.92 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.902 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -86.67 160.86 18.73 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.729 HD13 ' HH ' ' A' ' 99' ' ' TYR . 6.7 tt -61.66 -42.85 99.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.274 0.559 . . . . 0.0 109.624 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.59 -18.51 62.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.943 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.26 20.71 13.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.576 -172.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.895 HD11 HD12 ' A' ' 135' ' ' LEU . 22.6 mm -71.87 120.86 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.896 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 t -107.05 147.7 29.64 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.433 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.19 -33.27 73.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.467 ' HB2' ' HB2' ' A' ' 153' ' ' SER . . . -60.65 -28.79 68.84 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.744 0.653 . . . . 0.0 112.07 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.892 ' HE3' ' HB3' ' A' ' 155' ' ' PRO . 11.9 mmt -82.94 -26.84 31.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.769 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.447 ' HA ' HG11 ' A' ' 101' ' ' VAL . 2.2 t -92.68 -23.01 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 -175.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.6 pp -170.04 164.79 9.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.131 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.435 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 19.6 p -113.66 118.66 42.82 Favored Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.622 174.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 32.9 Cg_endo -65.92 -82.44 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.747 2.298 . . . . 0.0 112.287 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.687 ' HB ' ' OG1' ' A' ' 151' ' ' THR . 5.2 t -109.64 -6.58 11.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 37.9 mt-10 89.69 -73.52 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.687 ' OG1' ' HB ' ' A' ' 149' ' ' VAL . 44.4 m 53.79 21.9 2.95 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 163.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.4 50.65 58.3 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.56 -175.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 143' ' ' ALA . 9.7 p -64.11 125.45 24.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.207 0.527 . . . . 0.0 111.731 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -93.73 153.94 41.04 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.81 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.892 ' HB3' ' HE3' ' A' ' 144' ' ' MET . 6.2 Cg_exo -64.65 -163.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.205 1.937 . . . . 0.0 111.975 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -32.23 50.51 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -175.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.45 37.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.589 ' HA ' ' HG2' ' A' ' 155' ' ' PRO . 34.8 t0 59.0 72.49 0.53 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.862 -167.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.461 ' H ' ' HG2' ' A' ' 155' ' ' PRO . 12.2 t70 -168.95 -143.11 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -172.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.426 ' H ' ' CG ' ' A' ' 159' ' ' ASP . 56.1 mm-40 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.351 172.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 37.2 ttpt . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.589 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . . . -137.07 144.38 43.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 4.4 pt20 -147.11 132.17 18.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 110.665 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.674 HG23 ' HB2' ' A' ' 59' ' ' ALA . 30.1 pt -116.13 136.34 53.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.15 0.5 . . . . 0.0 110.985 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -105.2 132.17 51.75 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.443 ' CD2' ' HB2' ' A' ' 64' ' ' GLN . 11.1 mp -99.37 157.08 16.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.173 0.511 . . . . 0.0 111.527 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.431 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 26.4 tt0 -74.22 124.32 26.16 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.224 175.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.85 -42.64 3.12 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.244 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 15.7 t -82.13 123.83 79.22 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.0 Cg_exo -79.46 -11.6 14.3 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.983 2.455 . . . . 0.0 112.628 -176.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -97.98 131.97 25.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.981 0.419 . . . . 0.0 110.881 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 59.7 Cg_endo -93.37 137.45 1.33 Allowed 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 123.184 2.589 . . . . 0.0 112.355 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 8.1 tt -88.06 119.68 28.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -129.68 135.63 48.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.138 0.494 . . . . 0.0 111.42 -177.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.512 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 44.2 m-85 -142.04 153.2 44.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.038 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 t -64.51 -49.32 71.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.082 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 24.3 mt-30 -67.79 119.27 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.778 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.861 HG23 ' HB3' ' A' ' 81' ' ' ALA . 60.1 t -71.98 -50.23 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.641 ' HB3' ' HG3' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -53.99 -30.01 45.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.156 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.466 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 33.8 t70 -76.05 -50.08 15.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.7 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 36' ' ' ALA . . . -68.77 -39.25 80.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.585 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.627 HD12 ' HB1' ' A' ' 114' ' ' ALA . 11.1 pt -68.11 -31.47 51.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.795 0.331 . . . . 0.0 110.283 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.1 91.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.32 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -57.6 -41.9 82.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.747 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.674 ' HB2' HG23 ' A' ' 38' ' ' ILE . . . -61.16 -17.44 52.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.096 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 45.5 mtm180 -102.79 7.39 39.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.414 -175.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.86 -82.47 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.081 -1.057 . . . . 0.0 112.77 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -50.49 -56.83 2.71 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.361 2.708 . . . . 0.0 113.56 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 52.22 -102.97 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.045 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.443 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 74.3 mt-30 -152.6 -86.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 tt -142.93 4.58 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 122.028 0.918 . . . . 0.0 109.346 174.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -138.29 161.65 58.03 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.143 -173.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.431 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 72.0 Cg_endo -76.77 157.4 35.36 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.273 1.982 . . . . 0.0 111.714 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.1 pt -74.05 151.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.095 0.474 . . . . 0.0 111.357 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.44 -48.1 3.04 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.07 143.96 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.415 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.532 HD12 HG23 ' A' ' 56' ' ' ILE . 3.3 tt -123.48 131.98 72.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.055 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -111.65 132.06 54.85 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.603 HG23 HG13 ' A' ' 92' ' ' ILE . 17.1 m -126.25 140.89 47.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 121.499 0.666 . . . . 0.0 110.63 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -95.56 110.46 22.54 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -67.54 79.87 0.17 Allowed 'General case' 0 C--O 1.222 -0.374 0 O-C-N 124.367 1.042 . . . . 0.0 108.737 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.881 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 23.7 ptm 178.76 179.53 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.255 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.724 ' HA3' ' HB2' ' A' ' 81' ' ' ALA . . . 140.34 -33.59 2.06 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.416 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.441 ' C ' ' H ' ' A' ' 80' ' ' GLY . . . 48.11 78.86 0.07 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.822 0.449 . . . . 0.0 111.26 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 73.78 -28.89 0.19 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.36 0.664 . . . . 0.0 111.819 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 78' ' ' ALA . . . -78.17 -5.54 87.31 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.884 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.861 ' HB3' HG23 ' A' ' 52' ' ' VAL . . . -113.22 -74.43 0.63 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.281 0.562 . . . . 0.0 110.274 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.44 ' H ' ' HB1' ' A' ' 81' ' ' ALA . 7.3 p -104.26 152.56 22.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 169.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -76.1 -25.29 55.3 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.261 0.553 . . . . 0.0 110.188 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.05 -13.95 51.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.426 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 38.8 mt-30 72.16 139.29 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 113.826 -1.533 . . . . 0.0 112.337 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 85' ' ' GLN . 28.9 Cg_endo -86.78 -83.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.196 2.597 . . . . 0.0 113.007 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.31 -137.21 4.57 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.385 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.99 136.84 38.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.58 0.352 . . . . 0.0 111.459 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.881 ' HA2' ' HB3' ' A' ' 76' ' ' MET . . . -66.39 87.52 0.12 Allowed Glycine 0 C--N 1.333 0.408 0 O-C-N 124.091 0.869 . . . . 0.0 115.205 -168.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -100.59 146.76 26.74 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -99.6 130.51 45.84 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.472 -0.768 . . . . 0.0 109.891 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.603 HG13 HG23 ' A' ' 73' ' ' VAL . 2.5 pt -145.28 158.27 13.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.187 0.518 . . . . 0.0 112.316 -177.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.03 117.66 25.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 170.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.572 ' HB3' HG13 ' A' ' 73' ' ' VAL . . . -65.77 -39.63 91.21 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -169.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.682 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -68.69 -24.36 64.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.724 0.773 . . . . 0.0 109.393 -177.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -100.83 26.36 6.97 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.522 177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.46 176.48 7.43 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.363 -0.21 . . . . 0.0 110.474 -173.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -94.54 135.79 35.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.414 0.626 . . . . 0.0 110.418 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.629 ' HH ' HD13 ' A' ' 137' ' ' LEU . 8.1 m-85 -120.55 136.23 54.85 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.228 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.528 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -113.22 128.55 69.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.381 0.61 . . . . 0.0 110.112 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.0 t -101.68 109.24 25.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.404 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.521 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -80.68 126.21 7.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.643 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.3 m -92.54 -30.98 15.38 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.461 ' HB2' ' HB2' ' A' ' 130' ' ' GLU . . . -80.5 -47.02 14.89 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -163.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -129.12 12.59 6.12 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.022 -0.424 . . . . 0.0 111.281 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.655 ' HD3' ' HB3' ' A' ' 113' ' ' GLU . 1.4 tpm_? -89.5 -91.68 0.13 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.95 -169.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -170.93 40.25 0.19 Allowed Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.502 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -65.37 -29.88 76.31 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.908 -1.139 . . . . 0.0 111.174 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 88.4 mmm -109.12 20.87 17.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.395 -0.402 . . . . 0.0 110.692 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -160.32 -124.22 0.72 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.401 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.98 100.98 18.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 110.844 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.4 146.41 50.24 Favored 'Trans proline' 0 C--N 1.331 -0.382 0 C-N-CA 123.61 2.874 . . . . 0.0 113.407 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.655 ' HB3' ' HD3' ' A' ' 106' ' ' ARG . 27.5 tt0 -114.88 127.48 55.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.75 172.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.627 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -93.91 129.99 40.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.528 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 48.8 t -102.16 105.29 41.81 Favored Pre-proline 0 C--N 1.321 -0.671 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.312 174.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -89.35 110.98 0.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.821 3.014 . . . . 0.0 111.218 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.67 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.6 t80 -119.62 149.03 42.62 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.503 ' HB2' HD11 ' A' ' 92' ' ' ILE . 44.1 t -71.6 -32.77 68.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.925 0.393 . . . . 0.0 111.06 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.67 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 66.9 m -99.24 124.16 44.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.848 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.91 -45.41 82.06 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -65.58 -28.7 69.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.349 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -68.8 -42.08 77.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.465 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.09 79.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.305 0.574 . . . . 0.0 110.1 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.65 -32.31 69.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.744 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -65.19 -32.38 74.03 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.077 0.465 . . . . 0.0 110.703 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -61.71 -39.61 92.09 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.714 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 42.1 t -73.14 -28.82 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.658 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 6.7 tp -56.32 -43.99 79.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.957 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.64 -50.75 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.255 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.915 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.5 pt-20 -152.7 -76.16 0.13 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.486 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.915 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.48 -130.87 11.69 Favored Glycine 0 C--N 1.334 0.424 0 O-C-N 123.543 0.527 . . . . 0.0 112.974 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.641 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -179.84 -89.64 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.36 139.47 50.66 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 177.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.73 119.66 51.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.742 HD12 HD12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -147.04 165.65 29.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.111 -177.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.05 162.73 15.2 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.775 ' HA ' HG12 ' A' ' 140' ' ' ILE . 1.1 tt -62.59 -32.64 73.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.133 0.492 . . . . 0.0 109.675 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.8 -11.65 58.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.252 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -125.53 21.5 7.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.775 HG12 ' HA ' ' A' ' 137' ' ' LEU . 30.4 mm -71.63 118.18 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -119.28 147.68 44.01 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.238 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.548 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 13.4 p-10 -69.37 -26.92 64.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.72 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.83 -28.74 69.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.772 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.4 mmt -83.9 -26.2 29.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.412 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.3 -22.8 5.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.357 -172.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.4 pp -143.61 142.81 31.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.581 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 32.4 p -113.12 122.8 34.86 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.093 -178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -64.81 -75.75 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.314 2.009 . . . . 0.0 111.51 174.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.37 11.23 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 152' ' ' GLY . 37.6 mt-10 67.51 -79.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.326 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.4 t 43.76 -62.57 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.931 1.692 . . . . 0.0 113.928 -171.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 150' ' ' GLU . . . 150.28 55.25 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.3 t -89.95 148.68 22.97 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 157' ' ' ALA . 20.4 mm-40 -71.06 136.01 84.9 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.213 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.526 ' HD2' ' O ' ' A' ' 157' ' ' ALA . 98.3 Cg_endo -78.36 -118.29 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.819 2.346 . . . . 0.0 112.239 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.445 ' H ' ' HB2' ' A' ' 155' ' ' PRO . 0.0 OUTLIER -60.46 -27.19 67.34 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.052 0.453 . . . . 0.0 109.784 177.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.526 ' O ' ' HD2' ' A' ' 155' ' ' PRO . . . -179.84 -118.26 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.808 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -123.55 14.87 9.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.543 1.163 . . . . 0.0 108.564 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.29 30.89 1.82 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.251 -167.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.203 -177.806 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.589 ' H ' ' HB2' ' A' ' 74' ' ' ASN . 37.2 ttmt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.401 ' HB3' ' HB1' ' A' ' 55' ' ' ALA . . . -144.55 144.29 31.24 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 112.024 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -149.17 135.28 19.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.101 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.582 HG22 ' HB2' ' A' ' 59' ' ' ALA . 33.7 pt -115.93 138.84 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.024 0.44 . . . . 0.0 111.103 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -107.57 121.15 44.07 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 66' ' ' ALA . 10.5 mp -87.58 147.86 25.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.006 0.432 . . . . 0.0 110.912 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 27.6 tt0 -74.06 124.3 26.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.659 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.03 -38.4 3.2 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.884 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 28.0 t -82.1 125.06 78.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.2 Cg_exo -80.44 1.77 9.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.998 2.465 . . . . 0.0 112.786 -176.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -107.28 132.86 20.63 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 9.4 Cg_endo -92.66 115.76 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.611 2.874 . . . . 0.0 111.702 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.61 108.33 7.3 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -113.23 137.97 50.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.19 0.519 . . . . 0.0 111.318 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.546 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 36.6 m-85 -139.58 143.95 37.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.223 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.586 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 33.9 m -56.37 -54.43 45.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.534 ' HG2' ' HA ' ' A' ' 83' ' ' TRP . 48.4 mt-30 -63.62 125.58 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.148 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 56' ' ' ILE . 18.5 t -65.28 -50.62 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.621 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -58.1 -28.27 64.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.376 -178.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.621 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 11.5 t70 -75.95 -51.6 12.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 110.184 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.546 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -64.93 -39.93 94.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.336 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.513 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 28.7 pt -69.31 -31.88 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.951 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.05 82.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 0.0 110.791 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -62.3 -32.04 72.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.481 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 38' ' ' ILE . . . -70.75 -18.27 62.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.513 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 23.9 mtm180 -94.41 3.73 54.78 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.43 -60.49 0.23 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 119.412 -1.375 . . . . 0.0 114.414 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -40.47 -44.25 4.3 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.799 2.999 . . . . 0.0 114.781 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -82.26 99.7 9.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.148 0.499 . . . . 0.0 111.364 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -106.45 111.06 23.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -176.68 -42.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.079 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.582 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -151.78 151.25 28.01 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.5 Cg_endo -72.22 158.12 52.48 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.056 1.837 . . . . 0.0 111.741 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.0 pt -81.54 117.59 27.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.067 0.461 . . . . 0.0 110.434 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 tt -77.82 -48.05 17.44 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.19 138.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.218 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.567 HG22 ' HB3' ' A' ' 95' ' ' ASP . 3.6 tt -107.99 129.76 61.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.947 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.528 ' HA ' ' O ' ' A' ' 92' ' ' ILE . 79.6 m-85 -111.71 127.25 55.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.55 HG21 ' HB3' ' A' ' 94' ' ' ALA . 27.7 m -123.03 151.7 27.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.045 0.45 . . . . 0.0 110.061 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.589 ' HB2' ' H ' ' A' ' 35' ' ' LYS . 15.6 m120 -86.03 97.03 10.05 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 76' ' ' MET . 10.3 t70 -45.08 106.6 0.08 Allowed 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 125.581 1.801 . . . . 0.0 110.449 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -179.71 87.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 O-C-N 125.46 1.725 . . . . 0.0 109.16 178.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.593 ' HA3' HG11 ' A' ' 115' ' ' VAL . . . -126.93 28.94 4.51 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.541 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.524 ' H ' ' HG3' ' A' ' 86' ' ' PRO . . . -79.55 43.76 0.58 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.427 0.632 . . . . 0.0 110.509 -174.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -175.05 9.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.194 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.68 7.32 55.71 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.038 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 55.3 53.1 10.43 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 110.047 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.613 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 26.4 p -83.67 177.55 8.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.625 -169.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.534 ' HA ' ' HG2' ' A' ' 51' ' ' GLN . 35.5 p90 -66.39 -25.05 66.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.189 0.519 . . . . 0.0 110.149 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -82.91 -35.14 26.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.702 176.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.613 ' HG2' ' O ' ' A' ' 82' ' ' THR . 0.9 OUTLIER 66.75 165.24 0.12 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.49 175.054 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.524 ' HG3' ' H ' ' A' ' 78' ' ' ALA . 87.6 Cg_endo -90.31 5.66 4.3 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.054 1.836 . . . . 0.0 111.997 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.94 -179.68 16.05 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.038 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.96 146.12 51.36 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.64 -172.81 13.17 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.205 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 36.8 m-80 -95.18 151.6 19.08 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -97.51 129.75 44.65 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.076 -1.015 . . . . 0.0 111.121 -170.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.705 HD11 ' HB2' ' A' ' 118' ' ' SER . 24.9 pt -144.0 166.2 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.594 -173.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.09 106.3 14.78 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.55 ' HB3' HG21 ' A' ' 73' ' ' VAL . . . -69.84 -32.5 70.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.923 -173.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.777 ' HA ' HD12 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -71.45 -23.87 61.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.72 0.771 . . . . 0.0 109.889 -177.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -99.45 29.6 3.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.07 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.21 -176.37 4.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -95.72 138.05 33.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.546 0.689 . . . . 0.0 110.621 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.531 ' CE1' HD13 ' A' ' 137' ' ' LEU . 2.3 m-85 -120.53 136.62 54.72 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.028 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.78 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -114.46 123.14 69.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.438 0.637 . . . . 0.0 110.41 173.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.8 t -101.56 127.6 54.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.427 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -86.71 121.37 5.75 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.116 -173.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.4 m -92.48 -37.15 12.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.688 0.28 . . . . 0.0 110.79 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.14 -44.71 16.11 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.042 0.449 . . . . 0.0 110.9 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.527 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 50.8 mtp180 -134.62 121.6 21.11 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.541 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 165.55 -175.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.542 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -79.23 42.3 2.35 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.066 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.78 -24.69 70.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.6 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.8 ttp -103.57 -3.49 25.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.853 0.359 . . . . 0.0 110.474 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -153.91 -110.14 0.39 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.972 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.542 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.47 99.32 14.84 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.676 0.274 . . . . 0.0 111.208 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.68 147.01 75.04 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.64 2.893 . . . . 0.0 113.659 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.541 ' CD ' ' HE ' ' A' ' 106' ' ' ARG . 1.6 mp0 -114.68 142.34 46.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.536 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -107.68 130.8 54.89 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.613 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.78 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 96.5 t -100.97 105.55 39.17 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 120.969 0.414 . . . . 0.0 110.38 175.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.536 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.3 Cg_exo -87.91 127.52 2.23 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.645 2.897 . . . . 0.0 112.387 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -134.07 148.82 51.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.487 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.705 ' HB2' HD11 ' A' ' 92' ' ' ILE . 33.0 t -80.48 -16.73 53.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.139 0.495 . . . . 0.0 109.947 174.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.8 m -108.58 131.9 54.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.523 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.15 -48.67 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.073 0.463 . . . . 0.0 110.921 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -63.64 -28.5 69.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.888 -173.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.59 -40.2 76.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.385 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.37 -35.78 71.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 110.121 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.96 88.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.785 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.508 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -63.28 -30.07 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.001 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -66.06 -40.45 90.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.712 HG21 ' H ' ' A' ' 132' ' ' GLY . 59.5 t -72.25 -29.11 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.415 0.626 . . . . 0.0 110.395 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 7.7 tp -58.04 -43.7 86.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.122 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.83 -50.97 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.666 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.715 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.8 pt-20 -141.6 -92.91 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.468 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.715 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 47.98 -145.41 5.58 Favored Glycine 0 C--N 1.333 0.398 0 O-C-N 123.517 0.511 . . . . 0.0 113.984 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.712 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -172.62 -81.49 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.06 139.27 51.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.847 0.356 . . . . 0.0 110.793 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.13 115.21 43.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.215 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.76 HD12 HD11 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -140.04 159.82 41.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.786 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.66 157.48 24.64 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 95' ' ' ASP . 6.3 tt -60.95 -34.95 75.53 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.35 -13.8 59.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.759 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -127.66 29.64 5.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.126 0.488 . . . . 0.0 110.635 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.76 HD11 HD12 ' A' ' 135' ' ' LEU . 36.1 mm -71.58 121.42 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.5 t -108.95 147.87 31.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.154 177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.428 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.6 p-10 -69.27 -32.84 72.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.67 -29.77 66.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.019 -175.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.906 ' HA ' ' HE1' ' A' ' 144' ' ' MET . 6.2 mmt -87.19 -33.86 19.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.457 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.9 t -78.99 -23.51 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.359 0.599 . . . . 0.0 109.915 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 1.8 pp -150.18 106.76 3.51 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.77 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 23.7 p -80.06 120.1 78.68 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.555 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 9.8 Cg_endo -55.76 -72.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.768 2.312 . . . . 0.0 111.671 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.7 t -129.27 10.25 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 151' ' ' THR . 42.4 mt-10 67.47 -77.92 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.326 -173.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 150' ' ' GLU . 5.8 t 53.07 -41.4 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.899 1.679 . . . . 0.0 114.936 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.37 15.6 4.09 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.3 p -70.55 142.37 51.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.598 0.237 . . . . 0.0 111.264 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.57 ' HG2' ' HB2' ' A' ' 158' ' ' ASP . 2.8 mp0 -56.61 126.07 69.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.274 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.404 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 27.1 Cg_endo -62.85 -86.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.334 2.689 . . . . 0.0 113.601 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -28.36 15.92 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.029 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 177.2 19.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.344 0.402 . . . . 0.0 111.385 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.57 ' HB2' ' HG2' ' A' ' 154' ' ' GLU . 32.2 t70 53.42 84.9 0.05 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.398 0.618 . . . . 0.0 109.571 -171.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -163.91 -43.31 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.582 -165.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.815 179.735 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.67 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 69.6 tttt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.702 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -143.78 143.77 31.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.027 -175.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 3.4 pt20 -149.31 129.64 13.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.586 174.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.465 HG21 ' CG1' ' A' ' 71' ' ' ILE . 29.9 pt -116.11 135.29 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -103.24 121.45 42.73 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 10.4 mp -86.1 141.28 29.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.088 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.638 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 32.7 tt0 -74.0 124.35 26.05 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.599 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.18 -14.21 64.24 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.269 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 34.7 t -105.86 125.47 33.13 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.6 Cg_exo -78.0 5.99 4.95 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.944 2.429 . . . . 0.0 112.733 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -129.69 132.74 24.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.321 . . . . 0.0 111.182 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 7.6 Cg_endo -89.92 165.45 4.88 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.593 2.862 . . . . 0.0 112.133 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 7.1 tt -107.68 118.71 37.46 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -101.91 134.69 44.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.24 146.83 27.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.155 0.502 . . . . 0.0 110.85 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -69.27 -36.36 77.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.298 0.57 . . . . 0.0 110.63 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.888 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 51.8 mt-30 -84.94 122.7 29.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.834 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.702 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 2.6 t -67.6 -51.7 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.587 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -52.62 -41.17 63.48 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.179 -178.73 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.587 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 29.8 t0 -76.34 -43.05 42.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.754 0.311 . . . . 0.0 111.105 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.2 -37.66 75.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.704 0.288 . . . . 0.0 111.443 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.711 HD12 ' HB1' ' A' ' 114' ' ' ALA . 24.4 pt -68.19 -31.29 51.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.37 -42.44 96.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.295 174.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -57.17 -37.75 72.57 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.155 0.502 . . . . 0.0 110.438 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.563 ' HB3' HD11 ' A' ' 68' ' ' ILE . . . -64.63 -18.89 65.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.111 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -94.66 -6.69 42.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -179.48 -58.98 0.08 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.998 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -65.56 46.3 0.18 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.527 2.818 . . . . 0.0 114.555 -178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -96.26 165.7 12.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.711 ' HG3' HG22 ' A' ' 65' ' ' ILE . 10.4 pt20 -92.86 -18.85 22.32 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -169.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.711 HG22 ' HG3' ' A' ' 64' ' ' GLN . 6.5 tt 179.32 -39.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.382 . . . . 0.0 111.976 -174.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 40' ' ' LEU . . . -104.99 146.76 33.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.58 -171.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 55.9 Cg_endo -71.8 163.77 37.81 Favored 'Trans proline' 0 C--O 1.224 -0.183 0 C-N-CA 123.159 2.573 . . . . 0.0 111.73 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.563 HD11 ' HB3' ' A' ' 59' ' ' ALA . 27.6 pt -79.3 127.19 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.149 0.499 . . . . 0.0 110.737 177.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 tt -91.78 -48.13 6.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -159.17 138.75 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.84 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.465 ' CG1' HG21 ' A' ' 38' ' ' ILE . 3.0 tt -117.07 131.53 69.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.215 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -111.85 128.34 56.1 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.475 HG21 ' HB1' ' A' ' 94' ' ' ALA . 29.6 m -127.83 139.49 51.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 120.834 0.35 . . . . 0.0 110.096 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.67 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 2.2 m-20 -84.64 107.04 16.64 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -69.6 142.35 53.55 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 124.371 1.045 . . . . 0.0 109.494 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.777 ' O ' ' HG2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER 168.28 -29.13 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 124.511 1.132 . . . . 0.0 109.039 -170.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 81' ' ' ALA . . . -69.47 68.49 0.54 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.622 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.97 106.78 2.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.445 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.22 26.49 15.94 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.539 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.9 -72.38 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.73 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.527 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . . . 57.19 52.35 9.05 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.309 0.576 . . . . 0.0 110.338 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.46 175.75 9.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.178 -173.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.888 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 31.7 p90 -68.8 -20.68 64.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.369 0.604 . . . . 0.0 110.162 175.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.85 -31.8 31.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.838 173.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 62.36 171.38 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.353 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.777 ' HG2' ' O ' ' A' ' 76' ' ' MET . 5.7 Cg_exo -83.88 -5.06 10.62 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.929 1.753 . . . . 0.0 110.372 166.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.09 174.06 13.22 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -174.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -77.14 146.07 37.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.607 0.704 . . . . 0.0 109.468 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.4 ' HA3' ' HG2' ' A' ' 76' ' ' MET . . . -136.91 -140.18 4.05 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.655 -175.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 19.2 m120 -100.31 145.44 28.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 74' ' ' ASN . 37.3 p90 -98.52 130.94 45.1 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.549 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.695 HD11 ' HB2' ' A' ' 118' ' ' SER . 1.8 pt -133.6 151.92 34.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.656 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.85 102.67 4.13 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . . . -61.02 -31.59 71.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.153 0.501 . . . . 0.0 110.935 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.605 ' HA ' HD12 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -58.03 -31.05 66.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.165 176.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -111.39 27.7 9.43 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.868 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -122.52 178.59 4.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.529 0.204 . . . . 0.0 110.775 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -92.74 131.61 37.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.251 0.548 . . . . 0.0 110.779 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -120.49 136.12 54.86 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.338 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.454 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 4.2 p -113.71 129.48 69.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-O 121.866 0.841 . . . . 0.0 110.571 172.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.522 ' HA ' HH11 ' A' ' 106' ' ' ARG . 38.1 t -104.01 111.84 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.282 172.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.679 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -74.67 124.07 7.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.314 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 p -86.71 -31.23 21.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.957 0.408 . . . . 0.0 110.564 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -78.41 -35.04 47.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.714 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.609 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 60.2 mtp180 -121.13 -140.84 0.33 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.369 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.522 HH11 ' HA ' ' A' ' 101' ' ' VAL . 22.4 ttt180 72.25 176.57 0.27 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.467 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -71.94 -48.96 24.52 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.096 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.08 -96.89 0.33 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.339 -0.934 . . . . 0.0 110.832 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.0 mtt -99.48 -3.8 32.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.281 0.562 . . . . 0.0 109.735 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.78 -123.37 2.72 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.717 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.467 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.19 94.66 5.84 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 117.077 0.439 . . . . 0.0 110.663 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.92 113.18 3.15 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.74 2.293 . . . . 0.0 113.125 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -114.65 130.53 56.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.836 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.711 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -100.16 132.8 45.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.456 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.454 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 14.3 t -99.38 105.87 35.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.674 176.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -90.73 131.45 1.58 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 124.2 3.267 . . . . 0.0 112.329 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -128.82 153.27 47.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.695 ' HB2' HD11 ' A' ' 92' ' ' ILE . 38.4 t -85.08 -27.76 26.08 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 170.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.4 m -96.02 115.99 28.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.142 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -57.8 -45.75 85.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.315 0.578 . . . . 0.0 111.139 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -63.38 -28.54 70.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.368 -172.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -64.48 -42.45 95.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.075 0.464 . . . . 0.0 110.296 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.403 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -68.45 -37.34 80.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.283 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.3 98.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.709 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.42 83.6 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.12 0.486 . . . . 0.0 110.447 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -61.88 -40.7 96.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.762 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.622 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 78.6 t -66.19 -40.17 86.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.017 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 66.4 mt -56.86 -34.62 68.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.599 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.04 -41.86 13.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.231 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.609 ' OE1' ' HD3' ' A' ' 105' ' ' ARG . 7.6 pt-20 -161.12 -35.18 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -172.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.679 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -53.61 163.88 2.59 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.232 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -111.41 -66.26 0.52 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.705 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.433 HE21 ' HB3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -130.13 141.56 50.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.829 0.347 . . . . 0.0 110.675 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.3 t -103.34 113.75 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.188 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.689 HD12 HD11 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -138.65 164.87 28.39 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.987 -176.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.27 170.07 13.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 95' ' ' ASP . 3.6 tt -66.36 -30.52 70.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.304 0.573 . . . . 0.0 109.629 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.22 -12.1 60.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.587 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -109.43 12.82 24.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.689 HD11 HD12 ' A' ' 135' ' ' LEU . 41.8 mm -71.88 119.12 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.082 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.495 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.3 t -119.37 147.12 44.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.849 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.413 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.1 p-10 -69.41 -25.49 64.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.053 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.27 -28.8 69.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.669 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.965 ' HE2' ' HA ' ' A' ' 144' ' ' MET . 3.9 mmt -87.1 -28.96 22.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.037 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 141' ' ' THR . 8.6 t -79.16 -23.56 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.263 0.554 . . . . 0.0 110.476 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.2 pp -155.9 139.75 16.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.77 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.1 p -95.97 120.58 62.73 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.832 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.36 -78.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.175 1.917 . . . . 0.0 111.285 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.62 6.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 65.91 -74.94 0.05 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.308 -167.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.0 t 43.32 31.06 0.35 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.626 1.17 . . . . 0.0 114.062 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 71.97 23.59 77.78 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.012 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.3 t -96.38 124.51 40.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.018 0.437 . . . . 0.0 109.824 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -80.0 149.62 70.43 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.333 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.601 ' HB3' ' HE1' ' A' ' 144' ' ' MET . 10.8 Cg_endo -55.82 -33.53 88.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.164 2.576 . . . . 0.0 112.445 -176.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.561 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 3.3 ptp85 -155.35 -69.25 0.12 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.318 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.561 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -145.93 69.65 1.22 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.23 31.66 0.39 Allowed 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.31 1.006 . . . . 0.0 111.81 -175.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 160' ' ' GLU . 11.9 t70 -130.49 -166.02 1.63 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.412 ' H ' ' CG ' ' A' ' 159' ' ' ASP . 7.1 mm-40 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.731 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 40.1 ttmt . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.57 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -126.54 144.35 50.9 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.448 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . 11.7 pt20 -148.84 136.76 20.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.963 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.677 HG23 ' HB2' ' A' ' 59' ' ' ALA . 30.3 pt -115.9 134.82 57.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.103 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -98.83 116.9 32.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.564 HD23 ' HB2' ' A' ' 66' ' ' ALA . 3.0 mp -92.26 142.34 27.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.964 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.757 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 34.7 tt0 -74.0 132.43 42.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.23 -36.46 3.19 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.5 -175.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.507 ' HB2' ' CB ' ' A' ' 40' ' ' LEU . 68.8 m -82.14 124.5 78.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.014 0.435 . . . . 0.0 110.332 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 2.5 Cg_endo -82.86 -3.47 11.16 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.134 2.556 . . . . 0.0 112.884 -176.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -125.39 133.98 25.37 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.719 -177.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 5.9 Cg_exo -79.1 141.88 16.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.999 2.466 . . . . 0.0 111.847 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.501 ' HB3' HG12 ' A' ' 38' ' ' ILE . 6.3 tt -91.48 107.23 19.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . 38.4 p90 -116.81 137.68 52.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.173 0.511 . . . . 0.0 111.14 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -138.58 143.15 39.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.513 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 5.3 p -55.69 -40.7 72.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.224 0.535 . . . . 0.0 110.982 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.514 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 68.4 mt-30 -82.1 114.85 20.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.396 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.621 HG21 HE22 ' A' ' 85' ' ' GLN . 45.4 t -58.53 -47.89 87.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.298 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -58.68 -28.43 65.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.626 -178.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.468 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 22.5 t70 -75.99 -51.12 13.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.022 0.439 . . . . 0.0 110.257 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.71 95.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.344 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.703 HG23 HD12 ' A' ' 71' ' ' ILE . 28.4 pt -69.08 -31.92 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.316 . . . . 0.0 110.546 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.95 82.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.707 0.289 . . . . 0.0 110.339 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 62' ' ' PRO . 10.1 m-85 -62.12 -35.63 79.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.244 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.677 ' HB2' HG23 ' A' ' 38' ' ' ILE . . . -63.19 -18.1 63.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.707 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -81.71 -3.26 53.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.72 -42.64 0.96 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 119.63 -1.272 . . . . 0.0 114.68 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.486 ' HB2' ' HA ' ' A' ' 58' ' ' TYR . 93.2 Cg_exo -49.32 -16.68 1.21 Allowed 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 123.515 2.81 . . . . 0.0 115.367 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -68.38 -30.84 69.87 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.522 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 41.9 35.41 0.53 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.826 1.25 . . . . 0.0 114.059 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 tt -132.51 -47.55 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.564 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -152.2 151.84 28.37 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.623 0.249 . . . . 0.0 110.917 -175.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.757 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 74.5 Cg_endo -70.35 148.88 62.2 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.366 2.044 . . . . 0.0 111.805 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 68' ' ' ILE . 27.5 pt -84.4 105.33 13.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.394 0.616 . . . . 0.0 110.335 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.8 tt -67.27 -47.36 70.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -161.16 138.38 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.119 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.703 HD12 HG23 ' A' ' 56' ' ' ILE . 2.8 tt -108.34 131.13 59.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.76 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -112.03 128.21 56.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.228 0.537 . . . . 0.0 110.007 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.482 HG21 ' HB1' ' A' ' 94' ' ' ALA . 30.7 m -126.21 136.64 60.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.069 0.461 . . . . 0.0 109.839 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 91' ' ' TRP . 0.2 OUTLIER -83.72 101.04 11.28 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.279 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.432 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 61.1 t0 -55.92 103.73 0.11 Allowed 'General case' 0 C--O 1.236 0.386 0 O-C-N 124.774 1.296 . . . . 0.0 110.058 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.842 ' O ' ' HG2' ' A' ' 86' ' ' PRO . 52.6 mtt -127.64 -26.21 3.02 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.07 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.725 ' HA3' ' HB3' ' A' ' 81' ' ' ALA . . . -70.66 58.07 0.94 Allowed Glycine 0 C--O 1.226 -0.348 0 O-C-N 123.951 0.782 . . . . 0.0 115.015 -165.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.38 33.9 0.69 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.381 0.61 . . . . 0.0 109.846 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -171.53 8.54 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.548 -171.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.416 ' HA2' ' HZ ' ' A' ' 126' ' ' PHE . . . 127.02 -26.13 5.1 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.568 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.725 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . . . 67.68 70.06 0.35 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.399 0.619 . . . . 0.0 110.315 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.2 p -83.97 175.06 9.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.359 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.514 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 21.1 p-90 -70.2 -20.86 63.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.213 0.53 . . . . 0.0 110.321 174.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -83.08 -35.88 25.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.005 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.621 HE22 HG21 ' A' ' 52' ' ' VAL . 0.6 OUTLIER 68.1 140.74 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.144 173.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.842 ' HG2' ' O ' ' A' ' 76' ' ' MET . 52.1 Cg_exo -57.46 -48.38 17.62 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.925 2.416 . . . . 0.0 113.032 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.99 -141.65 8.32 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.682 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -67.1 139.67 57.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.973 0.415 . . . . 0.0 111.521 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -150.99 -165.05 12.47 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -100.15 138.45 37.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 117.08 0.44 . . . . 0.0 110.116 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.55 ' HA ' ' HA ' ' A' ' 74' ' ' ASN . 15.4 p-90 -98.61 131.08 45.09 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.416 -177.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.468 HD13 ' CA ' ' A' ' 118' ' ' SER . 3.7 pt -141.88 163.19 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.247 -170.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.39 107.31 10.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.384 171.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB1' HG21 ' A' ' 73' ' ' VAL . . . -62.61 -35.28 79.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.004 0.43 . . . . 0.0 111.229 -176.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.752 ' HA ' HD12 ' A' ' 137' ' ' LEU . 8.9 t70 -59.78 -26.82 66.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.88 0.848 . . . . 0.0 110.27 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -116.4 36.06 4.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.646 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.27 178.96 6.5 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.796 0.331 . . . . 0.0 110.55 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -97.51 138.11 35.44 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.426 0.631 . . . . 0.0 109.924 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.404 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 5.6 m-85 -120.09 135.65 54.87 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.029 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.939 HG13 HG12 ' A' ' 115' ' ' VAL . 2.2 p -115.3 120.6 65.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.717 0.77 . . . . 0.0 109.473 170.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 64.4 t -101.74 115.94 44.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.57 -1.196 . . . . 0.0 108.58 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.469 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -77.61 120.87 5.64 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.263 -176.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 m -92.5 -29.16 16.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.926 0.394 . . . . 0.0 110.382 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.98 -43.97 17.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.133 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 46.6 mtp180 -130.93 121.19 24.72 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.557 HH22 ' HZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER 172.84 175.21 0.1 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.804 0.69 . . . . 0.0 109.863 177.387 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.88 -78.47 0.09 OUTLIER Glycine 0 C--N 1.337 0.587 0 O-C-N 123.363 0.414 . . . . 0.0 113.402 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.37 -76.9 0.76 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.329 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -83.63 -3.67 57.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.155 0.503 . . . . 0.0 110.749 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -130.55 -124.0 2.56 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.403 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.42 96.99 9.36 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 28.3 Cg_endo -64.5 147.64 90.45 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.765 2.31 . . . . 0.0 112.695 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.495 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 1.6 mp0 -115.0 121.83 44.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.709 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.08 131.51 39.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.939 HG12 HG13 ' A' ' 100' ' ' VAL . 1.4 p -108.8 106.77 59.35 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.783 0.802 . . . . 0.0 110.352 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 7.6 Cg_exo -81.86 119.99 3.35 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 124.414 3.409 . . . . 0.0 112.65 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -108.05 153.39 23.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.956 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.468 ' CA ' HD13 ' A' ' 92' ' ' ILE . 48.1 t -81.01 -43.06 20.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.184 174.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.6 m -100.65 131.09 46.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.292 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.568 ' HD2' ' N ' ' A' ' 121' ' ' ASP . 0.0 OUTLIER -65.32 -33.71 76.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.347 -177.072 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.568 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 10.8 p-10 -68.17 -28.51 67.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.196 0.522 . . . . 0.0 110.072 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -69.41 -39.28 78.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.788 173.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.6 82.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.49 94.28 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.687 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.07 73.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.031 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.557 ' HZ ' HH22 ' A' ' 106' ' ' ARG . 44.6 t80 -66.02 -40.34 90.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.07 177.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.665 HG21 ' H ' ' A' ' 132' ' ' GLY . 65.0 t -73.05 -29.07 27.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.452 0.644 . . . . 0.0 110.255 176.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.36 -36.23 81.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.929 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.19 -50.6 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.627 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.779 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 1.9 pt-20 -146.64 -88.92 0.09 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.298 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.779 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 49.85 -142.9 11.81 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 123.412 0.445 . . . . 0.0 113.794 174.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.665 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -175.62 -82.86 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.0 139.44 51.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 176.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.8 t -101.1 113.95 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.955 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.63 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -139.85 165.7 26.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.068 -176.619 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -88.68 168.2 12.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 95' ' ' ASP . 3.6 tt -63.4 -32.46 73.9 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.83 -16.07 63.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.028 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -111.88 12.39 20.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.488 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.63 HD11 HD12 ' A' ' 135' ' ' LEU . 16.4 mm -71.87 119.71 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.2 t -119.29 145.5 46.07 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.958 174.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -69.57 -27.52 65.2 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.082 0.239 . . . . 0.0 110.406 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.64 -28.98 68.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.885 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.713 ' HG2' ' HB3' ' A' ' 155' ' ' PRO . 3.9 mmt -84.72 -33.97 23.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.728 0.299 . . . . 0.0 111.425 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.5 t -79.81 -23.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.341 0.591 . . . . 0.0 110.275 -177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.8 pp -159.88 143.3 14.15 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.773 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.604 ' HB ' ' HA ' ' A' ' 150' ' ' GLU . 16.7 p -106.51 120.42 48.55 Favored Pre-proline 0 C--N 1.318 -0.774 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.887 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 14.7 Cg_endo -58.9 -53.17 4.02 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.676 2.251 . . . . 0.0 111.83 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.417 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 1.4 t -135.62 20.28 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.604 ' HA ' ' HB ' ' A' ' 147' ' ' THR . 5.2 mm-40 64.81 -83.6 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.3 -168.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 t 44.83 7.45 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 57.38 46.36 91.93 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.297 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 25.4 m -71.08 144.75 50.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.776 0.288 . . . . 0.0 110.563 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 158' ' ' ASP . 45.2 mt-10 -75.8 122.88 87.91 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.713 ' HB3' ' HG2' ' A' ' 144' ' ' MET . 6.8 Cg_endo -48.53 -85.4 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 124.228 3.286 . . . . 0.0 114.299 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.93 -22.3 12.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.216 0.532 . . . . 0.0 109.904 175.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -175.9 21.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.241 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 29.8 t0 53.81 71.88 0.48 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.307 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.65 -39.83 1.97 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.323 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.45 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 1.7 pm0 . . . . . 0 C--O 1.25 1.079 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.503 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.651 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -132.45 144.12 50.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.68 0.276 . . . . 0.0 110.645 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 20.3 pt20 -149.16 131.63 15.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.092 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.736 HG21 ' HB ' ' A' ' 71' ' ' ILE . 29.8 pt -115.78 133.23 62.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.148 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -103.99 123.9 48.04 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.551 ' CB ' ' HB2' ' A' ' 43' ' ' SER . 6.4 mp -90.35 148.52 22.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.33 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.616 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 35.7 tt0 -74.16 124.06 25.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.31 -28.8 4.57 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.066 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.551 ' HB2' ' CB ' ' A' ' 40' ' ' LEU . 59.7 m -81.72 124.51 79.57 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.923 0.392 . . . . 0.0 110.347 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 4.2 Cg_exo -78.12 -13.34 15.6 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.373 2.715 . . . . 0.0 113.298 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.63 133.62 24.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.369 . . . . 0.0 111.266 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HG2' ' CE2' ' A' ' 48' ' ' PHE . 96.8 Cg_endo -85.98 168.51 9.26 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.873 2.382 . . . . 0.0 112.472 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 8.0 tt -111.75 116.21 30.34 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.419 ' CE2' ' HG2' ' A' ' 46' ' ' PRO . 98.6 m-85 -96.08 136.19 36.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.355 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.01 133.15 18.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.2 m -66.23 -40.48 90.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.395 0.617 . . . . 0.0 109.613 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.818 ' HG2' ' HB2' ' A' ' 83' ' ' TRP . 50.3 mt-30 -77.31 102.22 6.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.316 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.651 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 13.8 t -56.73 -50.05 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.177 0.513 . . . . 0.0 110.129 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.562 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -55.44 -33.89 64.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.812 -1.086 . . . . 0.0 112.782 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.436 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 7.8 t70 -76.34 -43.55 40.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.138 0.494 . . . . 0.0 110.084 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.52 -34.75 70.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.746 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.562 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 10.4 pt -68.56 -31.67 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.76 88.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.542 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -60.29 -44.89 94.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.97 0.414 . . . . 0.0 111.356 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.46 -17.88 63.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.478 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -105.04 12.63 31.99 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 179.21 -71.94 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.118 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -65.74 37.94 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.829 0 C-N-CA 124.189 3.26 . . . . 0.0 114.994 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -68.57 144.14 54.65 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 173.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -53.83 -82.25 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -169.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.8 tt -137.5 4.3 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.065 0.936 . . . . 0.0 109.559 -177.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 41' ' ' GLU . . . -141.33 156.45 67.33 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.52 -174.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.616 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.6 Cg_endo -72.62 160.26 46.91 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.184 1.923 . . . . 0.0 111.045 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.7 pt -77.19 134.81 27.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.333 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.4 tt -89.98 -52.64 4.87 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 p -161.34 141.26 3.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.761 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.736 ' HB ' HG21 ' A' ' 38' ' ' ILE . 1.7 tt -107.72 134.08 50.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.606 174.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.84 145.42 39.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.638 HG21 ' HB2' ' A' ' 94' ' ' ALA . 31.1 m -137.77 143.21 34.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.392 0.615 . . . . 0.0 110.642 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.655 ' O ' ' HG3' ' A' ' 76' ' ' MET . 93.3 m-20 -78.39 105.46 9.66 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 168.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 1.054 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 31.5 t0 -58.78 121.46 11.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.368 -175.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.84 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -154.37 48.59 0.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.622 -179.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.806 ' HA2' ' HB3' ' A' ' 81' ' ' ALA . . . -101.25 49.49 1.05 Allowed Glycine 0 C--N 1.314 -0.694 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.507 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.04 79.15 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.765 0.317 . . . . 0.0 110.561 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 57.94 25.7 12.49 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.763 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.6 -74.25 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.049 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.806 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . 59.33 62.17 1.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.406 0.622 . . . . 0.0 110.869 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 77.6 p -83.82 176.14 9.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.882 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.818 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 46.6 p90 -69.25 -22.58 63.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 0.0 110.496 177.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -85.19 -24.59 27.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.616 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 71.68 158.86 0.16 Allowed Pre-proline 0 N--CA 1.468 0.471 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.433 173.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.84 ' HD2' ' HB2' ' A' ' 76' ' ' MET . 19.6 Cg_endo -88.16 8.16 4.22 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.801 2.334 . . . . 0.0 111.476 169.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.66 130.8 6.23 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.797 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -72.44 126.79 30.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.732 0.266 . . . . 0.0 110.457 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.49 -65.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.505 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 1.054 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 61.9 t30 -85.6 153.17 22.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -122.57 128.8 51.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.941 HG21 ' HB2' ' A' ' 118' ' ' SER . 21.7 pt -145.64 166.14 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.282 0.563 . . . . 0.0 112.354 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.24 101.59 12.64 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.217 -0.902 . . . . 0.0 108.852 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.687 ' O ' ' HG ' ' A' ' 137' ' ' LEU . . . -59.03 -40.01 83.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.029 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.709 ' HB2' HG22 ' A' ' 71' ' ' ILE . 24.0 t70 -63.3 -11.05 19.02 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.458 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -130.35 50.7 2.17 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.594 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -149.5 -169.2 3.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.469 0.176 . . . . 0.0 110.709 -173.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -94.82 142.25 27.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.52 0.676 . . . . 0.0 111.147 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.5 135.7 54.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.853 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.602 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.2 p -115.16 124.01 71.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.622 0.725 . . . . 0.0 110.007 169.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.557 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 43.8 t -101.65 106.92 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.753 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.87 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -72.62 141.16 30.35 Favored Glycine 0 C--O 1.223 -0.536 0 CA-C-N 116.057 -0.52 . . . . 0.0 114.219 -170.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.3 m -92.13 -32.77 15.0 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.625 -0.338 . . . . 0.0 111.207 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.648 ' HB1' ' HB2' ' A' ' 130' ' ' GLU . . . -88.29 -46.18 9.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.615 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 35.7 mtp-105 -104.73 -92.64 0.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.145 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 145' ' ' VAL . 37.2 ttp85 51.41 -87.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.78 23.75 0.02 OUTLIER Glycine 0 C--O 1.222 -0.652 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.207 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -57.78 -26.82 58.28 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.283 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 70.7 mtm -105.68 15.98 26.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.66 0.267 . . . . 0.0 110.553 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.52 -120.92 0.54 Allowed Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.47 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.3 104.33 40.33 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.621 0.211 . . . . 0.0 110.743 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 6.8 Cg_endo -51.28 124.1 13.39 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.544 2.829 . . . . 0.0 113.124 177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.73 146.14 41.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.962 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.524 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -125.05 132.82 53.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.916 -175.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.693 HG22 ' HB2' ' A' ' 81' ' ' ALA . 67.6 t -96.7 106.36 29.6 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.879 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 1.2 Cg_endo -90.44 105.75 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.702 2.935 . . . . 0.0 111.056 175.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.861 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.2 t80 -117.95 149.07 41.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.911 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.941 ' HB2' HG21 ' A' ' 92' ' ' ILE . 47.9 t -71.01 -35.73 72.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.915 0.388 . . . . 0.0 110.488 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.861 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 7.3 m -97.85 127.14 43.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.764 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -43.16 98.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.155 0.502 . . . . 0.0 110.584 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.75 -32.63 71.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.856 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -74.66 -37.99 62.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.733 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.36 76.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.21 0.528 . . . . 0.0 110.12 176.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.86 -32.18 70.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.832 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.2 89.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.042 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.96 -40.27 94.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.694 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.658 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 93.0 t -63.55 -38.2 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.695 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.38 -36.85 74.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.575 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.71 -45.75 16.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.254 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.648 ' HB2' ' HB1' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -161.4 -36.03 0.05 OUTLIER 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.87 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -46.71 163.09 0.17 Allowed Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.075 -0.966 . . . . 0.0 114.034 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.94 -72.63 0.71 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.82 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.574 ' HB3' ' CB ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -124.73 144.47 50.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.821 0.343 . . . . 0.0 111.078 -178.501 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.32 113.47 42.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.379 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -134.86 148.91 50.24 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.782 -179.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.85 161.02 23.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.614 0.245 . . . . 0.0 110.456 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -57.92 -27.29 63.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.037 -178.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.03 -16.06 60.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.779 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -123.7 20.48 9.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.945 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.723 HD11 HD11 ' A' ' 135' ' ' LEU . 19.6 mm -71.76 121.52 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.518 HG23 ' HG2' ' A' ' 144' ' ' MET . 4.0 t -114.68 145.77 41.65 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.538 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.2 p-10 -69.75 -24.48 63.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.381 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.02 68.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.795 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.633 ' SD ' ' HB3' ' A' ' 155' ' ' PRO . 19.9 mmt -77.96 -40.28 39.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.952 0.406 . . . . 0.0 110.794 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.411 ' O ' ' NH1' ' A' ' 106' ' ' ARG . 2.4 t -85.73 -21.31 7.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.173 0.511 . . . . 0.0 111.33 -174.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.0 pp -144.56 127.67 16.6 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.343 0.592 . . . . 0.0 110.543 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 21.2 p -102.73 120.45 52.72 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.486 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.35 -58.39 1.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.799 2.333 . . . . 0.0 112.354 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.96 3.68 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.009 0.433 . . . . 0.0 110.209 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.453 ' O ' HG23 ' A' ' 151' ' ' THR . 35.8 mt-10 65.95 -73.42 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.211 -166.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 150' ' ' GLU . 0.6 OUTLIER 57.8 -4.52 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.974 1.309 . . . . 0.0 114.181 172.509 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 92.36 25.58 20.87 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.005 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 56.3 p -97.16 125.36 41.62 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.65 145.41 95.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.633 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 37.4 Cg_exo -35.1 -58.67 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.998 3.132 . . . . 0.0 113.495 -176.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -141.81 -42.55 0.35 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.66 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -165.22 25.81 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.825 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.4 t0 53.91 77.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -165.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -136.96 24.25 3.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.563 -167.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.574 ' CB ' ' HB3' ' A' ' 133' ' ' GLN . 2.8 pt-20 . . . . . 0 C--O 1.246 0.918 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.269 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.604 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -126.96 143.88 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.21 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 1.7 pm0 -149.06 136.28 20.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.934 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.867 HG23 ' HB2' ' A' ' 59' ' ' ALA . 37.1 pt -115.82 132.67 64.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.114 0.483 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -99.19 126.36 44.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 66' ' ' ALA . 9.0 mp -91.75 151.98 20.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.006 -175.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.538 ' HA ' HD12 ' A' ' 69' ' ' LEU . 26.9 tt0 -74.01 125.44 28.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.958 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.62 -30.9 5.12 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.213 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 14.7 t -92.16 124.23 60.39 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -84.73 19.62 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.168 2.579 . . . . 0.0 112.109 -178.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.91 133.58 24.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.527 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -91.51 138.08 2.1 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.659 2.239 . . . . 0.0 112.732 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.447 ' HB3' HG12 ' A' ' 38' ' ' ILE . 3.6 tt -89.28 104.16 16.73 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 47.3 p90 -113.21 151.06 31.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.335 -175.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -149.8 149.6 30.75 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.65 -59.47 4.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.122 0.487 . . . . 0.0 110.482 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.616 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 32.7 mt-30 -65.4 121.96 16.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.459 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.604 HG12 ' HB1' ' A' ' 36' ' ' ALA . 12.6 t -59.92 -49.99 81.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.579 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -55.06 -30.28 59.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.482 179.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.616 ' HB2' ' HB2' ' A' ' 51' ' ' GLN . 5.2 t0 -76.13 -51.17 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.843 0.354 . . . . 0.0 110.805 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.74 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -67.89 -35.54 78.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.456 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.757 HG23 HD12 ' A' ' 71' ' ' ILE . 20.9 pt -67.79 -31.68 53.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.305 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.17 95.08 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.411 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.806 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 36.1 m-85 -57.97 -42.23 84.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.198 0.523 . . . . 0.0 110.77 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.867 ' HB2' HG23 ' A' ' 38' ' ' ILE . . . -63.36 -19.79 64.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.387 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -105.26 12.23 32.04 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.863 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.41 -72.59 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.656 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.806 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 25.9 Cg_exo -67.79 47.61 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.823 3.015 . . . . 0.0 113.606 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.552 ' OE1' ' HA ' ' A' ' 67' ' ' PRO . 9.4 pt-20 -81.37 -3.27 52.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.268 0.556 . . . . 0.0 110.217 177.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 72.45 -78.67 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.844 171.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -129.67 -52.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -171.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -97.31 148.49 34.49 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.432 0.158 . . . . 0.0 110.713 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.552 ' HA ' ' OE1' ' A' ' 63' ' ' GLU . 59.4 Cg_endo -71.81 157.72 54.59 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.447 2.098 . . . . 0.0 111.936 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 68' ' ' ILE . 47.5 pt -75.1 122.16 28.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.263 0.554 . . . . 0.0 110.261 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 41' ' ' GLU . 5.6 tt -88.22 -47.96 8.05 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.46 138.72 2.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.547 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.757 HD12 HG23 ' A' ' 56' ' ' ILE . 2.6 tt -110.19 131.58 60.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.315 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -111.94 142.16 44.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.881 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.66 143.66 31.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.968 0.414 . . . . 0.0 110.773 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.465 HD22 ' HA ' ' A' ' 88' ' ' ASP . 33.7 t30 -79.57 101.11 8.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 167.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 76' ' ' MET . 54.5 t0 -63.63 106.99 1.05 Allowed 'General case' 0 C--O 1.242 0.707 0 O-C-N 124.47 1.107 . . . . 0.0 110.628 -174.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.601 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 3.6 mmt -152.29 58.95 0.83 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 113.442 -1.708 . . . . 0.0 107.86 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.28 26.46 21.2 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.042 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.15 39.45 0.82 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.979 0.419 . . . . 0.0 110.953 -172.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -179.43 -11.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.238 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 126.14 -4.32 7.82 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.997 -177.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.27 65.39 1.09 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.622 0.725 . . . . 0.0 109.956 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.7 p -83.81 177.1 8.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.419 -171.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 68.8 t90 -59.43 -40.6 87.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.075 0.464 . . . . 0.0 110.026 175.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.32 -34.15 48.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.089 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.08 159.79 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.983 1.313 . . . . 0.0 112.935 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.545 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 8.2 Cg_exo -58.47 -25.93 75.97 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.67 1.58 . . . . 0.0 112.188 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.601 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . 135.39 -149.51 19.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.966 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.465 ' HA ' HD22 ' A' ' 74' ' ' ASN . 7.6 p-10 -77.55 137.52 38.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.999 0.428 . . . . 0.0 110.285 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.81 -141.85 3.99 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.549 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -100.6 133.65 44.73 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -98.16 130.25 44.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.13 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.693 HD12 ' HB2' ' A' ' 118' ' ' SER . 6.9 pt -145.04 166.42 11.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.934 -173.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.26 107.16 15.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.05 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . . . -62.1 -27.78 69.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.136 0.493 . . . . 0.0 110.479 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.741 ' HA ' HD12 ' A' ' 137' ' ' LEU . 22.7 t70 -59.54 -25.19 64.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.413 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -123.65 43.14 3.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.384 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -139.86 -177.93 5.2 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -173.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -97.95 138.04 35.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.394 0.616 . . . . 0.0 110.646 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' A' ' 116' ' ' PRO . 3.1 m-85 -120.46 135.33 55.09 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.104 -177.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.674 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.9 p -113.66 124.82 70.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.514 0.673 . . . . 0.0 109.816 173.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.59 113.87 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.419 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -79.44 121.84 5.63 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.011 -1.09 . . . . 0.0 112.774 -172.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.8 m -92.68 -41.02 10.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.854 0.359 . . . . 0.0 110.313 175.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.21 -43.84 63.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 -174.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -133.84 114.72 13.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.454 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 176.0 -168.88 0.05 Allowed 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.554 0.534 . . . . 0.0 110.086 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.466 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -65.56 -50.99 51.73 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.925 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.06 -102.15 0.68 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.272 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.3 mmt -86.46 -3.92 59.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 110.757 174.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.49 -124.53 5.08 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.466 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.35 96.13 8.01 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.56 0.18 . . . . 0.0 111.084 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.37 141.89 70.15 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.552 2.168 . . . . 0.0 111.9 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 36.5 mt-10 -125.94 140.63 52.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.605 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.75 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -105.95 131.47 53.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.859 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.674 ' HB ' HG13 ' A' ' 100' ' ' VAL . 59.4 t -100.59 106.14 41.37 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.6 Cg_endo -87.75 122.92 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.695 2.93 . . . . 0.0 111.552 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.58 ' HD1' ' H ' ' A' ' 119' ' ' SER . 3.6 t80 -130.43 151.11 51.27 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.693 ' HB2' HD12 ' A' ' 92' ' ' ILE . 33.8 t -73.47 -35.79 65.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.58 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 15.2 m -105.96 128.83 54.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.798 0.332 . . . . 0.0 110.846 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -49.85 57.9 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.787 -176.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -67.14 -28.38 68.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.29 0.567 . . . . 0.0 109.74 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.558 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 66.3 mm-40 -71.46 -34.84 70.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.594 172.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.64 -35.09 76.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.338 0.59 . . . . 0.0 109.69 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.43 75.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.695 173.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.1 -32.3 73.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.39 . . . . 0.0 110.444 175.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -63.79 -37.49 87.58 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.624 HG21 ' H ' ' A' ' 132' ' ' GLY . 58.9 t -69.57 -30.48 45.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.447 176.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 tp -59.5 -39.6 84.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.949 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.44 -47.85 13.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.686 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.809 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.6 pt-20 -149.94 -89.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.459 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.809 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 44.88 -143.33 2.95 Favored Glycine 0 C--N 1.334 0.453 0 O-C-N 123.588 0.555 . . . . 0.0 114.297 174.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.624 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -176.08 -81.26 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.437 HE21 ' HB3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -130.21 145.97 51.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.586 0.231 . . . . 0.0 110.568 175.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.21 116.31 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.149 0.499 . . . . 0.0 110.682 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.841 HD11 HD11 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -141.0 164.13 31.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.955 -178.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.31 163.3 18.68 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 95' ' ' ASP . 0.6 OUTLIER -66.4 -31.57 72.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.399 0.618 . . . . 0.0 109.505 178.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.87 -9.12 58.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.878 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.27 17.9 11.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.23 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.841 HD11 HD11 ' A' ' 135' ' ' LEU . 26.3 mm -71.87 121.99 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.147 0.499 . . . . 0.0 110.627 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -112.23 149.56 32.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.261 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 2.2 p-10 -68.92 -29.86 68.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.556 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.43 68.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.66 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.536 ' HE3' ' HA ' ' A' ' 160' ' ' GLU . 13.4 mmt -87.11 -36.95 17.81 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.16 -22.73 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 121.09 0.471 . . . . 0.0 110.672 -174.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.3 pp -148.64 141.25 24.44 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.014 -177.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.3 p -126.0 135.55 27.24 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.053 0.454 . . . . 0.0 111.132 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.8 -49.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.822 2.348 . . . . 0.0 111.809 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 151' ' ' THR . 8.0 t -159.23 85.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -176.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -50.82 74.6 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.226 168.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 149' ' ' VAL . 10.2 t -106.92 21.21 17.9 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.756 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.73 78.0 0.8 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.132 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.2 m -129.96 139.33 51.1 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.54 125.67 92.12 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.726 0.298 . . . . 0.0 110.294 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.55 -73.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.85 2.367 . . . . 0.0 112.253 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.609 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -108.67 -54.07 2.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.786 176.633 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.609 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -151.84 37.76 0.58 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -174.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' A' ' 157' ' ' ALA . 32.9 t70 73.74 -30.01 0.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.235 -175.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 157' ' ' ALA . 6.2 t70 -73.72 -168.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.362 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.536 ' HA ' ' HE3' ' A' ' 144' ' ' MET . 39.2 mt-10 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.595 -0.717 . . . . 0.0 109.926 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.549 ' H ' ' HB3' ' A' ' 74' ' ' ASN . 26.9 ttpp . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.602 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -126.71 142.54 51.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 9.0 pt20 -149.39 133.66 17.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.474 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.527 HG21 ' HB2' ' A' ' 59' ' ' ALA . 39.0 pt -115.63 136.21 53.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.957 0.408 . . . . 0.0 110.946 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -105.77 131.84 52.63 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.888 HD21 ' HB3' ' A' ' 64' ' ' GLN . 8.7 mp -89.19 152.57 21.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.113 0.482 . . . . 0.0 111.672 -173.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.844 ' HG3' HD11 ' A' ' 69' ' ' LEU . 32.0 tt0 -74.22 124.78 27.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.62 -41.1 2.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.238 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.446 ' HB3' ' CB ' ' A' ' 40' ' ' LEU . 31.2 t -81.92 123.96 79.6 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.038 0.447 . . . . 0.0 110.446 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.0 Cg_exo -81.74 5.63 6.18 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.322 2.682 . . . . 0.0 112.455 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -100.37 131.18 24.35 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.574 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 97.8 Cg_endo -101.41 161.08 0.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.573 2.848 . . . . 0.0 112.984 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.437 ' HB3' HG12 ' A' ' 38' ' ' ILE . 7.6 tt -117.73 114.93 24.05 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -118.24 135.77 54.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.61 0.719 . . . . 0.0 111.582 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.42 135.17 31.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.624 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.9 m -63.93 -29.49 70.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.579 0.704 . . . . 0.0 109.171 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.606 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 14.3 mt-30 -75.97 95.98 3.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.702 175.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.602 HG12 ' HB1' ' A' ' 36' ' ' ALA . 10.8 t -57.65 -52.03 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.058 0.456 . . . . 0.0 111.019 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.53 ' HA ' HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -54.15 -30.11 47.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.364 -178.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.524 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 1.2 m-20 -73.98 -53.47 9.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.761 0.315 . . . . 0.0 111.189 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.404 ' HB1' ' CB ' ' A' ' 36' ' ' ALA . . . -67.21 -35.97 80.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.256 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.648 HD12 ' HB1' ' A' ' 114' ' ' ALA . 17.7 pt -70.35 -32.52 50.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.521 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.17 -44.97 74.74 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.567 174.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.468 ' HD1' ' HG2' ' A' ' 62' ' ' PRO . 22.1 m-85 -62.39 -35.11 78.18 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.527 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -61.04 -17.8 54.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 112.017 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -84.8 -15.57 44.43 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.35 -73.02 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.264 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.468 ' HG2' ' HD1' ' A' ' 58' ' ' TYR . 84.8 Cg_exo -48.67 -47.01 22.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.329 2.686 . . . . 0.0 113.205 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 54.76 -91.08 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.564 0.746 . . . . 0.0 111.723 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.888 ' HB3' HD21 ' A' ' 40' ' ' LEU . 5.7 tp-100 -174.27 -61.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.186 0.517 . . . . 0.0 109.672 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.0 tt -168.42 -38.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.603 ' HB2' HD22 ' A' ' 40' ' ' LEU . . . -106.63 165.3 13.17 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.493 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 73.0 Cg_endo -74.53 156.59 45.14 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.649 1.566 . . . . 0.0 111.628 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.3 pt -69.87 128.15 32.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.219 0.533 . . . . 0.0 110.909 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.844 HD11 ' HG3' ' A' ' 41' ' ' GLU . 42.6 tp -89.32 -48.95 7.01 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.99 138.45 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.631 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.569 HD12 HG23 ' A' ' 56' ' ' ILE . 2.7 tt -110.89 135.42 50.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.429 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -112.91 138.81 49.2 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.559 HG22 ' HB1' ' A' ' 94' ' ' ALA . 19.7 m -128.94 137.88 56.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.289 0.566 . . . . 0.0 110.551 175.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.549 ' HB3' ' H ' ' A' ' 35' ' ' LYS . 27.9 t-20 -78.63 104.17 9.07 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -72.49 121.54 19.79 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 124.256 0.973 . . . . 0.0 109.73 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.535 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -151.84 92.37 1.73 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.611 -176.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.7 -56.84 3.84 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.886 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 81' ' ' ALA . . . 70.99 -52.07 0.68 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.984 0.914 . . . . 0.0 112.49 175.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.91 -34.07 58.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.99 0.424 . . . . 0.0 110.791 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -97.29 -65.33 0.9 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 78' ' ' ALA . . . 44.06 64.54 1.26 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.59 0.756 . . . . 0.0 112.908 175.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.9 p -84.0 176.14 9.05 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.606 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 26.1 p90 -73.32 -12.83 60.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.164 0.507 . . . . 0.0 110.287 175.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.82 -35.15 22.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 68.02 161.04 0.14 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.768 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 76' ' ' MET . 69.9 Cg_endo -93.52 29.35 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.195 1.93 . . . . 0.0 111.634 176.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.15 161.92 18.64 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.721 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -77.35 123.23 26.22 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -106.56 -139.18 9.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.145 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -100.04 149.45 23.47 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 67.2 p-90 -98.44 134.72 41.03 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.232 0.539 . . . . 0.0 110.639 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 118' ' ' SER . 4.3 pt -133.78 151.91 33.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.543 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.04 102.54 4.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.559 ' HB1' HG22 ' A' ' 73' ' ' VAL . . . -61.16 -34.81 75.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.337 -176.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.643 ' HA ' HD12 ' A' ' 137' ' ' LEU . 16.7 t70 -57.81 -30.34 65.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.707 0.765 . . . . 0.0 110.354 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -111.24 26.79 10.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.826 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.17 177.39 5.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.718 0.294 . . . . 0.0 111.06 -173.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -90.44 131.34 36.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.453 0.644 . . . . 0.0 110.535 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.62 135.33 55.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.071 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.685 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.8 p -112.82 125.46 70.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.745 0.783 . . . . 0.0 110.334 174.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.673 ' HA ' HH11 ' A' ' 106' ' ' ARG . 47.9 t -101.81 107.87 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.998 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.44 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -69.6 124.27 15.11 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.547 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.4 m -88.6 -31.01 18.81 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.77 -44.33 11.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.738 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -133.59 109.52 9.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.755 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.746 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 13.7 ttt180 -168.64 -72.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.601 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.67 46.04 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.523 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -61.8 -39.49 97.54 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.699 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 45.2 tpp -109.39 -4.21 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.559 0.695 . . . . 0.0 110.1 174.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.88 -132.87 5.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.208 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.3 102.6 29.96 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.74 129.47 24.95 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.253 2.636 . . . . 0.0 114.01 -175.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.746 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 47.9 mm-40 -114.21 129.33 56.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.364 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.648 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -102.22 131.06 49.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.824 -0.171 . . . . 0.0 111.263 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.685 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 85.7 t -101.61 105.74 42.41 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.772 173.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -90.09 127.04 1.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.762 2.975 . . . . 0.0 111.795 175.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.26 149.81 52.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.195 -176.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.737 ' HB2' HD12 ' A' ' 92' ' ' ILE . 47.9 t -79.1 -18.25 53.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.893 0.378 . . . . 0.0 110.758 176.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.7 m -119.85 134.24 55.31 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.77 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -67.48 -49.52 63.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -60.13 -28.99 68.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.452 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -70.23 -43.28 70.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.268 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.7 -30.2 69.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.148 176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.1 -38.09 72.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.639 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.57 74.79 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.264 0.554 . . . . 0.0 110.272 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.69 -39.64 92.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.847 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.821 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 94.6 t -70.78 -34.81 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.929 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 67.6 mt -56.36 -40.94 75.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.62 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.53 -48.97 11.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.699 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.766 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.5 pt-20 -145.4 -82.72 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.101 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.821 ' HA3' ' HA ' ' A' ' 127' ' ' VAL . . . 38.23 -142.24 0.35 Allowed Glycine 0 C--N 1.337 0.606 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.757 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -179.73 -87.28 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.454 HE21 ' HB ' ' A' ' 101' ' ' VAL . 1.9 pm0 -129.86 141.46 50.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.675 0.274 . . . . 0.0 110.863 175.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.48 113.22 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.04 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.709 HD12 HD12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.41 165.05 27.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.656 -178.239 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.31 161.79 19.36 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.675 ' HA ' HG12 ' A' ' 140' ' ' ILE . 5.9 tt -61.75 -36.78 82.0 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.85 -11.48 27.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.487 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -126.0 23.15 7.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.012 0.434 . . . . 0.0 110.895 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.709 HD12 HD12 ' A' ' 135' ' ' LEU . 34.4 mm -71.82 119.12 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 145' ' ' VAL . 14.1 t -119.26 148.65 42.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.681 -176.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.522 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 1.5 p30 -66.07 -41.73 90.35 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -171.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 155' ' ' PRO . . . -57.03 -28.6 62.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.501 ' SD ' ' HB2' ' A' ' 155' ' ' PRO . 19.2 mmt -82.19 -26.83 33.0 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 141' ' ' THR . 10.9 t -97.88 -23.19 4.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -170.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.6 pp -136.33 156.4 48.69 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.969 -172.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.5 p -111.99 119.52 44.08 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.044 0.449 . . . . 0.0 110.779 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.19 -81.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.581 2.187 . . . . 0.0 111.976 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.564 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 4.1 t -129.35 -2.48 2.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 15.0 mm-40 87.83 -77.78 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -169.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.555 ' OG1' ' HB ' ' A' ' 149' ' ' VAL . 13.0 m 68.46 -42.33 0.47 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 163.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.83 20.91 5.88 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.9 m -84.02 126.55 33.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.585 0.231 . . . . 0.0 110.438 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.702 ' HB3' ' HB2' ' A' ' 158' ' ' ASP . 4.3 mp0 -71.14 126.57 91.98 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.157 177.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.501 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 61.8 Cg_endo -72.94 126.94 11.7 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.633 2.222 . . . . 0.0 111.325 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 155' ' ' PRO . 18.5 tpp85 69.66 -63.07 0.4 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.527 0.517 . . . . 0.0 110.471 -175.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -179.07 13.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.275 0.63 . . . . 0.0 109.92 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.702 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 14.0 t70 57.59 30.88 19.49 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -169.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.01 -68.22 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.679 -172.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.751 179.643 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.566 ' HB3' ' OD1' ' A' ' 74' ' ' ASN . 43.7 tttp . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.715 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -144.72 144.75 31.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.763 0.316 . . . . 0.0 111.671 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 22.3 pt20 -145.56 134.8 22.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.874 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.686 HG12 ' HB3' ' A' ' 47' ' ' LEU . 3.9 pt -119.81 143.24 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.248 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -116.82 127.88 54.74 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.711 HD21 ' HB2' ' A' ' 66' ' ' ALA . 10.3 mp -92.07 142.42 27.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.068 0.461 . . . . 0.0 111.082 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.75 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 44.8 tt0 -73.83 124.69 26.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.866 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.05 -27.29 11.58 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.146 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.3 t -92.0 125.56 56.45 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.1 Cg_exo -80.5 12.12 2.67 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.132 2.554 . . . . 0.0 112.833 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.45 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -130.15 133.25 24.73 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.876 0.369 . . . . 0.0 110.961 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 55.6 Cg_endo -97.42 170.83 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.388 2.725 . . . . 0.0 112.782 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.686 ' HB3' HG12 ' A' ' 38' ' ' ILE . 14.4 tp -107.04 130.64 54.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.94 177.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -114.45 134.47 54.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.1 147.6 27.97 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 110.688 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 55.3 m -70.38 -52.58 21.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.143 173.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.479 HE21 ' HB3' ' A' ' 83' ' ' TRP . 39.8 mt-30 -67.37 113.09 4.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.718 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.715 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 6.2 t -60.48 -50.48 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.565 0.697 . . . . 0.0 109.444 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.646 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -60.21 -28.79 68.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.548 -176.765 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.646 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 14.2 t70 -76.14 -45.5 33.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.781 0.324 . . . . 0.0 110.482 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.52 72.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.275 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.572 ' CD1' ' HB1' ' A' ' 114' ' ' ALA . 16.4 pt -71.19 -32.51 47.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 0.0 110.179 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.26 -36.34 79.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.16 0.505 . . . . 0.0 110.302 172.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.444 ' CD1' HD21 ' A' ' 47' ' ' LEU . 33.8 t80 -60.62 -33.23 72.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.279 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.636 ' HB3' HD11 ' A' ' 68' ' ' ILE . . . -72.37 -18.1 61.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.605 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.542 ' NH2' ' HG ' ' A' ' 137' ' ' LEU . 75.1 mtt85 -105.62 13.14 30.33 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.36 -78.63 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.538 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -43.37 -35.54 5.71 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 124.041 3.161 . . . . 0.0 114.774 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -67.61 128.66 37.28 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.759 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -169.68 -36.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.122 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.9 -27.46 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.542 0.687 . . . . 0.0 109.644 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.711 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -152.1 141.2 14.08 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.309 175.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.75 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 70.4 Cg_endo -74.23 155.12 46.81 Favored 'Trans proline' 0 CA--C 1.52 -0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.282 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.636 HD11 ' HB3' ' A' ' 59' ' ' ALA . 27.5 pt -75.74 116.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.373 0.606 . . . . 0.0 110.484 174.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -79.12 -47.84 15.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 p -161.08 150.16 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.775 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.568 HD12 HG23 ' A' ' 56' ' ' ILE . 5.7 tt -128.0 128.61 69.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.448 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -111.99 133.46 54.15 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.421 HG21 ' HB2' ' A' ' 94' ' ' ALA . 34.6 m -132.2 156.6 42.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.108 0.48 . . . . 0.0 110.668 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.566 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 12.3 m120 -92.34 104.56 16.89 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.442 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 10.3 t0 -49.56 103.9 0.06 Allowed 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 125.35 1.656 . . . . 0.0 109.525 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.553 ' SD ' ' HB3' ' A' ' 85' ' ' GLN . 3.3 ttm -144.69 41.04 1.31 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.038 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 79' ' ' ALA . . . -89.62 18.1 48.53 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.644 -175.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.06 22.17 0.11 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.216 0.532 . . . . 0.0 111.474 -175.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.51 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -172.89 20.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.493 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.51 -2.29 77.32 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.347 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.443 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . . . 60.47 66.82 0.89 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.688 0.756 . . . . 0.0 110.315 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 p -83.73 175.59 9.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.445 -176.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.479 ' HB3' HE21 ' A' ' 51' ' ' GLN . 59.8 p-90 -67.26 -23.92 65.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.981 0.42 . . . . 0.0 110.767 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.03 -35.55 42.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.553 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 24.2 mt-30 66.8 142.97 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.578 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -57.61 -42.22 62.76 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.015 1.81 . . . . 0.0 112.07 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.2 -64.56 0.6 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.247 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.32 131.79 38.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.7 0.286 . . . . 0.0 110.619 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 75' ' ' ASP . . . -147.47 139.74 8.04 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.401 -177.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.3 t30 -100.13 149.14 23.83 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -98.48 129.74 45.08 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.705 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.733 HG21 ' HB2' ' A' ' 118' ' ' SER . 20.3 pt -145.02 166.17 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.967 -174.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.69 114.1 23.1 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 73' ' ' VAL . . . -69.46 -38.07 77.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.036 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.743 ' HA ' HD12 ' A' ' 137' ' ' LEU . 0.6 OUTLIER -68.03 -25.24 65.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.738 0.78 . . . . 0.0 109.752 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -98.9 37.35 1.53 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.262 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.48 179.24 7.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.35 -171.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -93.59 141.8 28.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.304 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -120.67 137.08 54.64 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.558 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.827 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -115.16 123.21 70.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.504 0.669 . . . . 0.0 109.368 172.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.475 ' HB ' ' HG2' ' A' ' 133' ' ' GLN . 56.4 t -101.53 107.13 20.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.31 123.25 7.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.793 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.4 t -92.42 -35.4 13.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.893 0.378 . . . . 0.0 110.146 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.39 -45.08 20.21 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.943 0.401 . . . . 0.0 111.568 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.434 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 48.9 mtp180 -129.58 111.72 13.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.617 ' NE ' ' HA ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -177.81 -170.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -54.54 -37.56 61.01 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.67 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.45 -105.26 1.09 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.041 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 86.7 mtp -92.94 -4.0 53.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.979 0.419 . . . . 0.0 110.374 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -95.15 -129.51 5.8 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.782 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.423 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.27 96.58 8.52 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 176.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 18.1 Cg_endo -59.72 151.51 69.78 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.401 2.734 . . . . 0.0 113.314 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.465 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 2.5 mp0 -117.1 146.13 43.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.54 175.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.572 ' HB1' ' CD1' ' A' ' 56' ' ' ILE . . . -103.98 131.13 51.53 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.827 ' HB ' HG13 ' A' ' 100' ' ' VAL . 5.7 t -99.19 105.22 31.07 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.3 Cg_exo -87.07 133.35 3.4 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.556 2.837 . . . . 0.0 112.89 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -129.26 149.67 50.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.46 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.733 ' HB2' HG21 ' A' ' 92' ' ' ILE . 32.5 t -78.05 -38.19 45.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.064 0.459 . . . . 0.0 109.837 172.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 m -96.28 135.33 38.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.818 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -46.2 84.85 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -64.73 -28.46 69.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.875 -172.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -64.98 -38.66 91.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.95 0.405 . . . . 0.0 110.677 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.481 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -73.02 -36.16 66.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.077 176.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.0 -44.99 83.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.065 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.65 -34.14 75.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 110.9 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -62.78 -40.51 97.53 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.806 HG21 ' H ' ' A' ' 132' ' ' GLY . 91.7 t -72.43 -32.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.603 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.4 tp -57.75 -43.67 85.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.1 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.44 -44.64 15.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.164 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.675 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.2 pt-20 -150.69 -93.29 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.403 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.675 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.27 -138.12 7.73 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 114.438 0.535 . . . . 0.0 114.438 173.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.806 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -176.95 -83.09 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.475 ' HG2' ' HB ' ' A' ' 101' ' ' VAL . 13.2 pm0 -130.07 142.16 50.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.645 0.259 . . . . 0.0 110.937 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.5 t -109.45 120.14 60.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.046 0.451 . . . . 0.0 110.729 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.841 HD12 HD13 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -147.2 165.69 29.25 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.547 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.91 164.05 18.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.743 HD12 ' HA ' ' A' ' 95' ' ' ASP . 8.6 tt -63.88 -35.52 80.91 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.02 -10.14 59.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.975 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -117.85 20.27 13.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.493 0.663 . . . . 0.0 110.043 -174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.841 HD13 HD12 ' A' ' 135' ' ' LEU . 35.8 mm -76.58 121.69 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.895 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.488 HG21 ' HB2' ' A' ' 144' ' ' MET . 0.5 OUTLIER -106.08 145.85 30.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.858 171.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -69.96 -33.17 71.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.018 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.19 -27.37 68.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.406 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.488 ' HB2' HG21 ' A' ' 141' ' ' THR . 1.7 mmt -73.45 -38.8 65.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.871 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.9 t -83.67 -22.61 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.275 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 pp -151.08 133.44 15.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.594 -0.443 . . . . 0.0 111.406 -174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.8 p -125.93 120.85 24.15 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.305 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.4 -59.59 0.41 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.898 2.399 . . . . 0.0 113.392 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.3 t -125.21 6.62 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.93 0.395 . . . . 0.0 110.68 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 60.91 47.62 7.46 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.82 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 t -71.9 -3.33 21.87 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 82.8 28.92 36.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.868 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 p -70.49 141.08 52.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.661 0.267 . . . . 0.0 111.231 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.499 ' OE2' ' HB2' ' A' ' 158' ' ' ASP . 37.9 mt-10 -59.73 125.84 81.26 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.204 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.74 -72.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 123.146 2.564 . . . . 0.0 112.723 -176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -117.66 -33.57 4.5 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.476 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.503 ' C ' ' H ' ' A' ' 159' ' ' ASP . . . -171.05 39.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.895 -173.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.499 ' HB2' ' OE2' ' A' ' 154' ' ' GLU . 14.6 t70 71.99 -37.26 0.38 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.292 0.637 . . . . 0.0 110.659 -174.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.9 t70 -65.24 -163.38 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.249 175.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.835 177.072 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.806 ' H ' ' HB2' ' A' ' 74' ' ' ASN . 36.6 ttpt . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.503 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -134.16 144.54 48.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.149 0.431 . . . . 0.0 111.859 -177.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 28.9 pt20 -147.02 136.83 23.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.872 174.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.611 HG21 ' HB ' ' A' ' 71' ' ' ILE . 35.5 pt -120.06 132.75 68.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.2 0.524 . . . . 0.0 111.495 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -105.75 119.06 38.2 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.464 HD21 ' HB2' ' A' ' 66' ' ' ALA . 9.9 mp -92.94 142.78 26.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.039 0.447 . . . . 0.0 110.738 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.676 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 31.4 tt0 -71.34 124.2 24.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.702 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.67 -17.16 58.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.594 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.429 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 37.5 t -92.38 125.96 54.29 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 1.4 Cg_endo -83.56 10.07 3.83 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.08 2.52 . . . . 0.0 112.678 -178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -134.3 134.2 22.45 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.786 0.327 . . . . 0.0 111.35 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 9.1 Cg_endo -89.2 125.36 1.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.484 2.789 . . . . 0.0 111.422 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.36 102.97 13.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.439 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 44.5 p90 -103.14 139.57 38.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.732 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -144.59 142.88 30.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.705 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.595 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 4.8 m -57.15 -44.1 83.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.077 0.465 . . . . 0.0 111.426 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.633 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 46.1 mt-30 -78.46 119.89 22.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.163 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.503 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 9.9 t -64.49 -50.39 76.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.599 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.01 -29.84 45.07 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.512 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.599 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 22.2 t70 -76.34 -51.55 11.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.828 0.347 . . . . 0.0 110.691 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.51 81.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.283 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.469 HD12 ' HB1' ' A' ' 114' ' ' ALA . 31.0 pt -67.6 -30.79 49.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.407 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -62.58 -46.11 89.83 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.547 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.402 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 30.1 m-85 -62.14 -40.88 97.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.888 0.375 . . . . 0.0 110.839 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.545 ' O ' HD13 ' A' ' 68' ' ' ILE . . . -60.83 -20.67 62.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.732 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 48.6 mtm105 -95.43 12.36 29.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.18 -62.35 0.32 Allowed Glycine 0 C--O 1.226 -0.354 0 C-N-CA 119.779 -1.201 . . . . 0.0 113.645 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 18.1 Cg_exo -70.8 49.46 0.94 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.441 2.761 . . . . 0.0 114.323 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -84.26 -89.23 0.1 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.601 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.599 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 22.1 tp60 -164.23 -51.7 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.499 0.591 . . . . 0.0 112.018 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.504 HG22 ' HG3' ' A' ' 64' ' ' GLN . 14.6 tt 177.52 -27.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.258 0.551 . . . . 0.0 110.703 -170.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.464 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -99.41 144.56 28.51 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.455 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.676 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 53.5 Cg_endo -68.62 152.69 74.46 Favored 'Trans proline' 0 CA--C 1.517 -0.332 0 C-N-CA 122.383 2.055 . . . . 0.0 111.371 176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.545 HD13 ' O ' ' A' ' 59' ' ' ALA . 29.5 pt -81.58 107.17 13.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.498 0.666 . . . . 0.0 110.059 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -69.86 -49.42 52.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 p -161.22 138.94 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.927 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.611 ' HB ' HG21 ' A' ' 38' ' ' ILE . 2.6 tt -112.87 128.58 69.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.754 174.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -111.84 128.87 56.25 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 94' ' ' ALA . 35.4 m -128.28 153.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.212 0.529 . . . . 0.0 110.565 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.806 ' HB2' ' H ' ' A' ' 35' ' ' LYS . 15.2 m120 -87.65 103.88 16.0 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -47.36 113.99 0.79 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 125.684 1.865 . . . . 0.0 110.7 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.603 ' HG2' ' O ' ' A' ' 74' ' ' ASN . 11.6 ptp -158.97 117.58 2.94 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.794 0.684 . . . . 0.0 110.074 -176.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.768 ' HA3' ' CZ ' ' A' ' 117' ' ' PHE . . . -151.12 44.89 0.66 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.656 -1.259 . . . . 0.0 113.941 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -97.79 26.42 5.13 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -176.95 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.674 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.534 ' HA2' ' CG2' ' A' ' 115' ' ' VAL . . . 131.03 20.67 1.14 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.281 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 55.83 54.52 8.05 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.421 0.629 . . . . 0.0 110.908 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.7 p -83.57 176.6 8.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.196 -174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.633 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 44.5 p90 -64.66 -28.51 69.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.041 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -80.35 -33.07 37.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 70.37 138.1 0.06 OUTLIER Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.951 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.445 ' CG ' ' HB2' ' A' ' 76' ' ' MET . 36.5 Cg_endo -65.78 -60.08 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.292 1.995 . . . . 0.0 112.808 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.24 -38.21 0.41 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.794 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.504 ' O ' ' HB3' ' A' ' 76' ' ' MET . 10.9 p-10 -72.41 146.75 46.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 176.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.93 94.23 0.11 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.023 -1.085 . . . . 0.0 113.67 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 49.9 m-80 -100.29 151.83 21.02 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.5 p90 -98.13 126.95 43.81 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.268 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.875 HG22 ' HB2' ' A' ' 118' ' ' SER . 34.5 pt -145.62 166.73 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.083 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -95.12 103.5 15.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 172.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -63.59 -30.52 71.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.25 -175.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.731 ' HA ' HD12 ' A' ' 137' ' ' LEU . 21.8 t70 -59.43 -24.26 63.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.697 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -120.51 33.97 5.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.329 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.41 -177.64 4.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.293 -171.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.94 137.4 33.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.545 0.688 . . . . 0.0 110.422 -177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.441 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 6.0 m-85 -120.65 135.69 55.04 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.372 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.564 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 6.3 p -112.24 120.92 63.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.462 0.649 . . . . 0.0 109.643 170.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.432 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 96.9 t -101.61 107.35 21.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.442 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -70.25 122.33 11.03 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.389 -175.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 m -92.31 -20.55 20.99 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.737 0.303 . . . . 0.0 110.821 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.99 -19.08 19.02 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.27 0.557 . . . . 0.0 110.453 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 23.3 mmm-85 -112.53 -30.63 7.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.416 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.751 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 5.4 mpt_? -120.88 -161.71 0.91 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.512 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.834 ' HA2' ' HD3' ' A' ' 112' ' ' PRO . . . 70.11 51.02 25.08 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -171.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.45 -127.04 0.16 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 114.483 -0.858 . . . . 0.0 113.068 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 66.2 mtt -97.93 21.32 10.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.665 0.745 . . . . 0.0 109.493 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.22 -114.07 0.29 Allowed Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.167 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.524 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.19 115.91 63.17 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.878 ' HG2' ' HA ' ' A' ' 145' ' ' VAL . 1.9 Cg_endo -44.09 157.15 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.905 3.07 . . . . 0.0 113.212 164.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.751 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 43.3 mt-10 -113.47 125.97 54.81 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.469 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -93.76 131.97 38.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.873 -168.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.564 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 2.4 t -97.41 106.07 29.87 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 5.7 Cg_exo -85.91 131.07 3.72 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.225 2.617 . . . . 0.0 112.731 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.768 ' CZ ' ' HA3' ' A' ' 77' ' ' GLY . 81.6 m-85 -129.82 149.8 51.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.505 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.875 ' HB2' HG22 ' A' ' 92' ' ' ILE . 16.6 t -87.23 -26.56 23.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.4 m -91.98 110.62 21.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.929 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -58.77 -46.82 86.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.245 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -62.82 -28.74 70.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.214 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.61 -44.82 81.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.891 0.377 . . . . 0.0 110.225 174.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -65.85 -35.62 81.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.329 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.81 -41.49 62.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.477 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.0 -33.2 74.92 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.207 0.527 . . . . 0.0 110.529 177.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -59.84 -38.41 81.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.576 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.628 HG21 ' H ' ' A' ' 132' ' ' GLY . 61.7 t -73.17 -30.91 32.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.098 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mp -56.82 -48.98 76.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.233 0.54 . . . . 0.0 110.72 176.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.73 -38.25 47.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.21 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.633 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.1 pt-20 -159.26 -90.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.708 -178.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.633 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 45.51 -139.05 6.0 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 123.827 0.704 . . . . 0.0 113.54 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.628 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -172.97 -89.54 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -128.44 139.15 52.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.809 0.337 . . . . 0.0 110.58 177.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 75.4 t -99.5 113.41 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.572 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.89 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.81 160.96 38.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.691 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.28 162.96 15.57 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.731 HD12 ' HA ' ' A' ' 95' ' ' ASP . 7.0 tt -64.3 -30.52 71.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.43 0.634 . . . . 0.0 109.495 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.91 -10.41 59.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.915 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -124.8 19.92 8.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.041 0.448 . . . . 0.0 110.407 -176.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.89 HD11 HD12 ' A' ' 135' ' ' LEU . 26.9 mm -72.1 119.76 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.491 ' O ' HG21 ' A' ' 145' ' ' VAL . 2.2 t -103.02 148.29 25.89 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.203 175.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.44 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 6.0 p-10 -68.94 -29.2 67.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.53 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.54 -32.29 66.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.453 ' HG3' ' HG3' ' A' ' 133' ' ' GLN . 18.0 mmt -86.99 -26.55 23.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.463 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.878 ' HA ' ' HG2' ' A' ' 112' ' ' PRO . 1.3 t -103.3 -3.22 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 111.405 -173.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.8 pp -169.64 132.87 1.23 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.822 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.403 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 1.8 p -94.0 118.69 67.26 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.245 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 24.0 Cg_endo -62.47 -68.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.953 2.435 . . . . 0.0 112.917 -177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 64.6 t -114.7 -27.56 2.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.043 -173.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 5.4 mm-40 68.99 46.15 0.86 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.977 0.894 . . . . 0.0 108.791 -166.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.4 t -75.72 -13.98 60.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.636 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.13 50.27 6.92 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.61 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.2 t -130.14 161.42 31.13 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -57.16 132.57 80.69 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.49 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.9 -72.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.536 2.824 . . . . 0.0 112.801 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.22 -44.83 3.21 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.263 173.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.28 44.35 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.384 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.0 t70 56.59 32.78 21.55 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.321 1.058 . . . . 0.0 109.637 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -142.07 -179.18 6.08 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 133' ' ' GLN . 9.9 mm-40 . . . . . 0 C--O 1.243 0.757 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.878 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 34.6 ttmt . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -139.21 144.92 38.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.153 0.433 . . . . 0.0 111.754 -176.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 13.8 pt20 -149.19 134.49 18.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 173.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.591 HG21 ' HB ' ' A' ' 71' ' ' ILE . 23.1 pt -115.8 132.91 63.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.135 0.493 . . . . 0.0 111.403 -177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -98.99 116.97 32.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 66' ' ' ALA . 9.5 mp -90.4 140.48 29.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.888 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.814 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 35.4 tt0 -71.91 124.9 25.88 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.317 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.35 -15.54 61.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.709 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 30.6 t -94.48 124.87 53.94 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.0 Cg_endo -81.47 2.95 8.2 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.091 2.527 . . . . 0.0 112.13 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -135.23 134.6 21.55 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.544 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 1.3 Cg_endo -83.68 147.63 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.21 2.607 . . . . 0.0 112.249 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 tt -99.15 112.58 24.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 33.9 p90 -108.62 143.85 37.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.984 0.421 . . . . 0.0 111.365 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -150.03 139.65 21.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.878 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 17.2 m -63.21 -29.98 71.22 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -176.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -90.3 113.69 25.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.673 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.779 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 17.1 t -64.33 -50.66 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.007 0.432 . . . . 0.0 110.889 -177.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.66 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.79 -29.46 62.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.931 -177.375 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.66 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 5.1 t70 -76.12 -47.9 22.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.193 0.52 . . . . 0.0 109.828 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.23 80.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.459 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.59 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 36.8 pt -69.16 -32.75 55.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.191 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.567 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . . . -68.22 -42.15 80.23 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 110.214 174.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.416 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 35.6 t80 -61.85 -31.31 71.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.721 178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 68' ' ' ILE . . . -73.23 -17.0 61.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.152 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.59 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 38.2 mtm105 -97.72 8.26 44.99 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.76 -67.69 0.03 OUTLIER Glycine 0 C--N 1.322 -0.198 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.234 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 64' ' ' GLN . 75.0 Cg_exo -55.17 -0.85 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.844 3.03 . . . . 0.0 115.119 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.44 37.61 0.28 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.651 0.739 . . . . 0.0 110.595 174.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 62' ' ' PRO . 10.7 pt20 -79.91 -14.85 58.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.631 -175.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tp -90.55 -38.62 11.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.212 0.53 . . . . 0.0 110.164 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.684 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -148.01 139.7 13.98 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.814 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 73.0 Cg_endo -74.17 150.73 42.96 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.328 2.019 . . . . 0.0 112.039 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.49 HG22 ' HB3' ' A' ' 59' ' ' ALA . 37.8 pt -74.79 123.71 30.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.168 0.509 . . . . 0.0 110.303 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -88.34 -53.07 4.86 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.8 142.36 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.287 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.591 ' HB ' HG21 ' A' ' 38' ' ' ILE . 2.6 tt -113.5 136.0 51.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.457 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -111.94 133.93 53.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.95 159.14 43.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.453 0.644 . . . . 0.0 111.72 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.66 ' HB2' ' H ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -95.52 106.98 19.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.141 171.197 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 90' ' ' ASN . 13.0 t70 -50.99 121.8 6.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 125.088 1.493 . . . . 0.0 109.816 175.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.832 ' HE1' ' HB3' ' A' ' 85' ' ' GLN . 29.4 mtp -124.21 49.36 1.79 Allowed 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -165.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.45 -30.53 0.84 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.818 169.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.937 ' HA ' HG12 ' A' ' 115' ' ' VAL . . . 87.79 -64.44 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.986 0.915 . . . . 0.0 111.801 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.13 -38.34 24.74 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.548 0.53 . . . . 0.0 111.794 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.5 -81.82 1.27 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.554 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.657 ' HA ' ' HE2' ' A' ' 76' ' ' MET . . . 56.41 22.32 6.32 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 176.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 36.1 p -84.38 175.44 9.36 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.478 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 2.6 p90 -63.26 -23.27 67.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.802 0.334 . . . . 0.0 110.546 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -81.75 -29.88 32.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.592 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.832 ' HB3' ' HE1' ' A' ' 76' ' ' MET . 0.0 OUTLIER 57.09 162.82 0.08 OUTLIER Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.782 1.233 . . . . 0.0 112.469 174.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.44 -9.96 16.1 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.36 1.374 . . . . 0.0 111.477 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 137.65 -177.57 19.8 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.11 140.14 40.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.438 0.619 . . . . 0.0 109.408 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.46 -126.74 2.87 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.989 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 35.4 m-80 -96.46 150.81 20.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.576 -173.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -99.0 126.14 44.63 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.466 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.721 HD11 ' HB2' ' A' ' 118' ' ' SER . 9.8 pt -145.72 166.54 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.137 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.58 106.44 18.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.75 -33.2 73.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.121 0.486 . . . . 0.0 110.76 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.546 ' HA ' HD12 ' A' ' 137' ' ' LEU . 20.9 t70 -59.63 -24.96 64.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.41 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -121.53 33.86 5.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.394 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -135.26 -172.77 3.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.318 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.557 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 97.8 m-85 -95.36 139.16 32.05 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.521 0.676 . . . . 0.0 111.041 -176.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.611 ' CE1' HG21 ' A' ' 101' ' ' VAL . 17.9 t80 -120.34 131.04 54.69 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.651 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.9 p -109.52 123.07 65.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.705 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.611 HG21 ' CE1' ' A' ' 99' ' ' TYR . 4.0 t -101.74 103.01 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.394 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.645 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -69.26 134.49 26.82 Favored Glycine 0 N--CA 1.45 -0.432 0 O-C-N 123.574 0.546 . . . . 0.0 113.524 -173.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -92.08 -36.98 13.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.652 0.263 . . . . 0.0 110.317 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.08 -43.74 17.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 0.0 110.385 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.569 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 41.3 mtp-105 -132.84 132.78 42.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.668 177.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.975 HH21 HG11 ' A' ' 145' ' ' VAL . 12.7 ttt85 -172.08 -62.63 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.814 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.83 -61.2 0.23 Allowed Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.83 -94.53 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.527 -0.368 . . . . 0.0 112.42 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.81 -4.49 59.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.981 0.42 . . . . 0.0 110.896 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -110.65 -129.84 5.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.623 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.17 102.2 26.91 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.718 0.259 . . . . 0.0 110.584 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 26.8 Cg_endo -61.86 128.06 23.26 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 123.745 2.964 . . . . 0.0 112.983 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.442 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 5.0 mm-40 -114.34 139.97 49.02 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.593 -177.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.551 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -123.59 134.59 53.79 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.64 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 78' ' ' ALA . 46.1 t -98.13 106.68 36.56 Favored Pre-proline 0 C--N 1.314 -0.973 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.983 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 5.3 Cg_exo -84.55 110.17 1.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.157 2.571 . . . . 0.0 111.283 173.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.714 ' HD1' ' H ' ' A' ' 119' ' ' SER . 4.1 t80 -120.06 151.03 39.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.971 -174.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.721 ' HB2' HD11 ' A' ' 92' ' ' ILE . 33.1 t -74.89 -37.26 62.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.778 0.323 . . . . 0.0 110.953 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.714 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 9.6 m -95.95 128.22 42.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.608 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 3.7 ttt180 -62.42 -48.97 77.33 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.133 0.492 . . . . 0.0 111.215 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -63.11 -31.59 72.76 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.786 -172.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -67.48 -40.44 85.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.731 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.17 -34.59 76.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.124 0.488 . . . . 0.0 109.747 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.09 74.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.865 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.35 97.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.142 0.496 . . . . 0.0 109.964 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -60.11 -38.74 83.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.836 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.68 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 60.8 t -64.57 -43.85 96.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.195 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.2 mt -52.46 -40.15 61.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.202 0.525 . . . . 0.0 110.678 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.86 -44.01 19.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.96 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.569 ' OE1' ' HD3' ' A' ' 105' ' ' ARG . 6.9 pt-20 -158.97 -33.49 0.06 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -172.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.68 ' CA ' ' HA ' ' A' ' 127' ' ' VAL . . . -52.76 167.01 1.12 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.257 -0.429 . . . . 0.0 113.907 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.64 -81.76 1.4 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.269 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.632 ' HG2' ' HG3' ' A' ' 144' ' ' MET . 2.1 pt20 -125.99 144.39 50.72 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.958 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.88 113.15 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.325 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.555 HD12 HD11 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -133.87 164.56 26.99 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.502 -178.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.86 163.84 22.01 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 95' ' ' ASP . 0.8 OUTLIER -62.61 -24.81 67.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.864 0.364 . . . . 0.0 110.691 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.29 -19.97 57.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.949 0.404 . . . . 0.0 111.151 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -104.35 19.33 20.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.852 -173.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.555 HD11 HD12 ' A' ' 135' ' ' LEU . 48.8 mm -71.88 120.37 20.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.216 0.531 . . . . 0.0 111.084 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.766 HG21 ' HB2' ' A' ' 144' ' ' MET . 0.8 OUTLIER -99.42 145.99 26.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.131 177.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.79 -32.21 70.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.045 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.23 -29.2 67.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.504 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.851 ' HA ' ' HE3' ' A' ' 144' ' ' MET . 0.0 OUTLIER -78.94 -35.48 43.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.343 175.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.975 HG11 HH21 ' A' ' 106' ' ' ARG . 55.9 t -78.27 -25.36 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.382 -167.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -160.7 146.61 14.89 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.26 -174.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.4 p -109.01 119.15 49.66 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 121.057 0.456 . . . . 0.0 110.719 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.442 ' HG2' ' H ' ' A' ' 149' ' ' VAL . 38.1 Cg_endo -67.24 -67.86 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.913 2.408 . . . . 0.0 112.364 179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.442 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 2.1 t -122.0 1.65 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.79 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 68.24 -76.73 0.05 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.341 -170.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.8 t 42.29 21.67 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.159 1.384 . . . . 0.0 114.643 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 66.29 26.91 72.69 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.885 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.9 m -76.33 152.67 36.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.052 0.426 . . . . 0.0 110.573 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.431 ' CG ' ' HB2' ' A' ' 158' ' ' ASP . 2.5 mp0 -70.63 142.32 88.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.698 ' HB2' ' HE2' ' A' ' 144' ' ' MET . 69.4 Cg_endo -80.55 19.91 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.72 2.28 . . . . 0.0 112.799 -172.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.402 ' HE ' ' CD ' ' A' ' 133' ' ' GLN . 11.9 ptp85 177.06 -45.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.423 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 162.54 -16.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.11 -161.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.431 ' HB2' ' CG ' ' A' ' 154' ' ' GLU . 25.1 t0 59.14 31.24 21.11 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.283 1.039 . . . . 0.0 108.761 -168.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.37 -49.58 22.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.665 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 5.0 pt-20 . . . . . 0 C--O 1.254 1.323 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.362 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 50' ' ' SER . 40.0 ttmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.677 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -132.19 144.21 50.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.641 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . 11.9 pt20 -145.06 144.71 31.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.967 0.413 . . . . 0.0 110.574 177.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.681 HG23 ' HB2' ' A' ' 59' ' ' ALA . 23.2 pt -115.94 134.24 59.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 120.969 0.414 . . . . 0.0 110.415 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -98.67 116.87 31.86 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.567 HD21 ' HB2' ' A' ' 66' ' ' ALA . 9.3 mp -89.16 139.0 30.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.234 -174.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.842 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 40.8 tt0 -73.89 122.39 22.45 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.51 -4.18 66.43 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.568 -173.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 46.9 t -120.02 128.28 25.93 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.7 Cg_exo -79.1 -12.8 14.3 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.105 2.537 . . . . 0.0 111.704 176.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.462 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -115.39 133.8 22.69 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.62 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 2.2 Cg_endo -86.06 149.88 9.47 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.365 2.71 . . . . 0.0 112.149 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.9 tt -94.7 109.77 21.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.641 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . 31.1 p90 -115.54 147.87 40.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.374 0.607 . . . . 0.0 111.834 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -139.24 154.08 47.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.015 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 6.2 m -56.42 -50.98 70.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.155 0.502 . . . . 0.0 110.917 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -77.38 136.06 38.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.397 -178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.677 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 48.4 t -73.17 -50.7 29.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.467 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -52.78 -32.96 46.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.522 177.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.448 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 15.9 t70 -76.13 -50.0 15.8 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.864 0.364 . . . . 0.0 110.72 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 36' ' ' ALA . . . -67.93 -36.09 79.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.682 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.7 HG23 HD12 ' A' ' 71' ' ' ILE . 31.1 pt -66.02 -31.24 52.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.7 -0.4 . . . . 0.0 109.925 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.3 96.7 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.744 174.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.524 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 54.4 m-85 -58.1 -41.19 82.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.967 0.413 . . . . 0.0 111.046 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.681 ' HB2' HG23 ' A' ' 38' ' ' ILE . . . -63.61 -17.63 63.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.128 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.04 12.24 32.45 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.56 -68.22 0.09 OUTLIER Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.268 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -68.14 46.47 0.34 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.586 2.858 . . . . 0.0 113.642 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.96 172.96 13.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.752 0.311 . . . . 0.0 110.285 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 84.1 mm-40 -96.81 -164.58 1.16 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.843 0.354 . . . . 0.0 110.91 -176.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.3 tt -62.12 -19.4 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.379 0.609 . . . . 0.0 111.17 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.567 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -105.97 141.01 21.81 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.842 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 42.1 Cg_endo -69.36 162.79 40.46 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.967 2.445 . . . . 0.0 112.122 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.9 pt -84.38 116.57 28.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.1 0.476 . . . . 0.0 110.674 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 tt -84.08 -52.58 6.18 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.11 139.86 7.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.662 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.7 HD12 HG23 ' A' ' 56' ' ' ILE . 4.1 tt -108.92 126.89 65.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.133 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -111.55 128.76 56.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.954 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.581 HG22 HG13 ' A' ' 92' ' ' ILE . 31.2 m -123.43 134.25 66.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.118 0.485 . . . . 0.0 110.101 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -89.5 99.44 12.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.611 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 25.6 t70 -68.82 85.94 0.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.778 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.714 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 21.7 ptm -165.17 -168.12 1.33 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.349 0.595 . . . . 0.0 112.268 -174.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.26 -42.9 2.42 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.768 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . . . 51.88 28.33 5.01 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.111 0.536 . . . . 0.0 112.124 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.06 -62.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.97 -11.31 30.38 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.321 -0.942 . . . . 0.0 114.389 -170.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.473 ' HB3' HG21 ' A' ' 52' ' ' VAL . . . -61.38 -52.62 63.86 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.953 0.883 . . . . 0.0 109.325 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.0 p -129.62 152.75 48.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 114.001 -1.454 . . . . 0.0 107.497 168.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -72.22 -19.59 61.7 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.439 0.637 . . . . 0.0 110.054 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -85.14 -18.48 34.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.776 175.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 10.4 mt-30 69.75 141.35 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.358 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.768 ' HD2' ' HA ' ' A' ' 78' ' ' ALA . 73.7 Cg_endo -91.49 -82.17 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.918 2.412 . . . . 0.0 112.929 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.15 -126.2 1.67 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.378 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.68 146.62 48.11 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 122.013 0.125 . . . . 0.0 110.957 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.714 ' HA2' ' HB3' ' A' ' 76' ' ' MET . . . -70.78 90.01 0.39 Allowed Glycine 0 CA--C 1.518 0.278 0 O-C-N 123.66 0.6 . . . . 0.0 113.964 -175.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -100.16 149.5 23.47 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -100.17 127.8 46.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.581 HG13 HG22 ' A' ' 73' ' ' VAL . 1.4 pt -145.51 156.65 13.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.59 117.99 30.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 164.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.93 79.41 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -169.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.623 ' HA ' ' CB ' ' A' ' 137' ' ' LEU . 9.4 p-10 -66.9 -28.01 67.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.009 0.909 . . . . 0.0 109.789 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -105.32 33.33 3.74 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.177 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.58 171.48 12.55 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.215 -0.303 . . . . 0.0 110.351 -174.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -89.54 136.15 33.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.314 0.578 . . . . 0.0 110.013 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.527 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 7.6 m-85 -120.39 136.95 54.55 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.983 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.411 ' CG1' HG11 ' A' ' 115' ' ' VAL . 2.2 p -120.9 125.47 74.08 Favored 'Isoleucine or valine' 0 C--O 1.251 1.146 0 CA-C-O 121.691 0.758 . . . . 0.0 109.428 170.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.556 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 59.1 t -108.57 117.16 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.117 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -75.8 124.49 7.48 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.155 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.5 m -90.43 -23.45 21.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.013 0.435 . . . . 0.0 110.172 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 130' ' ' GLU . . . -82.35 -45.17 15.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.224 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.607 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 47.2 mtp180 -139.23 93.75 2.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.029 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 0.1 OUTLIER -147.84 169.45 19.77 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.451 176.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.602 ' H ' ' HA ' ' A' ' 112' ' ' PRO . . . -79.51 45.85 2.95 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.836 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.8 -25.26 63.51 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.502 171.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.8 ptm -108.36 21.21 17.64 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.746 -0.727 . . . . 0.0 110.213 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -176.3 -116.7 0.47 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.013 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.59 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.45 102.5 29.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.949 0.404 . . . . 0.0 111.378 177.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.602 ' HA ' ' H ' ' A' ' 107' ' ' GLY . 88.0 Cg_endo -74.54 151.83 42.45 Favored 'Trans proline' 0 N--CA 1.467 -0.078 0 C-N-CA 123.253 2.635 . . . . 0.0 111.948 177.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.532 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 1.7 tp10 -118.94 123.24 44.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.308 -177.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -99.88 121.43 41.3 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.51 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 6.4 p -110.81 106.63 57.77 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.235 176.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.527 ' HG3' ' CE2' ' A' ' 99' ' ' TYR . 5.1 Cg_exo -84.98 112.21 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.379 3.386 . . . . 0.0 111.872 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -103.98 149.42 25.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.337 0.589 . . . . 0.0 111.015 -177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -79.68 -43.78 22.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.3 m -83.61 111.31 19.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.087 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -56.93 -45.0 83.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.741 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.8 -28.17 69.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.973 -173.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -67.47 -43.99 79.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.338 . . . . 0.0 110.521 174.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.8 92.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.243 0.544 . . . . 0.0 110.208 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.16 74.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.107 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 128' ' ' LEU . . . -61.63 -39.9 92.94 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 111.186 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -57.63 -40.29 78.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.758 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.556 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 42.4 t -71.79 -28.39 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.843 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 54.2 mt -57.85 -49.82 75.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.451 175.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.55 -48.66 54.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.176 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.928 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.5 pt-20 -157.81 -75.97 0.08 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.566 175.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.928 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.0 -136.85 8.1 Favored Glycine 0 N--CA 1.448 -0.546 0 O-C-N 123.601 0.563 . . . . 0.0 112.914 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.536 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -166.31 -91.91 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.556 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.48 139.7 50.53 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 176.393 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.61 118.19 41.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.779 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.27 164.37 29.42 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.464 -176.727 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.02 165.57 13.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.675 ' HA ' HG12 ' A' ' 140' ' ' ILE . 4.2 tt -64.55 -30.15 71.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.122 0.486 . . . . 0.0 109.95 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.19 -10.68 59.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.011 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -118.99 15.59 13.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.41 0.624 . . . . 0.0 110.262 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.779 HD11 HD12 ' A' ' 135' ' ' LEU . 28.3 mm -72.07 121.52 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.923 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.466 HG21 ' HG2' ' A' ' 144' ' ' MET . 1.2 t -115.39 147.03 41.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -69.4 -31.71 70.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.947 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.93 -29.36 60.0 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.367 0.417 . . . . 0.0 112.076 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.553 ' HE1' ' HB2' ' A' ' 155' ' ' PRO . 12.5 mmt -75.74 -34.88 60.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.14 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.532 ' HB ' HD13 ' A' ' 146' ' ' LEU . 2.7 t -86.12 -25.28 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.049 -172.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.532 HD13 ' HB ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -179.65 149.2 0.36 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.444 -176.012 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.401 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 43.0 p -103.07 120.18 53.05 Favored Pre-proline 0 C--N 1.317 -0.842 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.557 -178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 37.3 Cg_endo -68.39 -77.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.499 2.133 . . . . 0.0 111.483 173.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.6 t -128.86 -27.44 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 73.45 31.54 1.33 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.268 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 t -86.27 16.28 4.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.791 0.805 . . . . 0.0 109.407 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -113.91 -149.04 10.07 Favored Glycine 0 N--CA 1.437 -1.259 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.716 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.1 m -99.89 162.66 12.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.275 -0.462 . . . . 0.0 110.351 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.31 143.43 85.25 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.553 ' HB2' ' HE1' ' A' ' 144' ' ' MET . 15.5 Cg_endo -56.9 -29.52 82.2 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.878 2.385 . . . . 0.0 113.213 -173.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.566 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 3.2 ptp180 -166.25 -54.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.549 175.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.566 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -160.19 28.3 0.17 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.867 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.8 t70 55.0 75.66 0.3 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.962 0.887 . . . . 0.0 108.92 -168.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.434 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 26.0 t0 -128.97 25.13 5.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.739 1.257 . . . . 0.0 107.863 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.411 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 3.1 pt-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-N 113.221 -1.809 . . . . 0.0 111.137 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.574 ' HB3' ' OD1' ' A' ' 74' ' ' ASN . 30.0 ttpt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.588 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -139.99 142.64 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.34 . . . . 0.0 111.052 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 12.8 pt20 -149.58 137.45 20.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.599 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.431 HG23 ' HB ' ' A' ' 71' ' ' ILE . 23.9 pt -115.88 142.91 27.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 0.0 111.111 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -118.72 129.84 55.49 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.475 HD22 ' HB2' ' A' ' 66' ' ' ALA . 10.3 mp -95.7 146.54 24.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.853 0.358 . . . . 0.0 111.167 -175.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.635 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 22.1 tt0 -74.05 125.37 28.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.722 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.09 -13.34 61.72 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.201 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 24.3 t -104.3 125.29 34.65 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 4.2 Cg_exo -80.83 10.47 3.34 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.057 2.505 . . . . 0.0 112.733 -177.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.15 133.23 24.52 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.812 0.339 . . . . 0.0 111.455 -177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -98.11 153.69 0.83 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.744 2.963 . . . . 0.0 112.382 173.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 3.0 tm? -110.76 105.54 14.43 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -112.61 136.77 51.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.16 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.434 ' HE2' HE21 ' A' ' 51' ' ' GLN . 10.7 t80 -149.98 154.97 39.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.144 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.6 m -64.04 -38.78 92.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.298 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.881 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 45.4 mt-30 -72.42 108.69 5.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.571 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.831 HG23 ' HE3' ' A' ' 76' ' ' MET . 12.3 t -62.55 -51.52 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.633 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -53.95 -34.53 59.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.577 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.633 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 28.3 t70 -76.31 -46.69 26.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.767 0.317 . . . . 0.0 110.6 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.803 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -71.23 -39.03 71.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.426 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.531 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 27.3 pt -63.75 -30.81 50.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.66 99.18 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 174.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.803 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 61.6 m-85 -56.91 -39.16 73.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.979 0.418 . . . . 0.0 110.799 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.86 -17.8 64.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.894 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 15.3 mtm180 -102.37 12.61 36.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.57 -60.31 0.19 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.303 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.468 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 23.6 Cg_exo -66.57 35.19 0.13 Allowed 'Trans proline' 0 N--CA 1.48 0.686 0 C-N-CA 123.774 2.983 . . . . 0.0 114.959 -177.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.437 ' OE2' ' HA ' ' A' ' 67' ' ' PRO . 4.6 pt-20 -83.42 128.03 34.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 170.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -47.58 -92.74 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -170.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -125.85 -5.49 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.077 0.941 . . . . 0.0 109.516 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 41' ' ' GLU . . . -113.13 141.92 26.48 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.988 -176.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.635 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.0 Cg_endo -70.1 155.06 65.71 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 C-N-CA 122.413 2.076 . . . . 0.0 111.786 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 68' ' ' ILE . 22.8 pt -71.08 109.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.17 0.51 . . . . 0.0 110.287 175.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -71.7 -52.01 19.98 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 p -161.23 138.81 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.443 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.531 HG22 ' HB2' ' A' ' 95' ' ' ASP . 1.4 tt -111.39 135.85 49.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.465 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 92' ' ' ILE . 87.0 m-85 -115.23 134.64 54.96 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.118 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 94' ' ' ALA . 27.1 m -126.53 150.11 32.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.92 0.39 . . . . 0.0 110.086 176.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.574 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 14.0 m120 -83.71 104.9 14.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.543 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 18.7 t70 -55.37 120.66 7.46 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 125.476 1.735 . . . . 0.0 110.29 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.831 ' HE3' HG23 ' A' ' 52' ' ' VAL . 22.3 mtm -128.63 -165.25 1.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.303 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.79 61.49 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 166.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.483 ' HB2' HG12 ' A' ' 115' ' ' VAL . . . 74.31 -32.27 0.23 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.789 0.836 . . . . 0.0 112.881 169.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.71 -32.9 63.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.047 0.451 . . . . 0.0 110.581 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.28 -68.47 1.17 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.234 172.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 53.14 34.87 18.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.265 0.555 . . . . 0.0 112.135 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.5 p -83.59 177.61 8.34 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.227 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.881 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 47.0 p90 -64.13 -24.83 67.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.174 0.511 . . . . 0.0 111.081 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.74 -27.24 27.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 64.55 173.79 0.07 OUTLIER Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.746 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.547 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 59.6 Cg_endo -97.04 6.08 1.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.399 2.066 . . . . 0.0 111.264 173.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.32 157.56 7.81 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.364 -175.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.94 126.71 31.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.842 0.353 . . . . 0.0 110.417 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -118.6 -159.13 11.03 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.487 -174.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 76.9 m-20 -81.39 151.98 27.67 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -98.08 129.83 44.9 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 121.318 -0.864 . . . . 0.0 110.209 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.71 HD11 ' HB2' ' A' ' 118' ' ' SER . 20.3 pt -138.54 161.23 30.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.985 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.25 100.57 7.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.431 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.516 ' HB3' HG21 ' A' ' 73' ' ' VAL . . . -66.28 -34.97 79.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.798 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.599 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 31.3 t70 -61.06 -24.88 66.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.618 0.723 . . . . 0.0 110.138 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -111.64 22.01 15.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.839 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.92 178.79 4.18 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.961 0.41 . . . . 0.0 111.156 -170.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -96.32 130.48 43.41 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.099 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.78 ' HH ' HD13 ' A' ' 137' ' ' LEU . 11.2 m-85 -120.48 136.56 54.72 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.918 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.823 HG13 ' HB ' ' A' ' 115' ' ' VAL . 1.5 p -121.06 125.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.216 0.531 . . . . 0.0 110.226 172.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.723 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 55.6 t -101.75 125.47 55.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.634 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -87.55 126.84 8.2 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.753 -174.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.7 m -92.66 -21.27 20.11 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.551 0.215 . . . . 0.0 111.084 177.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.636 ' HB1' ' HB2' ' A' ' 130' ' ' GLU . . . -89.02 -46.46 8.84 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -170.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -129.89 19.71 5.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.351 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.67 ' HG3' ' H ' ' A' ' 107' ' ' GLY . 8.9 tpp180 -112.0 -161.65 0.76 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.858 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.67 ' H ' ' HG3' ' A' ' 106' ' ' ARG . . . 66.58 46.17 78.78 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -163.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -56.95 -98.22 0.01 OUTLIER Glycine 0 CA--C 1.517 0.161 0 CA-C-N 113.78 -1.21 . . . . 0.0 115.771 -164.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.1 ttt -87.95 21.6 2.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.568 0.699 . . . . 0.0 110.957 -169.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 135.53 -57.69 0.68 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -177.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.438 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.29 122.68 44.36 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HA ' ' HA2' ' A' ' 107' ' ' GLY . 5.2 Cg_endo -47.42 152.35 2.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.884 2.389 . . . . 0.0 112.372 173.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.519 ' CB ' ' HD2' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -114.01 131.81 56.22 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -172.018 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.608 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.8 130.16 39.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.442 -174.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.823 ' HB ' HG13 ' A' ' 100' ' ' VAL . 93.1 t -94.85 103.94 13.1 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.4 Cg_exo -91.23 120.38 0.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.548 2.832 . . . . 0.0 112.171 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.36 148.81 50.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.375 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.71 ' HB2' HD11 ' A' ' 92' ' ' ILE . 42.2 t -80.26 -26.86 38.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 173.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.0 m -101.17 121.26 41.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.538 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -59.21 -46.66 87.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.618 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -62.76 -28.97 70.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.272 -173.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -69.63 -38.13 77.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.64 -36.93 81.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.302 0.572 . . . . 0.0 109.755 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.85 -35.85 82.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.573 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.73 78.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.443 ' HZ ' HH21 ' A' ' 106' ' ' ARG . 63.8 t80 -63.48 -41.01 98.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.789 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 41.3 t -72.95 -30.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.202 0.525 . . . . 0.0 110.251 177.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.2 -36.87 76.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.084 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.08 -50.94 7.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.15 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.899 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 1.3 pt-20 -146.94 -81.61 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.093 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.899 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 52.52 -146.82 15.46 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.669 173.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.53 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -172.53 -84.18 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.723 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.43 145.23 51.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.728 0.299 . . . . 0.0 110.509 174.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.7 t -101.23 113.3 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.267 0.556 . . . . 0.0 109.535 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.797 HD12 HD11 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -130.48 164.86 23.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.918 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.41 ' H ' ' HB3' ' A' ' 139' ' ' ASP . . . -90.66 166.18 13.3 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.78 HD13 ' HH ' ' A' ' 99' ' ' TYR . 5.8 tt -64.38 -38.64 91.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.76 -10.24 57.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.26 175.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 136' ' ' ALA . 31.3 t70 -120.24 18.58 12.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.413 0.625 . . . . 0.0 110.389 -175.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.797 HD11 HD12 ' A' ' 135' ' ' LEU . 25.2 mm -72.02 121.35 22.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 145' ' ' VAL . 2.5 t -116.67 148.88 40.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.093 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.526 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 4.3 p30 -68.96 -26.36 65.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.605 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.29 69.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.995 0.426 . . . . 0.0 111.324 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.563 ' HE3' ' HG3' ' A' ' 133' ' ' GLN . 11.5 mmt -86.96 -32.23 20.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.401 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 141' ' ' THR . 4.2 t -86.75 -23.7 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.13 0.49 . . . . 0.0 110.726 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.4 pp -153.4 125.5 7.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.324 -176.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.2 p -102.85 131.68 21.99 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.656 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.31 -99.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.661 2.241 . . . . 0.0 111.386 172.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.622 ' HB ' HG22 ' A' ' 151' ' ' THR . 4.8 t -115.21 -5.78 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 70.19 7.84 6.39 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.573 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.622 HG22 ' HB ' ' A' ' 149' ' ' VAL . 7.6 t -82.18 73.5 9.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 122.195 0.998 . . . . 0.0 109.035 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.83 -140.46 2.99 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.72 -173.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -102.34 161.32 13.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.06 132.08 93.72 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.534 ' HG2' ' OD2' ' A' ' 159' ' ' ASP . 14.3 Cg_exo -46.45 -75.67 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.641 2.894 . . . . 0.0 114.465 -167.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.603 ' HG3' ' OD1' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -92.87 -36.69 12.68 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.649 -176.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 173.16 38.95 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.8 t70 62.7 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -164.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.603 ' OD1' ' HG3' ' A' ' 156' ' ' ARG . 8.3 m-20 -63.55 161.36 14.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.386 -157.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 C--O 1.252 1.194 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.329 -176.292 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 28.6 ttpp . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -147.62 144.54 28.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.613 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 14.5 pt20 -147.31 126.82 13.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.898 0.38 . . . . 0.0 110.558 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.859 HG12 ' HB3' ' A' ' 47' ' ' LEU . 7.8 pt -117.3 138.13 48.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.12 0.486 . . . . 0.0 111.113 -176.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -103.95 126.97 51.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.518 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 66' ' ' ALA . 9.0 mp -92.18 139.87 30.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.068 0.461 . . . . 0.0 111.286 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.746 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 36.8 tt0 -74.54 124.33 26.43 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.429 176.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.0 -15.7 62.57 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.533 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.475 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 33.4 t -120.0 124.09 28.04 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 120.957 0.408 . . . . 0.0 110.202 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 2.8 Cg_exo -77.31 7.71 3.61 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.055 2.503 . . . . 0.0 112.487 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -102.56 131.2 22.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.871 0.367 . . . . 0.0 111.254 -178.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 37.5 Cg_endo -98.88 136.89 0.31 Allowed 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.803 3.002 . . . . 0.0 112.69 174.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.859 ' HB3' HG12 ' A' ' 38' ' ' ILE . 13.8 tp -82.99 129.84 35.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.701 176.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.422 ' HE1' ' HG2' ' A' ' 46' ' ' PRO . 51.6 m-85 -118.38 133.12 56.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.96 0.41 . . . . 0.0 111.162 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 11.4 m-85 -150.2 148.96 29.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.477 174.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 m -77.32 -32.04 54.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.056 0.455 . . . . 0.0 110.488 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.713 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 41.5 mt-30 -88.14 122.53 31.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.682 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 56' ' ' ILE . 6.2 t -63.77 -51.04 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.644 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -51.25 -36.44 42.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.867 179.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.644 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 36.0 t70 -76.39 -49.22 17.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.823 0.344 . . . . 0.0 110.604 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.563 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -62.53 -42.49 99.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.446 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.857 HD12 ' HB1' ' A' ' 114' ' ' ALA . 21.9 pt -65.42 -31.48 54.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.284 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.537 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . . . -60.87 -43.62 98.17 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 120.591 0.234 . . . . 0.0 110.487 174.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.657 ' HA ' ' HG2' ' A' ' 62' ' ' PRO . 11.8 m-85 -61.1 -40.11 92.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.285 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HB3' HG23 ' A' ' 68' ' ' ILE . . . -67.05 -27.03 67.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.432 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.537 ' HE ' ' HA ' ' A' ' 57' ' ' ALA . 83.4 mtm180 -88.57 -1.48 58.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.019 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.06 -75.75 0.03 OUTLIER Glycine 0 CA--C 1.52 0.348 0 C-N-CA 119.581 -1.295 . . . . 0.0 114.045 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.657 ' HG2' ' HA ' ' A' ' 58' ' ' TYR . 30.7 Cg_exo -37.96 -51.31 1.93 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 124.314 3.343 . . . . 0.0 114.665 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -76.94 98.34 4.89 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -117.09 -23.11 8.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.208 -173.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.5 tp -67.45 -29.32 45.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.009 0.433 . . . . 0.0 111.244 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.801 ' HB2' HD21 ' A' ' 40' ' ' LEU . . . -141.5 141.45 22.96 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.746 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 57.8 Cg_endo -73.38 163.21 38.36 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.43 2.086 . . . . 0.0 111.993 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.453 HG23 ' HB3' ' A' ' 59' ' ' ALA . 14.3 pt -85.49 121.02 36.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.337 0.589 . . . . 0.0 110.882 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.81 -59.43 2.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.252 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.16 138.54 20.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.203 0.525 . . . . 0.0 110.298 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.527 HG13 HG23 ' A' ' 38' ' ' ILE . 2.3 tt -122.52 129.25 75.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.399 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -111.73 130.69 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.4 m -127.4 139.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.77 0.795 . . . . 0.0 111.25 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -87.58 101.67 13.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 170.338 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.921 ' HB3' ' HB2' ' A' ' 90' ' ' ASN . 12.5 t0 -46.95 108.34 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.846 1.341 . . . . 0.0 109.267 175.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.568 ' C ' ' HG3' ' A' ' 86' ' ' PRO . 14.0 ttt -162.65 -101.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.591 -165.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.472 ' H ' ' HB3' ' A' ' 76' ' ' MET . . . -79.7 63.1 4.06 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-O 122.112 0.84 . . . . 0.0 111.978 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 115' ' ' VAL . . . -142.75 -55.05 0.42 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.176 -1.512 . . . . 0.0 107.018 174.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.81 -20.76 65.21 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.039 166.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.648 ' HA3' ' HD3' ' A' ' 86' ' ' PRO . . . -89.37 -96.65 1.07 Allowed Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.158 175.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -178.88 -51.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.521 ' OG1' ' HB2' ' A' ' 85' ' ' GLN . 71.9 p -107.7 175.75 5.38 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.713 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 10.9 p90 -70.45 -31.13 68.16 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.273 0.559 . . . . 0.0 110.125 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.87 -28.69 25.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.036 -174.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.521 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.9 OUTLIER -61.71 -60.19 11.07 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -167.669 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.648 ' HD3' ' HA3' ' A' ' 80' ' ' GLY . 7.0 Cg_endo -44.75 -57.57 1.98 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.298 2.665 . . . . 0.0 113.523 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.49 -45.7 2.57 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -77.01 146.85 37.15 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.407 0.283 . . . . 0.0 110.474 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.96 100.65 0.29 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.857 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.921 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 91.7 m-20 -95.85 150.26 20.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 175.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -109.6 128.08 54.97 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.194 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.3 pt -145.52 163.45 11.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.635 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.7 109.13 21.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.62 -33.03 74.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.792 -174.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.857 ' HA ' HD12 ' A' ' 137' ' ' LEU . 12.7 t70 -58.66 -31.46 68.18 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.83 0.824 . . . . 0.0 110.566 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -111.31 38.29 2.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.207 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 117' ' ' PHE . . . -140.09 169.81 17.01 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.535 -168.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -90.25 143.28 26.91 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.096 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.466 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 3.2 m-85 -119.81 134.3 55.29 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.828 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.631 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.2 p -113.17 121.54 65.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.655 HG13 HH11 ' A' ' 106' ' ' ARG . 19.7 t -101.79 103.06 14.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.756 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -68.75 133.11 27.12 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.777 -173.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.9 t -92.11 -21.99 20.14 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.64 -43.81 68.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.608 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.511 ' HB2' ' OE1' ' A' ' 113' ' ' GLU . 77.1 mtt180 -100.97 -85.84 0.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.672 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.756 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 3.7 ttp180 58.42 -96.6 0.07 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.484 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.422 ' H ' ' HB3' ' A' ' 106' ' ' ARG . . . 167.6 -60.56 0.21 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -170.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 61.73 -84.83 0.03 OUTLIER Glycine 0 C--N 1.332 0.341 0 O-C-N 123.823 0.366 . . . . 0.0 113.034 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.2 tpt -82.99 -4.36 58.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.023 0.44 . . . . 0.0 110.381 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.79 -128.98 3.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.474 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.1 102.97 31.49 Favored Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 122.918 -0.166 . . . . 0.0 111.137 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 2.4 Cg_endo -47.31 150.51 3.36 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.413 3.409 . . . . 0.0 113.936 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.682 ' HB3' ' HA ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -114.42 138.11 50.98 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.293 -172.191 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.857 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -128.77 130.33 46.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.649 172.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.631 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 14.5 t -106.97 104.85 53.63 Favored Pre-proline 0 C--N 1.315 -0.933 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.553 172.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 2.7 Cg_exo -84.76 123.75 2.9 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.79 2.994 . . . . 0.0 112.697 178.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' A' ' 97' ' ' ALA . 43.1 m-85 -127.0 149.18 50.01 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.879 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.9 t -79.68 -26.63 40.92 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.569 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 19.3 m -100.51 124.11 45.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.957 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -37.24 84.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.283 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.569 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 19.5 p-10 -63.65 -32.37 73.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.661 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.49 ' HG2' ' HB2' ' A' ' 119' ' ' SER . 43.7 mm-40 -64.28 -42.7 96.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.998 0.428 . . . . 0.0 110.259 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.85 -37.88 79.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.718 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.86 94.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.67 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.425 ' HA ' HD11 ' A' ' 128' ' ' LEU . . . -59.92 -35.65 75.36 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 110.943 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -65.24 -37.37 87.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.204 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.475 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 46.9 t -72.24 -32.21 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.561 178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 125' ' ' ALA . 69.5 mt -58.33 -40.38 81.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.84 -49.63 9.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.549 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.644 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.6 pt-20 -149.65 -90.14 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.944 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.644 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 51.4 -149.76 7.66 Favored Glycine 0 C--N 1.331 0.267 0 N-CA-C 114.203 0.441 . . . . 0.0 114.203 173.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -163.86 -96.73 0.11 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.53 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -123.32 144.33 49.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.941 0.37 . . . . 0.0 110.513 176.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.5 t -101.17 122.4 53.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.346 0.593 . . . . 0.0 110.646 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.577 HD21 ' HA ' ' A' ' 140' ' ' ILE . 0.4 OUTLIER -147.11 154.7 41.44 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.669 178.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.48 168.61 19.21 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' A' ' 95' ' ' ASP . 7.0 tt -67.71 -34.13 76.27 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.99 -15.33 60.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.254 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -111.23 0.69 16.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.24 0.543 . . . . 0.0 110.861 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.577 ' HA ' HD21 ' A' ' 135' ' ' LEU . 1.4 tt -71.64 144.79 12.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.514 0.673 . . . . 0.0 110.902 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.32 148.16 43.49 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.421 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -69.05 -30.41 68.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.006 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.825 ' HB1' ' HB3' ' A' ' 155' ' ' PRO . . . -65.29 -28.55 69.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.701 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.1 mmt -78.34 -26.23 46.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.672 0.272 . . . . 0.0 111.279 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.412 HG12 ' HD2' ' A' ' 60' ' ' ARG . 4.0 t -86.58 -23.54 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.059 0.457 . . . . 0.0 110.763 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 pp -157.04 132.42 9.17 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.18 -175.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.7 p -107.04 135.65 19.56 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.586 0.708 . . . . 0.0 111.642 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.468 ' HB2' ' H ' ' A' ' 149' ' ' VAL . 51.7 Cg_endo -93.04 -131.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.804 3.002 . . . . 0.0 111.47 175.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.468 ' H ' ' HB2' ' A' ' 148' ' ' PRO . 6.8 t -97.78 2.85 10.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.743 0.782 . . . . 0.0 109.123 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 42.0 mt-10 59.98 22.1 11.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.579 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.6 t -87.28 26.72 1.16 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.102 0.953 . . . . 0.0 109.03 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . -118.48 -124.46 3.36 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.273 -172.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.1 p -129.39 161.77 29.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.642 0.258 . . . . 0.0 110.651 -176.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.553 ' HB3' ' HA ' ' A' ' 158' ' ' ASP . 2.0 mp0 -71.6 139.96 84.01 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.727 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.825 ' HB3' ' HB1' ' A' ' 143' ' ' ALA . 52.6 Cg_endo -72.93 -29.91 11.64 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.816 2.344 . . . . 0.0 111.86 176.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.57 ' HG3' ' HA ' ' A' ' 159' ' ' ASP . 6.8 ptp180 -144.55 -141.72 0.12 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.614 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.417 ' H ' ' HB2' ' A' ' 156' ' ' ARG . . . -71.1 72.7 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 170.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.559 ' O ' ' HD2' ' A' ' 155' ' ' PRO . 9.8 t70 62.27 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -164.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.57 ' HA ' ' HG3' ' A' ' 156' ' ' ARG . 5.0 p-10 -171.81 -166.67 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.573 0.225 . . . . 0.0 110.552 167.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 C--O 1.251 1.182 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.845 -175.898 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 37.0 tttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.477 ' HB1' HG12 ' A' ' 52' ' ' VAL . . . -141.49 143.08 33.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.699 0.681 . . . . 0.0 112.135 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 10.7 pt20 -149.29 139.26 22.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.538 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.525 HG23 ' HB ' ' A' ' 71' ' ' ILE . 17.1 pt -122.33 138.14 53.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.163 0.506 . . . . 0.0 111.622 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -98.86 116.39 31.0 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 173.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.806 HD23 ' HB2' ' A' ' 66' ' ' ALA . 8.4 mp -92.17 134.24 35.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.98 0.419 . . . . 0.0 110.765 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.866 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 39.9 tt0 -71.75 125.82 28.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.516 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.67 -26.63 23.89 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 23.1 t -97.79 126.08 42.11 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.3 Cg_exo -74.2 -9.59 22.0 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.878 2.385 . . . . 0.0 113.177 -174.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.25 146.55 49.58 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.821 0.343 . . . . 0.0 111.587 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.24 151.45 26.58 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.824 2.349 . . . . 0.0 112.389 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tt -108.77 101.18 10.32 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 53.9 p90 -101.62 151.98 21.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.819 0.342 . . . . 0.0 110.592 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -148.04 149.74 32.65 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.656 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -64.28 -48.65 74.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.339 0.59 . . . . 0.0 110.764 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.708 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 35.0 mt-30 -78.63 113.99 17.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.391 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.493 ' O ' HG12 ' A' ' 56' ' ' ILE . 9.1 t -57.58 -48.83 82.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.642 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.34 -30.99 53.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.702 -178.409 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.642 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 14.1 t70 -76.37 -48.48 19.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.804 0.335 . . . . 0.0 110.683 -177.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.77 83.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.333 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.774 HD12 ' HB1' ' A' ' 114' ' ' ALA . 23.3 pt -67.47 -30.24 48.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.728 0.299 . . . . 0.0 110.676 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.07 88.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.861 0.362 . . . . 0.0 110.309 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -59.66 -37.32 78.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.434 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.693 ' HB3' HD11 ' A' ' 68' ' ' ILE . . . -70.58 -18.28 62.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.905 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.527 HH12 HG13 ' A' ' 145' ' ' VAL . 48.9 mtm180 -105.07 12.38 32.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.57 -72.42 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.317 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.24 -2.01 0.22 Allowed 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 123.905 3.07 . . . . 0.0 115.145 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.472 ' OE1' HG12 ' A' ' 68' ' ' ILE . 1.1 pt-20 -74.4 53.63 0.54 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.578 0.704 . . . . 0.0 110.033 171.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -92.33 -39.93 11.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.725 -176.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -75.79 -30.22 21.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.074 0.464 . . . . 0.0 110.545 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.806 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -152.06 140.41 13.45 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.347 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.866 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 80.4 Cg_endo -77.9 153.77 29.43 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.546 2.164 . . . . 0.0 112.134 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.693 HD11 ' HB3' ' A' ' 59' ' ' ALA . 46.6 pt -77.96 125.47 37.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.304 0.573 . . . . 0.0 110.188 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tt -86.0 -52.5 5.67 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -156.66 141.12 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.129 176.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.525 ' HB ' HG23 ' A' ' 38' ' ' ILE . 2.9 tt -114.6 129.19 71.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.322 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.443 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 87.1 m-85 -111.96 128.24 56.1 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.499 HG22 ' HB3' ' A' ' 94' ' ' ALA . 28.2 m -126.05 157.02 36.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.455 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -86.95 110.3 19.93 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 15.8 t70 -52.8 98.06 0.02 OUTLIER 'General case' 0 C--O 1.239 0.542 0 O-C-N 125.338 1.649 . . . . 0.0 109.503 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.607 ' SD ' ' HB2' ' A' ' 86' ' ' PRO . 2.0 mmt -179.71 87.74 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.548 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 79' ' ' ALA . . . -146.57 36.87 1.23 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 16.88 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -167.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.447 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -156.04 7.09 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.893 0.378 . . . . 0.0 110.537 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.41 ' HA3' ' NH1' ' A' ' 106' ' ' ARG . . . 130.0 -12.18 5.86 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.259 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.29 63.74 0.76 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.604 0.716 . . . . 0.0 109.945 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 46.3 p -83.81 176.71 8.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.409 -172.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.708 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 41.3 p-90 -66.62 -25.08 66.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.155 0.502 . . . . 0.0 110.275 172.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -77.5 -36.16 52.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.24 175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 67.93 150.64 0.12 Allowed Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.889 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.607 ' HB2' ' SD ' ' A' ' 76' ' ' MET . 17.1 Cg_exo -72.7 0.2 7.98 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.701 2.267 . . . . 0.0 111.568 169.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.46 176.26 15.64 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.055 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.34 135.76 38.4 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.77 -136.6 3.59 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.073 -174.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 53.7 t30 -89.91 151.34 21.78 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -173.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -98.8 128.91 45.16 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.896 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.696 HG22 ' HB2' ' A' ' 118' ' ' SER . 25.9 pt -145.17 162.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.185 -175.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.29 110.7 19.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.499 ' HB3' HG22 ' A' ' 73' ' ' VAL . . . -69.51 -35.25 75.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -172.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.69 ' HA ' HD12 ' A' ' 137' ' ' LEU . 0.2 OUTLIER -68.35 -22.73 64.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.797 0.808 . . . . 0.0 109.791 -178.394 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.412 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 43.2 mmtm -102.68 26.5 7.92 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.767 175.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.09 176.69 7.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.475 -171.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -91.36 134.48 34.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.035 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 135' ' ' LEU . 7.8 m-85 -120.39 136.16 54.81 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.946 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.863 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.1 p -115.62 122.39 69.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.445 0.64 . . . . 0.0 109.639 173.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.645 HG23 HD11 ' A' ' 135' ' ' LEU . 48.1 t -101.59 109.78 26.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.742 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -69.69 125.05 16.15 Favored Glycine 0 N--CA 1.448 -0.531 0 O-C-N 123.986 0.804 . . . . 0.0 113.263 -173.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.0 t -90.13 -38.58 13.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.839 0.352 . . . . 0.0 110.227 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -80.29 -43.72 20.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 111.466 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.537 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 79.8 mtt180 -125.65 107.08 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.014 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.725 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 1.2 tpp180 173.93 -177.28 0.08 Allowed 'General case' 0 C--O 1.232 0.165 0 O-C-N 123.941 0.776 . . . . 0.0 109.68 171.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.02 -57.33 19.82 Favored Glycine 0 N--CA 1.451 -0.33 0 O-C-N 123.368 0.417 . . . . 0.0 113.615 -176.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.63 -98.26 0.59 Allowed Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.63 ' HE2' ' HA ' ' A' ' 148' ' ' PRO . 4.1 mmt -86.99 -3.35 59.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.952 0.406 . . . . 0.0 110.733 173.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.7 -127.93 6.12 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.24 96.17 7.9 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.787 0.327 . . . . 0.0 110.598 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.43 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 72.6 Cg_endo -76.51 147.64 28.72 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.384 2.056 . . . . 0.0 112.498 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.725 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 32.1 mt-10 -129.33 131.68 46.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.462 -176.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.774 ' HB1' HD12 ' A' ' 56' ' ' ILE . . . -93.87 131.1 39.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.499 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.863 ' HB ' HG13 ' A' ' 100' ' ' VAL . 87.0 t -95.94 106.28 26.96 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 120.89 0.376 . . . . 0.0 110.227 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.3 Cg_endo -91.55 123.68 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.586 2.857 . . . . 0.0 112.677 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -132.97 150.42 52.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.092 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.696 ' HB2' HG22 ' A' ' 92' ' ' ILE . 9.7 t -86.9 -21.92 26.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.1 m -93.77 119.48 32.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.873 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -61.62 -48.01 82.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.096 0.474 . . . . 0.0 111.202 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.59 -29.57 70.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.618 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -62.15 -41.58 98.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.578 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 100' ' ' VAL . . . -69.87 -37.02 75.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.131 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.68 86.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.048 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.95 82.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.105 0.479 . . . . 0.0 110.452 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -60.66 -42.86 97.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.736 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.62 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 55.1 t -61.97 -42.33 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.158 177.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tp -54.36 -36.16 63.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.784 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.06 -40.1 15.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.29 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -164.52 -35.13 0.03 OUTLIER 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.742 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -49.39 156.07 1.81 Allowed Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.45 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.449 ' N ' ' HA2' ' A' ' 102' ' ' GLY . . . -94.03 -82.67 1.56 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.949 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.581 HE21 HD22 ' A' ' 135' ' ' LEU . 12.6 pt20 -130.36 150.42 51.6 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.835 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.34 113.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.366 0.603 . . . . 0.0 110.214 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.645 HD11 HG23 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -133.89 159.97 39.07 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.759 -179.047 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.69 168.63 15.07 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.69 HD12 ' HA ' ' A' ' 95' ' ' ASP . 6.0 tt -65.2 -32.08 73.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.312 0.577 . . . . 0.0 109.497 178.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.91 -10.26 59.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.735 176.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -116.4 14.92 15.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.297 -174.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.536 HD11 HD12 ' A' ' 135' ' ' LEU . 36.6 mm -71.49 121.41 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.76 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 145' ' ' VAL . 1.5 t -108.36 147.82 30.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.126 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -69.41 -22.87 63.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.122 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' A' ' 155' ' ' PRO . . . -67.4 -30.07 69.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.654 -175.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.452 ' HG3' ' HG2' ' A' ' 133' ' ' GLN . 78.1 mmm -86.44 -37.78 17.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.832 0.348 . . . . 0.0 111.189 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.527 HG13 HH12 ' A' ' 60' ' ' ARG . 13.3 t -78.81 -21.86 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.522 0.677 . . . . 0.0 110.44 -174.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -147.31 104.82 3.68 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.119 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.496 ' HB ' ' OE2' ' A' ' 150' ' ' GLU . 20.0 p -102.06 123.91 41.86 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.613 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.63 ' HA ' ' HE2' ' A' ' 109' ' ' MET . 71.9 Cg_endo -74.51 44.42 1.07 Allowed 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.405 2.737 . . . . 0.0 112.251 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 149' ' ' VAL . 6.5 t 54.79 28.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 122.067 0.937 . . . . 0.0 109.869 -174.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.496 ' OE2' ' HB ' ' A' ' 147' ' ' THR . 1.8 mp0 59.28 23.06 11.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.214 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 148' ' ' PRO . 6.9 t -81.57 13.77 2.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.792 0.806 . . . . 0.0 109.539 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . -119.55 -142.59 6.78 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.788 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.4 t -96.61 163.23 13.11 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -57.11 151.88 32.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 11.4 Cg_endo -54.39 -22.99 29.06 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.07 2.513 . . . . 0.0 113.087 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.547 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 2.1 ptp180 -174.96 -54.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.256 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.547 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -163.21 30.39 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.761 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.5 t70 54.22 68.25 0.88 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.845 0.831 . . . . 0.0 109.465 -170.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -100.51 -6.14 25.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.397 -172.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.076 -179.608 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.951 ' H ' ' HB3' ' A' ' 74' ' ' ASN . 79.8 tttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.675 ' HB1' ' HA ' ' A' ' 52' ' ' VAL . . . -143.15 144.75 32.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.046 0.385 . . . . 0.0 111.401 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 3.9 pt20 -149.2 140.1 22.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.595 HG23 ' HB ' ' A' ' 71' ' ' ILE . 24.2 pt -115.77 131.15 69.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.112 0.482 . . . . 0.0 110.19 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -98.75 118.22 34.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.838 HD23 ' HB2' ' A' ' 66' ' ' ALA . 8.4 mp -84.04 153.24 23.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.375 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.515 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 28.9 tt0 -74.12 126.84 31.45 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.962 177.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.82 -41.46 3.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.561 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.423 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.9 t -81.93 125.28 77.97 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.1 Cg_exo -79.09 -3.97 13.53 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.14 2.56 . . . . 0.0 112.493 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -101.82 133.54 20.69 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.59 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 61.2 Cg_endo -92.03 133.44 1.31 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.01 2.473 . . . . 0.0 112.315 176.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.9 tt -86.96 105.62 17.25 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.582 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 40.2 p90 -111.79 143.73 42.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.183 0.516 . . . . 0.0 111.468 -175.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -150.01 138.92 20.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.1 m -58.91 -37.0 75.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.95 0.405 . . . . 0.0 111.342 -177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.503 ' HB3' ' HD2' ' A' ' 53' ' ' ARG . 51.2 mt-30 -81.86 109.29 16.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.432 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.675 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . 39.8 t -59.31 -46.77 92.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.147 0.499 . . . . 0.0 110.661 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HG3' ' H ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -57.15 -30.29 64.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.469 -178.375 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -74.6 -48.64 25.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 110.28 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.81 90.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.75 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.1 pt -66.05 -31.74 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.545 0.212 . . . . 0.0 110.579 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.3 90.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.781 176.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.608 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 54.5 m-85 -62.74 -37.49 86.79 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 111.444 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.725 ' HB3' HD11 ' A' ' 68' ' ' ILE . . . -63.99 -17.87 63.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.229 -175.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 -100.31 12.66 36.61 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -173.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.48 -56.41 0.34 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.457 -1.354 . . . . 0.0 113.863 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.608 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 34.2 Cg_exo -60.62 6.53 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.346 2.698 . . . . 0.0 114.458 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -66.89 105.54 1.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 170.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -128.68 77.82 1.81 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.39 0.614 . . . . 0.0 110.864 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.443 HG21 ' N ' ' A' ' 66' ' ' ALA . 5.4 tp 177.42 -52.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.723 176.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.838 ' HB2' HD23 ' A' ' 40' ' ' LEU . . . -152.28 146.33 18.34 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.515 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 66.7 Cg_endo -72.41 156.71 54.23 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.109 1.873 . . . . 0.0 111.994 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.725 HD11 ' HB3' ' A' ' 59' ' ' ALA . 46.1 pt -73.47 129.94 36.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.08 0.467 . . . . 0.0 110.577 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tt -88.86 -49.67 6.67 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -160.46 139.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.067 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.595 ' HB ' HG23 ' A' ' 38' ' ' ILE . 4.4 tt -108.94 129.87 62.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 120.912 0.387 . . . . 0.0 110.115 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -111.84 127.29 55.78 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.401 HG11 HG12 ' A' ' 52' ' ' VAL . 27.6 m -124.63 153.72 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.007 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.951 ' HB3' ' H ' ' A' ' 35' ' ' LYS . 25.7 t-20 -80.17 102.0 9.15 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.773 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 25.5 t70 -49.66 107.1 0.13 Allowed 'General case' 0 C--O 1.243 0.72 0 O-C-N 125.808 1.943 . . . . 0.0 110.973 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.518 ' HG3' ' O ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -171.36 151.56 3.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.377 -179.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.5 50.3 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.598 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.68 88.83 3.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.19 32.04 20.72 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.485 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.15 -90.87 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.991 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' HB2' HG23 ' A' ' 115' ' ' VAL . . . 61.86 33.15 17.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.541 0.686 . . . . 0.0 110.278 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.534 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 20.4 p -83.74 177.08 8.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.721 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -55.51 -35.64 65.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.811 0.339 . . . . 0.0 111.288 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -77.24 -30.37 54.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' A' ' 82' ' ' THR . 22.8 mt-30 63.88 170.28 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.498 175.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -94.44 9.73 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.547 2.165 . . . . 0.0 111.468 171.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.24 130.08 5.97 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.018 -177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -64.65 135.09 55.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.696 0.284 . . . . 0.0 110.769 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.27 -79.0 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.172 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.773 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 43.9 t30 -100.07 153.49 19.18 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -120.02 131.35 55.11 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 121.691 -0.631 . . . . 0.0 110.676 173.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.762 HG21 ' HB2' ' A' ' 118' ' ' SER . 42.1 pt -141.98 167.37 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.839 -175.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 96' ' ' LYS . . . -84.64 116.99 23.49 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 171.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.18 -39.63 78.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.596 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.857 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 2.4 p-10 -78.13 0.58 24.29 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.939 0.876 . . . . 0.0 110.645 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.493 ' HB2' ' HB1' ' A' ' 93' ' ' ALA . 40.3 mmtm -127.18 56.49 1.52 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.235 169.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.507 ' H ' HD22 ' A' ' 137' ' ' LEU . . . -156.76 -170.12 3.21 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 121.738 -0.601 . . . . 0.0 112.101 -172.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.97 140.96 31.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.023 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.431 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 2.2 m-85 -120.68 136.75 54.76 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.09 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.502 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.0 p -113.08 120.49 63.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.773 0.797 . . . . 0.0 109.614 168.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.56 ' HB ' HE21 ' A' ' 133' ' ' GLN . 99.7 t -101.87 106.77 20.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.556 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.7 130.74 28.48 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.745 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.2 t -92.37 -28.91 16.61 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -87.26 -45.46 10.6 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.973 0.416 . . . . 0.0 110.133 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -128.93 129.8 45.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.482 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 1.004 HH21 HG11 ' A' ' 145' ' ' VAL . 36.6 ttt85 -170.07 -64.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.085 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 164.26 -44.63 0.31 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -177.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.19 -111.41 4.08 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.318 -0.467 . . . . 0.0 111.995 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.6 mtp -86.22 -3.78 59.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.178 0.514 . . . . 0.0 110.198 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.43 -126.28 3.91 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.473 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.39 92.85 4.28 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.938 0.369 . . . . 0.0 111.03 175.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.24 121.89 10.31 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.228 2.619 . . . . 0.0 112.715 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.48 139.27 49.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.026 0.441 . . . . 0.0 110.576 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.581 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -120.46 133.89 55.35 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.238 -172.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.502 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 39.9 t -100.84 105.02 35.56 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.541 -0.464 . . . . 0.0 109.942 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.9 Cg_exo -89.1 124.82 1.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.758 2.972 . . . . 0.0 111.356 171.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.579 ' HD1' ' H ' ' A' ' 119' ' ' SER . 1.7 t80 -135.73 149.13 49.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -176.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.762 ' HB2' HG21 ' A' ' 92' ' ' ILE . 24.1 t -80.35 -31.11 38.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.258 0.551 . . . . 0.0 110.273 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.579 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 16.3 m -90.08 113.37 25.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.346 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -43.04 75.54 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.402 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -63.83 -31.51 72.72 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.682 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.485 ' HG3' ' CE1' ' A' ' 117' ' ' PHE . 43.3 mm-40 -66.23 -43.0 87.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.84 175.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.1 80.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.111 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.43 79.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.874 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -59.7 -31.36 69.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.251 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -62.68 -44.02 97.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.661 HG21 ' H ' ' A' ' 132' ' ' GLY . 56.5 t -72.91 -29.21 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.469 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 9.0 tp -58.22 -35.84 72.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.016 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.68 -50.11 7.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.988 175.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.785 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.9 pt-20 -156.26 -79.95 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.39 175.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.785 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.55 -129.7 11.41 Favored Glycine 0 C--N 1.335 0.502 0 O-C-N 123.522 0.514 . . . . 0.0 112.753 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.661 ' H ' HG21 ' A' ' 127' ' ' VAL . . . -174.67 -83.01 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.56 HE21 ' HB ' ' A' ' 101' ' ' VAL . 2.8 pm0 -130.22 139.28 50.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.819 0.342 . . . . 0.0 110.516 174.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 76.4 t -98.1 124.13 50.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.703 ' HB3' HH21 ' A' ' 156' ' ' ARG . 0.3 OUTLIER -146.99 152.52 38.74 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.815 -177.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.469 ' O ' HG12 ' A' ' 140' ' ' ILE . . . -92.47 173.3 7.86 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.568 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.857 ' HG ' ' O ' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -48.4 -40.73 26.8 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.305 178.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.61 -29.76 67.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.676 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -95.52 3.9 53.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.309 0.576 . . . . 0.0 110.33 -175.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.62 HD12 HD12 ' A' ' 135' ' ' LEU . 26.2 mm -71.37 119.43 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.279 0.561 . . . . 0.0 109.842 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.5 t -119.39 148.43 43.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.003 173.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.436 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.1 p-10 -69.05 -25.81 64.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.729 0.3 . . . . 0.0 110.41 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.69 70.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.217 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.579 ' HE2' ' HG2' ' A' ' 156' ' ' ARG . 10.6 mmt -83.51 -34.11 25.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.07 0.462 . . . . 0.0 110.596 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 1.004 HG11 HH21 ' A' ' 106' ' ' ARG . 38.8 t -78.99 -25.21 13.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.488 -173.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.4 pp -158.07 151.82 23.76 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.276 -174.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . 0.413 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 16.0 p -101.87 120.08 55.07 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.663 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 19.9 Cg_endo -62.87 -71.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.364 2.043 . . . . 0.0 111.213 175.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.13 12.63 3.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.462 ' O ' HG21 ' A' ' 151' ' ' THR . 39.4 mt-10 65.84 -76.87 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.798 -169.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 150' ' ' GLU . 1.1 t 53.71 -0.94 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.986 1.314 . . . . 0.0 114.348 176.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . 71.86 30.24 66.14 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.027 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.6 p -86.05 141.62 29.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.82 0.31 . . . . 0.0 110.509 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.0 125.33 91.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.577 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.17 -95.38 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.062 2.508 . . . . 0.0 112.647 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.703 HH21 ' HB3' ' A' ' 135' ' ' LEU . 1.9 ptp180 -67.89 -32.4 72.86 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 172.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 156' ' ' ARG . . . 172.67 -175.1 0.05 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.981 -1.918 . . . . 0.0 106.483 -174.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -82.59 60.72 5.34 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 122.013 0.911 . . . . 0.0 109.368 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -99.19 -15.88 18.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.196 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--O 1.253 1.251 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.999 -176.791 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 85.6 tttt . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.593 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -143.56 144.17 31.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.413 0.149 . . . . 0.0 110.823 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 29.0 pt20 -149.01 134.7 18.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.148 0.499 . . . . 0.0 110.767 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.669 HG22 ' HB ' ' A' ' 71' ' ' ILE . 37.6 pt -115.92 129.18 72.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.657 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -98.87 116.47 31.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.5 mp -91.85 142.72 27.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.873 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.95 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 34.4 tt0 -74.26 125.06 27.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.603 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.93 -23.74 33.0 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.731 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.509 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 39.7 t -88.49 129.41 49.31 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.4 Cg_exo -77.58 -3.35 13.51 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.897 2.398 . . . . 0.0 112.323 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.25 139.69 32.36 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.813 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.76 149.47 8.53 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.596 2.197 . . . . 0.0 112.167 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 10.3 tt -89.07 111.57 22.34 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -124.11 135.95 53.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.204 0.526 . . . . 0.0 111.623 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -146.82 162.65 38.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.567 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 30.2 t -72.46 -41.89 65.56 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.919 ' HG2' ' HB2' ' A' ' 83' ' ' TRP . 37.9 mt-30 -65.65 113.08 3.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.485 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.593 HG13 ' HB2' ' A' ' 36' ' ' ALA . 4.5 t -72.66 -52.03 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.23 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.537 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -52.09 -35.71 48.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.444 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 51' ' ' GLN . 29.1 t70 -76.05 -51.9 11.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.577 0.227 . . . . 0.0 110.999 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.89 94.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.36 . . . . 0.0 111.394 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.926 HD12 ' HB3' ' A' ' 114' ' ' ALA . 23.9 pt -66.91 -30.56 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.691 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.24 97.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.663 0.268 . . . . 0.0 110.663 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.644 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 16.6 m-85 -63.05 -34.02 76.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.364 . . . . 0.0 110.785 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -69.68 -16.81 63.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.557 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.511 HH12 ' HG2' ' A' ' 112' ' ' PRO . 49.9 mtm180 -102.52 -0.7 31.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.049 -175.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.503 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -154.57 -73.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.998 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.644 ' HD2' ' HA ' ' A' ' 58' ' ' TYR . 76.2 Cg_exo -55.65 0.32 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.085 3.19 . . . . 0.0 115.095 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -79.78 9.09 5.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.935 0.397 . . . . 0.0 111.142 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 84.3 mm-40 -62.64 -18.01 61.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.89 0.376 . . . . 0.0 111.452 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.4 tp -70.49 -45.01 76.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.697 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.596 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.13 140.68 13.65 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.95 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 64.7 Cg_endo -68.31 143.76 59.62 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 122.244 1.963 . . . . 0.0 112.021 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.8 pt -74.07 113.11 11.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.229 0.538 . . . . 0.0 110.333 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.6 -50.8 10.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.8 p -161.2 140.45 2.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.227 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.669 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.7 tt -112.99 131.9 63.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.628 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 97.2 m-85 -111.84 135.51 52.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.444 HG23 HG13 ' A' ' 92' ' ' ILE . 27.8 m -131.59 140.82 47.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.445 0.64 . . . . 0.0 111.161 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 13.0 m120 -90.28 99.9 12.83 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -54.63 104.67 0.12 Allowed 'General case' 0 C--O 1.239 0.529 0 O-C-N 124.485 1.116 . . . . 0.0 111.025 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.653 ' O ' ' HD2' ' A' ' 86' ' ' PRO . 64.8 mtt -144.61 52.55 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.414 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.05 -52.56 4.51 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.338 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 67.12 -84.36 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.255 0.622 . . . . 0.0 112.221 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.71 -15.99 15.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.824 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.51 -43.25 96.88 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.647 ' CB ' ' HD3' ' A' ' 86' ' ' PRO . . . -95.02 -154.79 0.44 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.374 173.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.0 p -103.6 177.76 4.75 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.864 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.919 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 3.3 p90 -55.49 -13.27 1.43 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 172.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.61 -35.61 39.27 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 71.74 150.13 0.13 Allowed Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.38 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.653 ' HD2' ' O ' ' A' ' 76' ' ' MET . 48.2 Cg_endo -72.89 -61.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.455 2.104 . . . . 0.0 113.1 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.51 -179.21 39.65 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.372 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.14 136.82 42.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.196 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.3 -113.18 1.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.834 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -100.51 152.02 20.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.515 0.198 . . . . 0.0 111.053 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -105.25 124.94 50.39 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 168.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 1.004 HG21 ' HB2' ' A' ' 118' ' ' SER . 8.8 pt -145.81 164.48 10.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . . . -96.87 107.22 19.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.591 ' HB1' ' HE1' ' A' ' 99' ' ' TYR . . . -57.64 -33.14 67.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 111.188 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.795 ' HA ' HD13 ' A' ' 137' ' ' LEU . 9.1 t70 -62.12 -28.17 69.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.033 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -114.65 33.44 5.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.201 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -138.24 -175.07 3.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.739 0.304 . . . . 0.0 110.902 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -91.34 138.98 31.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.497 0.665 . . . . 0.0 110.61 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.591 ' HE1' ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -120.52 135.03 55.2 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.565 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.912 HG13 HG13 ' A' ' 115' ' ' VAL . 1.1 p -118.57 124.63 73.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.604 0.716 . . . . 0.0 109.752 169.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.577 HG11 ' HA ' ' A' ' 145' ' ' VAL . 65.3 t -101.65 117.82 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.149 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.719 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -77.87 125.82 7.42 Favored Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.452 -171.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -91.88 -36.71 13.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 110.909 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.11 -43.65 23.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.37 . . . . 0.0 111.138 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 71.4 mtp180 -131.02 96.97 4.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.543 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.789 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 2.8 tpp180 172.82 175.32 0.1 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.663 0.602 . . . . 0.0 109.905 173.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.1 70.4 3.15 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.366 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.19 -42.68 98.73 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.358 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.6 mtm -109.55 16.52 22.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.275 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.429 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -139.21 -122.33 1.98 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.475 -175.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.36 92.83 4.24 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 110.915 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.622 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 73.9 Cg_endo -77.3 135.34 14.95 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.61 2.207 . . . . 0.0 112.958 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.789 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 30.9 mt-10 -115.13 146.45 41.34 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.029 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.926 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -118.42 133.14 56.11 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.738 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.912 HG13 HG13 ' A' ' 100' ' ' VAL . 0.5 OUTLIER -101.86 105.69 43.03 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.685 171.047 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 6.6 Cg_exo -81.99 123.8 4.21 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 124.425 3.416 . . . . 0.0 111.77 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.76 ' HD1' ' H ' ' A' ' 119' ' ' SER . 1.2 t80 -135.16 149.59 49.99 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.988 0.423 . . . . 0.0 110.154 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . 1.004 ' HB2' HG21 ' A' ' 92' ' ' ILE . 29.2 t -78.34 -34.68 48.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.615 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.76 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 8.0 m -91.34 116.93 29.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.211 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -58.14 -44.56 87.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.965 0.412 . . . . 0.0 111.495 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -61.63 -31.56 71.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.099 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -67.48 -41.52 84.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.655 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.39 83.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.128 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.25 92.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.774 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.16 86.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.101 0.477 . . . . 0.0 110.567 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -62.0 -38.71 89.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.84 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.607 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 48.2 t -65.99 -42.8 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.903 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.2 mt -53.96 -35.36 61.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.643 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.01 -46.6 11.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.0 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -159.07 -34.58 0.06 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.719 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -50.43 157.86 1.98 Allowed Glycine 0 C--N 1.32 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.024 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -101.27 -68.5 0.83 Allowed Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.74 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.451 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.2 140.96 50.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.741 0.305 . . . . 0.0 110.831 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.411 HG23 HG21 ' A' ' 127' ' ' VAL . 89.0 t -98.38 112.87 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.284 0.564 . . . . 0.0 109.664 172.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.882 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -137.58 144.88 42.23 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.766 -178.26 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.96 157.59 37.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' ' 95' ' ' ASP . 4.5 tt -63.32 -28.85 70.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.418 0.628 . . . . 0.0 109.673 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.32 -9.56 53.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.425 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -123.45 18.1 9.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.09 0.472 . . . . 0.0 110.539 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.882 HD13 HD13 ' A' ' 135' ' ' LEU . 38.2 mm -71.78 121.65 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.197 0.522 . . . . 0.0 110.387 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . 1.022 HG21 ' HA ' ' A' ' 156' ' ' ARG . 2.9 t -111.47 148.24 33.57 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.722 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.497 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.3 p-10 -69.27 -22.31 63.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.681 0.277 . . . . 0.0 110.656 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.27 -33.41 74.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.936 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.654 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 7.2 mmt -87.26 -30.14 21.14 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.806 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.577 ' HA ' HG11 ' A' ' 101' ' ' VAL . 5.0 t -80.53 -22.91 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.991 0.424 . . . . 0.0 110.746 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.6 pp -154.47 134.26 12.93 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.372 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.9 p -116.39 149.37 43.55 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.162 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -58.99 -58.05 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.476 2.117 . . . . 0.0 109.621 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 25.7 t -127.56 -72.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 165.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 149' ' ' VAL . 7.5 mt-10 165.2 -77.03 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.438 1.495 . . . . 0.0 108.493 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.7 t 46.18 28.99 0.73 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.504 1.122 . . . . 0.0 113.129 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 74.92 64.36 2.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.286 -176.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.6 t -89.93 162.08 15.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.922 0.392 . . . . 0.0 110.873 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -88.69 150.97 47.12 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.108 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.642 ' HA ' ' SD ' ' A' ' 144' ' ' MET . 60.3 Cg_endo -73.12 -136.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.991 2.461 . . . . 0.0 113.125 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.022 ' HA ' HG21 ' A' ' 141' ' ' THR . 0.0 OUTLIER -57.21 -29.14 63.49 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -174.917 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -179.49 20.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.371 0.419 . . . . 0.0 110.638 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.1 t70 48.49 70.52 0.44 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.684 0.754 . . . . 0.0 109.133 -169.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.519 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 14.3 t70 -145.14 -42.18 0.23 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.53 -167.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 C--O 1.247 0.963 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.691 -179.787 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 74' ' ' ASN . 16.5 ttmm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.558 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -133.14 141.88 48.37 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.84 175.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 9.4 pt20 -149.65 132.66 16.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.828 174.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.628 HG21 ' HB2' ' A' ' 59' ' ' ALA . 28.6 pt -115.95 133.68 61.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.3 0.571 . . . . 0.0 111.458 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -103.81 119.51 39.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.696 HD23 ' HB3' ' A' ' 66' ' ' ALA . 11.1 mp -89.63 153.95 20.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.276 0.56 . . . . 0.0 111.503 -174.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.593 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 29.7 tt0 -71.68 125.54 27.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.635 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.31 -27.36 5.7 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.199 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.514 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.9 t -87.98 128.38 54.14 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 8.9 Cg_endo -87.29 -1.35 7.74 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.122 2.548 . . . . 0.0 112.612 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.23 132.98 21.83 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.828 0.347 . . . . 0.0 111.053 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -87.77 124.57 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.675 2.25 . . . . 0.0 112.036 174.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 7.2 tt -80.56 109.0 14.67 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -108.84 143.13 38.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.988 0.423 . . . . 0.0 110.831 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.613 ' HD1' ' H ' ' A' ' 51' ' ' GLN . 1.9 t80 -144.66 145.24 31.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.696 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.7 m -63.97 -34.95 79.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.194 0.521 . . . . 0.0 110.201 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.623 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 76.1 mt-30 -83.38 105.96 14.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.051 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 36' ' ' ALA . 8.6 t -56.37 -51.46 63.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.285 0.564 . . . . 0.0 109.57 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.65 ' HB3' ' HB3' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -55.5 -32.84 63.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.682 -1.145 . . . . 0.0 113.205 -178.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.552 ' HB2' HH11 ' A' ' 53' ' ' ARG . 22.8 t70 -76.28 -50.08 15.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.013 0.435 . . . . 0.0 110.839 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -64.95 -39.47 93.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.276 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.675 HD12 ' HB3' ' A' ' 114' ' ' ALA . 16.2 pt -70.16 -30.53 43.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.625 0.25 . . . . 0.0 110.628 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.07 82.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.141 0.496 . . . . 0.0 110.075 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -62.01 -34.91 77.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.13 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.687 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -72.89 -18.17 61.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.993 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -96.52 12.47 31.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -172.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.32 -61.51 0.1 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.521 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.35 22.43 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.145 2.563 . . . . 0.0 114.8 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.65 74.09 9.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.134 0.968 . . . . 0.0 110.376 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.454 ' O ' HG22 ' A' ' 65' ' ' ILE . 83.5 mt-30 -79.09 145.82 33.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.25 -172.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 64' ' ' GLN . 1.9 tp 72.74 -38.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.91 1.284 . . . . 0.0 112.345 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.696 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -133.44 139.57 34.35 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 122.007 -0.433 . . . . 0.0 110.413 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 96.2 Cg_endo -85.59 159.97 10.8 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.95 2.434 . . . . 0.0 112.061 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.687 HD13 ' HB1' ' A' ' 59' ' ' ALA . 28.0 pt -77.08 113.35 16.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.31 0.576 . . . . 0.0 110.465 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -77.54 -46.81 21.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.7 p -158.28 138.82 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.395 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.604 HD11 HG22 ' A' ' 56' ' ' ILE . 2.6 tt -116.94 134.35 60.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.027 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.94 128.78 56.26 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 94' ' ' ALA . 29.0 m -126.96 151.93 34.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.26 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 16.5 m120 -91.49 105.65 17.91 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.54 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.589 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 18.3 t70 -48.26 134.02 15.04 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 125.928 2.018 . . . . 0.0 110.844 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 74' ' ' ASN . 23.9 mmt -127.04 176.55 7.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -167.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.406 ' H ' ' HG2' ' A' ' 86' ' ' PRO . . . -60.95 -19.38 56.37 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.73 173.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 83.47 -45.16 0.11 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.16 0.584 . . . . 0.0 112.33 168.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.54 -44.22 76.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.061 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.03 -87.1 0.78 Allowed Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.506 173.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.439 ' H ' ' HD3' ' A' ' 86' ' ' PRO . . . 53.73 26.16 5.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.52 0.676 . . . . 0.0 111.699 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.0 p -83.67 179.16 7.68 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.983 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.623 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 48.6 p90 -59.5 -24.2 63.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.733 0.301 . . . . 0.0 111.267 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -81.37 -35.29 30.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.824 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 68.74 140.22 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.668 174.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.496 ' HD2' ' SD ' ' A' ' 76' ' ' MET . 96.5 Cg_endo -85.14 31.71 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.36 2.04 . . . . 0.0 113.577 -173.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 118.01 -171.83 14.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.125 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.4 147.22 36.14 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.493 0.317 . . . . 0.0 110.728 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -141.58 -158.06 7.4 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.169 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.603 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 41.9 m-80 -100.17 150.44 22.51 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 40.8 p-90 -98.56 130.28 45.11 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.444 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.758 HG21 ' HB2' ' A' ' 118' ' ' SER . 14.1 pt -143.97 160.6 15.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.601 -173.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.68 101.16 9.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.108 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.579 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -62.11 -38.95 90.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.349 -172.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 14.0 t70 -58.85 -30.43 67.69 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.666 0.746 . . . . 0.0 110.301 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -107.96 25.73 11.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.123 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.13 -177.21 3.79 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.847 0.356 . . . . 0.0 110.485 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -97.79 136.81 37.59 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.527 0.68 . . . . 0.0 110.475 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.66 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 7.6 m-85 -120.5 136.18 54.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.88 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.705 HG13 ' HB ' ' A' ' 115' ' ' VAL . 3.2 p -114.77 127.89 72.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.423 0.63 . . . . 0.0 109.762 174.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.597 HG11 ' HA ' ' A' ' 145' ' ' VAL . 96.4 t -101.46 103.49 14.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -80.49 123.16 5.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.555 -174.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.8 t -92.51 -29.54 16.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.587 0.232 . . . . 0.0 110.756 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.18 60.74 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -171.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -139.19 101.53 4.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.421 173.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.952 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 19.4 tpp180 -175.06 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.845 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.65 42.09 0.15 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.113 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.97 -34.38 89.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.266 -0.968 . . . . 0.0 111.715 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.0 ttt -109.5 2.23 20.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.096 0.474 . . . . 0.0 110.326 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.425 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -136.56 -123.52 2.26 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.72 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.8 99.08 12.61 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.977 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 72.1 Cg_endo -79.18 151.38 23.44 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.143 2.562 . . . . 0.0 113.696 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.952 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 25.9 mt-10 -128.82 146.52 50.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.603 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.675 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -93.79 130.93 39.62 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.945 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.705 ' HB ' HG13 ' A' ' 100' ' ' VAL . 55.4 t -101.28 106.4 45.13 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 6.1 Cg_exo -86.26 132.52 3.79 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.656 2.904 . . . . 0.0 112.305 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.755 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.8 t80 -137.66 149.43 46.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.758 ' HB2' HG21 ' A' ' 92' ' ' ILE . 35.5 t -77.97 -37.88 46.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.846 0.355 . . . . 0.0 111.148 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.755 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 17.8 m -95.75 129.74 42.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.826 0.346 . . . . 0.0 110.645 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -65.92 -49.72 66.97 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.229 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -63.18 -29.65 70.95 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.554 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -65.73 -42.92 90.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.554 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.7 -36.95 73.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.229 0.538 . . . . 0.0 110.035 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.03 -34.56 71.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.846 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.69 81.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.036 0.446 . . . . 0.0 110.356 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -62.43 -37.59 86.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.751 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.7 HG22 ' H ' ' A' ' 132' ' ' GLY . 93.2 t -70.95 -38.13 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.974 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.1 mt -53.24 -50.95 63.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.368 0.604 . . . . 0.0 110.11 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.59 78.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.133 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.76 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.3 pt-20 -165.55 -82.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.58 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.76 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 39.6 -132.79 2.15 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 123.915 0.759 . . . . 0.0 114.45 175.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.7 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -171.23 -93.37 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.77 139.66 51.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.711 0.291 . . . . 0.0 110.715 174.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.496 HG23 HG21 ' A' ' 127' ' ' VAL . 99.4 t -97.43 123.17 49.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.378 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.886 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -147.02 164.38 33.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.563 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.14 164.38 15.04 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.625 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 4.1 tt -61.44 -40.05 93.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.97 -8.62 38.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.592 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -124.67 17.96 8.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.248 0.547 . . . . 0.0 110.748 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.886 HD13 HD13 ' A' ' 135' ' ' LEU . 26.1 mm -71.78 121.92 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -116.86 146.0 43.2 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.96 -30.73 68.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.717 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.76 -28.78 68.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.923 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.6 mmt -77.62 -41.21 39.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.783 0.325 . . . . 0.0 110.953 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.597 ' HA ' HG11 ' A' ' 101' ' ' VAL . 3.0 t -81.52 -23.79 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.393 . . . . 0.0 111.217 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -156.62 159.33 38.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.552 -175.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 150' ' ' GLU . 3.4 p -100.02 120.35 57.11 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.657 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.26 -69.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.1 2.533 . . . . 0.0 112.406 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.69 0.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.288 0.566 . . . . 0.0 109.646 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.453 ' HG2' ' HB ' ' A' ' 147' ' ' THR . 40.1 mt-10 57.36 55.8 5.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.422 -175.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 t -90.94 -6.84 53.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.055 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 82.42 26.57 46.78 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.535 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 p -84.41 161.93 20.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.667 0.27 . . . . 0.0 110.646 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.885 ' HB3' ' H ' ' A' ' 158' ' ' ASP . 43.3 mp0 -61.38 131.96 92.58 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.59 -24.68 25.61 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.698 2.265 . . . . 0.0 113.253 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.498 HH11 ' HB3' ' A' ' 157' ' ' ALA . 5.8 ppt_? -155.13 -39.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.14 0.495 . . . . 0.0 110.527 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.498 ' HB3' HH11 ' A' ' 156' ' ' ARG . . . 179.33 53.89 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.885 ' H ' ' HB3' ' A' ' 154' ' ' GLU . 13.5 t70 63.38 -144.9 0.34 Allowed 'General case' 0 C--O 1.237 0.424 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 -156.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -154.17 161.49 41.82 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 119.662 1.119 . . . . 0.0 112.408 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 C--O 1.248 0.975 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.343 -173.281 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 28.7 tttm . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.767 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -135.91 143.71 45.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.541 0.21 . . . . 0.0 111.099 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -149.35 139.55 22.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.645 0.26 . . . . 0.0 110.417 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.449 HG22 ' HB ' ' A' ' 71' ' ' ILE . 32.5 pt -116.01 136.1 54.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.992 0.425 . . . . 0.0 111.429 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -104.87 123.71 48.2 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.9 mp -97.74 148.99 22.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.187 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.819 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 40.6 tt0 -74.04 125.5 28.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.616 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.03 -29.28 10.23 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.592 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 t -92.4 124.98 57.79 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.26 -7.39 12.94 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.878 2.385 . . . . 0.0 111.958 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -113.71 133.95 22.14 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.632 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 97.1 Cg_endo -91.01 143.24 3.25 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.084 2.523 . . . . 0.0 112.656 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.2 tt -89.41 121.41 31.63 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -107.85 147.22 31.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 111.527 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.529 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 1.5 m-85 -143.12 141.94 31.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.146 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.5 m -72.42 -28.73 63.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.0 109.487 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.532 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 80.6 mt-30 -86.84 109.39 19.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.92 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.767 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 17.2 t -63.54 -51.17 73.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.294 0.569 . . . . 0.0 109.909 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.634 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.33 -29.07 60.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.111 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.634 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 8.8 t70 -76.21 -47.27 24.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.532 -176.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -72.31 -36.08 68.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.485 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.518 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 22.8 pt -68.23 -35.24 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.436 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.31 -40.96 81.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.03 0.443 . . . . 0.0 110.338 172.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.47 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 33.2 t80 -62.29 -28.31 69.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.686 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.1 -15.9 61.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.288 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 60' ' ' ARG . 40.6 mtp-105 -98.19 11.71 36.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -172.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.96 -60.97 0.09 OUTLIER Glycine 0 CA--C 1.52 0.404 0 C-N-CA 119.274 -1.441 . . . . 0.0 114.469 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 58' ' ' TYR . 37.5 Cg_exo -59.81 -7.6 6.24 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.265 2.643 . . . . 0.0 115.149 -176.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.861 ' HG3' HG23 ' A' ' 68' ' ' ILE . 3.2 pm0 -77.41 89.61 3.8 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.41 1.1 . . . . 0.0 109.604 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -106.78 -24.64 12.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.045 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.2 tp -68.6 -40.21 81.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.275 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.596 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.24 152.65 29.8 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.538 177.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.819 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 59.8 Cg_endo -72.65 160.03 47.37 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.259 1.973 . . . . 0.0 111.447 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.861 HG23 ' HG3' ' A' ' 63' ' ' GLU . 29.1 pt -80.35 132.52 31.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.05 0.452 . . . . 0.0 111.035 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.08 -51.89 3.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -161.23 138.56 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.469 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.55 HG22 ' HB2' ' A' ' 95' ' ' ASP . 2.7 tt -108.15 134.64 49.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.153 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -111.88 130.07 55.95 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.95 145.61 27.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.026 0.441 . . . . 0.0 109.877 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 17.0 m120 -85.56 100.87 12.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.246 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -56.24 109.21 0.56 Allowed 'General case' 0 C--O 1.238 0.48 0 O-C-N 125.292 1.62 . . . . 0.0 110.136 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.495 ' SD ' ' HG2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -159.73 107.23 1.7 Allowed 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.291 -179.599 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.21 -68.3 2.05 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.399 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.582 ' HB1' HG13 ' A' ' 115' ' ' VAL . . . 67.42 -50.85 0.5 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.72 0.808 . . . . 0.0 112.51 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.85 -36.3 69.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.066 0.46 . . . . 0.0 110.547 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.31 -71.3 1.16 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 78' ' ' ALA . . . 51.41 54.49 11.0 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 124.176 0.574 . . . . 0.0 112.052 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.5 p -83.82 175.94 9.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.532 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 28.0 p-90 -66.53 -20.0 65.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.152 0.501 . . . . 0.0 110.254 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -84.76 -26.28 27.69 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.655 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 63.76 171.49 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.604 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.951 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.495 ' HG2' ' SD ' ' A' ' 76' ' ' MET . 38.4 Cg_endo -92.16 0.77 4.16 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.636 1.557 . . . . 0.0 112.06 172.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.3 -168.55 20.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.869 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.16 146.45 37.09 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.22 -166.55 12.15 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.159 -1.019 . . . . 0.0 113.277 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.3 t-20 -77.65 152.34 33.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.133 -0.534 . . . . 0.0 110.087 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -98.05 128.7 44.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.436 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.3 pt -140.57 143.59 28.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.77 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.92 102.44 4.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.177 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.91 78.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.237 0.542 . . . . 0.0 111.066 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.55 ' HB2' HG22 ' A' ' 71' ' ' ILE . 21.8 t70 -61.85 -24.63 67.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.64 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -115.97 27.56 9.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.995 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.35 178.84 5.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.651 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -92.67 136.02 33.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.431 0.634 . . . . 0.0 110.592 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.479 ' HE2' HD12 ' A' ' 56' ' ' ILE . 8.7 m-85 -120.54 136.22 54.85 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.739 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.736 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.7 p -113.9 125.98 71.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 CA-C-O 121.835 0.826 . . . . 0.0 110.423 173.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.681 ' HA ' HH11 ' A' ' 106' ' ' ARG . 40.8 t -102.03 113.4 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.461 174.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.66 122.57 7.2 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 119.975 -1.107 . . . . 0.0 111.553 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t -89.03 -28.46 20.15 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.34 -44.25 12.98 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.861 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.673 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 60.9 mtp180 -146.01 127.16 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.322 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.681 HH11 ' HA ' ' A' ' 101' ' ' VAL . 7.6 ttt180 -176.58 -53.37 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.626 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 151.39 26.33 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.28 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.26 -38.15 92.86 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.919 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 67.4 mtt -109.36 21.34 17.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.73 0.3 . . . . 0.0 110.637 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.55 -125.5 0.93 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.816 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.42 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.32 101.7 24.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.942 0.401 . . . . 0.0 110.375 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.547 ' HA ' ' HA3' ' A' ' 107' ' ' GLY . 43.0 Cg_endo -66.94 123.4 10.93 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 123.229 2.619 . . . . 0.0 113.301 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.38 131.13 56.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.79 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.591 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -98.13 131.77 44.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.85 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.736 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 93.3 t -98.04 104.54 22.87 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.826 174.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.0 Cg_endo -96.53 127.18 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.975 3.117 . . . . 0.0 112.064 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.546 ' HD2' ' H ' ' A' ' 119' ' ' SER . 1.1 t80 -147.06 148.78 32.0 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.4 m -86.87 -17.54 33.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.938 0.399 . . . . 0.0 110.759 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.546 ' H ' ' HD2' ' A' ' 117' ' ' PHE . 43.9 m -92.3 107.56 19.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.922 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.5 -44.62 72.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.782 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -63.42 -28.03 69.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.311 -173.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.524 ' HG3' ' CE2' ' A' ' 117' ' ' PHE . 40.9 mm-40 -66.4 -44.64 82.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.067 0.46 . . . . 0.0 110.242 174.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.05 77.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.364 0.602 . . . . 0.0 109.707 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.67 95.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.571 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -59.8 -33.85 72.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.295 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -64.37 -43.75 93.54 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 132' ' ' GLY . 40.5 t -72.95 -28.62 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.277 0.561 . . . . 0.0 110.397 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 9.3 tp -57.6 -38.64 75.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.921 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.02 -46.46 11.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.419 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.765 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.5 pt-20 -156.58 -80.05 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.621 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.765 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.36 -133.43 10.85 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 114.249 0.46 . . . . 0.0 114.249 174.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.702 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -178.39 -85.47 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.475 ' HG3' ' SD ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -130.16 139.5 50.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.629 0.252 . . . . 0.0 110.975 178.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.2 t -103.72 112.85 38.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.522 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.791 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -139.7 165.5 27.1 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.016 -175.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.81 161.29 14.92 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.666 ' HA ' HG12 ' A' ' 140' ' ' ILE . 1.6 tt -60.77 -31.03 70.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.188 0.518 . . . . 0.0 110.086 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.59 -22.91 67.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.645 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.28 26.01 9.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.043 -174.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.791 HD13 HD13 ' A' ' 135' ' ' LEU . 31.1 mm -71.69 119.48 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.498 ' CG2' ' HG2' ' A' ' 144' ' ' MET . 5.6 t -119.49 149.48 41.82 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.068 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 15.7 p-10 -68.99 -27.45 65.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.93 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.67 70.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.667 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.498 ' HG2' ' CG2' ' A' ' 141' ' ' THR . 12.8 mmt -75.73 -37.66 59.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.968 0.413 . . . . 0.0 110.699 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.69 -23.44 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.48 -171.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.5 pp -153.0 142.42 21.69 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.209 -174.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.4 p -122.75 150.33 58.26 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.589 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.07 -59.75 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.293 1.995 . . . . 0.0 109.592 171.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 28.7 t -119.73 -71.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 166.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 149' ' ' VAL . 11.4 mt-10 172.28 -76.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.625 1.57 . . . . 0.0 107.569 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 150' ' ' GLU . 0.6 OUTLIER 64.35 -31.17 0.12 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.878 1.271 . . . . 0.0 113.973 173.017 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 97.41 54.99 1.2 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.2 t -102.66 144.68 30.74 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.667 ' HG2' ' HB3' ' A' ' 158' ' ' ASP . 2.2 mp0 -57.71 126.26 75.43 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 110.66 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 157' ' ' ALA . 59.8 Cg_endo -73.85 -85.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.029 2.486 . . . . 0.0 113.236 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.425 ' HD2' ' HB3' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -75.5 -27.23 58.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.419 1.104 . . . . 0.0 108.089 174.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.511 ' O ' ' HD2' ' A' ' 155' ' ' PRO . . . 165.73 -162.9 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 112.563 -2.108 . . . . 0.0 105.448 -170.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.667 ' HB3' ' HG2' ' A' ' 154' ' ' GLU . 4.0 p30 -106.26 17.45 23.44 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 36.1 t70 -66.26 -83.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.475 -1.238 . . . . 0.0 111.358 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.558 176.557 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 50' ' ' SER . 88.0 tttt . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -132.89 145.05 50.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.713 0.292 . . . . 0.0 111.226 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 10.4 pt20 -149.13 134.55 18.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.413 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.728 HG21 ' HB2' ' A' ' 59' ' ' ALA . 22.3 pt -115.58 135.69 54.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.183 0.516 . . . . 0.0 110.923 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -104.73 119.64 39.47 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.5 mp -81.16 151.66 28.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.38 -175.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.34 125.53 28.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.374 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.7 -36.75 3.22 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.634 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 41.5 t -81.6 125.45 78.36 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.932 0.396 . . . . 0.0 110.359 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.5 Cg_exo -78.74 -1.42 11.58 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.179 2.586 . . . . 0.0 112.289 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -114.63 134.01 22.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.69 0.281 . . . . 0.0 111.106 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 98.5 Cg_endo -93.37 162.25 2.45 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.331 2.687 . . . . 0.0 112.69 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.5 tt -115.21 116.27 28.07 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 20.6 p90 -119.62 146.04 45.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.286 0.565 . . . . 0.0 111.732 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.407 ' HD1' ' H ' ' A' ' 51' ' ' GLN . 3.5 t80 -149.96 143.84 25.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.068 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 16.4 m -60.24 -45.61 92.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.096 0.475 . . . . 0.0 110.76 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.588 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 66.8 mt-30 -69.7 111.1 5.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.493 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 8.9 t -61.95 -52.42 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.948 0.404 . . . . 0.0 110.456 -177.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.566 HH11 ' HB2' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.86 -29.9 56.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.411 178.59 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.566 ' HB2' HH11 ' A' ' 53' ' ' ARG . 29.0 t70 -76.16 -51.56 11.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.953 0.406 . . . . 0.0 110.234 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.746 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -68.02 -38.3 82.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.676 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 28.3 pt -65.82 -30.24 49.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.66 96.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.678 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.746 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 70.2 m-85 -60.4 -44.97 95.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.712 0.292 . . . . 0.0 110.847 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.728 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -61.01 -18.18 56.25 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -105.05 12.5 32.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.824 0.345 . . . . 0.0 111.396 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.91 -85.4 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.34 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -48.05 -55.3 4.15 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.672 2.914 . . . . 0.0 113.858 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 57.21 -89.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.775 0.672 . . . . 0.0 110.43 -173.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.541 ' HB3' HD21 ' A' ' 40' ' ' LEU . 58.7 tt0 -178.97 -59.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tp -165.87 -40.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.048 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -94.12 152.16 40.15 Favored Pre-proline 0 N--CA 1.446 -0.675 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.007 173.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.59 161.38 46.25 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.768 1.645 . . . . 0.0 111.305 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.5 pt -73.79 136.98 24.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.196 0.522 . . . . 0.0 110.786 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tt -98.37 -47.89 5.25 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.01 138.75 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.8 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' A' ' 95' ' ' ASP . 2.8 tt -111.08 133.23 57.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.079 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -112.86 145.06 41.35 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 36' ' ' ALA . 18.8 m -136.35 155.88 35.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.231 0.538 . . . . 0.0 110.912 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -91.21 102.65 15.37 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 21.2 t70 -57.0 108.53 0.52 Allowed 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 125.034 1.459 . . . . 0.0 111.252 -175.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.599 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 1.6 mmt -161.12 62.02 0.29 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.555 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.937 ' HA2' ' HB2' ' A' ' 81' ' ' ALA . . . -100.15 27.02 22.28 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.78 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.44 97.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.94 0.435 . . . . 0.0 111.067 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 56.4 33.97 23.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.398 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.56 -59.7 0.22 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 119.148 -1.501 . . . . 0.0 114.566 176.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.937 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . . . 60.64 56.55 2.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.364 0.602 . . . . 0.0 110.375 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.6 p -83.99 177.18 8.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.069 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.588 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 24.5 p90 -66.71 -24.21 66.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.267 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.85 -31.89 27.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 66.59 157.36 0.13 Allowed Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.059 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 76' ' ' MET . 21.8 Cg_exo -70.76 -22.02 28.05 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.532 2.155 . . . . 0.0 111.1 170.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . 146.87 -162.99 28.61 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.515 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.74 141.95 42.51 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 76' ' ' MET . . . -131.11 -156.14 8.42 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.484 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -96.66 155.72 16.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.442 -175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -97.53 127.39 43.45 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.694 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.803 HD13 ' HB2' ' A' ' 118' ' ' SER . 26.6 pt -145.3 166.97 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.33 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.73 117.32 29.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.86 -35.54 74.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.737 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.754 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -70.63 -18.22 62.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.932 0.872 . . . . 0.0 109.718 -178.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.468 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 41.1 mmtm -107.12 21.06 18.12 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.678 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.21 177.59 4.83 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.797 0.332 . . . . 0.0 110.87 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -92.02 133.36 35.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.966 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -120.66 135.76 55.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.465 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.447 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.7 p -112.16 127.84 69.11 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-O 121.695 0.759 . . . . 0.0 110.422 174.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.542 ' HA ' HH11 ' A' ' 106' ' ' ARG . 43.8 t -102.89 103.92 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.119 174.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.45 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -70.35 125.02 14.01 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.453 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.6 m -92.21 -14.42 29.04 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.186 0.517 . . . . 0.0 110.032 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -91.88 -43.57 9.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.008 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.664 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 54.1 mtp180 -121.41 -107.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 119.292 -0.385 . . . . 0.0 109.988 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.542 HH11 ' HA ' ' A' ' 101' ' ' VAL . 5.0 tpt180 68.26 -60.66 0.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 176.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . -178.62 -61.11 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 58.56 -94.34 0.05 OUTLIER Glycine 0 C--N 1.332 0.319 0 O-C-N 123.92 0.424 . . . . 0.0 113.159 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -83.05 -3.97 57.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.986 0.422 . . . . 0.0 110.94 -178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.98 -135.89 5.24 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -102.36 108.16 56.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.803 0.301 . . . . 0.0 110.342 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HA ' ' HA3' ' A' ' 107' ' ' GLY . 18.4 Cg_endo -59.88 128.06 25.49 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 123.185 2.59 . . . . 0.0 112.99 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.414 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 43.1 mt-10 -114.52 135.35 54.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.904 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.544 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.77 131.62 38.95 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.827 -174.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.447 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 8.8 t -101.31 105.39 39.38 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.625 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.4 Cg_exo -86.97 136.84 4.33 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.713 2.942 . . . . 0.0 112.341 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -129.27 149.01 51.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.049 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.803 ' HB2' HD13 ' A' ' 92' ' ' ILE . 30.9 t -85.2 -35.61 21.53 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.9 m -91.59 118.7 30.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.763 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -59.74 -42.55 93.42 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.429 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -65.9 -31.7 72.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.892 -173.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -64.55 -40.44 95.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.746 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.03 -42.54 84.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.51 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.26 -41.19 99.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.855 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.42 -31.27 72.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.91 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -64.95 -36.52 84.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.916 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 62.1 t -73.02 -27.83 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.649 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mp -61.73 -46.23 90.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.086 0.469 . . . . 0.0 110.809 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.91 -49.92 26.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.485 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.669 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 0.7 OUTLIER -145.96 -86.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.757 178.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.916 ' HA3' ' HA ' ' A' ' 127' ' ' VAL . . . 50.44 -148.68 6.94 Favored Glycine 0 N--CA 1.444 -0.792 0 O-C-N 123.642 0.588 . . . . 0.0 113.702 172.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.588 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -179.96 -84.77 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -130.22 141.17 50.66 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 38.4 t -104.63 113.96 43.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.643 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.765 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.28 164.17 29.92 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.699 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.72 166.3 17.13 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.754 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 4.7 tt -62.22 -33.44 74.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.351 0.596 . . . . 0.0 109.611 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.02 60.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.168 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -117.44 17.47 14.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.292 0.568 . . . . 0.0 110.073 -176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.765 HD13 HD13 ' A' ' 135' ' ' LEU . 31.9 mm -71.93 120.28 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.312 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.6 t -119.1 147.82 43.73 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.978 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -69.26 -31.32 69.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.891 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.77 -28.82 66.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.798 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.617 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 8.2 mmt -87.18 -26.45 23.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.494 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.421 ' HA ' HG11 ' A' ' 101' ' ' VAL . 16.4 t -85.56 -24.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.207 0.527 . . . . 0.0 110.521 -177.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -160.3 151.88 19.75 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.566 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.44 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 4.0 p -94.59 120.06 65.43 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 120.829 0.347 . . . . 0.0 111.214 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 36.8 Cg_endo -66.6 -67.57 0.04 OUTLIER 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.73 2.287 . . . . 0.0 111.511 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.408 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 2.4 t -118.66 5.39 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 152' ' ' GLY . 22.4 mt-10 66.58 -81.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.699 -170.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.1 t 43.31 -59.99 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.134 1.774 . . . . 0.0 114.999 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 150' ' ' GLU . . . 118.34 63.37 0.3 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -175.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.1 m -116.91 161.58 19.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.545 0.212 . . . . 0.0 110.467 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 158' ' ' ASP . 1.6 mp0 -66.54 135.17 94.53 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.712 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 154' ' ' GLU . 74.1 Cg_endo -81.21 -89.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 123.037 2.491 . . . . 0.0 114.583 -169.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.443 ' HD2' ' HB3' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -66.21 -25.71 67.04 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.001 0.429 . . . . 0.0 111.393 -173.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -171.03 -82.34 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 6.3 p-10 -171.18 20.67 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.443 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 30.5 t70 -78.11 -83.02 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.339 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.186 173.73 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 22.1 ttmm . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -131.4 148.48 52.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.83 0.286 . . . . 0.0 111.275 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 13.8 pt20 -149.04 134.47 18.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 36.1 pt -115.94 137.82 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.821 -0.549 . . . . 0.0 110.892 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -108.95 126.52 53.18 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.572 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.8 mp -97.51 150.52 21.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.931 0.396 . . . . 0.0 111.502 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.719 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 38.2 tt0 -74.15 129.15 37.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.591 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.34 -34.7 4.05 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.842 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.471 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 33.2 t -81.9 129.99 62.49 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.1 Cg_endo -85.44 2.36 7.78 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.966 2.444 . . . . 0.0 112.439 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -122.43 134.54 24.93 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 120.845 0.355 . . . . 0.0 111.41 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 10.3 Cg_endo -91.1 145.05 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.488 2.792 . . . . 0.0 112.051 174.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 2.8 tm? -93.21 114.53 27.03 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -95.49 135.37 37.23 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 55' ' ' ALA . 5.6 t80 -147.26 131.24 17.19 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.65 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 70.1 m -57.82 -49.02 78.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.056 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -71.21 108.47 4.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.543 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 10.6 t -56.53 -50.18 74.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.65 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.88 -33.56 66.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.785 -177.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.65 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 11.8 t70 -76.52 -43.01 41.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.901 0.381 . . . . 0.0 110.848 -175.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -72.8 -39.51 66.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.277 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.592 HD12 ' HB3' ' A' ' 114' ' ' ALA . 12.0 pt -65.36 -29.95 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.942 0.401 . . . . 0.0 110.014 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.577 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -63.32 -41.79 98.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.823 173.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.431 ' CD2' ' HA ' ' A' ' 55' ' ' ALA . 21.1 m-30 -55.66 -43.8 76.61 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.126 0.489 . . . . 0.0 110.469 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' A' ' 68' ' ' ILE . . . -61.2 -17.11 51.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.824 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 60' ' ' ARG . 37.5 mtp180 -101.62 12.06 37.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.98 -60.33 0.36 Allowed Glycine 0 CA--C 1.518 0.239 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.549 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 33.4 Cg_exo -63.36 51.18 0.14 Allowed 'Trans proline' 0 N--CA 1.48 0.694 0 C-N-CA 123.874 3.049 . . . . 0.0 114.242 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -104.1 -175.34 2.77 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 173.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -106.52 -161.76 0.81 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.103 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -53.42 -34.85 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.671 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.572 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -85.06 140.49 37.06 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.668 0.27 . . . . 0.0 110.53 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.719 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 73.9 Cg_endo -78.17 159.68 29.96 Favored 'Trans proline' 0 CA--C 1.521 -0.137 0 C-N-CA 122.975 2.45 . . . . 0.0 112.559 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.419 HG21 ' HA ' ' A' ' 59' ' ' ALA . 45.1 pt -74.29 131.94 34.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 41' ' ' GLU . 6.1 tt -97.91 -49.5 4.77 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -161.15 138.03 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.876 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 56' ' ' ILE . 2.8 tt -108.33 133.41 53.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.661 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.472 ' HB2' ' HG3' ' A' ' 37' ' ' GLN . 93.9 m-85 -113.7 143.21 44.99 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 94' ' ' ALA . 20.6 m -133.31 156.93 42.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.584 0.707 . . . . 0.0 110.392 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 11.3 m120 -93.67 106.16 18.14 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 171.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 90' ' ' ASN . 18.2 t70 -46.37 97.75 0.01 OUTLIER 'General case' 0 C--O 1.233 0.232 0 O-C-N 125.384 1.677 . . . . 0.0 110.719 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.565 ' HB3' ' HG2' ' A' ' 86' ' ' PRO . 65.5 mtt -147.86 51.2 1.04 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.19 -174.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 80' ' ' GLY . . . -91.86 27.07 10.52 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.035 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.506 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . . . -71.42 96.82 1.53 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -175.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 68.98 22.93 6.8 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.93 0.769 . . . . 0.0 110.515 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.511 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . 146.66 -116.6 0.87 Allowed Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 175.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 80' ' ' GLY . . . 158.21 62.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -171.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.0 p -83.64 175.37 9.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.572 -169.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.457 ' H ' ' HD1' ' A' ' 83' ' ' TRP . 1.4 p-90 -71.55 -30.41 65.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.452 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -84.88 -24.33 28.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.316 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 69.03 154.39 0.14 Allowed Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.508 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.565 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 14.9 Cg_exo -50.04 -38.2 48.99 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.173 1.916 . . . . 0.0 112.132 171.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.25 -84.51 0.33 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.351 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.59 148.61 35.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.4 157.51 29.87 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.784 -1.198 . . . . 0.0 113.741 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 14.9 m-80 -92.58 151.84 19.93 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 25.1 p-90 -98.6 128.61 44.97 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 118.917 -1.113 . . . . 0.0 109.891 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.844 HG21 ' HB2' ' A' ' 118' ' ' SER . 23.3 pt -145.6 167.03 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.291 -176.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.83 116.04 23.84 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.56 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -69.92 -42.26 73.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -171.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -67.87 -23.11 65.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.777 0.798 . . . . 0.0 109.684 -177.027 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -101.06 32.55 3.18 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.816 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.41 178.47 7.04 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.662 -172.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -92.64 135.11 34.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.271 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.598 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 7.2 m-85 -120.73 135.9 55.01 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.417 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.92 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.4 p -114.96 120.32 64.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.639 0.733 . . . . 0.0 109.869 171.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.808 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 95.5 t -101.95 119.05 49.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.584 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.504 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -82.62 121.1 5.34 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.412 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.4 m -92.59 -28.92 16.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.003 0.43 . . . . 0.0 110.231 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.91 -44.16 64.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.158 -176.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 70.6 mtt180 -138.07 118.11 13.43 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.678 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 1.3 tpp180 175.27 -170.65 0.06 Allowed 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.499 0.499 . . . . 0.0 109.682 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.466 ' H ' ' HG3' ' A' ' 106' ' ' ARG . . . -51.83 -70.8 0.78 Allowed Glycine 0 C--N 1.335 0.527 0 O-C-N 123.623 0.577 . . . . 0.0 112.883 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.95 -78.16 0.65 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.138 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -89.91 -4.23 57.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.187 0.518 . . . . 0.0 110.076 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -121.55 -128.67 3.53 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.381 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.481 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -102.94 99.27 13.39 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.93 0.395 . . . . 0.0 111.163 177.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 35.6 Cg_endo -64.66 151.64 84.88 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 123.191 2.594 . . . . 0.0 112.229 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.678 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 41.3 mt-10 -118.21 146.36 44.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.42 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 99' ' ' TYR . . . -106.63 130.91 54.3 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.031 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.92 ' HB ' HG13 ' A' ' 100' ' ' VAL . 57.3 t -98.05 105.19 26.47 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.9 Cg_exo -86.76 132.52 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.751 2.967 . . . . 0.0 112.989 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -136.51 149.47 48.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.714 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.844 ' HB2' HG21 ' A' ' 92' ' ' ILE . 42.0 t -84.54 -19.75 32.68 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 170.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.454 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 15.7 m -105.59 115.51 30.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.3 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -44.78 80.96 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.158 0.504 . . . . 0.0 110.979 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.454 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 20.4 p-10 -62.46 -29.34 70.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.121 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -71.29 -40.41 70.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.688 175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.63 -37.38 84.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.143 0.497 . . . . 0.0 109.986 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.31 -35.11 78.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.659 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.422 ' HA ' HD12 ' A' ' 128' ' ' LEU . . . -63.93 -34.81 78.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.776 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -63.18 -36.46 83.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.799 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.653 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 44.4 t -71.91 -31.75 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.486 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 125' ' ' ALA . 67.7 mt -60.54 -35.39 75.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.726 176.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.24 -50.22 7.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.813 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.8 pt-20 -148.32 -85.18 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.842 175.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.813 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 52.05 -146.84 13.54 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 170.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.601 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -171.33 -89.06 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.808 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.29 160.1 34.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 175.655 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.37 113.32 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.182 0.515 . . . . 0.0 110.246 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.939 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -134.57 165.13 25.92 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.902 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -86.67 160.86 18.73 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.738 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 6.7 tt -61.66 -42.85 99.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.274 0.559 . . . . 0.0 109.624 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.59 -18.51 62.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.943 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.26 20.71 13.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.576 -172.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.939 HD13 HD13 ' A' ' 135' ' ' LEU . 22.6 mm -71.87 120.86 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.896 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 t -107.05 147.7 29.64 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.433 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.19 -33.27 73.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.65 -28.79 68.84 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.744 0.653 . . . . 0.0 112.07 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.481 ' CE ' ' HB3' ' A' ' 155' ' ' PRO . 11.9 mmt -82.94 -26.84 31.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.769 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.483 ' HA ' HG11 ' A' ' 101' ' ' VAL . 2.2 t -92.68 -23.01 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 -175.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.6 pp -170.04 164.79 9.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.131 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.448 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 19.6 p -113.66 118.66 42.82 Favored Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.622 174.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 32.9 Cg_endo -65.92 -82.44 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.747 2.298 . . . . 0.0 112.287 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.688 ' HB ' ' OG1' ' A' ' 151' ' ' THR . 5.2 t -109.64 -6.58 11.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 37.9 mt-10 89.69 -73.52 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.688 ' OG1' ' HB ' ' A' ' 149' ' ' VAL . 44.4 m 53.79 21.9 2.95 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 163.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.4 50.65 58.3 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.56 -175.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.7 p -64.11 125.45 24.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.207 0.527 . . . . 0.0 111.731 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -93.73 153.94 41.04 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.81 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.556 ' HG2' ' HA ' ' A' ' 158' ' ' ASP . 6.2 Cg_exo -64.65 -163.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.205 1.937 . . . . 0.0 111.975 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -32.23 50.51 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -175.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.45 37.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.556 ' HA ' ' HG2' ' A' ' 155' ' ' PRO . 34.8 t0 59.0 72.49 0.53 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.862 -167.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.418 ' H ' ' HG2' ' A' ' 155' ' ' PRO . 12.2 t70 -168.95 -143.11 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -172.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.351 172.448 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 37.2 ttpt . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -137.07 144.38 43.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 26.9 pt20 -147.11 132.17 18.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 110.665 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 59' ' ' ALA . 30.1 pt -116.13 136.34 53.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.15 0.5 . . . . 0.0 110.985 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -105.2 132.17 51.75 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 11.1 mp -99.37 157.08 16.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.173 0.511 . . . . 0.0 111.527 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 26.4 tt0 -74.22 124.32 26.16 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.224 175.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.85 -42.64 3.12 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.244 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 15.7 t -82.13 123.83 79.22 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.0 Cg_exo -79.46 -11.6 14.3 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.983 2.455 . . . . 0.0 112.628 -176.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -97.98 131.97 25.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.981 0.419 . . . . 0.0 110.881 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 59.7 Cg_endo -93.37 137.45 1.33 Allowed 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 123.184 2.589 . . . . 0.0 112.355 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 8.1 tt -88.06 119.68 28.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -129.68 135.63 48.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.138 0.494 . . . . 0.0 111.42 -177.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.518 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 44.2 m-85 -142.04 153.2 44.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.038 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 t -64.51 -49.32 71.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.082 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 70.3 mt-30 -67.79 119.27 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.778 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.963 HG23 ' HB1' ' A' ' 81' ' ' ALA . 60.1 t -71.98 -50.23 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.661 ' HB3' ' HG3' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -53.99 -30.01 45.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.156 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.456 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 33.8 t70 -76.05 -50.08 15.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.7 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -68.77 -39.25 80.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.585 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.615 HD12 ' HE2' ' A' ' 99' ' ' TYR . 11.1 pt -68.11 -31.47 51.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.795 0.331 . . . . 0.0 110.283 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.1 91.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.32 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -57.6 -41.9 82.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.747 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -61.16 -17.44 52.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.096 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 45.5 mtm180 -102.79 7.39 39.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.414 -175.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.86 -82.47 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.081 -1.057 . . . . 0.0 112.77 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -50.49 -56.83 2.71 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.361 2.708 . . . . 0.0 113.56 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 52.22 -102.97 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.045 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.442 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 28.0 mt-30 -152.6 -86.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 tt -142.93 4.58 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 122.028 0.918 . . . . 0.0 109.346 174.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.442 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -138.29 161.65 58.03 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.143 -173.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.456 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 72.0 Cg_endo -76.77 157.4 35.36 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.273 1.982 . . . . 0.0 111.714 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.1 pt -74.05 151.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.095 0.474 . . . . 0.0 111.357 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.44 -48.1 3.04 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.07 143.96 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.415 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.551 HD11 HG22 ' A' ' 56' ' ' ILE . 3.3 tt -123.48 131.98 72.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.055 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -111.65 132.06 54.85 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.597 HG23 HG13 ' A' ' 92' ' ' ILE . 17.1 m -126.25 140.89 47.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 121.499 0.666 . . . . 0.0 110.63 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 6.6 m-20 -95.56 110.46 22.54 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -67.54 79.87 0.17 Allowed 'General case' 0 C--O 1.222 -0.374 0 O-C-N 124.367 1.042 . . . . 0.0 108.737 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.901 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 23.7 ptm 178.76 179.53 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.255 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.429 ' HA3' ' HB2' ' A' ' 81' ' ' ALA . . . 140.34 -33.59 2.06 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.416 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 80' ' ' GLY . . . 48.11 78.86 0.07 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.822 0.449 . . . . 0.0 111.26 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 73.78 -28.89 0.19 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.36 0.664 . . . . 0.0 111.819 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 78' ' ' ALA . . . -78.17 -5.54 87.31 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.884 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.963 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -113.22 -74.43 0.63 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.281 0.562 . . . . 0.0 110.274 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 p -104.26 152.56 22.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 169.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -76.1 -25.29 55.3 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.261 0.553 . . . . 0.0 110.188 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.05 -13.95 51.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 38.8 mt-30 72.16 139.29 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 113.826 -1.533 . . . . 0.0 112.337 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 85' ' ' GLN . 28.9 Cg_endo -86.78 -83.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.196 2.597 . . . . 0.0 113.007 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.31 -137.21 4.57 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.385 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.99 136.84 38.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.58 0.352 . . . . 0.0 111.459 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.901 ' HA2' ' HB3' ' A' ' 76' ' ' MET . . . -66.39 87.52 0.12 Allowed Glycine 0 C--N 1.333 0.408 0 O-C-N 124.091 0.869 . . . . 0.0 115.205 -168.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -100.59 146.76 26.74 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -99.6 130.51 45.84 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.472 -0.768 . . . . 0.0 109.891 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.597 HG13 HG23 ' A' ' 73' ' ' VAL . 2.5 pt -145.28 158.27 13.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.187 0.518 . . . . 0.0 112.316 -177.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.03 117.66 25.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 170.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -65.77 -39.63 91.21 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -169.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.723 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -68.69 -24.36 64.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.724 0.773 . . . . 0.0 109.393 -177.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.407 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 44.2 mmtm -100.83 26.36 6.97 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.522 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.46 176.48 7.43 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.363 -0.21 . . . . 0.0 110.474 -173.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -94.54 135.79 35.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.414 0.626 . . . . 0.0 110.418 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.615 ' HE2' HD12 ' A' ' 56' ' ' ILE . 8.1 m-85 -120.55 136.23 54.85 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.228 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -113.22 128.55 69.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.381 0.61 . . . . 0.0 110.112 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.0 t -101.68 109.24 25.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.404 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -80.68 126.21 7.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.643 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.3 m -92.54 -30.98 15.38 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -80.5 -47.02 14.89 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -163.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -129.12 12.59 6.12 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.022 -0.424 . . . . 0.0 111.281 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.648 ' HD3' ' HB3' ' A' ' 113' ' ' GLU . 1.4 tpm_? -89.5 -91.68 0.13 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.95 -169.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -170.93 40.25 0.19 Allowed Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.502 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -65.37 -29.88 76.31 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.908 -1.139 . . . . 0.0 111.174 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 88.4 mmm -109.12 20.87 17.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.395 -0.402 . . . . 0.0 110.692 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -160.32 -124.22 0.72 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.401 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.98 100.98 18.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 110.844 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.4 146.41 50.24 Favored 'Trans proline' 0 C--N 1.331 -0.382 0 C-N-CA 123.61 2.874 . . . . 0.0 113.407 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.661 ' HG3' ' HB3' ' A' ' 53' ' ' ARG . 27.5 tt0 -114.88 127.48 55.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.75 172.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.52 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.91 129.99 40.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.538 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 48.8 t -102.16 105.29 41.81 Favored Pre-proline 0 C--N 1.321 -0.671 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.312 174.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -89.35 110.98 0.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.821 3.014 . . . . 0.0 111.218 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.73 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.6 t80 -119.62 149.03 42.62 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.517 ' HB2' HD13 ' A' ' 92' ' ' ILE . 44.1 t -71.6 -32.77 68.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.925 0.393 . . . . 0.0 111.06 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.73 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 66.9 m -99.24 124.16 44.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.848 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.91 -45.41 82.06 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -65.58 -28.7 69.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.349 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -68.8 -42.08 77.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.465 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.09 79.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.305 0.574 . . . . 0.0 110.1 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.65 -32.31 69.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.744 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -65.19 -32.38 74.03 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.077 0.465 . . . . 0.0 110.703 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.467 ' HD2' HG21 ' A' ' 100' ' ' VAL . 79.6 t80 -61.71 -39.61 92.09 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.714 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 42.1 t -73.14 -28.82 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.658 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 6.7 tp -56.32 -43.99 79.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.957 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.64 -50.75 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.255 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.911 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.5 pt-20 -152.7 -76.16 0.13 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.486 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.911 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.48 -130.87 11.69 Favored Glycine 0 C--N 1.334 0.424 0 O-C-N 123.543 0.527 . . . . 0.0 112.974 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.65 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -179.84 -89.64 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.36 139.47 50.66 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 177.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.73 119.66 51.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.757 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -147.04 165.65 29.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.111 -177.242 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.05 162.73 15.2 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.791 ' HA ' HG12 ' A' ' 140' ' ' ILE . 1.1 tt -62.59 -32.64 73.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.133 0.492 . . . . 0.0 109.675 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.8 -11.65 58.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.252 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -125.53 21.5 7.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.791 HG12 ' HA ' ' A' ' 137' ' ' LEU . 30.4 mm -71.63 118.18 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -119.28 147.68 44.01 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.238 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.557 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 13.4 p-10 -69.37 -26.92 64.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.72 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.83 -28.74 69.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.772 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.4 mmt -83.9 -26.2 29.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.412 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.3 -22.8 5.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.357 -172.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.4 pp -143.61 142.81 31.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.581 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 32.4 p -113.12 122.8 34.86 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.093 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 22.4 Cg_endo -64.81 -75.75 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.314 2.009 . . . . 0.0 111.51 174.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.37 11.23 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 152' ' ' GLY . 37.6 mt-10 67.51 -79.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.326 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 152' ' ' GLY . 12.4 t 43.76 -62.57 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.931 1.692 . . . . 0.0 113.928 -171.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 150' ' ' GLU . . . 150.28 55.25 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.3 t -89.95 148.68 22.97 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 157' ' ' ALA . 20.4 mm-40 -71.06 136.01 84.9 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.213 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 157' ' ' ALA . 98.3 Cg_endo -78.36 -118.29 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.819 2.346 . . . . 0.0 112.239 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.435 ' H ' ' HB2' ' A' ' 155' ' ' PRO . 0.0 OUTLIER -60.46 -27.19 67.34 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.052 0.453 . . . . 0.0 109.784 177.011 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.513 ' O ' ' HD2' ' A' ' 155' ' ' PRO . . . -179.84 -118.26 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.808 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -123.55 14.87 9.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.543 1.163 . . . . 0.0 108.564 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.29 30.89 1.82 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.251 -167.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.203 -177.806 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 50' ' ' SER . 37.2 ttmt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -144.55 144.29 31.24 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 112.024 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -149.17 135.28 19.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.101 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 59' ' ' ALA . 33.7 pt -115.93 138.84 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.024 0.44 . . . . 0.0 111.103 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -107.57 121.15 44.07 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.581 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.5 mp -87.58 147.86 25.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.006 0.432 . . . . 0.0 110.912 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.534 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 27.6 tt0 -74.06 124.3 26.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.659 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.03 -38.4 3.2 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.884 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 28.0 t -82.1 125.06 78.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.2 Cg_exo -80.44 1.77 9.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.998 2.465 . . . . 0.0 112.786 -176.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -107.28 132.86 20.63 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 9.4 Cg_endo -92.66 115.76 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.611 2.874 . . . . 0.0 111.702 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.61 108.33 7.3 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -113.23 137.97 50.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.19 0.519 . . . . 0.0 111.318 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.577 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 36.6 m-85 -139.58 143.95 37.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.223 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 33.9 m -56.37 -54.43 45.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.561 ' HG2' ' HA ' ' A' ' 83' ' ' TRP . 48.4 mt-30 -63.62 125.58 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.148 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.5 t -65.28 -50.62 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.613 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -58.1 -28.27 64.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.376 -178.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.613 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 11.5 t70 -75.95 -51.6 12.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 110.184 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -64.93 -39.93 94.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.336 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 71' ' ' ILE . 28.7 pt -69.31 -31.88 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.951 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.05 82.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 0.0 110.791 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -62.3 -32.04 72.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.481 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.608 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -70.75 -18.27 62.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 23.9 mtm180 -94.41 3.73 54.78 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.43 -60.49 0.23 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 119.412 -1.375 . . . . 0.0 114.414 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -40.47 -44.25 4.3 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.799 2.999 . . . . 0.0 114.781 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -82.26 99.7 9.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.148 0.499 . . . . 0.0 111.364 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -106.45 111.06 23.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -176.68 -42.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.079 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.581 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -151.78 151.25 28.01 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.534 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.5 Cg_endo -72.22 158.12 52.48 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.056 1.837 . . . . 0.0 111.741 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.0 pt -81.54 117.59 27.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.067 0.461 . . . . 0.0 110.434 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 tt -77.82 -48.05 17.44 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.19 138.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.218 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' A' ' 95' ' ' ASP . 3.6 tt -107.99 129.76 61.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.947 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.533 ' HA ' ' O ' ' A' ' 92' ' ' ILE . 79.6 m-85 -111.71 127.25 55.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 94' ' ' ALA . 27.7 m -123.03 151.7 27.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.045 0.45 . . . . 0.0 110.061 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.535 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 15.6 m120 -86.03 97.03 10.05 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 90' ' ' ASN . 10.3 t70 -45.08 106.6 0.08 Allowed 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 125.581 1.801 . . . . 0.0 110.449 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -179.71 87.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 O-C-N 125.46 1.725 . . . . 0.0 109.16 178.575 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA3' HG13 ' A' ' 115' ' ' VAL . . . -126.93 28.94 4.51 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.541 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.53 ' H ' ' HG3' ' A' ' 86' ' ' PRO . . . -79.55 43.76 0.58 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.427 0.632 . . . . 0.0 110.509 -174.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -175.05 9.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.194 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.68 7.32 55.71 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.038 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 55.3 53.1 10.43 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 110.047 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.609 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 26.4 p -83.67 177.55 8.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.625 -169.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.561 ' HA ' ' HG2' ' A' ' 51' ' ' GLN . 35.5 p90 -66.39 -25.05 66.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.189 0.519 . . . . 0.0 110.149 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -82.91 -35.14 26.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.702 176.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER 66.75 165.24 0.12 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.49 175.054 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.53 ' HG3' ' H ' ' A' ' 78' ' ' ALA . 87.6 Cg_endo -90.31 5.66 4.3 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.054 1.836 . . . . 0.0 111.997 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.94 -179.68 16.05 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.038 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.96 146.12 51.36 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.64 -172.81 13.17 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.205 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 36.8 m-80 -95.18 151.6 19.08 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -97.51 129.75 44.65 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.076 -1.015 . . . . 0.0 111.121 -170.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.71 HD13 ' HB2' ' A' ' 118' ' ' SER . 24.9 pt -144.0 166.2 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.594 -173.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.09 106.3 14.78 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.583 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -69.84 -32.5 70.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.923 -173.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.735 ' HA ' HD13 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -71.45 -23.87 61.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.72 0.771 . . . . 0.0 109.889 -177.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -99.45 29.6 3.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.07 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.21 -176.37 4.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -95.72 138.05 33.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.546 0.689 . . . . 0.0 110.621 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CE1' HD12 ' A' ' 137' ' ' LEU . 2.3 m-85 -120.53 136.62 54.72 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.028 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.797 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -114.46 123.14 69.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.438 0.637 . . . . 0.0 110.41 173.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.8 t -101.56 127.6 54.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.439 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -86.71 121.37 5.75 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.116 -173.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.4 m -92.48 -37.15 12.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.688 0.28 . . . . 0.0 110.79 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.14 -44.71 16.11 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.042 0.449 . . . . 0.0 110.9 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 50.8 mtp180 -134.62 121.6 21.11 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.562 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 165.55 -175.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.548 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -79.23 42.3 2.35 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.066 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.78 -24.69 70.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.6 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.8 ttp -103.57 -3.49 25.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.853 0.359 . . . . 0.0 110.474 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -153.91 -110.14 0.39 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.972 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.548 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.47 99.32 14.84 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.676 0.274 . . . . 0.0 111.208 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.519 ' HA ' ' H ' ' A' ' 107' ' ' GLY . 49.6 Cg_endo -67.68 147.01 75.04 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.64 2.893 . . . . 0.0 113.659 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.562 ' CD ' ' HE ' ' A' ' 106' ' ' ARG . 1.6 mp0 -114.68 142.34 46.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -107.68 130.8 54.89 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.613 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.797 ' HB ' HG13 ' A' ' 100' ' ' VAL . 96.5 t -100.97 105.55 39.17 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 120.969 0.414 . . . . 0.0 110.38 175.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.3 Cg_exo -87.91 127.52 2.23 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.645 2.897 . . . . 0.0 112.387 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -134.07 148.82 51.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.487 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.71 ' HB2' HD13 ' A' ' 92' ' ' ILE . 33.0 t -80.48 -16.73 53.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.139 0.495 . . . . 0.0 109.947 174.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.8 m -108.58 131.9 54.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.523 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -68.15 -48.67 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.073 0.463 . . . . 0.0 110.921 179.453 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -63.64 -28.5 69.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.888 -173.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.59 -40.2 76.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.385 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.37 -35.78 71.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 110.121 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.96 88.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.785 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -63.28 -30.07 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.001 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -66.06 -40.45 90.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.741 HG22 ' H ' ' A' ' 132' ' ' GLY . 59.5 t -72.25 -29.11 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.415 0.626 . . . . 0.0 110.395 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 7.7 tp -58.04 -43.7 86.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.122 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.83 -50.97 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.666 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.688 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.8 pt-20 -141.6 -92.91 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.468 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.688 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 47.98 -145.41 5.58 Favored Glycine 0 C--N 1.333 0.398 0 O-C-N 123.517 0.511 . . . . 0.0 113.984 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.741 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -172.62 -81.49 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.06 139.27 51.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.847 0.356 . . . . 0.0 110.793 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.13 115.21 43.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.215 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.779 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -140.04 159.82 41.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.786 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.66 157.48 24.64 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 95' ' ' ASP . 6.3 tt -60.95 -34.95 75.53 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.35 -13.8 59.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.759 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -127.66 29.64 5.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.126 0.488 . . . . 0.0 110.635 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.779 HD13 HD13 ' A' ' 135' ' ' LEU . 36.1 mm -71.58 121.42 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.5 t -108.95 147.87 31.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.154 177.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.6 p-10 -69.27 -32.84 72.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.67 -29.77 66.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.019 -175.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.544 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 6.2 mmt -87.19 -33.86 19.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.457 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 141' ' ' THR . 3.9 t -78.99 -23.51 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.359 0.599 . . . . 0.0 109.915 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 1.8 pp -150.18 106.76 3.51 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.77 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.426 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 23.7 p -80.06 120.1 78.68 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.555 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 9.8 Cg_endo -55.76 -72.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.768 2.312 . . . . 0.0 111.671 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.7 t -129.27 10.25 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.467 ' O ' HG22 ' A' ' 151' ' ' THR . 42.4 mt-10 67.47 -77.92 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.326 -173.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 150' ' ' GLU . 5.8 t 53.07 -41.4 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.899 1.679 . . . . 0.0 114.936 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.37 15.6 4.09 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.3 p -70.55 142.37 51.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.598 0.237 . . . . 0.0 111.264 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.602 ' HG2' ' HB2' ' A' ' 158' ' ' ASP . 2.8 mp0 -56.61 126.07 69.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.274 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.436 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 27.1 Cg_endo -62.85 -86.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.334 2.689 . . . . 0.0 113.601 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -28.36 15.92 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.029 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 177.2 19.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.344 0.402 . . . . 0.0 111.385 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.602 ' HB2' ' HG2' ' A' ' 154' ' ' GLU . 32.2 t70 53.42 84.9 0.05 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.398 0.618 . . . . 0.0 109.571 -171.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -163.91 -43.31 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.582 -165.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.815 179.735 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 69.6 tttt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -143.78 143.77 31.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.027 -175.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 14.2 pt20 -149.31 129.64 13.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.586 174.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.469 HG22 ' CG1' ' A' ' 71' ' ' ILE . 29.9 pt -116.11 135.29 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -103.24 121.45 42.73 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.4 mp -86.1 141.28 29.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.088 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.653 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 32.7 tt0 -74.0 124.35 26.05 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.599 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.18 -14.21 64.24 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.269 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.44 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 34.7 t -105.86 125.47 33.13 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.6 Cg_exo -78.0 5.99 4.95 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.944 2.429 . . . . 0.0 112.733 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -129.69 132.74 24.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.321 . . . . 0.0 111.182 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 7.6 Cg_endo -89.92 165.45 4.88 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.593 2.862 . . . . 0.0 112.133 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 7.1 tt -107.68 118.71 37.46 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -101.91 134.69 44.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.24 146.83 27.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.155 0.502 . . . . 0.0 110.85 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -69.27 -36.36 77.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.298 0.57 . . . . 0.0 110.63 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.92 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 51.8 mt-30 -84.94 122.7 29.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.834 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.774 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 2.6 t -67.6 -51.7 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.577 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -52.62 -41.17 63.48 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.179 -178.73 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.577 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 29.8 t0 -76.34 -43.05 42.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.754 0.311 . . . . 0.0 111.105 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.2 -37.66 75.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.704 0.288 . . . . 0.0 111.443 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.763 HD12 ' HB3' ' A' ' 114' ' ' ALA . 24.4 pt -68.19 -31.29 51.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.419 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -64.37 -42.44 96.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.295 174.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -57.17 -37.75 72.57 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.155 0.502 . . . . 0.0 110.438 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.568 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -64.63 -18.89 65.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.111 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -94.66 -6.69 42.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -179.48 -58.98 0.08 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.998 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 26.4 Cg_exo -65.56 46.3 0.18 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.527 2.818 . . . . 0.0 114.555 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -96.26 165.7 12.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.731 ' HG3' HG22 ' A' ' 65' ' ' ILE . 10.4 pt20 -92.86 -18.85 22.32 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -169.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.731 HG22 ' HG3' ' A' ' 64' ' ' GLN . 6.5 tt 179.32 -39.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.382 . . . . 0.0 111.976 -174.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.545 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -104.99 146.76 33.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.58 -171.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.653 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 55.9 Cg_endo -71.8 163.77 37.81 Favored 'Trans proline' 0 C--O 1.224 -0.183 0 C-N-CA 123.159 2.573 . . . . 0.0 111.73 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.568 HD13 ' HB1' ' A' ' 59' ' ' ALA . 27.6 pt -79.3 127.19 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.149 0.499 . . . . 0.0 110.737 177.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 tt -91.78 -48.13 6.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -159.17 138.75 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.84 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.469 ' CG1' HG22 ' A' ' 38' ' ' ILE . 3.0 tt -117.07 131.53 69.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.215 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -111.85 128.34 56.1 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 94' ' ' ALA . 29.6 m -127.83 139.49 51.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 120.834 0.35 . . . . 0.0 110.096 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 2.2 m-20 -84.64 107.04 16.64 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -69.6 142.35 53.55 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 124.371 1.045 . . . . 0.0 109.494 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.783 ' O ' ' HG2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER 168.28 -29.13 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 124.511 1.132 . . . . 0.0 109.039 -170.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.601 ' HA3' ' HB2' ' A' ' 81' ' ' ALA . . . -69.47 68.49 0.54 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.622 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.97 106.78 2.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.445 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.22 26.49 15.94 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.539 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.9 -72.38 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.73 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.601 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . . . 57.19 52.35 9.05 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.309 0.576 . . . . 0.0 110.338 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.46 175.75 9.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.178 -173.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.92 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 31.7 p90 -68.8 -20.68 64.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.369 0.604 . . . . 0.0 110.162 175.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.85 -31.8 31.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.838 173.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 62.36 171.38 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.353 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.783 ' HG2' ' O ' ' A' ' 76' ' ' MET . 5.7 Cg_exo -83.88 -5.06 10.62 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.929 1.753 . . . . 0.0 110.372 166.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.09 174.06 13.22 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -174.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -77.14 146.07 37.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.607 0.704 . . . . 0.0 109.468 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.433 ' HA3' ' HG2' ' A' ' 76' ' ' MET . . . -136.91 -140.18 4.05 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.655 -175.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 19.2 m120 -100.31 145.44 28.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 74' ' ' ASN . 37.3 p90 -98.52 130.94 45.1 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.549 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.694 HD13 ' HB2' ' A' ' 118' ' ' SER . 1.8 pt -133.6 151.92 34.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.656 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.85 102.67 4.13 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.559 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . . . -61.02 -31.59 71.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.153 0.501 . . . . 0.0 110.935 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 1.0 OUTLIER -58.03 -31.05 66.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.165 176.41 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -111.39 27.7 9.43 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.868 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -122.52 178.59 4.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.529 0.204 . . . . 0.0 110.775 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -92.74 131.61 37.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.251 0.548 . . . . 0.0 110.779 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -120.49 136.12 54.86 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.338 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.463 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 4.2 p -113.71 129.48 69.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-O 121.866 0.841 . . . . 0.0 110.571 172.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.551 ' HA ' HH11 ' A' ' 106' ' ' ARG . 38.1 t -104.01 111.84 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.282 172.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.695 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -74.67 124.07 7.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.314 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 p -86.71 -31.23 21.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.957 0.408 . . . . 0.0 110.564 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -78.41 -35.04 47.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.714 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.62 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 60.2 mtp180 -121.13 -140.84 0.33 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.369 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.551 HH11 ' HA ' ' A' ' 101' ' ' VAL . 22.4 ttt180 72.25 176.57 0.27 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.478 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -71.94 -48.96 24.52 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.096 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.08 -96.89 0.33 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.339 -0.934 . . . . 0.0 110.832 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.0 mtt -99.48 -3.8 32.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.281 0.562 . . . . 0.0 109.735 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.78 -123.37 2.72 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.717 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.478 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.19 94.66 5.84 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 117.077 0.439 . . . . 0.0 110.663 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.92 113.18 3.15 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.74 2.293 . . . . 0.0 113.125 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -114.65 130.53 56.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.836 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.763 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -100.16 132.8 45.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.456 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.463 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 14.3 t -99.38 105.87 35.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.674 176.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -90.73 131.45 1.58 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 124.2 3.267 . . . . 0.0 112.329 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -128.82 153.27 47.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.694 ' HB2' HD13 ' A' ' 92' ' ' ILE . 38.4 t -85.08 -27.76 26.08 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 170.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.4 m -96.02 115.99 28.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.142 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -57.8 -45.75 85.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.315 0.578 . . . . 0.0 111.139 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -63.38 -28.54 70.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.368 -172.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -64.48 -42.45 95.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.075 0.464 . . . . 0.0 110.296 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -68.45 -37.34 80.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.283 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.3 98.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.709 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.42 83.6 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.12 0.486 . . . . 0.0 110.447 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -61.88 -40.7 96.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.762 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.631 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 78.6 t -66.19 -40.17 86.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.017 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 66.4 mt -56.86 -34.62 68.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.599 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.04 -41.86 13.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.231 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.62 ' OE1' ' HD3' ' A' ' 105' ' ' ARG . 7.6 pt-20 -161.12 -35.18 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -172.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.695 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -53.61 163.88 2.59 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.232 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -111.41 -66.26 0.52 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.705 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.424 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.13 141.56 50.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.829 0.347 . . . . 0.0 110.675 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.3 t -103.34 113.75 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.188 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.704 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -138.65 164.87 28.39 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.987 -176.304 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.27 170.07 13.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.541 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 3.6 tt -66.36 -30.52 70.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.304 0.573 . . . . 0.0 109.629 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.22 -12.1 60.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.587 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -109.43 12.82 24.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.704 HD13 HD13 ' A' ' 135' ' ' LEU . 41.8 mm -71.88 119.12 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.082 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.3 t -119.37 147.12 44.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.849 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.426 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.1 p-10 -69.41 -25.49 64.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.053 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.27 -28.8 69.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.669 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.637 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 3.9 mmt -87.1 -28.96 22.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.037 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 141' ' ' THR . 8.6 t -79.16 -23.56 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.263 0.554 . . . . 0.0 110.476 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.2 pp -155.9 139.75 16.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.77 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.1 p -95.97 120.58 62.73 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.832 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.36 -78.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.175 1.917 . . . . 0.0 111.285 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.62 6.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 65.91 -74.94 0.05 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.308 -167.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.0 t 43.32 31.06 0.35 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.626 1.17 . . . . 0.0 114.062 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 71.97 23.59 77.78 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.012 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.3 t -96.38 124.51 40.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.018 0.437 . . . . 0.0 109.824 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -80.0 149.62 70.43 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.333 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.428 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 10.8 Cg_endo -55.82 -33.53 88.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.164 2.576 . . . . 0.0 112.445 -176.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.543 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 3.3 ptp85 -155.35 -69.25 0.12 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.318 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.543 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -145.93 69.65 1.22 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.23 31.66 0.39 Allowed 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.31 1.006 . . . . 0.0 111.81 -175.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 155' ' ' PRO . 11.9 t70 -130.49 -166.02 1.63 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.731 179.35 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 40.1 ttmt . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -126.54 144.35 50.9 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.448 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . 11.7 pt20 -148.84 136.76 20.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.963 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 59' ' ' ALA . 30.3 pt -115.9 134.82 57.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.103 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -98.83 116.9 32.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' A' ' 66' ' ' ALA . 3.0 mp -92.26 142.34 27.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.964 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.796 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 34.7 tt0 -74.0 132.43 42.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.23 -36.46 3.19 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.5 -175.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.517 ' HB2' ' CB ' ' A' ' 40' ' ' LEU . 68.8 m -82.14 124.5 78.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.014 0.435 . . . . 0.0 110.332 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 2.5 Cg_endo -82.86 -3.47 11.16 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.134 2.556 . . . . 0.0 112.884 -176.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -125.39 133.98 25.37 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.719 -177.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 5.9 Cg_exo -79.1 141.88 16.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.999 2.466 . . . . 0.0 111.847 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.516 ' HB3' HG12 ' A' ' 38' ' ' ILE . 6.3 tt -91.48 107.23 19.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.472 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . 38.4 p90 -116.81 137.68 52.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.173 0.511 . . . . 0.0 111.14 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -138.58 143.15 39.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.516 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 5.3 p -55.69 -40.7 72.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.224 0.535 . . . . 0.0 110.982 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.523 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 68.4 mt-30 -82.1 114.85 20.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.396 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.584 HG13 ' HB2' ' A' ' 36' ' ' ALA . 45.4 t -58.53 -47.89 87.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.298 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -58.68 -28.43 65.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.626 -178.273 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.459 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 22.5 t70 -75.99 -51.12 13.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.022 0.439 . . . . 0.0 110.257 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.71 95.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.344 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.705 HG22 HD11 ' A' ' 71' ' ' ILE . 28.4 pt -69.08 -31.92 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.316 . . . . 0.0 110.546 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.95 82.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.707 0.289 . . . . 0.0 110.339 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 62' ' ' PRO . 10.1 m-85 -62.12 -35.63 79.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.244 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -63.19 -18.1 63.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.707 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -81.71 -3.26 53.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.72 -42.64 0.96 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 119.63 -1.272 . . . . 0.0 114.68 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' A' ' 58' ' ' TYR . 93.2 Cg_exo -49.32 -16.68 1.21 Allowed 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 123.515 2.81 . . . . 0.0 115.367 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -68.38 -30.84 69.87 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.522 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 41.9 35.41 0.53 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.826 1.25 . . . . 0.0 114.059 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 tt -132.51 -47.55 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.594 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.2 151.84 28.37 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.623 0.249 . . . . 0.0 110.917 -175.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.796 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 74.5 Cg_endo -70.35 148.88 62.2 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.366 2.044 . . . . 0.0 111.805 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 68' ' ' ILE . 27.5 pt -84.4 105.33 13.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.394 0.616 . . . . 0.0 110.335 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.8 tt -67.27 -47.36 70.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -161.16 138.38 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.119 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 56' ' ' ILE . 2.8 tt -108.34 131.13 59.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.76 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -112.03 128.21 56.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.228 0.537 . . . . 0.0 110.007 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 94' ' ' ALA . 30.7 m -126.21 136.64 60.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.069 0.461 . . . . 0.0 109.839 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 91' ' ' TRP . 24.8 t-20 -83.72 101.04 11.28 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.441 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 61.1 t0 -55.92 103.73 0.11 Allowed 'General case' 0 C--O 1.236 0.386 0 O-C-N 124.774 1.296 . . . . 0.0 110.058 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.829 ' O ' ' HG2' ' A' ' 86' ' ' PRO . 52.6 mtt -127.64 -26.21 3.02 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.07 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.735 ' HA3' ' HB2' ' A' ' 81' ' ' ALA . . . -70.66 58.07 0.94 Allowed Glycine 0 C--O 1.226 -0.348 0 O-C-N 123.951 0.782 . . . . 0.0 115.015 -165.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.38 33.9 0.69 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.381 0.61 . . . . 0.0 109.846 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -171.53 8.54 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.548 -171.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.43 ' HA2' ' HZ ' ' A' ' 126' ' ' PHE . . . 127.02 -26.13 5.1 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.568 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.735 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . . . 67.68 70.06 0.35 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.399 0.619 . . . . 0.0 110.315 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.2 p -83.97 175.06 9.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.359 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.523 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 21.1 p-90 -70.2 -20.86 63.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.213 0.53 . . . . 0.0 110.321 174.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -83.08 -35.88 25.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.005 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.507 HE22 ' N ' ' A' ' 35' ' ' LYS . 0.9 OUTLIER 68.1 140.74 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.144 173.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.829 ' HG2' ' O ' ' A' ' 76' ' ' MET . 52.1 Cg_exo -57.46 -48.38 17.62 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.925 2.416 . . . . 0.0 113.032 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.99 -141.65 8.32 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.682 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -67.1 139.67 57.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.973 0.415 . . . . 0.0 111.521 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -150.99 -165.05 12.47 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -100.15 138.45 37.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 117.08 0.44 . . . . 0.0 110.116 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 74' ' ' ASN . 15.4 p-90 -98.61 131.08 45.09 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.416 -177.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.48 HD13 ' CA ' ' A' ' 118' ' ' SER . 3.7 pt -141.88 163.19 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.247 -170.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.39 107.31 10.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.384 171.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -62.61 -35.28 79.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.004 0.43 . . . . 0.0 111.229 -176.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.706 ' HA ' HD13 ' A' ' 137' ' ' LEU . 8.9 t70 -59.78 -26.82 66.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.88 0.848 . . . . 0.0 110.27 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -116.4 36.06 4.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.646 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.27 178.96 6.5 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.796 0.331 . . . . 0.0 110.55 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -97.51 138.11 35.44 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.426 0.631 . . . . 0.0 109.924 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.413 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 5.6 m-85 -120.09 135.65 54.87 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.029 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.946 HG13 HG13 ' A' ' 115' ' ' VAL . 2.2 p -115.3 120.6 65.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.717 0.77 . . . . 0.0 109.473 170.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 64.4 t -101.74 115.94 44.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.57 -1.196 . . . . 0.0 108.58 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.48 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -77.61 120.87 5.64 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.263 -176.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 m -92.5 -29.16 16.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.926 0.394 . . . . 0.0 110.382 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.98 -43.97 17.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.133 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 46.6 mtp180 -130.93 121.19 24.72 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.577 HH22 ' HZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER 172.84 175.21 0.1 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.804 0.69 . . . . 0.0 109.863 177.387 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.88 -78.47 0.09 OUTLIER Glycine 0 C--N 1.337 0.587 0 O-C-N 123.363 0.414 . . . . 0.0 113.402 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.37 -76.9 0.76 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.329 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -83.63 -3.67 57.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.155 0.503 . . . . 0.0 110.749 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -130.55 -124.0 2.56 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.426 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.42 96.99 9.36 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 28.3 Cg_endo -64.5 147.64 90.45 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.765 2.31 . . . . 0.0 112.695 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.493 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 1.6 mp0 -115.0 121.83 44.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.709 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . . . -94.08 131.51 39.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 175.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.946 HG13 HG13 ' A' ' 100' ' ' VAL . 1.4 p -108.8 106.77 59.35 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.783 0.802 . . . . 0.0 110.352 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HB2' HG21 ' A' ' 73' ' ' VAL . 7.6 Cg_exo -81.86 119.99 3.35 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 124.414 3.409 . . . . 0.0 112.65 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -108.05 153.39 23.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.956 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.48 ' CA ' HD13 ' A' ' 92' ' ' ILE . 48.1 t -81.01 -43.06 20.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.184 174.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.401 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 19.6 m -100.65 131.09 46.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.292 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.577 ' HD2' ' N ' ' A' ' 121' ' ' ASP . 0.0 OUTLIER -65.32 -33.71 76.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.347 -177.072 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.577 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 10.8 p-10 -68.17 -28.51 67.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.196 0.522 . . . . 0.0 110.072 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -69.41 -39.28 78.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.788 173.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.6 82.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.49 94.28 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.687 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.07 73.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.031 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.577 ' HZ ' HH22 ' A' ' 106' ' ' ARG . 44.6 t80 -66.02 -40.34 90.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.07 177.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.709 HG22 ' H ' ' A' ' 132' ' ' GLY . 65.0 t -73.05 -29.07 27.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.452 0.644 . . . . 0.0 110.255 176.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.36 -36.23 81.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.929 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.19 -50.6 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.627 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.742 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 1.9 pt-20 -146.64 -88.92 0.09 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.298 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.742 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 49.85 -142.9 11.81 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 123.412 0.445 . . . . 0.0 113.794 174.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.709 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -175.62 -82.86 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -130.0 139.44 51.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 176.507 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.8 t -101.1 113.95 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.955 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.629 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -139.85 165.7 26.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.068 -176.619 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -88.68 168.2 12.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.706 HD13 ' HA ' ' A' ' 95' ' ' ASP . 3.6 tt -63.4 -32.46 73.9 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.83 -16.07 63.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.028 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -111.88 12.39 20.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.488 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.629 HD13 HD13 ' A' ' 135' ' ' LEU . 16.4 mm -71.87 119.71 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 145' ' ' VAL . 5.2 t -119.29 145.5 46.07 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.958 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.405 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 14.9 p-10 -69.57 -27.52 65.2 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.082 0.239 . . . . 0.0 110.406 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.64 -28.98 68.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.885 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.736 ' HG2' ' HB3' ' A' ' 155' ' ' PRO . 3.9 mmt -84.72 -33.97 23.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.728 0.299 . . . . 0.0 111.425 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 141' ' ' THR . 3.5 t -79.81 -23.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.341 0.591 . . . . 0.0 110.275 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.8 pp -159.88 143.3 14.15 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.773 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' A' ' 150' ' ' GLU . 16.7 p -106.51 120.42 48.55 Favored Pre-proline 0 C--N 1.318 -0.774 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.887 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 14.7 Cg_endo -58.9 -53.17 4.02 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.676 2.251 . . . . 0.0 111.83 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 1.4 t -135.62 20.28 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.597 ' HA ' ' HB ' ' A' ' 147' ' ' THR . 5.2 mm-40 64.81 -83.6 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.3 -168.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 t 44.83 7.45 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 57.38 46.36 91.93 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.297 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 25.4 m -71.08 144.75 50.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.776 0.288 . . . . 0.0 110.563 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 158' ' ' ASP . 45.2 mt-10 -75.8 122.88 87.91 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.736 ' HB3' ' HG2' ' A' ' 144' ' ' MET . 6.8 Cg_endo -48.53 -85.4 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 124.228 3.286 . . . . 0.0 114.299 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.93 -22.3 12.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.216 0.532 . . . . 0.0 109.904 175.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -175.9 21.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.241 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 29.8 t0 53.81 71.88 0.48 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.307 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.65 -39.83 1.97 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.323 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 1.7 pm0 . . . . . 0 C--O 1.25 1.079 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.503 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.716 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -132.45 144.12 50.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.68 0.276 . . . . 0.0 110.645 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 20.3 pt20 -149.16 131.63 15.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.092 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.751 HG22 ' HB ' ' A' ' 71' ' ' ILE . 29.8 pt -115.78 133.23 62.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.148 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -103.99 123.9 48.04 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.568 ' CB ' ' HB2' ' A' ' 43' ' ' SER . 6.4 mp -90.35 148.52 22.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.33 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.633 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 35.7 tt0 -74.16 124.06 25.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.31 -28.8 4.57 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.066 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.568 ' HB2' ' CB ' ' A' ' 40' ' ' LEU . 59.7 m -81.72 124.51 79.57 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.923 0.392 . . . . 0.0 110.347 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 4.2 Cg_exo -78.12 -13.34 15.6 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.373 2.715 . . . . 0.0 113.298 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.63 133.62 24.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.369 . . . . 0.0 111.266 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.435 ' HG2' ' CE2' ' A' ' 48' ' ' PHE . 96.8 Cg_endo -85.98 168.51 9.26 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.873 2.382 . . . . 0.0 112.472 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 8.0 tt -111.75 116.21 30.34 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.435 ' CE2' ' HG2' ' A' ' 46' ' ' PRO . 98.6 m-85 -96.08 136.19 36.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.355 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.411 ' HD1' ' H ' ' A' ' 51' ' ' GLN . 0.8 OUTLIER -148.01 133.15 18.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.2 m -66.23 -40.48 90.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.395 0.617 . . . . 0.0 109.613 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.829 ' HG2' ' HB2' ' A' ' 83' ' ' TRP . 50.3 mt-30 -77.31 102.22 6.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.316 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.716 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 13.8 t -56.73 -50.05 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.177 0.513 . . . . 0.0 110.129 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.572 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -55.44 -33.89 64.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.812 -1.086 . . . . 0.0 112.782 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.433 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 7.8 t70 -76.34 -43.55 40.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.138 0.494 . . . . 0.0 110.084 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 58' ' ' TYR . . . -71.52 -34.75 70.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.746 -178.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 10.4 pt -68.56 -31.67 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.76 88.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.542 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 19.6 m-85 -60.29 -44.89 94.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.97 0.414 . . . . 0.0 111.356 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.46 -17.88 63.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.478 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -105.04 12.63 31.99 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 179.21 -71.94 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.118 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -65.74 37.94 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.829 0 C-N-CA 124.189 3.26 . . . . 0.0 114.994 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.432 ' H ' ' HG2' ' A' ' 63' ' ' GLU . 15.1 pt-20 -68.57 144.14 54.65 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 173.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -53.83 -82.25 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -169.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 65' ' ' ILE . 12.8 tt -137.5 4.3 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.065 0.936 . . . . 0.0 109.559 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 41' ' ' GLU . . . -141.33 156.45 67.33 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.52 -174.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.6 Cg_endo -72.62 160.26 46.91 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.184 1.923 . . . . 0.0 111.045 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.7 pt -77.19 134.81 27.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.333 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.4 tt -89.98 -52.64 4.87 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 p -161.34 141.26 3.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.761 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.751 ' HB ' HG22 ' A' ' 38' ' ' ILE . 1.7 tt -107.72 134.08 50.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.606 174.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.84 145.42 39.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 94' ' ' ALA . 31.1 m -137.77 143.21 34.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.392 0.615 . . . . 0.0 110.642 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.665 ' O ' ' HG3' ' A' ' 76' ' ' MET . 93.3 m-20 -78.39 105.46 9.66 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 168.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 1.072 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 31.5 t0 -58.78 121.46 11.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.368 -175.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.843 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -154.37 48.59 0.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.622 -179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.833 ' HA2' ' HB2' ' A' ' 81' ' ' ALA . . . -101.25 49.49 1.05 Allowed Glycine 0 C--N 1.314 -0.694 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.507 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.04 79.15 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.765 0.317 . . . . 0.0 110.561 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 57.94 25.7 12.49 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.763 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.6 -74.25 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.049 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.833 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . . . 59.33 62.17 1.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.406 0.622 . . . . 0.0 110.869 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 77.6 p -83.82 176.14 9.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.882 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.829 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 46.6 p90 -69.25 -22.58 63.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 0.0 110.496 177.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -85.19 -24.59 27.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.616 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 71.68 158.86 0.16 Allowed Pre-proline 0 N--CA 1.468 0.471 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.433 173.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.843 ' HD2' ' HB2' ' A' ' 76' ' ' MET . 19.6 Cg_endo -88.16 8.16 4.22 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.801 2.334 . . . . 0.0 111.476 169.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.66 130.8 6.23 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.797 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -72.44 126.79 30.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.732 0.266 . . . . 0.0 110.457 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.49 -65.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.505 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 1.072 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 61.9 t30 -85.6 153.17 22.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -122.57 128.8 51.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.953 HG21 ' HB2' ' A' ' 118' ' ' SER . 21.7 pt -145.64 166.14 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.282 0.563 . . . . 0.0 112.354 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.24 101.59 12.64 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.217 -0.902 . . . . 0.0 108.852 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.685 ' O ' ' HG ' ' A' ' 137' ' ' LEU . . . -59.03 -40.01 83.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.029 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.725 ' HB2' HG22 ' A' ' 71' ' ' ILE . 24.0 t70 -63.3 -11.05 19.02 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.458 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -130.35 50.7 2.17 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.594 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -149.5 -169.2 3.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.469 0.176 . . . . 0.0 110.709 -173.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -94.82 142.25 27.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.52 0.676 . . . . 0.0 111.147 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.5 135.7 54.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.853 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.613 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.2 p -115.16 124.01 71.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.622 0.725 . . . . 0.0 110.007 169.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.569 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 43.8 t -101.65 106.92 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.753 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.901 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -72.62 141.16 30.35 Favored Glycine 0 C--O 1.223 -0.536 0 CA-C-N 116.057 -0.52 . . . . 0.0 114.219 -170.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.3 m -92.13 -32.77 15.0 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.625 -0.338 . . . . 0.0 111.207 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -88.29 -46.18 9.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 35.7 mtp-105 -104.73 -92.64 0.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.145 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 145' ' ' VAL . 37.2 ttp85 51.41 -87.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.78 23.75 0.02 OUTLIER Glycine 0 C--O 1.222 -0.652 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.207 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -57.78 -26.82 58.28 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.283 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 70.7 mtm -105.68 15.98 26.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.66 0.267 . . . . 0.0 110.553 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.52 -120.92 0.54 Allowed Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.3 104.33 40.33 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.621 0.211 . . . . 0.0 110.743 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 6.8 Cg_endo -51.28 124.1 13.39 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.544 2.829 . . . . 0.0 113.124 177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.73 146.14 41.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.962 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -125.05 132.82 53.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.916 -175.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.721 HG22 ' HB3' ' A' ' 81' ' ' ALA . 67.6 t -96.7 106.36 29.6 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.879 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 1.2 Cg_endo -90.44 105.75 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.702 2.935 . . . . 0.0 111.056 175.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.92 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.2 t80 -117.95 149.07 41.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.911 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.953 ' HB2' HG21 ' A' ' 92' ' ' ILE . 47.9 t -71.01 -35.73 72.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.915 0.388 . . . . 0.0 110.488 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.92 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 7.3 m -97.85 127.14 43.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.764 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -43.16 98.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.155 0.502 . . . . 0.0 110.584 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.75 -32.63 71.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.856 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -74.66 -37.99 62.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.733 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.36 76.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.21 0.528 . . . . 0.0 110.12 176.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.86 -32.18 70.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.832 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.2 89.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.042 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.96 -40.27 94.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.694 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.668 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 93.0 t -63.55 -38.2 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.695 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.38 -36.85 74.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.575 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.71 -45.75 16.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.254 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.686 ' HB2' ' HB3' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -161.4 -36.03 0.05 OUTLIER 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.039 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.901 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -46.71 163.09 0.17 Allowed Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.075 -0.966 . . . . 0.0 114.034 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.94 -72.63 0.71 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.82 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.59 ' HB3' ' CB ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -124.73 144.47 50.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.821 0.343 . . . . 0.0 111.078 -178.501 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.32 113.47 42.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.379 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.784 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -134.86 148.91 50.24 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.782 -179.046 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.85 161.02 23.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.614 0.245 . . . . 0.0 110.456 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -57.92 -27.29 63.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.037 -178.482 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.03 -16.06 60.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.779 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -123.7 20.48 9.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.945 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.784 HD13 HD13 ' A' ' 135' ' ' LEU . 19.6 mm -71.76 121.52 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.533 HG23 ' HG2' ' A' ' 144' ' ' MET . 4.0 t -114.68 145.77 41.65 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.554 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.2 p-10 -69.75 -24.48 63.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.381 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.02 68.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.795 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.66 ' SD ' ' HB3' ' A' ' 155' ' ' PRO . 19.9 mmt -77.96 -40.28 39.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.952 0.406 . . . . 0.0 110.794 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.411 ' O ' ' NH1' ' A' ' 106' ' ' ARG . 2.4 t -85.73 -21.31 7.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.173 0.511 . . . . 0.0 111.33 -174.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.0 pp -144.56 127.67 16.6 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.343 0.592 . . . . 0.0 110.543 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 21.2 p -102.73 120.45 52.72 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.486 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.35 -58.39 1.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.799 2.333 . . . . 0.0 112.354 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.96 3.68 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.009 0.433 . . . . 0.0 110.209 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.455 ' O ' HG22 ' A' ' 151' ' ' THR . 35.8 mt-10 65.95 -73.42 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.211 -166.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 150' ' ' GLU . 0.6 OUTLIER 57.8 -4.52 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.974 1.309 . . . . 0.0 114.181 172.509 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 92.36 25.58 20.87 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.005 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 56.3 p -97.16 125.36 41.62 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.65 145.41 95.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.66 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 37.4 Cg_exo -35.1 -58.67 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.998 3.132 . . . . 0.0 113.495 -176.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -141.81 -42.55 0.35 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.66 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -165.22 25.81 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.825 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.4 t0 53.91 77.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -165.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -136.96 24.25 3.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.563 -167.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.59 ' CB ' ' HB3' ' A' ' 133' ' ' GLN . 2.8 pt-20 . . . . . 0 C--O 1.246 0.918 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.269 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' SER . 27.2 ttpp . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -126.96 143.88 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.21 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 1.7 pm0 -149.06 136.28 20.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.934 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.89 HG21 ' HB2' ' A' ' 59' ' ' ALA . 37.1 pt -115.82 132.67 64.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.114 0.483 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -99.19 126.36 44.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.571 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.0 mp -91.75 151.98 20.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.006 -175.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.552 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 26.9 tt0 -74.01 125.44 28.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.958 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.62 -30.9 5.12 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.213 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.53 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 14.7 t -92.16 124.23 60.39 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.53 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -84.73 19.62 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.168 2.579 . . . . 0.0 112.109 -178.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.91 133.58 24.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.527 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -91.51 138.08 2.1 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.659 2.239 . . . . 0.0 112.732 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.468 ' HB3' HG12 ' A' ' 38' ' ' ILE . 3.6 tt -89.28 104.16 16.73 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 47.3 p90 -113.21 151.06 31.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.335 -175.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' HE2' HE21 ' A' ' 51' ' ' GLN . 14.5 t80 -149.8 149.6 30.75 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -53.65 -59.47 4.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.122 0.487 . . . . 0.0 110.482 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.656 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 32.7 mt-30 -65.4 121.96 16.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.459 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.598 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 12.6 t -59.92 -49.99 81.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.58 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -55.06 -30.28 59.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.482 179.562 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.656 ' HB2' ' HB2' ' A' ' 51' ' ' GLN . 5.2 t0 -76.13 -51.17 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.843 0.354 . . . . 0.0 110.805 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.743 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -67.89 -35.54 78.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.456 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.826 HD12 ' HB3' ' A' ' 114' ' ' ALA . 20.9 pt -67.79 -31.68 53.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.305 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.17 95.08 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.411 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.834 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 36.1 m-85 -57.97 -42.23 84.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.198 0.523 . . . . 0.0 110.77 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.89 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -63.36 -19.79 64.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.387 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -105.26 12.23 32.04 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.863 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.41 -72.59 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.656 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.834 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 25.9 Cg_exo -67.79 47.61 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.823 3.015 . . . . 0.0 113.606 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.561 ' OE1' ' HA ' ' A' ' 67' ' ' PRO . 9.4 pt-20 -81.37 -3.27 52.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.268 0.556 . . . . 0.0 110.217 177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 72.45 -78.67 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.844 171.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -129.67 -52.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -171.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -97.31 148.49 34.49 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.432 0.158 . . . . 0.0 110.713 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.561 ' HA ' ' OE1' ' A' ' 63' ' ' GLU . 59.4 Cg_endo -71.81 157.72 54.59 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.447 2.098 . . . . 0.0 111.936 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 68' ' ' ILE . 47.5 pt -75.1 122.16 28.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.263 0.554 . . . . 0.0 110.261 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 41' ' ' GLU . 5.6 tt -88.22 -47.96 8.05 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.46 138.72 2.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.547 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.776 HD11 HG22 ' A' ' 56' ' ' ILE . 2.6 tt -110.19 131.58 60.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.315 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -111.94 142.16 44.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.881 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.66 143.66 31.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.968 0.414 . . . . 0.0 110.773 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.521 HD21 ' HA ' ' A' ' 88' ' ' ASP . 33.7 t30 -79.57 101.11 8.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 167.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 76' ' ' MET . 54.5 t0 -63.63 106.99 1.05 Allowed 'General case' 0 C--O 1.242 0.707 0 O-C-N 124.47 1.107 . . . . 0.0 110.628 -174.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.601 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 3.6 mmt -152.29 58.95 0.83 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 113.442 -1.708 . . . . 0.0 107.86 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.28 26.46 21.2 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.042 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.15 39.45 0.82 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.979 0.419 . . . . 0.0 110.953 -172.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 80' ' ' GLY . . . -179.43 -11.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.238 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.429 ' H ' ' H ' ' A' ' 79' ' ' ALA . . . 126.14 -4.32 7.82 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.997 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.27 65.39 1.09 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.622 0.725 . . . . 0.0 109.956 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.7 p -83.81 177.1 8.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.419 -171.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.409 ' HA ' ' HG2' ' A' ' 51' ' ' GLN . 68.8 t90 -59.43 -40.6 87.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.075 0.464 . . . . 0.0 110.026 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.32 -34.15 48.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.089 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.08 159.79 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.983 1.313 . . . . 0.0 112.935 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 8.2 Cg_exo -58.47 -25.93 75.97 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.67 1.58 . . . . 0.0 112.188 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.601 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . 135.39 -149.51 19.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.966 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.521 ' HA ' HD21 ' A' ' 74' ' ' ASN . 7.6 p-10 -77.55 137.52 38.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.999 0.428 . . . . 0.0 110.285 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.81 -141.85 3.99 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.549 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -100.6 133.65 44.73 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -98.16 130.25 44.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.13 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.688 HD13 ' HB2' ' A' ' 118' ' ' SER . 6.9 pt -145.04 166.42 11.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.934 -173.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.26 107.16 15.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.05 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . . . -62.1 -27.78 69.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.136 0.493 . . . . 0.0 110.479 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.548 ' HA ' HD13 ' A' ' 137' ' ' LEU . 22.7 t70 -59.54 -25.19 64.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.413 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -123.65 43.14 3.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.384 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -139.86 -177.93 5.2 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -173.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -97.95 138.04 35.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.394 0.616 . . . . 0.0 110.646 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 116' ' ' PRO . 3.1 m-85 -120.46 135.33 55.09 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.104 -177.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.9 p -113.66 124.82 70.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.514 0.673 . . . . 0.0 109.816 173.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.59 113.87 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.433 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -79.44 121.84 5.63 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.011 -1.09 . . . . 0.0 112.774 -172.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.8 m -92.68 -41.02 10.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.854 0.359 . . . . 0.0 110.313 175.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.21 -43.84 63.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 -174.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -133.84 114.72 13.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.523 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 176.0 -168.88 0.05 Allowed 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.554 0.534 . . . . 0.0 110.086 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.478 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -65.56 -50.99 51.73 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.925 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.06 -102.15 0.68 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.272 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.3 mmt -86.46 -3.92 59.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 110.757 174.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.49 -124.53 5.08 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.478 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.35 96.13 8.01 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.56 0.18 . . . . 0.0 111.084 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.37 141.89 70.15 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.552 2.168 . . . . 0.0 111.9 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.523 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 36.5 mt-10 -125.94 140.63 52.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.605 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.826 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -105.95 131.47 53.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.859 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.678 ' HB ' HG13 ' A' ' 100' ' ' VAL . 59.4 t -100.59 106.14 41.37 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.6 Cg_endo -87.75 122.92 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.695 2.93 . . . . 0.0 111.552 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.631 ' HD1' ' H ' ' A' ' 119' ' ' SER . 3.6 t80 -130.43 151.11 51.27 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.688 ' HB2' HD13 ' A' ' 92' ' ' ILE . 33.8 t -73.47 -35.79 65.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.631 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 15.2 m -105.96 128.83 54.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.798 0.332 . . . . 0.0 110.846 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -49.85 57.9 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.787 -176.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -67.14 -28.38 68.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.29 0.567 . . . . 0.0 109.74 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 66.3 mm-40 -71.46 -34.84 70.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.594 172.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.64 -35.09 76.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.338 0.59 . . . . 0.0 109.69 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.43 75.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.695 173.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.1 -32.3 73.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.39 . . . . 0.0 110.444 175.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -63.79 -37.49 87.58 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.65 HG22 ' H ' ' A' ' 132' ' ' GLY . 58.9 t -69.57 -30.48 45.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.447 176.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 tp -59.5 -39.6 84.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.949 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.44 -47.85 13.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.686 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.811 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.6 pt-20 -149.94 -89.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.459 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.811 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 44.88 -143.33 2.95 Favored Glycine 0 C--N 1.334 0.453 0 O-C-N 123.588 0.555 . . . . 0.0 114.297 174.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.65 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -176.08 -81.26 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -130.21 145.97 51.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.586 0.231 . . . . 0.0 110.568 175.836 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.21 116.31 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.149 0.499 . . . . 0.0 110.682 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.854 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -141.0 164.13 31.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.955 -178.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.31 163.3 18.68 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.548 HD13 ' HA ' ' A' ' 95' ' ' ASP . 0.6 OUTLIER -66.4 -31.57 72.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.399 0.618 . . . . 0.0 109.505 178.649 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.87 -9.12 58.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.878 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.27 17.9 11.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.23 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.854 HD13 HD13 ' A' ' 135' ' ' LEU . 26.3 mm -71.87 121.99 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.147 0.499 . . . . 0.0 110.627 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -112.23 149.56 32.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.261 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.474 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 2.2 p-10 -68.92 -29.86 68.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.556 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.43 68.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.66 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.548 ' HE3' ' HA ' ' A' ' 160' ' ' GLU . 13.4 mmt -87.11 -36.95 17.81 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.16 -22.73 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 121.09 0.471 . . . . 0.0 110.672 -174.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.3 pp -148.64 141.25 24.44 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.014 -177.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.3 p -126.0 135.55 27.24 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.053 0.454 . . . . 0.0 111.132 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.8 -49.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.822 2.348 . . . . 0.0 111.809 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 151' ' ' THR . 8.0 t -159.23 85.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -176.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -50.82 74.6 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.226 168.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 149' ' ' VAL . 10.2 t -106.92 21.21 17.9 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.756 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.73 78.0 0.8 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.132 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.2 m -129.96 139.33 51.1 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.54 125.67 92.12 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.726 0.298 . . . . 0.0 110.294 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.55 -73.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.85 2.367 . . . . 0.0 112.253 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.596 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -108.67 -54.07 2.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.786 176.633 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.596 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -151.84 37.76 0.58 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -174.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 157' ' ' ALA . 32.9 t70 73.74 -30.01 0.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.235 -175.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 157' ' ' ALA . 6.2 t70 -73.72 -168.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.362 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.548 ' HA ' ' HE3' ' A' ' 144' ' ' MET . 39.2 mt-10 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.595 -0.717 . . . . 0.0 109.926 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.593 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -126.71 142.54 51.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 9.0 pt20 -149.39 133.66 17.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.474 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.538 HG21 ' HB2' ' A' ' 59' ' ' ALA . 39.0 pt -115.63 136.21 53.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.957 0.408 . . . . 0.0 110.946 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -105.77 131.84 52.63 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.949 HD21 ' HB3' ' A' ' 64' ' ' GLN . 8.7 mp -89.19 152.57 21.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.113 0.482 . . . . 0.0 111.672 -173.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.859 ' HG3' HD13 ' A' ' 69' ' ' LEU . 32.0 tt0 -74.22 124.78 27.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.62 -41.1 2.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.238 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.534 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 31.2 t -81.92 123.96 79.6 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.038 0.447 . . . . 0.0 110.446 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.0 Cg_exo -81.74 5.63 6.18 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.322 2.682 . . . . 0.0 112.455 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -100.37 131.18 24.35 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.574 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 97.8 Cg_endo -101.41 161.08 0.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.573 2.848 . . . . 0.0 112.984 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.446 ' HB3' HG12 ' A' ' 38' ' ' ILE . 7.6 tt -117.73 114.93 24.05 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -118.24 135.77 54.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.61 0.719 . . . . 0.0 111.582 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.42 135.17 31.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.624 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.9 m -63.93 -29.49 70.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.579 0.704 . . . . 0.0 109.171 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.645 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 14.3 mt-30 -75.97 95.98 3.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.702 175.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.593 HG13 ' HB2' ' A' ' 36' ' ' ALA . 10.8 t -57.65 -52.03 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.058 0.456 . . . . 0.0 111.019 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.512 ' HA ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -54.15 -30.11 47.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.364 -178.295 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.511 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 1.2 m-20 -73.98 -53.47 9.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.761 0.315 . . . . 0.0 111.189 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -67.21 -35.97 80.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.256 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.609 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 17.7 pt -70.35 -32.52 50.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.521 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.17 -44.97 74.74 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.567 174.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.458 ' HD1' ' HG2' ' A' ' 62' ' ' PRO . 22.1 m-85 -62.39 -35.11 78.18 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -61.04 -17.8 54.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 112.017 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -84.8 -15.57 44.43 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.35 -73.02 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.264 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.458 ' HG2' ' HD1' ' A' ' 58' ' ' TYR . 84.8 Cg_exo -48.67 -47.01 22.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.329 2.686 . . . . 0.0 113.205 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.433 ' OE2' ' HA ' ' A' ' 67' ' ' PRO . 44.9 mt-10 54.76 -91.08 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.564 0.746 . . . . 0.0 111.723 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.949 ' HB3' HD21 ' A' ' 40' ' ' LEU . 5.7 tp-100 -174.27 -61.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.186 0.517 . . . . 0.0 109.672 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.0 tt -168.42 -38.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -106.63 165.3 13.17 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 73.0 Cg_endo -74.53 156.59 45.14 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.649 1.566 . . . . 0.0 111.628 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.3 pt -69.87 128.15 32.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.219 0.533 . . . . 0.0 110.909 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.859 HD13 ' HG3' ' A' ' 41' ' ' GLU . 42.6 tp -89.32 -48.95 7.01 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.99 138.45 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.631 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.544 HD11 HG22 ' A' ' 56' ' ' ILE . 2.7 tt -110.89 135.42 50.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.429 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -112.91 138.81 49.2 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 94' ' ' ALA . 19.7 m -128.94 137.88 56.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.289 0.566 . . . . 0.0 110.551 175.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.492 ' O ' ' HG3' ' A' ' 76' ' ' MET . 27.9 t-20 -78.63 104.17 9.07 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -72.49 121.54 19.79 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 124.256 0.973 . . . . 0.0 109.73 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.519 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -151.84 92.37 1.73 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.611 -176.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.7 -56.84 3.84 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.886 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HA ' ' HB2' ' A' ' 81' ' ' ALA . . . 70.99 -52.07 0.68 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.984 0.914 . . . . 0.0 112.49 175.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.91 -34.07 58.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.99 0.424 . . . . 0.0 110.791 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -97.29 -65.33 0.9 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 78' ' ' ALA . . . 44.06 64.54 1.26 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.59 0.756 . . . . 0.0 112.908 175.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.9 p -84.0 176.14 9.05 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.645 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 26.1 p90 -73.32 -12.83 60.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.164 0.507 . . . . 0.0 110.287 175.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.82 -35.15 22.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 68.02 161.04 0.14 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.768 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 76' ' ' MET . 69.9 Cg_endo -93.52 29.35 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.195 1.93 . . . . 0.0 111.634 176.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.15 161.92 18.64 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.721 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -77.35 123.23 26.22 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -106.56 -139.18 9.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.145 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -100.04 149.45 23.47 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 67.2 p-90 -98.44 134.72 41.03 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.232 0.539 . . . . 0.0 110.639 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.737 HD13 ' HB2' ' A' ' 118' ' ' SER . 4.3 pt -133.78 151.91 33.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.543 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.04 102.54 4.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.54 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -61.16 -34.81 75.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.337 -176.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 137' ' ' LEU . 16.7 t70 -57.81 -30.34 65.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.707 0.765 . . . . 0.0 110.354 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -111.24 26.79 10.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.826 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -120.17 177.39 5.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.718 0.294 . . . . 0.0 111.06 -173.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -90.44 131.34 36.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.453 0.644 . . . . 0.0 110.535 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.62 135.33 55.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.071 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.697 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.8 p -112.82 125.46 70.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.745 0.783 . . . . 0.0 110.334 174.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.7 ' HA ' HH11 ' A' ' 106' ' ' ARG . 47.9 t -101.81 107.87 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.998 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.449 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -69.6 124.27 15.11 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.547 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.4 m -88.6 -31.01 18.81 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.77 -44.33 11.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.738 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -133.59 109.52 9.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.755 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.797 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 13.7 ttt180 -168.64 -72.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.601 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.67 46.04 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.523 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -61.8 -39.49 97.54 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.699 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 45.2 tpp -109.39 -4.21 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.559 0.695 . . . . 0.0 110.1 174.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.88 -132.87 5.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.208 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.3 102.6 29.96 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 34.0 Cg_endo -63.74 129.47 24.95 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.253 2.636 . . . . 0.0 114.01 -175.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.797 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 47.9 mm-40 -114.21 129.33 56.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.364 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.609 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . . . -102.22 131.06 49.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.824 -0.171 . . . . 0.0 111.263 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.697 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 85.7 t -101.61 105.74 42.41 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.772 173.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -90.09 127.04 1.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.762 2.975 . . . . 0.0 111.795 175.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.26 149.81 52.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.195 -176.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.737 ' HB2' HD13 ' A' ' 92' ' ' ILE . 47.9 t -79.1 -18.25 53.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.893 0.378 . . . . 0.0 110.758 176.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.7 m -119.85 134.24 55.31 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.77 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -67.48 -49.52 63.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -60.13 -28.99 68.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.452 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -70.23 -43.28 70.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.268 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.7 -30.2 69.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.148 176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.1 -38.09 72.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.639 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.57 74.79 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.264 0.554 . . . . 0.0 110.272 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.69 -39.64 92.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.847 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.829 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 94.6 t -70.78 -34.81 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.929 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 67.6 mt -56.36 -40.94 75.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.62 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.53 -48.97 11.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.699 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.751 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.5 pt-20 -145.4 -82.72 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.101 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.829 ' HA3' ' HA ' ' A' ' 127' ' ' VAL . . . 38.23 -142.24 0.35 Allowed Glycine 0 C--N 1.337 0.606 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.784 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -179.73 -87.28 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.491 HE21 ' HB ' ' A' ' 101' ' ' VAL . 1.9 pm0 -129.86 141.46 50.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.675 0.274 . . . . 0.0 110.863 175.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.48 113.22 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.04 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.73 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.41 165.05 27.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.656 -178.239 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.31 161.79 19.36 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.69 ' HA ' HG12 ' A' ' 140' ' ' ILE . 5.9 tt -61.75 -36.78 82.0 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.85 -11.48 27.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.487 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -126.0 23.15 7.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.012 0.434 . . . . 0.0 110.895 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.73 HD13 HD13 ' A' ' 135' ' ' LEU . 34.4 mm -71.82 119.12 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 145' ' ' VAL . 14.1 t -119.26 148.65 42.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.681 -176.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.528 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 1.5 p30 -66.07 -41.73 90.35 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -171.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 155' ' ' PRO . . . -57.03 -28.6 62.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.523 ' SD ' ' HB2' ' A' ' 155' ' ' PRO . 19.2 mmt -82.19 -26.83 33.0 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 141' ' ' THR . 10.9 t -97.88 -23.19 4.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -170.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.6 pp -136.33 156.4 48.69 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.969 -172.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.5 p -111.99 119.52 44.08 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.044 0.449 . . . . 0.0 110.779 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.19 -81.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.581 2.187 . . . . 0.0 111.976 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.557 ' HB ' ' OG1' ' A' ' 151' ' ' THR . 4.1 t -129.35 -2.48 2.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 15.0 mm-40 87.83 -77.78 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -169.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.557 ' OG1' ' HB ' ' A' ' 149' ' ' VAL . 13.0 m 68.46 -42.33 0.47 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 163.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.83 20.91 5.88 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.9 m -84.02 126.55 33.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.585 0.231 . . . . 0.0 110.438 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.718 ' HB3' ' HB2' ' A' ' 158' ' ' ASP . 4.3 mp0 -71.14 126.57 91.98 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.157 177.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.523 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 61.8 Cg_endo -72.94 126.94 11.7 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.633 2.222 . . . . 0.0 111.325 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 155' ' ' PRO . 18.5 tpp85 69.66 -63.07 0.4 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.527 0.517 . . . . 0.0 110.471 -175.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 158' ' ' ASP . . . -179.07 13.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.275 0.63 . . . . 0.0 109.92 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.718 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 14.0 t70 57.59 30.88 19.49 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -169.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.01 -68.22 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.679 -172.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.751 179.643 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.573 ' HB3' ' OD1' ' A' ' 74' ' ' ASN . 43.7 tttp . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.769 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -144.72 144.75 31.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.763 0.316 . . . . 0.0 111.671 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 22.3 pt20 -145.56 134.8 22.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.874 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' A' ' 47' ' ' LEU . 3.9 pt -119.81 143.24 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.248 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -116.82 127.88 54.74 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.3 mp -92.07 142.42 27.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.068 0.461 . . . . 0.0 111.082 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.783 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 44.8 tt0 -73.83 124.69 26.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.866 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.05 -27.29 11.58 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.146 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.3 t -92.0 125.56 56.45 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.1 Cg_exo -80.5 12.12 2.67 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.132 2.554 . . . . 0.0 112.833 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -130.15 133.25 24.73 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.876 0.369 . . . . 0.0 110.961 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 55.6 Cg_endo -97.42 170.83 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.388 2.725 . . . . 0.0 112.782 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.722 ' HB3' HG12 ' A' ' 38' ' ' ILE . 14.4 tp -107.04 130.64 54.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.94 177.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -114.45 134.47 54.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.1 147.6 27.97 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 110.688 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 55.3 m -70.38 -52.58 21.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.143 173.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.5 HE21 ' HB3' ' A' ' 83' ' ' TRP . 39.8 mt-30 -67.37 113.09 4.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.718 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.769 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 6.2 t -60.48 -50.48 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.565 0.697 . . . . 0.0 109.444 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.631 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -60.21 -28.79 68.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.548 -176.765 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.631 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 14.2 t70 -76.14 -45.5 33.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.781 0.324 . . . . 0.0 110.482 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.52 72.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.275 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.617 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 16.4 pt -71.19 -32.51 47.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 0.0 110.179 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.26 -36.34 79.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.16 0.505 . . . . 0.0 110.302 172.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.456 ' CD1' HD22 ' A' ' 47' ' ' LEU . 33.8 t80 -60.62 -33.23 72.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.279 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.653 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -72.37 -18.1 61.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.605 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.55 ' NH2' ' HG ' ' A' ' 137' ' ' LEU . 75.1 mtt85 -105.62 13.14 30.33 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.36 -78.63 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.538 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -43.37 -35.54 5.71 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 124.041 3.161 . . . . 0.0 114.774 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -67.61 128.66 37.28 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.759 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -169.68 -36.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.122 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.9 -27.46 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.542 0.687 . . . . 0.0 109.644 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.748 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.1 141.2 14.08 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.309 175.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.783 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 70.4 Cg_endo -74.23 155.12 46.81 Favored 'Trans proline' 0 CA--C 1.52 -0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.282 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.653 HD13 ' HB1' ' A' ' 59' ' ' ALA . 27.5 pt -75.74 116.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.373 0.606 . . . . 0.0 110.484 174.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -79.12 -47.84 15.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 p -161.08 150.16 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.775 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.572 HD11 HG22 ' A' ' 56' ' ' ILE . 5.7 tt -128.0 128.61 69.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.448 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -111.99 133.46 54.15 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 94' ' ' ALA . 34.6 m -132.2 156.6 42.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.108 0.48 . . . . 0.0 110.668 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.573 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 12.3 m120 -92.34 104.56 16.89 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.459 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 10.3 t0 -49.56 103.9 0.06 Allowed 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 125.35 1.656 . . . . 0.0 109.525 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' ' 85' ' ' GLN . 3.3 ttm -144.69 41.04 1.31 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.038 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 79' ' ' ALA . . . -89.62 18.1 48.53 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.644 -175.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.06 22.17 0.11 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.216 0.532 . . . . 0.0 111.474 -175.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -172.89 20.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.493 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.401 ' HA2' ' CG2' ' A' ' 115' ' ' VAL . . . 91.51 -2.29 77.32 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.347 -176.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . . . 60.47 66.82 0.89 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.688 0.756 . . . . 0.0 110.315 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 p -83.73 175.59 9.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.445 -176.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.5 ' HB3' HE21 ' A' ' 51' ' ' GLN . 59.8 p-90 -67.26 -23.92 65.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.981 0.42 . . . . 0.0 110.767 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.03 -35.55 42.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.58 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 24.2 mt-30 66.8 142.97 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.578 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -57.61 -42.22 62.76 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.015 1.81 . . . . 0.0 112.07 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.2 -64.56 0.6 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.247 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.32 131.79 38.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.7 0.286 . . . . 0.0 110.619 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 75' ' ' ASP . . . -147.47 139.74 8.04 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.401 -177.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.3 t30 -100.13 149.14 23.83 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -98.48 129.74 45.08 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.705 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.747 HG21 ' HB2' ' A' ' 118' ' ' SER . 20.3 pt -145.02 166.17 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.967 -174.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.69 114.1 23.1 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -69.46 -38.07 77.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.036 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.73 ' HA ' HD13 ' A' ' 137' ' ' LEU . 0.6 OUTLIER -68.03 -25.24 65.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.738 0.78 . . . . 0.0 109.752 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -98.9 37.35 1.53 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.262 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 117' ' ' PHE . . . -145.48 179.24 7.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.35 -171.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -93.59 141.8 28.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.304 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.406 ' CE1' HD12 ' A' ' 137' ' ' LEU . 2.9 m-85 -120.67 137.08 54.64 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.558 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.848 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -115.16 123.21 70.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.504 0.669 . . . . 0.0 109.368 172.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.482 ' HB ' ' HG2' ' A' ' 133' ' ' GLN . 56.4 t -101.53 107.13 20.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.31 123.25 7.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.793 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.4 t -92.42 -35.4 13.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.893 0.378 . . . . 0.0 110.146 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.39 -45.08 20.21 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.943 0.401 . . . . 0.0 111.568 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.437 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 48.9 mtp180 -129.58 111.72 13.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.633 ' NE ' ' HA ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -177.81 -170.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.623 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -54.54 -37.56 61.01 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.67 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.45 -105.26 1.09 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.041 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 86.7 mtp -92.94 -4.0 53.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.979 0.419 . . . . 0.0 110.374 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -95.15 -129.51 5.8 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.782 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.27 96.58 8.52 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 176.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 18.1 Cg_endo -59.72 151.51 69.78 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.401 2.734 . . . . 0.0 113.314 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.514 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 2.5 mp0 -117.1 146.13 43.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.54 175.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.617 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . . . -103.98 131.13 51.53 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.848 ' HB ' HG13 ' A' ' 100' ' ' VAL . 5.7 t -99.19 105.22 31.07 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.3 Cg_exo -87.07 133.35 3.4 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.556 2.837 . . . . 0.0 112.89 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.4 ' O ' ' HB1' ' A' ' 97' ' ' ALA . 35.8 m-85 -129.26 149.67 50.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.46 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.747 ' HB2' HG21 ' A' ' 92' ' ' ILE . 32.5 t -78.05 -38.19 45.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.064 0.459 . . . . 0.0 109.837 172.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 m -96.28 135.33 38.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.818 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -46.2 84.85 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -64.73 -28.46 69.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.875 -172.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -64.98 -38.66 91.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.95 0.405 . . . . 0.0 110.677 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -73.02 -36.16 66.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.077 176.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.0 -44.99 83.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.065 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.65 -34.14 75.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 110.9 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -62.78 -40.51 97.53 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.85 HG22 ' H ' ' A' ' 132' ' ' GLY . 91.7 t -72.43 -32.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.603 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.4 tp -57.75 -43.67 85.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.1 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.44 -44.64 15.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.164 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.653 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.2 pt-20 -150.69 -93.29 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.403 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.653 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.27 -138.12 7.73 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 114.438 0.535 . . . . 0.0 114.438 173.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.85 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -176.95 -83.09 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.482 ' HG2' ' HB ' ' A' ' 101' ' ' VAL . 13.2 pm0 -130.07 142.16 50.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.645 0.259 . . . . 0.0 110.937 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.5 t -109.45 120.14 60.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.046 0.451 . . . . 0.0 110.729 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.791 HD13 HD13 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -147.2 165.69 29.25 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.547 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.91 164.05 18.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 95' ' ' ASP . 8.6 tt -63.88 -35.52 80.91 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.02 -10.14 59.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.975 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -117.85 20.27 13.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.493 0.663 . . . . 0.0 110.043 -174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.791 HD13 HD13 ' A' ' 135' ' ' LEU . 35.8 mm -76.58 121.69 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.895 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.478 HG23 ' HB2' ' A' ' 144' ' ' MET . 0.5 OUTLIER -106.08 145.85 30.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.858 171.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -69.96 -33.17 71.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.018 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.19 -27.37 68.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.406 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.478 ' HB2' HG23 ' A' ' 141' ' ' THR . 1.7 mmt -73.45 -38.8 65.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.871 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.9 t -83.67 -22.61 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.275 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 pp -151.08 133.44 15.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.594 -0.443 . . . . 0.0 111.406 -174.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.8 p -125.93 120.85 24.15 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.305 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.4 -59.59 0.41 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.898 2.399 . . . . 0.0 113.392 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.3 t -125.21 6.62 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.93 0.395 . . . . 0.0 110.68 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 60.91 47.62 7.46 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.82 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 t -71.9 -3.33 21.87 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 82.8 28.92 36.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.868 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 p -70.49 141.08 52.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.661 0.267 . . . . 0.0 111.231 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.507 ' OE2' ' HB2' ' A' ' 158' ' ' ASP . 37.9 mt-10 -59.73 125.84 81.26 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.204 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.74 -72.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 123.146 2.564 . . . . 0.0 112.723 -176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -117.66 -33.57 4.5 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.476 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 159' ' ' ASP . . . -171.05 39.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.895 -173.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.507 ' HB2' ' OE2' ' A' ' 154' ' ' GLU . 14.6 t70 71.99 -37.26 0.38 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.292 0.637 . . . . 0.0 110.659 -174.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.9 t70 -65.24 -163.38 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.249 175.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.835 177.072 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.623 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 36.6 ttpt . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -134.16 144.54 48.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.149 0.431 . . . . 0.0 111.859 -177.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 28.9 pt20 -147.02 136.83 23.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.872 174.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.631 HG22 ' HB ' ' A' ' 71' ' ' ILE . 35.5 pt -120.06 132.75 68.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.2 0.524 . . . . 0.0 111.495 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -105.75 119.06 38.2 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.9 mp -92.94 142.78 26.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.039 0.447 . . . . 0.0 110.738 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.718 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 31.4 tt0 -71.34 124.2 24.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.702 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.67 -17.16 58.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.594 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 37.5 t -92.38 125.96 54.29 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 1.4 Cg_endo -83.56 10.07 3.83 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.08 2.52 . . . . 0.0 112.678 -178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -134.3 134.2 22.45 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.786 0.327 . . . . 0.0 111.35 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 9.1 Cg_endo -89.2 125.36 1.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.484 2.789 . . . . 0.0 111.422 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.36 102.97 13.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 44.5 p90 -103.14 139.57 38.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.732 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -144.59 142.88 30.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.705 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.623 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 4.8 m -57.15 -44.1 83.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.077 0.465 . . . . 0.0 111.426 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.652 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 46.1 mt-30 -78.46 119.89 22.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.163 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.573 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 9.9 t -64.49 -50.39 76.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.602 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.01 -29.84 45.07 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.512 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.602 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 22.2 t70 -76.34 -51.55 11.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.828 0.347 . . . . 0.0 110.691 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -68.04 -37.51 81.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.283 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 114' ' ' ALA . 31.0 pt -67.6 -30.79 49.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.428 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -62.58 -46.11 89.83 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.547 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.407 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 30.1 m-85 -62.14 -40.88 97.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.888 0.375 . . . . 0.0 110.839 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -60.83 -20.67 62.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.732 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 48.6 mtm105 -95.43 12.36 29.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.18 -62.35 0.32 Allowed Glycine 0 C--O 1.226 -0.354 0 C-N-CA 119.779 -1.201 . . . . 0.0 113.645 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 18.1 Cg_exo -70.8 49.46 0.94 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.441 2.761 . . . . 0.0 114.323 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -84.26 -89.23 0.1 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.601 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.595 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 22.1 tp60 -164.23 -51.7 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.499 0.591 . . . . 0.0 112.018 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.516 HG22 ' HG3' ' A' ' 64' ' ' GLN . 14.6 tt 177.52 -27.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.258 0.551 . . . . 0.0 110.703 -170.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.474 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -99.41 144.56 28.51 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.455 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.718 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 53.5 Cg_endo -68.62 152.69 74.46 Favored 'Trans proline' 0 CA--C 1.517 -0.332 0 C-N-CA 122.383 2.055 . . . . 0.0 111.371 176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 59' ' ' ALA . 29.5 pt -81.58 107.17 13.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.498 0.666 . . . . 0.0 110.059 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -69.86 -49.42 52.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 p -161.22 138.94 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.927 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.6 tt -112.87 128.58 69.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.754 174.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -111.84 128.87 56.25 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 94' ' ' ALA . 35.4 m -128.28 153.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.212 0.529 . . . . 0.0 110.565 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.605 ' O ' ' HG2' ' A' ' 76' ' ' MET . 15.2 m120 -87.65 103.88 16.0 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -47.36 113.99 0.79 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 125.684 1.865 . . . . 0.0 110.7 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.605 ' HG2' ' O ' ' A' ' 74' ' ' ASN . 11.6 ptp -158.97 117.58 2.94 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.794 0.684 . . . . 0.0 110.074 -176.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.776 ' HA3' ' CZ ' ' A' ' 117' ' ' PHE . . . -151.12 44.89 0.66 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.656 -1.259 . . . . 0.0 113.941 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -97.79 26.42 5.13 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -176.95 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.674 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.546 ' HA2' ' CG2' ' A' ' 115' ' ' VAL . . . 131.03 20.67 1.14 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.281 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.403 ' HB1' ' CG2' ' A' ' 52' ' ' VAL . . . 55.83 54.52 8.05 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.421 0.629 . . . . 0.0 110.908 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.7 p -83.57 176.6 8.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.196 -174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.652 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 44.5 p90 -64.66 -28.51 69.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.041 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -80.35 -33.07 37.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 70.37 138.1 0.06 OUTLIER Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.951 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.454 ' CG ' ' HB2' ' A' ' 76' ' ' MET . 36.5 Cg_endo -65.78 -60.08 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.292 1.995 . . . . 0.0 112.808 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.24 -38.21 0.41 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.794 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 76' ' ' MET . 10.9 p-10 -72.41 146.75 46.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 176.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.93 94.23 0.11 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.023 -1.085 . . . . 0.0 113.67 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 49.9 m-80 -100.29 151.83 21.02 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.5 p90 -98.13 126.95 43.81 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.268 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.901 HG21 ' HB2' ' A' ' 118' ' ' SER . 34.5 pt -145.62 166.73 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.083 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -95.12 103.5 15.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 172.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.484 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -63.59 -30.52 71.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.25 -175.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.736 ' HA ' HD13 ' A' ' 137' ' ' LEU . 21.8 t70 -59.43 -24.26 63.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.697 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -120.51 33.97 5.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.329 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.425 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -133.41 -177.64 4.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.293 -171.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.94 137.4 33.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.545 0.688 . . . . 0.0 110.422 -177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.61 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 6.0 m-85 -120.65 135.69 55.04 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.372 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.577 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 6.3 p -112.24 120.92 63.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.462 0.649 . . . . 0.0 109.643 170.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.442 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 96.9 t -101.61 107.35 21.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -70.25 122.33 11.03 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.389 -175.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 m -92.31 -20.55 20.99 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.737 0.303 . . . . 0.0 110.821 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.99 -19.08 19.02 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.27 0.557 . . . . 0.0 110.453 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.404 HH11 ' CD ' ' A' ' 130' ' ' GLU . 23.3 mmm-85 -112.53 -30.63 7.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.416 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.864 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 5.4 mpt_? -120.88 -161.71 0.91 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.512 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.807 ' HA2' ' HD3' ' A' ' 112' ' ' PRO . . . 70.11 51.02 25.08 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -171.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.45 -127.04 0.16 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 114.483 -0.858 . . . . 0.0 113.068 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 66.2 mtt -97.93 21.32 10.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.665 0.745 . . . . 0.0 109.493 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.22 -114.07 0.29 Allowed Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.167 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.538 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.19 115.91 63.17 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.885 ' HG2' ' HA ' ' A' ' 145' ' ' VAL . 1.9 Cg_endo -44.09 157.15 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.905 3.07 . . . . 0.0 113.212 164.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.864 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 43.3 mt-10 -113.47 125.97 54.81 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 99' ' ' TYR . . . -93.76 131.97 38.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.873 -168.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.577 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 2.4 t -97.41 106.07 29.87 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 5.7 Cg_exo -85.91 131.07 3.72 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.225 2.617 . . . . 0.0 112.731 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.776 ' CZ ' ' HA3' ' A' ' 77' ' ' GLY . 81.6 m-85 -129.82 149.8 51.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.505 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.901 ' HB2' HG21 ' A' ' 92' ' ' ILE . 16.6 t -87.23 -26.56 23.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.4 m -91.98 110.62 21.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.929 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -58.77 -46.82 86.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.245 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -62.82 -28.74 70.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.214 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.61 -44.82 81.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.891 0.377 . . . . 0.0 110.225 174.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.415 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -65.85 -35.62 81.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.329 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.81 -41.49 62.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.477 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.0 -33.2 74.92 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.207 0.527 . . . . 0.0 110.529 177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -59.84 -38.41 81.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.576 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.662 HG22 ' H ' ' A' ' 132' ' ' GLY . 61.7 t -73.17 -30.91 32.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.098 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mp -56.82 -48.98 76.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.233 0.54 . . . . 0.0 110.72 176.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.73 -38.25 47.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.21 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.622 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.1 pt-20 -159.26 -90.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.708 -178.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.622 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 45.51 -139.05 6.0 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 123.827 0.704 . . . . 0.0 113.54 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.662 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -172.97 -89.54 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.497 ' HB2' ' HB3' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -128.44 139.15 52.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.809 0.337 . . . . 0.0 110.58 177.66 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 75.4 t -99.5 113.41 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.572 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.907 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.81 160.96 38.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.691 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.28 162.96 15.57 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.736 HD13 ' HA ' ' A' ' 95' ' ' ASP . 7.0 tt -64.3 -30.52 71.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.43 0.634 . . . . 0.0 109.495 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.91 -10.41 59.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.915 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -124.8 19.92 8.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.041 0.448 . . . . 0.0 110.407 -176.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.907 HD13 HD13 ' A' ' 135' ' ' LEU . 26.9 mm -72.1 119.76 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 145' ' ' VAL . 2.2 t -103.02 148.29 25.89 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.203 175.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 6.0 p-10 -68.94 -29.2 67.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.53 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.54 -32.29 66.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.456 ' HG3' ' HG3' ' A' ' 133' ' ' GLN . 18.0 mmt -86.99 -26.55 23.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.463 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.885 ' HA ' ' HG2' ' A' ' 112' ' ' PRO . 1.3 t -103.3 -3.22 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 111.405 -173.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.8 pp -169.64 132.87 1.23 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.822 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 1.8 p -94.0 118.69 67.26 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.245 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 24.0 Cg_endo -62.47 -68.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.953 2.435 . . . . 0.0 112.917 -177.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 64.6 t -114.7 -27.56 2.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.043 -173.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 5.4 mm-40 68.99 46.15 0.86 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.977 0.894 . . . . 0.0 108.791 -166.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.4 t -75.72 -13.98 60.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.636 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.13 50.27 6.92 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.61 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.2 t -130.14 161.42 31.13 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -57.16 132.57 80.69 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.49 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.9 -72.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.536 2.824 . . . . 0.0 112.801 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.22 -44.83 3.21 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.263 173.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.28 44.35 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.384 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.0 t70 56.59 32.78 21.55 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.321 1.058 . . . . 0.0 109.637 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -142.07 -179.18 6.08 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 133' ' ' GLN . 9.9 mm-40 . . . . . 0 C--O 1.243 0.757 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.914 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 34.6 ttmt . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.753 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -139.21 144.92 38.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.153 0.433 . . . . 0.0 111.754 -176.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 13.8 pt20 -149.19 134.49 18.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 173.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.619 HG22 ' HB ' ' A' ' 71' ' ' ILE . 23.1 pt -115.8 132.91 63.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.135 0.493 . . . . 0.0 111.403 -177.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -98.99 116.97 32.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.692 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.5 mp -90.4 140.48 29.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.888 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.865 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 35.4 tt0 -71.91 124.9 25.88 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.317 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.35 -15.54 61.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.709 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.501 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 30.6 t -94.48 124.87 53.94 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.0 Cg_endo -81.47 2.95 8.2 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.091 2.527 . . . . 0.0 112.13 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -135.23 134.6 21.55 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.544 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 1.3 Cg_endo -83.68 147.63 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.21 2.607 . . . . 0.0 112.249 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 tt -99.15 112.58 24.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 33.9 p90 -108.62 143.85 37.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.984 0.421 . . . . 0.0 111.365 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -150.03 139.65 21.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.914 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 17.2 m -63.21 -29.98 71.22 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -176.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.406 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 66.4 mt-30 -90.3 113.69 25.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.673 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.753 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 17.1 t -64.33 -50.66 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.007 0.432 . . . . 0.0 110.889 -177.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.649 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.79 -29.46 62.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.931 -177.375 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.649 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 5.1 t70 -76.12 -47.9 22.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.193 0.52 . . . . 0.0 109.828 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.23 80.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.459 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.597 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 36.8 pt -69.16 -32.75 55.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.191 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . . . -68.22 -42.15 80.23 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 110.214 174.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.85 -31.31 71.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.721 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.469 ' HB1' HG21 ' A' ' 68' ' ' ILE . . . -73.23 -17.0 61.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.152 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.602 ' HE ' ' HA ' ' A' ' 57' ' ' ALA . 38.2 mtm105 -97.72 8.26 44.99 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.76 -67.69 0.03 OUTLIER Glycine 0 C--N 1.322 -0.198 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.234 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.17 -0.85 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.844 3.03 . . . . 0.0 115.119 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -78.44 37.61 0.28 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.651 0.739 . . . . 0.0 110.595 174.489 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -79.91 -14.85 58.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.631 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tp -90.55 -38.62 11.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.212 0.53 . . . . 0.0 110.164 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.692 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -148.01 139.7 13.98 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.865 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 73.0 Cg_endo -74.17 150.73 42.96 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.328 2.019 . . . . 0.0 112.039 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.469 HG21 ' HB1' ' A' ' 59' ' ' ALA . 37.8 pt -74.79 123.71 30.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.168 0.509 . . . . 0.0 110.303 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -88.34 -53.07 4.86 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.8 142.36 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.287 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.619 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.6 tt -113.5 136.0 51.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.457 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -111.94 133.93 53.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.95 159.14 43.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.453 0.644 . . . . 0.0 111.72 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -95.52 106.98 19.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.141 171.197 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 90' ' ' ASN . 13.0 t70 -50.99 121.8 6.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 125.088 1.493 . . . . 0.0 109.816 175.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.48 ' SD ' ' N ' ' A' ' 35' ' ' LYS . 29.4 mtp -124.21 49.36 1.79 Allowed 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -165.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 78' ' ' ALA . . . 73.45 -30.53 0.84 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.818 169.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.965 ' HA ' HG11 ' A' ' 115' ' ' VAL . . . 87.79 -64.44 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.986 0.915 . . . . 0.0 111.801 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.13 -38.34 24.74 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.548 0.53 . . . . 0.0 111.794 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.5 -81.82 1.27 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.554 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 56.41 22.32 6.32 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 36.1 p -84.38 175.44 9.36 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.478 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 2.6 p90 -63.26 -23.27 67.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.802 0.334 . . . . 0.0 110.546 172.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -81.75 -29.88 32.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.592 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.467 ' HB3' ' HE2' ' A' ' 76' ' ' MET . 0.0 OUTLIER 57.09 162.82 0.08 OUTLIER Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.782 1.233 . . . . 0.0 112.469 174.451 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.44 -9.96 16.1 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.36 1.374 . . . . 0.0 111.477 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 137.65 -177.57 19.8 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.11 140.14 40.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.438 0.619 . . . . 0.0 109.408 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.46 -126.74 2.87 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.989 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 35.4 m-80 -96.46 150.81 20.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.576 -173.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -99.0 126.14 44.63 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.466 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.734 HD13 ' HB2' ' A' ' 118' ' ' SER . 9.8 pt -145.72 166.54 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.137 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.58 106.44 18.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.427 ' C ' HD12 ' A' ' 137' ' ' LEU . . . -61.75 -33.2 73.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.121 0.486 . . . . 0.0 110.76 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.491 ' HB2' HG22 ' A' ' 71' ' ' ILE . 20.9 t70 -59.63 -24.96 64.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.41 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -121.53 33.86 5.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.394 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -135.26 -172.77 3.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.318 -175.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 97.8 m-85 -95.36 139.16 32.05 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.521 0.676 . . . . 0.0 111.041 -176.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.616 ' CE1' HG22 ' A' ' 101' ' ' VAL . 17.9 t80 -120.34 131.04 54.69 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.659 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.9 p -109.52 123.07 65.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.705 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' ' 144' ' ' MET . 4.0 t -101.74 103.01 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.394 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.662 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -69.26 134.49 26.82 Favored Glycine 0 N--CA 1.45 -0.432 0 O-C-N 123.574 0.546 . . . . 0.0 113.524 -173.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -92.08 -36.98 13.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.652 0.263 . . . . 0.0 110.317 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.08 -43.74 17.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 0.0 110.385 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.567 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 41.3 mtp-105 -132.84 132.78 42.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.668 177.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 1.027 HH21 HG13 ' A' ' 145' ' ' VAL . 12.7 ttt85 -172.08 -62.63 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.814 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.83 -61.2 0.23 Allowed Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.83 -94.53 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.527 -0.368 . . . . 0.0 112.42 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.81 -4.49 59.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.981 0.42 . . . . 0.0 110.896 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -110.65 -129.84 5.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.623 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.439 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.17 102.2 26.91 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.718 0.259 . . . . 0.0 110.584 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 26.8 Cg_endo -61.86 128.06 23.26 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 123.745 2.964 . . . . 0.0 112.983 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.466 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 5.0 mm-40 -114.34 139.97 49.02 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.593 -177.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.552 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -123.59 134.59 53.79 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.64 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.965 HG11 ' HA ' ' A' ' 78' ' ' ALA . 46.1 t -98.13 106.68 36.56 Favored Pre-proline 0 C--N 1.314 -0.973 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.983 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 5.3 Cg_exo -84.55 110.17 1.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.157 2.571 . . . . 0.0 111.283 173.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.78 ' HD1' ' H ' ' A' ' 119' ' ' SER . 4.1 t80 -120.06 151.03 39.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.971 -174.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.734 ' HB2' HD13 ' A' ' 92' ' ' ILE . 33.1 t -74.89 -37.26 62.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.778 0.323 . . . . 0.0 110.953 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.78 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 9.6 m -95.95 128.22 42.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.608 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 3.7 ttt180 -62.42 -48.97 77.33 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.133 0.492 . . . . 0.0 111.215 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -63.11 -31.59 72.76 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.786 -172.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -67.48 -40.44 85.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.731 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.17 -34.59 76.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.124 0.488 . . . . 0.0 109.747 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.09 74.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.865 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.35 97.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.142 0.496 . . . . 0.0 109.964 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -60.11 -38.74 83.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.836 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.689 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 60.8 t -64.57 -43.85 96.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.195 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.2 mt -52.46 -40.15 61.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.202 0.525 . . . . 0.0 110.678 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.86 -44.01 19.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.96 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.567 ' OE1' ' HD3' ' A' ' 105' ' ' ARG . 6.9 pt-20 -158.97 -33.49 0.06 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -172.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.689 ' CA ' ' HA ' ' A' ' 127' ' ' VAL . . . -52.76 167.01 1.12 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.257 -0.429 . . . . 0.0 113.907 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.64 -81.76 1.4 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.269 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.619 ' HG2' ' HG3' ' A' ' 144' ' ' MET . 2.1 pt20 -125.99 144.39 50.72 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.958 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.415 HG23 HG21 ' A' ' 127' ' ' VAL . 61.1 t -98.88 113.15 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.325 176.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.603 ' H ' HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -133.87 164.56 26.99 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.502 -178.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.86 163.84 22.01 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.444 HD23 HG13 ' A' ' 140' ' ' ILE . 0.8 OUTLIER -62.61 -24.81 67.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.864 0.364 . . . . 0.0 110.691 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.29 -19.97 57.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.949 0.404 . . . . 0.0 111.151 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -104.35 19.33 20.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.852 -173.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.592 HD13 HD13 ' A' ' 135' ' ' LEU . 48.8 mm -71.88 120.37 20.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.216 0.531 . . . . 0.0 111.084 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.789 HG23 ' HB2' ' A' ' 144' ' ' MET . 0.8 OUTLIER -99.42 145.99 26.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.131 177.339 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.79 -32.21 70.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.045 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.23 -29.2 67.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.504 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.789 ' HB2' HG23 ' A' ' 141' ' ' THR . 0.0 OUTLIER -78.94 -35.48 43.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.343 175.195 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 1.027 HG13 HH21 ' A' ' 106' ' ' ARG . 55.9 t -78.27 -25.36 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.382 -167.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -160.7 146.61 14.89 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.26 -174.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.4 p -109.01 119.15 49.66 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 121.057 0.456 . . . . 0.0 110.719 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.24 -67.86 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.913 2.408 . . . . 0.0 112.364 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.0 1.65 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.79 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 68.24 -76.73 0.05 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.341 -170.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.8 t 42.29 21.67 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.159 1.384 . . . . 0.0 114.643 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 66.29 26.91 72.69 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.885 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.9 m -76.33 152.67 36.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.052 0.426 . . . . 0.0 110.573 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 158' ' ' ASP . 2.5 mp0 -70.63 142.32 88.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.423 ' HB2' ' HE2' ' A' ' 144' ' ' MET . 69.4 Cg_endo -80.55 19.91 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.72 2.28 . . . . 0.0 112.799 -172.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.449 ' HE ' ' CD ' ' A' ' 133' ' ' GLN . 11.9 ptp85 177.06 -45.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.423 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 162.54 -16.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.11 -161.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.472 ' HB2' ' HG2' ' A' ' 154' ' ' GLU . 25.1 t0 59.14 31.24 21.11 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.283 1.039 . . . . 0.0 108.761 -168.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.37 -49.58 22.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.665 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 5.0 pt-20 . . . . . 0 C--O 1.254 1.323 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.362 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 50' ' ' SER . 40.0 ttmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.738 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -132.19 144.21 50.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . 11.9 pt20 -145.06 144.71 31.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.967 0.413 . . . . 0.0 110.574 177.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.705 HG21 ' HB2' ' A' ' 59' ' ' ALA . 23.2 pt -115.94 134.24 59.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 120.969 0.414 . . . . 0.0 110.415 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -98.67 116.87 31.86 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.592 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.3 mp -89.16 139.0 30.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.234 -174.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.856 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 40.8 tt0 -73.89 122.39 22.45 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.51 -4.18 66.43 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.568 -173.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 46.9 t -120.02 128.28 25.93 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.7 Cg_exo -79.1 -12.8 14.3 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.105 2.537 . . . . 0.0 111.704 176.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -115.39 133.8 22.69 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.62 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 2.2 Cg_endo -86.06 149.88 9.47 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.365 2.71 . . . . 0.0 112.149 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.9 tt -94.7 109.77 21.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.675 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . 31.1 p90 -115.54 147.87 40.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.374 0.607 . . . . 0.0 111.834 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -139.24 154.08 47.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.015 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 6.2 m -56.42 -50.98 70.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.155 0.502 . . . . 0.0 110.917 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.402 ' HB2' ' CB ' ' A' ' 54' ' ' ASP . 55.2 mt-30 -77.38 136.06 38.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.397 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.738 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 48.4 t -73.17 -50.7 29.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -52.78 -32.96 46.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.522 177.11 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.442 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 15.9 t70 -76.13 -50.0 15.8 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.864 0.364 . . . . 0.0 110.72 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -67.93 -36.09 79.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.682 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.726 HG22 HD11 ' A' ' 71' ' ' ILE . 31.1 pt -66.02 -31.24 52.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.7 -0.4 . . . . 0.0 109.925 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 54' ' ' ASP . . . -61.27 -41.3 96.7 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.744 174.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.541 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 54.4 m-85 -58.1 -41.19 82.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.967 0.413 . . . . 0.0 111.046 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -63.61 -17.63 63.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.128 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.04 12.24 32.45 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.56 -68.22 0.09 OUTLIER Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.268 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 23.9 Cg_exo -68.14 46.47 0.34 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.586 2.858 . . . . 0.0 113.642 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.96 172.96 13.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.752 0.311 . . . . 0.0 110.285 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.454 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 84.1 mm-40 -96.81 -164.58 1.16 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.843 0.354 . . . . 0.0 110.91 -176.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.3 tt -62.12 -19.4 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.379 0.609 . . . . 0.0 111.17 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.592 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -105.97 141.01 21.81 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.856 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 42.1 Cg_endo -69.36 162.79 40.46 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.967 2.445 . . . . 0.0 112.122 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.9 pt -84.38 116.57 28.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.1 0.476 . . . . 0.0 110.674 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 tt -84.08 -52.58 6.18 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.11 139.86 7.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.662 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.726 HD11 HG22 ' A' ' 56' ' ' ILE . 4.1 tt -108.92 126.89 65.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.133 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -111.55 128.76 56.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.954 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.562 HG23 HG13 ' A' ' 92' ' ' ILE . 31.2 m -123.43 134.25 66.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.118 0.485 . . . . 0.0 110.101 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -89.5 99.44 12.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.607 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 25.6 t70 -68.82 85.94 0.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.778 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.745 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 21.7 ptm -165.17 -168.12 1.33 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.349 0.595 . . . . 0.0 112.268 -174.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.26 -42.9 2.42 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.787 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . . . 51.88 28.33 5.01 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.111 0.536 . . . . 0.0 112.124 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.06 -62.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.97 -11.31 30.38 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.321 -0.942 . . . . 0.0 114.389 -170.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.687 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -61.38 -52.62 63.86 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.953 0.883 . . . . 0.0 109.325 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.0 p -129.62 152.75 48.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 114.001 -1.454 . . . . 0.0 107.497 168.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -72.22 -19.59 61.7 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.439 0.637 . . . . 0.0 110.054 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -85.14 -18.48 34.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.776 175.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 61.3 mt-30 69.75 141.35 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.358 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.787 ' HD2' ' HA ' ' A' ' 78' ' ' ALA . 73.7 Cg_endo -91.49 -82.17 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.918 2.412 . . . . 0.0 112.929 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.15 -126.2 1.67 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.378 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.68 146.62 48.11 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 122.013 0.125 . . . . 0.0 110.957 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.745 ' HA2' ' HB3' ' A' ' 76' ' ' MET . . . -70.78 90.01 0.39 Allowed Glycine 0 CA--C 1.518 0.278 0 O-C-N 123.66 0.6 . . . . 0.0 113.964 -175.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -100.16 149.5 23.47 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -100.17 127.8 46.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.562 HG13 HG23 ' A' ' 73' ' ' VAL . 1.4 pt -145.51 156.65 13.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.59 117.99 30.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 164.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.93 79.41 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -169.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.658 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 9.4 p-10 -66.9 -28.01 67.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.009 0.909 . . . . 0.0 109.789 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -105.32 33.33 3.74 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.177 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.58 171.48 12.55 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.215 -0.303 . . . . 0.0 110.351 -174.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -89.54 136.15 33.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.314 0.578 . . . . 0.0 110.013 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 7.6 m-85 -120.39 136.95 54.55 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.983 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.416 ' CG1' HG13 ' A' ' 115' ' ' VAL . 2.2 p -120.9 125.47 74.08 Favored 'Isoleucine or valine' 0 C--O 1.251 1.146 0 CA-C-O 121.691 0.758 . . . . 0.0 109.428 170.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.57 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 59.1 t -108.57 117.16 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.117 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -75.8 124.49 7.48 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.155 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.5 m -90.43 -23.45 21.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.013 0.435 . . . . 0.0 110.172 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -82.35 -45.17 15.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.224 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.617 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 47.2 mtp180 -139.23 93.75 2.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.029 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.567 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -147.84 169.45 19.77 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.451 176.744 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.687 ' H ' ' HA ' ' A' ' 112' ' ' PRO . . . -79.51 45.85 2.95 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.836 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.8 -25.26 63.51 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.502 171.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.8 ptm -108.36 21.21 17.64 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.746 -0.727 . . . . 0.0 110.213 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -176.3 -116.7 0.47 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.013 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.589 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.45 102.5 29.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.949 0.404 . . . . 0.0 111.378 177.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.687 ' HA ' ' H ' ' A' ' 107' ' ' GLY . 88.0 Cg_endo -74.54 151.83 42.45 Favored 'Trans proline' 0 N--CA 1.467 -0.078 0 C-N-CA 123.253 2.635 . . . . 0.0 111.948 177.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.567 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 1.7 tp10 -118.94 123.24 44.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.308 -177.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.501 ' HB3' HD11 ' A' ' 56' ' ' ILE . . . -99.88 121.43 41.3 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.488 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 6.4 p -110.81 106.63 57.77 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.235 176.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.528 ' HG3' ' CE2' ' A' ' 99' ' ' TYR . 5.1 Cg_exo -84.98 112.21 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.379 3.386 . . . . 0.0 111.872 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -103.98 149.42 25.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.337 0.589 . . . . 0.0 111.015 -177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -79.68 -43.78 22.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.3 m -83.61 111.31 19.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.087 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -56.93 -45.0 83.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.741 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.8 -28.17 69.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.973 -173.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -67.47 -43.99 79.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.338 . . . . 0.0 110.521 174.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.8 92.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.243 0.544 . . . . 0.0 110.208 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.16 74.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.107 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' LEU . . . -61.63 -39.9 92.94 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 111.186 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -57.63 -40.29 78.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.758 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.589 HG22 ' H ' ' A' ' 132' ' ' GLY . 42.4 t -71.79 -28.39 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.843 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 54.2 mt -57.85 -49.82 75.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.451 175.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.55 -48.66 54.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.176 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.918 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.5 pt-20 -157.81 -75.97 0.08 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.566 175.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.918 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.0 -136.85 8.1 Favored Glycine 0 N--CA 1.448 -0.546 0 O-C-N 123.601 0.563 . . . . 0.0 112.914 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.589 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -166.31 -91.91 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.57 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.48 139.7 50.53 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 176.393 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.61 118.19 41.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.781 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.27 164.37 29.42 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.464 -176.727 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.02 165.57 13.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.685 ' HA ' HG12 ' A' ' 140' ' ' ILE . 4.2 tt -64.55 -30.15 71.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.122 0.486 . . . . 0.0 109.95 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.19 -10.68 59.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.011 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -118.99 15.59 13.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.41 0.624 . . . . 0.0 110.262 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.781 HD13 HD13 ' A' ' 135' ' ' LEU . 28.3 mm -72.07 121.52 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.923 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.497 HG23 ' HG2' ' A' ' 144' ' ' MET . 1.2 t -115.39 147.03 41.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -69.4 -31.71 70.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.947 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.93 -29.36 60.0 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.367 0.417 . . . . 0.0 112.076 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.497 ' HG2' HG23 ' A' ' 141' ' ' THR . 12.5 mmt -75.74 -34.88 60.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.14 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.549 ' HB ' HD12 ' A' ' 146' ' ' LEU . 2.7 t -86.12 -25.28 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.049 -172.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.549 HD12 ' HB ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -179.65 149.2 0.36 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.444 -176.012 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.415 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 43.0 p -103.07 120.18 53.05 Favored Pre-proline 0 C--N 1.317 -0.842 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.557 -178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 37.3 Cg_endo -68.39 -77.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.499 2.133 . . . . 0.0 111.483 173.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.6 t -128.86 -27.44 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 73.45 31.54 1.33 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.268 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 t -86.27 16.28 4.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.791 0.805 . . . . 0.0 109.407 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -113.91 -149.04 10.07 Favored Glycine 0 N--CA 1.437 -1.259 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.716 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.1 m -99.89 162.66 12.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.275 -0.462 . . . . 0.0 110.351 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.31 143.43 85.25 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.9 -29.52 82.2 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.878 2.385 . . . . 0.0 113.213 -173.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.549 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 3.2 ptp180 -166.25 -54.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.549 175.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.549 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -160.19 28.3 0.17 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.867 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.8 t70 55.0 75.66 0.3 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.962 0.887 . . . . 0.0 108.92 -168.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.453 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 26.0 t0 -128.97 25.13 5.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.739 1.257 . . . . 0.0 107.863 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.428 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 3.1 pt-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-N 113.221 -1.809 . . . . 0.0 111.137 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.589 ' HB3' ' OD1' ' A' ' 74' ' ' ASN . 30.0 ttpt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -139.99 142.64 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.34 . . . . 0.0 111.052 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 12.8 pt20 -149.58 137.45 20.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.599 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.473 HG22 ' HB ' ' A' ' 71' ' ' ILE . 23.9 pt -115.88 142.91 27.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 0.0 111.111 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -118.72 129.84 55.49 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.3 mp -95.7 146.54 24.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.853 0.358 . . . . 0.0 111.167 -175.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.672 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 22.1 tt0 -74.05 125.37 28.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.722 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.09 -13.34 61.72 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.201 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 24.3 t -104.3 125.29 34.65 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 4.2 Cg_exo -80.83 10.47 3.34 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.057 2.505 . . . . 0.0 112.733 -177.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -124.15 133.23 24.52 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.812 0.339 . . . . 0.0 111.455 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 70.8 Cg_endo -98.11 153.69 0.83 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.744 2.963 . . . . 0.0 112.382 173.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 3.0 tm? -110.76 105.54 14.43 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -112.61 136.77 51.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.16 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.461 ' HE2' HE21 ' A' ' 51' ' ' GLN . 10.7 t80 -149.98 154.97 39.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.144 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.6 m -64.04 -38.78 92.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.298 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.92 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 45.4 mt-30 -72.42 108.69 5.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.571 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 36' ' ' ALA . 12.3 t -62.55 -51.52 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.621 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -53.95 -34.53 59.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.577 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.621 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 28.3 t70 -76.31 -46.69 26.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.767 0.317 . . . . 0.0 110.6 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.821 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -71.23 -39.03 71.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.426 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.538 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 27.3 pt -63.75 -30.81 50.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 54' ' ' ASP . . . -61.6 -42.66 99.18 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 174.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.821 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 61.6 m-85 -56.91 -39.16 73.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.979 0.418 . . . . 0.0 110.799 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' A' ' 68' ' ' ILE . . . -65.86 -17.8 64.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.894 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 15.3 mtm180 -102.37 12.61 36.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.57 -60.31 0.19 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.303 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 23.6 Cg_exo -66.57 35.19 0.13 Allowed 'Trans proline' 0 N--CA 1.48 0.686 0 C-N-CA 123.774 2.983 . . . . 0.0 114.959 -177.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 67' ' ' PRO . 4.6 pt-20 -83.42 128.03 34.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 170.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -47.58 -92.74 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -170.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -125.85 -5.49 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.077 0.941 . . . . 0.0 109.516 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 41' ' ' GLU . . . -113.13 141.92 26.48 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.988 -176.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.672 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.0 Cg_endo -70.1 155.06 65.71 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 C-N-CA 122.413 2.076 . . . . 0.0 111.786 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 68' ' ' ILE . 22.8 pt -71.08 109.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.17 0.51 . . . . 0.0 110.287 175.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -71.7 -52.01 19.98 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 p -161.23 138.81 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.443 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.56 HG22 ' HB2' ' A' ' 95' ' ' ASP . 1.4 tt -111.39 135.85 49.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.465 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 92' ' ' ILE . 87.0 m-85 -115.23 134.64 54.96 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.118 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 94' ' ' ALA . 27.1 m -126.53 150.11 32.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.92 0.39 . . . . 0.0 110.086 176.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.589 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 14.0 m120 -83.71 104.9 14.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.55 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 18.7 t70 -55.37 120.66 7.46 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 125.476 1.735 . . . . 0.0 110.29 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' A' ' 74' ' ' ASN . 22.3 mtm -128.63 -165.25 1.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.303 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.79 61.49 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 166.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.595 ' HB1' HG13 ' A' ' 115' ' ' VAL . . . 74.31 -32.27 0.23 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.789 0.836 . . . . 0.0 112.881 169.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.71 -32.9 63.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.047 0.451 . . . . 0.0 110.581 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.28 -68.47 1.17 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.234 172.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 53.14 34.87 18.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.265 0.555 . . . . 0.0 112.135 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.5 p -83.59 177.61 8.34 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.227 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.92 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 47.0 p90 -64.13 -24.83 67.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.174 0.511 . . . . 0.0 111.081 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.74 -27.24 27.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 64.55 173.79 0.07 OUTLIER Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.746 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.573 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 59.6 Cg_endo -97.04 6.08 1.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.399 2.066 . . . . 0.0 111.264 173.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.32 157.56 7.81 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.364 -175.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.94 126.71 31.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.842 0.353 . . . . 0.0 110.417 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -118.6 -159.13 11.03 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.487 -174.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 76.9 m-20 -81.39 151.98 27.67 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -98.08 129.83 44.9 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 121.318 -0.864 . . . . 0.0 110.209 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.753 HD13 ' HB2' ' A' ' 118' ' ' SER . 20.3 pt -138.54 161.23 30.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.985 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.25 100.57 7.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.431 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -66.28 -34.97 79.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.798 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.613 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 31.3 t70 -61.06 -24.88 66.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.618 0.723 . . . . 0.0 110.138 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -111.64 22.01 15.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.839 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.92 178.79 4.18 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.961 0.41 . . . . 0.0 111.156 -170.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -96.32 130.48 43.41 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.099 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.554 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 11.2 m-85 -120.48 136.56 54.72 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.918 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.867 HG13 ' HB ' ' A' ' 115' ' ' VAL . 1.5 p -121.06 125.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.216 0.531 . . . . 0.0 110.226 172.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.732 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 55.6 t -101.75 125.47 55.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.652 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -87.55 126.84 8.2 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.753 -174.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.7 m -92.66 -21.27 20.11 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.551 0.215 . . . . 0.0 111.084 177.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -89.02 -46.46 8.84 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -170.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -129.89 19.71 5.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.351 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.665 ' HG3' ' H ' ' A' ' 107' ' ' GLY . 8.9 tpp180 -112.0 -161.65 0.76 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.858 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.665 ' H ' ' HG3' ' A' ' 106' ' ' ARG . . . 66.58 46.17 78.78 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -163.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -56.95 -98.22 0.01 OUTLIER Glycine 0 CA--C 1.517 0.161 0 CA-C-N 113.78 -1.21 . . . . 0.0 115.771 -164.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.1 ttt -87.95 21.6 2.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.568 0.699 . . . . 0.0 110.957 -169.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 135.53 -57.69 0.68 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -177.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.459 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.29 122.68 44.36 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.47 ' CA ' ' HA2' ' A' ' 107' ' ' GLY . 5.2 Cg_endo -47.42 152.35 2.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.884 2.389 . . . . 0.0 112.372 173.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.548 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -114.01 131.81 56.22 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -172.018 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.602 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.8 130.16 39.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.442 -174.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.867 ' HB ' HG13 ' A' ' 100' ' ' VAL . 93.1 t -94.85 103.94 13.1 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.4 Cg_exo -91.23 120.38 0.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.548 2.832 . . . . 0.0 112.171 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.36 148.81 50.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.375 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.753 ' HB2' HD13 ' A' ' 92' ' ' ILE . 42.2 t -80.26 -26.86 38.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 173.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.0 m -101.17 121.26 41.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.538 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -59.21 -46.66 87.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.618 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -62.76 -28.97 70.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.272 -173.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -69.63 -38.13 77.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.64 -36.93 81.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.302 0.572 . . . . 0.0 109.755 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.85 -35.85 82.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.573 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.73 78.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.461 ' HZ ' HH21 ' A' ' 106' ' ' ARG . 63.8 t80 -63.48 -41.01 98.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.803 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 41.3 t -72.95 -30.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.202 0.525 . . . . 0.0 110.251 177.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.2 -36.87 76.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.084 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.08 -50.94 7.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.15 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.88 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 1.3 pt-20 -146.94 -81.61 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.093 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.88 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 52.52 -146.82 15.46 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.669 173.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -172.53 -84.18 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.732 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.43 145.23 51.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.728 0.299 . . . . 0.0 110.509 174.853 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.7 t -101.23 113.3 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.267 0.556 . . . . 0.0 109.535 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.809 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -130.48 164.86 23.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.918 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.476 ' H ' ' HB3' ' A' ' 139' ' ' ASP . . . -90.66 166.18 13.3 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.613 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 5.8 tt -64.38 -38.64 91.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.76 -10.24 57.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.26 175.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 136' ' ' ALA . 31.3 t70 -120.24 18.58 12.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.413 0.625 . . . . 0.0 110.389 -175.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.809 HD13 HD13 ' A' ' 135' ' ' LEU . 25.2 mm -72.02 121.35 22.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 145' ' ' VAL . 2.5 t -116.67 148.88 40.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.093 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.538 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 4.3 p30 -68.96 -26.36 65.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.605 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.29 69.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.995 0.426 . . . . 0.0 111.324 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.722 ' HE2' ' HB2' ' A' ' 155' ' ' PRO . 11.5 mmt -86.96 -32.23 20.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.401 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 141' ' ' THR . 4.2 t -86.75 -23.7 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.13 0.49 . . . . 0.0 110.726 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.4 pp -153.4 125.5 7.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.324 -176.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.2 p -102.85 131.68 21.99 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.656 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.31 -99.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.661 2.241 . . . . 0.0 111.386 172.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.634 ' HB ' HG22 ' A' ' 151' ' ' THR . 4.8 t -115.21 -5.78 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 70.19 7.84 6.39 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.573 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.634 HG22 ' HB ' ' A' ' 149' ' ' VAL . 7.6 t -82.18 73.5 9.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 122.195 0.998 . . . . 0.0 109.035 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.83 -140.46 2.99 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.72 -173.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -102.34 161.32 13.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.06 132.08 93.72 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.722 ' HB2' ' HE2' ' A' ' 144' ' ' MET . 14.3 Cg_exo -46.45 -75.67 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.641 2.894 . . . . 0.0 114.465 -167.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.614 ' HG3' ' OD1' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -92.87 -36.69 12.68 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.649 -176.746 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 173.16 38.95 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.8 t70 62.7 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -164.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.614 ' OD1' ' HG3' ' A' ' 156' ' ' ARG . 8.3 m-20 -63.55 161.36 14.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.386 -157.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 C--O 1.252 1.194 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.329 -176.292 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 28.6 ttpp . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -147.62 144.54 28.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.633 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 14.5 pt20 -147.31 126.82 13.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.898 0.38 . . . . 0.0 110.558 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.886 HG12 ' HB3' ' A' ' 47' ' ' LEU . 7.8 pt -117.3 138.13 48.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.12 0.486 . . . . 0.0 111.113 -176.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -103.95 126.97 51.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.518 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.828 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.0 mp -92.18 139.87 30.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.068 0.461 . . . . 0.0 111.286 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.763 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 36.8 tt0 -74.54 124.33 26.43 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.429 176.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.0 -15.7 62.57 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.533 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.483 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 33.4 t -120.0 124.09 28.04 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 120.957 0.408 . . . . 0.0 110.202 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 2.8 Cg_exo -77.31 7.71 3.61 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.055 2.503 . . . . 0.0 112.487 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.496 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -102.56 131.2 22.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.871 0.367 . . . . 0.0 111.254 -178.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 37.5 Cg_endo -98.88 136.89 0.31 Allowed 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.803 3.002 . . . . 0.0 112.69 174.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.886 ' HB3' HG12 ' A' ' 38' ' ' ILE . 13.8 tp -82.99 129.84 35.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.701 176.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.422 ' HE1' ' HG2' ' A' ' 46' ' ' PRO . 51.6 m-85 -118.38 133.12 56.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.96 0.41 . . . . 0.0 111.162 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.67 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 11.4 m-85 -150.2 148.96 29.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.477 174.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 m -77.32 -32.04 54.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.056 0.455 . . . . 0.0 110.488 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.741 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 41.5 mt-30 -88.14 122.53 31.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.682 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.639 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 6.2 t -63.77 -51.04 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.638 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -51.25 -36.44 42.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.867 179.124 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.638 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 36.0 t70 -76.39 -49.22 17.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.823 0.344 . . . . 0.0 110.604 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -62.53 -42.49 99.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.446 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.003 HD12 ' HB3' ' A' ' 114' ' ' ALA . 21.9 pt -65.42 -31.48 54.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.284 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.579 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . . . -60.87 -43.62 98.17 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 120.591 0.234 . . . . 0.0 110.487 174.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.64 ' HA ' ' HG2' ' A' ' 62' ' ' PRO . 11.8 m-85 -61.1 -40.11 92.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.285 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.44 ' HB1' HG21 ' A' ' 68' ' ' ILE . . . -67.05 -27.03 67.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.432 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.579 ' HE ' ' HA ' ' A' ' 57' ' ' ALA . 83.4 mtm180 -88.57 -1.48 58.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.019 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.06 -75.75 0.03 OUTLIER Glycine 0 CA--C 1.52 0.348 0 C-N-CA 119.581 -1.295 . . . . 0.0 114.045 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.64 ' HG2' ' HA ' ' A' ' 58' ' ' TYR . 30.7 Cg_exo -37.96 -51.31 1.93 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 124.314 3.343 . . . . 0.0 114.665 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -76.94 98.34 4.89 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -117.09 -23.11 8.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.208 -173.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.5 tp -67.45 -29.32 45.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.009 0.433 . . . . 0.0 111.244 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.828 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -141.5 141.45 22.96 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.763 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 57.8 Cg_endo -73.38 163.21 38.36 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.43 2.086 . . . . 0.0 111.993 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.44 HG21 ' HB1' ' A' ' 59' ' ' ALA . 14.3 pt -85.49 121.02 36.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.337 0.589 . . . . 0.0 110.882 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.81 -59.43 2.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.252 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.16 138.54 20.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.203 0.525 . . . . 0.0 110.298 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.506 HG13 HG22 ' A' ' 38' ' ' ILE . 2.3 tt -122.52 129.25 75.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.399 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -111.73 130.69 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.4 m -127.4 139.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.77 0.795 . . . . 0.0 111.25 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 7.0 m-20 -87.58 101.67 13.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 170.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.944 ' HB3' ' HB2' ' A' ' 90' ' ' ASN . 12.5 t0 -46.95 108.34 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.846 1.341 . . . . 0.0 109.267 175.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.572 ' C ' ' HG3' ' A' ' 86' ' ' PRO . 14.0 ttt -162.65 -101.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.591 -165.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.469 ' H ' ' HB3' ' A' ' 76' ' ' MET . . . -79.7 63.1 4.06 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-O 122.112 0.84 . . . . 0.0 111.978 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 115' ' ' VAL . . . -142.75 -55.05 0.42 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.176 -1.512 . . . . 0.0 107.018 174.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.81 -20.76 65.21 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.039 166.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.643 ' HA3' ' HD3' ' A' ' 86' ' ' PRO . . . -89.37 -96.65 1.07 Allowed Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.158 175.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -178.88 -51.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 85' ' ' GLN . 71.9 p -107.7 175.75 5.38 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.741 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 10.9 p90 -70.45 -31.13 68.16 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.273 0.559 . . . . 0.0 110.125 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.87 -28.69 25.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.036 -174.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.509 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.9 OUTLIER -61.71 -60.19 11.07 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -167.669 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.643 ' HD3' ' HA3' ' A' ' 80' ' ' GLY . 7.0 Cg_endo -44.75 -57.57 1.98 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.298 2.665 . . . . 0.0 113.523 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.49 -45.7 2.57 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 76' ' ' MET . 11.4 m-20 -77.01 146.85 37.15 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.407 0.283 . . . . 0.0 110.474 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.96 100.65 0.29 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.857 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 91.7 m-20 -95.85 150.26 20.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 175.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -109.6 128.08 54.97 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.194 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.3 pt -145.52 163.45 11.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.635 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.7 109.13 21.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.62 -33.03 74.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.792 -174.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.87 ' HA ' HD13 ' A' ' 137' ' ' LEU . 12.7 t70 -58.66 -31.46 68.18 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.83 0.824 . . . . 0.0 110.566 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -111.31 38.29 2.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.207 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' A' ' 117' ' ' PHE . . . -140.09 169.81 17.01 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.535 -168.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -90.25 143.28 26.91 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.096 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.478 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 3.2 m-85 -119.81 134.3 55.29 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.828 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.642 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.2 p -113.17 121.54 65.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.624 HG12 HH11 ' A' ' 106' ' ' ARG . 19.7 t -101.79 103.06 14.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.755 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -68.75 133.11 27.12 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.777 -173.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.9 t -92.11 -21.99 20.14 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.64 -43.81 68.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.608 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.519 ' HB2' ' OE1' ' A' ' 113' ' ' GLU . 77.1 mtt180 -100.97 -85.84 0.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.672 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.755 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 3.7 ttp180 58.42 -96.6 0.07 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.484 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 167.6 -60.56 0.21 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -170.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 61.73 -84.83 0.03 OUTLIER Glycine 0 C--N 1.332 0.341 0 O-C-N 123.823 0.366 . . . . 0.0 113.034 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.2 tpt -82.99 -4.36 58.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.023 0.44 . . . . 0.0 110.381 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.79 -128.98 3.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.474 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.444 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.1 102.97 31.49 Favored Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 122.918 -0.166 . . . . 0.0 111.137 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 2.4 Cg_endo -47.31 150.51 3.36 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.413 3.409 . . . . 0.0 113.936 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.704 ' HB3' ' HA ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -114.42 138.11 50.98 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.293 -172.191 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 1.003 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -128.77 130.33 46.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.649 172.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.642 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 14.5 t -106.97 104.85 53.63 Favored Pre-proline 0 C--N 1.315 -0.933 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.553 172.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 2.7 Cg_exo -84.76 123.75 2.9 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.79 2.994 . . . . 0.0 112.697 178.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.469 ' O ' ' HB1' ' A' ' 97' ' ' ALA . 43.1 m-85 -127.0 149.18 50.01 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.879 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.9 t -79.68 -26.63 40.92 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.588 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 19.3 m -100.51 124.11 45.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.957 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -37.24 84.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.283 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.588 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 19.5 p-10 -63.65 -32.37 73.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.661 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 119' ' ' SER . 43.7 mm-40 -64.28 -42.7 96.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.998 0.428 . . . . 0.0 110.259 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.85 -37.88 79.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.718 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.86 94.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.67 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' A' ' 128' ' ' LEU . . . -59.92 -35.65 75.36 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 110.943 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -65.24 -37.37 87.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.204 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.488 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 46.9 t -72.24 -32.21 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.561 178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 125' ' ' ALA . 69.5 mt -58.33 -40.38 81.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.84 -49.63 9.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.549 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.647 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.6 pt-20 -149.65 -90.14 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.944 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.647 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 51.4 -149.76 7.66 Favored Glycine 0 C--N 1.331 0.267 0 N-CA-C 114.203 0.441 . . . . 0.0 114.203 173.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.427 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -163.86 -96.73 0.11 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.541 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -123.32 144.33 49.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.941 0.37 . . . . 0.0 110.513 176.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.5 t -101.17 122.4 53.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.346 0.593 . . . . 0.0 110.646 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 140' ' ' ILE . 0.4 OUTLIER -147.11 154.7 41.44 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.669 178.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.411 ' H ' ' HB3' ' A' ' 139' ' ' ASP . . . -79.48 168.61 19.21 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.87 HD13 ' HA ' ' A' ' 95' ' ' ASP . 7.0 tt -67.71 -34.13 76.27 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.99 -15.33 60.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.254 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 136' ' ' ALA . 36.2 t70 -111.23 0.69 16.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.24 0.543 . . . . 0.0 110.861 -174.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.588 ' HA ' HD22 ' A' ' 135' ' ' LEU . 1.4 tt -71.64 144.79 12.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.514 0.673 . . . . 0.0 110.902 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.32 148.16 43.49 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.421 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -69.05 -30.41 68.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.006 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.841 ' HB3' ' HB3' ' A' ' 155' ' ' PRO . . . -65.29 -28.55 69.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.701 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.1 mmt -78.34 -26.23 46.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.672 0.272 . . . . 0.0 111.279 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.462 HG11 ' HD2' ' A' ' 60' ' ' ARG . 4.0 t -86.58 -23.54 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.059 0.457 . . . . 0.0 110.763 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 pp -157.04 132.42 9.17 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.18 -175.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 34.7 p -107.04 135.65 19.56 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.586 0.708 . . . . 0.0 111.642 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.472 ' HG2' ' H ' ' A' ' 150' ' ' GLU . 51.7 Cg_endo -93.04 -131.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.804 3.002 . . . . 0.0 111.47 175.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.434 ' H ' ' HB2' ' A' ' 148' ' ' PRO . 6.8 t -97.78 2.85 10.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.743 0.782 . . . . 0.0 109.123 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.472 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 42.0 mt-10 59.98 22.1 11.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.579 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.6 t -87.28 26.72 1.16 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.102 0.953 . . . . 0.0 109.03 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -118.48 -124.46 3.36 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.273 -172.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.1 p -129.39 161.77 29.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.642 0.258 . . . . 0.0 110.651 -176.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.499 ' HB3' ' HA ' ' A' ' 158' ' ' ASP . 2.0 mp0 -71.6 139.96 84.01 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.727 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.841 ' HB3' ' HB3' ' A' ' 143' ' ' ALA . 52.6 Cg_endo -72.93 -29.91 11.64 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.816 2.344 . . . . 0.0 111.86 176.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 159' ' ' ASP . 6.8 ptp180 -144.55 -141.72 0.12 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.614 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.417 ' H ' ' HB2' ' A' ' 156' ' ' ARG . . . -71.1 72.7 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 170.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 155' ' ' PRO . 9.8 t70 62.27 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -164.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.577 ' HA ' ' HG3' ' A' ' 156' ' ' ARG . 5.0 p-10 -171.81 -166.67 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.573 0.225 . . . . 0.0 110.552 167.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 C--O 1.251 1.182 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.845 -175.898 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 37.0 tttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.491 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -141.49 143.08 33.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.699 0.681 . . . . 0.0 112.135 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 10.7 pt20 -149.29 139.26 22.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.538 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.564 HG22 ' HB ' ' A' ' 71' ' ' ILE . 17.1 pt -122.33 138.14 53.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.163 0.506 . . . . 0.0 111.622 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -98.86 116.39 31.0 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 173.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.814 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.4 mp -92.17 134.24 35.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.98 0.419 . . . . 0.0 110.765 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.896 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 39.9 tt0 -71.75 125.82 28.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.516 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.67 -26.63 23.89 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 23.1 t -97.79 126.08 42.11 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.3 Cg_exo -74.2 -9.59 22.0 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.878 2.385 . . . . 0.0 113.177 -174.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.25 146.55 49.58 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.821 0.343 . . . . 0.0 111.587 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.24 151.45 26.58 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.824 2.349 . . . . 0.0 112.389 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tt -108.77 101.18 10.32 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 53.9 p90 -101.62 151.98 21.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.819 0.342 . . . . 0.0 110.592 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -148.04 149.74 32.65 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.656 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -64.28 -48.65 74.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.339 0.59 . . . . 0.0 110.764 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.725 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 35.0 mt-30 -78.63 113.99 17.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.391 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 36' ' ' ALA . 9.1 t -57.58 -48.83 82.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.639 HH11 ' HB2' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.34 -30.99 53.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.702 -178.409 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.639 ' HB2' HH11 ' A' ' 53' ' ' ARG . 14.1 t70 -76.37 -48.48 19.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.804 0.335 . . . . 0.0 110.683 -177.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.77 83.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.333 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.855 HD12 ' HB3' ' A' ' 114' ' ' ALA . 23.3 pt -67.47 -30.24 48.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.728 0.299 . . . . 0.0 110.676 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.07 88.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.861 0.362 . . . . 0.0 110.309 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -59.66 -37.32 78.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.434 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -70.58 -18.28 62.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.905 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.572 HH12 HG11 ' A' ' 145' ' ' VAL . 48.9 mtm180 -105.07 12.38 32.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.57 -72.42 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.317 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.24 -2.01 0.22 Allowed 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 123.905 3.07 . . . . 0.0 115.145 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.481 ' OE1' HG12 ' A' ' 68' ' ' ILE . 1.1 pt-20 -74.4 53.63 0.54 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.578 0.704 . . . . 0.0 110.033 171.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -92.33 -39.93 11.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.725 -176.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -75.79 -30.22 21.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.074 0.464 . . . . 0.0 110.545 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.814 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.06 140.41 13.45 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.347 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.896 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 80.4 Cg_endo -77.9 153.77 29.43 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.546 2.164 . . . . 0.0 112.134 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.709 HD13 ' HB1' ' A' ' 59' ' ' ALA . 46.6 pt -77.96 125.47 37.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.304 0.573 . . . . 0.0 110.188 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tt -86.0 -52.5 5.67 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -156.66 141.12 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.129 176.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.564 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.9 tt -114.6 129.19 71.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.322 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.462 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 87.1 m-85 -111.96 128.24 56.1 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 94' ' ' ALA . 28.2 m -126.05 157.02 36.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.455 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 6.1 m-20 -86.95 110.3 19.93 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 15.8 t70 -52.8 98.06 0.02 OUTLIER 'General case' 0 C--O 1.239 0.542 0 O-C-N 125.338 1.649 . . . . 0.0 109.503 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.633 ' SD ' ' HB2' ' A' ' 86' ' ' PRO . 2.0 mmt -179.71 87.74 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.548 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 79' ' ' ALA . . . -146.57 36.87 1.23 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 16.88 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -167.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -156.04 7.09 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.893 0.378 . . . . 0.0 110.537 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA3' ' NH1' ' A' ' 106' ' ' ARG . . . 130.0 -12.18 5.86 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.259 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.29 63.74 0.76 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.604 0.716 . . . . 0.0 109.945 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 46.3 p -83.81 176.71 8.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.409 -172.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.725 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 41.3 p-90 -66.62 -25.08 66.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.155 0.502 . . . . 0.0 110.275 172.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -77.5 -36.16 52.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.24 175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 67.93 150.64 0.12 Allowed Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.889 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.633 ' HB2' ' SD ' ' A' ' 76' ' ' MET . 17.1 Cg_exo -72.7 0.2 7.98 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.701 2.267 . . . . 0.0 111.568 169.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.46 176.26 15.64 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.055 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.34 135.76 38.4 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.77 -136.6 3.59 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.073 -174.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.599 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 53.7 t30 -89.91 151.34 21.78 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -173.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -98.8 128.91 45.16 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.896 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.714 HG21 ' HB2' ' A' ' 118' ' ' SER . 25.9 pt -145.17 162.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.185 -175.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.29 110.7 19.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.501 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -69.51 -35.25 75.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -172.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.656 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -68.35 -22.73 64.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.797 0.808 . . . . 0.0 109.791 -178.394 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 43.2 mmtm -102.68 26.5 7.92 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.767 175.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.09 176.69 7.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.475 -171.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -91.36 134.48 34.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.035 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.514 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 7.8 m-85 -120.39 136.16 54.81 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.946 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.897 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.1 p -115.62 122.39 69.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.445 0.64 . . . . 0.0 109.639 173.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.683 HG23 HD11 ' A' ' 135' ' ' LEU . 48.1 t -101.59 109.78 26.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.765 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -69.69 125.05 16.15 Favored Glycine 0 N--CA 1.448 -0.531 0 O-C-N 123.986 0.804 . . . . 0.0 113.263 -173.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.0 t -90.13 -38.58 13.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.839 0.352 . . . . 0.0 110.227 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -80.29 -43.72 20.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 111.466 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 79.8 mtt180 -125.65 107.08 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.014 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.731 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 1.2 tpp180 173.93 -177.28 0.08 Allowed 'General case' 0 C--O 1.232 0.165 0 O-C-N 123.941 0.776 . . . . 0.0 109.68 171.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.02 -57.33 19.82 Favored Glycine 0 N--CA 1.451 -0.33 0 O-C-N 123.368 0.417 . . . . 0.0 113.615 -176.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.63 -98.26 0.59 Allowed Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.428 ' CE ' ' HA ' ' A' ' 148' ' ' PRO . 4.1 mmt -86.99 -3.35 59.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.952 0.406 . . . . 0.0 110.733 173.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.7 -127.93 6.12 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.24 96.17 7.9 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.787 0.327 . . . . 0.0 110.598 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 72.6 Cg_endo -76.51 147.64 28.72 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.384 2.056 . . . . 0.0 112.498 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.731 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 32.1 mt-10 -129.33 131.68 46.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.462 -176.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.855 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -93.87 131.1 39.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.499 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.897 ' HB ' HG13 ' A' ' 100' ' ' VAL . 87.0 t -95.94 106.28 26.96 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 120.89 0.376 . . . . 0.0 110.227 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.3 Cg_endo -91.55 123.68 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.586 2.857 . . . . 0.0 112.677 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -132.97 150.42 52.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.092 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.714 ' HB2' HG21 ' A' ' 92' ' ' ILE . 9.7 t -86.9 -21.92 26.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.1 m -93.77 119.48 32.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.873 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -61.62 -48.01 82.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.096 0.474 . . . . 0.0 111.202 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.59 -29.57 70.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.618 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -62.15 -41.58 98.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.578 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -69.87 -37.02 75.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.131 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.68 86.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.048 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.95 82.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.105 0.479 . . . . 0.0 110.452 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -60.66 -42.86 97.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.736 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.631 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 55.1 t -61.97 -42.33 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.158 177.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tp -54.36 -36.16 63.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.784 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.06 -40.1 15.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.29 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -164.52 -35.13 0.03 OUTLIER 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.765 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -49.39 156.07 1.81 Allowed Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.45 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.443 ' N ' ' HA2' ' A' ' 102' ' ' GLY . . . -94.03 -82.67 1.56 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.949 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.491 ' NE2' ' HB3' ' A' ' 159' ' ' ASP . 3.3 pt20 -130.36 150.42 51.6 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.835 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.34 113.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.366 0.603 . . . . 0.0 110.214 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.683 HD11 HG23 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -133.89 159.97 39.07 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.759 -179.047 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.434 ' H ' ' HB3' ' A' ' 139' ' ' ASP . . . -84.69 168.63 15.07 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.656 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 6.0 tt -65.2 -32.08 73.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.312 0.577 . . . . 0.0 109.497 178.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.91 -10.26 59.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.735 176.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 136' ' ' ALA . 18.0 t70 -116.4 14.92 15.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.297 -174.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.644 HD13 HD13 ' A' ' 135' ' ' LEU . 36.6 mm -71.49 121.41 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.76 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.5 t -108.36 147.82 30.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.126 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -69.41 -22.87 63.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.122 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 155' ' ' PRO . . . -67.4 -30.07 69.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.654 -175.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.445 ' HG3' ' HG2' ' A' ' 133' ' ' GLN . 78.1 mmm -86.44 -37.78 17.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.832 0.348 . . . . 0.0 111.189 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.572 HG11 HH12 ' A' ' 60' ' ' ARG . 13.3 t -78.81 -21.86 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.522 0.677 . . . . 0.0 110.44 -174.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -147.31 104.82 3.68 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.119 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.5 ' HB ' ' OE2' ' A' ' 150' ' ' GLU . 20.0 p -102.06 123.91 41.86 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.613 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.499 ' O ' HG22 ' A' ' 151' ' ' THR . 71.9 Cg_endo -74.51 44.42 1.07 Allowed 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.405 2.737 . . . . 0.0 112.251 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.458 ' O ' HG12 ' A' ' 149' ' ' VAL . 6.5 t 54.79 28.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 122.067 0.937 . . . . 0.0 109.869 -174.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.5 ' OE2' ' HB ' ' A' ' 147' ' ' THR . 1.8 mp0 59.28 23.06 11.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.214 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 148' ' ' PRO . 6.9 t -81.57 13.77 2.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.792 0.806 . . . . 0.0 109.539 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . -119.55 -142.59 6.78 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.788 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.4 t -96.61 163.23 13.11 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -57.11 151.88 32.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.511 ' HA ' ' HB1' ' A' ' 143' ' ' ALA . 11.4 Cg_endo -54.39 -22.99 29.06 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.07 2.513 . . . . 0.0 113.087 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.53 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 2.1 ptp180 -174.96 -54.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.256 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.53 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -163.21 30.39 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.761 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.5 t70 54.22 68.25 0.88 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.845 0.831 . . . . 0.0 109.465 -170.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.491 ' HB3' ' NE2' ' A' ' 133' ' ' GLN . 27.7 t0 -100.51 -6.14 25.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.397 -172.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.076 -179.608 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.604 ' N ' ' HB3' ' A' ' 74' ' ' ASN . 79.8 tttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.737 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -143.15 144.75 32.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.046 0.385 . . . . 0.0 111.401 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 12.5 pt20 -149.2 140.1 22.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.615 HG22 ' HB ' ' A' ' 71' ' ' ILE . 24.2 pt -115.77 131.15 69.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.112 0.482 . . . . 0.0 110.19 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -98.75 118.22 34.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.848 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.4 mp -84.04 153.24 23.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.375 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.545 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 28.9 tt0 -74.12 126.84 31.45 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.962 177.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.82 -41.46 3.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.561 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.9 t -81.93 125.28 77.97 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.1 Cg_exo -79.09 -3.97 13.53 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.14 2.56 . . . . 0.0 112.493 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -101.82 133.54 20.69 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.59 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 61.2 Cg_endo -92.03 133.44 1.31 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.01 2.473 . . . . 0.0 112.315 176.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.9 tt -86.96 105.62 17.25 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 40.2 p90 -111.79 143.73 42.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.183 0.516 . . . . 0.0 111.468 -175.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -150.01 138.92 20.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.422 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 15.1 m -58.91 -37.0 75.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.95 0.405 . . . . 0.0 111.342 -177.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.539 ' HB3' ' HD2' ' A' ' 53' ' ' ARG . 51.2 mt-30 -81.86 109.29 16.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.432 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.737 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 39.8 t -59.31 -46.77 92.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.147 0.499 . . . . 0.0 110.661 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.539 ' HD2' ' HB3' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -57.15 -30.29 64.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.469 -178.375 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -74.6 -48.64 25.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 110.28 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.81 90.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.75 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 53' ' ' ARG . 35.1 pt -66.05 -31.74 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.545 0.212 . . . . 0.0 110.579 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.3 90.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.781 176.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.629 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 54.5 m-85 -62.74 -37.49 86.79 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 111.444 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.733 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -63.99 -17.87 63.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.229 -175.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 -100.31 12.66 36.61 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -173.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.48 -56.41 0.34 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.457 -1.354 . . . . 0.0 113.863 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.629 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 34.2 Cg_exo -60.62 6.53 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.346 2.698 . . . . 0.0 114.458 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -66.89 105.54 1.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 170.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -128.68 77.82 1.81 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.39 0.614 . . . . 0.0 110.864 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 66' ' ' ALA . 5.4 tp 177.42 -52.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.723 176.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.848 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.28 146.33 18.34 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.545 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 66.7 Cg_endo -72.41 156.71 54.23 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.109 1.873 . . . . 0.0 111.994 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.733 HD13 ' HB1' ' A' ' 59' ' ' ALA . 46.1 pt -73.47 129.94 36.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.08 0.467 . . . . 0.0 110.577 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tt -88.86 -49.67 6.67 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -160.46 139.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.067 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 38' ' ' ILE . 4.4 tt -108.94 129.87 62.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 120.912 0.387 . . . . 0.0 110.115 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -111.84 127.29 55.78 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.63 153.72 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.007 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.604 ' HB3' ' N ' ' A' ' 35' ' ' LYS . 25.7 t-20 -80.17 102.0 9.15 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 25.5 t70 -49.66 107.1 0.13 Allowed 'General case' 0 C--O 1.243 0.72 0 O-C-N 125.808 1.943 . . . . 0.0 110.973 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.534 ' HG3' ' O ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -171.36 151.56 3.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.377 -179.419 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.5 50.3 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.598 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.68 88.83 3.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.19 32.04 20.72 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.485 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.15 -90.87 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.991 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.496 ' HB3' HG22 ' A' ' 115' ' ' VAL . . . 61.86 33.15 17.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.541 0.686 . . . . 0.0 110.278 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.558 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 20.4 p -83.74 177.08 8.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.721 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -55.51 -35.64 65.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.811 0.339 . . . . 0.0 111.288 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -77.24 -30.37 54.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 82' ' ' THR . 22.8 mt-30 63.88 170.28 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.498 175.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -94.44 9.73 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.547 2.165 . . . . 0.0 111.468 171.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.24 130.08 5.97 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.018 -177.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -64.65 135.09 55.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.696 0.284 . . . . 0.0 110.769 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.27 -79.0 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.172 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.774 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 43.9 t30 -100.07 153.49 19.18 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -120.02 131.35 55.11 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 121.691 -0.631 . . . . 0.0 110.676 173.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.78 HG21 ' HB2' ' A' ' 118' ' ' SER . 42.1 pt -141.98 167.37 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.839 -175.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 96' ' ' LYS . . . -84.64 116.99 23.49 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 171.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.457 ' O ' HD11 ' A' ' 137' ' ' LEU . . . -69.18 -39.63 78.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.596 -174.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.863 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 2.4 p-10 -78.13 0.58 24.29 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.939 0.876 . . . . 0.0 110.645 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 40.3 mmtm -127.18 56.49 1.52 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.235 169.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.647 ' H ' HD21 ' A' ' 137' ' ' LEU . . . -156.76 -170.12 3.21 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 121.738 -0.601 . . . . 0.0 112.101 -172.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.97 140.96 31.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.023 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 2.2 m-85 -120.68 136.75 54.76 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.09 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.511 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.0 p -113.08 120.49 63.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.773 0.797 . . . . 0.0 109.614 168.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.608 HG23 HD11 ' A' ' 135' ' ' LEU . 99.7 t -101.87 106.77 20.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.556 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.7 130.74 28.48 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.745 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.2 t -92.37 -28.91 16.61 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -87.26 -45.46 10.6 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.973 0.416 . . . . 0.0 110.133 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -128.93 129.8 45.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.482 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.952 HH21 HG13 ' A' ' 145' ' ' VAL . 36.6 ttt85 -170.07 -64.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.085 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 164.26 -44.63 0.31 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -177.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.19 -111.41 4.08 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.318 -0.467 . . . . 0.0 111.995 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.6 mtp -86.22 -3.78 59.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.178 0.514 . . . . 0.0 110.198 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.43 -126.28 3.91 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.473 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.39 92.85 4.28 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.938 0.369 . . . . 0.0 111.03 175.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.24 121.89 10.31 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.228 2.619 . . . . 0.0 112.715 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.48 139.27 49.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.026 0.441 . . . . 0.0 110.576 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.585 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -120.46 133.89 55.35 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.238 -172.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 39.9 t -100.84 105.02 35.56 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.541 -0.464 . . . . 0.0 109.942 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.9 Cg_exo -89.1 124.82 1.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.758 2.972 . . . . 0.0 111.356 171.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.644 ' HD1' ' H ' ' A' ' 119' ' ' SER . 1.7 t80 -135.73 149.13 49.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -176.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.78 ' HB2' HG21 ' A' ' 92' ' ' ILE . 24.1 t -80.35 -31.11 38.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.258 0.551 . . . . 0.0 110.273 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.644 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 16.3 m -90.08 113.37 25.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.346 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -43.04 75.54 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.402 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -63.83 -31.51 72.72 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.682 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.49 ' HG3' ' CE1' ' A' ' 117' ' ' PHE . 43.3 mm-40 -66.23 -43.0 87.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.84 175.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.1 80.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.111 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.43 79.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.874 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -59.7 -31.36 69.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.251 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -62.68 -44.02 97.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.677 HG22 ' H ' ' A' ' 132' ' ' GLY . 56.5 t -72.91 -29.21 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.469 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 9.0 tp -58.22 -35.84 72.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.016 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.68 -50.11 7.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.988 175.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.784 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.9 pt-20 -156.26 -79.95 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.39 175.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . 0.784 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.55 -129.7 11.41 Favored Glycine 0 C--N 1.335 0.502 0 O-C-N 123.522 0.514 . . . . 0.0 112.753 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.677 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -174.67 -83.01 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -130.22 139.28 50.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.819 0.342 . . . . 0.0 110.516 174.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.422 HG23 HG21 ' A' ' 127' ' ' VAL . 76.4 t -98.1 124.13 50.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.798 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -146.99 152.52 38.74 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.815 -177.173 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 140' ' ' ILE . . . -92.47 173.3 7.86 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.568 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.946 HD22 ' H ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -48.4 -40.73 26.8 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.305 178.785 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.61 -29.76 67.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.676 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.404 ' OD2' ' HB3' ' A' ' 135' ' ' LEU . 13.4 t70 -95.52 3.9 53.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.309 0.576 . . . . 0.0 110.33 -175.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.798 HD13 HD13 ' A' ' 135' ' ' LEU . 26.2 mm -71.37 119.43 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.279 0.561 . . . . 0.0 109.842 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.417 ' CG2' ' HG2' ' A' ' 144' ' ' MET . 3.5 t -119.39 148.43 43.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.003 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.1 p-10 -69.05 -25.81 64.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.729 0.3 . . . . 0.0 110.41 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.69 70.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.217 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.572 ' HE2' ' HG2' ' A' ' 156' ' ' ARG . 10.6 mmt -83.51 -34.11 25.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.07 0.462 . . . . 0.0 110.596 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.952 HG13 HH21 ' A' ' 106' ' ' ARG . 38.8 t -78.99 -25.21 13.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.488 -173.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.4 pp -158.07 151.82 23.76 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.276 -174.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.431 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 16.0 p -101.87 120.08 55.07 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.663 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 19.9 Cg_endo -62.87 -71.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.364 2.043 . . . . 0.0 111.213 175.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.13 12.63 3.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 151' ' ' THR . 39.4 mt-10 65.84 -76.87 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.798 -169.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 150' ' ' GLU . 1.1 t 53.71 -0.94 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.986 1.314 . . . . 0.0 114.348 176.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . 71.86 30.24 66.14 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.027 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.6 p -86.05 141.62 29.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.82 0.31 . . . . 0.0 110.509 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.0 125.33 91.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.577 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.17 -95.38 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.062 2.508 . . . . 0.0 112.647 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.718 HH21 ' HB3' ' A' ' 135' ' ' LEU . 1.9 ptp180 -67.89 -32.4 72.86 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 172.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.55 ' N ' ' HG3' ' A' ' 156' ' ' ARG . . . 172.67 -175.1 0.05 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.981 -1.918 . . . . 0.0 106.483 -174.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -82.59 60.72 5.34 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 122.013 0.911 . . . . 0.0 109.368 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -99.19 -15.88 18.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.196 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--O 1.253 1.251 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.999 -176.791 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 85.6 tttt . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.593 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -143.56 144.17 31.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.413 0.149 . . . . 0.0 110.823 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 29.0 pt20 -149.01 134.7 18.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.148 0.499 . . . . 0.0 110.767 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.669 HG22 ' HB ' ' A' ' 71' ' ' ILE . 37.6 pt -115.92 129.18 72.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.657 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -98.87 116.47 31.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.5 mp -91.85 142.72 27.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.873 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.95 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 34.4 tt0 -74.26 125.06 27.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.603 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.93 -23.74 33.0 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.731 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.509 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 39.7 t -88.49 129.41 49.31 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.4 Cg_exo -77.58 -3.35 13.51 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.897 2.398 . . . . 0.0 112.323 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.25 139.69 32.36 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.813 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.76 149.47 8.53 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.596 2.197 . . . . 0.0 112.167 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 10.3 tt -89.07 111.57 22.34 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -124.11 135.95 53.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.204 0.526 . . . . 0.0 111.623 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -146.82 162.65 38.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.567 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 30.2 t -72.46 -41.89 65.56 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.919 ' HG2' ' HB2' ' A' ' 83' ' ' TRP . 37.9 mt-30 -65.65 113.08 3.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.485 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.593 HG13 ' HB2' ' A' ' 36' ' ' ALA . 4.5 t -72.66 -52.03 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.23 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.537 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -52.09 -35.71 48.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.444 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 51' ' ' GLN . 29.1 t70 -76.05 -51.9 11.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.577 0.227 . . . . 0.0 110.999 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.89 94.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.36 . . . . 0.0 111.394 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.926 HD12 ' HB3' ' A' ' 114' ' ' ALA . 23.9 pt -66.91 -30.56 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.691 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.24 97.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.663 0.268 . . . . 0.0 110.663 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.644 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 16.6 m-85 -63.05 -34.02 76.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.364 . . . . 0.0 110.785 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -69.68 -16.81 63.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.557 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.511 HH12 ' HG2' ' A' ' 112' ' ' PRO . 49.9 mtm180 -102.52 -0.7 31.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.049 -175.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.503 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -154.57 -73.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.998 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.644 ' HD2' ' HA ' ' A' ' 58' ' ' TYR . 76.2 Cg_exo -55.65 0.32 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.085 3.19 . . . . 0.0 115.095 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -79.78 9.09 5.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.935 0.397 . . . . 0.0 111.142 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 84.3 mm-40 -62.64 -18.01 61.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.89 0.376 . . . . 0.0 111.452 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.4 tp -70.49 -45.01 76.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.697 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.596 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.13 140.68 13.65 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.95 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 64.7 Cg_endo -68.31 143.76 59.62 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 122.244 1.963 . . . . 0.0 112.021 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.8 pt -74.07 113.11 11.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.229 0.538 . . . . 0.0 110.333 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.6 -50.8 10.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.8 p -161.2 140.45 2.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.227 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.669 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.7 tt -112.99 131.9 63.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.628 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 97.2 m-85 -111.84 135.51 52.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.444 HG23 HG13 ' A' ' 92' ' ' ILE . 27.8 m -131.59 140.82 47.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.445 0.64 . . . . 0.0 111.161 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 13.0 m120 -90.28 99.9 12.83 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -54.63 104.67 0.12 Allowed 'General case' 0 C--O 1.239 0.529 0 O-C-N 124.485 1.116 . . . . 0.0 111.025 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.653 ' O ' ' HD2' ' A' ' 86' ' ' PRO . 64.8 mtt -144.61 52.55 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.414 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.05 -52.56 4.51 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.338 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 67.12 -84.36 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.255 0.622 . . . . 0.0 112.221 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.71 -15.99 15.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.824 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.51 -43.25 96.88 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.647 ' CB ' ' HD3' ' A' ' 86' ' ' PRO . . . -95.02 -154.79 0.44 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.374 173.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.0 p -103.6 177.76 4.75 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.864 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.919 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 3.3 p90 -55.49 -13.27 1.43 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 172.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.61 -35.61 39.27 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 71.74 150.13 0.13 Allowed Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.38 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.653 ' HD2' ' O ' ' A' ' 76' ' ' MET . 48.2 Cg_endo -72.89 -61.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.455 2.104 . . . . 0.0 113.1 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.51 -179.21 39.65 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.372 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.14 136.82 42.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.196 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.3 -113.18 1.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.834 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -100.51 152.02 20.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.515 0.198 . . . . 0.0 111.053 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -105.25 124.94 50.39 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 168.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 1.004 HG21 ' HB2' ' A' ' 118' ' ' SER . 8.8 pt -145.81 164.48 10.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . . . -96.87 107.22 19.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.591 ' HB1' ' HE1' ' A' ' 99' ' ' TYR . . . -57.64 -33.14 67.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 111.188 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.795 ' HA ' HD13 ' A' ' 137' ' ' LEU . 9.1 t70 -62.12 -28.17 69.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.033 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -114.65 33.44 5.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.201 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -138.24 -175.07 3.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.739 0.304 . . . . 0.0 110.902 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -91.34 138.98 31.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.497 0.665 . . . . 0.0 110.61 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.591 ' HE1' ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -120.52 135.03 55.2 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.565 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.912 HG13 HG13 ' A' ' 115' ' ' VAL . 1.1 p -118.57 124.63 73.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.604 0.716 . . . . 0.0 109.752 169.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.577 HG11 ' HA ' ' A' ' 145' ' ' VAL . 65.3 t -101.65 117.82 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.149 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.719 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -77.87 125.82 7.42 Favored Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.452 -171.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -91.88 -36.71 13.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 110.909 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.11 -43.65 23.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.37 . . . . 0.0 111.138 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 71.4 mtp180 -131.02 96.97 4.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.543 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.789 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 2.8 tpp180 172.82 175.32 0.1 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.663 0.602 . . . . 0.0 109.905 173.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.1 70.4 3.15 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.366 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.19 -42.68 98.73 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.358 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.6 mtm -109.55 16.52 22.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.275 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.429 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -139.21 -122.33 1.98 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.475 -175.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.36 92.83 4.24 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 110.915 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.622 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 73.9 Cg_endo -77.3 135.34 14.95 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.61 2.207 . . . . 0.0 112.958 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.789 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 30.9 mt-10 -115.13 146.45 41.34 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.029 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.926 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -118.42 133.14 56.11 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.738 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.912 HG13 HG13 ' A' ' 100' ' ' VAL . 0.5 OUTLIER -101.86 105.69 43.03 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.685 171.047 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 6.6 Cg_exo -81.99 123.8 4.21 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 124.425 3.416 . . . . 0.0 111.77 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.76 ' HD1' ' H ' ' A' ' 119' ' ' SER . 1.2 t80 -135.16 149.59 49.99 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.988 0.423 . . . . 0.0 110.154 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . 1.004 ' HB2' HG21 ' A' ' 92' ' ' ILE . 29.2 t -78.34 -34.68 48.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.615 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.76 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 8.0 m -91.34 116.93 29.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.211 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -58.14 -44.56 87.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.965 0.412 . . . . 0.0 111.495 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -61.63 -31.56 71.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.099 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -67.48 -41.52 84.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.655 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.39 83.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.128 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.25 92.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.774 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.16 86.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.101 0.477 . . . . 0.0 110.567 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -62.0 -38.71 89.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.84 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.607 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 48.2 t -65.99 -42.8 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.903 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.2 mt -53.96 -35.36 61.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.643 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.01 -46.6 11.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.0 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -159.07 -34.58 0.06 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.719 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -50.43 157.86 1.98 Allowed Glycine 0 C--N 1.32 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.024 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -101.27 -68.5 0.83 Allowed Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.74 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.451 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.2 140.96 50.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.741 0.305 . . . . 0.0 110.831 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.411 HG23 HG21 ' A' ' 127' ' ' VAL . 89.0 t -98.38 112.87 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.284 0.564 . . . . 0.0 109.664 172.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.882 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -137.58 144.88 42.23 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.766 -178.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.96 157.59 37.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' ' 95' ' ' ASP . 4.5 tt -63.32 -28.85 70.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.418 0.628 . . . . 0.0 109.673 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.32 -9.56 53.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.425 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -123.45 18.1 9.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.09 0.472 . . . . 0.0 110.539 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.882 HD13 HD13 ' A' ' 135' ' ' LEU . 38.2 mm -71.78 121.65 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.197 0.522 . . . . 0.0 110.387 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 1.022 HG21 ' HA ' ' A' ' 156' ' ' ARG . 2.9 t -111.47 148.24 33.57 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.722 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.497 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.3 p-10 -69.27 -22.31 63.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.681 0.277 . . . . 0.0 110.656 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.27 -33.41 74.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.936 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.654 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 7.2 mmt -87.26 -30.14 21.14 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.806 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.577 ' HA ' HG11 ' A' ' 101' ' ' VAL . 5.0 t -80.53 -22.91 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.991 0.424 . . . . 0.0 110.746 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.6 pp -154.47 134.26 12.93 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.372 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.9 p -116.39 149.37 43.55 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.162 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -58.99 -58.05 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.476 2.117 . . . . 0.0 109.621 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 25.7 t -127.56 -72.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 165.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 149' ' ' VAL . 7.5 mt-10 165.2 -77.03 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.438 1.495 . . . . 0.0 108.493 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.7 t 46.18 28.99 0.73 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.504 1.122 . . . . 0.0 113.129 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 74.92 64.36 2.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.286 -176.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.6 t -89.93 162.08 15.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.922 0.392 . . . . 0.0 110.873 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -88.69 150.97 47.12 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.108 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.642 ' HA ' ' SD ' ' A' ' 144' ' ' MET . 60.3 Cg_endo -73.12 -136.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.991 2.461 . . . . 0.0 113.125 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.022 ' HA ' HG21 ' A' ' 141' ' ' THR . 0.0 OUTLIER -57.21 -29.14 63.49 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -174.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -179.49 20.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.371 0.419 . . . . 0.0 110.638 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.1 t70 48.49 70.52 0.44 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.684 0.754 . . . . 0.0 109.133 -169.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.519 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 14.3 t70 -145.14 -42.18 0.23 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.53 -167.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 C--O 1.247 0.963 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.691 -179.787 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 74' ' ' ASN . 16.5 ttmm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.558 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -133.14 141.88 48.37 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.84 175.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 9.4 pt20 -149.65 132.66 16.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.828 174.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.628 HG21 ' HB2' ' A' ' 59' ' ' ALA . 28.6 pt -115.95 133.68 61.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.3 0.571 . . . . 0.0 111.458 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -103.81 119.51 39.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.696 HD23 ' HB3' ' A' ' 66' ' ' ALA . 11.1 mp -89.63 153.95 20.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.276 0.56 . . . . 0.0 111.503 -174.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.593 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 29.7 tt0 -71.68 125.54 27.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.635 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.31 -27.36 5.7 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.199 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.514 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.9 t -87.98 128.38 54.14 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 8.9 Cg_endo -87.29 -1.35 7.74 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.122 2.548 . . . . 0.0 112.612 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.23 132.98 21.83 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.828 0.347 . . . . 0.0 111.053 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -87.77 124.57 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.675 2.25 . . . . 0.0 112.036 174.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 7.2 tt -80.56 109.0 14.67 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -108.84 143.13 38.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.988 0.423 . . . . 0.0 110.831 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.613 ' HD1' ' H ' ' A' ' 51' ' ' GLN . 1.9 t80 -144.66 145.24 31.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.696 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.7 m -63.97 -34.95 79.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.194 0.521 . . . . 0.0 110.201 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.623 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 76.1 mt-30 -83.38 105.96 14.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.051 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 36' ' ' ALA . 8.6 t -56.37 -51.46 63.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.285 0.564 . . . . 0.0 109.57 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.65 ' HB3' ' HB3' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -55.5 -32.84 63.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.682 -1.145 . . . . 0.0 113.205 -178.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.552 ' HB2' HH11 ' A' ' 53' ' ' ARG . 22.8 t70 -76.28 -50.08 15.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.013 0.435 . . . . 0.0 110.839 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -64.95 -39.47 93.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.276 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.675 HD12 ' HB3' ' A' ' 114' ' ' ALA . 16.2 pt -70.16 -30.53 43.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.625 0.25 . . . . 0.0 110.628 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.07 82.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.141 0.496 . . . . 0.0 110.075 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -62.01 -34.91 77.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.13 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.687 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -72.89 -18.17 61.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.993 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -96.52 12.47 31.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -172.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.32 -61.51 0.1 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.521 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.35 22.43 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.145 2.563 . . . . 0.0 114.8 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.65 74.09 9.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.134 0.968 . . . . 0.0 110.376 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.454 ' O ' HG22 ' A' ' 65' ' ' ILE . 83.5 mt-30 -79.09 145.82 33.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.25 -172.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 64' ' ' GLN . 1.9 tp 72.74 -38.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.91 1.284 . . . . 0.0 112.345 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.696 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -133.44 139.57 34.35 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 122.007 -0.433 . . . . 0.0 110.413 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 96.2 Cg_endo -85.59 159.97 10.8 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.95 2.434 . . . . 0.0 112.061 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.687 HD13 ' HB1' ' A' ' 59' ' ' ALA . 28.0 pt -77.08 113.35 16.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.31 0.576 . . . . 0.0 110.465 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -77.54 -46.81 21.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.7 p -158.28 138.82 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.395 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.604 HD11 HG22 ' A' ' 56' ' ' ILE . 2.6 tt -116.94 134.35 60.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.027 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.94 128.78 56.26 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 94' ' ' ALA . 29.0 m -126.96 151.93 34.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.26 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 16.5 m120 -91.49 105.65 17.91 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.54 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.589 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 18.3 t70 -48.26 134.02 15.04 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 125.928 2.018 . . . . 0.0 110.844 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 74' ' ' ASN . 23.9 mmt -127.04 176.55 7.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -167.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.406 ' H ' ' HG2' ' A' ' 86' ' ' PRO . . . -60.95 -19.38 56.37 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.73 173.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 83.47 -45.16 0.11 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.16 0.584 . . . . 0.0 112.33 168.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.54 -44.22 76.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.061 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.03 -87.1 0.78 Allowed Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.506 173.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.439 ' H ' ' HD3' ' A' ' 86' ' ' PRO . . . 53.73 26.16 5.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.52 0.676 . . . . 0.0 111.699 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.0 p -83.67 179.16 7.68 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.983 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.623 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 48.6 p90 -59.5 -24.2 63.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.733 0.301 . . . . 0.0 111.267 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -81.37 -35.29 30.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.824 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 68.74 140.22 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.668 174.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.496 ' HD2' ' SD ' ' A' ' 76' ' ' MET . 96.5 Cg_endo -85.14 31.71 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.36 2.04 . . . . 0.0 113.577 -173.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 118.01 -171.83 14.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.125 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.4 147.22 36.14 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.493 0.317 . . . . 0.0 110.728 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -141.58 -158.06 7.4 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.169 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.603 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 41.9 m-80 -100.17 150.44 22.51 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 40.8 p-90 -98.56 130.28 45.11 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.444 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.758 HG21 ' HB2' ' A' ' 118' ' ' SER . 14.1 pt -143.97 160.6 15.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.601 -173.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.68 101.16 9.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.108 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.579 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -62.11 -38.95 90.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.349 -172.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 14.0 t70 -58.85 -30.43 67.69 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.666 0.746 . . . . 0.0 110.301 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -107.96 25.73 11.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.123 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.13 -177.21 3.79 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.847 0.356 . . . . 0.0 110.485 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -97.79 136.81 37.59 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.527 0.68 . . . . 0.0 110.475 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.66 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 7.6 m-85 -120.5 136.18 54.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.88 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.705 HG13 ' HB ' ' A' ' 115' ' ' VAL . 3.2 p -114.77 127.89 72.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.423 0.63 . . . . 0.0 109.762 174.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.597 HG11 ' HA ' ' A' ' 145' ' ' VAL . 96.4 t -101.46 103.49 14.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -80.49 123.16 5.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.555 -174.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.8 t -92.51 -29.54 16.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.587 0.232 . . . . 0.0 110.756 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.18 60.74 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -171.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -139.19 101.53 4.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.421 173.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.952 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 19.4 tpp180 -175.06 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.845 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.65 42.09 0.15 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.113 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.97 -34.38 89.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.266 -0.968 . . . . 0.0 111.715 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.0 ttt -109.5 2.23 20.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.096 0.474 . . . . 0.0 110.326 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.425 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -136.56 -123.52 2.26 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.72 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.8 99.08 12.61 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.977 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 72.1 Cg_endo -79.18 151.38 23.44 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.143 2.562 . . . . 0.0 113.696 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.952 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 25.9 mt-10 -128.82 146.52 50.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.603 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.675 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -93.79 130.93 39.62 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.945 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.705 ' HB ' HG13 ' A' ' 100' ' ' VAL . 55.4 t -101.28 106.4 45.13 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 6.1 Cg_exo -86.26 132.52 3.79 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.656 2.904 . . . . 0.0 112.305 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.755 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.8 t80 -137.66 149.43 46.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.758 ' HB2' HG21 ' A' ' 92' ' ' ILE . 35.5 t -77.97 -37.88 46.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.846 0.355 . . . . 0.0 111.148 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.755 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 17.8 m -95.75 129.74 42.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.826 0.346 . . . . 0.0 110.645 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -65.92 -49.72 66.97 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.229 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -63.18 -29.65 70.95 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.554 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -65.73 -42.92 90.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.554 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.7 -36.95 73.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.229 0.538 . . . . 0.0 110.035 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.03 -34.56 71.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.846 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.69 81.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.036 0.446 . . . . 0.0 110.356 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -62.43 -37.59 86.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.751 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.7 HG22 ' H ' ' A' ' 132' ' ' GLY . 93.2 t -70.95 -38.13 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.974 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.1 mt -53.24 -50.95 63.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.368 0.604 . . . . 0.0 110.11 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.59 78.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.133 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.76 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.3 pt-20 -165.55 -82.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.58 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.76 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 39.6 -132.79 2.15 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 123.915 0.759 . . . . 0.0 114.45 175.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.7 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -171.23 -93.37 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.77 139.66 51.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.711 0.291 . . . . 0.0 110.715 174.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.496 HG23 HG21 ' A' ' 127' ' ' VAL . 99.4 t -97.43 123.17 49.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.378 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.886 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -147.02 164.38 33.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.563 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.14 164.38 15.04 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.625 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 4.1 tt -61.44 -40.05 93.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.97 -8.62 38.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.592 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -124.67 17.96 8.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.248 0.547 . . . . 0.0 110.748 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.886 HD13 HD13 ' A' ' 135' ' ' LEU . 26.1 mm -71.78 121.92 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -116.86 146.0 43.2 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.96 -30.73 68.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.717 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.76 -28.78 68.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.923 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.6 mmt -77.62 -41.21 39.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.783 0.325 . . . . 0.0 110.953 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.597 ' HA ' HG11 ' A' ' 101' ' ' VAL . 3.0 t -81.52 -23.79 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.393 . . . . 0.0 111.217 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -156.62 159.33 38.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.552 -175.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 150' ' ' GLU . 3.4 p -100.02 120.35 57.11 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.657 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.26 -69.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.1 2.533 . . . . 0.0 112.406 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.69 0.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.288 0.566 . . . . 0.0 109.646 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.453 ' HG2' ' HB ' ' A' ' 147' ' ' THR . 40.1 mt-10 57.36 55.8 5.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.422 -175.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 t -90.94 -6.84 53.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.055 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 82.42 26.57 46.78 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.535 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 p -84.41 161.93 20.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.667 0.27 . . . . 0.0 110.646 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.885 ' HB3' ' H ' ' A' ' 158' ' ' ASP . 43.3 mp0 -61.38 131.96 92.58 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.59 -24.68 25.61 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.698 2.265 . . . . 0.0 113.253 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.498 HH11 ' HB3' ' A' ' 157' ' ' ALA . 5.8 ppt_? -155.13 -39.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.14 0.495 . . . . 0.0 110.527 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.498 ' HB3' HH11 ' A' ' 156' ' ' ARG . . . 179.33 53.89 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.885 ' H ' ' HB3' ' A' ' 154' ' ' GLU . 13.5 t70 63.38 -144.9 0.34 Allowed 'General case' 0 C--O 1.237 0.424 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 -156.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -154.17 161.49 41.82 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 119.662 1.119 . . . . 0.0 112.408 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 C--O 1.248 0.975 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.343 -173.281 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 28.7 tttm . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.767 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -135.91 143.71 45.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.541 0.21 . . . . 0.0 111.099 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -149.35 139.55 22.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.645 0.26 . . . . 0.0 110.417 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.449 HG22 ' HB ' ' A' ' 71' ' ' ILE . 32.5 pt -116.01 136.1 54.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.992 0.425 . . . . 0.0 111.429 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -104.87 123.71 48.2 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.9 mp -97.74 148.99 22.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.187 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.819 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 40.6 tt0 -74.04 125.5 28.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.616 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.03 -29.28 10.23 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.592 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 t -92.4 124.98 57.79 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.26 -7.39 12.94 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.878 2.385 . . . . 0.0 111.958 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -113.71 133.95 22.14 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.632 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 97.1 Cg_endo -91.01 143.24 3.25 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.084 2.523 . . . . 0.0 112.656 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.2 tt -89.41 121.41 31.63 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -107.85 147.22 31.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 111.527 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.529 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 1.5 m-85 -143.12 141.94 31.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.146 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.5 m -72.42 -28.73 63.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.0 109.487 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.532 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 80.6 mt-30 -86.84 109.39 19.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.92 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.767 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 17.2 t -63.54 -51.17 73.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.294 0.569 . . . . 0.0 109.909 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.634 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.33 -29.07 60.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.111 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.634 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 8.8 t70 -76.21 -47.27 24.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.532 -176.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -72.31 -36.08 68.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.485 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.518 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 22.8 pt -68.23 -35.24 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.436 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.31 -40.96 81.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.03 0.443 . . . . 0.0 110.338 172.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.47 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 33.2 t80 -62.29 -28.31 69.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.686 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.1 -15.9 61.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.288 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 60' ' ' ARG . 40.6 mtp-105 -98.19 11.71 36.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -172.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.96 -60.97 0.09 OUTLIER Glycine 0 CA--C 1.52 0.404 0 C-N-CA 119.274 -1.441 . . . . 0.0 114.469 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 58' ' ' TYR . 37.5 Cg_exo -59.81 -7.6 6.24 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.265 2.643 . . . . 0.0 115.149 -176.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.861 ' HG3' HG23 ' A' ' 68' ' ' ILE . 3.2 pm0 -77.41 89.61 3.8 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.41 1.1 . . . . 0.0 109.604 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -106.78 -24.64 12.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.045 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.2 tp -68.6 -40.21 81.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.275 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.596 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.24 152.65 29.8 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.538 177.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.819 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 59.8 Cg_endo -72.65 160.03 47.37 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.259 1.973 . . . . 0.0 111.447 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.861 HG23 ' HG3' ' A' ' 63' ' ' GLU . 29.1 pt -80.35 132.52 31.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.05 0.452 . . . . 0.0 111.035 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.08 -51.89 3.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -161.23 138.56 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.469 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.55 HG22 ' HB2' ' A' ' 95' ' ' ASP . 2.7 tt -108.15 134.64 49.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.153 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -111.88 130.07 55.95 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.95 145.61 27.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.026 0.441 . . . . 0.0 109.877 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 17.0 m120 -85.56 100.87 12.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.246 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -56.24 109.21 0.56 Allowed 'General case' 0 C--O 1.238 0.48 0 O-C-N 125.292 1.62 . . . . 0.0 110.136 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.495 ' SD ' ' HG2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -159.73 107.23 1.7 Allowed 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.291 -179.599 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.21 -68.3 2.05 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.399 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.582 ' HB1' HG13 ' A' ' 115' ' ' VAL . . . 67.42 -50.85 0.5 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.72 0.808 . . . . 0.0 112.51 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.85 -36.3 69.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.066 0.46 . . . . 0.0 110.547 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.31 -71.3 1.16 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 78' ' ' ALA . . . 51.41 54.49 11.0 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 124.176 0.574 . . . . 0.0 112.052 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.5 p -83.82 175.94 9.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.532 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 28.0 p-90 -66.53 -20.0 65.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.152 0.501 . . . . 0.0 110.254 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -84.76 -26.28 27.69 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.655 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 63.76 171.49 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.604 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.951 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.495 ' HG2' ' SD ' ' A' ' 76' ' ' MET . 38.4 Cg_endo -92.16 0.77 4.16 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.636 1.557 . . . . 0.0 112.06 172.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.3 -168.55 20.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.869 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.16 146.45 37.09 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.22 -166.55 12.15 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.159 -1.019 . . . . 0.0 113.277 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.3 t-20 -77.65 152.34 33.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.133 -0.534 . . . . 0.0 110.087 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -98.05 128.7 44.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.436 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.3 pt -140.57 143.59 28.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.77 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.92 102.44 4.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.177 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.91 78.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.237 0.542 . . . . 0.0 111.066 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.55 ' HB2' HG22 ' A' ' 71' ' ' ILE . 21.8 t70 -61.85 -24.63 67.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.64 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -115.97 27.56 9.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.995 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.35 178.84 5.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.651 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -92.67 136.02 33.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.431 0.634 . . . . 0.0 110.592 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.479 ' HE2' HD12 ' A' ' 56' ' ' ILE . 8.7 m-85 -120.54 136.22 54.85 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.739 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.736 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.7 p -113.9 125.98 71.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 CA-C-O 121.835 0.826 . . . . 0.0 110.423 173.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.681 ' HA ' HH11 ' A' ' 106' ' ' ARG . 40.8 t -102.03 113.4 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.461 174.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.66 122.57 7.2 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 119.975 -1.107 . . . . 0.0 111.553 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t -89.03 -28.46 20.15 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.34 -44.25 12.98 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.861 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.673 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 60.9 mtp180 -146.01 127.16 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.322 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.681 HH11 ' HA ' ' A' ' 101' ' ' VAL . 7.6 ttt180 -176.58 -53.37 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.626 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 151.39 26.33 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.28 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.26 -38.15 92.86 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.919 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 67.4 mtt -109.36 21.34 17.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.73 0.3 . . . . 0.0 110.637 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.55 -125.5 0.93 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.816 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.42 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.32 101.7 24.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.942 0.401 . . . . 0.0 110.375 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.547 ' HA ' ' HA3' ' A' ' 107' ' ' GLY . 43.0 Cg_endo -66.94 123.4 10.93 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 123.229 2.619 . . . . 0.0 113.301 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.38 131.13 56.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.79 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.591 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -98.13 131.77 44.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.85 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.736 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 93.3 t -98.04 104.54 22.87 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.826 174.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.0 Cg_endo -96.53 127.18 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.975 3.117 . . . . 0.0 112.064 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.546 ' HD2' ' H ' ' A' ' 119' ' ' SER . 1.1 t80 -147.06 148.78 32.0 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.4 m -86.87 -17.54 33.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.938 0.399 . . . . 0.0 110.759 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.546 ' H ' ' HD2' ' A' ' 117' ' ' PHE . 43.9 m -92.3 107.56 19.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.922 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.5 -44.62 72.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.782 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -63.42 -28.03 69.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.311 -173.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.524 ' HG3' ' CE2' ' A' ' 117' ' ' PHE . 40.9 mm-40 -66.4 -44.64 82.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.067 0.46 . . . . 0.0 110.242 174.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.05 77.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.364 0.602 . . . . 0.0 109.707 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.67 95.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.571 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -59.8 -33.85 72.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.295 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -64.37 -43.75 93.54 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 132' ' ' GLY . 40.5 t -72.95 -28.62 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.277 0.561 . . . . 0.0 110.397 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 9.3 tp -57.6 -38.64 75.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.921 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.02 -46.46 11.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.419 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.765 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.5 pt-20 -156.58 -80.05 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.621 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.765 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.36 -133.43 10.85 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 114.249 0.46 . . . . 0.0 114.249 174.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.702 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -178.39 -85.47 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.475 ' HG3' ' SD ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -130.16 139.5 50.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.629 0.252 . . . . 0.0 110.975 178.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.2 t -103.72 112.85 38.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.522 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.791 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -139.7 165.5 27.1 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.016 -175.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.81 161.29 14.92 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.666 ' HA ' HG12 ' A' ' 140' ' ' ILE . 1.6 tt -60.77 -31.03 70.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.188 0.518 . . . . 0.0 110.086 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.59 -22.91 67.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.645 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.28 26.01 9.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.043 -174.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.791 HD13 HD13 ' A' ' 135' ' ' LEU . 31.1 mm -71.69 119.48 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.498 ' CG2' ' HG2' ' A' ' 144' ' ' MET . 5.6 t -119.49 149.48 41.82 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.068 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 15.7 p-10 -68.99 -27.45 65.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.93 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.67 70.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.667 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.498 ' HG2' ' CG2' ' A' ' 141' ' ' THR . 12.8 mmt -75.73 -37.66 59.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.968 0.413 . . . . 0.0 110.699 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.69 -23.44 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.48 -171.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.5 pp -153.0 142.42 21.69 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.209 -174.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.4 p -122.75 150.33 58.26 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.589 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.07 -59.75 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.293 1.995 . . . . 0.0 109.592 171.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 28.7 t -119.73 -71.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 166.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 149' ' ' VAL . 11.4 mt-10 172.28 -76.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.625 1.57 . . . . 0.0 107.569 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 150' ' ' GLU . 0.6 OUTLIER 64.35 -31.17 0.12 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.878 1.271 . . . . 0.0 113.973 173.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 97.41 54.99 1.2 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.2 t -102.66 144.68 30.74 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.667 ' HG2' ' HB3' ' A' ' 158' ' ' ASP . 2.2 mp0 -57.71 126.26 75.43 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 110.66 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 157' ' ' ALA . 59.8 Cg_endo -73.85 -85.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.029 2.486 . . . . 0.0 113.236 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.425 ' HD2' ' HB3' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -75.5 -27.23 58.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.419 1.104 . . . . 0.0 108.089 174.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.511 ' O ' ' HD2' ' A' ' 155' ' ' PRO . . . 165.73 -162.9 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 112.563 -2.108 . . . . 0.0 105.448 -170.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.667 ' HB3' ' HG2' ' A' ' 154' ' ' GLU . 4.0 p30 -106.26 17.45 23.44 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 36.1 t70 -66.26 -83.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.475 -1.238 . . . . 0.0 111.358 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.558 176.557 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 50' ' ' SER . 88.0 tttt . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -132.89 145.05 50.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.713 0.292 . . . . 0.0 111.226 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 10.4 pt20 -149.13 134.55 18.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.413 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.728 HG21 ' HB2' ' A' ' 59' ' ' ALA . 22.3 pt -115.58 135.69 54.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.183 0.516 . . . . 0.0 110.923 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -104.73 119.64 39.47 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.5 mp -81.16 151.66 28.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.38 -175.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.34 125.53 28.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.374 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.7 -36.75 3.22 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.634 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 41.5 t -81.6 125.45 78.36 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.932 0.396 . . . . 0.0 110.359 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.5 Cg_exo -78.74 -1.42 11.58 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.179 2.586 . . . . 0.0 112.289 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -114.63 134.01 22.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.69 0.281 . . . . 0.0 111.106 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 98.5 Cg_endo -93.37 162.25 2.45 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.331 2.687 . . . . 0.0 112.69 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.5 tt -115.21 116.27 28.07 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 20.6 p90 -119.62 146.04 45.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.286 0.565 . . . . 0.0 111.732 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.407 ' HD1' ' H ' ' A' ' 51' ' ' GLN . 3.5 t80 -149.96 143.84 25.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.068 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 16.4 m -60.24 -45.61 92.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.096 0.475 . . . . 0.0 110.76 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.588 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 66.8 mt-30 -69.7 111.1 5.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.493 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 8.9 t -61.95 -52.42 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.948 0.404 . . . . 0.0 110.456 -177.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.566 HH11 ' HB2' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.86 -29.9 56.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.411 178.59 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.566 ' HB2' HH11 ' A' ' 53' ' ' ARG . 29.0 t70 -76.16 -51.56 11.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.953 0.406 . . . . 0.0 110.234 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.746 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -68.02 -38.3 82.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.676 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 28.3 pt -65.82 -30.24 49.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.66 96.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.678 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.746 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 70.2 m-85 -60.4 -44.97 95.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.712 0.292 . . . . 0.0 110.847 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.728 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -61.01 -18.18 56.25 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -105.05 12.5 32.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.824 0.345 . . . . 0.0 111.396 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.91 -85.4 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.34 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -48.05 -55.3 4.15 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.672 2.914 . . . . 0.0 113.858 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 57.21 -89.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.775 0.672 . . . . 0.0 110.43 -173.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.541 ' HB3' HD21 ' A' ' 40' ' ' LEU . 58.7 tt0 -178.97 -59.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tp -165.87 -40.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.048 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -94.12 152.16 40.15 Favored Pre-proline 0 N--CA 1.446 -0.675 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.007 173.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.59 161.38 46.25 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.768 1.645 . . . . 0.0 111.305 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.5 pt -73.79 136.98 24.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.196 0.522 . . . . 0.0 110.786 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tt -98.37 -47.89 5.25 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.01 138.75 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.8 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' A' ' 95' ' ' ASP . 2.8 tt -111.08 133.23 57.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.079 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -112.86 145.06 41.35 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 36' ' ' ALA . 18.8 m -136.35 155.88 35.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.231 0.538 . . . . 0.0 110.912 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -91.21 102.65 15.37 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 21.2 t70 -57.0 108.53 0.52 Allowed 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 125.034 1.459 . . . . 0.0 111.252 -175.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.599 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 1.6 mmt -161.12 62.02 0.29 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.555 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.937 ' HA2' ' HB2' ' A' ' 81' ' ' ALA . . . -100.15 27.02 22.28 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.78 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.44 97.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.94 0.435 . . . . 0.0 111.067 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 56.4 33.97 23.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.398 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.56 -59.7 0.22 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 119.148 -1.501 . . . . 0.0 114.566 176.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.937 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . . . 60.64 56.55 2.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.364 0.602 . . . . 0.0 110.375 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.6 p -83.99 177.18 8.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.069 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.588 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 24.5 p90 -66.71 -24.21 66.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.267 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.85 -31.89 27.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 66.59 157.36 0.13 Allowed Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.059 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 76' ' ' MET . 21.8 Cg_exo -70.76 -22.02 28.05 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.532 2.155 . . . . 0.0 111.1 170.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . 146.87 -162.99 28.61 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.515 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.74 141.95 42.51 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 76' ' ' MET . . . -131.11 -156.14 8.42 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.484 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -96.66 155.72 16.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.442 -175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -97.53 127.39 43.45 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.694 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.803 HD13 ' HB2' ' A' ' 118' ' ' SER . 26.6 pt -145.3 166.97 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.33 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.73 117.32 29.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.86 -35.54 74.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.737 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.754 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -70.63 -18.22 62.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.932 0.872 . . . . 0.0 109.718 -178.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.468 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 41.1 mmtm -107.12 21.06 18.12 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.678 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.21 177.59 4.83 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.797 0.332 . . . . 0.0 110.87 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -92.02 133.36 35.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.966 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -120.66 135.76 55.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.465 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.447 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.7 p -112.16 127.84 69.11 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-O 121.695 0.759 . . . . 0.0 110.422 174.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.542 ' HA ' HH11 ' A' ' 106' ' ' ARG . 43.8 t -102.89 103.92 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.119 174.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.45 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -70.35 125.02 14.01 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.453 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.6 m -92.21 -14.42 29.04 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.186 0.517 . . . . 0.0 110.032 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -91.88 -43.57 9.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.008 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.664 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 54.1 mtp180 -121.41 -107.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 119.292 -0.385 . . . . 0.0 109.988 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.542 HH11 ' HA ' ' A' ' 101' ' ' VAL . 5.0 tpt180 68.26 -60.66 0.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 176.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . -178.62 -61.11 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 58.56 -94.34 0.05 OUTLIER Glycine 0 C--N 1.332 0.319 0 O-C-N 123.92 0.424 . . . . 0.0 113.159 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -83.05 -3.97 57.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.986 0.422 . . . . 0.0 110.94 -178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.98 -135.89 5.24 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -102.36 108.16 56.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.803 0.301 . . . . 0.0 110.342 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HA ' ' HA3' ' A' ' 107' ' ' GLY . 18.4 Cg_endo -59.88 128.06 25.49 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 123.185 2.59 . . . . 0.0 112.99 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.414 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 43.1 mt-10 -114.52 135.35 54.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.904 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.544 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.77 131.62 38.95 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.827 -174.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.447 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 8.8 t -101.31 105.39 39.38 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.625 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.4 Cg_exo -86.97 136.84 4.33 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.713 2.942 . . . . 0.0 112.341 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -129.27 149.01 51.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.049 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.803 ' HB2' HD13 ' A' ' 92' ' ' ILE . 30.9 t -85.2 -35.61 21.53 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.9 m -91.59 118.7 30.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.763 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -59.74 -42.55 93.42 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.429 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -65.9 -31.7 72.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.892 -173.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -64.55 -40.44 95.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.746 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.03 -42.54 84.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.51 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.26 -41.19 99.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.855 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.42 -31.27 72.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.91 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -64.95 -36.52 84.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.916 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 62.1 t -73.02 -27.83 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.649 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mp -61.73 -46.23 90.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.086 0.469 . . . . 0.0 110.809 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.91 -49.92 26.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.485 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.669 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 0.7 OUTLIER -145.96 -86.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.757 178.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.916 ' HA3' ' HA ' ' A' ' 127' ' ' VAL . . . 50.44 -148.68 6.94 Favored Glycine 0 N--CA 1.444 -0.792 0 O-C-N 123.642 0.588 . . . . 0.0 113.702 172.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.588 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -179.96 -84.77 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -130.22 141.17 50.66 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 38.4 t -104.63 113.96 43.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.643 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.765 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.28 164.17 29.92 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.699 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.72 166.3 17.13 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.754 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 4.7 tt -62.22 -33.44 74.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.351 0.596 . . . . 0.0 109.611 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.02 60.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.168 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -117.44 17.47 14.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.292 0.568 . . . . 0.0 110.073 -176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.765 HD13 HD13 ' A' ' 135' ' ' LEU . 31.9 mm -71.93 120.28 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.312 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.6 t -119.1 147.82 43.73 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.978 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -69.26 -31.32 69.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.891 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.77 -28.82 66.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.798 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.617 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 8.2 mmt -87.18 -26.45 23.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.494 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.421 ' HA ' HG11 ' A' ' 101' ' ' VAL . 16.4 t -85.56 -24.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.207 0.527 . . . . 0.0 110.521 -177.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -160.3 151.88 19.75 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.566 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.44 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 4.0 p -94.59 120.06 65.43 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 120.829 0.347 . . . . 0.0 111.214 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 36.8 Cg_endo -66.6 -67.57 0.04 OUTLIER 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.73 2.287 . . . . 0.0 111.511 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.408 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 2.4 t -118.66 5.39 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 152' ' ' GLY . 22.4 mt-10 66.58 -81.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.699 -170.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.1 t 43.31 -59.99 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.134 1.774 . . . . 0.0 114.999 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 150' ' ' GLU . . . 118.34 63.37 0.3 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -175.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.1 m -116.91 161.58 19.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.545 0.212 . . . . 0.0 110.467 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 158' ' ' ASP . 1.6 mp0 -66.54 135.17 94.53 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.712 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 154' ' ' GLU . 74.1 Cg_endo -81.21 -89.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 123.037 2.491 . . . . 0.0 114.583 -169.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.443 ' HD2' ' HB3' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -66.21 -25.71 67.04 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.001 0.429 . . . . 0.0 111.393 -173.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -171.03 -82.34 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 6.3 p-10 -171.18 20.67 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.443 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 30.5 t70 -78.11 -83.02 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.339 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.186 173.73 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 22.1 ttmm . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -131.4 148.48 52.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.83 0.286 . . . . 0.0 111.275 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 13.8 pt20 -149.04 134.47 18.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 36.1 pt -115.94 137.82 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.821 -0.549 . . . . 0.0 110.892 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -108.95 126.52 53.18 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.572 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.8 mp -97.51 150.52 21.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.931 0.396 . . . . 0.0 111.502 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.719 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 38.2 tt0 -74.15 129.15 37.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.591 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.34 -34.7 4.05 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.842 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.471 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 33.2 t -81.9 129.99 62.49 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.1 Cg_endo -85.44 2.36 7.78 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.966 2.444 . . . . 0.0 112.439 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -122.43 134.54 24.93 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 120.845 0.355 . . . . 0.0 111.41 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 10.3 Cg_endo -91.1 145.05 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.488 2.792 . . . . 0.0 112.051 174.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 2.8 tm? -93.21 114.53 27.03 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -95.49 135.37 37.23 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 55' ' ' ALA . 5.6 t80 -147.26 131.24 17.19 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.65 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 70.1 m -57.82 -49.02 78.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.056 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -71.21 108.47 4.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.543 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 10.6 t -56.53 -50.18 74.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.65 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.88 -33.56 66.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.785 -177.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.65 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 11.8 t70 -76.52 -43.01 41.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.901 0.381 . . . . 0.0 110.848 -175.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -72.8 -39.51 66.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.277 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.592 HD12 ' HB3' ' A' ' 114' ' ' ALA . 12.0 pt -65.36 -29.95 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.942 0.401 . . . . 0.0 110.014 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.577 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -63.32 -41.79 98.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.823 173.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.431 ' CD2' ' HA ' ' A' ' 55' ' ' ALA . 21.1 m-30 -55.66 -43.8 76.61 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.126 0.489 . . . . 0.0 110.469 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' A' ' 68' ' ' ILE . . . -61.2 -17.11 51.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.824 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 60' ' ' ARG . 37.5 mtp180 -101.62 12.06 37.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.98 -60.33 0.36 Allowed Glycine 0 CA--C 1.518 0.239 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.549 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 33.4 Cg_exo -63.36 51.18 0.14 Allowed 'Trans proline' 0 N--CA 1.48 0.694 0 C-N-CA 123.874 3.049 . . . . 0.0 114.242 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -104.1 -175.34 2.77 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 173.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -106.52 -161.76 0.81 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.103 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -53.42 -34.85 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.671 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.572 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -85.06 140.49 37.06 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.668 0.27 . . . . 0.0 110.53 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.719 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 73.9 Cg_endo -78.17 159.68 29.96 Favored 'Trans proline' 0 CA--C 1.521 -0.137 0 C-N-CA 122.975 2.45 . . . . 0.0 112.559 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.419 HG21 ' HA ' ' A' ' 59' ' ' ALA . 45.1 pt -74.29 131.94 34.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 41' ' ' GLU . 6.1 tt -97.91 -49.5 4.77 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -161.15 138.03 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.876 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 56' ' ' ILE . 2.8 tt -108.33 133.41 53.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.661 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.472 ' HB2' ' HG3' ' A' ' 37' ' ' GLN . 93.9 m-85 -113.7 143.21 44.99 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 94' ' ' ALA . 20.6 m -133.31 156.93 42.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.584 0.707 . . . . 0.0 110.392 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 11.3 m120 -93.67 106.16 18.14 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 171.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 90' ' ' ASN . 18.2 t70 -46.37 97.75 0.01 OUTLIER 'General case' 0 C--O 1.233 0.232 0 O-C-N 125.384 1.677 . . . . 0.0 110.719 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.565 ' HB3' ' HG2' ' A' ' 86' ' ' PRO . 65.5 mtt -147.86 51.2 1.04 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.19 -174.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 80' ' ' GLY . . . -91.86 27.07 10.52 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.035 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.506 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . . . -71.42 96.82 1.53 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -175.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 68.98 22.93 6.8 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.93 0.769 . . . . 0.0 110.515 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.511 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . 146.66 -116.6 0.87 Allowed Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 175.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 80' ' ' GLY . . . 158.21 62.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -171.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.0 p -83.64 175.37 9.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.572 -169.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.457 ' H ' ' HD1' ' A' ' 83' ' ' TRP . 1.4 p-90 -71.55 -30.41 65.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.452 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -84.88 -24.33 28.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.316 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 69.03 154.39 0.14 Allowed Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.508 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.565 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 14.9 Cg_exo -50.04 -38.2 48.99 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.173 1.916 . . . . 0.0 112.132 171.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.25 -84.51 0.33 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.351 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.59 148.61 35.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.4 157.51 29.87 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.784 -1.198 . . . . 0.0 113.741 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 14.9 m-80 -92.58 151.84 19.93 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 25.1 p-90 -98.6 128.61 44.97 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 118.917 -1.113 . . . . 0.0 109.891 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.844 HG21 ' HB2' ' A' ' 118' ' ' SER . 23.3 pt -145.6 167.03 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.291 -176.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.83 116.04 23.84 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.56 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -69.92 -42.26 73.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -171.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -67.87 -23.11 65.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.777 0.798 . . . . 0.0 109.684 -177.027 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -101.06 32.55 3.18 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.816 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.41 178.47 7.04 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.662 -172.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -92.64 135.11 34.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.271 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.598 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 7.2 m-85 -120.73 135.9 55.01 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.417 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.92 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.4 p -114.96 120.32 64.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.639 0.733 . . . . 0.0 109.869 171.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.808 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 95.5 t -101.95 119.05 49.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.584 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.504 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -82.62 121.1 5.34 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.412 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.4 m -92.59 -28.92 16.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.003 0.43 . . . . 0.0 110.231 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.91 -44.16 64.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.158 -176.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 70.6 mtt180 -138.07 118.11 13.43 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.678 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 1.3 tpp180 175.27 -170.65 0.06 Allowed 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.499 0.499 . . . . 0.0 109.682 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.466 ' H ' ' HG3' ' A' ' 106' ' ' ARG . . . -51.83 -70.8 0.78 Allowed Glycine 0 C--N 1.335 0.527 0 O-C-N 123.623 0.577 . . . . 0.0 112.883 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.95 -78.16 0.65 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.138 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -89.91 -4.23 57.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.187 0.518 . . . . 0.0 110.076 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -121.55 -128.67 3.53 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.381 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.481 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -102.94 99.27 13.39 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.93 0.395 . . . . 0.0 111.163 177.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 35.6 Cg_endo -64.66 151.64 84.88 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 123.191 2.594 . . . . 0.0 112.229 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.678 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 41.3 mt-10 -118.21 146.36 44.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.42 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 99' ' ' TYR . . . -106.63 130.91 54.3 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.031 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.92 ' HB ' HG13 ' A' ' 100' ' ' VAL . 57.3 t -98.05 105.19 26.47 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.9 Cg_exo -86.76 132.52 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.751 2.967 . . . . 0.0 112.989 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -136.51 149.47 48.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.714 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.844 ' HB2' HG21 ' A' ' 92' ' ' ILE . 42.0 t -84.54 -19.75 32.68 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 170.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.454 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 15.7 m -105.59 115.51 30.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.3 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -44.78 80.96 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.158 0.504 . . . . 0.0 110.979 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.454 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 20.4 p-10 -62.46 -29.34 70.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.121 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -71.29 -40.41 70.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.688 175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.63 -37.38 84.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.143 0.497 . . . . 0.0 109.986 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.31 -35.11 78.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.659 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.422 ' HA ' HD12 ' A' ' 128' ' ' LEU . . . -63.93 -34.81 78.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.776 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -63.18 -36.46 83.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.799 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.653 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 44.4 t -71.91 -31.75 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.486 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 125' ' ' ALA . 67.7 mt -60.54 -35.39 75.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.726 176.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.24 -50.22 7.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.813 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.8 pt-20 -148.32 -85.18 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.842 175.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.813 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 52.05 -146.84 13.54 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 170.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.601 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -171.33 -89.06 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.808 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.29 160.1 34.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 175.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.37 113.32 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.182 0.515 . . . . 0.0 110.246 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.939 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -134.57 165.13 25.92 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.902 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -86.67 160.86 18.73 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.738 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 6.7 tt -61.66 -42.85 99.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.274 0.559 . . . . 0.0 109.624 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.59 -18.51 62.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.943 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.26 20.71 13.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.576 -172.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.939 HD13 HD13 ' A' ' 135' ' ' LEU . 22.6 mm -71.87 120.86 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.896 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 t -107.05 147.7 29.64 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.433 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.19 -33.27 73.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.65 -28.79 68.84 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.744 0.653 . . . . 0.0 112.07 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.481 ' CE ' ' HB3' ' A' ' 155' ' ' PRO . 11.9 mmt -82.94 -26.84 31.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.769 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.483 ' HA ' HG11 ' A' ' 101' ' ' VAL . 2.2 t -92.68 -23.01 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 -175.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.6 pp -170.04 164.79 9.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.131 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.448 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 19.6 p -113.66 118.66 42.82 Favored Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.622 174.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 32.9 Cg_endo -65.92 -82.44 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.747 2.298 . . . . 0.0 112.287 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.688 ' HB ' ' OG1' ' A' ' 151' ' ' THR . 5.2 t -109.64 -6.58 11.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 37.9 mt-10 89.69 -73.52 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.688 ' OG1' ' HB ' ' A' ' 149' ' ' VAL . 44.4 m 53.79 21.9 2.95 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 163.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.4 50.65 58.3 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.56 -175.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.7 p -64.11 125.45 24.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.207 0.527 . . . . 0.0 111.731 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -93.73 153.94 41.04 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.81 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.556 ' HG2' ' HA ' ' A' ' 158' ' ' ASP . 6.2 Cg_exo -64.65 -163.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.205 1.937 . . . . 0.0 111.975 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -32.23 50.51 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -175.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.45 37.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.556 ' HA ' ' HG2' ' A' ' 155' ' ' PRO . 34.8 t0 59.0 72.49 0.53 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.862 -167.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.418 ' H ' ' HG2' ' A' ' 155' ' ' PRO . 12.2 t70 -168.95 -143.11 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -172.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.351 172.448 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 37.2 ttpt . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -137.07 144.38 43.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 26.9 pt20 -147.11 132.17 18.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 110.665 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 59' ' ' ALA . 30.1 pt -116.13 136.34 53.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.15 0.5 . . . . 0.0 110.985 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -105.2 132.17 51.75 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 11.1 mp -99.37 157.08 16.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.173 0.511 . . . . 0.0 111.527 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 26.4 tt0 -74.22 124.32 26.16 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.224 175.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.85 -42.64 3.12 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.244 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 15.7 t -82.13 123.83 79.22 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.0 Cg_exo -79.46 -11.6 14.3 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.983 2.455 . . . . 0.0 112.628 -176.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -97.98 131.97 25.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.981 0.419 . . . . 0.0 110.881 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 59.7 Cg_endo -93.37 137.45 1.33 Allowed 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 123.184 2.589 . . . . 0.0 112.355 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 8.1 tt -88.06 119.68 28.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -129.68 135.63 48.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.138 0.494 . . . . 0.0 111.42 -177.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.518 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 44.2 m-85 -142.04 153.2 44.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.038 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 t -64.51 -49.32 71.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.082 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 70.3 mt-30 -67.79 119.27 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.778 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.963 HG23 ' HB1' ' A' ' 81' ' ' ALA . 60.1 t -71.98 -50.23 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.661 ' HB3' ' HG3' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -53.99 -30.01 45.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.156 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.456 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 33.8 t70 -76.05 -50.08 15.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.7 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -68.77 -39.25 80.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.585 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.615 HD12 ' HE2' ' A' ' 99' ' ' TYR . 11.1 pt -68.11 -31.47 51.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.795 0.331 . . . . 0.0 110.283 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.1 91.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.32 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -57.6 -41.9 82.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.747 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -61.16 -17.44 52.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.096 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 45.5 mtm180 -102.79 7.39 39.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.414 -175.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.86 -82.47 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.081 -1.057 . . . . 0.0 112.77 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -50.49 -56.83 2.71 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.361 2.708 . . . . 0.0 113.56 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 52.22 -102.97 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.045 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.442 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 28.0 mt-30 -152.6 -86.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 tt -142.93 4.58 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 122.028 0.918 . . . . 0.0 109.346 174.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.442 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -138.29 161.65 58.03 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.143 -173.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.456 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 72.0 Cg_endo -76.77 157.4 35.36 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.273 1.982 . . . . 0.0 111.714 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.1 pt -74.05 151.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.095 0.474 . . . . 0.0 111.357 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.44 -48.1 3.04 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.07 143.96 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.415 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.551 HD11 HG22 ' A' ' 56' ' ' ILE . 3.3 tt -123.48 131.98 72.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.055 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -111.65 132.06 54.85 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.597 HG23 HG13 ' A' ' 92' ' ' ILE . 17.1 m -126.25 140.89 47.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 121.499 0.666 . . . . 0.0 110.63 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 6.6 m-20 -95.56 110.46 22.54 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -67.54 79.87 0.17 Allowed 'General case' 0 C--O 1.222 -0.374 0 O-C-N 124.367 1.042 . . . . 0.0 108.737 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.901 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 23.7 ptm 178.76 179.53 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.255 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.429 ' HA3' ' HB2' ' A' ' 81' ' ' ALA . . . 140.34 -33.59 2.06 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.416 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 80' ' ' GLY . . . 48.11 78.86 0.07 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.822 0.449 . . . . 0.0 111.26 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 73.78 -28.89 0.19 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.36 0.664 . . . . 0.0 111.819 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 78' ' ' ALA . . . -78.17 -5.54 87.31 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.884 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.963 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -113.22 -74.43 0.63 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.281 0.562 . . . . 0.0 110.274 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 p -104.26 152.56 22.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 169.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -76.1 -25.29 55.3 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.261 0.553 . . . . 0.0 110.188 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.05 -13.95 51.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 38.8 mt-30 72.16 139.29 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 113.826 -1.533 . . . . 0.0 112.337 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 85' ' ' GLN . 28.9 Cg_endo -86.78 -83.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.196 2.597 . . . . 0.0 113.007 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.31 -137.21 4.57 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.385 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.99 136.84 38.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.58 0.352 . . . . 0.0 111.459 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.901 ' HA2' ' HB3' ' A' ' 76' ' ' MET . . . -66.39 87.52 0.12 Allowed Glycine 0 C--N 1.333 0.408 0 O-C-N 124.091 0.869 . . . . 0.0 115.205 -168.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -100.59 146.76 26.74 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -99.6 130.51 45.84 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.472 -0.768 . . . . 0.0 109.891 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.597 HG13 HG23 ' A' ' 73' ' ' VAL . 2.5 pt -145.28 158.27 13.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.187 0.518 . . . . 0.0 112.316 -177.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.03 117.66 25.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 170.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -65.77 -39.63 91.21 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -169.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.723 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -68.69 -24.36 64.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.724 0.773 . . . . 0.0 109.393 -177.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.407 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 44.2 mmtm -100.83 26.36 6.97 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.522 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.46 176.48 7.43 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.363 -0.21 . . . . 0.0 110.474 -173.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -94.54 135.79 35.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.414 0.626 . . . . 0.0 110.418 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.615 ' HE2' HD12 ' A' ' 56' ' ' ILE . 8.1 m-85 -120.55 136.23 54.85 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.228 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -113.22 128.55 69.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.381 0.61 . . . . 0.0 110.112 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.0 t -101.68 109.24 25.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.404 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -80.68 126.21 7.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.643 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.3 m -92.54 -30.98 15.38 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -80.5 -47.02 14.89 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -163.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -129.12 12.59 6.12 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.022 -0.424 . . . . 0.0 111.281 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.648 ' HD3' ' HB3' ' A' ' 113' ' ' GLU . 1.4 tpm_? -89.5 -91.68 0.13 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.95 -169.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -170.93 40.25 0.19 Allowed Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.502 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -65.37 -29.88 76.31 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.908 -1.139 . . . . 0.0 111.174 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 88.4 mmm -109.12 20.87 17.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.395 -0.402 . . . . 0.0 110.692 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -160.32 -124.22 0.72 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.401 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.98 100.98 18.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 110.844 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.4 146.41 50.24 Favored 'Trans proline' 0 C--N 1.331 -0.382 0 C-N-CA 123.61 2.874 . . . . 0.0 113.407 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.661 ' HG3' ' HB3' ' A' ' 53' ' ' ARG . 27.5 tt0 -114.88 127.48 55.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.75 172.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.52 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.91 129.99 40.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.538 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 48.8 t -102.16 105.29 41.81 Favored Pre-proline 0 C--N 1.321 -0.671 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.312 174.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -89.35 110.98 0.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.821 3.014 . . . . 0.0 111.218 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.73 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.6 t80 -119.62 149.03 42.62 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.517 ' HB2' HD13 ' A' ' 92' ' ' ILE . 44.1 t -71.6 -32.77 68.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.925 0.393 . . . . 0.0 111.06 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.73 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 66.9 m -99.24 124.16 44.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.848 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.91 -45.41 82.06 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -65.58 -28.7 69.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.349 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -68.8 -42.08 77.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.465 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.09 79.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.305 0.574 . . . . 0.0 110.1 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.65 -32.31 69.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.744 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -65.19 -32.38 74.03 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.077 0.465 . . . . 0.0 110.703 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.467 ' HD2' HG21 ' A' ' 100' ' ' VAL . 79.6 t80 -61.71 -39.61 92.09 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.714 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 42.1 t -73.14 -28.82 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.658 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 6.7 tp -56.32 -43.99 79.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.957 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.64 -50.75 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.255 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.911 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.5 pt-20 -152.7 -76.16 0.13 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.486 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.911 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.48 -130.87 11.69 Favored Glycine 0 C--N 1.334 0.424 0 O-C-N 123.543 0.527 . . . . 0.0 112.974 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.65 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -179.84 -89.64 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.36 139.47 50.66 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 177.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.73 119.66 51.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.757 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -147.04 165.65 29.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.111 -177.242 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.05 162.73 15.2 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.791 ' HA ' HG12 ' A' ' 140' ' ' ILE . 1.1 tt -62.59 -32.64 73.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.133 0.492 . . . . 0.0 109.675 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.8 -11.65 58.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.252 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -125.53 21.5 7.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.791 HG12 ' HA ' ' A' ' 137' ' ' LEU . 30.4 mm -71.63 118.18 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -119.28 147.68 44.01 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.238 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.557 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 13.4 p-10 -69.37 -26.92 64.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.72 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.83 -28.74 69.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.772 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.4 mmt -83.9 -26.2 29.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.412 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.3 -22.8 5.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.357 -172.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.4 pp -143.61 142.81 31.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.581 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 32.4 p -113.12 122.8 34.86 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.093 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 22.4 Cg_endo -64.81 -75.75 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.314 2.009 . . . . 0.0 111.51 174.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.37 11.23 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 152' ' ' GLY . 37.6 mt-10 67.51 -79.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.326 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 152' ' ' GLY . 12.4 t 43.76 -62.57 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.931 1.692 . . . . 0.0 113.928 -171.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 150' ' ' GLU . . . 150.28 55.25 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.3 t -89.95 148.68 22.97 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 157' ' ' ALA . 20.4 mm-40 -71.06 136.01 84.9 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.213 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 157' ' ' ALA . 98.3 Cg_endo -78.36 -118.29 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.819 2.346 . . . . 0.0 112.239 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.435 ' H ' ' HB2' ' A' ' 155' ' ' PRO . 0.0 OUTLIER -60.46 -27.19 67.34 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.052 0.453 . . . . 0.0 109.784 177.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.513 ' O ' ' HD2' ' A' ' 155' ' ' PRO . . . -179.84 -118.26 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.808 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -123.55 14.87 9.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.543 1.163 . . . . 0.0 108.564 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.29 30.89 1.82 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.251 -167.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.203 -177.806 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 50' ' ' SER . 37.2 ttmt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -144.55 144.29 31.24 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 112.024 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -149.17 135.28 19.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.101 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 59' ' ' ALA . 33.7 pt -115.93 138.84 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.024 0.44 . . . . 0.0 111.103 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -107.57 121.15 44.07 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.581 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.5 mp -87.58 147.86 25.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.006 0.432 . . . . 0.0 110.912 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.534 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 27.6 tt0 -74.06 124.3 26.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.659 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.03 -38.4 3.2 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.884 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 28.0 t -82.1 125.06 78.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.2 Cg_exo -80.44 1.77 9.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.998 2.465 . . . . 0.0 112.786 -176.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -107.28 132.86 20.63 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 9.4 Cg_endo -92.66 115.76 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.611 2.874 . . . . 0.0 111.702 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.61 108.33 7.3 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -113.23 137.97 50.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.19 0.519 . . . . 0.0 111.318 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.577 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 36.6 m-85 -139.58 143.95 37.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.223 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 33.9 m -56.37 -54.43 45.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.561 ' HG2' ' HA ' ' A' ' 83' ' ' TRP . 48.4 mt-30 -63.62 125.58 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.148 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.5 t -65.28 -50.62 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.613 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -58.1 -28.27 64.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.376 -178.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.613 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 11.5 t70 -75.95 -51.6 12.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 110.184 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -64.93 -39.93 94.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.336 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 71' ' ' ILE . 28.7 pt -69.31 -31.88 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.951 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.05 82.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 0.0 110.791 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -62.3 -32.04 72.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.481 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.608 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -70.75 -18.27 62.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 23.9 mtm180 -94.41 3.73 54.78 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.43 -60.49 0.23 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 119.412 -1.375 . . . . 0.0 114.414 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -40.47 -44.25 4.3 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.799 2.999 . . . . 0.0 114.781 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -82.26 99.7 9.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.148 0.499 . . . . 0.0 111.364 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -106.45 111.06 23.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -176.68 -42.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.079 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.581 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -151.78 151.25 28.01 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.534 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.5 Cg_endo -72.22 158.12 52.48 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.056 1.837 . . . . 0.0 111.741 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.0 pt -81.54 117.59 27.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.067 0.461 . . . . 0.0 110.434 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 tt -77.82 -48.05 17.44 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.19 138.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.218 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' A' ' 95' ' ' ASP . 3.6 tt -107.99 129.76 61.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.947 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.533 ' HA ' ' O ' ' A' ' 92' ' ' ILE . 79.6 m-85 -111.71 127.25 55.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 94' ' ' ALA . 27.7 m -123.03 151.7 27.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.045 0.45 . . . . 0.0 110.061 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.535 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 15.6 m120 -86.03 97.03 10.05 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 90' ' ' ASN . 10.3 t70 -45.08 106.6 0.08 Allowed 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 125.581 1.801 . . . . 0.0 110.449 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -179.71 87.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 O-C-N 125.46 1.725 . . . . 0.0 109.16 178.575 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA3' HG13 ' A' ' 115' ' ' VAL . . . -126.93 28.94 4.51 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.541 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.53 ' H ' ' HG3' ' A' ' 86' ' ' PRO . . . -79.55 43.76 0.58 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.427 0.632 . . . . 0.0 110.509 -174.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -175.05 9.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.194 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.68 7.32 55.71 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.038 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 55.3 53.1 10.43 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 110.047 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.609 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 26.4 p -83.67 177.55 8.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.625 -169.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.561 ' HA ' ' HG2' ' A' ' 51' ' ' GLN . 35.5 p90 -66.39 -25.05 66.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.189 0.519 . . . . 0.0 110.149 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -82.91 -35.14 26.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.702 176.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER 66.75 165.24 0.12 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.49 175.054 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.53 ' HG3' ' H ' ' A' ' 78' ' ' ALA . 87.6 Cg_endo -90.31 5.66 4.3 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.054 1.836 . . . . 0.0 111.997 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.94 -179.68 16.05 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.038 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.96 146.12 51.36 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.64 -172.81 13.17 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.205 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 36.8 m-80 -95.18 151.6 19.08 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -97.51 129.75 44.65 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.076 -1.015 . . . . 0.0 111.121 -170.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.71 HD13 ' HB2' ' A' ' 118' ' ' SER . 24.9 pt -144.0 166.2 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.594 -173.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.09 106.3 14.78 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.583 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -69.84 -32.5 70.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.923 -173.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.735 ' HA ' HD13 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -71.45 -23.87 61.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.72 0.771 . . . . 0.0 109.889 -177.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -99.45 29.6 3.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.07 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.21 -176.37 4.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -95.72 138.05 33.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.546 0.689 . . . . 0.0 110.621 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CE1' HD12 ' A' ' 137' ' ' LEU . 2.3 m-85 -120.53 136.62 54.72 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.028 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.797 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -114.46 123.14 69.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.438 0.637 . . . . 0.0 110.41 173.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.8 t -101.56 127.6 54.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.439 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -86.71 121.37 5.75 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.116 -173.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.4 m -92.48 -37.15 12.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.688 0.28 . . . . 0.0 110.79 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.14 -44.71 16.11 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.042 0.449 . . . . 0.0 110.9 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 50.8 mtp180 -134.62 121.6 21.11 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.562 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 165.55 -175.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.548 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -79.23 42.3 2.35 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.066 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.78 -24.69 70.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.6 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.8 ttp -103.57 -3.49 25.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.853 0.359 . . . . 0.0 110.474 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -153.91 -110.14 0.39 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.972 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.548 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.47 99.32 14.84 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.676 0.274 . . . . 0.0 111.208 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.519 ' HA ' ' H ' ' A' ' 107' ' ' GLY . 49.6 Cg_endo -67.68 147.01 75.04 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.64 2.893 . . . . 0.0 113.659 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.562 ' CD ' ' HE ' ' A' ' 106' ' ' ARG . 1.6 mp0 -114.68 142.34 46.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -107.68 130.8 54.89 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.613 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.797 ' HB ' HG13 ' A' ' 100' ' ' VAL . 96.5 t -100.97 105.55 39.17 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 120.969 0.414 . . . . 0.0 110.38 175.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.3 Cg_exo -87.91 127.52 2.23 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.645 2.897 . . . . 0.0 112.387 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -134.07 148.82 51.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.487 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.71 ' HB2' HD13 ' A' ' 92' ' ' ILE . 33.0 t -80.48 -16.73 53.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.139 0.495 . . . . 0.0 109.947 174.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.8 m -108.58 131.9 54.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.523 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -68.15 -48.67 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.073 0.463 . . . . 0.0 110.921 179.453 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -63.64 -28.5 69.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.888 -173.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.59 -40.2 76.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.385 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.37 -35.78 71.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 110.121 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.96 88.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.785 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -63.28 -30.07 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.001 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -66.06 -40.45 90.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.741 HG22 ' H ' ' A' ' 132' ' ' GLY . 59.5 t -72.25 -29.11 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.415 0.626 . . . . 0.0 110.395 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 7.7 tp -58.04 -43.7 86.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.122 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.83 -50.97 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.666 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.688 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.8 pt-20 -141.6 -92.91 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.468 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.688 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 47.98 -145.41 5.58 Favored Glycine 0 C--N 1.333 0.398 0 O-C-N 123.517 0.511 . . . . 0.0 113.984 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.741 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -172.62 -81.49 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.06 139.27 51.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.847 0.356 . . . . 0.0 110.793 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.13 115.21 43.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.215 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.779 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -140.04 159.82 41.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.786 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.66 157.48 24.64 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 95' ' ' ASP . 6.3 tt -60.95 -34.95 75.53 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.35 -13.8 59.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.759 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -127.66 29.64 5.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.126 0.488 . . . . 0.0 110.635 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.779 HD13 HD13 ' A' ' 135' ' ' LEU . 36.1 mm -71.58 121.42 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.5 t -108.95 147.87 31.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.154 177.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.6 p-10 -69.27 -32.84 72.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.67 -29.77 66.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.019 -175.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.544 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 6.2 mmt -87.19 -33.86 19.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.457 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 141' ' ' THR . 3.9 t -78.99 -23.51 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.359 0.599 . . . . 0.0 109.915 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 1.8 pp -150.18 106.76 3.51 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.77 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.426 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 23.7 p -80.06 120.1 78.68 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.555 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 9.8 Cg_endo -55.76 -72.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.768 2.312 . . . . 0.0 111.671 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.7 t -129.27 10.25 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.467 ' O ' HG22 ' A' ' 151' ' ' THR . 42.4 mt-10 67.47 -77.92 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.326 -173.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 150' ' ' GLU . 5.8 t 53.07 -41.4 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.899 1.679 . . . . 0.0 114.936 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.37 15.6 4.09 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.3 p -70.55 142.37 51.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.598 0.237 . . . . 0.0 111.264 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.602 ' HG2' ' HB2' ' A' ' 158' ' ' ASP . 2.8 mp0 -56.61 126.07 69.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.274 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.436 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 27.1 Cg_endo -62.85 -86.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.334 2.689 . . . . 0.0 113.601 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -28.36 15.92 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.029 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 177.2 19.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.344 0.402 . . . . 0.0 111.385 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.602 ' HB2' ' HG2' ' A' ' 154' ' ' GLU . 32.2 t70 53.42 84.9 0.05 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.398 0.618 . . . . 0.0 109.571 -171.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -163.91 -43.31 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.582 -165.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.815 179.735 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 69.6 tttt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -143.78 143.77 31.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.027 -175.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 14.2 pt20 -149.31 129.64 13.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.586 174.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.469 HG22 ' CG1' ' A' ' 71' ' ' ILE . 29.9 pt -116.11 135.29 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -103.24 121.45 42.73 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.4 mp -86.1 141.28 29.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.088 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.653 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 32.7 tt0 -74.0 124.35 26.05 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.599 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.18 -14.21 64.24 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.269 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.44 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 34.7 t -105.86 125.47 33.13 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.6 Cg_exo -78.0 5.99 4.95 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.944 2.429 . . . . 0.0 112.733 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -129.69 132.74 24.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.321 . . . . 0.0 111.182 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 7.6 Cg_endo -89.92 165.45 4.88 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.593 2.862 . . . . 0.0 112.133 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 7.1 tt -107.68 118.71 37.46 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -101.91 134.69 44.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.24 146.83 27.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.155 0.502 . . . . 0.0 110.85 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -69.27 -36.36 77.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.298 0.57 . . . . 0.0 110.63 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.92 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 51.8 mt-30 -84.94 122.7 29.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.834 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.774 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 2.6 t -67.6 -51.7 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.577 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -52.62 -41.17 63.48 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.179 -178.73 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.577 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 29.8 t0 -76.34 -43.05 42.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.754 0.311 . . . . 0.0 111.105 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.2 -37.66 75.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.704 0.288 . . . . 0.0 111.443 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.763 HD12 ' HB3' ' A' ' 114' ' ' ALA . 24.4 pt -68.19 -31.29 51.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.419 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -64.37 -42.44 96.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.295 174.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -57.17 -37.75 72.57 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.155 0.502 . . . . 0.0 110.438 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.568 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -64.63 -18.89 65.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.111 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -94.66 -6.69 42.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -179.48 -58.98 0.08 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.998 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 26.4 Cg_exo -65.56 46.3 0.18 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.527 2.818 . . . . 0.0 114.555 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -96.26 165.7 12.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.731 ' HG3' HG22 ' A' ' 65' ' ' ILE . 10.4 pt20 -92.86 -18.85 22.32 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -169.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.731 HG22 ' HG3' ' A' ' 64' ' ' GLN . 6.5 tt 179.32 -39.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.382 . . . . 0.0 111.976 -174.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.545 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -104.99 146.76 33.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.58 -171.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.653 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 55.9 Cg_endo -71.8 163.77 37.81 Favored 'Trans proline' 0 C--O 1.224 -0.183 0 C-N-CA 123.159 2.573 . . . . 0.0 111.73 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.568 HD13 ' HB1' ' A' ' 59' ' ' ALA . 27.6 pt -79.3 127.19 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.149 0.499 . . . . 0.0 110.737 177.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 tt -91.78 -48.13 6.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -159.17 138.75 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.84 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.469 ' CG1' HG22 ' A' ' 38' ' ' ILE . 3.0 tt -117.07 131.53 69.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.215 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -111.85 128.34 56.1 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 94' ' ' ALA . 29.6 m -127.83 139.49 51.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 120.834 0.35 . . . . 0.0 110.096 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 2.2 m-20 -84.64 107.04 16.64 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -69.6 142.35 53.55 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 124.371 1.045 . . . . 0.0 109.494 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.783 ' O ' ' HG2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER 168.28 -29.13 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 124.511 1.132 . . . . 0.0 109.039 -170.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.601 ' HA3' ' HB2' ' A' ' 81' ' ' ALA . . . -69.47 68.49 0.54 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.622 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.97 106.78 2.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.445 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.22 26.49 15.94 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.539 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.9 -72.38 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.73 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.601 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . . . 57.19 52.35 9.05 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.309 0.576 . . . . 0.0 110.338 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.46 175.75 9.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.178 -173.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.92 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 31.7 p90 -68.8 -20.68 64.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.369 0.604 . . . . 0.0 110.162 175.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.85 -31.8 31.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.838 173.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 62.36 171.38 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.353 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.783 ' HG2' ' O ' ' A' ' 76' ' ' MET . 5.7 Cg_exo -83.88 -5.06 10.62 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.929 1.753 . . . . 0.0 110.372 166.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.09 174.06 13.22 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -174.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -77.14 146.07 37.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.607 0.704 . . . . 0.0 109.468 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.433 ' HA3' ' HG2' ' A' ' 76' ' ' MET . . . -136.91 -140.18 4.05 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.655 -175.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 19.2 m120 -100.31 145.44 28.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 74' ' ' ASN . 37.3 p90 -98.52 130.94 45.1 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.549 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.694 HD13 ' HB2' ' A' ' 118' ' ' SER . 1.8 pt -133.6 151.92 34.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.656 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.85 102.67 4.13 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.559 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . . . -61.02 -31.59 71.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.153 0.501 . . . . 0.0 110.935 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 1.0 OUTLIER -58.03 -31.05 66.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.165 176.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -111.39 27.7 9.43 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.868 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -122.52 178.59 4.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.529 0.204 . . . . 0.0 110.775 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -92.74 131.61 37.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.251 0.548 . . . . 0.0 110.779 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -120.49 136.12 54.86 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.338 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.463 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 4.2 p -113.71 129.48 69.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-O 121.866 0.841 . . . . 0.0 110.571 172.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.551 ' HA ' HH11 ' A' ' 106' ' ' ARG . 38.1 t -104.01 111.84 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.282 172.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.695 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -74.67 124.07 7.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.314 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 p -86.71 -31.23 21.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.957 0.408 . . . . 0.0 110.564 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -78.41 -35.04 47.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.714 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.62 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 60.2 mtp180 -121.13 -140.84 0.33 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.369 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.551 HH11 ' HA ' ' A' ' 101' ' ' VAL . 22.4 ttt180 72.25 176.57 0.27 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.478 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -71.94 -48.96 24.52 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.096 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.08 -96.89 0.33 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.339 -0.934 . . . . 0.0 110.832 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.0 mtt -99.48 -3.8 32.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.281 0.562 . . . . 0.0 109.735 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.78 -123.37 2.72 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.717 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.478 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.19 94.66 5.84 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 117.077 0.439 . . . . 0.0 110.663 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.92 113.18 3.15 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.74 2.293 . . . . 0.0 113.125 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -114.65 130.53 56.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.836 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.763 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -100.16 132.8 45.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.456 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.463 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 14.3 t -99.38 105.87 35.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.674 176.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -90.73 131.45 1.58 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 124.2 3.267 . . . . 0.0 112.329 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -128.82 153.27 47.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.694 ' HB2' HD13 ' A' ' 92' ' ' ILE . 38.4 t -85.08 -27.76 26.08 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 170.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.4 m -96.02 115.99 28.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.142 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -57.8 -45.75 85.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.315 0.578 . . . . 0.0 111.139 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -63.38 -28.54 70.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.368 -172.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -64.48 -42.45 95.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.075 0.464 . . . . 0.0 110.296 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -68.45 -37.34 80.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.283 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.3 98.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.709 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.42 83.6 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.12 0.486 . . . . 0.0 110.447 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -61.88 -40.7 96.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.762 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.631 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 78.6 t -66.19 -40.17 86.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.017 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 66.4 mt -56.86 -34.62 68.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.599 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.04 -41.86 13.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.231 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.62 ' OE1' ' HD3' ' A' ' 105' ' ' ARG . 7.6 pt-20 -161.12 -35.18 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -172.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.695 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -53.61 163.88 2.59 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.232 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -111.41 -66.26 0.52 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.705 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.424 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.13 141.56 50.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.829 0.347 . . . . 0.0 110.675 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.3 t -103.34 113.75 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.188 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.704 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -138.65 164.87 28.39 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.987 -176.304 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.27 170.07 13.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.541 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 3.6 tt -66.36 -30.52 70.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.304 0.573 . . . . 0.0 109.629 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.22 -12.1 60.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.587 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -109.43 12.82 24.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.704 HD13 HD13 ' A' ' 135' ' ' LEU . 41.8 mm -71.88 119.12 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.082 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.3 t -119.37 147.12 44.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.849 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.426 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.1 p-10 -69.41 -25.49 64.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.053 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.27 -28.8 69.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.669 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.637 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 3.9 mmt -87.1 -28.96 22.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.037 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 141' ' ' THR . 8.6 t -79.16 -23.56 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.263 0.554 . . . . 0.0 110.476 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.2 pp -155.9 139.75 16.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.77 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.1 p -95.97 120.58 62.73 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.832 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.36 -78.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.175 1.917 . . . . 0.0 111.285 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.62 6.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 65.91 -74.94 0.05 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.308 -167.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.0 t 43.32 31.06 0.35 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.626 1.17 . . . . 0.0 114.062 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 71.97 23.59 77.78 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.012 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.3 t -96.38 124.51 40.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.018 0.437 . . . . 0.0 109.824 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -80.0 149.62 70.43 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.333 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.428 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 10.8 Cg_endo -55.82 -33.53 88.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.164 2.576 . . . . 0.0 112.445 -176.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.543 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 3.3 ptp85 -155.35 -69.25 0.12 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.318 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.543 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -145.93 69.65 1.22 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.23 31.66 0.39 Allowed 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.31 1.006 . . . . 0.0 111.81 -175.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 155' ' ' PRO . 11.9 t70 -130.49 -166.02 1.63 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.731 179.35 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 40.1 ttmt . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -126.54 144.35 50.9 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.448 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . 11.7 pt20 -148.84 136.76 20.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.963 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 59' ' ' ALA . 30.3 pt -115.9 134.82 57.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.103 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -98.83 116.9 32.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' A' ' 66' ' ' ALA . 3.0 mp -92.26 142.34 27.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.964 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.796 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 34.7 tt0 -74.0 132.43 42.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.23 -36.46 3.19 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.5 -175.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.517 ' HB2' ' CB ' ' A' ' 40' ' ' LEU . 68.8 m -82.14 124.5 78.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.014 0.435 . . . . 0.0 110.332 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 2.5 Cg_endo -82.86 -3.47 11.16 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.134 2.556 . . . . 0.0 112.884 -176.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -125.39 133.98 25.37 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.719 -177.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 5.9 Cg_exo -79.1 141.88 16.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.999 2.466 . . . . 0.0 111.847 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.516 ' HB3' HG12 ' A' ' 38' ' ' ILE . 6.3 tt -91.48 107.23 19.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . 38.4 p90 -116.81 137.68 52.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.173 0.511 . . . . 0.0 111.14 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -138.58 143.15 39.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.516 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 5.3 p -55.69 -40.7 72.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.224 0.535 . . . . 0.0 110.982 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.523 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 68.4 mt-30 -82.1 114.85 20.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.396 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.584 HG13 ' HB2' ' A' ' 36' ' ' ALA . 45.4 t -58.53 -47.89 87.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.298 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -58.68 -28.43 65.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.626 -178.273 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.459 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 22.5 t70 -75.99 -51.12 13.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.022 0.439 . . . . 0.0 110.257 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.71 95.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.344 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.705 HG22 HD11 ' A' ' 71' ' ' ILE . 28.4 pt -69.08 -31.92 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.316 . . . . 0.0 110.546 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.95 82.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.707 0.289 . . . . 0.0 110.339 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 62' ' ' PRO . 10.1 m-85 -62.12 -35.63 79.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.244 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -63.19 -18.1 63.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.707 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -81.71 -3.26 53.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.72 -42.64 0.96 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 119.63 -1.272 . . . . 0.0 114.68 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' A' ' 58' ' ' TYR . 93.2 Cg_exo -49.32 -16.68 1.21 Allowed 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 123.515 2.81 . . . . 0.0 115.367 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -68.38 -30.84 69.87 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.522 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 41.9 35.41 0.53 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.826 1.25 . . . . 0.0 114.059 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 tt -132.51 -47.55 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.594 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.2 151.84 28.37 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.623 0.249 . . . . 0.0 110.917 -175.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.796 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 74.5 Cg_endo -70.35 148.88 62.2 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.366 2.044 . . . . 0.0 111.805 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 68' ' ' ILE . 27.5 pt -84.4 105.33 13.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.394 0.616 . . . . 0.0 110.335 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.8 tt -67.27 -47.36 70.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -161.16 138.38 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.119 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 56' ' ' ILE . 2.8 tt -108.34 131.13 59.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.76 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -112.03 128.21 56.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.228 0.537 . . . . 0.0 110.007 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 94' ' ' ALA . 30.7 m -126.21 136.64 60.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.069 0.461 . . . . 0.0 109.839 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 91' ' ' TRP . 24.8 t-20 -83.72 101.04 11.28 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.441 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 61.1 t0 -55.92 103.73 0.11 Allowed 'General case' 0 C--O 1.236 0.386 0 O-C-N 124.774 1.296 . . . . 0.0 110.058 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.829 ' O ' ' HG2' ' A' ' 86' ' ' PRO . 52.6 mtt -127.64 -26.21 3.02 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.07 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.735 ' HA3' ' HB2' ' A' ' 81' ' ' ALA . . . -70.66 58.07 0.94 Allowed Glycine 0 C--O 1.226 -0.348 0 O-C-N 123.951 0.782 . . . . 0.0 115.015 -165.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.38 33.9 0.69 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.381 0.61 . . . . 0.0 109.846 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -171.53 8.54 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.548 -171.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.43 ' HA2' ' HZ ' ' A' ' 126' ' ' PHE . . . 127.02 -26.13 5.1 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.568 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.735 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . . . 67.68 70.06 0.35 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.399 0.619 . . . . 0.0 110.315 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.2 p -83.97 175.06 9.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.359 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.523 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 21.1 p-90 -70.2 -20.86 63.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.213 0.53 . . . . 0.0 110.321 174.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -83.08 -35.88 25.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.005 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.507 HE22 ' N ' ' A' ' 35' ' ' LYS . 0.9 OUTLIER 68.1 140.74 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.144 173.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.829 ' HG2' ' O ' ' A' ' 76' ' ' MET . 52.1 Cg_exo -57.46 -48.38 17.62 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.925 2.416 . . . . 0.0 113.032 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.99 -141.65 8.32 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.682 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -67.1 139.67 57.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.973 0.415 . . . . 0.0 111.521 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -150.99 -165.05 12.47 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -100.15 138.45 37.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 117.08 0.44 . . . . 0.0 110.116 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 74' ' ' ASN . 15.4 p-90 -98.61 131.08 45.09 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.416 -177.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.48 HD13 ' CA ' ' A' ' 118' ' ' SER . 3.7 pt -141.88 163.19 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.247 -170.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.39 107.31 10.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.384 171.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -62.61 -35.28 79.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.004 0.43 . . . . 0.0 111.229 -176.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.706 ' HA ' HD13 ' A' ' 137' ' ' LEU . 8.9 t70 -59.78 -26.82 66.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.88 0.848 . . . . 0.0 110.27 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -116.4 36.06 4.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.646 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.27 178.96 6.5 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.796 0.331 . . . . 0.0 110.55 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -97.51 138.11 35.44 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.426 0.631 . . . . 0.0 109.924 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.413 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 5.6 m-85 -120.09 135.65 54.87 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.029 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.946 HG13 HG13 ' A' ' 115' ' ' VAL . 2.2 p -115.3 120.6 65.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.717 0.77 . . . . 0.0 109.473 170.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 64.4 t -101.74 115.94 44.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.57 -1.196 . . . . 0.0 108.58 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.48 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -77.61 120.87 5.64 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.263 -176.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 m -92.5 -29.16 16.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.926 0.394 . . . . 0.0 110.382 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.98 -43.97 17.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.133 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 46.6 mtp180 -130.93 121.19 24.72 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.577 HH22 ' HZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER 172.84 175.21 0.1 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.804 0.69 . . . . 0.0 109.863 177.387 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.88 -78.47 0.09 OUTLIER Glycine 0 C--N 1.337 0.587 0 O-C-N 123.363 0.414 . . . . 0.0 113.402 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.37 -76.9 0.76 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.329 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -83.63 -3.67 57.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.155 0.503 . . . . 0.0 110.749 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -130.55 -124.0 2.56 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.426 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.42 96.99 9.36 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 28.3 Cg_endo -64.5 147.64 90.45 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.765 2.31 . . . . 0.0 112.695 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.493 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 1.6 mp0 -115.0 121.83 44.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.709 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . . . -94.08 131.51 39.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 175.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.946 HG13 HG13 ' A' ' 100' ' ' VAL . 1.4 p -108.8 106.77 59.35 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.783 0.802 . . . . 0.0 110.352 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HB2' HG21 ' A' ' 73' ' ' VAL . 7.6 Cg_exo -81.86 119.99 3.35 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 124.414 3.409 . . . . 0.0 112.65 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -108.05 153.39 23.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.956 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.48 ' CA ' HD13 ' A' ' 92' ' ' ILE . 48.1 t -81.01 -43.06 20.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.184 174.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.401 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 19.6 m -100.65 131.09 46.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.292 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.577 ' HD2' ' N ' ' A' ' 121' ' ' ASP . 0.0 OUTLIER -65.32 -33.71 76.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.347 -177.072 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.577 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 10.8 p-10 -68.17 -28.51 67.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.196 0.522 . . . . 0.0 110.072 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -69.41 -39.28 78.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.788 173.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.6 82.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.49 94.28 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.687 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.07 73.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.031 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.577 ' HZ ' HH22 ' A' ' 106' ' ' ARG . 44.6 t80 -66.02 -40.34 90.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.07 177.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.709 HG22 ' H ' ' A' ' 132' ' ' GLY . 65.0 t -73.05 -29.07 27.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.452 0.644 . . . . 0.0 110.255 176.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.36 -36.23 81.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.929 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.19 -50.6 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.627 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.742 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 1.9 pt-20 -146.64 -88.92 0.09 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.298 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.742 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 49.85 -142.9 11.81 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 123.412 0.445 . . . . 0.0 113.794 174.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.709 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -175.62 -82.86 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -130.0 139.44 51.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 176.507 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.8 t -101.1 113.95 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.955 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.629 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -139.85 165.7 26.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.068 -176.619 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -88.68 168.2 12.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.706 HD13 ' HA ' ' A' ' 95' ' ' ASP . 3.6 tt -63.4 -32.46 73.9 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.83 -16.07 63.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.028 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -111.88 12.39 20.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.488 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.629 HD13 HD13 ' A' ' 135' ' ' LEU . 16.4 mm -71.87 119.71 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 145' ' ' VAL . 5.2 t -119.29 145.5 46.07 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.958 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.405 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 14.9 p-10 -69.57 -27.52 65.2 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.082 0.239 . . . . 0.0 110.406 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.64 -28.98 68.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.885 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.736 ' HG2' ' HB3' ' A' ' 155' ' ' PRO . 3.9 mmt -84.72 -33.97 23.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.728 0.299 . . . . 0.0 111.425 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 141' ' ' THR . 3.5 t -79.81 -23.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.341 0.591 . . . . 0.0 110.275 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.8 pp -159.88 143.3 14.15 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.773 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' A' ' 150' ' ' GLU . 16.7 p -106.51 120.42 48.55 Favored Pre-proline 0 C--N 1.318 -0.774 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.887 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 14.7 Cg_endo -58.9 -53.17 4.02 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.676 2.251 . . . . 0.0 111.83 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 1.4 t -135.62 20.28 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.597 ' HA ' ' HB ' ' A' ' 147' ' ' THR . 5.2 mm-40 64.81 -83.6 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.3 -168.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 t 44.83 7.45 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 57.38 46.36 91.93 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.297 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 25.4 m -71.08 144.75 50.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.776 0.288 . . . . 0.0 110.563 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 158' ' ' ASP . 45.2 mt-10 -75.8 122.88 87.91 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.736 ' HB3' ' HG2' ' A' ' 144' ' ' MET . 6.8 Cg_endo -48.53 -85.4 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 124.228 3.286 . . . . 0.0 114.299 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.93 -22.3 12.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.216 0.532 . . . . 0.0 109.904 175.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -175.9 21.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.241 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 29.8 t0 53.81 71.88 0.48 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.307 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.65 -39.83 1.97 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.323 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 1.7 pm0 . . . . . 0 C--O 1.25 1.079 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.503 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.716 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -132.45 144.12 50.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.68 0.276 . . . . 0.0 110.645 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 20.3 pt20 -149.16 131.63 15.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.092 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.751 HG22 ' HB ' ' A' ' 71' ' ' ILE . 29.8 pt -115.78 133.23 62.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.148 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -103.99 123.9 48.04 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.568 ' CB ' ' HB2' ' A' ' 43' ' ' SER . 6.4 mp -90.35 148.52 22.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.33 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.633 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 35.7 tt0 -74.16 124.06 25.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.31 -28.8 4.57 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.066 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.568 ' HB2' ' CB ' ' A' ' 40' ' ' LEU . 59.7 m -81.72 124.51 79.57 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.923 0.392 . . . . 0.0 110.347 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 4.2 Cg_exo -78.12 -13.34 15.6 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.373 2.715 . . . . 0.0 113.298 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.63 133.62 24.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.369 . . . . 0.0 111.266 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.435 ' HG2' ' CE2' ' A' ' 48' ' ' PHE . 96.8 Cg_endo -85.98 168.51 9.26 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.873 2.382 . . . . 0.0 112.472 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 8.0 tt -111.75 116.21 30.34 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.435 ' CE2' ' HG2' ' A' ' 46' ' ' PRO . 98.6 m-85 -96.08 136.19 36.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.355 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.411 ' HD1' ' H ' ' A' ' 51' ' ' GLN . 0.8 OUTLIER -148.01 133.15 18.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.2 m -66.23 -40.48 90.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.395 0.617 . . . . 0.0 109.613 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.829 ' HG2' ' HB2' ' A' ' 83' ' ' TRP . 50.3 mt-30 -77.31 102.22 6.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.316 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.716 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 13.8 t -56.73 -50.05 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.177 0.513 . . . . 0.0 110.129 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.572 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -55.44 -33.89 64.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.812 -1.086 . . . . 0.0 112.782 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.433 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 7.8 t70 -76.34 -43.55 40.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.138 0.494 . . . . 0.0 110.084 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 58' ' ' TYR . . . -71.52 -34.75 70.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.746 -178.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 10.4 pt -68.56 -31.67 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.76 88.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.542 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 19.6 m-85 -60.29 -44.89 94.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.97 0.414 . . . . 0.0 111.356 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.46 -17.88 63.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.478 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -105.04 12.63 31.99 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 179.21 -71.94 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.118 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -65.74 37.94 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.829 0 C-N-CA 124.189 3.26 . . . . 0.0 114.994 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' H ' ' HG2' ' A' ' 63' ' ' GLU . 15.1 pt-20 -68.57 144.14 54.65 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 173.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -53.83 -82.25 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -169.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 65' ' ' ILE . 12.8 tt -137.5 4.3 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.065 0.936 . . . . 0.0 109.559 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 41' ' ' GLU . . . -141.33 156.45 67.33 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.52 -174.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.6 Cg_endo -72.62 160.26 46.91 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.184 1.923 . . . . 0.0 111.045 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.7 pt -77.19 134.81 27.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.333 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.4 tt -89.98 -52.64 4.87 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 p -161.34 141.26 3.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.761 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.751 ' HB ' HG22 ' A' ' 38' ' ' ILE . 1.7 tt -107.72 134.08 50.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.606 174.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.84 145.42 39.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 94' ' ' ALA . 31.1 m -137.77 143.21 34.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.392 0.615 . . . . 0.0 110.642 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.665 ' O ' ' HG3' ' A' ' 76' ' ' MET . 93.3 m-20 -78.39 105.46 9.66 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 168.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 1.072 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 31.5 t0 -58.78 121.46 11.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.368 -175.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.843 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -154.37 48.59 0.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.622 -179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.833 ' HA2' ' HB2' ' A' ' 81' ' ' ALA . . . -101.25 49.49 1.05 Allowed Glycine 0 C--N 1.314 -0.694 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.507 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.04 79.15 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.765 0.317 . . . . 0.0 110.561 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 57.94 25.7 12.49 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.763 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.6 -74.25 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.049 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.833 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . . . 59.33 62.17 1.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.406 0.622 . . . . 0.0 110.869 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 77.6 p -83.82 176.14 9.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.882 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.829 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 46.6 p90 -69.25 -22.58 63.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 0.0 110.496 177.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -85.19 -24.59 27.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.616 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 71.68 158.86 0.16 Allowed Pre-proline 0 N--CA 1.468 0.471 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.433 173.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.843 ' HD2' ' HB2' ' A' ' 76' ' ' MET . 19.6 Cg_endo -88.16 8.16 4.22 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.801 2.334 . . . . 0.0 111.476 169.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.66 130.8 6.23 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.797 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -72.44 126.79 30.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.732 0.266 . . . . 0.0 110.457 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.49 -65.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.505 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 1.072 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 61.9 t30 -85.6 153.17 22.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -122.57 128.8 51.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.953 HG21 ' HB2' ' A' ' 118' ' ' SER . 21.7 pt -145.64 166.14 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.282 0.563 . . . . 0.0 112.354 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.24 101.59 12.64 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.217 -0.902 . . . . 0.0 108.852 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.685 ' O ' ' HG ' ' A' ' 137' ' ' LEU . . . -59.03 -40.01 83.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.029 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.725 ' HB2' HG22 ' A' ' 71' ' ' ILE . 24.0 t70 -63.3 -11.05 19.02 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.458 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -130.35 50.7 2.17 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.594 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -149.5 -169.2 3.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.469 0.176 . . . . 0.0 110.709 -173.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -94.82 142.25 27.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.52 0.676 . . . . 0.0 111.147 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.5 135.7 54.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.853 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.613 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.2 p -115.16 124.01 71.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.622 0.725 . . . . 0.0 110.007 169.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.569 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 43.8 t -101.65 106.92 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.753 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.901 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -72.62 141.16 30.35 Favored Glycine 0 C--O 1.223 -0.536 0 CA-C-N 116.057 -0.52 . . . . 0.0 114.219 -170.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.3 m -92.13 -32.77 15.0 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.625 -0.338 . . . . 0.0 111.207 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -88.29 -46.18 9.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 35.7 mtp-105 -104.73 -92.64 0.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.145 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 145' ' ' VAL . 37.2 ttp85 51.41 -87.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.78 23.75 0.02 OUTLIER Glycine 0 C--O 1.222 -0.652 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.207 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -57.78 -26.82 58.28 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.283 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 70.7 mtm -105.68 15.98 26.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.66 0.267 . . . . 0.0 110.553 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.52 -120.92 0.54 Allowed Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.3 104.33 40.33 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.621 0.211 . . . . 0.0 110.743 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 6.8 Cg_endo -51.28 124.1 13.39 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.544 2.829 . . . . 0.0 113.124 177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.73 146.14 41.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.962 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -125.05 132.82 53.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.916 -175.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.721 HG22 ' HB3' ' A' ' 81' ' ' ALA . 67.6 t -96.7 106.36 29.6 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.879 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 1.2 Cg_endo -90.44 105.75 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.702 2.935 . . . . 0.0 111.056 175.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.92 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.2 t80 -117.95 149.07 41.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.911 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.953 ' HB2' HG21 ' A' ' 92' ' ' ILE . 47.9 t -71.01 -35.73 72.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.915 0.388 . . . . 0.0 110.488 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.92 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 7.3 m -97.85 127.14 43.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.764 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -43.16 98.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.155 0.502 . . . . 0.0 110.584 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.75 -32.63 71.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.856 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -74.66 -37.99 62.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.733 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.36 76.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.21 0.528 . . . . 0.0 110.12 176.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.86 -32.18 70.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.832 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.2 89.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.042 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.96 -40.27 94.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.694 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.668 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 93.0 t -63.55 -38.2 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.695 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.38 -36.85 74.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.575 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.71 -45.75 16.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.254 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.686 ' HB2' ' HB3' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -161.4 -36.03 0.05 OUTLIER 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.039 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.901 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -46.71 163.09 0.17 Allowed Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.075 -0.966 . . . . 0.0 114.034 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.94 -72.63 0.71 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.82 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.59 ' HB3' ' CB ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -124.73 144.47 50.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.821 0.343 . . . . 0.0 111.078 -178.501 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.32 113.47 42.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.379 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.784 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -134.86 148.91 50.24 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.782 -179.046 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.85 161.02 23.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.614 0.245 . . . . 0.0 110.456 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -57.92 -27.29 63.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.037 -178.482 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.03 -16.06 60.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.779 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -123.7 20.48 9.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.945 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.784 HD13 HD13 ' A' ' 135' ' ' LEU . 19.6 mm -71.76 121.52 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.533 HG23 ' HG2' ' A' ' 144' ' ' MET . 4.0 t -114.68 145.77 41.65 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.554 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.2 p-10 -69.75 -24.48 63.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.381 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.02 68.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.795 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.66 ' SD ' ' HB3' ' A' ' 155' ' ' PRO . 19.9 mmt -77.96 -40.28 39.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.952 0.406 . . . . 0.0 110.794 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.411 ' O ' ' NH1' ' A' ' 106' ' ' ARG . 2.4 t -85.73 -21.31 7.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.173 0.511 . . . . 0.0 111.33 -174.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.0 pp -144.56 127.67 16.6 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.343 0.592 . . . . 0.0 110.543 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 21.2 p -102.73 120.45 52.72 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.486 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.35 -58.39 1.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.799 2.333 . . . . 0.0 112.354 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.96 3.68 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.009 0.433 . . . . 0.0 110.209 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.455 ' O ' HG22 ' A' ' 151' ' ' THR . 35.8 mt-10 65.95 -73.42 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.211 -166.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 150' ' ' GLU . 0.6 OUTLIER 57.8 -4.52 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.974 1.309 . . . . 0.0 114.181 172.509 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 92.36 25.58 20.87 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.005 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 56.3 p -97.16 125.36 41.62 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.65 145.41 95.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.66 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 37.4 Cg_exo -35.1 -58.67 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.998 3.132 . . . . 0.0 113.495 -176.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -141.81 -42.55 0.35 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.66 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -165.22 25.81 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.825 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.4 t0 53.91 77.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -165.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -136.96 24.25 3.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.563 -167.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.59 ' CB ' ' HB3' ' A' ' 133' ' ' GLN . 2.8 pt-20 . . . . . 0 C--O 1.246 0.918 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.269 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' SER . 27.2 ttpp . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -126.96 143.88 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.21 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 1.7 pm0 -149.06 136.28 20.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.934 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.89 HG21 ' HB2' ' A' ' 59' ' ' ALA . 37.1 pt -115.82 132.67 64.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.114 0.483 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -99.19 126.36 44.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.571 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.0 mp -91.75 151.98 20.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.006 -175.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.552 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 26.9 tt0 -74.01 125.44 28.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.958 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.62 -30.9 5.12 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.213 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.53 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 14.7 t -92.16 124.23 60.39 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.53 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -84.73 19.62 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.168 2.579 . . . . 0.0 112.109 -178.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.91 133.58 24.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.527 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -91.51 138.08 2.1 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.659 2.239 . . . . 0.0 112.732 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.468 ' HB3' HG12 ' A' ' 38' ' ' ILE . 3.6 tt -89.28 104.16 16.73 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 47.3 p90 -113.21 151.06 31.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.335 -175.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' HE2' HE21 ' A' ' 51' ' ' GLN . 14.5 t80 -149.8 149.6 30.75 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -53.65 -59.47 4.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.122 0.487 . . . . 0.0 110.482 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.656 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 32.7 mt-30 -65.4 121.96 16.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.459 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.598 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 12.6 t -59.92 -49.99 81.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.58 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -55.06 -30.28 59.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.482 179.562 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.656 ' HB2' ' HB2' ' A' ' 51' ' ' GLN . 5.2 t0 -76.13 -51.17 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.843 0.354 . . . . 0.0 110.805 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.743 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -67.89 -35.54 78.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.456 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.826 HD12 ' HB3' ' A' ' 114' ' ' ALA . 20.9 pt -67.79 -31.68 53.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.305 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.17 95.08 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.411 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.834 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 36.1 m-85 -57.97 -42.23 84.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.198 0.523 . . . . 0.0 110.77 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.89 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -63.36 -19.79 64.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.387 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -105.26 12.23 32.04 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.863 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.41 -72.59 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.656 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.834 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 25.9 Cg_exo -67.79 47.61 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.823 3.015 . . . . 0.0 113.606 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.561 ' OE1' ' HA ' ' A' ' 67' ' ' PRO . 9.4 pt-20 -81.37 -3.27 52.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.268 0.556 . . . . 0.0 110.217 177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 72.45 -78.67 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.844 171.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -129.67 -52.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -171.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -97.31 148.49 34.49 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.432 0.158 . . . . 0.0 110.713 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.561 ' HA ' ' OE1' ' A' ' 63' ' ' GLU . 59.4 Cg_endo -71.81 157.72 54.59 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.447 2.098 . . . . 0.0 111.936 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 68' ' ' ILE . 47.5 pt -75.1 122.16 28.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.263 0.554 . . . . 0.0 110.261 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 41' ' ' GLU . 5.6 tt -88.22 -47.96 8.05 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.46 138.72 2.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.547 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.776 HD11 HG22 ' A' ' 56' ' ' ILE . 2.6 tt -110.19 131.58 60.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.315 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -111.94 142.16 44.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.881 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.66 143.66 31.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.968 0.414 . . . . 0.0 110.773 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.521 HD21 ' HA ' ' A' ' 88' ' ' ASP . 33.7 t30 -79.57 101.11 8.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 167.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 76' ' ' MET . 54.5 t0 -63.63 106.99 1.05 Allowed 'General case' 0 C--O 1.242 0.707 0 O-C-N 124.47 1.107 . . . . 0.0 110.628 -174.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.601 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 3.6 mmt -152.29 58.95 0.83 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 113.442 -1.708 . . . . 0.0 107.86 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.28 26.46 21.2 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.042 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.15 39.45 0.82 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.979 0.419 . . . . 0.0 110.953 -172.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 80' ' ' GLY . . . -179.43 -11.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.238 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.429 ' H ' ' H ' ' A' ' 79' ' ' ALA . . . 126.14 -4.32 7.82 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.997 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.27 65.39 1.09 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.622 0.725 . . . . 0.0 109.956 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.7 p -83.81 177.1 8.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.419 -171.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.409 ' HA ' ' HG2' ' A' ' 51' ' ' GLN . 68.8 t90 -59.43 -40.6 87.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.075 0.464 . . . . 0.0 110.026 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.32 -34.15 48.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.089 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.08 159.79 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.983 1.313 . . . . 0.0 112.935 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 8.2 Cg_exo -58.47 -25.93 75.97 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.67 1.58 . . . . 0.0 112.188 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.601 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . 135.39 -149.51 19.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.966 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.521 ' HA ' HD21 ' A' ' 74' ' ' ASN . 7.6 p-10 -77.55 137.52 38.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.999 0.428 . . . . 0.0 110.285 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.81 -141.85 3.99 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.549 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -100.6 133.65 44.73 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -98.16 130.25 44.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.13 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.688 HD13 ' HB2' ' A' ' 118' ' ' SER . 6.9 pt -145.04 166.42 11.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.934 -173.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.26 107.16 15.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.05 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . . . -62.1 -27.78 69.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.136 0.493 . . . . 0.0 110.479 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.548 ' HA ' HD13 ' A' ' 137' ' ' LEU . 22.7 t70 -59.54 -25.19 64.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.413 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -123.65 43.14 3.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.384 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -139.86 -177.93 5.2 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -173.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -97.95 138.04 35.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.394 0.616 . . . . 0.0 110.646 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 116' ' ' PRO . 3.1 m-85 -120.46 135.33 55.09 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.104 -177.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.9 p -113.66 124.82 70.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.514 0.673 . . . . 0.0 109.816 173.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.59 113.87 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.433 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -79.44 121.84 5.63 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.011 -1.09 . . . . 0.0 112.774 -172.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.8 m -92.68 -41.02 10.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.854 0.359 . . . . 0.0 110.313 175.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.21 -43.84 63.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 -174.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -133.84 114.72 13.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.523 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 176.0 -168.88 0.05 Allowed 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.554 0.534 . . . . 0.0 110.086 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.478 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -65.56 -50.99 51.73 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.925 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.06 -102.15 0.68 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.272 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.3 mmt -86.46 -3.92 59.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 110.757 174.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.49 -124.53 5.08 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.478 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.35 96.13 8.01 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.56 0.18 . . . . 0.0 111.084 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.37 141.89 70.15 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.552 2.168 . . . . 0.0 111.9 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.523 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 36.5 mt-10 -125.94 140.63 52.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.605 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.826 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -105.95 131.47 53.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.859 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.678 ' HB ' HG13 ' A' ' 100' ' ' VAL . 59.4 t -100.59 106.14 41.37 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.6 Cg_endo -87.75 122.92 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.695 2.93 . . . . 0.0 111.552 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.631 ' HD1' ' H ' ' A' ' 119' ' ' SER . 3.6 t80 -130.43 151.11 51.27 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.688 ' HB2' HD13 ' A' ' 92' ' ' ILE . 33.8 t -73.47 -35.79 65.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.631 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 15.2 m -105.96 128.83 54.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.798 0.332 . . . . 0.0 110.846 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -49.85 57.9 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.787 -176.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -67.14 -28.38 68.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.29 0.567 . . . . 0.0 109.74 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 66.3 mm-40 -71.46 -34.84 70.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.594 172.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.64 -35.09 76.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.338 0.59 . . . . 0.0 109.69 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.43 75.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.695 173.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.1 -32.3 73.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.39 . . . . 0.0 110.444 175.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -63.79 -37.49 87.58 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.65 HG22 ' H ' ' A' ' 132' ' ' GLY . 58.9 t -69.57 -30.48 45.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.447 176.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 tp -59.5 -39.6 84.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.949 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.44 -47.85 13.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.686 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.811 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.6 pt-20 -149.94 -89.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.459 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.811 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 44.88 -143.33 2.95 Favored Glycine 0 C--N 1.334 0.453 0 O-C-N 123.588 0.555 . . . . 0.0 114.297 174.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.65 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -176.08 -81.26 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -130.21 145.97 51.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.586 0.231 . . . . 0.0 110.568 175.836 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.21 116.31 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.149 0.499 . . . . 0.0 110.682 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.854 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -141.0 164.13 31.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.955 -178.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.31 163.3 18.68 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.548 HD13 ' HA ' ' A' ' 95' ' ' ASP . 0.6 OUTLIER -66.4 -31.57 72.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.399 0.618 . . . . 0.0 109.505 178.649 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.87 -9.12 58.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.878 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.27 17.9 11.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.23 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.854 HD13 HD13 ' A' ' 135' ' ' LEU . 26.3 mm -71.87 121.99 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.147 0.499 . . . . 0.0 110.627 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -112.23 149.56 32.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.261 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.474 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 2.2 p-10 -68.92 -29.86 68.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.556 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.43 68.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.66 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.548 ' HE3' ' HA ' ' A' ' 160' ' ' GLU . 13.4 mmt -87.11 -36.95 17.81 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.16 -22.73 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 121.09 0.471 . . . . 0.0 110.672 -174.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.3 pp -148.64 141.25 24.44 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.014 -177.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.3 p -126.0 135.55 27.24 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.053 0.454 . . . . 0.0 111.132 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.8 -49.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.822 2.348 . . . . 0.0 111.809 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 151' ' ' THR . 8.0 t -159.23 85.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -176.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -50.82 74.6 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.226 168.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 149' ' ' VAL . 10.2 t -106.92 21.21 17.9 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.756 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.73 78.0 0.8 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.132 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.2 m -129.96 139.33 51.1 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.54 125.67 92.12 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.726 0.298 . . . . 0.0 110.294 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.55 -73.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.85 2.367 . . . . 0.0 112.253 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.596 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -108.67 -54.07 2.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.786 176.633 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.596 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -151.84 37.76 0.58 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -174.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 157' ' ' ALA . 32.9 t70 73.74 -30.01 0.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.235 -175.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 157' ' ' ALA . 6.2 t70 -73.72 -168.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.362 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.548 ' HA ' ' HE3' ' A' ' 144' ' ' MET . 39.2 mt-10 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.595 -0.717 . . . . 0.0 109.926 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.593 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -126.71 142.54 51.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 9.0 pt20 -149.39 133.66 17.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.474 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.538 HG21 ' HB2' ' A' ' 59' ' ' ALA . 39.0 pt -115.63 136.21 53.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.957 0.408 . . . . 0.0 110.946 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -105.77 131.84 52.63 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.949 HD21 ' HB3' ' A' ' 64' ' ' GLN . 8.7 mp -89.19 152.57 21.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.113 0.482 . . . . 0.0 111.672 -173.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.859 ' HG3' HD13 ' A' ' 69' ' ' LEU . 32.0 tt0 -74.22 124.78 27.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.62 -41.1 2.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.238 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.534 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 31.2 t -81.92 123.96 79.6 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.038 0.447 . . . . 0.0 110.446 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.0 Cg_exo -81.74 5.63 6.18 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.322 2.682 . . . . 0.0 112.455 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -100.37 131.18 24.35 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.574 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 97.8 Cg_endo -101.41 161.08 0.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.573 2.848 . . . . 0.0 112.984 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.446 ' HB3' HG12 ' A' ' 38' ' ' ILE . 7.6 tt -117.73 114.93 24.05 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -118.24 135.77 54.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.61 0.719 . . . . 0.0 111.582 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.42 135.17 31.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.624 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.9 m -63.93 -29.49 70.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.579 0.704 . . . . 0.0 109.171 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.645 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 14.3 mt-30 -75.97 95.98 3.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.702 175.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.593 HG13 ' HB2' ' A' ' 36' ' ' ALA . 10.8 t -57.65 -52.03 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.058 0.456 . . . . 0.0 111.019 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' HA ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -54.15 -30.11 47.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.364 -178.295 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.511 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 1.2 m-20 -73.98 -53.47 9.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.761 0.315 . . . . 0.0 111.189 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -67.21 -35.97 80.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.256 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.609 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 17.7 pt -70.35 -32.52 50.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.521 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.17 -44.97 74.74 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.567 174.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.458 ' HD1' ' HG2' ' A' ' 62' ' ' PRO . 22.1 m-85 -62.39 -35.11 78.18 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -61.04 -17.8 54.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 112.017 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -84.8 -15.57 44.43 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.35 -73.02 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.264 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.458 ' HG2' ' HD1' ' A' ' 58' ' ' TYR . 84.8 Cg_exo -48.67 -47.01 22.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.329 2.686 . . . . 0.0 113.205 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.433 ' OE2' ' HA ' ' A' ' 67' ' ' PRO . 44.9 mt-10 54.76 -91.08 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.564 0.746 . . . . 0.0 111.723 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.949 ' HB3' HD21 ' A' ' 40' ' ' LEU . 5.7 tp-100 -174.27 -61.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.186 0.517 . . . . 0.0 109.672 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.0 tt -168.42 -38.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -106.63 165.3 13.17 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 73.0 Cg_endo -74.53 156.59 45.14 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.649 1.566 . . . . 0.0 111.628 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.3 pt -69.87 128.15 32.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.219 0.533 . . . . 0.0 110.909 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.859 HD13 ' HG3' ' A' ' 41' ' ' GLU . 42.6 tp -89.32 -48.95 7.01 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.99 138.45 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.631 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.544 HD11 HG22 ' A' ' 56' ' ' ILE . 2.7 tt -110.89 135.42 50.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.429 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -112.91 138.81 49.2 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 94' ' ' ALA . 19.7 m -128.94 137.88 56.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.289 0.566 . . . . 0.0 110.551 175.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.492 ' O ' ' HG3' ' A' ' 76' ' ' MET . 27.9 t-20 -78.63 104.17 9.07 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -72.49 121.54 19.79 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 124.256 0.973 . . . . 0.0 109.73 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.519 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -151.84 92.37 1.73 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.611 -176.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.7 -56.84 3.84 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.886 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HA ' ' HB2' ' A' ' 81' ' ' ALA . . . 70.99 -52.07 0.68 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.984 0.914 . . . . 0.0 112.49 175.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.91 -34.07 58.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.99 0.424 . . . . 0.0 110.791 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -97.29 -65.33 0.9 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 78' ' ' ALA . . . 44.06 64.54 1.26 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.59 0.756 . . . . 0.0 112.908 175.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.9 p -84.0 176.14 9.05 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.645 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 26.1 p90 -73.32 -12.83 60.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.164 0.507 . . . . 0.0 110.287 175.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.82 -35.15 22.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 68.02 161.04 0.14 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.768 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 76' ' ' MET . 69.9 Cg_endo -93.52 29.35 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.195 1.93 . . . . 0.0 111.634 176.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.15 161.92 18.64 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.721 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -77.35 123.23 26.22 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -106.56 -139.18 9.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.145 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -100.04 149.45 23.47 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 67.2 p-90 -98.44 134.72 41.03 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.232 0.539 . . . . 0.0 110.639 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.737 HD13 ' HB2' ' A' ' 118' ' ' SER . 4.3 pt -133.78 151.91 33.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.543 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.04 102.54 4.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.54 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -61.16 -34.81 75.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.337 -176.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 137' ' ' LEU . 16.7 t70 -57.81 -30.34 65.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.707 0.765 . . . . 0.0 110.354 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -111.24 26.79 10.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.826 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -120.17 177.39 5.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.718 0.294 . . . . 0.0 111.06 -173.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -90.44 131.34 36.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.453 0.644 . . . . 0.0 110.535 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.62 135.33 55.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.071 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.697 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.8 p -112.82 125.46 70.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.745 0.783 . . . . 0.0 110.334 174.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.7 ' HA ' HH11 ' A' ' 106' ' ' ARG . 47.9 t -101.81 107.87 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.998 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.449 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -69.6 124.27 15.11 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.547 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.4 m -88.6 -31.01 18.81 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.77 -44.33 11.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.738 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -133.59 109.52 9.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.755 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.797 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 13.7 ttt180 -168.64 -72.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.601 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.67 46.04 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.523 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -61.8 -39.49 97.54 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.699 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 45.2 tpp -109.39 -4.21 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.559 0.695 . . . . 0.0 110.1 174.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.88 -132.87 5.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.208 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.3 102.6 29.96 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 34.0 Cg_endo -63.74 129.47 24.95 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.253 2.636 . . . . 0.0 114.01 -175.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.797 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 47.9 mm-40 -114.21 129.33 56.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.364 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.609 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . . . -102.22 131.06 49.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.824 -0.171 . . . . 0.0 111.263 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.697 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 85.7 t -101.61 105.74 42.41 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.772 173.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -90.09 127.04 1.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.762 2.975 . . . . 0.0 111.795 175.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.26 149.81 52.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.195 -176.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.737 ' HB2' HD13 ' A' ' 92' ' ' ILE . 47.9 t -79.1 -18.25 53.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.893 0.378 . . . . 0.0 110.758 176.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.7 m -119.85 134.24 55.31 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.77 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -67.48 -49.52 63.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -60.13 -28.99 68.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.452 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -70.23 -43.28 70.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.268 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.7 -30.2 69.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.148 176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.1 -38.09 72.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.639 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.57 74.79 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.264 0.554 . . . . 0.0 110.272 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.69 -39.64 92.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.847 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.829 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 94.6 t -70.78 -34.81 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.929 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 67.6 mt -56.36 -40.94 75.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.62 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.53 -48.97 11.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.699 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.751 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.5 pt-20 -145.4 -82.72 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.101 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.829 ' HA3' ' HA ' ' A' ' 127' ' ' VAL . . . 38.23 -142.24 0.35 Allowed Glycine 0 C--N 1.337 0.606 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.784 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -179.73 -87.28 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.491 HE21 ' HB ' ' A' ' 101' ' ' VAL . 1.9 pm0 -129.86 141.46 50.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.675 0.274 . . . . 0.0 110.863 175.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.48 113.22 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.04 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.73 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.41 165.05 27.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.656 -178.239 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.31 161.79 19.36 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.69 ' HA ' HG12 ' A' ' 140' ' ' ILE . 5.9 tt -61.75 -36.78 82.0 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.85 -11.48 27.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.487 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -126.0 23.15 7.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.012 0.434 . . . . 0.0 110.895 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.73 HD13 HD13 ' A' ' 135' ' ' LEU . 34.4 mm -71.82 119.12 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 145' ' ' VAL . 14.1 t -119.26 148.65 42.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.681 -176.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.528 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 1.5 p30 -66.07 -41.73 90.35 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -171.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 155' ' ' PRO . . . -57.03 -28.6 62.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.523 ' SD ' ' HB2' ' A' ' 155' ' ' PRO . 19.2 mmt -82.19 -26.83 33.0 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 141' ' ' THR . 10.9 t -97.88 -23.19 4.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -170.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.6 pp -136.33 156.4 48.69 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.969 -172.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.5 p -111.99 119.52 44.08 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.044 0.449 . . . . 0.0 110.779 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.19 -81.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.581 2.187 . . . . 0.0 111.976 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.557 ' HB ' ' OG1' ' A' ' 151' ' ' THR . 4.1 t -129.35 -2.48 2.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 15.0 mm-40 87.83 -77.78 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -169.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.557 ' OG1' ' HB ' ' A' ' 149' ' ' VAL . 13.0 m 68.46 -42.33 0.47 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 163.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.83 20.91 5.88 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.9 m -84.02 126.55 33.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.585 0.231 . . . . 0.0 110.438 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.718 ' HB3' ' HB2' ' A' ' 158' ' ' ASP . 4.3 mp0 -71.14 126.57 91.98 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.157 177.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.523 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 61.8 Cg_endo -72.94 126.94 11.7 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.633 2.222 . . . . 0.0 111.325 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 155' ' ' PRO . 18.5 tpp85 69.66 -63.07 0.4 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.527 0.517 . . . . 0.0 110.471 -175.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 158' ' ' ASP . . . -179.07 13.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.275 0.63 . . . . 0.0 109.92 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.718 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 14.0 t70 57.59 30.88 19.49 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -169.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.01 -68.22 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.679 -172.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.751 179.643 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.573 ' HB3' ' OD1' ' A' ' 74' ' ' ASN . 43.7 tttp . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.769 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -144.72 144.75 31.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.763 0.316 . . . . 0.0 111.671 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 22.3 pt20 -145.56 134.8 22.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.874 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' A' ' 47' ' ' LEU . 3.9 pt -119.81 143.24 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.248 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -116.82 127.88 54.74 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.3 mp -92.07 142.42 27.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.068 0.461 . . . . 0.0 111.082 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.783 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 44.8 tt0 -73.83 124.69 26.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.866 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.05 -27.29 11.58 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.146 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.3 t -92.0 125.56 56.45 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.1 Cg_exo -80.5 12.12 2.67 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.132 2.554 . . . . 0.0 112.833 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -130.15 133.25 24.73 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.876 0.369 . . . . 0.0 110.961 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 55.6 Cg_endo -97.42 170.83 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.388 2.725 . . . . 0.0 112.782 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.722 ' HB3' HG12 ' A' ' 38' ' ' ILE . 14.4 tp -107.04 130.64 54.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.94 177.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -114.45 134.47 54.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.1 147.6 27.97 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 110.688 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 55.3 m -70.38 -52.58 21.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.143 173.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.5 HE21 ' HB3' ' A' ' 83' ' ' TRP . 39.8 mt-30 -67.37 113.09 4.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.718 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.769 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 6.2 t -60.48 -50.48 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.565 0.697 . . . . 0.0 109.444 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.631 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -60.21 -28.79 68.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.548 -176.765 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.631 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 14.2 t70 -76.14 -45.5 33.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.781 0.324 . . . . 0.0 110.482 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.52 72.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.275 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.617 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 16.4 pt -71.19 -32.51 47.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 0.0 110.179 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.26 -36.34 79.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.16 0.505 . . . . 0.0 110.302 172.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.456 ' CD1' HD22 ' A' ' 47' ' ' LEU . 33.8 t80 -60.62 -33.23 72.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.279 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.653 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -72.37 -18.1 61.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.605 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.55 ' NH2' ' HG ' ' A' ' 137' ' ' LEU . 75.1 mtt85 -105.62 13.14 30.33 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.36 -78.63 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.538 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -43.37 -35.54 5.71 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 124.041 3.161 . . . . 0.0 114.774 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -67.61 128.66 37.28 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.759 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -169.68 -36.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.122 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.9 -27.46 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.542 0.687 . . . . 0.0 109.644 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.748 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.1 141.2 14.08 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.309 175.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.783 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 70.4 Cg_endo -74.23 155.12 46.81 Favored 'Trans proline' 0 CA--C 1.52 -0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.282 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.653 HD13 ' HB1' ' A' ' 59' ' ' ALA . 27.5 pt -75.74 116.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.373 0.606 . . . . 0.0 110.484 174.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -79.12 -47.84 15.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 p -161.08 150.16 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.775 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.572 HD11 HG22 ' A' ' 56' ' ' ILE . 5.7 tt -128.0 128.61 69.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.448 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -111.99 133.46 54.15 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 94' ' ' ALA . 34.6 m -132.2 156.6 42.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.108 0.48 . . . . 0.0 110.668 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.573 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 12.3 m120 -92.34 104.56 16.89 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.459 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 10.3 t0 -49.56 103.9 0.06 Allowed 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 125.35 1.656 . . . . 0.0 109.525 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' ' 85' ' ' GLN . 3.3 ttm -144.69 41.04 1.31 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.038 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 79' ' ' ALA . . . -89.62 18.1 48.53 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.644 -175.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.06 22.17 0.11 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.216 0.532 . . . . 0.0 111.474 -175.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -172.89 20.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.493 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.401 ' HA2' ' CG2' ' A' ' 115' ' ' VAL . . . 91.51 -2.29 77.32 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.347 -176.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . . . 60.47 66.82 0.89 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.688 0.756 . . . . 0.0 110.315 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 p -83.73 175.59 9.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.445 -176.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.5 ' HB3' HE21 ' A' ' 51' ' ' GLN . 59.8 p-90 -67.26 -23.92 65.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.981 0.42 . . . . 0.0 110.767 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.03 -35.55 42.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.58 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 24.2 mt-30 66.8 142.97 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.578 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -57.61 -42.22 62.76 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.015 1.81 . . . . 0.0 112.07 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.2 -64.56 0.6 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.247 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.32 131.79 38.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.7 0.286 . . . . 0.0 110.619 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 75' ' ' ASP . . . -147.47 139.74 8.04 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.401 -177.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.3 t30 -100.13 149.14 23.83 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -98.48 129.74 45.08 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.705 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.747 HG21 ' HB2' ' A' ' 118' ' ' SER . 20.3 pt -145.02 166.17 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.967 -174.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.69 114.1 23.1 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -69.46 -38.07 77.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.036 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.73 ' HA ' HD13 ' A' ' 137' ' ' LEU . 0.6 OUTLIER -68.03 -25.24 65.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.738 0.78 . . . . 0.0 109.752 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -98.9 37.35 1.53 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.262 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 117' ' ' PHE . . . -145.48 179.24 7.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.35 -171.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -93.59 141.8 28.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.304 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.406 ' CE1' HD12 ' A' ' 137' ' ' LEU . 2.9 m-85 -120.67 137.08 54.64 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.558 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.848 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -115.16 123.21 70.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.504 0.669 . . . . 0.0 109.368 172.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.482 ' HB ' ' HG2' ' A' ' 133' ' ' GLN . 56.4 t -101.53 107.13 20.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.31 123.25 7.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.793 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.4 t -92.42 -35.4 13.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.893 0.378 . . . . 0.0 110.146 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.39 -45.08 20.21 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.943 0.401 . . . . 0.0 111.568 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.437 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 48.9 mtp180 -129.58 111.72 13.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.633 ' NE ' ' HA ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -177.81 -170.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.623 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -54.54 -37.56 61.01 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.67 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.45 -105.26 1.09 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.041 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 86.7 mtp -92.94 -4.0 53.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.979 0.419 . . . . 0.0 110.374 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -95.15 -129.51 5.8 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.782 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.27 96.58 8.52 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 176.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 18.1 Cg_endo -59.72 151.51 69.78 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.401 2.734 . . . . 0.0 113.314 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.514 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 2.5 mp0 -117.1 146.13 43.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.54 175.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.617 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . . . -103.98 131.13 51.53 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.848 ' HB ' HG13 ' A' ' 100' ' ' VAL . 5.7 t -99.19 105.22 31.07 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.3 Cg_exo -87.07 133.35 3.4 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.556 2.837 . . . . 0.0 112.89 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.4 ' O ' ' HB1' ' A' ' 97' ' ' ALA . 35.8 m-85 -129.26 149.67 50.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.46 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.747 ' HB2' HG21 ' A' ' 92' ' ' ILE . 32.5 t -78.05 -38.19 45.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.064 0.459 . . . . 0.0 109.837 172.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 m -96.28 135.33 38.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.818 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -46.2 84.85 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -64.73 -28.46 69.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.875 -172.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -64.98 -38.66 91.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.95 0.405 . . . . 0.0 110.677 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -73.02 -36.16 66.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.077 176.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.0 -44.99 83.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.065 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.65 -34.14 75.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 110.9 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -62.78 -40.51 97.53 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.85 HG22 ' H ' ' A' ' 132' ' ' GLY . 91.7 t -72.43 -32.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.603 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.4 tp -57.75 -43.67 85.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.1 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.44 -44.64 15.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.164 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.653 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.2 pt-20 -150.69 -93.29 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.403 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.653 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.27 -138.12 7.73 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 114.438 0.535 . . . . 0.0 114.438 173.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.85 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -176.95 -83.09 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.482 ' HG2' ' HB ' ' A' ' 101' ' ' VAL . 13.2 pm0 -130.07 142.16 50.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.645 0.259 . . . . 0.0 110.937 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.5 t -109.45 120.14 60.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.046 0.451 . . . . 0.0 110.729 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.791 HD13 HD13 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -147.2 165.69 29.25 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.547 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.91 164.05 18.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 95' ' ' ASP . 8.6 tt -63.88 -35.52 80.91 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.02 -10.14 59.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.975 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -117.85 20.27 13.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.493 0.663 . . . . 0.0 110.043 -174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.791 HD13 HD13 ' A' ' 135' ' ' LEU . 35.8 mm -76.58 121.69 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.895 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.478 HG23 ' HB2' ' A' ' 144' ' ' MET . 0.5 OUTLIER -106.08 145.85 30.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.858 171.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -69.96 -33.17 71.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.018 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.19 -27.37 68.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.406 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.478 ' HB2' HG23 ' A' ' 141' ' ' THR . 1.7 mmt -73.45 -38.8 65.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.871 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.9 t -83.67 -22.61 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.275 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 pp -151.08 133.44 15.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.594 -0.443 . . . . 0.0 111.406 -174.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.8 p -125.93 120.85 24.15 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.305 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.4 -59.59 0.41 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.898 2.399 . . . . 0.0 113.392 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.3 t -125.21 6.62 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.93 0.395 . . . . 0.0 110.68 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 60.91 47.62 7.46 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.82 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 t -71.9 -3.33 21.87 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 82.8 28.92 36.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.868 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 p -70.49 141.08 52.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.661 0.267 . . . . 0.0 111.231 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.507 ' OE2' ' HB2' ' A' ' 158' ' ' ASP . 37.9 mt-10 -59.73 125.84 81.26 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.204 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.74 -72.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 123.146 2.564 . . . . 0.0 112.723 -176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -117.66 -33.57 4.5 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.476 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 159' ' ' ASP . . . -171.05 39.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.895 -173.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.507 ' HB2' ' OE2' ' A' ' 154' ' ' GLU . 14.6 t70 71.99 -37.26 0.38 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.292 0.637 . . . . 0.0 110.659 -174.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.9 t70 -65.24 -163.38 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.249 175.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.835 177.072 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.623 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 36.6 ttpt . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -134.16 144.54 48.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.149 0.431 . . . . 0.0 111.859 -177.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 28.9 pt20 -147.02 136.83 23.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.872 174.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.631 HG22 ' HB ' ' A' ' 71' ' ' ILE . 35.5 pt -120.06 132.75 68.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.2 0.524 . . . . 0.0 111.495 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -105.75 119.06 38.2 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.9 mp -92.94 142.78 26.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.039 0.447 . . . . 0.0 110.738 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.718 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 31.4 tt0 -71.34 124.2 24.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.702 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.67 -17.16 58.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.594 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 37.5 t -92.38 125.96 54.29 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 1.4 Cg_endo -83.56 10.07 3.83 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.08 2.52 . . . . 0.0 112.678 -178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -134.3 134.2 22.45 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.786 0.327 . . . . 0.0 111.35 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 9.1 Cg_endo -89.2 125.36 1.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.484 2.789 . . . . 0.0 111.422 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.36 102.97 13.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 44.5 p90 -103.14 139.57 38.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.732 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -144.59 142.88 30.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.705 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.623 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 4.8 m -57.15 -44.1 83.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.077 0.465 . . . . 0.0 111.426 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.652 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 46.1 mt-30 -78.46 119.89 22.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.163 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.573 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 9.9 t -64.49 -50.39 76.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.602 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.01 -29.84 45.07 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.512 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.602 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 22.2 t70 -76.34 -51.55 11.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.828 0.347 . . . . 0.0 110.691 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -68.04 -37.51 81.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.283 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 114' ' ' ALA . 31.0 pt -67.6 -30.79 49.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.428 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -62.58 -46.11 89.83 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.547 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.407 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 30.1 m-85 -62.14 -40.88 97.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.888 0.375 . . . . 0.0 110.839 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -60.83 -20.67 62.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.732 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 48.6 mtm105 -95.43 12.36 29.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.18 -62.35 0.32 Allowed Glycine 0 C--O 1.226 -0.354 0 C-N-CA 119.779 -1.201 . . . . 0.0 113.645 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 18.1 Cg_exo -70.8 49.46 0.94 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.441 2.761 . . . . 0.0 114.323 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -84.26 -89.23 0.1 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.601 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.595 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 22.1 tp60 -164.23 -51.7 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.499 0.591 . . . . 0.0 112.018 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.516 HG22 ' HG3' ' A' ' 64' ' ' GLN . 14.6 tt 177.52 -27.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.258 0.551 . . . . 0.0 110.703 -170.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.474 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -99.41 144.56 28.51 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.455 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.718 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 53.5 Cg_endo -68.62 152.69 74.46 Favored 'Trans proline' 0 CA--C 1.517 -0.332 0 C-N-CA 122.383 2.055 . . . . 0.0 111.371 176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 59' ' ' ALA . 29.5 pt -81.58 107.17 13.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.498 0.666 . . . . 0.0 110.059 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -69.86 -49.42 52.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 p -161.22 138.94 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.927 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.6 tt -112.87 128.58 69.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.754 174.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -111.84 128.87 56.25 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 94' ' ' ALA . 35.4 m -128.28 153.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.212 0.529 . . . . 0.0 110.565 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.605 ' O ' ' HG2' ' A' ' 76' ' ' MET . 15.2 m120 -87.65 103.88 16.0 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -47.36 113.99 0.79 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 125.684 1.865 . . . . 0.0 110.7 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.605 ' HG2' ' O ' ' A' ' 74' ' ' ASN . 11.6 ptp -158.97 117.58 2.94 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.794 0.684 . . . . 0.0 110.074 -176.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.776 ' HA3' ' CZ ' ' A' ' 117' ' ' PHE . . . -151.12 44.89 0.66 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.656 -1.259 . . . . 0.0 113.941 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -97.79 26.42 5.13 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -176.95 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.674 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.546 ' HA2' ' CG2' ' A' ' 115' ' ' VAL . . . 131.03 20.67 1.14 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.281 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.403 ' HB1' ' CG2' ' A' ' 52' ' ' VAL . . . 55.83 54.52 8.05 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.421 0.629 . . . . 0.0 110.908 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.7 p -83.57 176.6 8.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.196 -174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.652 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 44.5 p90 -64.66 -28.51 69.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.041 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -80.35 -33.07 37.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 70.37 138.1 0.06 OUTLIER Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.951 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.454 ' CG ' ' HB2' ' A' ' 76' ' ' MET . 36.5 Cg_endo -65.78 -60.08 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.292 1.995 . . . . 0.0 112.808 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.24 -38.21 0.41 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.794 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 76' ' ' MET . 10.9 p-10 -72.41 146.75 46.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 176.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.93 94.23 0.11 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.023 -1.085 . . . . 0.0 113.67 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 49.9 m-80 -100.29 151.83 21.02 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.5 p90 -98.13 126.95 43.81 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.268 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.901 HG21 ' HB2' ' A' ' 118' ' ' SER . 34.5 pt -145.62 166.73 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.083 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -95.12 103.5 15.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 172.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.484 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -63.59 -30.52 71.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.25 -175.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.736 ' HA ' HD13 ' A' ' 137' ' ' LEU . 21.8 t70 -59.43 -24.26 63.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.697 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -120.51 33.97 5.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.329 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.425 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -133.41 -177.64 4.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.293 -171.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.94 137.4 33.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.545 0.688 . . . . 0.0 110.422 -177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.61 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 6.0 m-85 -120.65 135.69 55.04 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.372 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.577 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 6.3 p -112.24 120.92 63.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.462 0.649 . . . . 0.0 109.643 170.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.442 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 96.9 t -101.61 107.35 21.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -70.25 122.33 11.03 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.389 -175.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 m -92.31 -20.55 20.99 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.737 0.303 . . . . 0.0 110.821 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.99 -19.08 19.02 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.27 0.557 . . . . 0.0 110.453 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.404 HH11 ' CD ' ' A' ' 130' ' ' GLU . 23.3 mmm-85 -112.53 -30.63 7.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.416 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.864 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 5.4 mpt_? -120.88 -161.71 0.91 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.512 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.807 ' HA2' ' HD3' ' A' ' 112' ' ' PRO . . . 70.11 51.02 25.08 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -171.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.45 -127.04 0.16 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 114.483 -0.858 . . . . 0.0 113.068 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 66.2 mtt -97.93 21.32 10.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.665 0.745 . . . . 0.0 109.493 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.22 -114.07 0.29 Allowed Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.167 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.538 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.19 115.91 63.17 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.885 ' HG2' ' HA ' ' A' ' 145' ' ' VAL . 1.9 Cg_endo -44.09 157.15 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.905 3.07 . . . . 0.0 113.212 164.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.864 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 43.3 mt-10 -113.47 125.97 54.81 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 99' ' ' TYR . . . -93.76 131.97 38.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.873 -168.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.577 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 2.4 t -97.41 106.07 29.87 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 5.7 Cg_exo -85.91 131.07 3.72 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.225 2.617 . . . . 0.0 112.731 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.776 ' CZ ' ' HA3' ' A' ' 77' ' ' GLY . 81.6 m-85 -129.82 149.8 51.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.505 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.901 ' HB2' HG21 ' A' ' 92' ' ' ILE . 16.6 t -87.23 -26.56 23.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.4 m -91.98 110.62 21.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.929 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -58.77 -46.82 86.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.245 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -62.82 -28.74 70.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.214 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.61 -44.82 81.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.891 0.377 . . . . 0.0 110.225 174.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.415 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -65.85 -35.62 81.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.329 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.81 -41.49 62.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.477 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.0 -33.2 74.92 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.207 0.527 . . . . 0.0 110.529 177.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -59.84 -38.41 81.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.576 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.662 HG22 ' H ' ' A' ' 132' ' ' GLY . 61.7 t -73.17 -30.91 32.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.098 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mp -56.82 -48.98 76.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.233 0.54 . . . . 0.0 110.72 176.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.73 -38.25 47.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.21 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.622 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.1 pt-20 -159.26 -90.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.708 -178.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.622 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 45.51 -139.05 6.0 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 123.827 0.704 . . . . 0.0 113.54 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.662 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -172.97 -89.54 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.497 ' HB2' ' HB3' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -128.44 139.15 52.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.809 0.337 . . . . 0.0 110.58 177.66 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 75.4 t -99.5 113.41 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.572 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.907 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.81 160.96 38.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.691 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.28 162.96 15.57 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.736 HD13 ' HA ' ' A' ' 95' ' ' ASP . 7.0 tt -64.3 -30.52 71.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.43 0.634 . . . . 0.0 109.495 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.91 -10.41 59.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.915 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -124.8 19.92 8.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.041 0.448 . . . . 0.0 110.407 -176.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.907 HD13 HD13 ' A' ' 135' ' ' LEU . 26.9 mm -72.1 119.76 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 145' ' ' VAL . 2.2 t -103.02 148.29 25.89 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.203 175.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 6.0 p-10 -68.94 -29.2 67.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.53 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.54 -32.29 66.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.456 ' HG3' ' HG3' ' A' ' 133' ' ' GLN . 18.0 mmt -86.99 -26.55 23.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.463 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.885 ' HA ' ' HG2' ' A' ' 112' ' ' PRO . 1.3 t -103.3 -3.22 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 111.405 -173.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.8 pp -169.64 132.87 1.23 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.822 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 1.8 p -94.0 118.69 67.26 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.245 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 24.0 Cg_endo -62.47 -68.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.953 2.435 . . . . 0.0 112.917 -177.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 64.6 t -114.7 -27.56 2.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.043 -173.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 5.4 mm-40 68.99 46.15 0.86 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.977 0.894 . . . . 0.0 108.791 -166.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.4 t -75.72 -13.98 60.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.636 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.13 50.27 6.92 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.61 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.2 t -130.14 161.42 31.13 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -57.16 132.57 80.69 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.49 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.9 -72.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.536 2.824 . . . . 0.0 112.801 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.22 -44.83 3.21 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.263 173.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.28 44.35 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.384 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.0 t70 56.59 32.78 21.55 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.321 1.058 . . . . 0.0 109.637 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -142.07 -179.18 6.08 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 133' ' ' GLN . 9.9 mm-40 . . . . . 0 C--O 1.243 0.757 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.914 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 34.6 ttmt . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.753 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -139.21 144.92 38.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.153 0.433 . . . . 0.0 111.754 -176.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 13.8 pt20 -149.19 134.49 18.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 173.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.619 HG22 ' HB ' ' A' ' 71' ' ' ILE . 23.1 pt -115.8 132.91 63.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.135 0.493 . . . . 0.0 111.403 -177.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -98.99 116.97 32.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.692 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.5 mp -90.4 140.48 29.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.888 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.865 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 35.4 tt0 -71.91 124.9 25.88 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.317 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.35 -15.54 61.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.709 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.501 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 30.6 t -94.48 124.87 53.94 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.0 Cg_endo -81.47 2.95 8.2 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.091 2.527 . . . . 0.0 112.13 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -135.23 134.6 21.55 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.544 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 1.3 Cg_endo -83.68 147.63 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.21 2.607 . . . . 0.0 112.249 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 tt -99.15 112.58 24.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 33.9 p90 -108.62 143.85 37.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.984 0.421 . . . . 0.0 111.365 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -150.03 139.65 21.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.914 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 17.2 m -63.21 -29.98 71.22 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -176.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.406 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 66.4 mt-30 -90.3 113.69 25.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.673 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.753 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 17.1 t -64.33 -50.66 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.007 0.432 . . . . 0.0 110.889 -177.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.649 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.79 -29.46 62.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.931 -177.375 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.649 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 5.1 t70 -76.12 -47.9 22.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.193 0.52 . . . . 0.0 109.828 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.23 80.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.459 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.597 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 36.8 pt -69.16 -32.75 55.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.191 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . . . -68.22 -42.15 80.23 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 110.214 174.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.85 -31.31 71.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.721 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.469 ' HB1' HG21 ' A' ' 68' ' ' ILE . . . -73.23 -17.0 61.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.152 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.602 ' HE ' ' HA ' ' A' ' 57' ' ' ALA . 38.2 mtm105 -97.72 8.26 44.99 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.76 -67.69 0.03 OUTLIER Glycine 0 C--N 1.322 -0.198 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.234 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.17 -0.85 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.844 3.03 . . . . 0.0 115.119 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -78.44 37.61 0.28 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.651 0.739 . . . . 0.0 110.595 174.489 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -79.91 -14.85 58.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.631 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tp -90.55 -38.62 11.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.212 0.53 . . . . 0.0 110.164 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.692 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -148.01 139.7 13.98 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.865 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 73.0 Cg_endo -74.17 150.73 42.96 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.328 2.019 . . . . 0.0 112.039 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.469 HG21 ' HB1' ' A' ' 59' ' ' ALA . 37.8 pt -74.79 123.71 30.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.168 0.509 . . . . 0.0 110.303 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -88.34 -53.07 4.86 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.8 142.36 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.287 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.619 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.6 tt -113.5 136.0 51.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.457 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -111.94 133.93 53.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.95 159.14 43.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.453 0.644 . . . . 0.0 111.72 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -95.52 106.98 19.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.141 171.197 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 90' ' ' ASN . 13.0 t70 -50.99 121.8 6.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 125.088 1.493 . . . . 0.0 109.816 175.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.48 ' SD ' ' N ' ' A' ' 35' ' ' LYS . 29.4 mtp -124.21 49.36 1.79 Allowed 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -165.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 78' ' ' ALA . . . 73.45 -30.53 0.84 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.818 169.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.965 ' HA ' HG11 ' A' ' 115' ' ' VAL . . . 87.79 -64.44 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.986 0.915 . . . . 0.0 111.801 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.13 -38.34 24.74 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.548 0.53 . . . . 0.0 111.794 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.5 -81.82 1.27 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.554 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 56.41 22.32 6.32 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 36.1 p -84.38 175.44 9.36 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.478 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 2.6 p90 -63.26 -23.27 67.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.802 0.334 . . . . 0.0 110.546 172.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -81.75 -29.88 32.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.592 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.467 ' HB3' ' HE2' ' A' ' 76' ' ' MET . 0.0 OUTLIER 57.09 162.82 0.08 OUTLIER Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.782 1.233 . . . . 0.0 112.469 174.451 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.44 -9.96 16.1 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.36 1.374 . . . . 0.0 111.477 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 137.65 -177.57 19.8 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.11 140.14 40.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.438 0.619 . . . . 0.0 109.408 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.46 -126.74 2.87 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.989 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 35.4 m-80 -96.46 150.81 20.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.576 -173.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -99.0 126.14 44.63 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.466 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.734 HD13 ' HB2' ' A' ' 118' ' ' SER . 9.8 pt -145.72 166.54 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.137 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.58 106.44 18.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.427 ' C ' HD12 ' A' ' 137' ' ' LEU . . . -61.75 -33.2 73.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.121 0.486 . . . . 0.0 110.76 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.491 ' HB2' HG22 ' A' ' 71' ' ' ILE . 20.9 t70 -59.63 -24.96 64.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.41 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -121.53 33.86 5.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.394 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -135.26 -172.77 3.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.318 -175.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 97.8 m-85 -95.36 139.16 32.05 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.521 0.676 . . . . 0.0 111.041 -176.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.616 ' CE1' HG22 ' A' ' 101' ' ' VAL . 17.9 t80 -120.34 131.04 54.69 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.659 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.9 p -109.52 123.07 65.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.705 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' ' 144' ' ' MET . 4.0 t -101.74 103.01 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.394 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.662 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -69.26 134.49 26.82 Favored Glycine 0 N--CA 1.45 -0.432 0 O-C-N 123.574 0.546 . . . . 0.0 113.524 -173.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -92.08 -36.98 13.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.652 0.263 . . . . 0.0 110.317 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.08 -43.74 17.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 0.0 110.385 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.567 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 41.3 mtp-105 -132.84 132.78 42.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.668 177.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 1.027 HH21 HG13 ' A' ' 145' ' ' VAL . 12.7 ttt85 -172.08 -62.63 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.814 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.83 -61.2 0.23 Allowed Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.83 -94.53 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.527 -0.368 . . . . 0.0 112.42 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.81 -4.49 59.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.981 0.42 . . . . 0.0 110.896 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -110.65 -129.84 5.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.623 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.439 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.17 102.2 26.91 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.718 0.259 . . . . 0.0 110.584 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 26.8 Cg_endo -61.86 128.06 23.26 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 123.745 2.964 . . . . 0.0 112.983 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.466 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 5.0 mm-40 -114.34 139.97 49.02 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.593 -177.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.552 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -123.59 134.59 53.79 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.64 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.965 HG11 ' HA ' ' A' ' 78' ' ' ALA . 46.1 t -98.13 106.68 36.56 Favored Pre-proline 0 C--N 1.314 -0.973 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.983 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 5.3 Cg_exo -84.55 110.17 1.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.157 2.571 . . . . 0.0 111.283 173.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.78 ' HD1' ' H ' ' A' ' 119' ' ' SER . 4.1 t80 -120.06 151.03 39.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.971 -174.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.734 ' HB2' HD13 ' A' ' 92' ' ' ILE . 33.1 t -74.89 -37.26 62.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.778 0.323 . . . . 0.0 110.953 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.78 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 9.6 m -95.95 128.22 42.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.608 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 3.7 ttt180 -62.42 -48.97 77.33 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.133 0.492 . . . . 0.0 111.215 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -63.11 -31.59 72.76 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.786 -172.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -67.48 -40.44 85.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.731 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.17 -34.59 76.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.124 0.488 . . . . 0.0 109.747 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.09 74.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.865 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.35 97.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.142 0.496 . . . . 0.0 109.964 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -60.11 -38.74 83.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.836 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.689 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 60.8 t -64.57 -43.85 96.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.195 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.2 mt -52.46 -40.15 61.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.202 0.525 . . . . 0.0 110.678 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.86 -44.01 19.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.96 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.567 ' OE1' ' HD3' ' A' ' 105' ' ' ARG . 6.9 pt-20 -158.97 -33.49 0.06 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -172.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.689 ' CA ' ' HA ' ' A' ' 127' ' ' VAL . . . -52.76 167.01 1.12 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.257 -0.429 . . . . 0.0 113.907 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.64 -81.76 1.4 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.269 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.619 ' HG2' ' HG3' ' A' ' 144' ' ' MET . 2.1 pt20 -125.99 144.39 50.72 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.958 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.415 HG23 HG21 ' A' ' 127' ' ' VAL . 61.1 t -98.88 113.15 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.325 176.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.603 ' H ' HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -133.87 164.56 26.99 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.502 -178.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.86 163.84 22.01 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.444 HD23 HG13 ' A' ' 140' ' ' ILE . 0.8 OUTLIER -62.61 -24.81 67.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.864 0.364 . . . . 0.0 110.691 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.29 -19.97 57.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.949 0.404 . . . . 0.0 111.151 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -104.35 19.33 20.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.852 -173.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.592 HD13 HD13 ' A' ' 135' ' ' LEU . 48.8 mm -71.88 120.37 20.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.216 0.531 . . . . 0.0 111.084 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.789 HG23 ' HB2' ' A' ' 144' ' ' MET . 0.8 OUTLIER -99.42 145.99 26.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.131 177.339 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.79 -32.21 70.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.045 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.23 -29.2 67.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.504 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.789 ' HB2' HG23 ' A' ' 141' ' ' THR . 0.0 OUTLIER -78.94 -35.48 43.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.343 175.195 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 1.027 HG13 HH21 ' A' ' 106' ' ' ARG . 55.9 t -78.27 -25.36 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.382 -167.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -160.7 146.61 14.89 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.26 -174.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.4 p -109.01 119.15 49.66 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 121.057 0.456 . . . . 0.0 110.719 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.24 -67.86 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.913 2.408 . . . . 0.0 112.364 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.0 1.65 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.79 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 68.24 -76.73 0.05 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.341 -170.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.8 t 42.29 21.67 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.159 1.384 . . . . 0.0 114.643 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 66.29 26.91 72.69 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.885 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.9 m -76.33 152.67 36.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.052 0.426 . . . . 0.0 110.573 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 158' ' ' ASP . 2.5 mp0 -70.63 142.32 88.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.423 ' HB2' ' HE2' ' A' ' 144' ' ' MET . 69.4 Cg_endo -80.55 19.91 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.72 2.28 . . . . 0.0 112.799 -172.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.449 ' HE ' ' CD ' ' A' ' 133' ' ' GLN . 11.9 ptp85 177.06 -45.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.423 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 162.54 -16.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.11 -161.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.472 ' HB2' ' HG2' ' A' ' 154' ' ' GLU . 25.1 t0 59.14 31.24 21.11 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.283 1.039 . . . . 0.0 108.761 -168.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.37 -49.58 22.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.665 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 5.0 pt-20 . . . . . 0 C--O 1.254 1.323 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.362 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 50' ' ' SER . 40.0 ttmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.738 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -132.19 144.21 50.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . 11.9 pt20 -145.06 144.71 31.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.967 0.413 . . . . 0.0 110.574 177.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.705 HG21 ' HB2' ' A' ' 59' ' ' ALA . 23.2 pt -115.94 134.24 59.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 120.969 0.414 . . . . 0.0 110.415 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -98.67 116.87 31.86 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.592 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.3 mp -89.16 139.0 30.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.234 -174.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.856 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 40.8 tt0 -73.89 122.39 22.45 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.51 -4.18 66.43 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.568 -173.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 46.9 t -120.02 128.28 25.93 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.7 Cg_exo -79.1 -12.8 14.3 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.105 2.537 . . . . 0.0 111.704 176.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -115.39 133.8 22.69 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.62 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 2.2 Cg_endo -86.06 149.88 9.47 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.365 2.71 . . . . 0.0 112.149 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.9 tt -94.7 109.77 21.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.675 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . 31.1 p90 -115.54 147.87 40.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.374 0.607 . . . . 0.0 111.834 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -139.24 154.08 47.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.015 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 6.2 m -56.42 -50.98 70.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.155 0.502 . . . . 0.0 110.917 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.402 ' HB2' ' CB ' ' A' ' 54' ' ' ASP . 55.2 mt-30 -77.38 136.06 38.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.397 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.738 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 48.4 t -73.17 -50.7 29.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -52.78 -32.96 46.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.522 177.11 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.442 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 15.9 t70 -76.13 -50.0 15.8 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.864 0.364 . . . . 0.0 110.72 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -67.93 -36.09 79.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.682 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.726 HG22 HD11 ' A' ' 71' ' ' ILE . 31.1 pt -66.02 -31.24 52.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.7 -0.4 . . . . 0.0 109.925 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 54' ' ' ASP . . . -61.27 -41.3 96.7 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.744 174.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.541 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 54.4 m-85 -58.1 -41.19 82.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.967 0.413 . . . . 0.0 111.046 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -63.61 -17.63 63.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.128 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.04 12.24 32.45 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.56 -68.22 0.09 OUTLIER Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.268 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 23.9 Cg_exo -68.14 46.47 0.34 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.586 2.858 . . . . 0.0 113.642 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.96 172.96 13.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.752 0.311 . . . . 0.0 110.285 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.454 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 84.1 mm-40 -96.81 -164.58 1.16 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.843 0.354 . . . . 0.0 110.91 -176.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.3 tt -62.12 -19.4 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.379 0.609 . . . . 0.0 111.17 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.592 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -105.97 141.01 21.81 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.856 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 42.1 Cg_endo -69.36 162.79 40.46 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.967 2.445 . . . . 0.0 112.122 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.9 pt -84.38 116.57 28.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.1 0.476 . . . . 0.0 110.674 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 tt -84.08 -52.58 6.18 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.11 139.86 7.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.662 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.726 HD11 HG22 ' A' ' 56' ' ' ILE . 4.1 tt -108.92 126.89 65.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.133 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -111.55 128.76 56.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.954 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.562 HG23 HG13 ' A' ' 92' ' ' ILE . 31.2 m -123.43 134.25 66.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.118 0.485 . . . . 0.0 110.101 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -89.5 99.44 12.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.607 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 25.6 t70 -68.82 85.94 0.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.778 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.745 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 21.7 ptm -165.17 -168.12 1.33 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.349 0.595 . . . . 0.0 112.268 -174.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.26 -42.9 2.42 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.787 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . . . 51.88 28.33 5.01 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.111 0.536 . . . . 0.0 112.124 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.06 -62.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.97 -11.31 30.38 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.321 -0.942 . . . . 0.0 114.389 -170.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.687 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -61.38 -52.62 63.86 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.953 0.883 . . . . 0.0 109.325 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.0 p -129.62 152.75 48.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 114.001 -1.454 . . . . 0.0 107.497 168.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -72.22 -19.59 61.7 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.439 0.637 . . . . 0.0 110.054 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -85.14 -18.48 34.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.776 175.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 61.3 mt-30 69.75 141.35 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.358 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.787 ' HD2' ' HA ' ' A' ' 78' ' ' ALA . 73.7 Cg_endo -91.49 -82.17 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.918 2.412 . . . . 0.0 112.929 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.15 -126.2 1.67 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.378 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.68 146.62 48.11 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 122.013 0.125 . . . . 0.0 110.957 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.745 ' HA2' ' HB3' ' A' ' 76' ' ' MET . . . -70.78 90.01 0.39 Allowed Glycine 0 CA--C 1.518 0.278 0 O-C-N 123.66 0.6 . . . . 0.0 113.964 -175.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -100.16 149.5 23.47 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -100.17 127.8 46.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.562 HG13 HG23 ' A' ' 73' ' ' VAL . 1.4 pt -145.51 156.65 13.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.59 117.99 30.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 164.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.93 79.41 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -169.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.658 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 9.4 p-10 -66.9 -28.01 67.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.009 0.909 . . . . 0.0 109.789 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -105.32 33.33 3.74 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.177 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.58 171.48 12.55 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.215 -0.303 . . . . 0.0 110.351 -174.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -89.54 136.15 33.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.314 0.578 . . . . 0.0 110.013 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 7.6 m-85 -120.39 136.95 54.55 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.983 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.416 ' CG1' HG13 ' A' ' 115' ' ' VAL . 2.2 p -120.9 125.47 74.08 Favored 'Isoleucine or valine' 0 C--O 1.251 1.146 0 CA-C-O 121.691 0.758 . . . . 0.0 109.428 170.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.57 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 59.1 t -108.57 117.16 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.117 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -75.8 124.49 7.48 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.155 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.5 m -90.43 -23.45 21.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.013 0.435 . . . . 0.0 110.172 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -82.35 -45.17 15.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.224 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.617 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 47.2 mtp180 -139.23 93.75 2.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.029 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.567 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -147.84 169.45 19.77 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.451 176.744 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.687 ' H ' ' HA ' ' A' ' 112' ' ' PRO . . . -79.51 45.85 2.95 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.836 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.8 -25.26 63.51 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.502 171.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.8 ptm -108.36 21.21 17.64 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.746 -0.727 . . . . 0.0 110.213 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -176.3 -116.7 0.47 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.013 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.589 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.45 102.5 29.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.949 0.404 . . . . 0.0 111.378 177.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.687 ' HA ' ' H ' ' A' ' 107' ' ' GLY . 88.0 Cg_endo -74.54 151.83 42.45 Favored 'Trans proline' 0 N--CA 1.467 -0.078 0 C-N-CA 123.253 2.635 . . . . 0.0 111.948 177.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.567 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 1.7 tp10 -118.94 123.24 44.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.308 -177.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.501 ' HB3' HD11 ' A' ' 56' ' ' ILE . . . -99.88 121.43 41.3 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.488 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 6.4 p -110.81 106.63 57.77 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.235 176.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.528 ' HG3' ' CE2' ' A' ' 99' ' ' TYR . 5.1 Cg_exo -84.98 112.21 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.379 3.386 . . . . 0.0 111.872 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -103.98 149.42 25.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.337 0.589 . . . . 0.0 111.015 -177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -79.68 -43.78 22.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.3 m -83.61 111.31 19.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.087 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -56.93 -45.0 83.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.741 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.8 -28.17 69.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.973 -173.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -67.47 -43.99 79.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.338 . . . . 0.0 110.521 174.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.8 92.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.243 0.544 . . . . 0.0 110.208 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.16 74.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.107 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' LEU . . . -61.63 -39.9 92.94 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 111.186 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -57.63 -40.29 78.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.758 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.589 HG22 ' H ' ' A' ' 132' ' ' GLY . 42.4 t -71.79 -28.39 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.843 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 54.2 mt -57.85 -49.82 75.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.451 175.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.55 -48.66 54.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.176 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.918 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.5 pt-20 -157.81 -75.97 0.08 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.566 175.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.918 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.0 -136.85 8.1 Favored Glycine 0 N--CA 1.448 -0.546 0 O-C-N 123.601 0.563 . . . . 0.0 112.914 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.589 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -166.31 -91.91 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.57 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.48 139.7 50.53 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 176.393 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.61 118.19 41.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.781 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.27 164.37 29.42 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.464 -176.727 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.02 165.57 13.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.685 ' HA ' HG12 ' A' ' 140' ' ' ILE . 4.2 tt -64.55 -30.15 71.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.122 0.486 . . . . 0.0 109.95 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.19 -10.68 59.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.011 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -118.99 15.59 13.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.41 0.624 . . . . 0.0 110.262 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.781 HD13 HD13 ' A' ' 135' ' ' LEU . 28.3 mm -72.07 121.52 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.923 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.497 HG23 ' HG2' ' A' ' 144' ' ' MET . 1.2 t -115.39 147.03 41.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -69.4 -31.71 70.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.947 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.93 -29.36 60.0 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.367 0.417 . . . . 0.0 112.076 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.497 ' HG2' HG23 ' A' ' 141' ' ' THR . 12.5 mmt -75.74 -34.88 60.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.14 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.549 ' HB ' HD12 ' A' ' 146' ' ' LEU . 2.7 t -86.12 -25.28 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.049 -172.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.549 HD12 ' HB ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -179.65 149.2 0.36 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.444 -176.012 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.415 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 43.0 p -103.07 120.18 53.05 Favored Pre-proline 0 C--N 1.317 -0.842 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.557 -178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 37.3 Cg_endo -68.39 -77.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.499 2.133 . . . . 0.0 111.483 173.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.6 t -128.86 -27.44 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 73.45 31.54 1.33 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.268 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 t -86.27 16.28 4.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.791 0.805 . . . . 0.0 109.407 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -113.91 -149.04 10.07 Favored Glycine 0 N--CA 1.437 -1.259 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.716 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.1 m -99.89 162.66 12.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.275 -0.462 . . . . 0.0 110.351 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.31 143.43 85.25 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.9 -29.52 82.2 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.878 2.385 . . . . 0.0 113.213 -173.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.549 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 3.2 ptp180 -166.25 -54.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.549 175.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.549 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -160.19 28.3 0.17 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.867 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.8 t70 55.0 75.66 0.3 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.962 0.887 . . . . 0.0 108.92 -168.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.453 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 26.0 t0 -128.97 25.13 5.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.739 1.257 . . . . 0.0 107.863 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.428 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 3.1 pt-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-N 113.221 -1.809 . . . . 0.0 111.137 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.589 ' HB3' ' OD1' ' A' ' 74' ' ' ASN . 30.0 ttpt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -139.99 142.64 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.34 . . . . 0.0 111.052 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 12.8 pt20 -149.58 137.45 20.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.599 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.473 HG22 ' HB ' ' A' ' 71' ' ' ILE . 23.9 pt -115.88 142.91 27.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 0.0 111.111 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -118.72 129.84 55.49 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.3 mp -95.7 146.54 24.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.853 0.358 . . . . 0.0 111.167 -175.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.672 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 22.1 tt0 -74.05 125.37 28.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.722 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.09 -13.34 61.72 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.201 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 24.3 t -104.3 125.29 34.65 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 4.2 Cg_exo -80.83 10.47 3.34 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.057 2.505 . . . . 0.0 112.733 -177.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -124.15 133.23 24.52 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.812 0.339 . . . . 0.0 111.455 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 70.8 Cg_endo -98.11 153.69 0.83 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.744 2.963 . . . . 0.0 112.382 173.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 3.0 tm? -110.76 105.54 14.43 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -112.61 136.77 51.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.16 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.461 ' HE2' HE21 ' A' ' 51' ' ' GLN . 10.7 t80 -149.98 154.97 39.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.144 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.6 m -64.04 -38.78 92.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.298 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.92 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 45.4 mt-30 -72.42 108.69 5.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.571 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 36' ' ' ALA . 12.3 t -62.55 -51.52 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.621 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -53.95 -34.53 59.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.577 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.621 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 28.3 t70 -76.31 -46.69 26.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.767 0.317 . . . . 0.0 110.6 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.821 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -71.23 -39.03 71.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.426 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.538 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 27.3 pt -63.75 -30.81 50.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 54' ' ' ASP . . . -61.6 -42.66 99.18 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 174.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.821 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 61.6 m-85 -56.91 -39.16 73.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.979 0.418 . . . . 0.0 110.799 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' A' ' 68' ' ' ILE . . . -65.86 -17.8 64.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.894 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 15.3 mtm180 -102.37 12.61 36.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.57 -60.31 0.19 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.303 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 23.6 Cg_exo -66.57 35.19 0.13 Allowed 'Trans proline' 0 N--CA 1.48 0.686 0 C-N-CA 123.774 2.983 . . . . 0.0 114.959 -177.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 67' ' ' PRO . 4.6 pt-20 -83.42 128.03 34.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 170.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -47.58 -92.74 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -170.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -125.85 -5.49 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.077 0.941 . . . . 0.0 109.516 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 41' ' ' GLU . . . -113.13 141.92 26.48 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.988 -176.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.672 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.0 Cg_endo -70.1 155.06 65.71 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 C-N-CA 122.413 2.076 . . . . 0.0 111.786 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 68' ' ' ILE . 22.8 pt -71.08 109.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.17 0.51 . . . . 0.0 110.287 175.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -71.7 -52.01 19.98 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 p -161.23 138.81 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.443 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.56 HG22 ' HB2' ' A' ' 95' ' ' ASP . 1.4 tt -111.39 135.85 49.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.465 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 92' ' ' ILE . 87.0 m-85 -115.23 134.64 54.96 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.118 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 94' ' ' ALA . 27.1 m -126.53 150.11 32.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.92 0.39 . . . . 0.0 110.086 176.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.589 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 14.0 m120 -83.71 104.9 14.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.55 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 18.7 t70 -55.37 120.66 7.46 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 125.476 1.735 . . . . 0.0 110.29 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' A' ' 74' ' ' ASN . 22.3 mtm -128.63 -165.25 1.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.303 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.79 61.49 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 166.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.595 ' HB1' HG13 ' A' ' 115' ' ' VAL . . . 74.31 -32.27 0.23 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.789 0.836 . . . . 0.0 112.881 169.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.71 -32.9 63.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.047 0.451 . . . . 0.0 110.581 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.28 -68.47 1.17 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.234 172.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 53.14 34.87 18.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.265 0.555 . . . . 0.0 112.135 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.5 p -83.59 177.61 8.34 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.227 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.92 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 47.0 p90 -64.13 -24.83 67.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.174 0.511 . . . . 0.0 111.081 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.74 -27.24 27.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 64.55 173.79 0.07 OUTLIER Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.746 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.573 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 59.6 Cg_endo -97.04 6.08 1.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.399 2.066 . . . . 0.0 111.264 173.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.32 157.56 7.81 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.364 -175.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.94 126.71 31.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.842 0.353 . . . . 0.0 110.417 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -118.6 -159.13 11.03 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.487 -174.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 76.9 m-20 -81.39 151.98 27.67 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -98.08 129.83 44.9 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 121.318 -0.864 . . . . 0.0 110.209 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.753 HD13 ' HB2' ' A' ' 118' ' ' SER . 20.3 pt -138.54 161.23 30.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.985 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.25 100.57 7.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.431 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -66.28 -34.97 79.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.798 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.613 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 31.3 t70 -61.06 -24.88 66.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.618 0.723 . . . . 0.0 110.138 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -111.64 22.01 15.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.839 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.92 178.79 4.18 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.961 0.41 . . . . 0.0 111.156 -170.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -96.32 130.48 43.41 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.099 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.554 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 11.2 m-85 -120.48 136.56 54.72 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.918 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.867 HG13 ' HB ' ' A' ' 115' ' ' VAL . 1.5 p -121.06 125.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.216 0.531 . . . . 0.0 110.226 172.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.732 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 55.6 t -101.75 125.47 55.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.652 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -87.55 126.84 8.2 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.753 -174.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.7 m -92.66 -21.27 20.11 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.551 0.215 . . . . 0.0 111.084 177.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -89.02 -46.46 8.84 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -170.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -129.89 19.71 5.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.351 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.665 ' HG3' ' H ' ' A' ' 107' ' ' GLY . 8.9 tpp180 -112.0 -161.65 0.76 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.858 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.665 ' H ' ' HG3' ' A' ' 106' ' ' ARG . . . 66.58 46.17 78.78 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -163.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -56.95 -98.22 0.01 OUTLIER Glycine 0 CA--C 1.517 0.161 0 CA-C-N 113.78 -1.21 . . . . 0.0 115.771 -164.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.1 ttt -87.95 21.6 2.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.568 0.699 . . . . 0.0 110.957 -169.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 135.53 -57.69 0.68 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -177.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.459 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.29 122.68 44.36 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.47 ' CA ' ' HA2' ' A' ' 107' ' ' GLY . 5.2 Cg_endo -47.42 152.35 2.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.884 2.389 . . . . 0.0 112.372 173.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.548 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -114.01 131.81 56.22 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -172.018 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.602 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.8 130.16 39.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.442 -174.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.867 ' HB ' HG13 ' A' ' 100' ' ' VAL . 93.1 t -94.85 103.94 13.1 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.4 Cg_exo -91.23 120.38 0.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.548 2.832 . . . . 0.0 112.171 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.36 148.81 50.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.375 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.753 ' HB2' HD13 ' A' ' 92' ' ' ILE . 42.2 t -80.26 -26.86 38.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 173.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.0 m -101.17 121.26 41.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.538 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -59.21 -46.66 87.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.618 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -62.76 -28.97 70.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.272 -173.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -69.63 -38.13 77.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.64 -36.93 81.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.302 0.572 . . . . 0.0 109.755 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.85 -35.85 82.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.573 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.73 78.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.461 ' HZ ' HH21 ' A' ' 106' ' ' ARG . 63.8 t80 -63.48 -41.01 98.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.803 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 41.3 t -72.95 -30.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.202 0.525 . . . . 0.0 110.251 177.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.2 -36.87 76.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.084 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.08 -50.94 7.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.15 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.88 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 1.3 pt-20 -146.94 -81.61 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.093 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.88 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 52.52 -146.82 15.46 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.669 173.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -172.53 -84.18 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.732 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.43 145.23 51.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.728 0.299 . . . . 0.0 110.509 174.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.7 t -101.23 113.3 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.267 0.556 . . . . 0.0 109.535 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.809 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -130.48 164.86 23.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.918 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.476 ' H ' ' HB3' ' A' ' 139' ' ' ASP . . . -90.66 166.18 13.3 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.613 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 5.8 tt -64.38 -38.64 91.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.76 -10.24 57.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.26 175.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 136' ' ' ALA . 31.3 t70 -120.24 18.58 12.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.413 0.625 . . . . 0.0 110.389 -175.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.809 HD13 HD13 ' A' ' 135' ' ' LEU . 25.2 mm -72.02 121.35 22.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 145' ' ' VAL . 2.5 t -116.67 148.88 40.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.093 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.538 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 4.3 p30 -68.96 -26.36 65.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.605 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.29 69.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.995 0.426 . . . . 0.0 111.324 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.722 ' HE2' ' HB2' ' A' ' 155' ' ' PRO . 11.5 mmt -86.96 -32.23 20.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.401 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 141' ' ' THR . 4.2 t -86.75 -23.7 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.13 0.49 . . . . 0.0 110.726 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.4 pp -153.4 125.5 7.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.324 -176.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.2 p -102.85 131.68 21.99 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.656 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.31 -99.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.661 2.241 . . . . 0.0 111.386 172.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.634 ' HB ' HG22 ' A' ' 151' ' ' THR . 4.8 t -115.21 -5.78 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 70.19 7.84 6.39 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.573 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.634 HG22 ' HB ' ' A' ' 149' ' ' VAL . 7.6 t -82.18 73.5 9.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 122.195 0.998 . . . . 0.0 109.035 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.83 -140.46 2.99 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.72 -173.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -102.34 161.32 13.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.06 132.08 93.72 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.722 ' HB2' ' HE2' ' A' ' 144' ' ' MET . 14.3 Cg_exo -46.45 -75.67 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.641 2.894 . . . . 0.0 114.465 -167.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.614 ' HG3' ' OD1' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -92.87 -36.69 12.68 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.649 -176.746 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 173.16 38.95 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.8 t70 62.7 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -164.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.614 ' OD1' ' HG3' ' A' ' 156' ' ' ARG . 8.3 m-20 -63.55 161.36 14.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.386 -157.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 C--O 1.252 1.194 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.329 -176.292 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 28.6 ttpp . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -147.62 144.54 28.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.633 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 14.5 pt20 -147.31 126.82 13.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.898 0.38 . . . . 0.0 110.558 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.886 HG12 ' HB3' ' A' ' 47' ' ' LEU . 7.8 pt -117.3 138.13 48.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.12 0.486 . . . . 0.0 111.113 -176.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -103.95 126.97 51.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.518 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.828 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.0 mp -92.18 139.87 30.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.068 0.461 . . . . 0.0 111.286 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.763 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 36.8 tt0 -74.54 124.33 26.43 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.429 176.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.0 -15.7 62.57 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.533 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.483 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 33.4 t -120.0 124.09 28.04 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 120.957 0.408 . . . . 0.0 110.202 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 2.8 Cg_exo -77.31 7.71 3.61 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.055 2.503 . . . . 0.0 112.487 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.496 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -102.56 131.2 22.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.871 0.367 . . . . 0.0 111.254 -178.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 37.5 Cg_endo -98.88 136.89 0.31 Allowed 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.803 3.002 . . . . 0.0 112.69 174.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.886 ' HB3' HG12 ' A' ' 38' ' ' ILE . 13.8 tp -82.99 129.84 35.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.701 176.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.422 ' HE1' ' HG2' ' A' ' 46' ' ' PRO . 51.6 m-85 -118.38 133.12 56.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.96 0.41 . . . . 0.0 111.162 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.67 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 11.4 m-85 -150.2 148.96 29.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.477 174.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 m -77.32 -32.04 54.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.056 0.455 . . . . 0.0 110.488 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.741 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 41.5 mt-30 -88.14 122.53 31.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.682 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.639 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 6.2 t -63.77 -51.04 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.638 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -51.25 -36.44 42.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.867 179.124 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.638 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 36.0 t70 -76.39 -49.22 17.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.823 0.344 . . . . 0.0 110.604 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -62.53 -42.49 99.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.446 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.003 HD12 ' HB3' ' A' ' 114' ' ' ALA . 21.9 pt -65.42 -31.48 54.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.284 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.579 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . . . -60.87 -43.62 98.17 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 120.591 0.234 . . . . 0.0 110.487 174.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.64 ' HA ' ' HG2' ' A' ' 62' ' ' PRO . 11.8 m-85 -61.1 -40.11 92.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.285 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.44 ' HB1' HG21 ' A' ' 68' ' ' ILE . . . -67.05 -27.03 67.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.432 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.579 ' HE ' ' HA ' ' A' ' 57' ' ' ALA . 83.4 mtm180 -88.57 -1.48 58.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.019 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.06 -75.75 0.03 OUTLIER Glycine 0 CA--C 1.52 0.348 0 C-N-CA 119.581 -1.295 . . . . 0.0 114.045 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.64 ' HG2' ' HA ' ' A' ' 58' ' ' TYR . 30.7 Cg_exo -37.96 -51.31 1.93 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 124.314 3.343 . . . . 0.0 114.665 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -76.94 98.34 4.89 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -117.09 -23.11 8.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.208 -173.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.5 tp -67.45 -29.32 45.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.009 0.433 . . . . 0.0 111.244 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.828 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -141.5 141.45 22.96 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.763 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 57.8 Cg_endo -73.38 163.21 38.36 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.43 2.086 . . . . 0.0 111.993 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.44 HG21 ' HB1' ' A' ' 59' ' ' ALA . 14.3 pt -85.49 121.02 36.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.337 0.589 . . . . 0.0 110.882 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.81 -59.43 2.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.252 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.16 138.54 20.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.203 0.525 . . . . 0.0 110.298 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.506 HG13 HG22 ' A' ' 38' ' ' ILE . 2.3 tt -122.52 129.25 75.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.399 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -111.73 130.69 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.4 m -127.4 139.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.77 0.795 . . . . 0.0 111.25 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 7.0 m-20 -87.58 101.67 13.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 170.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.944 ' HB3' ' HB2' ' A' ' 90' ' ' ASN . 12.5 t0 -46.95 108.34 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.846 1.341 . . . . 0.0 109.267 175.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.572 ' C ' ' HG3' ' A' ' 86' ' ' PRO . 14.0 ttt -162.65 -101.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.591 -165.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.469 ' H ' ' HB3' ' A' ' 76' ' ' MET . . . -79.7 63.1 4.06 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-O 122.112 0.84 . . . . 0.0 111.978 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 115' ' ' VAL . . . -142.75 -55.05 0.42 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.176 -1.512 . . . . 0.0 107.018 174.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.81 -20.76 65.21 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.039 166.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.643 ' HA3' ' HD3' ' A' ' 86' ' ' PRO . . . -89.37 -96.65 1.07 Allowed Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.158 175.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -178.88 -51.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 85' ' ' GLN . 71.9 p -107.7 175.75 5.38 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.741 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 10.9 p90 -70.45 -31.13 68.16 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.273 0.559 . . . . 0.0 110.125 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.87 -28.69 25.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.036 -174.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.509 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.9 OUTLIER -61.71 -60.19 11.07 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -167.669 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.643 ' HD3' ' HA3' ' A' ' 80' ' ' GLY . 7.0 Cg_endo -44.75 -57.57 1.98 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.298 2.665 . . . . 0.0 113.523 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.49 -45.7 2.57 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 76' ' ' MET . 11.4 m-20 -77.01 146.85 37.15 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.407 0.283 . . . . 0.0 110.474 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.96 100.65 0.29 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.857 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 91.7 m-20 -95.85 150.26 20.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 175.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -109.6 128.08 54.97 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.194 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.3 pt -145.52 163.45 11.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.635 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.7 109.13 21.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.62 -33.03 74.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.792 -174.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.87 ' HA ' HD13 ' A' ' 137' ' ' LEU . 12.7 t70 -58.66 -31.46 68.18 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.83 0.824 . . . . 0.0 110.566 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -111.31 38.29 2.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.207 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' A' ' 117' ' ' PHE . . . -140.09 169.81 17.01 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.535 -168.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -90.25 143.28 26.91 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.096 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.478 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 3.2 m-85 -119.81 134.3 55.29 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.828 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.642 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.2 p -113.17 121.54 65.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.624 HG12 HH11 ' A' ' 106' ' ' ARG . 19.7 t -101.79 103.06 14.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.755 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -68.75 133.11 27.12 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.777 -173.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.9 t -92.11 -21.99 20.14 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.64 -43.81 68.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.608 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.519 ' HB2' ' OE1' ' A' ' 113' ' ' GLU . 77.1 mtt180 -100.97 -85.84 0.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.672 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.755 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 3.7 ttp180 58.42 -96.6 0.07 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.484 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 167.6 -60.56 0.21 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -170.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 61.73 -84.83 0.03 OUTLIER Glycine 0 C--N 1.332 0.341 0 O-C-N 123.823 0.366 . . . . 0.0 113.034 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.2 tpt -82.99 -4.36 58.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.023 0.44 . . . . 0.0 110.381 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.79 -128.98 3.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.474 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.444 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.1 102.97 31.49 Favored Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 122.918 -0.166 . . . . 0.0 111.137 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 2.4 Cg_endo -47.31 150.51 3.36 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.413 3.409 . . . . 0.0 113.936 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.704 ' HB3' ' HA ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -114.42 138.11 50.98 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.293 -172.191 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.003 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -128.77 130.33 46.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.649 172.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.642 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 14.5 t -106.97 104.85 53.63 Favored Pre-proline 0 C--N 1.315 -0.933 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.553 172.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 2.7 Cg_exo -84.76 123.75 2.9 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.79 2.994 . . . . 0.0 112.697 178.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.469 ' O ' ' HB1' ' A' ' 97' ' ' ALA . 43.1 m-85 -127.0 149.18 50.01 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.879 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.9 t -79.68 -26.63 40.92 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.588 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 19.3 m -100.51 124.11 45.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.957 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -37.24 84.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.283 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.588 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 19.5 p-10 -63.65 -32.37 73.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.661 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 119' ' ' SER . 43.7 mm-40 -64.28 -42.7 96.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.998 0.428 . . . . 0.0 110.259 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.85 -37.88 79.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.718 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.86 94.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.67 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' A' ' 128' ' ' LEU . . . -59.92 -35.65 75.36 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 110.943 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -65.24 -37.37 87.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.204 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.488 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 46.9 t -72.24 -32.21 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.561 178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 125' ' ' ALA . 69.5 mt -58.33 -40.38 81.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.84 -49.63 9.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.549 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.647 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.6 pt-20 -149.65 -90.14 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.944 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.647 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 51.4 -149.76 7.66 Favored Glycine 0 C--N 1.331 0.267 0 N-CA-C 114.203 0.441 . . . . 0.0 114.203 173.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.427 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -163.86 -96.73 0.11 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.541 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -123.32 144.33 49.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.941 0.37 . . . . 0.0 110.513 176.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.5 t -101.17 122.4 53.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.346 0.593 . . . . 0.0 110.646 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 140' ' ' ILE . 0.4 OUTLIER -147.11 154.7 41.44 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.669 178.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.411 ' H ' ' HB3' ' A' ' 139' ' ' ASP . . . -79.48 168.61 19.21 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.87 HD13 ' HA ' ' A' ' 95' ' ' ASP . 7.0 tt -67.71 -34.13 76.27 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.99 -15.33 60.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.254 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 136' ' ' ALA . 36.2 t70 -111.23 0.69 16.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.24 0.543 . . . . 0.0 110.861 -174.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.588 ' HA ' HD22 ' A' ' 135' ' ' LEU . 1.4 tt -71.64 144.79 12.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.514 0.673 . . . . 0.0 110.902 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.32 148.16 43.49 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.421 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -69.05 -30.41 68.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.006 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.841 ' HB3' ' HB3' ' A' ' 155' ' ' PRO . . . -65.29 -28.55 69.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.701 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.1 mmt -78.34 -26.23 46.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.672 0.272 . . . . 0.0 111.279 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.462 HG11 ' HD2' ' A' ' 60' ' ' ARG . 4.0 t -86.58 -23.54 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.059 0.457 . . . . 0.0 110.763 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 pp -157.04 132.42 9.17 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.18 -175.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 34.7 p -107.04 135.65 19.56 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.586 0.708 . . . . 0.0 111.642 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.472 ' HG2' ' H ' ' A' ' 150' ' ' GLU . 51.7 Cg_endo -93.04 -131.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.804 3.002 . . . . 0.0 111.47 175.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.434 ' H ' ' HB2' ' A' ' 148' ' ' PRO . 6.8 t -97.78 2.85 10.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.743 0.782 . . . . 0.0 109.123 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.472 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 42.0 mt-10 59.98 22.1 11.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.579 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.6 t -87.28 26.72 1.16 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.102 0.953 . . . . 0.0 109.03 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -118.48 -124.46 3.36 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.273 -172.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.1 p -129.39 161.77 29.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.642 0.258 . . . . 0.0 110.651 -176.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.499 ' HB3' ' HA ' ' A' ' 158' ' ' ASP . 2.0 mp0 -71.6 139.96 84.01 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.727 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.841 ' HB3' ' HB3' ' A' ' 143' ' ' ALA . 52.6 Cg_endo -72.93 -29.91 11.64 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.816 2.344 . . . . 0.0 111.86 176.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 159' ' ' ASP . 6.8 ptp180 -144.55 -141.72 0.12 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.614 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.417 ' H ' ' HB2' ' A' ' 156' ' ' ARG . . . -71.1 72.7 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 170.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 155' ' ' PRO . 9.8 t70 62.27 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -164.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.577 ' HA ' ' HG3' ' A' ' 156' ' ' ARG . 5.0 p-10 -171.81 -166.67 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.573 0.225 . . . . 0.0 110.552 167.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 C--O 1.251 1.182 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.845 -175.898 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 37.0 tttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.491 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -141.49 143.08 33.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.699 0.681 . . . . 0.0 112.135 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 10.7 pt20 -149.29 139.26 22.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.538 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.564 HG22 ' HB ' ' A' ' 71' ' ' ILE . 17.1 pt -122.33 138.14 53.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.163 0.506 . . . . 0.0 111.622 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -98.86 116.39 31.0 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 173.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.814 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.4 mp -92.17 134.24 35.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.98 0.419 . . . . 0.0 110.765 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.896 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 39.9 tt0 -71.75 125.82 28.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.516 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.67 -26.63 23.89 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 23.1 t -97.79 126.08 42.11 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.3 Cg_exo -74.2 -9.59 22.0 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.878 2.385 . . . . 0.0 113.177 -174.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.25 146.55 49.58 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.821 0.343 . . . . 0.0 111.587 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.24 151.45 26.58 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.824 2.349 . . . . 0.0 112.389 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tt -108.77 101.18 10.32 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 53.9 p90 -101.62 151.98 21.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.819 0.342 . . . . 0.0 110.592 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -148.04 149.74 32.65 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.656 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -64.28 -48.65 74.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.339 0.59 . . . . 0.0 110.764 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.725 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 35.0 mt-30 -78.63 113.99 17.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.391 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 36' ' ' ALA . 9.1 t -57.58 -48.83 82.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.639 HH11 ' HB2' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.34 -30.99 53.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.702 -178.409 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.639 ' HB2' HH11 ' A' ' 53' ' ' ARG . 14.1 t70 -76.37 -48.48 19.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.804 0.335 . . . . 0.0 110.683 -177.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.77 83.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.333 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.855 HD12 ' HB3' ' A' ' 114' ' ' ALA . 23.3 pt -67.47 -30.24 48.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.728 0.299 . . . . 0.0 110.676 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.07 88.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.861 0.362 . . . . 0.0 110.309 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -59.66 -37.32 78.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.434 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -70.58 -18.28 62.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.905 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.572 HH12 HG11 ' A' ' 145' ' ' VAL . 48.9 mtm180 -105.07 12.38 32.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.57 -72.42 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.317 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.24 -2.01 0.22 Allowed 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 123.905 3.07 . . . . 0.0 115.145 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.481 ' OE1' HG12 ' A' ' 68' ' ' ILE . 1.1 pt-20 -74.4 53.63 0.54 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.578 0.704 . . . . 0.0 110.033 171.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -92.33 -39.93 11.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.725 -176.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -75.79 -30.22 21.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.074 0.464 . . . . 0.0 110.545 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.814 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.06 140.41 13.45 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.347 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.896 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 80.4 Cg_endo -77.9 153.77 29.43 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.546 2.164 . . . . 0.0 112.134 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.709 HD13 ' HB1' ' A' ' 59' ' ' ALA . 46.6 pt -77.96 125.47 37.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.304 0.573 . . . . 0.0 110.188 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tt -86.0 -52.5 5.67 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -156.66 141.12 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.129 176.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.564 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.9 tt -114.6 129.19 71.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.322 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.462 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 87.1 m-85 -111.96 128.24 56.1 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 94' ' ' ALA . 28.2 m -126.05 157.02 36.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.455 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 6.1 m-20 -86.95 110.3 19.93 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 15.8 t70 -52.8 98.06 0.02 OUTLIER 'General case' 0 C--O 1.239 0.542 0 O-C-N 125.338 1.649 . . . . 0.0 109.503 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.633 ' SD ' ' HB2' ' A' ' 86' ' ' PRO . 2.0 mmt -179.71 87.74 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.548 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 79' ' ' ALA . . . -146.57 36.87 1.23 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 16.88 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -167.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -156.04 7.09 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.893 0.378 . . . . 0.0 110.537 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA3' ' NH1' ' A' ' 106' ' ' ARG . . . 130.0 -12.18 5.86 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.259 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.29 63.74 0.76 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.604 0.716 . . . . 0.0 109.945 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 46.3 p -83.81 176.71 8.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.409 -172.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.725 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 41.3 p-90 -66.62 -25.08 66.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.155 0.502 . . . . 0.0 110.275 172.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -77.5 -36.16 52.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.24 175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 67.93 150.64 0.12 Allowed Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.889 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.633 ' HB2' ' SD ' ' A' ' 76' ' ' MET . 17.1 Cg_exo -72.7 0.2 7.98 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.701 2.267 . . . . 0.0 111.568 169.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.46 176.26 15.64 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.055 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.34 135.76 38.4 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.77 -136.6 3.59 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.073 -174.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.599 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 53.7 t30 -89.91 151.34 21.78 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -173.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -98.8 128.91 45.16 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.896 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.714 HG21 ' HB2' ' A' ' 118' ' ' SER . 25.9 pt -145.17 162.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.185 -175.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.29 110.7 19.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.501 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -69.51 -35.25 75.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -172.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.656 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -68.35 -22.73 64.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.797 0.808 . . . . 0.0 109.791 -178.394 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 43.2 mmtm -102.68 26.5 7.92 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.767 175.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.09 176.69 7.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.475 -171.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -91.36 134.48 34.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.035 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.514 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 7.8 m-85 -120.39 136.16 54.81 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.946 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.897 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.1 p -115.62 122.39 69.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.445 0.64 . . . . 0.0 109.639 173.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.683 HG23 HD11 ' A' ' 135' ' ' LEU . 48.1 t -101.59 109.78 26.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.765 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -69.69 125.05 16.15 Favored Glycine 0 N--CA 1.448 -0.531 0 O-C-N 123.986 0.804 . . . . 0.0 113.263 -173.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.0 t -90.13 -38.58 13.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.839 0.352 . . . . 0.0 110.227 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -80.29 -43.72 20.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 111.466 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 79.8 mtt180 -125.65 107.08 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.014 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.731 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 1.2 tpp180 173.93 -177.28 0.08 Allowed 'General case' 0 C--O 1.232 0.165 0 O-C-N 123.941 0.776 . . . . 0.0 109.68 171.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.02 -57.33 19.82 Favored Glycine 0 N--CA 1.451 -0.33 0 O-C-N 123.368 0.417 . . . . 0.0 113.615 -176.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.63 -98.26 0.59 Allowed Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.428 ' CE ' ' HA ' ' A' ' 148' ' ' PRO . 4.1 mmt -86.99 -3.35 59.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.952 0.406 . . . . 0.0 110.733 173.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.7 -127.93 6.12 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.24 96.17 7.9 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.787 0.327 . . . . 0.0 110.598 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 72.6 Cg_endo -76.51 147.64 28.72 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.384 2.056 . . . . 0.0 112.498 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.731 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 32.1 mt-10 -129.33 131.68 46.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.462 -176.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.855 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -93.87 131.1 39.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.499 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.897 ' HB ' HG13 ' A' ' 100' ' ' VAL . 87.0 t -95.94 106.28 26.96 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 120.89 0.376 . . . . 0.0 110.227 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.3 Cg_endo -91.55 123.68 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.586 2.857 . . . . 0.0 112.677 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -132.97 150.42 52.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.092 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.714 ' HB2' HG21 ' A' ' 92' ' ' ILE . 9.7 t -86.9 -21.92 26.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.1 m -93.77 119.48 32.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.873 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -61.62 -48.01 82.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.096 0.474 . . . . 0.0 111.202 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.59 -29.57 70.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.618 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -62.15 -41.58 98.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.578 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -69.87 -37.02 75.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.131 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.68 86.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.048 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.95 82.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.105 0.479 . . . . 0.0 110.452 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -60.66 -42.86 97.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.736 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.631 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 55.1 t -61.97 -42.33 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.158 177.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tp -54.36 -36.16 63.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.784 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.06 -40.1 15.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.29 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -164.52 -35.13 0.03 OUTLIER 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.765 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -49.39 156.07 1.81 Allowed Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.45 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.443 ' N ' ' HA2' ' A' ' 102' ' ' GLY . . . -94.03 -82.67 1.56 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.949 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.491 ' NE2' ' HB3' ' A' ' 159' ' ' ASP . 3.3 pt20 -130.36 150.42 51.6 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.835 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.34 113.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.366 0.603 . . . . 0.0 110.214 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.683 HD11 HG23 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -133.89 159.97 39.07 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.759 -179.047 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.434 ' H ' ' HB3' ' A' ' 139' ' ' ASP . . . -84.69 168.63 15.07 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.656 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 6.0 tt -65.2 -32.08 73.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.312 0.577 . . . . 0.0 109.497 178.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.91 -10.26 59.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.735 176.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 136' ' ' ALA . 18.0 t70 -116.4 14.92 15.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.297 -174.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.644 HD13 HD13 ' A' ' 135' ' ' LEU . 36.6 mm -71.49 121.41 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.76 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.5 t -108.36 147.82 30.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.126 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -69.41 -22.87 63.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.122 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 155' ' ' PRO . . . -67.4 -30.07 69.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.654 -175.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.445 ' HG3' ' HG2' ' A' ' 133' ' ' GLN . 78.1 mmm -86.44 -37.78 17.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.832 0.348 . . . . 0.0 111.189 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.572 HG11 HH12 ' A' ' 60' ' ' ARG . 13.3 t -78.81 -21.86 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.522 0.677 . . . . 0.0 110.44 -174.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -147.31 104.82 3.68 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.119 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.5 ' HB ' ' OE2' ' A' ' 150' ' ' GLU . 20.0 p -102.06 123.91 41.86 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.613 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.499 ' O ' HG22 ' A' ' 151' ' ' THR . 71.9 Cg_endo -74.51 44.42 1.07 Allowed 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.405 2.737 . . . . 0.0 112.251 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.458 ' O ' HG12 ' A' ' 149' ' ' VAL . 6.5 t 54.79 28.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 122.067 0.937 . . . . 0.0 109.869 -174.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.5 ' OE2' ' HB ' ' A' ' 147' ' ' THR . 1.8 mp0 59.28 23.06 11.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.214 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 148' ' ' PRO . 6.9 t -81.57 13.77 2.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.792 0.806 . . . . 0.0 109.539 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . -119.55 -142.59 6.78 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.788 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.4 t -96.61 163.23 13.11 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -57.11 151.88 32.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.511 ' HA ' ' HB1' ' A' ' 143' ' ' ALA . 11.4 Cg_endo -54.39 -22.99 29.06 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.07 2.513 . . . . 0.0 113.087 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.53 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 2.1 ptp180 -174.96 -54.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.256 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.53 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -163.21 30.39 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.761 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.5 t70 54.22 68.25 0.88 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.845 0.831 . . . . 0.0 109.465 -170.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.491 ' HB3' ' NE2' ' A' ' 133' ' ' GLN . 27.7 t0 -100.51 -6.14 25.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.397 -172.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.076 -179.608 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.604 ' N ' ' HB3' ' A' ' 74' ' ' ASN . 79.8 tttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.737 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -143.15 144.75 32.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.046 0.385 . . . . 0.0 111.401 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 12.5 pt20 -149.2 140.1 22.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.615 HG22 ' HB ' ' A' ' 71' ' ' ILE . 24.2 pt -115.77 131.15 69.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.112 0.482 . . . . 0.0 110.19 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -98.75 118.22 34.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.848 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.4 mp -84.04 153.24 23.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.375 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.545 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 28.9 tt0 -74.12 126.84 31.45 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.962 177.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.82 -41.46 3.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.561 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.9 t -81.93 125.28 77.97 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.1 Cg_exo -79.09 -3.97 13.53 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.14 2.56 . . . . 0.0 112.493 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -101.82 133.54 20.69 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.59 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 61.2 Cg_endo -92.03 133.44 1.31 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.01 2.473 . . . . 0.0 112.315 176.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.9 tt -86.96 105.62 17.25 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 40.2 p90 -111.79 143.73 42.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.183 0.516 . . . . 0.0 111.468 -175.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -150.01 138.92 20.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.422 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 15.1 m -58.91 -37.0 75.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.95 0.405 . . . . 0.0 111.342 -177.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.539 ' HB3' ' HD2' ' A' ' 53' ' ' ARG . 51.2 mt-30 -81.86 109.29 16.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.432 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.737 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 39.8 t -59.31 -46.77 92.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.147 0.499 . . . . 0.0 110.661 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.539 ' HD2' ' HB3' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -57.15 -30.29 64.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.469 -178.375 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -74.6 -48.64 25.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 110.28 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.81 90.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.75 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 53' ' ' ARG . 35.1 pt -66.05 -31.74 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.545 0.212 . . . . 0.0 110.579 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.3 90.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.781 176.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.629 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 54.5 m-85 -62.74 -37.49 86.79 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 111.444 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.733 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -63.99 -17.87 63.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.229 -175.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 -100.31 12.66 36.61 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -173.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.48 -56.41 0.34 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.457 -1.354 . . . . 0.0 113.863 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.629 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 34.2 Cg_exo -60.62 6.53 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.346 2.698 . . . . 0.0 114.458 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -66.89 105.54 1.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 170.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -128.68 77.82 1.81 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.39 0.614 . . . . 0.0 110.864 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 66' ' ' ALA . 5.4 tp 177.42 -52.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.723 176.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.848 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.28 146.33 18.34 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.545 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 66.7 Cg_endo -72.41 156.71 54.23 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.109 1.873 . . . . 0.0 111.994 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.733 HD13 ' HB1' ' A' ' 59' ' ' ALA . 46.1 pt -73.47 129.94 36.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.08 0.467 . . . . 0.0 110.577 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tt -88.86 -49.67 6.67 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -160.46 139.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.067 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 38' ' ' ILE . 4.4 tt -108.94 129.87 62.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 120.912 0.387 . . . . 0.0 110.115 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -111.84 127.29 55.78 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.63 153.72 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.007 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.604 ' HB3' ' N ' ' A' ' 35' ' ' LYS . 25.7 t-20 -80.17 102.0 9.15 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 25.5 t70 -49.66 107.1 0.13 Allowed 'General case' 0 C--O 1.243 0.72 0 O-C-N 125.808 1.943 . . . . 0.0 110.973 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.534 ' HG3' ' O ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -171.36 151.56 3.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.377 -179.419 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.5 50.3 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.598 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.68 88.83 3.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.19 32.04 20.72 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.485 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.15 -90.87 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.991 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.496 ' HB3' HG22 ' A' ' 115' ' ' VAL . . . 61.86 33.15 17.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.541 0.686 . . . . 0.0 110.278 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.558 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 20.4 p -83.74 177.08 8.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.721 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -55.51 -35.64 65.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.811 0.339 . . . . 0.0 111.288 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -77.24 -30.37 54.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 82' ' ' THR . 22.8 mt-30 63.88 170.28 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.498 175.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -94.44 9.73 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.547 2.165 . . . . 0.0 111.468 171.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.24 130.08 5.97 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.018 -177.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -64.65 135.09 55.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.696 0.284 . . . . 0.0 110.769 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.27 -79.0 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.172 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.774 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 43.9 t30 -100.07 153.49 19.18 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -120.02 131.35 55.11 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 121.691 -0.631 . . . . 0.0 110.676 173.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.78 HG21 ' HB2' ' A' ' 118' ' ' SER . 42.1 pt -141.98 167.37 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.839 -175.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 96' ' ' LYS . . . -84.64 116.99 23.49 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 171.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.457 ' O ' HD11 ' A' ' 137' ' ' LEU . . . -69.18 -39.63 78.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.596 -174.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.863 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 2.4 p-10 -78.13 0.58 24.29 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.939 0.876 . . . . 0.0 110.645 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 40.3 mmtm -127.18 56.49 1.52 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.235 169.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.647 ' H ' HD21 ' A' ' 137' ' ' LEU . . . -156.76 -170.12 3.21 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 121.738 -0.601 . . . . 0.0 112.101 -172.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.97 140.96 31.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.023 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 2.2 m-85 -120.68 136.75 54.76 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.09 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.511 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.0 p -113.08 120.49 63.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.773 0.797 . . . . 0.0 109.614 168.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.608 HG23 HD11 ' A' ' 135' ' ' LEU . 99.7 t -101.87 106.77 20.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.556 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.7 130.74 28.48 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.745 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.2 t -92.37 -28.91 16.61 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -87.26 -45.46 10.6 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.973 0.416 . . . . 0.0 110.133 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -128.93 129.8 45.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.482 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.952 HH21 HG13 ' A' ' 145' ' ' VAL . 36.6 ttt85 -170.07 -64.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.085 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 164.26 -44.63 0.31 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -177.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.19 -111.41 4.08 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.318 -0.467 . . . . 0.0 111.995 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.6 mtp -86.22 -3.78 59.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.178 0.514 . . . . 0.0 110.198 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.43 -126.28 3.91 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.473 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.39 92.85 4.28 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.938 0.369 . . . . 0.0 111.03 175.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.24 121.89 10.31 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.228 2.619 . . . . 0.0 112.715 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.48 139.27 49.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.026 0.441 . . . . 0.0 110.576 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.585 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -120.46 133.89 55.35 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.238 -172.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 39.9 t -100.84 105.02 35.56 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.541 -0.464 . . . . 0.0 109.942 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.9 Cg_exo -89.1 124.82 1.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.758 2.972 . . . . 0.0 111.356 171.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.644 ' HD1' ' H ' ' A' ' 119' ' ' SER . 1.7 t80 -135.73 149.13 49.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -176.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.78 ' HB2' HG21 ' A' ' 92' ' ' ILE . 24.1 t -80.35 -31.11 38.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.258 0.551 . . . . 0.0 110.273 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.644 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 16.3 m -90.08 113.37 25.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.346 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -43.04 75.54 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.402 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -63.83 -31.51 72.72 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.682 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.49 ' HG3' ' CE1' ' A' ' 117' ' ' PHE . 43.3 mm-40 -66.23 -43.0 87.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.84 175.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.1 80.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.111 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.43 79.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.874 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -59.7 -31.36 69.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.251 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -62.68 -44.02 97.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.677 HG22 ' H ' ' A' ' 132' ' ' GLY . 56.5 t -72.91 -29.21 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.469 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 9.0 tp -58.22 -35.84 72.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.016 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.68 -50.11 7.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.988 175.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.784 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.9 pt-20 -156.26 -79.95 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.39 175.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.784 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.55 -129.7 11.41 Favored Glycine 0 C--N 1.335 0.502 0 O-C-N 123.522 0.514 . . . . 0.0 112.753 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.677 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -174.67 -83.01 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -130.22 139.28 50.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.819 0.342 . . . . 0.0 110.516 174.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.422 HG23 HG21 ' A' ' 127' ' ' VAL . 76.4 t -98.1 124.13 50.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.798 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -146.99 152.52 38.74 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.815 -177.173 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 140' ' ' ILE . . . -92.47 173.3 7.86 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.568 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.946 HD22 ' H ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -48.4 -40.73 26.8 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.305 178.785 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.61 -29.76 67.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.676 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.404 ' OD2' ' HB3' ' A' ' 135' ' ' LEU . 13.4 t70 -95.52 3.9 53.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.309 0.576 . . . . 0.0 110.33 -175.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.798 HD13 HD13 ' A' ' 135' ' ' LEU . 26.2 mm -71.37 119.43 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.279 0.561 . . . . 0.0 109.842 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.417 ' CG2' ' HG2' ' A' ' 144' ' ' MET . 3.5 t -119.39 148.43 43.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.003 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.1 p-10 -69.05 -25.81 64.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.729 0.3 . . . . 0.0 110.41 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.69 70.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.217 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.572 ' HE2' ' HG2' ' A' ' 156' ' ' ARG . 10.6 mmt -83.51 -34.11 25.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.07 0.462 . . . . 0.0 110.596 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.952 HG13 HH21 ' A' ' 106' ' ' ARG . 38.8 t -78.99 -25.21 13.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.488 -173.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.4 pp -158.07 151.82 23.76 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.276 -174.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.431 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 16.0 p -101.87 120.08 55.07 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.663 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 19.9 Cg_endo -62.87 -71.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.364 2.043 . . . . 0.0 111.213 175.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.13 12.63 3.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 151' ' ' THR . 39.4 mt-10 65.84 -76.87 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.798 -169.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 150' ' ' GLU . 1.1 t 53.71 -0.94 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.986 1.314 . . . . 0.0 114.348 176.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . 71.86 30.24 66.14 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.027 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.6 p -86.05 141.62 29.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.82 0.31 . . . . 0.0 110.509 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.0 125.33 91.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.577 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.17 -95.38 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.062 2.508 . . . . 0.0 112.647 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.718 HH21 ' HB3' ' A' ' 135' ' ' LEU . 1.9 ptp180 -67.89 -32.4 72.86 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 172.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.55 ' N ' ' HG3' ' A' ' 156' ' ' ARG . . . 172.67 -175.1 0.05 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.981 -1.918 . . . . 0.0 106.483 -174.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -82.59 60.72 5.34 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 122.013 0.911 . . . . 0.0 109.368 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -99.19 -15.88 18.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.196 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--O 1.253 1.251 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.999 -176.791 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 85.6 tttt . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.593 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -143.56 144.17 31.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.413 0.149 . . . . 0.0 110.823 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 29.0 pt20 -149.01 134.7 18.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.148 0.499 . . . . 0.0 110.767 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.669 HG22 ' HB ' ' A' ' 71' ' ' ILE . 37.6 pt -115.92 129.18 72.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.657 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -98.87 116.47 31.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.5 mp -91.85 142.72 27.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.873 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.95 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 34.4 tt0 -74.26 125.06 27.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.603 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.93 -23.74 33.0 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.731 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.509 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 39.7 t -88.49 129.41 49.31 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.4 Cg_exo -77.58 -3.35 13.51 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.897 2.398 . . . . 0.0 112.323 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.25 139.69 32.36 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.813 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.76 149.47 8.53 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.596 2.197 . . . . 0.0 112.167 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 10.3 tt -89.07 111.57 22.34 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -124.11 135.95 53.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.204 0.526 . . . . 0.0 111.623 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -146.82 162.65 38.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.567 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 30.2 t -72.46 -41.89 65.56 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.919 ' HG2' ' HB2' ' A' ' 83' ' ' TRP . 37.9 mt-30 -65.65 113.08 3.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.485 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.593 HG13 ' HB2' ' A' ' 36' ' ' ALA . 4.5 t -72.66 -52.03 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.23 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.537 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -52.09 -35.71 48.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.444 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 51' ' ' GLN . 29.1 t70 -76.05 -51.9 11.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.577 0.227 . . . . 0.0 110.999 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.89 94.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.36 . . . . 0.0 111.394 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.926 HD12 ' HB3' ' A' ' 114' ' ' ALA . 23.9 pt -66.91 -30.56 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.691 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.24 97.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.663 0.268 . . . . 0.0 110.663 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.644 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 16.6 m-85 -63.05 -34.02 76.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.364 . . . . 0.0 110.785 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -69.68 -16.81 63.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.557 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.511 HH12 ' HG2' ' A' ' 112' ' ' PRO . 49.9 mtm180 -102.52 -0.7 31.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.049 -175.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.503 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -154.57 -73.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.998 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.644 ' HD2' ' HA ' ' A' ' 58' ' ' TYR . 76.2 Cg_exo -55.65 0.32 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.085 3.19 . . . . 0.0 115.095 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -79.78 9.09 5.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.935 0.397 . . . . 0.0 111.142 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 84.3 mm-40 -62.64 -18.01 61.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.89 0.376 . . . . 0.0 111.452 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.4 tp -70.49 -45.01 76.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.697 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.596 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.13 140.68 13.65 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.95 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 64.7 Cg_endo -68.31 143.76 59.62 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 122.244 1.963 . . . . 0.0 112.021 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.8 pt -74.07 113.11 11.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.229 0.538 . . . . 0.0 110.333 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.6 -50.8 10.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.8 p -161.2 140.45 2.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.227 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.669 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.7 tt -112.99 131.9 63.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.628 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 97.2 m-85 -111.84 135.51 52.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.444 HG23 HG13 ' A' ' 92' ' ' ILE . 27.8 m -131.59 140.82 47.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.445 0.64 . . . . 0.0 111.161 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 13.0 m120 -90.28 99.9 12.83 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -54.63 104.67 0.12 Allowed 'General case' 0 C--O 1.239 0.529 0 O-C-N 124.485 1.116 . . . . 0.0 111.025 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.653 ' O ' ' HD2' ' A' ' 86' ' ' PRO . 64.8 mtt -144.61 52.55 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.414 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.05 -52.56 4.51 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.338 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 67.12 -84.36 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.255 0.622 . . . . 0.0 112.221 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.71 -15.99 15.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.824 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.51 -43.25 96.88 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.647 ' CB ' ' HD3' ' A' ' 86' ' ' PRO . . . -95.02 -154.79 0.44 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.374 173.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.0 p -103.6 177.76 4.75 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.864 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.919 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 3.3 p90 -55.49 -13.27 1.43 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 172.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.61 -35.61 39.27 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 71.74 150.13 0.13 Allowed Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.38 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.653 ' HD2' ' O ' ' A' ' 76' ' ' MET . 48.2 Cg_endo -72.89 -61.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.455 2.104 . . . . 0.0 113.1 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.51 -179.21 39.65 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.372 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.14 136.82 42.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.196 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.3 -113.18 1.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.834 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -100.51 152.02 20.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.515 0.198 . . . . 0.0 111.053 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -105.25 124.94 50.39 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 168.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 1.004 HG21 ' HB2' ' A' ' 118' ' ' SER . 8.8 pt -145.81 164.48 10.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . . . -96.87 107.22 19.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.591 ' HB1' ' HE1' ' A' ' 99' ' ' TYR . . . -57.64 -33.14 67.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 111.188 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.795 ' HA ' HD13 ' A' ' 137' ' ' LEU . 9.1 t70 -62.12 -28.17 69.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.033 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -114.65 33.44 5.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.201 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -138.24 -175.07 3.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.739 0.304 . . . . 0.0 110.902 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -91.34 138.98 31.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.497 0.665 . . . . 0.0 110.61 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.591 ' HE1' ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -120.52 135.03 55.2 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.565 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.912 HG13 HG13 ' A' ' 115' ' ' VAL . 1.1 p -118.57 124.63 73.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.604 0.716 . . . . 0.0 109.752 169.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.577 HG11 ' HA ' ' A' ' 145' ' ' VAL . 65.3 t -101.65 117.82 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.149 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.719 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -77.87 125.82 7.42 Favored Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.452 -171.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -91.88 -36.71 13.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 110.909 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.11 -43.65 23.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.37 . . . . 0.0 111.138 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 71.4 mtp180 -131.02 96.97 4.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.543 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.789 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 2.8 tpp180 172.82 175.32 0.1 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.663 0.602 . . . . 0.0 109.905 173.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.1 70.4 3.15 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.366 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.19 -42.68 98.73 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.358 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.6 mtm -109.55 16.52 22.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.275 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.429 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -139.21 -122.33 1.98 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.475 -175.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.36 92.83 4.24 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 110.915 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.622 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 73.9 Cg_endo -77.3 135.34 14.95 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.61 2.207 . . . . 0.0 112.958 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.789 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 30.9 mt-10 -115.13 146.45 41.34 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.029 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.926 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -118.42 133.14 56.11 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.738 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.912 HG13 HG13 ' A' ' 100' ' ' VAL . 0.5 OUTLIER -101.86 105.69 43.03 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.685 171.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 6.6 Cg_exo -81.99 123.8 4.21 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 124.425 3.416 . . . . 0.0 111.77 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.76 ' HD1' ' H ' ' A' ' 119' ' ' SER . 1.2 t80 -135.16 149.59 49.99 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.988 0.423 . . . . 0.0 110.154 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 1.004 ' HB2' HG21 ' A' ' 92' ' ' ILE . 29.2 t -78.34 -34.68 48.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.615 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.76 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 8.0 m -91.34 116.93 29.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.211 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -58.14 -44.56 87.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.965 0.412 . . . . 0.0 111.495 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -61.63 -31.56 71.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.099 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -67.48 -41.52 84.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.655 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.39 83.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.128 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.25 92.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.774 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.16 86.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.101 0.477 . . . . 0.0 110.567 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -62.0 -38.71 89.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.84 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.607 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 48.2 t -65.99 -42.8 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.903 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.2 mt -53.96 -35.36 61.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.643 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.01 -46.6 11.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.0 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -159.07 -34.58 0.06 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.719 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -50.43 157.86 1.98 Allowed Glycine 0 C--N 1.32 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.024 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -101.27 -68.5 0.83 Allowed Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.74 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.451 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.2 140.96 50.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.741 0.305 . . . . 0.0 110.831 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.411 HG23 HG21 ' A' ' 127' ' ' VAL . 89.0 t -98.38 112.87 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.284 0.564 . . . . 0.0 109.664 172.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.882 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -137.58 144.88 42.23 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.766 -178.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.96 157.59 37.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' ' 95' ' ' ASP . 4.5 tt -63.32 -28.85 70.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.418 0.628 . . . . 0.0 109.673 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.32 -9.56 53.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.425 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -123.45 18.1 9.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.09 0.472 . . . . 0.0 110.539 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.882 HD13 HD13 ' A' ' 135' ' ' LEU . 38.2 mm -71.78 121.65 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.197 0.522 . . . . 0.0 110.387 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 1.022 HG21 ' HA ' ' A' ' 156' ' ' ARG . 2.9 t -111.47 148.24 33.57 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.722 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.497 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.3 p-10 -69.27 -22.31 63.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.681 0.277 . . . . 0.0 110.656 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.27 -33.41 74.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.936 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.654 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 7.2 mmt -87.26 -30.14 21.14 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.806 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.577 ' HA ' HG11 ' A' ' 101' ' ' VAL . 5.0 t -80.53 -22.91 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.991 0.424 . . . . 0.0 110.746 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.6 pp -154.47 134.26 12.93 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.372 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.9 p -116.39 149.37 43.55 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.162 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -58.99 -58.05 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.476 2.117 . . . . 0.0 109.621 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 25.7 t -127.56 -72.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 165.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 149' ' ' VAL . 7.5 mt-10 165.2 -77.03 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.438 1.495 . . . . 0.0 108.493 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.7 t 46.18 28.99 0.73 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.504 1.122 . . . . 0.0 113.129 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 74.92 64.36 2.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.286 -176.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.6 t -89.93 162.08 15.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.922 0.392 . . . . 0.0 110.873 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -88.69 150.97 47.12 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.108 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.642 ' HA ' ' SD ' ' A' ' 144' ' ' MET . 60.3 Cg_endo -73.12 -136.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.991 2.461 . . . . 0.0 113.125 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.022 ' HA ' HG21 ' A' ' 141' ' ' THR . 0.0 OUTLIER -57.21 -29.14 63.49 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -174.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -179.49 20.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.371 0.419 . . . . 0.0 110.638 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.1 t70 48.49 70.52 0.44 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.684 0.754 . . . . 0.0 109.133 -169.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.519 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 14.3 t70 -145.14 -42.18 0.23 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.53 -167.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 C--O 1.247 0.963 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.691 -179.787 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 74' ' ' ASN . 16.5 ttmm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.558 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -133.14 141.88 48.37 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.84 175.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 9.4 pt20 -149.65 132.66 16.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.828 174.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.628 HG21 ' HB2' ' A' ' 59' ' ' ALA . 28.6 pt -115.95 133.68 61.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.3 0.571 . . . . 0.0 111.458 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -103.81 119.51 39.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.696 HD23 ' HB3' ' A' ' 66' ' ' ALA . 11.1 mp -89.63 153.95 20.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.276 0.56 . . . . 0.0 111.503 -174.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.593 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 29.7 tt0 -71.68 125.54 27.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.635 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.31 -27.36 5.7 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.199 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.514 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.9 t -87.98 128.38 54.14 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 8.9 Cg_endo -87.29 -1.35 7.74 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.122 2.548 . . . . 0.0 112.612 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.23 132.98 21.83 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.828 0.347 . . . . 0.0 111.053 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -87.77 124.57 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.675 2.25 . . . . 0.0 112.036 174.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 7.2 tt -80.56 109.0 14.67 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -108.84 143.13 38.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.988 0.423 . . . . 0.0 110.831 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.613 ' HD1' ' H ' ' A' ' 51' ' ' GLN . 1.9 t80 -144.66 145.24 31.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.696 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.7 m -63.97 -34.95 79.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.194 0.521 . . . . 0.0 110.201 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.623 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 76.1 mt-30 -83.38 105.96 14.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.051 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 36' ' ' ALA . 8.6 t -56.37 -51.46 63.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.285 0.564 . . . . 0.0 109.57 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.65 ' HB3' ' HB3' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -55.5 -32.84 63.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.682 -1.145 . . . . 0.0 113.205 -178.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.552 ' HB2' HH11 ' A' ' 53' ' ' ARG . 22.8 t70 -76.28 -50.08 15.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.013 0.435 . . . . 0.0 110.839 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -64.95 -39.47 93.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.276 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.675 HD12 ' HB3' ' A' ' 114' ' ' ALA . 16.2 pt -70.16 -30.53 43.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.625 0.25 . . . . 0.0 110.628 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.07 82.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.141 0.496 . . . . 0.0 110.075 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -62.01 -34.91 77.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.13 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.687 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -72.89 -18.17 61.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.993 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -96.52 12.47 31.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -172.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.32 -61.51 0.1 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.521 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.35 22.43 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.145 2.563 . . . . 0.0 114.8 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.65 74.09 9.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.134 0.968 . . . . 0.0 110.376 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.454 ' O ' HG22 ' A' ' 65' ' ' ILE . 14.0 mt-30 -79.09 145.82 33.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.25 -172.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 64' ' ' GLN . 1.9 tp 72.74 -38.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.91 1.284 . . . . 0.0 112.345 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.696 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -133.44 139.57 34.35 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 122.007 -0.433 . . . . 0.0 110.413 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 96.2 Cg_endo -85.59 159.97 10.8 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.95 2.434 . . . . 0.0 112.061 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.687 HD13 ' HB1' ' A' ' 59' ' ' ALA . 28.0 pt -77.08 113.35 16.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.31 0.576 . . . . 0.0 110.465 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -77.54 -46.81 21.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.7 p -158.28 138.82 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.395 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.604 HD11 HG22 ' A' ' 56' ' ' ILE . 2.6 tt -116.94 134.35 60.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.027 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.94 128.78 56.26 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 94' ' ' ALA . 29.0 m -126.96 151.93 34.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.26 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 16.5 m120 -91.49 105.65 17.91 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.54 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.589 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 18.3 t70 -48.26 134.02 15.04 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 125.928 2.018 . . . . 0.0 110.844 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 74' ' ' ASN . 23.9 mmt -127.04 176.55 7.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -167.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.406 ' H ' ' HG2' ' A' ' 86' ' ' PRO . . . -60.95 -19.38 56.37 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.73 173.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 83.47 -45.16 0.11 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.16 0.584 . . . . 0.0 112.33 168.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.54 -44.22 76.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.061 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.03 -87.1 0.78 Allowed Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.506 173.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.439 ' H ' ' HD3' ' A' ' 86' ' ' PRO . . . 53.73 26.16 5.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.52 0.676 . . . . 0.0 111.699 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.0 p -83.67 179.16 7.68 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.983 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.623 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 48.6 p90 -59.5 -24.2 63.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.733 0.301 . . . . 0.0 111.267 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -81.37 -35.29 30.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.824 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 68.74 140.22 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.668 174.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.496 ' HD2' ' SD ' ' A' ' 76' ' ' MET . 96.5 Cg_endo -85.14 31.71 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.36 2.04 . . . . 0.0 113.577 -173.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 118.01 -171.83 14.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.125 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.4 147.22 36.14 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.493 0.317 . . . . 0.0 110.728 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -141.58 -158.06 7.4 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.169 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.603 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 41.9 m-80 -100.17 150.44 22.51 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 40.8 p-90 -98.56 130.28 45.11 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.444 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.758 HG21 ' HB2' ' A' ' 118' ' ' SER . 14.1 pt -143.97 160.6 15.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.601 -173.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.68 101.16 9.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.108 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.579 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -62.11 -38.95 90.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.349 -172.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 14.0 t70 -58.85 -30.43 67.69 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.666 0.746 . . . . 0.0 110.301 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -107.96 25.73 11.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.123 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.13 -177.21 3.79 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.847 0.356 . . . . 0.0 110.485 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -97.79 136.81 37.59 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.527 0.68 . . . . 0.0 110.475 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.66 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 7.6 m-85 -120.5 136.18 54.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.88 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.705 HG13 ' HB ' ' A' ' 115' ' ' VAL . 3.2 p -114.77 127.89 72.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.423 0.63 . . . . 0.0 109.762 174.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.597 HG11 ' HA ' ' A' ' 145' ' ' VAL . 96.4 t -101.46 103.49 14.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -80.49 123.16 5.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.555 -174.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.8 t -92.51 -29.54 16.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.587 0.232 . . . . 0.0 110.756 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.18 60.74 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -171.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -139.19 101.53 4.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.421 173.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.952 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 19.4 tpp180 -175.06 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.845 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.65 42.09 0.15 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.113 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.97 -34.38 89.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.266 -0.968 . . . . 0.0 111.715 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.0 ttt -109.5 2.23 20.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.096 0.474 . . . . 0.0 110.326 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.425 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -136.56 -123.52 2.26 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.72 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.8 99.08 12.61 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.977 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 72.1 Cg_endo -79.18 151.38 23.44 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.143 2.562 . . . . 0.0 113.696 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.952 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 25.9 mt-10 -128.82 146.52 50.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.603 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.675 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -93.79 130.93 39.62 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.945 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.705 ' HB ' HG13 ' A' ' 100' ' ' VAL . 55.4 t -101.28 106.4 45.13 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 6.1 Cg_exo -86.26 132.52 3.79 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.656 2.904 . . . . 0.0 112.305 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.755 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.8 t80 -137.66 149.43 46.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.758 ' HB2' HG21 ' A' ' 92' ' ' ILE . 35.5 t -77.97 -37.88 46.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.846 0.355 . . . . 0.0 111.148 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.755 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 17.8 m -95.75 129.74 42.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.826 0.346 . . . . 0.0 110.645 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -65.92 -49.72 66.97 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.229 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -63.18 -29.65 70.95 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.554 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -65.73 -42.92 90.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.554 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.7 -36.95 73.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.229 0.538 . . . . 0.0 110.035 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.03 -34.56 71.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.846 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.69 81.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.036 0.446 . . . . 0.0 110.356 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -62.43 -37.59 86.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.751 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.7 HG22 ' H ' ' A' ' 132' ' ' GLY . 93.2 t -70.95 -38.13 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.974 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.1 mt -53.24 -50.95 63.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.368 0.604 . . . . 0.0 110.11 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.59 78.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.133 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.76 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.3 pt-20 -165.55 -82.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.58 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.76 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 39.6 -132.79 2.15 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 123.915 0.759 . . . . 0.0 114.45 175.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.7 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -171.23 -93.37 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.77 139.66 51.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.711 0.291 . . . . 0.0 110.715 174.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.496 HG23 HG21 ' A' ' 127' ' ' VAL . 99.4 t -97.43 123.17 49.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.378 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.886 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -147.02 164.38 33.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.563 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.14 164.38 15.04 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.625 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 4.1 tt -61.44 -40.05 93.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.97 -8.62 38.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.592 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -124.67 17.96 8.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.248 0.547 . . . . 0.0 110.748 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.886 HD13 HD13 ' A' ' 135' ' ' LEU . 26.1 mm -71.78 121.92 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -116.86 146.0 43.2 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.96 -30.73 68.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.717 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.76 -28.78 68.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.923 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.6 mmt -77.62 -41.21 39.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.783 0.325 . . . . 0.0 110.953 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.597 ' HA ' HG11 ' A' ' 101' ' ' VAL . 3.0 t -81.52 -23.79 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.393 . . . . 0.0 111.217 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -156.62 159.33 38.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.552 -175.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 150' ' ' GLU . 3.4 p -100.02 120.35 57.11 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.657 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.26 -69.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.1 2.533 . . . . 0.0 112.406 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.69 0.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.288 0.566 . . . . 0.0 109.646 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.453 ' HG2' ' HB ' ' A' ' 147' ' ' THR . 40.1 mt-10 57.36 55.8 5.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.422 -175.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 t -90.94 -6.84 53.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.055 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 82.42 26.57 46.78 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.535 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 p -84.41 161.93 20.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.667 0.27 . . . . 0.0 110.646 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.885 ' HB3' ' H ' ' A' ' 158' ' ' ASP . 43.3 mp0 -61.38 131.96 92.58 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.59 -24.68 25.61 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.698 2.265 . . . . 0.0 113.253 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.498 HH11 ' HB3' ' A' ' 157' ' ' ALA . 5.8 ppt_? -155.13 -39.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.14 0.495 . . . . 0.0 110.527 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.498 ' HB3' HH11 ' A' ' 156' ' ' ARG . . . 179.33 53.89 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.885 ' H ' ' HB3' ' A' ' 154' ' ' GLU . 13.5 t70 63.38 -144.9 0.34 Allowed 'General case' 0 C--O 1.237 0.424 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 -156.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -154.17 161.49 41.82 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 119.662 1.119 . . . . 0.0 112.408 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 C--O 1.248 0.975 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.343 -173.281 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 28.7 tttm . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.767 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -135.91 143.71 45.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.541 0.21 . . . . 0.0 111.099 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -149.35 139.55 22.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.645 0.26 . . . . 0.0 110.417 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.449 HG22 ' HB ' ' A' ' 71' ' ' ILE . 32.5 pt -116.01 136.1 54.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.992 0.425 . . . . 0.0 111.429 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -104.87 123.71 48.2 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.9 mp -97.74 148.99 22.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.187 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.819 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 40.6 tt0 -74.04 125.5 28.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.616 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.03 -29.28 10.23 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.592 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 t -92.4 124.98 57.79 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.26 -7.39 12.94 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.878 2.385 . . . . 0.0 111.958 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -113.71 133.95 22.14 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.632 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 97.1 Cg_endo -91.01 143.24 3.25 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.084 2.523 . . . . 0.0 112.656 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.2 tt -89.41 121.41 31.63 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -107.85 147.22 31.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 111.527 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.529 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 1.5 m-85 -143.12 141.94 31.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.146 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.5 m -72.42 -28.73 63.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.0 109.487 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.532 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 17.1 mt-30 -86.84 109.39 19.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.92 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.767 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 17.2 t -63.54 -51.17 73.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.294 0.569 . . . . 0.0 109.909 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.634 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.33 -29.07 60.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.111 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.634 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 8.8 t70 -76.21 -47.27 24.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.532 -176.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -72.31 -36.08 68.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.485 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.518 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 22.8 pt -68.23 -35.24 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.436 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.31 -40.96 81.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.03 0.443 . . . . 0.0 110.338 172.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.47 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 33.2 t80 -62.29 -28.31 69.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.686 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.1 -15.9 61.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.288 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 60' ' ' ARG . 40.6 mtp-105 -98.19 11.71 36.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -172.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.96 -60.97 0.09 OUTLIER Glycine 0 CA--C 1.52 0.404 0 C-N-CA 119.274 -1.441 . . . . 0.0 114.469 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 58' ' ' TYR . 37.5 Cg_exo -59.81 -7.6 6.24 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.265 2.643 . . . . 0.0 115.149 -176.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.861 ' HG3' HG23 ' A' ' 68' ' ' ILE . 3.2 pm0 -77.41 89.61 3.8 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.41 1.1 . . . . 0.0 109.604 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -106.78 -24.64 12.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.045 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.2 tp -68.6 -40.21 81.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.275 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.596 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.24 152.65 29.8 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.538 177.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.819 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 59.8 Cg_endo -72.65 160.03 47.37 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.259 1.973 . . . . 0.0 111.447 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.861 HG23 ' HG3' ' A' ' 63' ' ' GLU . 29.1 pt -80.35 132.52 31.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.05 0.452 . . . . 0.0 111.035 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.08 -51.89 3.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -161.23 138.56 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.469 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.55 HG22 ' HB2' ' A' ' 95' ' ' ASP . 2.7 tt -108.15 134.64 49.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.153 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -111.88 130.07 55.95 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.95 145.61 27.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.026 0.441 . . . . 0.0 109.877 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 17.0 m120 -85.56 100.87 12.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.246 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -56.24 109.21 0.56 Allowed 'General case' 0 C--O 1.238 0.48 0 O-C-N 125.292 1.62 . . . . 0.0 110.136 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.495 ' SD ' ' HG2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -159.73 107.23 1.7 Allowed 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.291 -179.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.21 -68.3 2.05 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.399 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.582 ' HB1' HG13 ' A' ' 115' ' ' VAL . . . 67.42 -50.85 0.5 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.72 0.808 . . . . 0.0 112.51 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.85 -36.3 69.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.066 0.46 . . . . 0.0 110.547 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.31 -71.3 1.16 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 78' ' ' ALA . . . 51.41 54.49 11.0 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 124.176 0.574 . . . . 0.0 112.052 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.5 p -83.82 175.94 9.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.532 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 28.0 p-90 -66.53 -20.0 65.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.152 0.501 . . . . 0.0 110.254 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -84.76 -26.28 27.69 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.655 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 63.76 171.49 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.604 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.951 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.495 ' HG2' ' SD ' ' A' ' 76' ' ' MET . 38.4 Cg_endo -92.16 0.77 4.16 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.636 1.557 . . . . 0.0 112.06 172.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.3 -168.55 20.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.869 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.16 146.45 37.09 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.22 -166.55 12.15 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.159 -1.019 . . . . 0.0 113.277 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.3 t-20 -77.65 152.34 33.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.133 -0.534 . . . . 0.0 110.087 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -98.05 128.7 44.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.436 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.3 pt -140.57 143.59 28.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.77 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.92 102.44 4.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.177 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.91 78.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.237 0.542 . . . . 0.0 111.066 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.55 ' HB2' HG22 ' A' ' 71' ' ' ILE . 21.8 t70 -61.85 -24.63 67.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.64 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -115.97 27.56 9.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.995 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.35 178.84 5.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.651 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -92.67 136.02 33.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.431 0.634 . . . . 0.0 110.592 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.479 ' HE2' HD12 ' A' ' 56' ' ' ILE . 8.7 m-85 -120.54 136.22 54.85 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.739 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.736 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.7 p -113.9 125.98 71.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 CA-C-O 121.835 0.826 . . . . 0.0 110.423 173.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.681 ' HA ' HH11 ' A' ' 106' ' ' ARG . 40.8 t -102.03 113.4 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.461 174.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.66 122.57 7.2 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 119.975 -1.107 . . . . 0.0 111.553 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t -89.03 -28.46 20.15 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.34 -44.25 12.98 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.861 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.673 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 60.9 mtp180 -146.01 127.16 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.322 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.681 HH11 ' HA ' ' A' ' 101' ' ' VAL . 7.6 ttt180 -176.58 -53.37 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.626 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 151.39 26.33 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.28 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.26 -38.15 92.86 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.919 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 67.4 mtt -109.36 21.34 17.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.73 0.3 . . . . 0.0 110.637 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.55 -125.5 0.93 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.816 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.42 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.32 101.7 24.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.942 0.401 . . . . 0.0 110.375 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.547 ' HA ' ' HA3' ' A' ' 107' ' ' GLY . 43.0 Cg_endo -66.94 123.4 10.93 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 123.229 2.619 . . . . 0.0 113.301 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.38 131.13 56.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.79 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.591 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -98.13 131.77 44.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.85 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.736 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 93.3 t -98.04 104.54 22.87 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.826 174.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.0 Cg_endo -96.53 127.18 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.975 3.117 . . . . 0.0 112.064 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.546 ' HD2' ' H ' ' A' ' 119' ' ' SER . 1.1 t80 -147.06 148.78 32.0 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.4 m -86.87 -17.54 33.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.938 0.399 . . . . 0.0 110.759 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.546 ' H ' ' HD2' ' A' ' 117' ' ' PHE . 43.9 m -92.3 107.56 19.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.922 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.5 -44.62 72.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.782 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -63.42 -28.03 69.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.311 -173.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.524 ' HG3' ' CE2' ' A' ' 117' ' ' PHE . 40.9 mm-40 -66.4 -44.64 82.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.067 0.46 . . . . 0.0 110.242 174.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.05 77.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.364 0.602 . . . . 0.0 109.707 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.67 95.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.571 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -59.8 -33.85 72.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.295 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -64.37 -43.75 93.54 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 132' ' ' GLY . 40.5 t -72.95 -28.62 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.277 0.561 . . . . 0.0 110.397 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 9.3 tp -57.6 -38.64 75.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.921 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.02 -46.46 11.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.419 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.765 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.5 pt-20 -156.58 -80.05 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.621 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.765 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.36 -133.43 10.85 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 114.249 0.46 . . . . 0.0 114.249 174.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.702 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -178.39 -85.47 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.475 ' HG3' ' SD ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -130.16 139.5 50.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.629 0.252 . . . . 0.0 110.975 178.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.2 t -103.72 112.85 38.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.522 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.791 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -139.7 165.5 27.1 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.016 -175.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.81 161.29 14.92 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.666 ' HA ' HG12 ' A' ' 140' ' ' ILE . 1.6 tt -60.77 -31.03 70.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.188 0.518 . . . . 0.0 110.086 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.59 -22.91 67.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.645 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.28 26.01 9.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.043 -174.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.791 HD13 HD13 ' A' ' 135' ' ' LEU . 31.1 mm -71.69 119.48 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.498 ' CG2' ' HG2' ' A' ' 144' ' ' MET . 5.6 t -119.49 149.48 41.82 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.068 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 15.7 p-10 -68.99 -27.45 65.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.93 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.67 70.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.667 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.498 ' HG2' ' CG2' ' A' ' 141' ' ' THR . 12.8 mmt -75.73 -37.66 59.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.968 0.413 . . . . 0.0 110.699 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.69 -23.44 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.48 -171.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.5 pp -153.0 142.42 21.69 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.209 -174.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.4 p -122.75 150.33 58.26 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.589 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.07 -59.75 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.293 1.995 . . . . 0.0 109.592 171.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 28.7 t -119.73 -71.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 166.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 149' ' ' VAL . 11.4 mt-10 172.28 -76.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.625 1.57 . . . . 0.0 107.569 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 150' ' ' GLU . 0.6 OUTLIER 64.35 -31.17 0.12 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.878 1.271 . . . . 0.0 113.973 173.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 97.41 54.99 1.2 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.2 t -102.66 144.68 30.74 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.667 ' HG2' ' HB3' ' A' ' 158' ' ' ASP . 2.2 mp0 -57.71 126.26 75.43 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 110.66 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 157' ' ' ALA . 59.8 Cg_endo -73.85 -85.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.029 2.486 . . . . 0.0 113.236 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.425 ' HD2' ' HB3' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -75.5 -27.23 58.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.419 1.104 . . . . 0.0 108.089 174.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.511 ' O ' ' HD2' ' A' ' 155' ' ' PRO . . . 165.73 -162.9 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 112.563 -2.108 . . . . 0.0 105.448 -170.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.667 ' HB3' ' HG2' ' A' ' 154' ' ' GLU . 4.0 p30 -106.26 17.45 23.44 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 36.1 t70 -66.26 -83.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.475 -1.238 . . . . 0.0 111.358 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.558 176.557 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 50' ' ' SER . 88.0 tttt . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -132.89 145.05 50.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.713 0.292 . . . . 0.0 111.226 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 10.4 pt20 -149.13 134.55 18.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.413 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.728 HG21 ' HB2' ' A' ' 59' ' ' ALA . 22.3 pt -115.58 135.69 54.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.183 0.516 . . . . 0.0 110.923 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -104.73 119.64 39.47 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.5 mp -81.16 151.66 28.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.38 -175.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.34 125.53 28.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.374 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.7 -36.75 3.22 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.634 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 41.5 t -81.6 125.45 78.36 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.932 0.396 . . . . 0.0 110.359 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.5 Cg_exo -78.74 -1.42 11.58 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.179 2.586 . . . . 0.0 112.289 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -114.63 134.01 22.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.69 0.281 . . . . 0.0 111.106 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 98.5 Cg_endo -93.37 162.25 2.45 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.331 2.687 . . . . 0.0 112.69 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.5 tt -115.21 116.27 28.07 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 20.6 p90 -119.62 146.04 45.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.286 0.565 . . . . 0.0 111.732 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.407 ' HD1' ' H ' ' A' ' 51' ' ' GLN . 3.5 t80 -149.96 143.84 25.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.068 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 16.4 m -60.24 -45.61 92.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.096 0.475 . . . . 0.0 110.76 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.588 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 66.8 mt-30 -69.7 111.1 5.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.493 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 8.9 t -61.95 -52.42 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.948 0.404 . . . . 0.0 110.456 -177.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.566 HH11 ' HB2' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.86 -29.9 56.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.411 178.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.566 ' HB2' HH11 ' A' ' 53' ' ' ARG . 29.0 t70 -76.16 -51.56 11.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.953 0.406 . . . . 0.0 110.234 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.746 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -68.02 -38.3 82.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.676 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 28.3 pt -65.82 -30.24 49.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.66 96.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.678 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.746 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 70.2 m-85 -60.4 -44.97 95.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.712 0.292 . . . . 0.0 110.847 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.728 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -61.01 -18.18 56.25 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -105.05 12.5 32.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.824 0.345 . . . . 0.0 111.396 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.91 -85.4 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.34 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -48.05 -55.3 4.15 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.672 2.914 . . . . 0.0 113.858 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 57.21 -89.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.775 0.672 . . . . 0.0 110.43 -173.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.541 ' HB3' HD21 ' A' ' 40' ' ' LEU . 58.7 tt0 -178.97 -59.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tp -165.87 -40.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.048 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -94.12 152.16 40.15 Favored Pre-proline 0 N--CA 1.446 -0.675 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.007 173.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.59 161.38 46.25 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.768 1.645 . . . . 0.0 111.305 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.5 pt -73.79 136.98 24.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.196 0.522 . . . . 0.0 110.786 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tt -98.37 -47.89 5.25 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.01 138.75 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.8 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' A' ' 95' ' ' ASP . 2.8 tt -111.08 133.23 57.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.079 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -112.86 145.06 41.35 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 36' ' ' ALA . 18.8 m -136.35 155.88 35.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.231 0.538 . . . . 0.0 110.912 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -91.21 102.65 15.37 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 21.2 t70 -57.0 108.53 0.52 Allowed 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 125.034 1.459 . . . . 0.0 111.252 -175.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.599 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 1.6 mmt -161.12 62.02 0.29 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.555 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.937 ' HA2' ' HB2' ' A' ' 81' ' ' ALA . . . -100.15 27.02 22.28 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.78 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.44 97.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.94 0.435 . . . . 0.0 111.067 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 56.4 33.97 23.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.398 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.56 -59.7 0.22 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 119.148 -1.501 . . . . 0.0 114.566 176.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.937 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . . . 60.64 56.55 2.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.364 0.602 . . . . 0.0 110.375 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.6 p -83.99 177.18 8.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.069 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.588 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 24.5 p90 -66.71 -24.21 66.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.267 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.85 -31.89 27.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 66.59 157.36 0.13 Allowed Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.059 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 76' ' ' MET . 21.8 Cg_exo -70.76 -22.02 28.05 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.532 2.155 . . . . 0.0 111.1 170.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . 146.87 -162.99 28.61 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.515 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.74 141.95 42.51 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 76' ' ' MET . . . -131.11 -156.14 8.42 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.484 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -96.66 155.72 16.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.442 -175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -97.53 127.39 43.45 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.694 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.803 HD13 ' HB2' ' A' ' 118' ' ' SER . 26.6 pt -145.3 166.97 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.33 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.73 117.32 29.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.86 -35.54 74.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.737 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.754 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -70.63 -18.22 62.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.932 0.872 . . . . 0.0 109.718 -178.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.468 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 41.1 mmtm -107.12 21.06 18.12 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.678 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.21 177.59 4.83 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.797 0.332 . . . . 0.0 110.87 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -92.02 133.36 35.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.966 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -120.66 135.76 55.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.465 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.447 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.7 p -112.16 127.84 69.11 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-O 121.695 0.759 . . . . 0.0 110.422 174.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.542 ' HA ' HH11 ' A' ' 106' ' ' ARG . 43.8 t -102.89 103.92 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.119 174.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.45 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -70.35 125.02 14.01 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.453 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.6 m -92.21 -14.42 29.04 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.186 0.517 . . . . 0.0 110.032 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -91.88 -43.57 9.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.008 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.664 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 54.1 mtp180 -121.41 -107.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 119.292 -0.385 . . . . 0.0 109.988 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.542 HH11 ' HA ' ' A' ' 101' ' ' VAL . 5.0 tpt180 68.26 -60.66 0.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 176.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . -178.62 -61.11 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 58.56 -94.34 0.05 OUTLIER Glycine 0 C--N 1.332 0.319 0 O-C-N 123.92 0.424 . . . . 0.0 113.159 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -83.05 -3.97 57.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.986 0.422 . . . . 0.0 110.94 -178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.98 -135.89 5.24 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -102.36 108.16 56.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.803 0.301 . . . . 0.0 110.342 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HA ' ' HA3' ' A' ' 107' ' ' GLY . 18.4 Cg_endo -59.88 128.06 25.49 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 123.185 2.59 . . . . 0.0 112.99 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.414 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 43.1 mt-10 -114.52 135.35 54.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.904 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.544 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.77 131.62 38.95 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.827 -174.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.447 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 8.8 t -101.31 105.39 39.38 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.625 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.4 Cg_exo -86.97 136.84 4.33 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.713 2.942 . . . . 0.0 112.341 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -129.27 149.01 51.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.049 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.803 ' HB2' HD13 ' A' ' 92' ' ' ILE . 30.9 t -85.2 -35.61 21.53 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.9 m -91.59 118.7 30.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.763 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -59.74 -42.55 93.42 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.429 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -65.9 -31.7 72.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.892 -173.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -64.55 -40.44 95.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.746 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.03 -42.54 84.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.51 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.26 -41.19 99.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.855 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.42 -31.27 72.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.91 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -64.95 -36.52 84.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.916 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 62.1 t -73.02 -27.83 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.649 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mp -61.73 -46.23 90.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.086 0.469 . . . . 0.0 110.809 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.91 -49.92 26.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.485 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.669 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 0.7 OUTLIER -145.96 -86.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.757 178.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.916 ' HA3' ' HA ' ' A' ' 127' ' ' VAL . . . 50.44 -148.68 6.94 Favored Glycine 0 N--CA 1.444 -0.792 0 O-C-N 123.642 0.588 . . . . 0.0 113.702 172.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.588 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -179.96 -84.77 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -130.22 141.17 50.66 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 38.4 t -104.63 113.96 43.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.643 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.765 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.28 164.17 29.92 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.699 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.72 166.3 17.13 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.754 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 4.7 tt -62.22 -33.44 74.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.351 0.596 . . . . 0.0 109.611 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.02 60.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.168 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -117.44 17.47 14.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.292 0.568 . . . . 0.0 110.073 -176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.765 HD13 HD13 ' A' ' 135' ' ' LEU . 31.9 mm -71.93 120.28 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.312 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.6 t -119.1 147.82 43.73 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.978 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -69.26 -31.32 69.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.891 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.77 -28.82 66.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.798 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.617 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 8.2 mmt -87.18 -26.45 23.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.494 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.421 ' HA ' HG11 ' A' ' 101' ' ' VAL . 16.4 t -85.56 -24.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.207 0.527 . . . . 0.0 110.521 -177.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -160.3 151.88 19.75 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.566 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.44 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 4.0 p -94.59 120.06 65.43 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 120.829 0.347 . . . . 0.0 111.214 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 36.8 Cg_endo -66.6 -67.57 0.04 OUTLIER 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.73 2.287 . . . . 0.0 111.511 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.408 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 2.4 t -118.66 5.39 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 152' ' ' GLY . 22.4 mt-10 66.58 -81.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.699 -170.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.1 t 43.31 -59.99 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.134 1.774 . . . . 0.0 114.999 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 150' ' ' GLU . . . 118.34 63.37 0.3 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -175.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.1 m -116.91 161.58 19.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.545 0.212 . . . . 0.0 110.467 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 158' ' ' ASP . 1.6 mp0 -66.54 135.17 94.53 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.712 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 154' ' ' GLU . 74.1 Cg_endo -81.21 -89.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 123.037 2.491 . . . . 0.0 114.583 -169.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.443 ' HD2' ' HB3' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -66.21 -25.71 67.04 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.001 0.429 . . . . 0.0 111.393 -173.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -171.03 -82.34 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 6.3 p-10 -171.18 20.67 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.443 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 30.5 t70 -78.11 -83.02 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.339 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.186 173.73 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 22.1 ttmm . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -131.4 148.48 52.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.83 0.286 . . . . 0.0 111.275 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 1.7 pt20 -149.04 134.47 18.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 36.1 pt -115.94 137.82 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.821 -0.549 . . . . 0.0 110.892 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -108.95 126.52 53.18 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.572 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.8 mp -97.51 150.52 21.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.931 0.396 . . . . 0.0 111.502 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.719 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 38.2 tt0 -74.15 129.15 37.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.591 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.34 -34.7 4.05 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.842 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.471 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 33.2 t -81.9 129.99 62.49 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.1 Cg_endo -85.44 2.36 7.78 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.966 2.444 . . . . 0.0 112.439 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -122.43 134.54 24.93 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 120.845 0.355 . . . . 0.0 111.41 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 10.3 Cg_endo -91.1 145.05 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.488 2.792 . . . . 0.0 112.051 174.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 2.8 tm? -93.21 114.53 27.03 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -95.49 135.37 37.23 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 55' ' ' ALA . 5.6 t80 -147.26 131.24 17.19 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.65 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 70.1 m -57.82 -49.02 78.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.056 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -71.21 108.47 4.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.543 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 10.6 t -56.53 -50.18 74.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.65 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.88 -33.56 66.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.785 -177.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.65 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 11.8 t70 -76.52 -43.01 41.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.901 0.381 . . . . 0.0 110.848 -175.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -72.8 -39.51 66.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.277 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.592 HD12 ' HB3' ' A' ' 114' ' ' ALA . 12.0 pt -65.36 -29.95 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.942 0.401 . . . . 0.0 110.014 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.577 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -63.32 -41.79 98.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.823 173.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.431 ' CD2' ' HA ' ' A' ' 55' ' ' ALA . 21.1 m-30 -55.66 -43.8 76.61 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.126 0.489 . . . . 0.0 110.469 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' A' ' 68' ' ' ILE . . . -61.2 -17.11 51.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.824 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 60' ' ' ARG . 37.5 mtp180 -101.62 12.06 37.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.98 -60.33 0.36 Allowed Glycine 0 CA--C 1.518 0.239 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.549 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 33.4 Cg_exo -63.36 51.18 0.14 Allowed 'Trans proline' 0 N--CA 1.48 0.694 0 C-N-CA 123.874 3.049 . . . . 0.0 114.242 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -104.1 -175.34 2.77 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 173.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -106.52 -161.76 0.81 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.103 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -53.42 -34.85 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.671 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.572 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -85.06 140.49 37.06 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.668 0.27 . . . . 0.0 110.53 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.719 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 73.9 Cg_endo -78.17 159.68 29.96 Favored 'Trans proline' 0 CA--C 1.521 -0.137 0 C-N-CA 122.975 2.45 . . . . 0.0 112.559 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.419 HG21 ' HA ' ' A' ' 59' ' ' ALA . 45.1 pt -74.29 131.94 34.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 41' ' ' GLU . 6.1 tt -97.91 -49.5 4.77 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -161.15 138.03 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.876 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 56' ' ' ILE . 2.8 tt -108.33 133.41 53.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.661 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.472 ' HB2' ' HG3' ' A' ' 37' ' ' GLN . 93.9 m-85 -113.7 143.21 44.99 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 94' ' ' ALA . 20.6 m -133.31 156.93 42.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.584 0.707 . . . . 0.0 110.392 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 11.3 m120 -93.67 106.16 18.14 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 171.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 90' ' ' ASN . 18.2 t70 -46.37 97.75 0.01 OUTLIER 'General case' 0 C--O 1.233 0.232 0 O-C-N 125.384 1.677 . . . . 0.0 110.719 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.565 ' HB3' ' HG2' ' A' ' 86' ' ' PRO . 65.5 mtt -147.86 51.2 1.04 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.19 -174.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 80' ' ' GLY . . . -91.86 27.07 10.52 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.035 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.506 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . . . -71.42 96.82 1.53 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -175.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 68.98 22.93 6.8 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.93 0.769 . . . . 0.0 110.515 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.511 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . 146.66 -116.6 0.87 Allowed Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 175.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 80' ' ' GLY . . . 158.21 62.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -171.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.0 p -83.64 175.37 9.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.572 -169.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.457 ' H ' ' HD1' ' A' ' 83' ' ' TRP . 1.4 p-90 -71.55 -30.41 65.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.452 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -84.88 -24.33 28.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.316 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 69.03 154.39 0.14 Allowed Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.508 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.565 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 14.9 Cg_exo -50.04 -38.2 48.99 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.173 1.916 . . . . 0.0 112.132 171.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.25 -84.51 0.33 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.351 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.59 148.61 35.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.4 157.51 29.87 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.784 -1.198 . . . . 0.0 113.741 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 14.9 m-80 -92.58 151.84 19.93 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 25.1 p-90 -98.6 128.61 44.97 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 118.917 -1.113 . . . . 0.0 109.891 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.844 HG21 ' HB2' ' A' ' 118' ' ' SER . 23.3 pt -145.6 167.03 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.291 -176.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.83 116.04 23.84 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.56 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -69.92 -42.26 73.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -171.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -67.87 -23.11 65.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.777 0.798 . . . . 0.0 109.684 -177.027 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -101.06 32.55 3.18 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.816 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.41 178.47 7.04 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.662 -172.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -92.64 135.11 34.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.271 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.598 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 7.2 m-85 -120.73 135.9 55.01 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.417 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.92 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.4 p -114.96 120.32 64.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.639 0.733 . . . . 0.0 109.869 171.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.808 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 95.5 t -101.95 119.05 49.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.584 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.504 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -82.62 121.1 5.34 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.412 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.4 m -92.59 -28.92 16.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.003 0.43 . . . . 0.0 110.231 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.91 -44.16 64.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.158 -176.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 70.6 mtt180 -138.07 118.11 13.43 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.678 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 1.3 tpp180 175.27 -170.65 0.06 Allowed 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.499 0.499 . . . . 0.0 109.682 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.466 ' H ' ' HG3' ' A' ' 106' ' ' ARG . . . -51.83 -70.8 0.78 Allowed Glycine 0 C--N 1.335 0.527 0 O-C-N 123.623 0.577 . . . . 0.0 112.883 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.95 -78.16 0.65 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.138 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -89.91 -4.23 57.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.187 0.518 . . . . 0.0 110.076 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -121.55 -128.67 3.53 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.381 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.481 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -102.94 99.27 13.39 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.93 0.395 . . . . 0.0 111.163 177.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 35.6 Cg_endo -64.66 151.64 84.88 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 123.191 2.594 . . . . 0.0 112.229 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.678 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 41.3 mt-10 -118.21 146.36 44.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.42 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 99' ' ' TYR . . . -106.63 130.91 54.3 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.031 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.92 ' HB ' HG13 ' A' ' 100' ' ' VAL . 57.3 t -98.05 105.19 26.47 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.9 Cg_exo -86.76 132.52 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.751 2.967 . . . . 0.0 112.989 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -136.51 149.47 48.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.714 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.844 ' HB2' HG21 ' A' ' 92' ' ' ILE . 42.0 t -84.54 -19.75 32.68 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 170.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.454 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 15.7 m -105.59 115.51 30.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.3 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -44.78 80.96 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.158 0.504 . . . . 0.0 110.979 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.454 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 20.4 p-10 -62.46 -29.34 70.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.121 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -71.29 -40.41 70.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.688 175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.63 -37.38 84.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.143 0.497 . . . . 0.0 109.986 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.31 -35.11 78.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.659 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.422 ' HA ' HD12 ' A' ' 128' ' ' LEU . . . -63.93 -34.81 78.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.776 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -63.18 -36.46 83.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.799 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.653 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 44.4 t -71.91 -31.75 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.486 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 125' ' ' ALA . 67.7 mt -60.54 -35.39 75.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.726 176.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.24 -50.22 7.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.813 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.8 pt-20 -148.32 -85.18 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.842 175.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.813 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 52.05 -146.84 13.54 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 170.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.601 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -171.33 -89.06 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.808 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.29 160.1 34.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 175.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.37 113.32 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.182 0.515 . . . . 0.0 110.246 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.939 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -134.57 165.13 25.92 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.902 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -86.67 160.86 18.73 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.738 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 6.7 tt -61.66 -42.85 99.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.274 0.559 . . . . 0.0 109.624 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.59 -18.51 62.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.943 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.26 20.71 13.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.576 -172.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.939 HD13 HD13 ' A' ' 135' ' ' LEU . 22.6 mm -71.87 120.86 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.896 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 t -107.05 147.7 29.64 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.433 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.19 -33.27 73.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.65 -28.79 68.84 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.744 0.653 . . . . 0.0 112.07 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.481 ' CE ' ' HB3' ' A' ' 155' ' ' PRO . 11.9 mmt -82.94 -26.84 31.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.769 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.483 ' HA ' HG11 ' A' ' 101' ' ' VAL . 2.2 t -92.68 -23.01 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 -175.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.6 pp -170.04 164.79 9.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.131 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.448 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 19.6 p -113.66 118.66 42.82 Favored Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.622 174.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 32.9 Cg_endo -65.92 -82.44 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.747 2.298 . . . . 0.0 112.287 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.688 ' HB ' ' OG1' ' A' ' 151' ' ' THR . 5.2 t -109.64 -6.58 11.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 37.9 mt-10 89.69 -73.52 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.688 ' OG1' ' HB ' ' A' ' 149' ' ' VAL . 44.4 m 53.79 21.9 2.95 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 163.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.4 50.65 58.3 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.56 -175.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.7 p -64.11 125.45 24.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.207 0.527 . . . . 0.0 111.731 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -93.73 153.94 41.04 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.81 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.556 ' HG2' ' HA ' ' A' ' 158' ' ' ASP . 6.2 Cg_exo -64.65 -163.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.205 1.937 . . . . 0.0 111.975 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -32.23 50.51 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -175.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.45 37.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.556 ' HA ' ' HG2' ' A' ' 155' ' ' PRO . 34.8 t0 59.0 72.49 0.53 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.862 -167.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.418 ' H ' ' HG2' ' A' ' 155' ' ' PRO . 12.2 t70 -168.95 -143.11 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -172.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.351 172.448 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 37.2 ttpt . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -137.07 144.38 43.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 4.4 pt20 -147.11 132.17 18.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 110.665 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 59' ' ' ALA . 30.1 pt -116.13 136.34 53.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.15 0.5 . . . . 0.0 110.985 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -105.2 132.17 51.75 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 11.1 mp -99.37 157.08 16.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.173 0.511 . . . . 0.0 111.527 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 26.4 tt0 -74.22 124.32 26.16 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.224 175.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.85 -42.64 3.12 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.244 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 15.7 t -82.13 123.83 79.22 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.0 Cg_exo -79.46 -11.6 14.3 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.983 2.455 . . . . 0.0 112.628 -176.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -97.98 131.97 25.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.981 0.419 . . . . 0.0 110.881 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 59.7 Cg_endo -93.37 137.45 1.33 Allowed 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 123.184 2.589 . . . . 0.0 112.355 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 8.1 tt -88.06 119.68 28.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -129.68 135.63 48.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.138 0.494 . . . . 0.0 111.42 -177.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.518 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 44.2 m-85 -142.04 153.2 44.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.038 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 t -64.51 -49.32 71.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.082 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 24.3 mt-30 -67.79 119.27 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.778 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.963 HG23 ' HB1' ' A' ' 81' ' ' ALA . 60.1 t -71.98 -50.23 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.661 ' HB3' ' HG3' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -53.99 -30.01 45.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.156 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.456 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 33.8 t70 -76.05 -50.08 15.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.7 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -68.77 -39.25 80.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.585 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.615 HD12 ' HE2' ' A' ' 99' ' ' TYR . 11.1 pt -68.11 -31.47 51.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.795 0.331 . . . . 0.0 110.283 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.1 91.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.32 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -57.6 -41.9 82.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.747 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -61.16 -17.44 52.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.096 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 45.5 mtm180 -102.79 7.39 39.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.414 -175.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.86 -82.47 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.081 -1.057 . . . . 0.0 112.77 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -50.49 -56.83 2.71 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.361 2.708 . . . . 0.0 113.56 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 52.22 -102.97 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.045 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.464 HE21 ' HB2' ' A' ' 47' ' ' LEU . 74.3 mt-30 -152.6 -86.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 tt -142.93 4.58 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 122.028 0.918 . . . . 0.0 109.346 174.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.442 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -138.29 161.65 58.03 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.143 -173.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.456 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 72.0 Cg_endo -76.77 157.4 35.36 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.273 1.982 . . . . 0.0 111.714 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.1 pt -74.05 151.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.095 0.474 . . . . 0.0 111.357 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.44 -48.1 3.04 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.07 143.96 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.415 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.551 HD11 HG22 ' A' ' 56' ' ' ILE . 3.3 tt -123.48 131.98 72.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.055 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -111.65 132.06 54.85 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.597 HG23 HG13 ' A' ' 92' ' ' ILE . 17.1 m -126.25 140.89 47.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 121.499 0.666 . . . . 0.0 110.63 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -95.56 110.46 22.54 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -67.54 79.87 0.17 Allowed 'General case' 0 C--O 1.222 -0.374 0 O-C-N 124.367 1.042 . . . . 0.0 108.737 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.901 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 23.7 ptm 178.76 179.53 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.255 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.429 ' HA3' ' HB2' ' A' ' 81' ' ' ALA . . . 140.34 -33.59 2.06 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.416 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 80' ' ' GLY . . . 48.11 78.86 0.07 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.822 0.449 . . . . 0.0 111.26 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 73.78 -28.89 0.19 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.36 0.664 . . . . 0.0 111.819 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 78' ' ' ALA . . . -78.17 -5.54 87.31 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.884 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.963 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -113.22 -74.43 0.63 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.281 0.562 . . . . 0.0 110.274 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 p -104.26 152.56 22.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 169.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -76.1 -25.29 55.3 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.261 0.553 . . . . 0.0 110.188 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.05 -13.95 51.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 38.8 mt-30 72.16 139.29 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 113.826 -1.533 . . . . 0.0 112.337 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 85' ' ' GLN . 28.9 Cg_endo -86.78 -83.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.196 2.597 . . . . 0.0 113.007 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.31 -137.21 4.57 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.385 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.99 136.84 38.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.58 0.352 . . . . 0.0 111.459 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.901 ' HA2' ' HB3' ' A' ' 76' ' ' MET . . . -66.39 87.52 0.12 Allowed Glycine 0 C--N 1.333 0.408 0 O-C-N 124.091 0.869 . . . . 0.0 115.205 -168.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -100.59 146.76 26.74 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -99.6 130.51 45.84 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.472 -0.768 . . . . 0.0 109.891 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.597 HG13 HG23 ' A' ' 73' ' ' VAL . 2.5 pt -145.28 158.27 13.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.187 0.518 . . . . 0.0 112.316 -177.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.03 117.66 25.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 170.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -65.77 -39.63 91.21 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -169.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.723 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -68.69 -24.36 64.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.724 0.773 . . . . 0.0 109.393 -177.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.407 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 44.2 mmtm -100.83 26.36 6.97 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.522 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.46 176.48 7.43 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.363 -0.21 . . . . 0.0 110.474 -173.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -94.54 135.79 35.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.414 0.626 . . . . 0.0 110.418 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.615 ' HE2' HD12 ' A' ' 56' ' ' ILE . 8.1 m-85 -120.55 136.23 54.85 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.228 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -113.22 128.55 69.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.381 0.61 . . . . 0.0 110.112 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.0 t -101.68 109.24 25.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.404 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -80.68 126.21 7.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.643 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.3 m -92.54 -30.98 15.38 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -80.5 -47.02 14.89 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -163.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -129.12 12.59 6.12 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.022 -0.424 . . . . 0.0 111.281 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.648 ' HD3' ' HB3' ' A' ' 113' ' ' GLU . 1.4 tpm_? -89.5 -91.68 0.13 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.95 -169.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -170.93 40.25 0.19 Allowed Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.502 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -65.37 -29.88 76.31 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.908 -1.139 . . . . 0.0 111.174 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 88.4 mmm -109.12 20.87 17.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.395 -0.402 . . . . 0.0 110.692 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -160.32 -124.22 0.72 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.401 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.98 100.98 18.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 110.844 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.4 146.41 50.24 Favored 'Trans proline' 0 C--N 1.331 -0.382 0 C-N-CA 123.61 2.874 . . . . 0.0 113.407 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.661 ' HG3' ' HB3' ' A' ' 53' ' ' ARG . 27.5 tt0 -114.88 127.48 55.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.75 172.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.52 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.91 129.99 40.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.538 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 48.8 t -102.16 105.29 41.81 Favored Pre-proline 0 C--N 1.321 -0.671 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.312 174.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -89.35 110.98 0.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.821 3.014 . . . . 0.0 111.218 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.73 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.6 t80 -119.62 149.03 42.62 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.517 ' HB2' HD13 ' A' ' 92' ' ' ILE . 44.1 t -71.6 -32.77 68.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.925 0.393 . . . . 0.0 111.06 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.73 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 66.9 m -99.24 124.16 44.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.848 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.91 -45.41 82.06 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -65.58 -28.7 69.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.349 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -68.8 -42.08 77.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.465 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.09 79.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.305 0.574 . . . . 0.0 110.1 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.65 -32.31 69.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.744 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -65.19 -32.38 74.03 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.077 0.465 . . . . 0.0 110.703 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.467 ' HD2' HG21 ' A' ' 100' ' ' VAL . 79.6 t80 -61.71 -39.61 92.09 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.714 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 42.1 t -73.14 -28.82 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.658 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 6.7 tp -56.32 -43.99 79.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.957 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.64 -50.75 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.255 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.911 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.5 pt-20 -152.7 -76.16 0.13 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.486 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.911 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.48 -130.87 11.69 Favored Glycine 0 C--N 1.334 0.424 0 O-C-N 123.543 0.527 . . . . 0.0 112.974 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.65 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -179.84 -89.64 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.36 139.47 50.66 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 177.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.73 119.66 51.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.757 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -147.04 165.65 29.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.111 -177.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.05 162.73 15.2 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.791 ' HA ' HG12 ' A' ' 140' ' ' ILE . 1.1 tt -62.59 -32.64 73.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.133 0.492 . . . . 0.0 109.675 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.8 -11.65 58.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.252 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -125.53 21.5 7.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.791 HG12 ' HA ' ' A' ' 137' ' ' LEU . 30.4 mm -71.63 118.18 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -119.28 147.68 44.01 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.238 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.557 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 13.4 p-10 -69.37 -26.92 64.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.72 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.83 -28.74 69.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.772 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.4 mmt -83.9 -26.2 29.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.412 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.3 -22.8 5.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.357 -172.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.4 pp -143.61 142.81 31.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.581 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 32.4 p -113.12 122.8 34.86 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.093 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 22.4 Cg_endo -64.81 -75.75 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.314 2.009 . . . . 0.0 111.51 174.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.37 11.23 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 152' ' ' GLY . 37.6 mt-10 67.51 -79.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.326 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 152' ' ' GLY . 12.4 t 43.76 -62.57 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.931 1.692 . . . . 0.0 113.928 -171.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 150' ' ' GLU . . . 150.28 55.25 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.3 t -89.95 148.68 22.97 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 157' ' ' ALA . 20.4 mm-40 -71.06 136.01 84.9 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.213 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 157' ' ' ALA . 98.3 Cg_endo -78.36 -118.29 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.819 2.346 . . . . 0.0 112.239 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.435 ' H ' ' HB2' ' A' ' 155' ' ' PRO . 0.0 OUTLIER -60.46 -27.19 67.34 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.052 0.453 . . . . 0.0 109.784 177.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.513 ' O ' ' HD2' ' A' ' 155' ' ' PRO . . . -179.84 -118.26 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.808 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -123.55 14.87 9.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.543 1.163 . . . . 0.0 108.564 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.29 30.89 1.82 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.251 -167.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.203 -177.806 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 50' ' ' SER . 37.2 ttmt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -144.55 144.29 31.24 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 112.024 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -149.17 135.28 19.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.101 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 59' ' ' ALA . 33.7 pt -115.93 138.84 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.024 0.44 . . . . 0.0 111.103 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -107.57 121.15 44.07 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.581 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.5 mp -87.58 147.86 25.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.006 0.432 . . . . 0.0 110.912 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.534 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 27.6 tt0 -74.06 124.3 26.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.659 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.03 -38.4 3.2 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.884 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 28.0 t -82.1 125.06 78.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.2 Cg_exo -80.44 1.77 9.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.998 2.465 . . . . 0.0 112.786 -176.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -107.28 132.86 20.63 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 9.4 Cg_endo -92.66 115.76 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.611 2.874 . . . . 0.0 111.702 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.61 108.33 7.3 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -113.23 137.97 50.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.19 0.519 . . . . 0.0 111.318 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.577 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 36.6 m-85 -139.58 143.95 37.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.223 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 33.9 m -56.37 -54.43 45.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.561 ' HG2' ' HA ' ' A' ' 83' ' ' TRP . 48.4 mt-30 -63.62 125.58 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.148 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.5 t -65.28 -50.62 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.613 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -58.1 -28.27 64.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.376 -178.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.613 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 11.5 t70 -75.95 -51.6 12.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 110.184 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -64.93 -39.93 94.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.336 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 71' ' ' ILE . 28.7 pt -69.31 -31.88 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.951 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.05 82.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 0.0 110.791 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -62.3 -32.04 72.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.481 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.608 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -70.75 -18.27 62.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 23.9 mtm180 -94.41 3.73 54.78 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.43 -60.49 0.23 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 119.412 -1.375 . . . . 0.0 114.414 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -40.47 -44.25 4.3 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.799 2.999 . . . . 0.0 114.781 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -82.26 99.7 9.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.148 0.499 . . . . 0.0 111.364 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -106.45 111.06 23.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -176.68 -42.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.079 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.581 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -151.78 151.25 28.01 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.534 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.5 Cg_endo -72.22 158.12 52.48 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.056 1.837 . . . . 0.0 111.741 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.0 pt -81.54 117.59 27.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.067 0.461 . . . . 0.0 110.434 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 tt -77.82 -48.05 17.44 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.19 138.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.218 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' A' ' 95' ' ' ASP . 3.6 tt -107.99 129.76 61.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.947 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.533 ' HA ' ' O ' ' A' ' 92' ' ' ILE . 79.6 m-85 -111.71 127.25 55.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 94' ' ' ALA . 27.7 m -123.03 151.7 27.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.045 0.45 . . . . 0.0 110.061 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.535 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 15.6 m120 -86.03 97.03 10.05 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 90' ' ' ASN . 10.3 t70 -45.08 106.6 0.08 Allowed 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 125.581 1.801 . . . . 0.0 110.449 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -179.71 87.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 O-C-N 125.46 1.725 . . . . 0.0 109.16 178.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA3' HG13 ' A' ' 115' ' ' VAL . . . -126.93 28.94 4.51 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.541 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.53 ' H ' ' HG3' ' A' ' 86' ' ' PRO . . . -79.55 43.76 0.58 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.427 0.632 . . . . 0.0 110.509 -174.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -175.05 9.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.194 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.68 7.32 55.71 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.038 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 55.3 53.1 10.43 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 110.047 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.609 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 26.4 p -83.67 177.55 8.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.625 -169.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.561 ' HA ' ' HG2' ' A' ' 51' ' ' GLN . 35.5 p90 -66.39 -25.05 66.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.189 0.519 . . . . 0.0 110.149 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -82.91 -35.14 26.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.702 176.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 82' ' ' THR . 0.9 OUTLIER 66.75 165.24 0.12 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.49 175.054 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.53 ' HG3' ' H ' ' A' ' 78' ' ' ALA . 87.6 Cg_endo -90.31 5.66 4.3 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.054 1.836 . . . . 0.0 111.997 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.94 -179.68 16.05 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.038 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.96 146.12 51.36 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.64 -172.81 13.17 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.205 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 36.8 m-80 -95.18 151.6 19.08 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -97.51 129.75 44.65 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.076 -1.015 . . . . 0.0 111.121 -170.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.71 HD13 ' HB2' ' A' ' 118' ' ' SER . 24.9 pt -144.0 166.2 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.594 -173.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.09 106.3 14.78 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.583 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -69.84 -32.5 70.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.923 -173.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.735 ' HA ' HD13 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -71.45 -23.87 61.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.72 0.771 . . . . 0.0 109.889 -177.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -99.45 29.6 3.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.07 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.21 -176.37 4.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -95.72 138.05 33.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.546 0.689 . . . . 0.0 110.621 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CE1' HD12 ' A' ' 137' ' ' LEU . 2.3 m-85 -120.53 136.62 54.72 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.028 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.797 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -114.46 123.14 69.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.438 0.637 . . . . 0.0 110.41 173.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.8 t -101.56 127.6 54.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.439 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -86.71 121.37 5.75 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.116 -173.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.4 m -92.48 -37.15 12.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.688 0.28 . . . . 0.0 110.79 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.14 -44.71 16.11 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.042 0.449 . . . . 0.0 110.9 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 50.8 mtp180 -134.62 121.6 21.11 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.562 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 165.55 -175.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.548 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -79.23 42.3 2.35 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.066 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.78 -24.69 70.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.6 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.8 ttp -103.57 -3.49 25.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.853 0.359 . . . . 0.0 110.474 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -153.91 -110.14 0.39 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.972 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.548 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.47 99.32 14.84 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.676 0.274 . . . . 0.0 111.208 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.519 ' HA ' ' H ' ' A' ' 107' ' ' GLY . 49.6 Cg_endo -67.68 147.01 75.04 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.64 2.893 . . . . 0.0 113.659 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.562 ' CD ' ' HE ' ' A' ' 106' ' ' ARG . 1.6 mp0 -114.68 142.34 46.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -107.68 130.8 54.89 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.613 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.797 ' HB ' HG13 ' A' ' 100' ' ' VAL . 96.5 t -100.97 105.55 39.17 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 120.969 0.414 . . . . 0.0 110.38 175.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.3 Cg_exo -87.91 127.52 2.23 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.645 2.897 . . . . 0.0 112.387 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -134.07 148.82 51.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.487 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.71 ' HB2' HD13 ' A' ' 92' ' ' ILE . 33.0 t -80.48 -16.73 53.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.139 0.495 . . . . 0.0 109.947 174.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.8 m -108.58 131.9 54.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.523 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -68.15 -48.67 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.073 0.463 . . . . 0.0 110.921 179.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -63.64 -28.5 69.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.888 -173.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.59 -40.2 76.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.385 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.37 -35.78 71.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 110.121 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.96 88.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.785 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -63.28 -30.07 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.001 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -66.06 -40.45 90.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.741 HG22 ' H ' ' A' ' 132' ' ' GLY . 59.5 t -72.25 -29.11 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.415 0.626 . . . . 0.0 110.395 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 7.7 tp -58.04 -43.7 86.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.122 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.83 -50.97 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.666 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.688 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.8 pt-20 -141.6 -92.91 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.468 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.688 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 47.98 -145.41 5.58 Favored Glycine 0 C--N 1.333 0.398 0 O-C-N 123.517 0.511 . . . . 0.0 113.984 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.741 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -172.62 -81.49 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.06 139.27 51.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.847 0.356 . . . . 0.0 110.793 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.13 115.21 43.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.215 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.779 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -140.04 159.82 41.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.786 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.66 157.48 24.64 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 95' ' ' ASP . 6.3 tt -60.95 -34.95 75.53 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.35 -13.8 59.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.759 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -127.66 29.64 5.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.126 0.488 . . . . 0.0 110.635 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.779 HD13 HD13 ' A' ' 135' ' ' LEU . 36.1 mm -71.58 121.42 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.5 t -108.95 147.87 31.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.154 177.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.6 p-10 -69.27 -32.84 72.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.67 -29.77 66.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.019 -175.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.544 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 6.2 mmt -87.19 -33.86 19.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.457 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 141' ' ' THR . 3.9 t -78.99 -23.51 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.359 0.599 . . . . 0.0 109.915 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 1.8 pp -150.18 106.76 3.51 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.77 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.426 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 23.7 p -80.06 120.1 78.68 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.555 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 9.8 Cg_endo -55.76 -72.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.768 2.312 . . . . 0.0 111.671 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.7 t -129.27 10.25 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.467 ' O ' HG22 ' A' ' 151' ' ' THR . 42.4 mt-10 67.47 -77.92 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.326 -173.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 150' ' ' GLU . 5.8 t 53.07 -41.4 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.899 1.679 . . . . 0.0 114.936 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.37 15.6 4.09 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.3 p -70.55 142.37 51.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.598 0.237 . . . . 0.0 111.264 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.602 ' HG2' ' HB2' ' A' ' 158' ' ' ASP . 2.8 mp0 -56.61 126.07 69.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.274 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.436 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 27.1 Cg_endo -62.85 -86.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.334 2.689 . . . . 0.0 113.601 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -28.36 15.92 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.029 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 177.2 19.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.344 0.402 . . . . 0.0 111.385 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.602 ' HB2' ' HG2' ' A' ' 154' ' ' GLU . 32.2 t70 53.42 84.9 0.05 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.398 0.618 . . . . 0.0 109.571 -171.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -163.91 -43.31 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.582 -165.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.815 179.735 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 69.6 tttt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -143.78 143.77 31.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.027 -175.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 3.4 pt20 -149.31 129.64 13.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.586 174.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.469 HG22 ' CG1' ' A' ' 71' ' ' ILE . 29.9 pt -116.11 135.29 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -103.24 121.45 42.73 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.4 mp -86.1 141.28 29.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.088 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.653 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 32.7 tt0 -74.0 124.35 26.05 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.599 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.18 -14.21 64.24 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.269 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.44 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 34.7 t -105.86 125.47 33.13 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.6 Cg_exo -78.0 5.99 4.95 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.944 2.429 . . . . 0.0 112.733 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -129.69 132.74 24.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.321 . . . . 0.0 111.182 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 7.6 Cg_endo -89.92 165.45 4.88 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.593 2.862 . . . . 0.0 112.133 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 7.1 tt -107.68 118.71 37.46 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -101.91 134.69 44.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.24 146.83 27.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.155 0.502 . . . . 0.0 110.85 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -69.27 -36.36 77.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.298 0.57 . . . . 0.0 110.63 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.92 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 51.8 mt-30 -84.94 122.7 29.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.834 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.774 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 2.6 t -67.6 -51.7 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.577 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -52.62 -41.17 63.48 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.179 -178.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.577 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 29.8 t0 -76.34 -43.05 42.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.754 0.311 . . . . 0.0 111.105 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.2 -37.66 75.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.704 0.288 . . . . 0.0 111.443 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.763 HD12 ' HB3' ' A' ' 114' ' ' ALA . 24.4 pt -68.19 -31.29 51.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.419 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -64.37 -42.44 96.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.295 174.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -57.17 -37.75 72.57 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.155 0.502 . . . . 0.0 110.438 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.568 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -64.63 -18.89 65.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.111 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -94.66 -6.69 42.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -179.48 -58.98 0.08 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.998 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 26.4 Cg_exo -65.56 46.3 0.18 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.527 2.818 . . . . 0.0 114.555 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -96.26 165.7 12.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.731 ' HG3' HG22 ' A' ' 65' ' ' ILE . 10.4 pt20 -92.86 -18.85 22.32 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -169.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.731 HG22 ' HG3' ' A' ' 64' ' ' GLN . 6.5 tt 179.32 -39.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.382 . . . . 0.0 111.976 -174.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.545 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -104.99 146.76 33.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.58 -171.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.653 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 55.9 Cg_endo -71.8 163.77 37.81 Favored 'Trans proline' 0 C--O 1.224 -0.183 0 C-N-CA 123.159 2.573 . . . . 0.0 111.73 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.568 HD13 ' HB1' ' A' ' 59' ' ' ALA . 27.6 pt -79.3 127.19 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.149 0.499 . . . . 0.0 110.737 177.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 tt -91.78 -48.13 6.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -159.17 138.75 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.84 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.469 ' CG1' HG22 ' A' ' 38' ' ' ILE . 3.0 tt -117.07 131.53 69.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.215 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -111.85 128.34 56.1 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 94' ' ' ALA . 29.6 m -127.83 139.49 51.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 120.834 0.35 . . . . 0.0 110.096 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 2.2 m-20 -84.64 107.04 16.64 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -69.6 142.35 53.55 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 124.371 1.045 . . . . 0.0 109.494 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.783 ' O ' ' HG2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER 168.28 -29.13 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 124.511 1.132 . . . . 0.0 109.039 -170.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.601 ' HA3' ' HB2' ' A' ' 81' ' ' ALA . . . -69.47 68.49 0.54 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.622 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.97 106.78 2.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.445 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.22 26.49 15.94 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.539 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.9 -72.38 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.73 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.601 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . . . 57.19 52.35 9.05 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.309 0.576 . . . . 0.0 110.338 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.46 175.75 9.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.178 -173.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.92 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 31.7 p90 -68.8 -20.68 64.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.369 0.604 . . . . 0.0 110.162 175.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.85 -31.8 31.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.838 173.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 62.36 171.38 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.353 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.783 ' HG2' ' O ' ' A' ' 76' ' ' MET . 5.7 Cg_exo -83.88 -5.06 10.62 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.929 1.753 . . . . 0.0 110.372 166.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.09 174.06 13.22 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -174.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -77.14 146.07 37.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.607 0.704 . . . . 0.0 109.468 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.433 ' HA3' ' HG2' ' A' ' 76' ' ' MET . . . -136.91 -140.18 4.05 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.655 -175.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 19.2 m120 -100.31 145.44 28.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 74' ' ' ASN . 37.3 p90 -98.52 130.94 45.1 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.549 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.694 HD13 ' HB2' ' A' ' 118' ' ' SER . 1.8 pt -133.6 151.92 34.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.656 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.85 102.67 4.13 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.559 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . . . -61.02 -31.59 71.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.153 0.501 . . . . 0.0 110.935 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 1.0 OUTLIER -58.03 -31.05 66.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.165 176.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -111.39 27.7 9.43 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.868 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -122.52 178.59 4.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.529 0.204 . . . . 0.0 110.775 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -92.74 131.61 37.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.251 0.548 . . . . 0.0 110.779 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -120.49 136.12 54.86 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.338 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.463 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 4.2 p -113.71 129.48 69.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-O 121.866 0.841 . . . . 0.0 110.571 172.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.551 ' HA ' HH11 ' A' ' 106' ' ' ARG . 38.1 t -104.01 111.84 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.282 172.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.695 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -74.67 124.07 7.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.314 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 p -86.71 -31.23 21.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.957 0.408 . . . . 0.0 110.564 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -78.41 -35.04 47.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.714 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.62 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 60.2 mtp180 -121.13 -140.84 0.33 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.369 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.551 HH11 ' HA ' ' A' ' 101' ' ' VAL . 22.4 ttt180 72.25 176.57 0.27 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.478 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -71.94 -48.96 24.52 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.096 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.08 -96.89 0.33 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.339 -0.934 . . . . 0.0 110.832 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.0 mtt -99.48 -3.8 32.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.281 0.562 . . . . 0.0 109.735 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.78 -123.37 2.72 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.717 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.478 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.19 94.66 5.84 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 117.077 0.439 . . . . 0.0 110.663 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.92 113.18 3.15 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.74 2.293 . . . . 0.0 113.125 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -114.65 130.53 56.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.836 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.763 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -100.16 132.8 45.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.456 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.463 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 14.3 t -99.38 105.87 35.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.674 176.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -90.73 131.45 1.58 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 124.2 3.267 . . . . 0.0 112.329 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -128.82 153.27 47.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.694 ' HB2' HD13 ' A' ' 92' ' ' ILE . 38.4 t -85.08 -27.76 26.08 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 170.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.4 m -96.02 115.99 28.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.142 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -57.8 -45.75 85.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.315 0.578 . . . . 0.0 111.139 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -63.38 -28.54 70.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.368 -172.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -64.48 -42.45 95.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.075 0.464 . . . . 0.0 110.296 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -68.45 -37.34 80.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.283 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.3 98.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.709 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.42 83.6 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.12 0.486 . . . . 0.0 110.447 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -61.88 -40.7 96.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.762 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.631 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 78.6 t -66.19 -40.17 86.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.017 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 66.4 mt -56.86 -34.62 68.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.599 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.04 -41.86 13.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.231 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.62 ' OE1' ' HD3' ' A' ' 105' ' ' ARG . 7.6 pt-20 -161.12 -35.18 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -172.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.695 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -53.61 163.88 2.59 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.232 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -111.41 -66.26 0.52 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.705 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.424 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.13 141.56 50.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.829 0.347 . . . . 0.0 110.675 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.3 t -103.34 113.75 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.188 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.704 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -138.65 164.87 28.39 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.987 -176.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.27 170.07 13.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.541 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 3.6 tt -66.36 -30.52 70.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.304 0.573 . . . . 0.0 109.629 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.22 -12.1 60.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.587 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -109.43 12.82 24.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.704 HD13 HD13 ' A' ' 135' ' ' LEU . 41.8 mm -71.88 119.12 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.082 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.3 t -119.37 147.12 44.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.849 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.426 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.1 p-10 -69.41 -25.49 64.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.053 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.27 -28.8 69.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.669 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.637 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 3.9 mmt -87.1 -28.96 22.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.037 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 141' ' ' THR . 8.6 t -79.16 -23.56 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.263 0.554 . . . . 0.0 110.476 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.2 pp -155.9 139.75 16.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.77 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.1 p -95.97 120.58 62.73 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.832 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.36 -78.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.175 1.917 . . . . 0.0 111.285 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.62 6.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 65.91 -74.94 0.05 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.308 -167.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.0 t 43.32 31.06 0.35 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.626 1.17 . . . . 0.0 114.062 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 71.97 23.59 77.78 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.012 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.3 t -96.38 124.51 40.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.018 0.437 . . . . 0.0 109.824 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -80.0 149.62 70.43 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.333 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.428 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 10.8 Cg_endo -55.82 -33.53 88.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.164 2.576 . . . . 0.0 112.445 -176.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.543 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 3.3 ptp85 -155.35 -69.25 0.12 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.318 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.543 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -145.93 69.65 1.22 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.23 31.66 0.39 Allowed 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.31 1.006 . . . . 0.0 111.81 -175.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 155' ' ' PRO . 11.9 t70 -130.49 -166.02 1.63 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.731 179.35 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 40.1 ttmt . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -126.54 144.35 50.9 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.448 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . 11.7 pt20 -148.84 136.76 20.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.963 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 59' ' ' ALA . 30.3 pt -115.9 134.82 57.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.103 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -98.83 116.9 32.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' A' ' 66' ' ' ALA . 3.0 mp -92.26 142.34 27.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.964 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.796 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 34.7 tt0 -74.0 132.43 42.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.23 -36.46 3.19 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.5 -175.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.517 ' HB2' ' CB ' ' A' ' 40' ' ' LEU . 68.8 m -82.14 124.5 78.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.014 0.435 . . . . 0.0 110.332 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 2.5 Cg_endo -82.86 -3.47 11.16 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.134 2.556 . . . . 0.0 112.884 -176.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -125.39 133.98 25.37 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.719 -177.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 5.9 Cg_exo -79.1 141.88 16.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.999 2.466 . . . . 0.0 111.847 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.516 ' HB3' HG12 ' A' ' 38' ' ' ILE . 6.3 tt -91.48 107.23 19.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.472 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . 38.4 p90 -116.81 137.68 52.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.173 0.511 . . . . 0.0 111.14 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -138.58 143.15 39.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.516 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 5.3 p -55.69 -40.7 72.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.224 0.535 . . . . 0.0 110.982 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.523 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 68.4 mt-30 -82.1 114.85 20.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.396 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.686 HG23 HE22 ' A' ' 85' ' ' GLN . 45.4 t -58.53 -47.89 87.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.298 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -58.68 -28.43 65.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.626 -178.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.459 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 22.5 t70 -75.99 -51.12 13.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.022 0.439 . . . . 0.0 110.257 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.71 95.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.344 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.705 HG22 HD11 ' A' ' 71' ' ' ILE . 28.4 pt -69.08 -31.92 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.316 . . . . 0.0 110.546 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.95 82.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.707 0.289 . . . . 0.0 110.339 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 62' ' ' PRO . 10.1 m-85 -62.12 -35.63 79.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.244 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -63.19 -18.1 63.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.707 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -81.71 -3.26 53.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.72 -42.64 0.96 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 119.63 -1.272 . . . . 0.0 114.68 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' A' ' 58' ' ' TYR . 93.2 Cg_exo -49.32 -16.68 1.21 Allowed 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 123.515 2.81 . . . . 0.0 115.367 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -68.38 -30.84 69.87 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.522 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 41.9 35.41 0.53 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.826 1.25 . . . . 0.0 114.059 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 tt -132.51 -47.55 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.594 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.2 151.84 28.37 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.623 0.249 . . . . 0.0 110.917 -175.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.796 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 74.5 Cg_endo -70.35 148.88 62.2 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.366 2.044 . . . . 0.0 111.805 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 68' ' ' ILE . 27.5 pt -84.4 105.33 13.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.394 0.616 . . . . 0.0 110.335 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.8 tt -67.27 -47.36 70.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -161.16 138.38 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.119 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 56' ' ' ILE . 2.8 tt -108.34 131.13 59.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.76 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -112.03 128.21 56.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.228 0.537 . . . . 0.0 110.007 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 94' ' ' ALA . 30.7 m -126.21 136.64 60.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.069 0.461 . . . . 0.0 109.839 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 91' ' ' TRP . 0.2 OUTLIER -83.72 101.04 11.28 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.441 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 61.1 t0 -55.92 103.73 0.11 Allowed 'General case' 0 C--O 1.236 0.386 0 O-C-N 124.774 1.296 . . . . 0.0 110.058 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.829 ' O ' ' HG2' ' A' ' 86' ' ' PRO . 52.6 mtt -127.64 -26.21 3.02 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.07 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.735 ' HA3' ' HB2' ' A' ' 81' ' ' ALA . . . -70.66 58.07 0.94 Allowed Glycine 0 C--O 1.226 -0.348 0 O-C-N 123.951 0.782 . . . . 0.0 115.015 -165.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.38 33.9 0.69 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.381 0.61 . . . . 0.0 109.846 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -171.53 8.54 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.548 -171.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.43 ' HA2' ' HZ ' ' A' ' 126' ' ' PHE . . . 127.02 -26.13 5.1 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.568 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.735 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . . . 67.68 70.06 0.35 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.399 0.619 . . . . 0.0 110.315 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.2 p -83.97 175.06 9.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.359 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.523 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 21.1 p-90 -70.2 -20.86 63.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.213 0.53 . . . . 0.0 110.321 174.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -83.08 -35.88 25.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.005 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.686 HE22 HG23 ' A' ' 52' ' ' VAL . 0.6 OUTLIER 68.1 140.74 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.144 173.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.829 ' HG2' ' O ' ' A' ' 76' ' ' MET . 52.1 Cg_exo -57.46 -48.38 17.62 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.925 2.416 . . . . 0.0 113.032 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.99 -141.65 8.32 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.682 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -67.1 139.67 57.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.973 0.415 . . . . 0.0 111.521 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -150.99 -165.05 12.47 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -100.15 138.45 37.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 117.08 0.44 . . . . 0.0 110.116 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 74' ' ' ASN . 15.4 p-90 -98.61 131.08 45.09 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.416 -177.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.48 HD13 ' CA ' ' A' ' 118' ' ' SER . 3.7 pt -141.88 163.19 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.247 -170.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.39 107.31 10.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.384 171.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -62.61 -35.28 79.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.004 0.43 . . . . 0.0 111.229 -176.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.706 ' HA ' HD13 ' A' ' 137' ' ' LEU . 8.9 t70 -59.78 -26.82 66.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.88 0.848 . . . . 0.0 110.27 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -116.4 36.06 4.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.646 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.27 178.96 6.5 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.796 0.331 . . . . 0.0 110.55 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -97.51 138.11 35.44 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.426 0.631 . . . . 0.0 109.924 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.413 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 5.6 m-85 -120.09 135.65 54.87 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.029 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.946 HG13 HG13 ' A' ' 115' ' ' VAL . 2.2 p -115.3 120.6 65.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.717 0.77 . . . . 0.0 109.473 170.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 64.4 t -101.74 115.94 44.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.57 -1.196 . . . . 0.0 108.58 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.48 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -77.61 120.87 5.64 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.263 -176.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 m -92.5 -29.16 16.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.926 0.394 . . . . 0.0 110.382 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.98 -43.97 17.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.133 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 46.6 mtp180 -130.93 121.19 24.72 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.577 HH22 ' HZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER 172.84 175.21 0.1 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.804 0.69 . . . . 0.0 109.863 177.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.88 -78.47 0.09 OUTLIER Glycine 0 C--N 1.337 0.587 0 O-C-N 123.363 0.414 . . . . 0.0 113.402 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.37 -76.9 0.76 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.329 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -83.63 -3.67 57.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.155 0.503 . . . . 0.0 110.749 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -130.55 -124.0 2.56 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.426 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.42 96.99 9.36 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 28.3 Cg_endo -64.5 147.64 90.45 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.765 2.31 . . . . 0.0 112.695 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.493 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 1.6 mp0 -115.0 121.83 44.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.709 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . . . -94.08 131.51 39.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 175.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.946 HG13 HG13 ' A' ' 100' ' ' VAL . 1.4 p -108.8 106.77 59.35 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.783 0.802 . . . . 0.0 110.352 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HB2' HG21 ' A' ' 73' ' ' VAL . 7.6 Cg_exo -81.86 119.99 3.35 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 124.414 3.409 . . . . 0.0 112.65 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -108.05 153.39 23.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.956 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.48 ' CA ' HD13 ' A' ' 92' ' ' ILE . 48.1 t -81.01 -43.06 20.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.184 174.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.401 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 19.6 m -100.65 131.09 46.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.292 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.577 ' HD2' ' N ' ' A' ' 121' ' ' ASP . 0.0 OUTLIER -65.32 -33.71 76.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.347 -177.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.577 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 10.8 p-10 -68.17 -28.51 67.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.196 0.522 . . . . 0.0 110.072 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -69.41 -39.28 78.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.788 173.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.6 82.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.49 94.28 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.687 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.07 73.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.031 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.577 ' HZ ' HH22 ' A' ' 106' ' ' ARG . 44.6 t80 -66.02 -40.34 90.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.07 177.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.709 HG22 ' H ' ' A' ' 132' ' ' GLY . 65.0 t -73.05 -29.07 27.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.452 0.644 . . . . 0.0 110.255 176.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.36 -36.23 81.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.929 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.19 -50.6 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.627 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.742 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 1.9 pt-20 -146.64 -88.92 0.09 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.298 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.742 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 49.85 -142.9 11.81 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 123.412 0.445 . . . . 0.0 113.794 174.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.709 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -175.62 -82.86 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -130.0 139.44 51.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 176.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.8 t -101.1 113.95 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.955 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.629 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -139.85 165.7 26.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.068 -176.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -88.68 168.2 12.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.706 HD13 ' HA ' ' A' ' 95' ' ' ASP . 3.6 tt -63.4 -32.46 73.9 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.83 -16.07 63.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.028 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -111.88 12.39 20.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.488 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.629 HD13 HD13 ' A' ' 135' ' ' LEU . 16.4 mm -71.87 119.71 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 145' ' ' VAL . 5.2 t -119.29 145.5 46.07 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.958 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.405 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 14.9 p-10 -69.57 -27.52 65.2 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.082 0.239 . . . . 0.0 110.406 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.64 -28.98 68.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.885 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.736 ' HG2' ' HB3' ' A' ' 155' ' ' PRO . 3.9 mmt -84.72 -33.97 23.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.728 0.299 . . . . 0.0 111.425 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 141' ' ' THR . 3.5 t -79.81 -23.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.341 0.591 . . . . 0.0 110.275 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.8 pp -159.88 143.3 14.15 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.773 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' A' ' 150' ' ' GLU . 16.7 p -106.51 120.42 48.55 Favored Pre-proline 0 C--N 1.318 -0.774 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.887 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 14.7 Cg_endo -58.9 -53.17 4.02 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.676 2.251 . . . . 0.0 111.83 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 1.4 t -135.62 20.28 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.597 ' HA ' ' HB ' ' A' ' 147' ' ' THR . 5.2 mm-40 64.81 -83.6 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.3 -168.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 t 44.83 7.45 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 57.38 46.36 91.93 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.297 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 25.4 m -71.08 144.75 50.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.776 0.288 . . . . 0.0 110.563 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 158' ' ' ASP . 45.2 mt-10 -75.8 122.88 87.91 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.736 ' HB3' ' HG2' ' A' ' 144' ' ' MET . 6.8 Cg_endo -48.53 -85.4 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 124.228 3.286 . . . . 0.0 114.299 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.93 -22.3 12.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.216 0.532 . . . . 0.0 109.904 175.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -175.9 21.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.241 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 29.8 t0 53.81 71.88 0.48 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.307 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.65 -39.83 1.97 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.323 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 1.7 pm0 . . . . . 0 C--O 1.25 1.079 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.503 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.716 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -132.45 144.12 50.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.68 0.276 . . . . 0.0 110.645 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 20.3 pt20 -149.16 131.63 15.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.092 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.751 HG22 ' HB ' ' A' ' 71' ' ' ILE . 29.8 pt -115.78 133.23 62.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.148 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -103.99 123.9 48.04 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.568 ' CB ' ' HB2' ' A' ' 43' ' ' SER . 6.4 mp -90.35 148.52 22.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.33 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.633 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 35.7 tt0 -74.16 124.06 25.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.31 -28.8 4.57 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.066 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.568 ' HB2' ' CB ' ' A' ' 40' ' ' LEU . 59.7 m -81.72 124.51 79.57 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.923 0.392 . . . . 0.0 110.347 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 4.2 Cg_exo -78.12 -13.34 15.6 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.373 2.715 . . . . 0.0 113.298 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.63 133.62 24.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.369 . . . . 0.0 111.266 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.435 ' HG2' ' CE2' ' A' ' 48' ' ' PHE . 96.8 Cg_endo -85.98 168.51 9.26 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.873 2.382 . . . . 0.0 112.472 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 8.0 tt -111.75 116.21 30.34 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.435 ' CE2' ' HG2' ' A' ' 46' ' ' PRO . 98.6 m-85 -96.08 136.19 36.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.355 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.411 ' HD1' ' H ' ' A' ' 51' ' ' GLN . 0.8 OUTLIER -148.01 133.15 18.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.2 m -66.23 -40.48 90.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.395 0.617 . . . . 0.0 109.613 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.829 ' HG2' ' HB2' ' A' ' 83' ' ' TRP . 50.3 mt-30 -77.31 102.22 6.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.316 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.716 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 13.8 t -56.73 -50.05 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.177 0.513 . . . . 0.0 110.129 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.572 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -55.44 -33.89 64.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.812 -1.086 . . . . 0.0 112.782 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.433 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 7.8 t70 -76.34 -43.55 40.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.138 0.494 . . . . 0.0 110.084 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 58' ' ' TYR . . . -71.52 -34.75 70.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.746 -178.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 10.4 pt -68.56 -31.67 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.76 88.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.542 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 19.6 m-85 -60.29 -44.89 94.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.97 0.414 . . . . 0.0 111.356 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.46 -17.88 63.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.478 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -105.04 12.63 31.99 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 179.21 -71.94 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.118 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -65.74 37.94 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.829 0 C-N-CA 124.189 3.26 . . . . 0.0 114.994 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.432 ' H ' ' HG2' ' A' ' 63' ' ' GLU . 15.1 pt-20 -68.57 144.14 54.65 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 173.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -53.83 -82.25 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -169.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 65' ' ' ILE . 12.8 tt -137.5 4.3 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.065 0.936 . . . . 0.0 109.559 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 41' ' ' GLU . . . -141.33 156.45 67.33 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.52 -174.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.6 Cg_endo -72.62 160.26 46.91 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.184 1.923 . . . . 0.0 111.045 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.7 pt -77.19 134.81 27.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.333 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.4 tt -89.98 -52.64 4.87 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 p -161.34 141.26 3.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.761 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.751 ' HB ' HG22 ' A' ' 38' ' ' ILE . 1.7 tt -107.72 134.08 50.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.606 174.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.84 145.42 39.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 94' ' ' ALA . 31.1 m -137.77 143.21 34.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.392 0.615 . . . . 0.0 110.642 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.665 ' O ' ' HG3' ' A' ' 76' ' ' MET . 93.3 m-20 -78.39 105.46 9.66 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 168.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 1.072 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 31.5 t0 -58.78 121.46 11.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.368 -175.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.843 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -154.37 48.59 0.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.622 -179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.833 ' HA2' ' HB2' ' A' ' 81' ' ' ALA . . . -101.25 49.49 1.05 Allowed Glycine 0 C--N 1.314 -0.694 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.507 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.04 79.15 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.765 0.317 . . . . 0.0 110.561 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 57.94 25.7 12.49 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.763 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.6 -74.25 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.049 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.833 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . . . 59.33 62.17 1.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.406 0.622 . . . . 0.0 110.869 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 77.6 p -83.82 176.14 9.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.882 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.829 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 46.6 p90 -69.25 -22.58 63.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 0.0 110.496 177.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -85.19 -24.59 27.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.616 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 71.68 158.86 0.16 Allowed Pre-proline 0 N--CA 1.468 0.471 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.433 173.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.843 ' HD2' ' HB2' ' A' ' 76' ' ' MET . 19.6 Cg_endo -88.16 8.16 4.22 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.801 2.334 . . . . 0.0 111.476 169.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.66 130.8 6.23 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.797 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -72.44 126.79 30.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.732 0.266 . . . . 0.0 110.457 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.49 -65.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.505 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 1.072 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 61.9 t30 -85.6 153.17 22.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -122.57 128.8 51.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.953 HG21 ' HB2' ' A' ' 118' ' ' SER . 21.7 pt -145.64 166.14 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.282 0.563 . . . . 0.0 112.354 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.24 101.59 12.64 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.217 -0.902 . . . . 0.0 108.852 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.685 ' O ' ' HG ' ' A' ' 137' ' ' LEU . . . -59.03 -40.01 83.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.029 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.725 ' HB2' HG22 ' A' ' 71' ' ' ILE . 24.0 t70 -63.3 -11.05 19.02 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.458 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -130.35 50.7 2.17 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.594 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -149.5 -169.2 3.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.469 0.176 . . . . 0.0 110.709 -173.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -94.82 142.25 27.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.52 0.676 . . . . 0.0 111.147 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.5 135.7 54.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.853 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.613 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.2 p -115.16 124.01 71.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.622 0.725 . . . . 0.0 110.007 169.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.569 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 43.8 t -101.65 106.92 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.753 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.901 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -72.62 141.16 30.35 Favored Glycine 0 C--O 1.223 -0.536 0 CA-C-N 116.057 -0.52 . . . . 0.0 114.219 -170.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.3 m -92.13 -32.77 15.0 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.625 -0.338 . . . . 0.0 111.207 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -88.29 -46.18 9.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 35.7 mtp-105 -104.73 -92.64 0.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.145 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 145' ' ' VAL . 37.2 ttp85 51.41 -87.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.78 23.75 0.02 OUTLIER Glycine 0 C--O 1.222 -0.652 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.207 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -57.78 -26.82 58.28 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.283 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 70.7 mtm -105.68 15.98 26.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.66 0.267 . . . . 0.0 110.553 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.52 -120.92 0.54 Allowed Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.3 104.33 40.33 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.621 0.211 . . . . 0.0 110.743 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 6.8 Cg_endo -51.28 124.1 13.39 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.544 2.829 . . . . 0.0 113.124 177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.73 146.14 41.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.962 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -125.05 132.82 53.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.916 -175.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.721 HG22 ' HB3' ' A' ' 81' ' ' ALA . 67.6 t -96.7 106.36 29.6 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.879 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 1.2 Cg_endo -90.44 105.75 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.702 2.935 . . . . 0.0 111.056 175.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.92 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.2 t80 -117.95 149.07 41.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.911 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.953 ' HB2' HG21 ' A' ' 92' ' ' ILE . 47.9 t -71.01 -35.73 72.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.915 0.388 . . . . 0.0 110.488 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.92 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 7.3 m -97.85 127.14 43.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.764 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -43.16 98.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.155 0.502 . . . . 0.0 110.584 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.75 -32.63 71.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.856 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -74.66 -37.99 62.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.733 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.36 76.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.21 0.528 . . . . 0.0 110.12 176.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.86 -32.18 70.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.832 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.2 89.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.042 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.96 -40.27 94.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.694 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.668 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 93.0 t -63.55 -38.2 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.695 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.38 -36.85 74.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.575 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.71 -45.75 16.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.254 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.686 ' HB2' ' HB3' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -161.4 -36.03 0.05 OUTLIER 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.901 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -46.71 163.09 0.17 Allowed Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.075 -0.966 . . . . 0.0 114.034 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.94 -72.63 0.71 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.82 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.59 ' HB3' ' CB ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -124.73 144.47 50.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.821 0.343 . . . . 0.0 111.078 -178.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.32 113.47 42.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.379 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.784 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -134.86 148.91 50.24 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.782 -179.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.85 161.02 23.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.614 0.245 . . . . 0.0 110.456 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -57.92 -27.29 63.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.037 -178.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.03 -16.06 60.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.779 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -123.7 20.48 9.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.945 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.784 HD13 HD13 ' A' ' 135' ' ' LEU . 19.6 mm -71.76 121.52 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.533 HG23 ' HG2' ' A' ' 144' ' ' MET . 4.0 t -114.68 145.77 41.65 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.554 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.2 p-10 -69.75 -24.48 63.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.381 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.02 68.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.795 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.66 ' SD ' ' HB3' ' A' ' 155' ' ' PRO . 19.9 mmt -77.96 -40.28 39.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.952 0.406 . . . . 0.0 110.794 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.411 ' O ' ' NH1' ' A' ' 106' ' ' ARG . 2.4 t -85.73 -21.31 7.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.173 0.511 . . . . 0.0 111.33 -174.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.0 pp -144.56 127.67 16.6 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.343 0.592 . . . . 0.0 110.543 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 21.2 p -102.73 120.45 52.72 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.486 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.35 -58.39 1.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.799 2.333 . . . . 0.0 112.354 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.96 3.68 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.009 0.433 . . . . 0.0 110.209 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.455 ' O ' HG22 ' A' ' 151' ' ' THR . 35.8 mt-10 65.95 -73.42 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.211 -166.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 150' ' ' GLU . 0.6 OUTLIER 57.8 -4.52 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.974 1.309 . . . . 0.0 114.181 172.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 92.36 25.58 20.87 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.005 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 56.3 p -97.16 125.36 41.62 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.65 145.41 95.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.66 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 37.4 Cg_exo -35.1 -58.67 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.998 3.132 . . . . 0.0 113.495 -176.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -141.81 -42.55 0.35 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.66 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -165.22 25.81 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.825 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.4 t0 53.91 77.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -165.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -136.96 24.25 3.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.563 -167.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.59 ' CB ' ' HB3' ' A' ' 133' ' ' GLN . 2.8 pt-20 . . . . . 0 C--O 1.246 0.918 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.269 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' SER . 27.2 ttpp . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -126.96 143.88 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.21 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 1.7 pm0 -149.06 136.28 20.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.934 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.89 HG21 ' HB2' ' A' ' 59' ' ' ALA . 37.1 pt -115.82 132.67 64.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.114 0.483 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -99.19 126.36 44.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.571 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.0 mp -91.75 151.98 20.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.006 -175.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.552 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 26.9 tt0 -74.01 125.44 28.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.958 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.62 -30.9 5.12 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.213 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.53 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 14.7 t -92.16 124.23 60.39 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.53 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -84.73 19.62 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.168 2.579 . . . . 0.0 112.109 -178.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.91 133.58 24.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.527 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -91.51 138.08 2.1 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.659 2.239 . . . . 0.0 112.732 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.468 ' HB3' HG12 ' A' ' 38' ' ' ILE . 3.6 tt -89.28 104.16 16.73 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 47.3 p90 -113.21 151.06 31.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.335 -175.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' HE2' HE21 ' A' ' 51' ' ' GLN . 14.5 t80 -149.8 149.6 30.75 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -53.65 -59.47 4.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.122 0.487 . . . . 0.0 110.482 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.656 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 32.7 mt-30 -65.4 121.96 16.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.459 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.598 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 12.6 t -59.92 -49.99 81.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.58 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -55.06 -30.28 59.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.482 179.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.656 ' HB2' ' HB2' ' A' ' 51' ' ' GLN . 5.2 t0 -76.13 -51.17 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.843 0.354 . . . . 0.0 110.805 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.743 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -67.89 -35.54 78.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.456 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.826 HD12 ' HB3' ' A' ' 114' ' ' ALA . 20.9 pt -67.79 -31.68 53.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.305 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.17 95.08 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.411 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.834 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 36.1 m-85 -57.97 -42.23 84.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.198 0.523 . . . . 0.0 110.77 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.89 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -63.36 -19.79 64.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.387 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -105.26 12.23 32.04 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.863 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.41 -72.59 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.656 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.834 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 25.9 Cg_exo -67.79 47.61 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.823 3.015 . . . . 0.0 113.606 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.561 ' OE1' ' HA ' ' A' ' 67' ' ' PRO . 9.4 pt-20 -81.37 -3.27 52.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.268 0.556 . . . . 0.0 110.217 177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 72.45 -78.67 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.844 171.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -129.67 -52.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -171.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -97.31 148.49 34.49 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.432 0.158 . . . . 0.0 110.713 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.561 ' HA ' ' OE1' ' A' ' 63' ' ' GLU . 59.4 Cg_endo -71.81 157.72 54.59 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.447 2.098 . . . . 0.0 111.936 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 68' ' ' ILE . 47.5 pt -75.1 122.16 28.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.263 0.554 . . . . 0.0 110.261 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 41' ' ' GLU . 5.6 tt -88.22 -47.96 8.05 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.46 138.72 2.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.547 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.776 HD11 HG22 ' A' ' 56' ' ' ILE . 2.6 tt -110.19 131.58 60.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.315 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -111.94 142.16 44.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.881 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.66 143.66 31.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.968 0.414 . . . . 0.0 110.773 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.521 HD21 ' HA ' ' A' ' 88' ' ' ASP . 33.7 t30 -79.57 101.11 8.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 167.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 76' ' ' MET . 54.5 t0 -63.63 106.99 1.05 Allowed 'General case' 0 C--O 1.242 0.707 0 O-C-N 124.47 1.107 . . . . 0.0 110.628 -174.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.601 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 3.6 mmt -152.29 58.95 0.83 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 113.442 -1.708 . . . . 0.0 107.86 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.28 26.46 21.2 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.042 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.15 39.45 0.82 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.979 0.419 . . . . 0.0 110.953 -172.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 80' ' ' GLY . . . -179.43 -11.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.238 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.429 ' H ' ' H ' ' A' ' 79' ' ' ALA . . . 126.14 -4.32 7.82 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.997 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.27 65.39 1.09 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.622 0.725 . . . . 0.0 109.956 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.7 p -83.81 177.1 8.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.419 -171.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.409 ' HA ' ' HG2' ' A' ' 51' ' ' GLN . 68.8 t90 -59.43 -40.6 87.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.075 0.464 . . . . 0.0 110.026 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.32 -34.15 48.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.089 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.08 159.79 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.983 1.313 . . . . 0.0 112.935 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 8.2 Cg_exo -58.47 -25.93 75.97 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.67 1.58 . . . . 0.0 112.188 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.601 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . 135.39 -149.51 19.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.966 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.521 ' HA ' HD21 ' A' ' 74' ' ' ASN . 7.6 p-10 -77.55 137.52 38.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.999 0.428 . . . . 0.0 110.285 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.81 -141.85 3.99 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.549 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -100.6 133.65 44.73 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -98.16 130.25 44.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.13 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.688 HD13 ' HB2' ' A' ' 118' ' ' SER . 6.9 pt -145.04 166.42 11.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.934 -173.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.26 107.16 15.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.05 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . . . -62.1 -27.78 69.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.136 0.493 . . . . 0.0 110.479 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.548 ' HA ' HD13 ' A' ' 137' ' ' LEU . 22.7 t70 -59.54 -25.19 64.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.413 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -123.65 43.14 3.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.384 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -139.86 -177.93 5.2 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -173.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -97.95 138.04 35.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.394 0.616 . . . . 0.0 110.646 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 116' ' ' PRO . 3.1 m-85 -120.46 135.33 55.09 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.104 -177.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.9 p -113.66 124.82 70.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.514 0.673 . . . . 0.0 109.816 173.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.59 113.87 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.433 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -79.44 121.84 5.63 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.011 -1.09 . . . . 0.0 112.774 -172.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.8 m -92.68 -41.02 10.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.854 0.359 . . . . 0.0 110.313 175.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.21 -43.84 63.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 -174.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -133.84 114.72 13.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.523 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 176.0 -168.88 0.05 Allowed 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.554 0.534 . . . . 0.0 110.086 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.478 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -65.56 -50.99 51.73 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.925 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.06 -102.15 0.68 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.272 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.3 mmt -86.46 -3.92 59.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 110.757 174.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.49 -124.53 5.08 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.478 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.35 96.13 8.01 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.56 0.18 . . . . 0.0 111.084 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.37 141.89 70.15 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.552 2.168 . . . . 0.0 111.9 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.523 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 36.5 mt-10 -125.94 140.63 52.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.605 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.826 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -105.95 131.47 53.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.859 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.678 ' HB ' HG13 ' A' ' 100' ' ' VAL . 59.4 t -100.59 106.14 41.37 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.6 Cg_endo -87.75 122.92 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.695 2.93 . . . . 0.0 111.552 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.631 ' HD1' ' H ' ' A' ' 119' ' ' SER . 3.6 t80 -130.43 151.11 51.27 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.688 ' HB2' HD13 ' A' ' 92' ' ' ILE . 33.8 t -73.47 -35.79 65.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.631 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 15.2 m -105.96 128.83 54.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.798 0.332 . . . . 0.0 110.846 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -49.85 57.9 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.787 -176.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -67.14 -28.38 68.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.29 0.567 . . . . 0.0 109.74 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 66.3 mm-40 -71.46 -34.84 70.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.594 172.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.64 -35.09 76.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.338 0.59 . . . . 0.0 109.69 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.43 75.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.695 173.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.1 -32.3 73.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.39 . . . . 0.0 110.444 175.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -63.79 -37.49 87.58 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.65 HG22 ' H ' ' A' ' 132' ' ' GLY . 58.9 t -69.57 -30.48 45.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.447 176.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 tp -59.5 -39.6 84.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.949 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.44 -47.85 13.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.686 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.811 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.6 pt-20 -149.94 -89.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.459 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.811 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 44.88 -143.33 2.95 Favored Glycine 0 C--N 1.334 0.453 0 O-C-N 123.588 0.555 . . . . 0.0 114.297 174.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.65 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -176.08 -81.26 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -130.21 145.97 51.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.586 0.231 . . . . 0.0 110.568 175.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.21 116.31 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.149 0.499 . . . . 0.0 110.682 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.854 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -141.0 164.13 31.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.955 -178.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.31 163.3 18.68 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.548 HD13 ' HA ' ' A' ' 95' ' ' ASP . 0.6 OUTLIER -66.4 -31.57 72.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.399 0.618 . . . . 0.0 109.505 178.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.87 -9.12 58.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.878 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.27 17.9 11.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.23 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.854 HD13 HD13 ' A' ' 135' ' ' LEU . 26.3 mm -71.87 121.99 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.147 0.499 . . . . 0.0 110.627 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -112.23 149.56 32.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.261 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.474 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 2.2 p-10 -68.92 -29.86 68.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.556 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.43 68.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.66 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.548 ' HE3' ' HA ' ' A' ' 160' ' ' GLU . 13.4 mmt -87.11 -36.95 17.81 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.16 -22.73 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 121.09 0.471 . . . . 0.0 110.672 -174.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.3 pp -148.64 141.25 24.44 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.014 -177.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.3 p -126.0 135.55 27.24 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.053 0.454 . . . . 0.0 111.132 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.8 -49.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.822 2.348 . . . . 0.0 111.809 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 151' ' ' THR . 8.0 t -159.23 85.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -176.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -50.82 74.6 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.226 168.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 149' ' ' VAL . 10.2 t -106.92 21.21 17.9 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.756 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.73 78.0 0.8 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.132 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.2 m -129.96 139.33 51.1 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.54 125.67 92.12 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.726 0.298 . . . . 0.0 110.294 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.55 -73.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.85 2.367 . . . . 0.0 112.253 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.596 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -108.67 -54.07 2.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.786 176.633 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.596 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -151.84 37.76 0.58 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -174.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 157' ' ' ALA . 32.9 t70 73.74 -30.01 0.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.235 -175.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 157' ' ' ALA . 6.2 t70 -73.72 -168.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.362 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.548 ' HA ' ' HE3' ' A' ' 144' ' ' MET . 39.2 mt-10 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.595 -0.717 . . . . 0.0 109.926 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.593 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -126.71 142.54 51.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 9.0 pt20 -149.39 133.66 17.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.474 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.538 HG21 ' HB2' ' A' ' 59' ' ' ALA . 39.0 pt -115.63 136.21 53.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.957 0.408 . . . . 0.0 110.946 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -105.77 131.84 52.63 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.949 HD21 ' HB3' ' A' ' 64' ' ' GLN . 8.7 mp -89.19 152.57 21.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.113 0.482 . . . . 0.0 111.672 -173.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.859 ' HG3' HD13 ' A' ' 69' ' ' LEU . 32.0 tt0 -74.22 124.78 27.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.62 -41.1 2.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.238 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.534 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 31.2 t -81.92 123.96 79.6 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.038 0.447 . . . . 0.0 110.446 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.0 Cg_exo -81.74 5.63 6.18 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.322 2.682 . . . . 0.0 112.455 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -100.37 131.18 24.35 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.574 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 97.8 Cg_endo -101.41 161.08 0.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.573 2.848 . . . . 0.0 112.984 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.446 ' HB3' HG12 ' A' ' 38' ' ' ILE . 7.6 tt -117.73 114.93 24.05 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -118.24 135.77 54.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.61 0.719 . . . . 0.0 111.582 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.42 135.17 31.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.624 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.9 m -63.93 -29.49 70.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.579 0.704 . . . . 0.0 109.171 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.645 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 14.3 mt-30 -75.97 95.98 3.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.702 175.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.593 HG13 ' HB2' ' A' ' 36' ' ' ALA . 10.8 t -57.65 -52.03 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.058 0.456 . . . . 0.0 111.019 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.512 ' HA ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -54.15 -30.11 47.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.364 -178.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.511 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 1.2 m-20 -73.98 -53.47 9.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.761 0.315 . . . . 0.0 111.189 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -67.21 -35.97 80.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.256 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.609 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 17.7 pt -70.35 -32.52 50.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.521 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.17 -44.97 74.74 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.567 174.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.458 ' HD1' ' HG2' ' A' ' 62' ' ' PRO . 22.1 m-85 -62.39 -35.11 78.18 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -61.04 -17.8 54.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 112.017 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -84.8 -15.57 44.43 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.35 -73.02 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.264 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.458 ' HG2' ' HD1' ' A' ' 58' ' ' TYR . 84.8 Cg_exo -48.67 -47.01 22.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.329 2.686 . . . . 0.0 113.205 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.433 ' OE2' ' HA ' ' A' ' 67' ' ' PRO . 44.9 mt-10 54.76 -91.08 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.564 0.746 . . . . 0.0 111.723 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.949 ' HB3' HD21 ' A' ' 40' ' ' LEU . 5.7 tp-100 -174.27 -61.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.186 0.517 . . . . 0.0 109.672 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.0 tt -168.42 -38.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -106.63 165.3 13.17 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 73.0 Cg_endo -74.53 156.59 45.14 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.649 1.566 . . . . 0.0 111.628 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.3 pt -69.87 128.15 32.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.219 0.533 . . . . 0.0 110.909 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.859 HD13 ' HG3' ' A' ' 41' ' ' GLU . 42.6 tp -89.32 -48.95 7.01 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.99 138.45 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.631 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.544 HD11 HG22 ' A' ' 56' ' ' ILE . 2.7 tt -110.89 135.42 50.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.429 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -112.91 138.81 49.2 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 94' ' ' ALA . 19.7 m -128.94 137.88 56.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.289 0.566 . . . . 0.0 110.551 175.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.492 ' O ' ' HG3' ' A' ' 76' ' ' MET . 27.9 t-20 -78.63 104.17 9.07 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -72.49 121.54 19.79 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 124.256 0.973 . . . . 0.0 109.73 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.519 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -151.84 92.37 1.73 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.611 -176.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.7 -56.84 3.84 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.886 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HA ' ' HB2' ' A' ' 81' ' ' ALA . . . 70.99 -52.07 0.68 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.984 0.914 . . . . 0.0 112.49 175.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.91 -34.07 58.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.99 0.424 . . . . 0.0 110.791 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -97.29 -65.33 0.9 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 78' ' ' ALA . . . 44.06 64.54 1.26 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.59 0.756 . . . . 0.0 112.908 175.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.9 p -84.0 176.14 9.05 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.645 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 26.1 p90 -73.32 -12.83 60.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.164 0.507 . . . . 0.0 110.287 175.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.82 -35.15 22.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 68.02 161.04 0.14 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.768 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 76' ' ' MET . 69.9 Cg_endo -93.52 29.35 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.195 1.93 . . . . 0.0 111.634 176.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.15 161.92 18.64 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.721 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -77.35 123.23 26.22 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -106.56 -139.18 9.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.145 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -100.04 149.45 23.47 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 67.2 p-90 -98.44 134.72 41.03 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.232 0.539 . . . . 0.0 110.639 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.737 HD13 ' HB2' ' A' ' 118' ' ' SER . 4.3 pt -133.78 151.91 33.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.543 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.04 102.54 4.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.54 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -61.16 -34.81 75.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.337 -176.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 137' ' ' LEU . 16.7 t70 -57.81 -30.34 65.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.707 0.765 . . . . 0.0 110.354 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -111.24 26.79 10.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.826 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -120.17 177.39 5.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.718 0.294 . . . . 0.0 111.06 -173.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -90.44 131.34 36.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.453 0.644 . . . . 0.0 110.535 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.62 135.33 55.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.071 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.697 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.8 p -112.82 125.46 70.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.745 0.783 . . . . 0.0 110.334 174.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.7 ' HA ' HH11 ' A' ' 106' ' ' ARG . 47.9 t -101.81 107.87 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.998 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.449 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -69.6 124.27 15.11 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.547 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.4 m -88.6 -31.01 18.81 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.77 -44.33 11.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.738 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -133.59 109.52 9.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.755 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.797 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 13.7 ttt180 -168.64 -72.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.601 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.67 46.04 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.523 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -61.8 -39.49 97.54 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.699 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 45.2 tpp -109.39 -4.21 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.559 0.695 . . . . 0.0 110.1 174.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.88 -132.87 5.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.208 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.3 102.6 29.96 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 34.0 Cg_endo -63.74 129.47 24.95 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.253 2.636 . . . . 0.0 114.01 -175.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.797 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 47.9 mm-40 -114.21 129.33 56.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.364 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.609 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . . . -102.22 131.06 49.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.824 -0.171 . . . . 0.0 111.263 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.697 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 85.7 t -101.61 105.74 42.41 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.772 173.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -90.09 127.04 1.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.762 2.975 . . . . 0.0 111.795 175.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.26 149.81 52.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.195 -176.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.737 ' HB2' HD13 ' A' ' 92' ' ' ILE . 47.9 t -79.1 -18.25 53.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.893 0.378 . . . . 0.0 110.758 176.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.7 m -119.85 134.24 55.31 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.77 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -67.48 -49.52 63.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -60.13 -28.99 68.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.452 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -70.23 -43.28 70.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.268 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.7 -30.2 69.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.148 176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.1 -38.09 72.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.639 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.57 74.79 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.264 0.554 . . . . 0.0 110.272 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.69 -39.64 92.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.847 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.829 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 94.6 t -70.78 -34.81 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.929 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 67.6 mt -56.36 -40.94 75.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.62 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.53 -48.97 11.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.699 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.751 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.5 pt-20 -145.4 -82.72 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.101 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.829 ' HA3' ' HA ' ' A' ' 127' ' ' VAL . . . 38.23 -142.24 0.35 Allowed Glycine 0 C--N 1.337 0.606 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.784 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -179.73 -87.28 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.491 HE21 ' HB ' ' A' ' 101' ' ' VAL . 1.9 pm0 -129.86 141.46 50.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.675 0.274 . . . . 0.0 110.863 175.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.48 113.22 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.04 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.73 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.41 165.05 27.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.656 -178.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.31 161.79 19.36 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.69 ' HA ' HG12 ' A' ' 140' ' ' ILE . 5.9 tt -61.75 -36.78 82.0 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.85 -11.48 27.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.487 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -126.0 23.15 7.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.012 0.434 . . . . 0.0 110.895 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.73 HD13 HD13 ' A' ' 135' ' ' LEU . 34.4 mm -71.82 119.12 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 145' ' ' VAL . 14.1 t -119.26 148.65 42.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.681 -176.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.528 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 1.5 p30 -66.07 -41.73 90.35 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -171.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 155' ' ' PRO . . . -57.03 -28.6 62.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.523 ' SD ' ' HB2' ' A' ' 155' ' ' PRO . 19.2 mmt -82.19 -26.83 33.0 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 141' ' ' THR . 10.9 t -97.88 -23.19 4.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -170.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.6 pp -136.33 156.4 48.69 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.969 -172.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.5 p -111.99 119.52 44.08 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.044 0.449 . . . . 0.0 110.779 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.19 -81.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.581 2.187 . . . . 0.0 111.976 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.557 ' HB ' ' OG1' ' A' ' 151' ' ' THR . 4.1 t -129.35 -2.48 2.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 15.0 mm-40 87.83 -77.78 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -169.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.557 ' OG1' ' HB ' ' A' ' 149' ' ' VAL . 13.0 m 68.46 -42.33 0.47 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 163.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.83 20.91 5.88 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.9 m -84.02 126.55 33.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.585 0.231 . . . . 0.0 110.438 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.718 ' HB3' ' HB2' ' A' ' 158' ' ' ASP . 4.3 mp0 -71.14 126.57 91.98 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.157 177.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.523 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 61.8 Cg_endo -72.94 126.94 11.7 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.633 2.222 . . . . 0.0 111.325 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 155' ' ' PRO . 18.5 tpp85 69.66 -63.07 0.4 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.527 0.517 . . . . 0.0 110.471 -175.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 158' ' ' ASP . . . -179.07 13.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.275 0.63 . . . . 0.0 109.92 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.718 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 14.0 t70 57.59 30.88 19.49 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -169.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.01 -68.22 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.679 -172.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.751 179.643 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.573 ' HB3' ' OD1' ' A' ' 74' ' ' ASN . 43.7 tttp . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.769 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -144.72 144.75 31.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.763 0.316 . . . . 0.0 111.671 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 22.3 pt20 -145.56 134.8 22.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.874 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' A' ' 47' ' ' LEU . 3.9 pt -119.81 143.24 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.248 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -116.82 127.88 54.74 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.3 mp -92.07 142.42 27.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.068 0.461 . . . . 0.0 111.082 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.783 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 44.8 tt0 -73.83 124.69 26.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.866 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.05 -27.29 11.58 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.146 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.3 t -92.0 125.56 56.45 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.1 Cg_exo -80.5 12.12 2.67 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.132 2.554 . . . . 0.0 112.833 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -130.15 133.25 24.73 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.876 0.369 . . . . 0.0 110.961 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 55.6 Cg_endo -97.42 170.83 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.388 2.725 . . . . 0.0 112.782 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.722 ' HB3' HG12 ' A' ' 38' ' ' ILE . 14.4 tp -107.04 130.64 54.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.94 177.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -114.45 134.47 54.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.1 147.6 27.97 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 110.688 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 55.3 m -70.38 -52.58 21.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.143 173.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.5 HE21 ' HB3' ' A' ' 83' ' ' TRP . 39.8 mt-30 -67.37 113.09 4.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.718 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.769 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 6.2 t -60.48 -50.48 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.565 0.697 . . . . 0.0 109.444 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.631 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -60.21 -28.79 68.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.548 -176.765 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.631 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 14.2 t70 -76.14 -45.5 33.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.781 0.324 . . . . 0.0 110.482 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.52 72.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.275 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.617 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 16.4 pt -71.19 -32.51 47.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 0.0 110.179 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.26 -36.34 79.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.16 0.505 . . . . 0.0 110.302 172.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.456 ' CD1' HD22 ' A' ' 47' ' ' LEU . 33.8 t80 -60.62 -33.23 72.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.279 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.653 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -72.37 -18.1 61.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.605 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.55 ' NH2' ' HG ' ' A' ' 137' ' ' LEU . 75.1 mtt85 -105.62 13.14 30.33 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.36 -78.63 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.538 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -43.37 -35.54 5.71 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 124.041 3.161 . . . . 0.0 114.774 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -67.61 128.66 37.28 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.759 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -169.68 -36.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.122 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.9 -27.46 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.542 0.687 . . . . 0.0 109.644 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.748 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.1 141.2 14.08 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.309 175.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.783 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 70.4 Cg_endo -74.23 155.12 46.81 Favored 'Trans proline' 0 CA--C 1.52 -0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.282 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.653 HD13 ' HB1' ' A' ' 59' ' ' ALA . 27.5 pt -75.74 116.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.373 0.606 . . . . 0.0 110.484 174.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -79.12 -47.84 15.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 p -161.08 150.16 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.775 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.572 HD11 HG22 ' A' ' 56' ' ' ILE . 5.7 tt -128.0 128.61 69.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.448 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -111.99 133.46 54.15 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 94' ' ' ALA . 34.6 m -132.2 156.6 42.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.108 0.48 . . . . 0.0 110.668 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.573 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 12.3 m120 -92.34 104.56 16.89 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.459 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 10.3 t0 -49.56 103.9 0.06 Allowed 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 125.35 1.656 . . . . 0.0 109.525 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' ' 85' ' ' GLN . 3.3 ttm -144.69 41.04 1.31 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.038 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 79' ' ' ALA . . . -89.62 18.1 48.53 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.644 -175.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.06 22.17 0.11 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.216 0.532 . . . . 0.0 111.474 -175.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -172.89 20.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.493 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.401 ' HA2' ' CG2' ' A' ' 115' ' ' VAL . . . 91.51 -2.29 77.32 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.347 -176.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . . . 60.47 66.82 0.89 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.688 0.756 . . . . 0.0 110.315 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 p -83.73 175.59 9.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.445 -176.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.5 ' HB3' HE21 ' A' ' 51' ' ' GLN . 59.8 p-90 -67.26 -23.92 65.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.981 0.42 . . . . 0.0 110.767 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.03 -35.55 42.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.58 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 24.2 mt-30 66.8 142.97 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.578 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -57.61 -42.22 62.76 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.015 1.81 . . . . 0.0 112.07 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.2 -64.56 0.6 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.247 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.32 131.79 38.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.7 0.286 . . . . 0.0 110.619 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 75' ' ' ASP . . . -147.47 139.74 8.04 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.401 -177.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.3 t30 -100.13 149.14 23.83 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -98.48 129.74 45.08 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.705 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.747 HG21 ' HB2' ' A' ' 118' ' ' SER . 20.3 pt -145.02 166.17 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.967 -174.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.69 114.1 23.1 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -69.46 -38.07 77.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.036 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.73 ' HA ' HD13 ' A' ' 137' ' ' LEU . 0.6 OUTLIER -68.03 -25.24 65.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.738 0.78 . . . . 0.0 109.752 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -98.9 37.35 1.53 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.262 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 117' ' ' PHE . . . -145.48 179.24 7.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.35 -171.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -93.59 141.8 28.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.304 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.406 ' CE1' HD12 ' A' ' 137' ' ' LEU . 2.9 m-85 -120.67 137.08 54.64 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.558 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.848 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -115.16 123.21 70.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.504 0.669 . . . . 0.0 109.368 172.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.482 ' HB ' ' HG2' ' A' ' 133' ' ' GLN . 56.4 t -101.53 107.13 20.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.31 123.25 7.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.793 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.4 t -92.42 -35.4 13.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.893 0.378 . . . . 0.0 110.146 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.39 -45.08 20.21 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.943 0.401 . . . . 0.0 111.568 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.437 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 48.9 mtp180 -129.58 111.72 13.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.633 ' NE ' ' HA ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -177.81 -170.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -54.54 -37.56 61.01 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.67 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.45 -105.26 1.09 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.041 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 86.7 mtp -92.94 -4.0 53.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.979 0.419 . . . . 0.0 110.374 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -95.15 -129.51 5.8 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.782 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.27 96.58 8.52 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 176.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 18.1 Cg_endo -59.72 151.51 69.78 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.401 2.734 . . . . 0.0 113.314 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.514 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 2.5 mp0 -117.1 146.13 43.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.54 175.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.617 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . . . -103.98 131.13 51.53 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.848 ' HB ' HG13 ' A' ' 100' ' ' VAL . 5.7 t -99.19 105.22 31.07 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.3 Cg_exo -87.07 133.35 3.4 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.556 2.837 . . . . 0.0 112.89 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.4 ' O ' ' HB1' ' A' ' 97' ' ' ALA . 35.8 m-85 -129.26 149.67 50.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.46 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.747 ' HB2' HG21 ' A' ' 92' ' ' ILE . 32.5 t -78.05 -38.19 45.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.064 0.459 . . . . 0.0 109.837 172.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 m -96.28 135.33 38.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.818 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -46.2 84.85 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -64.73 -28.46 69.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.875 -172.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -64.98 -38.66 91.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.95 0.405 . . . . 0.0 110.677 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -73.02 -36.16 66.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.077 176.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.0 -44.99 83.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.065 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.65 -34.14 75.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 110.9 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -62.78 -40.51 97.53 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.85 HG22 ' H ' ' A' ' 132' ' ' GLY . 91.7 t -72.43 -32.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.603 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.4 tp -57.75 -43.67 85.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.1 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.44 -44.64 15.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.164 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.653 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.2 pt-20 -150.69 -93.29 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.403 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.653 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.27 -138.12 7.73 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 114.438 0.535 . . . . 0.0 114.438 173.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.85 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -176.95 -83.09 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.482 ' HG2' ' HB ' ' A' ' 101' ' ' VAL . 13.2 pm0 -130.07 142.16 50.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.645 0.259 . . . . 0.0 110.937 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.5 t -109.45 120.14 60.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.046 0.451 . . . . 0.0 110.729 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.791 HD13 HD13 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -147.2 165.69 29.25 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.547 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.91 164.05 18.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 95' ' ' ASP . 8.6 tt -63.88 -35.52 80.91 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.02 -10.14 59.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.975 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -117.85 20.27 13.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.493 0.663 . . . . 0.0 110.043 -174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.791 HD13 HD13 ' A' ' 135' ' ' LEU . 35.8 mm -76.58 121.69 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.895 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.478 HG23 ' HB2' ' A' ' 144' ' ' MET . 0.5 OUTLIER -106.08 145.85 30.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.858 171.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -69.96 -33.17 71.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.018 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.19 -27.37 68.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.406 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.478 ' HB2' HG23 ' A' ' 141' ' ' THR . 1.7 mmt -73.45 -38.8 65.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.871 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.9 t -83.67 -22.61 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.275 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 pp -151.08 133.44 15.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.594 -0.443 . . . . 0.0 111.406 -174.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.8 p -125.93 120.85 24.15 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.305 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.4 -59.59 0.41 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.898 2.399 . . . . 0.0 113.392 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.3 t -125.21 6.62 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.93 0.395 . . . . 0.0 110.68 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 60.91 47.62 7.46 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.82 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 t -71.9 -3.33 21.87 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 82.8 28.92 36.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.868 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 p -70.49 141.08 52.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.661 0.267 . . . . 0.0 111.231 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.507 ' OE2' ' HB2' ' A' ' 158' ' ' ASP . 37.9 mt-10 -59.73 125.84 81.26 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.204 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.74 -72.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 123.146 2.564 . . . . 0.0 112.723 -176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -117.66 -33.57 4.5 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.476 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 159' ' ' ASP . . . -171.05 39.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.895 -173.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.507 ' HB2' ' OE2' ' A' ' 154' ' ' GLU . 14.6 t70 71.99 -37.26 0.38 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.292 0.637 . . . . 0.0 110.659 -174.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.9 t70 -65.24 -163.38 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.249 175.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.835 177.072 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.623 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 36.6 ttpt . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -134.16 144.54 48.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.149 0.431 . . . . 0.0 111.859 -177.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 28.9 pt20 -147.02 136.83 23.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.872 174.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.631 HG22 ' HB ' ' A' ' 71' ' ' ILE . 35.5 pt -120.06 132.75 68.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.2 0.524 . . . . 0.0 111.495 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -105.75 119.06 38.2 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.9 mp -92.94 142.78 26.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.039 0.447 . . . . 0.0 110.738 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.718 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 31.4 tt0 -71.34 124.2 24.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.702 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.67 -17.16 58.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.594 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 37.5 t -92.38 125.96 54.29 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 1.4 Cg_endo -83.56 10.07 3.83 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.08 2.52 . . . . 0.0 112.678 -178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -134.3 134.2 22.45 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.786 0.327 . . . . 0.0 111.35 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 9.1 Cg_endo -89.2 125.36 1.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.484 2.789 . . . . 0.0 111.422 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.36 102.97 13.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 44.5 p90 -103.14 139.57 38.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.732 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -144.59 142.88 30.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.705 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.623 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 4.8 m -57.15 -44.1 83.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.077 0.465 . . . . 0.0 111.426 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.652 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 46.1 mt-30 -78.46 119.89 22.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.163 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.573 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 9.9 t -64.49 -50.39 76.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.602 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.01 -29.84 45.07 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.512 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.602 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 22.2 t70 -76.34 -51.55 11.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.828 0.347 . . . . 0.0 110.691 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -68.04 -37.51 81.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.283 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 114' ' ' ALA . 31.0 pt -67.6 -30.79 49.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.428 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -62.58 -46.11 89.83 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.547 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.407 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 30.1 m-85 -62.14 -40.88 97.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.888 0.375 . . . . 0.0 110.839 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -60.83 -20.67 62.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.732 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 48.6 mtm105 -95.43 12.36 29.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.18 -62.35 0.32 Allowed Glycine 0 C--O 1.226 -0.354 0 C-N-CA 119.779 -1.201 . . . . 0.0 113.645 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 18.1 Cg_exo -70.8 49.46 0.94 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.441 2.761 . . . . 0.0 114.323 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -84.26 -89.23 0.1 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.601 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.595 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 22.1 tp60 -164.23 -51.7 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.499 0.591 . . . . 0.0 112.018 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.516 HG22 ' HG3' ' A' ' 64' ' ' GLN . 14.6 tt 177.52 -27.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.258 0.551 . . . . 0.0 110.703 -170.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.474 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -99.41 144.56 28.51 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.455 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.718 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 53.5 Cg_endo -68.62 152.69 74.46 Favored 'Trans proline' 0 CA--C 1.517 -0.332 0 C-N-CA 122.383 2.055 . . . . 0.0 111.371 176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 59' ' ' ALA . 29.5 pt -81.58 107.17 13.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.498 0.666 . . . . 0.0 110.059 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -69.86 -49.42 52.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 p -161.22 138.94 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.927 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.6 tt -112.87 128.58 69.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.754 174.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -111.84 128.87 56.25 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 94' ' ' ALA . 35.4 m -128.28 153.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.212 0.529 . . . . 0.0 110.565 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.605 ' O ' ' HG2' ' A' ' 76' ' ' MET . 15.2 m120 -87.65 103.88 16.0 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -47.36 113.99 0.79 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 125.684 1.865 . . . . 0.0 110.7 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.605 ' HG2' ' O ' ' A' ' 74' ' ' ASN . 11.6 ptp -158.97 117.58 2.94 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.794 0.684 . . . . 0.0 110.074 -176.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.776 ' HA3' ' CZ ' ' A' ' 117' ' ' PHE . . . -151.12 44.89 0.66 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.656 -1.259 . . . . 0.0 113.941 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -97.79 26.42 5.13 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -176.95 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.674 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.546 ' HA2' ' CG2' ' A' ' 115' ' ' VAL . . . 131.03 20.67 1.14 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.281 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.403 ' HB1' ' CG2' ' A' ' 52' ' ' VAL . . . 55.83 54.52 8.05 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.421 0.629 . . . . 0.0 110.908 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.7 p -83.57 176.6 8.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.196 -174.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.652 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 44.5 p90 -64.66 -28.51 69.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.041 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -80.35 -33.07 37.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 70.37 138.1 0.06 OUTLIER Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.951 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.454 ' CG ' ' HB2' ' A' ' 76' ' ' MET . 36.5 Cg_endo -65.78 -60.08 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.292 1.995 . . . . 0.0 112.808 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.24 -38.21 0.41 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.794 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 76' ' ' MET . 10.9 p-10 -72.41 146.75 46.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 176.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.93 94.23 0.11 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.023 -1.085 . . . . 0.0 113.67 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 49.9 m-80 -100.29 151.83 21.02 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.5 p90 -98.13 126.95 43.81 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.268 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.901 HG21 ' HB2' ' A' ' 118' ' ' SER . 34.5 pt -145.62 166.73 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.083 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -95.12 103.5 15.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 172.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.484 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -63.59 -30.52 71.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.25 -175.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.736 ' HA ' HD13 ' A' ' 137' ' ' LEU . 21.8 t70 -59.43 -24.26 63.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.697 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -120.51 33.97 5.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.329 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.425 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -133.41 -177.64 4.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.293 -171.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.94 137.4 33.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.545 0.688 . . . . 0.0 110.422 -177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.61 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 6.0 m-85 -120.65 135.69 55.04 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.372 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.577 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 6.3 p -112.24 120.92 63.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.462 0.649 . . . . 0.0 109.643 170.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.442 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 96.9 t -101.61 107.35 21.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -70.25 122.33 11.03 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.389 -175.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 m -92.31 -20.55 20.99 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.737 0.303 . . . . 0.0 110.821 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.99 -19.08 19.02 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.27 0.557 . . . . 0.0 110.453 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.404 HH11 ' CD ' ' A' ' 130' ' ' GLU . 23.3 mmm-85 -112.53 -30.63 7.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.416 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.864 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 5.4 mpt_? -120.88 -161.71 0.91 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.512 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.807 ' HA2' ' HD3' ' A' ' 112' ' ' PRO . . . 70.11 51.02 25.08 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -171.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.45 -127.04 0.16 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 114.483 -0.858 . . . . 0.0 113.068 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 66.2 mtt -97.93 21.32 10.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.665 0.745 . . . . 0.0 109.493 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.22 -114.07 0.29 Allowed Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.167 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.538 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.19 115.91 63.17 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.885 ' HG2' ' HA ' ' A' ' 145' ' ' VAL . 1.9 Cg_endo -44.09 157.15 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.905 3.07 . . . . 0.0 113.212 164.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.864 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 43.3 mt-10 -113.47 125.97 54.81 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 99' ' ' TYR . . . -93.76 131.97 38.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.873 -168.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.577 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 2.4 t -97.41 106.07 29.87 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 5.7 Cg_exo -85.91 131.07 3.72 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.225 2.617 . . . . 0.0 112.731 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.776 ' CZ ' ' HA3' ' A' ' 77' ' ' GLY . 81.6 m-85 -129.82 149.8 51.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.505 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.901 ' HB2' HG21 ' A' ' 92' ' ' ILE . 16.6 t -87.23 -26.56 23.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.4 m -91.98 110.62 21.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.929 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -58.77 -46.82 86.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.245 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -62.82 -28.74 70.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.214 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.61 -44.82 81.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.891 0.377 . . . . 0.0 110.225 174.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.415 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -65.85 -35.62 81.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.329 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.81 -41.49 62.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.477 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.0 -33.2 74.92 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.207 0.527 . . . . 0.0 110.529 177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -59.84 -38.41 81.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.576 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.662 HG22 ' H ' ' A' ' 132' ' ' GLY . 61.7 t -73.17 -30.91 32.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.098 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mp -56.82 -48.98 76.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.233 0.54 . . . . 0.0 110.72 176.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.73 -38.25 47.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.21 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.622 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.1 pt-20 -159.26 -90.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.708 -178.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.622 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 45.51 -139.05 6.0 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 123.827 0.704 . . . . 0.0 113.54 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.662 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -172.97 -89.54 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.497 ' HB2' ' HB3' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -128.44 139.15 52.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.809 0.337 . . . . 0.0 110.58 177.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 75.4 t -99.5 113.41 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.572 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.907 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.81 160.96 38.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.691 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.28 162.96 15.57 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.736 HD13 ' HA ' ' A' ' 95' ' ' ASP . 7.0 tt -64.3 -30.52 71.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.43 0.634 . . . . 0.0 109.495 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.91 -10.41 59.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.915 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -124.8 19.92 8.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.041 0.448 . . . . 0.0 110.407 -176.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.907 HD13 HD13 ' A' ' 135' ' ' LEU . 26.9 mm -72.1 119.76 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 145' ' ' VAL . 2.2 t -103.02 148.29 25.89 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.203 175.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 6.0 p-10 -68.94 -29.2 67.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.53 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.54 -32.29 66.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.456 ' HG3' ' HG3' ' A' ' 133' ' ' GLN . 18.0 mmt -86.99 -26.55 23.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.463 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.885 ' HA ' ' HG2' ' A' ' 112' ' ' PRO . 1.3 t -103.3 -3.22 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 111.405 -173.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.8 pp -169.64 132.87 1.23 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.822 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 1.8 p -94.0 118.69 67.26 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.245 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 24.0 Cg_endo -62.47 -68.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.953 2.435 . . . . 0.0 112.917 -177.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 64.6 t -114.7 -27.56 2.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.043 -173.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 5.4 mm-40 68.99 46.15 0.86 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.977 0.894 . . . . 0.0 108.791 -166.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.4 t -75.72 -13.98 60.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.636 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.13 50.27 6.92 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.61 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.2 t -130.14 161.42 31.13 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -57.16 132.57 80.69 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.49 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.9 -72.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.536 2.824 . . . . 0.0 112.801 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.22 -44.83 3.21 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.263 173.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.28 44.35 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.384 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.0 t70 56.59 32.78 21.55 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.321 1.058 . . . . 0.0 109.637 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -142.07 -179.18 6.08 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 133' ' ' GLN . 9.9 mm-40 . . . . . 0 C--O 1.243 0.757 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.914 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 34.6 ttmt . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.753 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -139.21 144.92 38.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.153 0.433 . . . . 0.0 111.754 -176.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 13.8 pt20 -149.19 134.49 18.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 173.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.619 HG22 ' HB ' ' A' ' 71' ' ' ILE . 23.1 pt -115.8 132.91 63.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.135 0.493 . . . . 0.0 111.403 -177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -98.99 116.97 32.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.692 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.5 mp -90.4 140.48 29.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.888 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.865 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 35.4 tt0 -71.91 124.9 25.88 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.317 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.35 -15.54 61.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.709 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.501 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 30.6 t -94.48 124.87 53.94 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.0 Cg_endo -81.47 2.95 8.2 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.091 2.527 . . . . 0.0 112.13 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -135.23 134.6 21.55 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.544 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 1.3 Cg_endo -83.68 147.63 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.21 2.607 . . . . 0.0 112.249 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 tt -99.15 112.58 24.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 33.9 p90 -108.62 143.85 37.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.984 0.421 . . . . 0.0 111.365 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -150.03 139.65 21.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.914 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 17.2 m -63.21 -29.98 71.22 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -176.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.406 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 15.1 mt-30 -90.3 113.69 25.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.673 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.753 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 17.1 t -64.33 -50.66 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.007 0.432 . . . . 0.0 110.889 -177.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.649 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.79 -29.46 62.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.931 -177.375 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.649 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 5.1 t70 -76.12 -47.9 22.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.193 0.52 . . . . 0.0 109.828 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.23 80.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.459 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.597 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 36.8 pt -69.16 -32.75 55.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.191 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . . . -68.22 -42.15 80.23 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 110.214 174.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.85 -31.31 71.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.721 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.469 ' HB1' HG21 ' A' ' 68' ' ' ILE . . . -73.23 -17.0 61.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.152 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.602 ' HE ' ' HA ' ' A' ' 57' ' ' ALA . 38.2 mtm105 -97.72 8.26 44.99 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.76 -67.69 0.03 OUTLIER Glycine 0 C--N 1.322 -0.198 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.234 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.17 -0.85 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.844 3.03 . . . . 0.0 115.119 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -78.44 37.61 0.28 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.651 0.739 . . . . 0.0 110.595 174.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -79.91 -14.85 58.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.631 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tp -90.55 -38.62 11.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.212 0.53 . . . . 0.0 110.164 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.692 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -148.01 139.7 13.98 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.865 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 73.0 Cg_endo -74.17 150.73 42.96 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.328 2.019 . . . . 0.0 112.039 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.469 HG21 ' HB1' ' A' ' 59' ' ' ALA . 37.8 pt -74.79 123.71 30.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.168 0.509 . . . . 0.0 110.303 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -88.34 -53.07 4.86 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.8 142.36 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.287 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.619 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.6 tt -113.5 136.0 51.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.457 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -111.94 133.93 53.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.95 159.14 43.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.453 0.644 . . . . 0.0 111.72 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -95.52 106.98 19.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.141 171.197 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 90' ' ' ASN . 13.0 t70 -50.99 121.8 6.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 125.088 1.493 . . . . 0.0 109.816 175.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.48 ' SD ' ' N ' ' A' ' 35' ' ' LYS . 29.4 mtp -124.21 49.36 1.79 Allowed 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -165.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 78' ' ' ALA . . . 73.45 -30.53 0.84 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.818 169.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.965 ' HA ' HG11 ' A' ' 115' ' ' VAL . . . 87.79 -64.44 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.986 0.915 . . . . 0.0 111.801 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.13 -38.34 24.74 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.548 0.53 . . . . 0.0 111.794 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.5 -81.82 1.27 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.554 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 56.41 22.32 6.32 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 36.1 p -84.38 175.44 9.36 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.478 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 2.6 p90 -63.26 -23.27 67.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.802 0.334 . . . . 0.0 110.546 172.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -81.75 -29.88 32.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.592 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.467 ' HB3' ' HE2' ' A' ' 76' ' ' MET . 0.0 OUTLIER 57.09 162.82 0.08 OUTLIER Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.782 1.233 . . . . 0.0 112.469 174.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.44 -9.96 16.1 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.36 1.374 . . . . 0.0 111.477 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 137.65 -177.57 19.8 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.11 140.14 40.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.438 0.619 . . . . 0.0 109.408 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.46 -126.74 2.87 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.989 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 35.4 m-80 -96.46 150.81 20.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.576 -173.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -99.0 126.14 44.63 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.466 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.734 HD13 ' HB2' ' A' ' 118' ' ' SER . 9.8 pt -145.72 166.54 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.137 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.58 106.44 18.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.427 ' C ' HD12 ' A' ' 137' ' ' LEU . . . -61.75 -33.2 73.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.121 0.486 . . . . 0.0 110.76 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.491 ' HB2' HG22 ' A' ' 71' ' ' ILE . 20.9 t70 -59.63 -24.96 64.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.41 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -121.53 33.86 5.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.394 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -135.26 -172.77 3.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.318 -175.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 97.8 m-85 -95.36 139.16 32.05 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.521 0.676 . . . . 0.0 111.041 -176.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.616 ' CE1' HG22 ' A' ' 101' ' ' VAL . 17.9 t80 -120.34 131.04 54.69 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.659 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.9 p -109.52 123.07 65.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.705 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' ' 144' ' ' MET . 4.0 t -101.74 103.01 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.394 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.662 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -69.26 134.49 26.82 Favored Glycine 0 N--CA 1.45 -0.432 0 O-C-N 123.574 0.546 . . . . 0.0 113.524 -173.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -92.08 -36.98 13.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.652 0.263 . . . . 0.0 110.317 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.08 -43.74 17.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 0.0 110.385 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.567 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 41.3 mtp-105 -132.84 132.78 42.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.668 177.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 1.027 HH21 HG13 ' A' ' 145' ' ' VAL . 12.7 ttt85 -172.08 -62.63 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.814 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.83 -61.2 0.23 Allowed Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.83 -94.53 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.527 -0.368 . . . . 0.0 112.42 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.81 -4.49 59.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.981 0.42 . . . . 0.0 110.896 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -110.65 -129.84 5.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.623 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.439 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.17 102.2 26.91 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.718 0.259 . . . . 0.0 110.584 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 26.8 Cg_endo -61.86 128.06 23.26 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 123.745 2.964 . . . . 0.0 112.983 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.466 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 5.0 mm-40 -114.34 139.97 49.02 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.593 -177.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.552 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -123.59 134.59 53.79 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.64 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.965 HG11 ' HA ' ' A' ' 78' ' ' ALA . 46.1 t -98.13 106.68 36.56 Favored Pre-proline 0 C--N 1.314 -0.973 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.983 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 5.3 Cg_exo -84.55 110.17 1.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.157 2.571 . . . . 0.0 111.283 173.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.78 ' HD1' ' H ' ' A' ' 119' ' ' SER . 4.1 t80 -120.06 151.03 39.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.971 -174.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.734 ' HB2' HD13 ' A' ' 92' ' ' ILE . 33.1 t -74.89 -37.26 62.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.778 0.323 . . . . 0.0 110.953 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.78 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 9.6 m -95.95 128.22 42.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.608 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 3.7 ttt180 -62.42 -48.97 77.33 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.133 0.492 . . . . 0.0 111.215 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -63.11 -31.59 72.76 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.786 -172.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -67.48 -40.44 85.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.731 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.17 -34.59 76.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.124 0.488 . . . . 0.0 109.747 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.09 74.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.865 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.35 97.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.142 0.496 . . . . 0.0 109.964 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -60.11 -38.74 83.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.836 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.689 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 60.8 t -64.57 -43.85 96.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.195 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.2 mt -52.46 -40.15 61.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.202 0.525 . . . . 0.0 110.678 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.86 -44.01 19.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.96 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.567 ' OE1' ' HD3' ' A' ' 105' ' ' ARG . 6.9 pt-20 -158.97 -33.49 0.06 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -172.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.689 ' CA ' ' HA ' ' A' ' 127' ' ' VAL . . . -52.76 167.01 1.12 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.257 -0.429 . . . . 0.0 113.907 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.64 -81.76 1.4 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.269 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.619 ' HG2' ' HG3' ' A' ' 144' ' ' MET . 2.1 pt20 -125.99 144.39 50.72 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.958 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.415 HG23 HG21 ' A' ' 127' ' ' VAL . 61.1 t -98.88 113.15 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.325 176.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.603 ' H ' HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -133.87 164.56 26.99 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.502 -178.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.86 163.84 22.01 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.444 HD23 HG13 ' A' ' 140' ' ' ILE . 0.8 OUTLIER -62.61 -24.81 67.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.864 0.364 . . . . 0.0 110.691 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.29 -19.97 57.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.949 0.404 . . . . 0.0 111.151 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -104.35 19.33 20.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.852 -173.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.592 HD13 HD13 ' A' ' 135' ' ' LEU . 48.8 mm -71.88 120.37 20.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.216 0.531 . . . . 0.0 111.084 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.789 HG23 ' HB2' ' A' ' 144' ' ' MET . 0.8 OUTLIER -99.42 145.99 26.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.131 177.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.79 -32.21 70.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.045 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.23 -29.2 67.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.504 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.789 ' HB2' HG23 ' A' ' 141' ' ' THR . 0.0 OUTLIER -78.94 -35.48 43.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.343 175.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 1.027 HG13 HH21 ' A' ' 106' ' ' ARG . 55.9 t -78.27 -25.36 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.382 -167.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -160.7 146.61 14.89 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.26 -174.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.4 p -109.01 119.15 49.66 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 121.057 0.456 . . . . 0.0 110.719 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.24 -67.86 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.913 2.408 . . . . 0.0 112.364 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.0 1.65 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.79 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 68.24 -76.73 0.05 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.341 -170.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.8 t 42.29 21.67 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.159 1.384 . . . . 0.0 114.643 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 66.29 26.91 72.69 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.885 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.9 m -76.33 152.67 36.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.052 0.426 . . . . 0.0 110.573 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 158' ' ' ASP . 2.5 mp0 -70.63 142.32 88.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.423 ' HB2' ' HE2' ' A' ' 144' ' ' MET . 69.4 Cg_endo -80.55 19.91 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.72 2.28 . . . . 0.0 112.799 -172.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.449 ' HE ' ' CD ' ' A' ' 133' ' ' GLN . 11.9 ptp85 177.06 -45.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.423 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 162.54 -16.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.11 -161.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.472 ' HB2' ' HG2' ' A' ' 154' ' ' GLU . 25.1 t0 59.14 31.24 21.11 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.283 1.039 . . . . 0.0 108.761 -168.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.37 -49.58 22.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.665 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 5.0 pt-20 . . . . . 0 C--O 1.254 1.323 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.362 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 50' ' ' SER . 40.0 ttmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.738 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -132.19 144.21 50.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . 11.9 pt20 -145.06 144.71 31.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.967 0.413 . . . . 0.0 110.574 177.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.705 HG21 ' HB2' ' A' ' 59' ' ' ALA . 23.2 pt -115.94 134.24 59.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 120.969 0.414 . . . . 0.0 110.415 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -98.67 116.87 31.86 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.592 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.3 mp -89.16 139.0 30.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.234 -174.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.856 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 40.8 tt0 -73.89 122.39 22.45 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.51 -4.18 66.43 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.568 -173.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 46.9 t -120.02 128.28 25.93 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.7 Cg_exo -79.1 -12.8 14.3 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.105 2.537 . . . . 0.0 111.704 176.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -115.39 133.8 22.69 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.62 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 2.2 Cg_endo -86.06 149.88 9.47 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.365 2.71 . . . . 0.0 112.149 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.9 tt -94.7 109.77 21.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.675 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . 31.1 p90 -115.54 147.87 40.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.374 0.607 . . . . 0.0 111.834 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -139.24 154.08 47.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.015 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 6.2 m -56.42 -50.98 70.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.155 0.502 . . . . 0.0 110.917 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.402 ' HB2' ' CB ' ' A' ' 54' ' ' ASP . 55.2 mt-30 -77.38 136.06 38.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.397 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.738 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 48.4 t -73.17 -50.7 29.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -52.78 -32.96 46.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.522 177.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.442 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 15.9 t70 -76.13 -50.0 15.8 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.864 0.364 . . . . 0.0 110.72 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -67.93 -36.09 79.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.682 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.726 HG22 HD11 ' A' ' 71' ' ' ILE . 31.1 pt -66.02 -31.24 52.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.7 -0.4 . . . . 0.0 109.925 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 54' ' ' ASP . . . -61.27 -41.3 96.7 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.744 174.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.541 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 54.4 m-85 -58.1 -41.19 82.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.967 0.413 . . . . 0.0 111.046 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -63.61 -17.63 63.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.128 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.04 12.24 32.45 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.56 -68.22 0.09 OUTLIER Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.268 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 23.9 Cg_exo -68.14 46.47 0.34 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.586 2.858 . . . . 0.0 113.642 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.96 172.96 13.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.752 0.311 . . . . 0.0 110.285 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.454 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 84.1 mm-40 -96.81 -164.58 1.16 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.843 0.354 . . . . 0.0 110.91 -176.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.3 tt -62.12 -19.4 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.379 0.609 . . . . 0.0 111.17 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.592 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -105.97 141.01 21.81 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.856 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 42.1 Cg_endo -69.36 162.79 40.46 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.967 2.445 . . . . 0.0 112.122 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.9 pt -84.38 116.57 28.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.1 0.476 . . . . 0.0 110.674 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 tt -84.08 -52.58 6.18 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.11 139.86 7.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.662 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.726 HD11 HG22 ' A' ' 56' ' ' ILE . 4.1 tt -108.92 126.89 65.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.133 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -111.55 128.76 56.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.954 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.562 HG23 HG13 ' A' ' 92' ' ' ILE . 31.2 m -123.43 134.25 66.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.118 0.485 . . . . 0.0 110.101 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -89.5 99.44 12.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.607 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 25.6 t70 -68.82 85.94 0.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.778 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.745 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 21.7 ptm -165.17 -168.12 1.33 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.349 0.595 . . . . 0.0 112.268 -174.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.26 -42.9 2.42 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.787 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . . . 51.88 28.33 5.01 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.111 0.536 . . . . 0.0 112.124 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.06 -62.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.97 -11.31 30.38 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.321 -0.942 . . . . 0.0 114.389 -170.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.687 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -61.38 -52.62 63.86 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.953 0.883 . . . . 0.0 109.325 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.0 p -129.62 152.75 48.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 114.001 -1.454 . . . . 0.0 107.497 168.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -72.22 -19.59 61.7 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.439 0.637 . . . . 0.0 110.054 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -85.14 -18.48 34.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.776 175.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 10.4 mt-30 69.75 141.35 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.358 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.787 ' HD2' ' HA ' ' A' ' 78' ' ' ALA . 73.7 Cg_endo -91.49 -82.17 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.918 2.412 . . . . 0.0 112.929 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.15 -126.2 1.67 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.378 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.68 146.62 48.11 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 122.013 0.125 . . . . 0.0 110.957 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.745 ' HA2' ' HB3' ' A' ' 76' ' ' MET . . . -70.78 90.01 0.39 Allowed Glycine 0 CA--C 1.518 0.278 0 O-C-N 123.66 0.6 . . . . 0.0 113.964 -175.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -100.16 149.5 23.47 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -100.17 127.8 46.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.562 HG13 HG23 ' A' ' 73' ' ' VAL . 1.4 pt -145.51 156.65 13.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.59 117.99 30.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 164.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.93 79.41 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -169.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.658 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 9.4 p-10 -66.9 -28.01 67.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.009 0.909 . . . . 0.0 109.789 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -105.32 33.33 3.74 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.177 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.58 171.48 12.55 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.215 -0.303 . . . . 0.0 110.351 -174.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -89.54 136.15 33.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.314 0.578 . . . . 0.0 110.013 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 7.6 m-85 -120.39 136.95 54.55 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.983 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.416 ' CG1' HG13 ' A' ' 115' ' ' VAL . 2.2 p -120.9 125.47 74.08 Favored 'Isoleucine or valine' 0 C--O 1.251 1.146 0 CA-C-O 121.691 0.758 . . . . 0.0 109.428 170.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.57 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 59.1 t -108.57 117.16 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.117 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -75.8 124.49 7.48 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.155 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.5 m -90.43 -23.45 21.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.013 0.435 . . . . 0.0 110.172 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -82.35 -45.17 15.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.224 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.617 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 47.2 mtp180 -139.23 93.75 2.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.029 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.567 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -147.84 169.45 19.77 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.451 176.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.687 ' H ' ' HA ' ' A' ' 112' ' ' PRO . . . -79.51 45.85 2.95 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.836 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.8 -25.26 63.51 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.502 171.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.8 ptm -108.36 21.21 17.64 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.746 -0.727 . . . . 0.0 110.213 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -176.3 -116.7 0.47 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.013 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.589 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.45 102.5 29.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.949 0.404 . . . . 0.0 111.378 177.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.687 ' HA ' ' H ' ' A' ' 107' ' ' GLY . 88.0 Cg_endo -74.54 151.83 42.45 Favored 'Trans proline' 0 N--CA 1.467 -0.078 0 C-N-CA 123.253 2.635 . . . . 0.0 111.948 177.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.567 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 1.7 tp10 -118.94 123.24 44.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.308 -177.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.501 ' HB3' HD11 ' A' ' 56' ' ' ILE . . . -99.88 121.43 41.3 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.488 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 6.4 p -110.81 106.63 57.77 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.235 176.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.528 ' HG3' ' CE2' ' A' ' 99' ' ' TYR . 5.1 Cg_exo -84.98 112.21 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.379 3.386 . . . . 0.0 111.872 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -103.98 149.42 25.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.337 0.589 . . . . 0.0 111.015 -177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -79.68 -43.78 22.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.3 m -83.61 111.31 19.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.087 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -56.93 -45.0 83.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.741 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.8 -28.17 69.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.973 -173.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -67.47 -43.99 79.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.338 . . . . 0.0 110.521 174.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.8 92.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.243 0.544 . . . . 0.0 110.208 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.16 74.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.107 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' LEU . . . -61.63 -39.9 92.94 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 111.186 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -57.63 -40.29 78.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.758 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.589 HG22 ' H ' ' A' ' 132' ' ' GLY . 42.4 t -71.79 -28.39 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.843 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 54.2 mt -57.85 -49.82 75.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.451 175.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.55 -48.66 54.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.176 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.918 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.5 pt-20 -157.81 -75.97 0.08 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.566 175.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.918 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.0 -136.85 8.1 Favored Glycine 0 N--CA 1.448 -0.546 0 O-C-N 123.601 0.563 . . . . 0.0 112.914 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.589 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -166.31 -91.91 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.57 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.48 139.7 50.53 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 176.393 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.61 118.19 41.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.781 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.27 164.37 29.42 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.464 -176.727 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.02 165.57 13.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.685 ' HA ' HG12 ' A' ' 140' ' ' ILE . 4.2 tt -64.55 -30.15 71.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.122 0.486 . . . . 0.0 109.95 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.19 -10.68 59.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.011 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -118.99 15.59 13.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.41 0.624 . . . . 0.0 110.262 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.781 HD13 HD13 ' A' ' 135' ' ' LEU . 28.3 mm -72.07 121.52 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.923 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.497 HG23 ' HG2' ' A' ' 144' ' ' MET . 1.2 t -115.39 147.03 41.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -69.4 -31.71 70.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.947 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.93 -29.36 60.0 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.367 0.417 . . . . 0.0 112.076 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.497 ' HG2' HG23 ' A' ' 141' ' ' THR . 12.5 mmt -75.74 -34.88 60.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.14 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.549 ' HB ' HD12 ' A' ' 146' ' ' LEU . 2.7 t -86.12 -25.28 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.049 -172.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.549 HD12 ' HB ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -179.65 149.2 0.36 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.444 -176.012 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.415 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 43.0 p -103.07 120.18 53.05 Favored Pre-proline 0 C--N 1.317 -0.842 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.557 -178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 37.3 Cg_endo -68.39 -77.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.499 2.133 . . . . 0.0 111.483 173.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.6 t -128.86 -27.44 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 73.45 31.54 1.33 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.268 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 t -86.27 16.28 4.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.791 0.805 . . . . 0.0 109.407 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -113.91 -149.04 10.07 Favored Glycine 0 N--CA 1.437 -1.259 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.716 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.1 m -99.89 162.66 12.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.275 -0.462 . . . . 0.0 110.351 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.31 143.43 85.25 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.9 -29.52 82.2 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.878 2.385 . . . . 0.0 113.213 -173.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.549 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 3.2 ptp180 -166.25 -54.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.549 175.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.549 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -160.19 28.3 0.17 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.867 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.8 t70 55.0 75.66 0.3 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.962 0.887 . . . . 0.0 108.92 -168.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.453 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 26.0 t0 -128.97 25.13 5.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.739 1.257 . . . . 0.0 107.863 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.428 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 3.1 pt-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-N 113.221 -1.809 . . . . 0.0 111.137 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.589 ' HB3' ' OD1' ' A' ' 74' ' ' ASN . 30.0 ttpt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -139.99 142.64 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.34 . . . . 0.0 111.052 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 12.8 pt20 -149.58 137.45 20.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.599 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.473 HG22 ' HB ' ' A' ' 71' ' ' ILE . 23.9 pt -115.88 142.91 27.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 0.0 111.111 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -118.72 129.84 55.49 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.3 mp -95.7 146.54 24.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.853 0.358 . . . . 0.0 111.167 -175.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.672 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 22.1 tt0 -74.05 125.37 28.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.722 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.09 -13.34 61.72 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.201 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 24.3 t -104.3 125.29 34.65 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 4.2 Cg_exo -80.83 10.47 3.34 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.057 2.505 . . . . 0.0 112.733 -177.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -124.15 133.23 24.52 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.812 0.339 . . . . 0.0 111.455 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 70.8 Cg_endo -98.11 153.69 0.83 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.744 2.963 . . . . 0.0 112.382 173.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 3.0 tm? -110.76 105.54 14.43 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -112.61 136.77 51.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.16 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.461 ' HE2' HE21 ' A' ' 51' ' ' GLN . 10.7 t80 -149.98 154.97 39.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.144 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.6 m -64.04 -38.78 92.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.298 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.92 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 45.4 mt-30 -72.42 108.69 5.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.571 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 36' ' ' ALA . 12.3 t -62.55 -51.52 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.621 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -53.95 -34.53 59.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.577 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.621 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 28.3 t70 -76.31 -46.69 26.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.767 0.317 . . . . 0.0 110.6 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.821 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -71.23 -39.03 71.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.426 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.538 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 27.3 pt -63.75 -30.81 50.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 54' ' ' ASP . . . -61.6 -42.66 99.18 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 174.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.821 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 61.6 m-85 -56.91 -39.16 73.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.979 0.418 . . . . 0.0 110.799 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' A' ' 68' ' ' ILE . . . -65.86 -17.8 64.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.894 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 15.3 mtm180 -102.37 12.61 36.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.57 -60.31 0.19 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.303 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 23.6 Cg_exo -66.57 35.19 0.13 Allowed 'Trans proline' 0 N--CA 1.48 0.686 0 C-N-CA 123.774 2.983 . . . . 0.0 114.959 -177.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 67' ' ' PRO . 4.6 pt-20 -83.42 128.03 34.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 170.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -47.58 -92.74 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -170.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -125.85 -5.49 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.077 0.941 . . . . 0.0 109.516 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 41' ' ' GLU . . . -113.13 141.92 26.48 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.988 -176.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.672 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.0 Cg_endo -70.1 155.06 65.71 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 C-N-CA 122.413 2.076 . . . . 0.0 111.786 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 68' ' ' ILE . 22.8 pt -71.08 109.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.17 0.51 . . . . 0.0 110.287 175.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -71.7 -52.01 19.98 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 p -161.23 138.81 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.443 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.56 HG22 ' HB2' ' A' ' 95' ' ' ASP . 1.4 tt -111.39 135.85 49.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.465 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 92' ' ' ILE . 87.0 m-85 -115.23 134.64 54.96 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.118 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 94' ' ' ALA . 27.1 m -126.53 150.11 32.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.92 0.39 . . . . 0.0 110.086 176.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.589 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 14.0 m120 -83.71 104.9 14.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.55 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 18.7 t70 -55.37 120.66 7.46 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 125.476 1.735 . . . . 0.0 110.29 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' A' ' 74' ' ' ASN . 22.3 mtm -128.63 -165.25 1.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.303 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.79 61.49 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 166.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.595 ' HB1' HG13 ' A' ' 115' ' ' VAL . . . 74.31 -32.27 0.23 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.789 0.836 . . . . 0.0 112.881 169.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.71 -32.9 63.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.047 0.451 . . . . 0.0 110.581 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.28 -68.47 1.17 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.234 172.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 53.14 34.87 18.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.265 0.555 . . . . 0.0 112.135 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.5 p -83.59 177.61 8.34 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.227 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.92 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 47.0 p90 -64.13 -24.83 67.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.174 0.511 . . . . 0.0 111.081 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.74 -27.24 27.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 64.55 173.79 0.07 OUTLIER Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.746 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.573 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 59.6 Cg_endo -97.04 6.08 1.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.399 2.066 . . . . 0.0 111.264 173.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.32 157.56 7.81 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.364 -175.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.94 126.71 31.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.842 0.353 . . . . 0.0 110.417 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -118.6 -159.13 11.03 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.487 -174.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 76.9 m-20 -81.39 151.98 27.67 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -98.08 129.83 44.9 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 121.318 -0.864 . . . . 0.0 110.209 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.753 HD13 ' HB2' ' A' ' 118' ' ' SER . 20.3 pt -138.54 161.23 30.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.985 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.25 100.57 7.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.431 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -66.28 -34.97 79.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.798 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.613 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 31.3 t70 -61.06 -24.88 66.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.618 0.723 . . . . 0.0 110.138 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -111.64 22.01 15.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.839 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.92 178.79 4.18 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.961 0.41 . . . . 0.0 111.156 -170.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -96.32 130.48 43.41 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.099 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.554 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 11.2 m-85 -120.48 136.56 54.72 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.918 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.867 HG13 ' HB ' ' A' ' 115' ' ' VAL . 1.5 p -121.06 125.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.216 0.531 . . . . 0.0 110.226 172.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.732 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 55.6 t -101.75 125.47 55.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.652 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -87.55 126.84 8.2 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.753 -174.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.7 m -92.66 -21.27 20.11 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.551 0.215 . . . . 0.0 111.084 177.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -89.02 -46.46 8.84 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -170.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -129.89 19.71 5.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.351 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.665 ' HG3' ' H ' ' A' ' 107' ' ' GLY . 8.9 tpp180 -112.0 -161.65 0.76 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.858 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.665 ' H ' ' HG3' ' A' ' 106' ' ' ARG . . . 66.58 46.17 78.78 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -163.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -56.95 -98.22 0.01 OUTLIER Glycine 0 CA--C 1.517 0.161 0 CA-C-N 113.78 -1.21 . . . . 0.0 115.771 -164.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.1 ttt -87.95 21.6 2.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.568 0.699 . . . . 0.0 110.957 -169.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 135.53 -57.69 0.68 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -177.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.459 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.29 122.68 44.36 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.47 ' CA ' ' HA2' ' A' ' 107' ' ' GLY . 5.2 Cg_endo -47.42 152.35 2.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.884 2.389 . . . . 0.0 112.372 173.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.548 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -114.01 131.81 56.22 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -172.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.602 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.8 130.16 39.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.442 -174.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.867 ' HB ' HG13 ' A' ' 100' ' ' VAL . 93.1 t -94.85 103.94 13.1 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.4 Cg_exo -91.23 120.38 0.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.548 2.832 . . . . 0.0 112.171 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.36 148.81 50.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.375 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.753 ' HB2' HD13 ' A' ' 92' ' ' ILE . 42.2 t -80.26 -26.86 38.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 173.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.0 m -101.17 121.26 41.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.538 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -59.21 -46.66 87.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.618 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -62.76 -28.97 70.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.272 -173.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -69.63 -38.13 77.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.64 -36.93 81.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.302 0.572 . . . . 0.0 109.755 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.85 -35.85 82.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.573 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.73 78.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.461 ' HZ ' HH21 ' A' ' 106' ' ' ARG . 63.8 t80 -63.48 -41.01 98.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.803 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 41.3 t -72.95 -30.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.202 0.525 . . . . 0.0 110.251 177.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.2 -36.87 76.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.084 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.08 -50.94 7.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.15 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.88 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 1.3 pt-20 -146.94 -81.61 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.093 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.88 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 52.52 -146.82 15.46 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.669 173.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -172.53 -84.18 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.732 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.43 145.23 51.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.728 0.299 . . . . 0.0 110.509 174.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.7 t -101.23 113.3 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.267 0.556 . . . . 0.0 109.535 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.809 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -130.48 164.86 23.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.918 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.476 ' H ' ' HB3' ' A' ' 139' ' ' ASP . . . -90.66 166.18 13.3 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.613 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 5.8 tt -64.38 -38.64 91.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.76 -10.24 57.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.26 175.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 136' ' ' ALA . 31.3 t70 -120.24 18.58 12.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.413 0.625 . . . . 0.0 110.389 -175.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.809 HD13 HD13 ' A' ' 135' ' ' LEU . 25.2 mm -72.02 121.35 22.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 145' ' ' VAL . 2.5 t -116.67 148.88 40.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.093 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.538 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 4.3 p30 -68.96 -26.36 65.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.605 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.29 69.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.995 0.426 . . . . 0.0 111.324 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.722 ' HE2' ' HB2' ' A' ' 155' ' ' PRO . 11.5 mmt -86.96 -32.23 20.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.401 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 141' ' ' THR . 4.2 t -86.75 -23.7 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.13 0.49 . . . . 0.0 110.726 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.4 pp -153.4 125.5 7.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.324 -176.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.2 p -102.85 131.68 21.99 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.656 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.31 -99.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.661 2.241 . . . . 0.0 111.386 172.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.634 ' HB ' HG22 ' A' ' 151' ' ' THR . 4.8 t -115.21 -5.78 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 70.19 7.84 6.39 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.573 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.634 HG22 ' HB ' ' A' ' 149' ' ' VAL . 7.6 t -82.18 73.5 9.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 122.195 0.998 . . . . 0.0 109.035 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.83 -140.46 2.99 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.72 -173.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -102.34 161.32 13.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.06 132.08 93.72 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.722 ' HB2' ' HE2' ' A' ' 144' ' ' MET . 14.3 Cg_exo -46.45 -75.67 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.641 2.894 . . . . 0.0 114.465 -167.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.614 ' HG3' ' OD1' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -92.87 -36.69 12.68 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.649 -176.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 173.16 38.95 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.8 t70 62.7 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -164.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.614 ' OD1' ' HG3' ' A' ' 156' ' ' ARG . 8.3 m-20 -63.55 161.36 14.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.386 -157.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 C--O 1.252 1.194 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.329 -176.292 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 28.6 ttpp . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -147.62 144.54 28.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.633 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 14.5 pt20 -147.31 126.82 13.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.898 0.38 . . . . 0.0 110.558 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.886 HG12 ' HB3' ' A' ' 47' ' ' LEU . 7.8 pt -117.3 138.13 48.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.12 0.486 . . . . 0.0 111.113 -176.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -103.95 126.97 51.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.518 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.828 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.0 mp -92.18 139.87 30.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.068 0.461 . . . . 0.0 111.286 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.763 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 36.8 tt0 -74.54 124.33 26.43 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.429 176.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.0 -15.7 62.57 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.533 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.483 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 33.4 t -120.0 124.09 28.04 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 120.957 0.408 . . . . 0.0 110.202 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 2.8 Cg_exo -77.31 7.71 3.61 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.055 2.503 . . . . 0.0 112.487 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.496 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -102.56 131.2 22.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.871 0.367 . . . . 0.0 111.254 -178.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 37.5 Cg_endo -98.88 136.89 0.31 Allowed 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.803 3.002 . . . . 0.0 112.69 174.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.886 ' HB3' HG12 ' A' ' 38' ' ' ILE . 13.8 tp -82.99 129.84 35.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.701 176.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.422 ' HE1' ' HG2' ' A' ' 46' ' ' PRO . 51.6 m-85 -118.38 133.12 56.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.96 0.41 . . . . 0.0 111.162 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.67 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 11.4 m-85 -150.2 148.96 29.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.477 174.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 m -77.32 -32.04 54.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.056 0.455 . . . . 0.0 110.488 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.741 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 41.5 mt-30 -88.14 122.53 31.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.682 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.639 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 6.2 t -63.77 -51.04 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.638 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -51.25 -36.44 42.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.867 179.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.638 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 36.0 t70 -76.39 -49.22 17.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.823 0.344 . . . . 0.0 110.604 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -62.53 -42.49 99.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.446 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.003 HD12 ' HB3' ' A' ' 114' ' ' ALA . 21.9 pt -65.42 -31.48 54.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.284 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.579 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . . . -60.87 -43.62 98.17 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 120.591 0.234 . . . . 0.0 110.487 174.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.64 ' HA ' ' HG2' ' A' ' 62' ' ' PRO . 11.8 m-85 -61.1 -40.11 92.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.285 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.44 ' HB1' HG21 ' A' ' 68' ' ' ILE . . . -67.05 -27.03 67.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.432 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.579 ' HE ' ' HA ' ' A' ' 57' ' ' ALA . 83.4 mtm180 -88.57 -1.48 58.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.019 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.06 -75.75 0.03 OUTLIER Glycine 0 CA--C 1.52 0.348 0 C-N-CA 119.581 -1.295 . . . . 0.0 114.045 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.64 ' HG2' ' HA ' ' A' ' 58' ' ' TYR . 30.7 Cg_exo -37.96 -51.31 1.93 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 124.314 3.343 . . . . 0.0 114.665 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -76.94 98.34 4.89 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -117.09 -23.11 8.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.208 -173.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.5 tp -67.45 -29.32 45.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.009 0.433 . . . . 0.0 111.244 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.828 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -141.5 141.45 22.96 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.763 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 57.8 Cg_endo -73.38 163.21 38.36 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.43 2.086 . . . . 0.0 111.993 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.44 HG21 ' HB1' ' A' ' 59' ' ' ALA . 14.3 pt -85.49 121.02 36.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.337 0.589 . . . . 0.0 110.882 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.81 -59.43 2.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.252 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.16 138.54 20.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.203 0.525 . . . . 0.0 110.298 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.506 HG13 HG22 ' A' ' 38' ' ' ILE . 2.3 tt -122.52 129.25 75.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.399 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -111.73 130.69 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.4 m -127.4 139.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.77 0.795 . . . . 0.0 111.25 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -87.58 101.67 13.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 170.338 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.944 ' HB3' ' HB2' ' A' ' 90' ' ' ASN . 12.5 t0 -46.95 108.34 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.846 1.341 . . . . 0.0 109.267 175.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.572 ' C ' ' HG3' ' A' ' 86' ' ' PRO . 14.0 ttt -162.65 -101.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.591 -165.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.469 ' H ' ' HB3' ' A' ' 76' ' ' MET . . . -79.7 63.1 4.06 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-O 122.112 0.84 . . . . 0.0 111.978 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 115' ' ' VAL . . . -142.75 -55.05 0.42 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.176 -1.512 . . . . 0.0 107.018 174.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.81 -20.76 65.21 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.039 166.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.643 ' HA3' ' HD3' ' A' ' 86' ' ' PRO . . . -89.37 -96.65 1.07 Allowed Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.158 175.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -178.88 -51.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 85' ' ' GLN . 71.9 p -107.7 175.75 5.38 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.741 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 10.9 p90 -70.45 -31.13 68.16 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.273 0.559 . . . . 0.0 110.125 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.87 -28.69 25.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.036 -174.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.509 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.9 OUTLIER -61.71 -60.19 11.07 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -167.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.643 ' HD3' ' HA3' ' A' ' 80' ' ' GLY . 7.0 Cg_endo -44.75 -57.57 1.98 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.298 2.665 . . . . 0.0 113.523 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.49 -45.7 2.57 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 76' ' ' MET . 11.4 m-20 -77.01 146.85 37.15 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.407 0.283 . . . . 0.0 110.474 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.96 100.65 0.29 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.857 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 91.7 m-20 -95.85 150.26 20.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 175.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -109.6 128.08 54.97 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.194 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.3 pt -145.52 163.45 11.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.635 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.7 109.13 21.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.62 -33.03 74.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.792 -174.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.87 ' HA ' HD13 ' A' ' 137' ' ' LEU . 12.7 t70 -58.66 -31.46 68.18 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.83 0.824 . . . . 0.0 110.566 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -111.31 38.29 2.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.207 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' A' ' 117' ' ' PHE . . . -140.09 169.81 17.01 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.535 -168.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -90.25 143.28 26.91 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.096 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.478 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 3.2 m-85 -119.81 134.3 55.29 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.828 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.642 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.2 p -113.17 121.54 65.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.624 HG12 HH11 ' A' ' 106' ' ' ARG . 19.7 t -101.79 103.06 14.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.755 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -68.75 133.11 27.12 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.777 -173.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.9 t -92.11 -21.99 20.14 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.64 -43.81 68.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.608 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.519 ' HB2' ' OE1' ' A' ' 113' ' ' GLU . 77.1 mtt180 -100.97 -85.84 0.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.672 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.755 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 3.7 ttp180 58.42 -96.6 0.07 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.484 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 167.6 -60.56 0.21 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -170.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 61.73 -84.83 0.03 OUTLIER Glycine 0 C--N 1.332 0.341 0 O-C-N 123.823 0.366 . . . . 0.0 113.034 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.2 tpt -82.99 -4.36 58.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.023 0.44 . . . . 0.0 110.381 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.79 -128.98 3.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.474 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.444 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.1 102.97 31.49 Favored Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 122.918 -0.166 . . . . 0.0 111.137 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 2.4 Cg_endo -47.31 150.51 3.36 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.413 3.409 . . . . 0.0 113.936 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.704 ' HB3' ' HA ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -114.42 138.11 50.98 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.293 -172.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 1.003 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -128.77 130.33 46.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.649 172.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.642 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 14.5 t -106.97 104.85 53.63 Favored Pre-proline 0 C--N 1.315 -0.933 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.553 172.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 2.7 Cg_exo -84.76 123.75 2.9 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.79 2.994 . . . . 0.0 112.697 178.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.469 ' O ' ' HB1' ' A' ' 97' ' ' ALA . 43.1 m-85 -127.0 149.18 50.01 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.879 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.9 t -79.68 -26.63 40.92 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.588 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 19.3 m -100.51 124.11 45.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.957 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -37.24 84.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.283 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.588 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 19.5 p-10 -63.65 -32.37 73.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.661 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 119' ' ' SER . 43.7 mm-40 -64.28 -42.7 96.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.998 0.428 . . . . 0.0 110.259 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.85 -37.88 79.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.718 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.86 94.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.67 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' A' ' 128' ' ' LEU . . . -59.92 -35.65 75.36 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 110.943 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -65.24 -37.37 87.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.204 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.488 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 46.9 t -72.24 -32.21 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.561 178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 125' ' ' ALA . 69.5 mt -58.33 -40.38 81.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.84 -49.63 9.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.549 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.647 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.6 pt-20 -149.65 -90.14 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.944 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.647 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 51.4 -149.76 7.66 Favored Glycine 0 C--N 1.331 0.267 0 N-CA-C 114.203 0.441 . . . . 0.0 114.203 173.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.427 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -163.86 -96.73 0.11 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.541 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -123.32 144.33 49.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.941 0.37 . . . . 0.0 110.513 176.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.5 t -101.17 122.4 53.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.346 0.593 . . . . 0.0 110.646 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 140' ' ' ILE . 0.4 OUTLIER -147.11 154.7 41.44 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.669 178.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.411 ' H ' ' HB3' ' A' ' 139' ' ' ASP . . . -79.48 168.61 19.21 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.87 HD13 ' HA ' ' A' ' 95' ' ' ASP . 7.0 tt -67.71 -34.13 76.27 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.99 -15.33 60.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.254 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 136' ' ' ALA . 36.2 t70 -111.23 0.69 16.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.24 0.543 . . . . 0.0 110.861 -174.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.588 ' HA ' HD22 ' A' ' 135' ' ' LEU . 1.4 tt -71.64 144.79 12.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.514 0.673 . . . . 0.0 110.902 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.32 148.16 43.49 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.421 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -69.05 -30.41 68.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.006 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.841 ' HB3' ' HB3' ' A' ' 155' ' ' PRO . . . -65.29 -28.55 69.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.701 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.1 mmt -78.34 -26.23 46.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.672 0.272 . . . . 0.0 111.279 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.462 HG11 ' HD2' ' A' ' 60' ' ' ARG . 4.0 t -86.58 -23.54 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.059 0.457 . . . . 0.0 110.763 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 pp -157.04 132.42 9.17 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.18 -175.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 34.7 p -107.04 135.65 19.56 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.586 0.708 . . . . 0.0 111.642 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.472 ' HG2' ' H ' ' A' ' 150' ' ' GLU . 51.7 Cg_endo -93.04 -131.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.804 3.002 . . . . 0.0 111.47 175.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.434 ' H ' ' HB2' ' A' ' 148' ' ' PRO . 6.8 t -97.78 2.85 10.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.743 0.782 . . . . 0.0 109.123 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.472 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 42.0 mt-10 59.98 22.1 11.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.579 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.6 t -87.28 26.72 1.16 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.102 0.953 . . . . 0.0 109.03 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -118.48 -124.46 3.36 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.273 -172.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.1 p -129.39 161.77 29.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.642 0.258 . . . . 0.0 110.651 -176.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.499 ' HB3' ' HA ' ' A' ' 158' ' ' ASP . 2.0 mp0 -71.6 139.96 84.01 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.727 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.841 ' HB3' ' HB3' ' A' ' 143' ' ' ALA . 52.6 Cg_endo -72.93 -29.91 11.64 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.816 2.344 . . . . 0.0 111.86 176.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 159' ' ' ASP . 6.8 ptp180 -144.55 -141.72 0.12 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.614 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.417 ' H ' ' HB2' ' A' ' 156' ' ' ARG . . . -71.1 72.7 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 170.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 155' ' ' PRO . 9.8 t70 62.27 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -164.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.577 ' HA ' ' HG3' ' A' ' 156' ' ' ARG . 5.0 p-10 -171.81 -166.67 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.573 0.225 . . . . 0.0 110.552 167.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 C--O 1.251 1.182 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.845 -175.898 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 37.0 tttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.491 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -141.49 143.08 33.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.699 0.681 . . . . 0.0 112.135 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 10.7 pt20 -149.29 139.26 22.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.538 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.564 HG22 ' HB ' ' A' ' 71' ' ' ILE . 17.1 pt -122.33 138.14 53.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.163 0.506 . . . . 0.0 111.622 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -98.86 116.39 31.0 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 173.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.814 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.4 mp -92.17 134.24 35.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.98 0.419 . . . . 0.0 110.765 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.896 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 39.9 tt0 -71.75 125.82 28.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.516 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.67 -26.63 23.89 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 23.1 t -97.79 126.08 42.11 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.3 Cg_exo -74.2 -9.59 22.0 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.878 2.385 . . . . 0.0 113.177 -174.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.25 146.55 49.58 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.821 0.343 . . . . 0.0 111.587 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.24 151.45 26.58 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.824 2.349 . . . . 0.0 112.389 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tt -108.77 101.18 10.32 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 53.9 p90 -101.62 151.98 21.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.819 0.342 . . . . 0.0 110.592 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -148.04 149.74 32.65 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.656 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -64.28 -48.65 74.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.339 0.59 . . . . 0.0 110.764 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.725 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 35.0 mt-30 -78.63 113.99 17.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.391 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 36' ' ' ALA . 9.1 t -57.58 -48.83 82.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.639 HH11 ' HB2' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.34 -30.99 53.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.702 -178.409 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.639 ' HB2' HH11 ' A' ' 53' ' ' ARG . 14.1 t70 -76.37 -48.48 19.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.804 0.335 . . . . 0.0 110.683 -177.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.77 83.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.333 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.855 HD12 ' HB3' ' A' ' 114' ' ' ALA . 23.3 pt -67.47 -30.24 48.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.728 0.299 . . . . 0.0 110.676 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.07 88.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.861 0.362 . . . . 0.0 110.309 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -59.66 -37.32 78.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.434 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -70.58 -18.28 62.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.905 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.572 HH12 HG11 ' A' ' 145' ' ' VAL . 48.9 mtm180 -105.07 12.38 32.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.57 -72.42 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.317 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.24 -2.01 0.22 Allowed 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 123.905 3.07 . . . . 0.0 115.145 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.481 ' OE1' HG12 ' A' ' 68' ' ' ILE . 1.1 pt-20 -74.4 53.63 0.54 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.578 0.704 . . . . 0.0 110.033 171.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -92.33 -39.93 11.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.725 -176.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -75.79 -30.22 21.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.074 0.464 . . . . 0.0 110.545 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.814 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.06 140.41 13.45 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.347 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.896 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 80.4 Cg_endo -77.9 153.77 29.43 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.546 2.164 . . . . 0.0 112.134 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.709 HD13 ' HB1' ' A' ' 59' ' ' ALA . 46.6 pt -77.96 125.47 37.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.304 0.573 . . . . 0.0 110.188 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tt -86.0 -52.5 5.67 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -156.66 141.12 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.129 176.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.564 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.9 tt -114.6 129.19 71.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.322 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.462 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 87.1 m-85 -111.96 128.24 56.1 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 94' ' ' ALA . 28.2 m -126.05 157.02 36.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.455 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -86.95 110.3 19.93 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 15.8 t70 -52.8 98.06 0.02 OUTLIER 'General case' 0 C--O 1.239 0.542 0 O-C-N 125.338 1.649 . . . . 0.0 109.503 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.633 ' SD ' ' HB2' ' A' ' 86' ' ' PRO . 2.0 mmt -179.71 87.74 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.548 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 79' ' ' ALA . . . -146.57 36.87 1.23 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 16.88 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -167.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -156.04 7.09 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.893 0.378 . . . . 0.0 110.537 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA3' ' NH1' ' A' ' 106' ' ' ARG . . . 130.0 -12.18 5.86 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.259 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.29 63.74 0.76 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.604 0.716 . . . . 0.0 109.945 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 46.3 p -83.81 176.71 8.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.409 -172.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.725 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 41.3 p-90 -66.62 -25.08 66.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.155 0.502 . . . . 0.0 110.275 172.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -77.5 -36.16 52.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.24 175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 67.93 150.64 0.12 Allowed Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.889 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.633 ' HB2' ' SD ' ' A' ' 76' ' ' MET . 17.1 Cg_exo -72.7 0.2 7.98 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.701 2.267 . . . . 0.0 111.568 169.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.46 176.26 15.64 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.055 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.34 135.76 38.4 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.77 -136.6 3.59 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.073 -174.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.599 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 53.7 t30 -89.91 151.34 21.78 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -173.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -98.8 128.91 45.16 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.896 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.714 HG21 ' HB2' ' A' ' 118' ' ' SER . 25.9 pt -145.17 162.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.185 -175.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.29 110.7 19.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.501 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -69.51 -35.25 75.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -172.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.656 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -68.35 -22.73 64.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.797 0.808 . . . . 0.0 109.791 -178.394 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 43.2 mmtm -102.68 26.5 7.92 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.767 175.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.09 176.69 7.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.475 -171.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -91.36 134.48 34.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.035 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.514 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 7.8 m-85 -120.39 136.16 54.81 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.946 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.897 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.1 p -115.62 122.39 69.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.445 0.64 . . . . 0.0 109.639 173.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.683 HG23 HD11 ' A' ' 135' ' ' LEU . 48.1 t -101.59 109.78 26.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.765 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -69.69 125.05 16.15 Favored Glycine 0 N--CA 1.448 -0.531 0 O-C-N 123.986 0.804 . . . . 0.0 113.263 -173.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.0 t -90.13 -38.58 13.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.839 0.352 . . . . 0.0 110.227 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -80.29 -43.72 20.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 111.466 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 79.8 mtt180 -125.65 107.08 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.014 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.731 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 1.2 tpp180 173.93 -177.28 0.08 Allowed 'General case' 0 C--O 1.232 0.165 0 O-C-N 123.941 0.776 . . . . 0.0 109.68 171.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.02 -57.33 19.82 Favored Glycine 0 N--CA 1.451 -0.33 0 O-C-N 123.368 0.417 . . . . 0.0 113.615 -176.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.63 -98.26 0.59 Allowed Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.428 ' CE ' ' HA ' ' A' ' 148' ' ' PRO . 4.1 mmt -86.99 -3.35 59.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.952 0.406 . . . . 0.0 110.733 173.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.7 -127.93 6.12 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.24 96.17 7.9 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.787 0.327 . . . . 0.0 110.598 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 72.6 Cg_endo -76.51 147.64 28.72 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.384 2.056 . . . . 0.0 112.498 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.731 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 32.1 mt-10 -129.33 131.68 46.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.462 -176.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.855 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -93.87 131.1 39.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.499 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.897 ' HB ' HG13 ' A' ' 100' ' ' VAL . 87.0 t -95.94 106.28 26.96 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 120.89 0.376 . . . . 0.0 110.227 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.3 Cg_endo -91.55 123.68 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.586 2.857 . . . . 0.0 112.677 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -132.97 150.42 52.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.092 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.714 ' HB2' HG21 ' A' ' 92' ' ' ILE . 9.7 t -86.9 -21.92 26.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.1 m -93.77 119.48 32.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.873 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -61.62 -48.01 82.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.096 0.474 . . . . 0.0 111.202 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.59 -29.57 70.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.618 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -62.15 -41.58 98.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.578 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -69.87 -37.02 75.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.131 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.68 86.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.048 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.95 82.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.105 0.479 . . . . 0.0 110.452 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -60.66 -42.86 97.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.736 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.631 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 55.1 t -61.97 -42.33 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.158 177.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tp -54.36 -36.16 63.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.784 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.06 -40.1 15.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.29 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -164.52 -35.13 0.03 OUTLIER 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.765 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -49.39 156.07 1.81 Allowed Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.45 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.443 ' N ' ' HA2' ' A' ' 102' ' ' GLY . . . -94.03 -82.67 1.56 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.949 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.609 HE21 HD23 ' A' ' 135' ' ' LEU . 12.6 pt20 -130.36 150.42 51.6 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.835 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.34 113.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.366 0.603 . . . . 0.0 110.214 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.683 HD11 HG23 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -133.89 159.97 39.07 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.759 -179.047 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.434 ' H ' ' HB3' ' A' ' 139' ' ' ASP . . . -84.69 168.63 15.07 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.656 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 6.0 tt -65.2 -32.08 73.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.312 0.577 . . . . 0.0 109.497 178.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.91 -10.26 59.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.735 176.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 136' ' ' ALA . 18.0 t70 -116.4 14.92 15.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.297 -174.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.644 HD13 HD13 ' A' ' 135' ' ' LEU . 36.6 mm -71.49 121.41 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.76 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.5 t -108.36 147.82 30.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.126 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -69.41 -22.87 63.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.122 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 155' ' ' PRO . . . -67.4 -30.07 69.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.654 -175.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.445 ' HG3' ' HG2' ' A' ' 133' ' ' GLN . 78.1 mmm -86.44 -37.78 17.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.832 0.348 . . . . 0.0 111.189 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.572 HG11 HH12 ' A' ' 60' ' ' ARG . 13.3 t -78.81 -21.86 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.522 0.677 . . . . 0.0 110.44 -174.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -147.31 104.82 3.68 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.119 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.5 ' HB ' ' OE2' ' A' ' 150' ' ' GLU . 20.0 p -102.06 123.91 41.86 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.613 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.499 ' O ' HG22 ' A' ' 151' ' ' THR . 71.9 Cg_endo -74.51 44.42 1.07 Allowed 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.405 2.737 . . . . 0.0 112.251 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.458 ' O ' HG12 ' A' ' 149' ' ' VAL . 6.5 t 54.79 28.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 122.067 0.937 . . . . 0.0 109.869 -174.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.5 ' OE2' ' HB ' ' A' ' 147' ' ' THR . 1.8 mp0 59.28 23.06 11.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.214 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 148' ' ' PRO . 6.9 t -81.57 13.77 2.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.792 0.806 . . . . 0.0 109.539 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . -119.55 -142.59 6.78 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.788 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.4 t -96.61 163.23 13.11 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -57.11 151.88 32.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.511 ' HA ' ' HB1' ' A' ' 143' ' ' ALA . 11.4 Cg_endo -54.39 -22.99 29.06 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.07 2.513 . . . . 0.0 113.087 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.53 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 2.1 ptp180 -174.96 -54.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.256 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.53 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -163.21 30.39 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.761 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.5 t70 54.22 68.25 0.88 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.845 0.831 . . . . 0.0 109.465 -170.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -100.51 -6.14 25.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.397 -172.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.076 -179.608 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.604 ' N ' ' HB3' ' A' ' 74' ' ' ASN . 79.8 tttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.737 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -143.15 144.75 32.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.046 0.385 . . . . 0.0 111.401 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 3.9 pt20 -149.2 140.1 22.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.615 HG22 ' HB ' ' A' ' 71' ' ' ILE . 24.2 pt -115.77 131.15 69.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.112 0.482 . . . . 0.0 110.19 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -98.75 118.22 34.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.848 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.4 mp -84.04 153.24 23.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.375 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.545 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 28.9 tt0 -74.12 126.84 31.45 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.962 177.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.82 -41.46 3.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.561 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.9 t -81.93 125.28 77.97 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.1 Cg_exo -79.09 -3.97 13.53 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.14 2.56 . . . . 0.0 112.493 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -101.82 133.54 20.69 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.59 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 61.2 Cg_endo -92.03 133.44 1.31 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.01 2.473 . . . . 0.0 112.315 176.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.9 tt -86.96 105.62 17.25 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 40.2 p90 -111.79 143.73 42.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.183 0.516 . . . . 0.0 111.468 -175.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -150.01 138.92 20.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.422 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 15.1 m -58.91 -37.0 75.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.95 0.405 . . . . 0.0 111.342 -177.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.539 ' HB3' ' HD2' ' A' ' 53' ' ' ARG . 51.2 mt-30 -81.86 109.29 16.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.432 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.737 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 39.8 t -59.31 -46.77 92.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.147 0.499 . . . . 0.0 110.661 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.539 ' HD2' ' HB3' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -57.15 -30.29 64.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.469 -178.375 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -74.6 -48.64 25.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 110.28 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.81 90.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.75 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 53' ' ' ARG . 35.1 pt -66.05 -31.74 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.545 0.212 . . . . 0.0 110.579 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.3 90.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.781 176.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.629 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 54.5 m-85 -62.74 -37.49 86.79 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 111.444 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.733 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -63.99 -17.87 63.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.229 -175.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 -100.31 12.66 36.61 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -173.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.48 -56.41 0.34 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.457 -1.354 . . . . 0.0 113.863 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.629 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 34.2 Cg_exo -60.62 6.53 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.346 2.698 . . . . 0.0 114.458 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -66.89 105.54 1.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 170.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -128.68 77.82 1.81 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.39 0.614 . . . . 0.0 110.864 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 66' ' ' ALA . 5.4 tp 177.42 -52.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.723 176.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.848 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.28 146.33 18.34 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.545 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 66.7 Cg_endo -72.41 156.71 54.23 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.109 1.873 . . . . 0.0 111.994 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.733 HD13 ' HB1' ' A' ' 59' ' ' ALA . 46.1 pt -73.47 129.94 36.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.08 0.467 . . . . 0.0 110.577 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tt -88.86 -49.67 6.67 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -160.46 139.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.067 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 38' ' ' ILE . 4.4 tt -108.94 129.87 62.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 120.912 0.387 . . . . 0.0 110.115 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -111.84 127.29 55.78 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.63 153.72 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.007 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.604 ' HB3' ' N ' ' A' ' 35' ' ' LYS . 25.7 t-20 -80.17 102.0 9.15 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 25.5 t70 -49.66 107.1 0.13 Allowed 'General case' 0 C--O 1.243 0.72 0 O-C-N 125.808 1.943 . . . . 0.0 110.973 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.534 ' HG3' ' O ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -171.36 151.56 3.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.377 -179.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.5 50.3 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.598 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.68 88.83 3.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.19 32.04 20.72 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.485 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.15 -90.87 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.991 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.496 ' HB3' HG22 ' A' ' 115' ' ' VAL . . . 61.86 33.15 17.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.541 0.686 . . . . 0.0 110.278 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.558 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 20.4 p -83.74 177.08 8.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.721 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -55.51 -35.64 65.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.811 0.339 . . . . 0.0 111.288 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -77.24 -30.37 54.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 82' ' ' THR . 22.8 mt-30 63.88 170.28 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.498 175.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -94.44 9.73 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.547 2.165 . . . . 0.0 111.468 171.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.24 130.08 5.97 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.018 -177.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -64.65 135.09 55.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.696 0.284 . . . . 0.0 110.769 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.27 -79.0 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.172 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.774 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 43.9 t30 -100.07 153.49 19.18 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -120.02 131.35 55.11 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 121.691 -0.631 . . . . 0.0 110.676 173.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.78 HG21 ' HB2' ' A' ' 118' ' ' SER . 42.1 pt -141.98 167.37 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.839 -175.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 96' ' ' LYS . . . -84.64 116.99 23.49 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 171.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.457 ' O ' HD11 ' A' ' 137' ' ' LEU . . . -69.18 -39.63 78.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.596 -174.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.863 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 2.4 p-10 -78.13 0.58 24.29 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.939 0.876 . . . . 0.0 110.645 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 40.3 mmtm -127.18 56.49 1.52 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.235 169.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.647 ' H ' HD21 ' A' ' 137' ' ' LEU . . . -156.76 -170.12 3.21 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 121.738 -0.601 . . . . 0.0 112.101 -172.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.97 140.96 31.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.023 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 2.2 m-85 -120.68 136.75 54.76 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.09 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.511 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.0 p -113.08 120.49 63.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.773 0.797 . . . . 0.0 109.614 168.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.608 HG23 HD11 ' A' ' 135' ' ' LEU . 99.7 t -101.87 106.77 20.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.556 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.7 130.74 28.48 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.745 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.2 t -92.37 -28.91 16.61 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -87.26 -45.46 10.6 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.973 0.416 . . . . 0.0 110.133 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -128.93 129.8 45.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.482 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.952 HH21 HG13 ' A' ' 145' ' ' VAL . 36.6 ttt85 -170.07 -64.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.085 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 164.26 -44.63 0.31 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -177.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.19 -111.41 4.08 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.318 -0.467 . . . . 0.0 111.995 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.6 mtp -86.22 -3.78 59.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.178 0.514 . . . . 0.0 110.198 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.43 -126.28 3.91 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.473 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.39 92.85 4.28 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.938 0.369 . . . . 0.0 111.03 175.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.24 121.89 10.31 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.228 2.619 . . . . 0.0 112.715 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.48 139.27 49.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.026 0.441 . . . . 0.0 110.576 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.585 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -120.46 133.89 55.35 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.238 -172.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 39.9 t -100.84 105.02 35.56 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.541 -0.464 . . . . 0.0 109.942 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.9 Cg_exo -89.1 124.82 1.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.758 2.972 . . . . 0.0 111.356 171.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.644 ' HD1' ' H ' ' A' ' 119' ' ' SER . 1.7 t80 -135.73 149.13 49.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -176.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.78 ' HB2' HG21 ' A' ' 92' ' ' ILE . 24.1 t -80.35 -31.11 38.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.258 0.551 . . . . 0.0 110.273 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.644 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 16.3 m -90.08 113.37 25.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.346 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -43.04 75.54 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.402 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -63.83 -31.51 72.72 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.682 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.49 ' HG3' ' CE1' ' A' ' 117' ' ' PHE . 43.3 mm-40 -66.23 -43.0 87.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.84 175.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.1 80.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.111 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.43 79.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.874 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -59.7 -31.36 69.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.251 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -62.68 -44.02 97.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.677 HG22 ' H ' ' A' ' 132' ' ' GLY . 56.5 t -72.91 -29.21 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.469 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 9.0 tp -58.22 -35.84 72.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.016 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.68 -50.11 7.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.988 175.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.784 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.9 pt-20 -156.26 -79.95 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.39 175.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . 0.784 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.55 -129.7 11.41 Favored Glycine 0 C--N 1.335 0.502 0 O-C-N 123.522 0.514 . . . . 0.0 112.753 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.677 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -174.67 -83.01 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.606 HE21 ' HB ' ' A' ' 101' ' ' VAL . 2.8 pm0 -130.22 139.28 50.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.819 0.342 . . . . 0.0 110.516 174.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.422 HG23 HG21 ' A' ' 127' ' ' VAL . 76.4 t -98.1 124.13 50.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.798 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -146.99 152.52 38.74 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.815 -177.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 140' ' ' ILE . . . -92.47 173.3 7.86 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.568 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.946 HD22 ' H ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -48.4 -40.73 26.8 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.305 178.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.61 -29.76 67.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.676 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.404 ' OD2' ' HB3' ' A' ' 135' ' ' LEU . 13.4 t70 -95.52 3.9 53.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.309 0.576 . . . . 0.0 110.33 -175.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.798 HD13 HD13 ' A' ' 135' ' ' LEU . 26.2 mm -71.37 119.43 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.279 0.561 . . . . 0.0 109.842 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.417 ' CG2' ' HG2' ' A' ' 144' ' ' MET . 3.5 t -119.39 148.43 43.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.003 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.1 p-10 -69.05 -25.81 64.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.729 0.3 . . . . 0.0 110.41 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.69 70.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.217 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.572 ' HE2' ' HG2' ' A' ' 156' ' ' ARG . 10.6 mmt -83.51 -34.11 25.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.07 0.462 . . . . 0.0 110.596 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.952 HG13 HH21 ' A' ' 106' ' ' ARG . 38.8 t -78.99 -25.21 13.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.488 -173.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.4 pp -158.07 151.82 23.76 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.276 -174.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.431 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 16.0 p -101.87 120.08 55.07 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.663 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 19.9 Cg_endo -62.87 -71.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.364 2.043 . . . . 0.0 111.213 175.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.13 12.63 3.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 151' ' ' THR . 39.4 mt-10 65.84 -76.87 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.798 -169.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 150' ' ' GLU . 1.1 t 53.71 -0.94 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.986 1.314 . . . . 0.0 114.348 176.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . 71.86 30.24 66.14 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.027 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.6 p -86.05 141.62 29.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.82 0.31 . . . . 0.0 110.509 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.0 125.33 91.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.577 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.17 -95.38 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.062 2.508 . . . . 0.0 112.647 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.718 HH21 ' HB3' ' A' ' 135' ' ' LEU . 1.9 ptp180 -67.89 -32.4 72.86 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 172.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.55 ' N ' ' HG3' ' A' ' 156' ' ' ARG . . . 172.67 -175.1 0.05 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.981 -1.918 . . . . 0.0 106.483 -174.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -82.59 60.72 5.34 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 122.013 0.911 . . . . 0.0 109.368 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -99.19 -15.88 18.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.196 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--O 1.253 1.251 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.999 -176.791 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 85.6 tttt . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.593 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -143.56 144.17 31.83 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.413 0.149 . . . . 0.0 110.823 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 29.0 pt20 -149.01 134.7 18.76 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.148 0.499 . . . . 0.0 110.767 175.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.669 HG22 ' HB ' ' A' ' 71' ' ' ILE . 37.6 pt -115.92 129.18 72.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.657 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -98.87 116.47 31.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.5 mp -91.85 142.72 27.27 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.873 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.95 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 34.4 tt0 -74.26 125.06 27.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.603 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.93 -23.74 33.0 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.731 -176.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.509 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 39.7 t -88.49 129.41 49.31 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.4 Cg_exo -77.58 -3.35 13.51 Favored 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.897 2.398 . . . . 0.0 112.323 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.25 139.69 32.36 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.813 -177.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.76 149.47 8.53 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.596 2.197 . . . . 0.0 112.167 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 10.3 tt -89.07 111.57 22.34 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -124.11 135.95 53.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.204 0.526 . . . . 0.0 111.623 -173.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -146.82 162.65 38.17 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.567 176.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 30.2 t -72.46 -41.89 65.56 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 174.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.919 ' HG2' ' HB2' ' A' ' 83' ' ' TRP . 37.9 mt-30 -65.65 113.08 3.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.485 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.593 HG13 ' HB2' ' A' ' 36' ' ' ALA . 4.5 t -72.66 -52.03 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.23 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.537 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -52.09 -35.71 48.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.444 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 51' ' ' GLN . 29.1 t70 -76.05 -51.9 11.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.577 0.227 . . . . 0.0 110.999 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.29 -39.89 94.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.36 . . . . 0.0 111.394 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.926 HD12 ' HB3' ' A' ' 114' ' ' ALA . 23.9 pt -66.91 -30.56 50.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.691 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.81 -41.24 97.52 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.663 0.268 . . . . 0.0 110.663 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.644 ' HA ' ' HD2' ' A' ' 62' ' ' PRO . 16.6 m-85 -63.05 -34.02 76.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.863 0.364 . . . . 0.0 110.785 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.645 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -69.68 -16.81 63.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.557 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.511 HH12 ' HG2' ' A' ' 112' ' ' PRO . 49.9 mtm180 -102.52 -0.7 31.82 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.049 -175.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.503 ' O ' ' HG2' ' A' ' 64' ' ' GLN . . . -154.57 -73.85 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.998 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.644 ' HD2' ' HA ' ' A' ' 58' ' ' TYR . 76.2 Cg_exo -55.65 0.32 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.085 3.19 . . . . 0.0 115.095 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -79.78 9.09 5.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.935 0.397 . . . . 0.0 111.142 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 61' ' ' GLY . 84.3 mm-40 -62.64 -18.01 61.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.89 0.376 . . . . 0.0 111.452 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.4 tp -70.49 -45.01 76.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.697 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.596 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.13 140.68 13.65 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.95 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 64.7 Cg_endo -68.31 143.76 59.62 Favored 'Trans proline' 0 CA--C 1.516 -0.375 0 C-N-CA 122.244 1.963 . . . . 0.0 112.021 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.8 pt -74.07 113.11 11.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 121.229 0.538 . . . . 0.0 110.333 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 tt -78.6 -50.8 10.88 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.8 p -161.2 140.45 2.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.227 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.669 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.7 tt -112.99 131.9 63.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.628 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 93' ' ' ALA . 97.2 m-85 -111.84 135.51 52.36 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.444 HG23 HG13 ' A' ' 92' ' ' ILE . 27.8 m -131.59 140.82 47.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 121.445 0.64 . . . . 0.0 111.161 -177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 13.0 m120 -90.28 99.9 12.83 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 170.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -54.63 104.67 0.12 Allowed 'General case' 0 C--O 1.239 0.529 0 O-C-N 124.485 1.116 . . . . 0.0 111.025 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.653 ' O ' ' HD2' ' A' ' 86' ' ' PRO . 64.8 mtt -144.61 52.55 1.25 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.414 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.05 -52.56 4.51 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.338 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 67.12 -84.36 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.255 0.622 . . . . 0.0 112.221 174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.71 -15.99 15.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.824 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.51 -43.25 96.88 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.647 ' CB ' ' HD3' ' A' ' 86' ' ' PRO . . . -95.02 -154.79 0.44 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.776 -0.712 . . . . 0.0 110.374 173.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.0 p -103.6 177.76 4.75 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.864 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.919 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 3.3 p90 -55.49 -13.27 1.43 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 172.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.61 -35.61 39.27 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 71.74 150.13 0.13 Allowed Pre-proline 0 N--CA 1.468 0.431 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.38 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.653 ' HD2' ' O ' ' A' ' 76' ' ' MET . 48.2 Cg_endo -72.89 -61.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.455 2.104 . . . . 0.0 113.1 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -166.51 -179.21 39.65 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.372 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.14 136.82 42.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.996 0.427 . . . . 0.0 111.196 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.3 -113.18 1.24 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.834 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -100.51 152.02 20.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.515 0.198 . . . . 0.0 111.053 -173.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -105.25 124.94 50.39 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 168.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 1.004 HG21 ' HB2' ' A' ' 118' ' ' SER . 8.8 pt -145.81 164.48 10.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 72' ' ' TYR . . . -96.87 107.22 19.68 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 169.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.591 ' HB1' ' HE1' ' A' ' 99' ' ' TYR . . . -57.64 -33.14 67.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.055 0.455 . . . . 0.0 111.188 -175.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.795 ' HA ' HD13 ' A' ' 137' ' ' LEU . 9.1 t70 -62.12 -28.17 69.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.033 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -114.65 33.44 5.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.201 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -138.24 -175.07 3.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.739 0.304 . . . . 0.0 110.902 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -91.34 138.98 31.16 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.497 0.665 . . . . 0.0 110.61 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.591 ' HE1' ' HB1' ' A' ' 94' ' ' ALA . 0.4 OUTLIER -120.52 135.03 55.2 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.565 179.109 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.912 HG13 HG13 ' A' ' 115' ' ' VAL . 1.1 p -118.57 124.63 73.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-O 121.604 0.716 . . . . 0.0 109.752 169.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.577 HG11 ' HA ' ' A' ' 145' ' ' VAL . 65.3 t -101.65 117.82 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 CA-C-N 113.733 -1.576 . . . . 0.0 108.149 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.719 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -77.87 125.82 7.42 Favored Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.452 -171.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 29.0 t -91.88 -36.71 13.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.816 0.341 . . . . 0.0 110.909 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.11 -43.65 23.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.878 0.37 . . . . 0.0 111.138 -177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 71.4 mtp180 -131.02 96.97 4.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.543 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.789 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 2.8 tpp180 172.82 175.32 0.1 Allowed 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.663 0.602 . . . . 0.0 109.905 173.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.1 70.4 3.15 Favored Glycine 0 C--O 1.225 -0.442 0 C-N-CA 121.317 -0.468 . . . . 0.0 113.366 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.19 -42.68 98.73 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.358 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.6 mtm -109.55 16.52 22.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.275 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.429 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -139.21 -122.33 1.98 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.475 -175.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.36 92.83 4.24 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 110.915 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.622 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 73.9 Cg_endo -77.3 135.34 14.95 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.61 2.207 . . . . 0.0 112.958 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.789 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 30.9 mt-10 -115.13 146.45 41.34 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.029 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.926 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -118.42 133.14 56.11 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.738 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.912 HG13 HG13 ' A' ' 100' ' ' VAL . 0.5 OUTLIER -101.86 105.69 43.03 Favored Pre-proline 0 C--N 1.317 -0.836 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.685 171.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 6.6 Cg_exo -81.99 123.8 4.21 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 124.425 3.416 . . . . 0.0 111.77 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.76 ' HD1' ' H ' ' A' ' 119' ' ' SER . 1.2 t80 -135.16 149.59 49.99 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.988 0.423 . . . . 0.0 110.154 -177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 1.004 ' HB2' HG21 ' A' ' 92' ' ' ILE . 29.2 t -78.34 -34.68 48.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.615 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.76 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 8.0 m -91.34 116.93 29.24 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.211 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -58.14 -44.56 87.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.965 0.412 . . . . 0.0 111.495 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -61.63 -31.56 71.66 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.099 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -67.48 -41.52 84.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.867 0.365 . . . . 0.0 110.655 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.39 83.84 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.128 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.31 -39.25 92.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.774 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.74 -38.16 86.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.101 0.477 . . . . 0.0 110.567 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -62.0 -38.71 89.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.84 177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.607 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 48.2 t -65.99 -42.8 92.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.903 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 64.2 mt -53.96 -35.36 61.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.643 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.01 -46.6 11.86 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.0 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -159.07 -34.58 0.06 Allowed 'General case' 0 C--O 1.237 0.397 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.719 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -50.43 157.86 1.98 Allowed Glycine 0 C--N 1.32 -0.327 0 CA-C-N 116.028 -0.533 . . . . 0.0 113.024 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -101.27 -68.5 0.83 Allowed Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.74 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.451 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.2 140.96 50.68 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.741 0.305 . . . . 0.0 110.831 -179.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.411 HG23 HG21 ' A' ' 127' ' ' VAL . 89.0 t -98.38 112.87 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.284 0.564 . . . . 0.0 109.664 172.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.882 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -137.58 144.88 42.23 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.766 -178.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -69.96 157.59 37.19 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' ' 95' ' ' ASP . 4.5 tt -63.32 -28.85 70.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.418 0.628 . . . . 0.0 109.673 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.32 -9.56 53.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.425 175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -123.45 18.1 9.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.09 0.472 . . . . 0.0 110.539 -177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.882 HD13 HD13 ' A' ' 135' ' ' LEU . 38.2 mm -71.78 121.65 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 CA-C-O 121.197 0.522 . . . . 0.0 110.387 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 1.022 HG21 ' HA ' ' A' ' 156' ' ' ARG . 2.9 t -111.47 148.24 33.57 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.722 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.497 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.3 p-10 -69.27 -22.31 63.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.681 0.277 . . . . 0.0 110.656 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.27 -33.41 74.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.936 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.654 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 7.2 mmt -87.26 -30.14 21.14 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.806 -177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.577 ' HA ' HG11 ' A' ' 101' ' ' VAL . 5.0 t -80.53 -22.91 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.991 0.424 . . . . 0.0 110.746 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.6 pp -154.47 134.26 12.93 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.372 -177.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 4.9 p -116.39 149.37 43.55 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.162 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -58.99 -58.05 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.476 2.117 . . . . 0.0 109.621 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 25.7 t -127.56 -72.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 165.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 149' ' ' VAL . 7.5 mt-10 165.2 -77.03 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 125.438 1.495 . . . . 0.0 108.493 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.7 t 46.18 28.99 0.73 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.504 1.122 . . . . 0.0 113.129 175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 74.92 64.36 2.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.286 -176.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.6 t -89.93 162.08 15.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.922 0.392 . . . . 0.0 110.873 -175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -88.69 150.97 47.12 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.108 -174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.642 ' HA ' ' SD ' ' A' ' 144' ' ' MET . 60.3 Cg_endo -73.12 -136.81 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.991 2.461 . . . . 0.0 113.125 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.022 ' HA ' HG21 ' A' ' 141' ' ' THR . 0.0 OUTLIER -57.21 -29.14 63.49 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -174.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -179.49 20.72 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.371 0.419 . . . . 0.0 110.638 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.1 t70 48.49 70.52 0.44 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.684 0.754 . . . . 0.0 109.133 -169.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.519 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 14.3 t70 -145.14 -42.18 0.23 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.53 -167.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 C--O 1.247 0.963 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.691 -179.787 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.595 ' N ' ' HB2' ' A' ' 74' ' ' ASN . 16.5 ttmm . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.558 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -133.14 141.88 48.37 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.84 175.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 9.4 pt20 -149.65 132.66 16.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.828 174.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.628 HG21 ' HB2' ' A' ' 59' ' ' ALA . 28.6 pt -115.95 133.68 61.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.3 0.571 . . . . 0.0 111.458 -177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -103.81 119.51 39.07 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.696 HD23 ' HB3' ' A' ' 66' ' ' ALA . 11.1 mp -89.63 153.95 20.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.276 0.56 . . . . 0.0 111.503 -174.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.593 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 29.7 tt0 -71.68 125.54 27.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.635 178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.31 -27.36 5.7 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.199 -177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.514 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.9 t -87.98 128.38 54.14 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 8.9 Cg_endo -87.29 -1.35 7.74 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.122 2.548 . . . . 0.0 112.612 -177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -112.23 132.98 21.83 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.828 0.347 . . . . 0.0 111.053 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -87.77 124.57 1.9 Allowed 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.675 2.25 . . . . 0.0 112.036 174.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 7.2 tt -80.56 109.0 14.67 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -108.84 143.13 38.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.988 0.423 . . . . 0.0 110.831 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.613 ' HD1' ' H ' ' A' ' 51' ' ' GLN . 1.9 t80 -144.66 145.24 31.65 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.696 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.7 m -63.97 -34.95 79.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.194 0.521 . . . . 0.0 110.201 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.623 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 76.1 mt-30 -83.38 105.96 14.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.051 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 36' ' ' ALA . 8.6 t -56.37 -51.46 63.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.285 0.564 . . . . 0.0 109.57 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.65 ' HB3' ' HB3' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -55.5 -32.84 63.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.682 -1.145 . . . . 0.0 113.205 -178.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.552 ' HB2' HH11 ' A' ' 53' ' ' ARG . 22.8 t70 -76.28 -50.08 15.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.013 0.435 . . . . 0.0 110.839 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -64.95 -39.47 93.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.276 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.675 HD12 ' HB3' ' A' ' 114' ' ' ALA . 16.2 pt -70.16 -30.53 43.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.625 0.25 . . . . 0.0 110.628 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.76 -42.07 82.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.141 0.496 . . . . 0.0 110.075 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -62.01 -34.91 77.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.13 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.687 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -72.89 -18.17 61.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.993 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 52.0 mtm180 -96.52 12.47 31.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -172.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 176.32 -61.51 0.1 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.848 -1.168 . . . . 0.0 113.521 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.35 22.43 0.13 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.145 2.563 . . . . 0.0 114.8 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.65 74.09 9.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.134 0.968 . . . . 0.0 110.376 177.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.454 ' O ' HG22 ' A' ' 65' ' ' ILE . 14.0 mt-30 -79.09 145.82 33.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.25 -172.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 64' ' ' GLN . 1.9 tp 72.74 -38.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.91 1.284 . . . . 0.0 112.345 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.696 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -133.44 139.57 34.35 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 122.007 -0.433 . . . . 0.0 110.413 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 41' ' ' GLU . 96.2 Cg_endo -85.59 159.97 10.8 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.95 2.434 . . . . 0.0 112.061 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.687 HD13 ' HB1' ' A' ' 59' ' ' ALA . 28.0 pt -77.08 113.35 16.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.31 0.576 . . . . 0.0 110.465 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -77.54 -46.81 21.18 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.7 p -158.28 138.82 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.395 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.604 HD11 HG22 ' A' ' 56' ' ' ILE . 2.6 tt -116.94 134.35 60.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.027 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -111.94 128.78 56.26 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 94' ' ' ALA . 29.0 m -126.96 151.93 34.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.26 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.603 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 16.5 m120 -91.49 105.65 17.91 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.54 175.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.589 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 18.3 t70 -48.26 134.02 15.04 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 125.928 2.018 . . . . 0.0 110.844 177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 74' ' ' ASN . 23.9 mmt -127.04 176.55 7.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -167.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.406 ' H ' ' HG2' ' A' ' 86' ' ' PRO . . . -60.95 -19.38 56.37 Favored Glycine 0 C--N 1.335 0.487 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.73 173.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 83.47 -45.16 0.11 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.16 0.584 . . . . 0.0 112.33 168.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.54 -44.22 76.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.411 0.624 . . . . 0.0 110.061 175.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.03 -87.1 0.78 Allowed Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.506 173.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.439 ' H ' ' HD3' ' A' ' 86' ' ' PRO . . . 53.73 26.16 5.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.52 0.676 . . . . 0.0 111.699 -179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.0 p -83.67 179.16 7.68 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.983 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.623 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 48.6 p90 -59.5 -24.2 63.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.733 0.301 . . . . 0.0 111.267 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -81.37 -35.29 30.99 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.824 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 68.74 140.22 0.07 OUTLIER Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.668 174.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.496 ' HD2' ' SD ' ' A' ' 76' ' ' MET . 96.5 Cg_endo -85.14 31.71 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.36 2.04 . . . . 0.0 113.577 -173.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 118.01 -171.83 14.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.125 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -77.4 147.22 36.14 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.493 0.317 . . . . 0.0 110.728 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.589 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -141.58 -158.06 7.4 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.169 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.603 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 41.9 m-80 -100.17 150.44 22.51 Favored 'General case' 0 C--O 1.211 -0.938 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -176.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 40.8 p-90 -98.56 130.28 45.11 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.444 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.758 HG21 ' HB2' ' A' ' 118' ' ' SER . 14.1 pt -143.97 160.6 15.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.601 -173.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.68 101.16 9.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.108 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.579 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -62.11 -38.95 90.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.349 -172.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.625 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 14.0 t70 -58.85 -30.43 67.69 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.666 0.746 . . . . 0.0 110.301 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -107.96 25.73 11.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.123 -175.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.13 -177.21 3.79 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 120.847 0.356 . . . . 0.0 110.485 -172.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -97.79 136.81 37.59 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.527 0.68 . . . . 0.0 110.475 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.66 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 7.6 m-85 -120.5 136.18 54.85 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.88 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.705 HG13 ' HB ' ' A' ' 115' ' ' VAL . 3.2 p -114.77 127.89 72.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.423 0.63 . . . . 0.0 109.762 174.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.597 HG11 ' HA ' ' A' ' 145' ' ' VAL . 96.4 t -101.46 103.49 14.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -80.49 123.16 5.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.555 -174.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.8 t -92.51 -29.54 16.16 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.587 0.232 . . . . 0.0 110.756 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -47.18 60.74 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -171.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -139.19 101.53 4.29 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.421 173.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.952 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 19.4 tpp180 -175.06 -80.77 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.845 178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -173.65 42.09 0.15 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.113 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -63.97 -34.38 89.76 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.266 -0.968 . . . . 0.0 111.715 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 27.0 ttt -109.5 2.23 20.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.096 0.474 . . . . 0.0 110.326 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.425 ' O ' ' HD3' ' A' ' 112' ' ' PRO . . . -136.56 -123.52 2.26 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.142 -0.551 . . . . 0.0 112.72 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.8 99.08 12.61 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.925 0.393 . . . . 0.0 110.977 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 110' ' ' GLY . 72.1 Cg_endo -79.18 151.38 23.44 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.143 2.562 . . . . 0.0 113.696 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.952 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 25.9 mt-10 -128.82 146.52 50.9 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.603 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.675 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -93.79 130.93 39.62 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.945 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.705 ' HB ' HG13 ' A' ' 100' ' ' VAL . 55.4 t -101.28 106.4 45.13 Favored Pre-proline 0 C--N 1.32 -0.68 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 6.1 Cg_exo -86.26 132.52 3.79 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 123.656 2.904 . . . . 0.0 112.305 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.755 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.8 t80 -137.66 149.43 46.56 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.758 ' HB2' HG21 ' A' ' 92' ' ' ILE . 35.5 t -77.97 -37.88 46.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.846 0.355 . . . . 0.0 111.148 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.755 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 17.8 m -95.75 129.74 42.88 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.826 0.346 . . . . 0.0 110.645 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -65.92 -49.72 66.97 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.229 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -63.18 -29.65 70.95 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.554 -172.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -65.73 -42.92 90.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.554 174.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -70.7 -36.95 73.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.229 0.538 . . . . 0.0 110.035 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.03 -34.56 71.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.846 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.85 -36.69 81.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.036 0.446 . . . . 0.0 110.356 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -62.43 -37.59 86.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.751 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.7 HG22 ' H ' ' A' ' 132' ' ' GLY . 93.2 t -70.95 -38.13 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.974 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.1 mt -53.24 -50.95 63.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.368 0.604 . . . . 0.0 110.11 175.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.59 78.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.133 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.76 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.3 pt-20 -165.55 -82.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.58 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.76 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 39.6 -132.79 2.15 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 123.915 0.759 . . . . 0.0 114.45 175.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.7 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -171.23 -93.37 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.77 139.66 51.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.711 0.291 . . . . 0.0 110.715 174.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.496 HG23 HG21 ' A' ' 127' ' ' VAL . 99.4 t -97.43 123.17 49.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.378 176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.886 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -147.02 164.38 33.19 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.563 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.14 164.38 15.04 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.625 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 4.1 tt -61.44 -40.05 93.05 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.97 -8.62 38.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.592 176.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -124.67 17.96 8.75 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.248 0.547 . . . . 0.0 110.748 -175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.886 HD13 HD13 ' A' ' 135' ' ' LEU . 26.1 mm -71.78 121.92 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.9 t -116.86 146.0 43.2 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 172.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -69.96 -30.73 68.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.717 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.76 -28.78 68.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.923 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.6 mmt -77.62 -41.21 39.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.783 0.325 . . . . 0.0 110.953 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.597 ' HA ' HG11 ' A' ' 101' ' ' VAL . 3.0 t -81.52 -23.79 10.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.926 0.393 . . . . 0.0 111.217 -173.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -156.62 159.33 38.37 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.552 -175.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.453 ' HB ' ' HG2' ' A' ' 150' ' ' GLU . 3.4 p -100.02 120.35 57.11 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.657 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -58.26 -69.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.1 2.533 . . . . 0.0 112.406 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.69 0.75 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.288 0.566 . . . . 0.0 109.646 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.453 ' HG2' ' HB ' ' A' ' 147' ' ' THR . 40.1 mt-10 57.36 55.8 5.54 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.422 -175.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 t -90.94 -6.84 53.52 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.055 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 82.42 26.57 46.78 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.535 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.2 p -84.41 161.93 20.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.667 0.27 . . . . 0.0 110.646 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.885 ' HB3' ' H ' ' A' ' 158' ' ' ASP . 43.3 mp0 -61.38 131.96 92.58 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.59 -24.68 25.61 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.698 2.265 . . . . 0.0 113.253 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.498 HH11 ' HB3' ' A' ' 157' ' ' ALA . 5.8 ppt_? -155.13 -39.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.14 0.495 . . . . 0.0 110.527 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.498 ' HB3' HH11 ' A' ' 156' ' ' ARG . . . 179.33 53.89 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.885 ' H ' ' HB3' ' A' ' 154' ' ' GLU . 13.5 t70 63.38 -144.9 0.34 Allowed 'General case' 0 C--O 1.237 0.424 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 -156.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -154.17 161.49 41.82 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 119.662 1.119 . . . . 0.0 112.408 173.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 C--O 1.248 0.975 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.343 -173.281 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 28.7 tttm . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.767 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -135.91 143.71 45.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.541 0.21 . . . . 0.0 111.099 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -149.35 139.55 22.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.645 0.26 . . . . 0.0 110.417 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.449 HG22 ' HB ' ' A' ' 71' ' ' ILE . 32.5 pt -116.01 136.1 54.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.992 0.425 . . . . 0.0 111.429 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -104.87 123.71 48.2 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.9 mp -97.74 148.99 22.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.187 -174.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.819 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 40.6 tt0 -74.04 125.5 28.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.616 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.03 -29.28 10.23 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.592 -176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 t -92.4 124.98 57.79 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -81.26 -7.39 12.94 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.878 2.385 . . . . 0.0 111.958 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -113.71 133.95 22.14 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.632 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 97.1 Cg_endo -91.01 143.24 3.25 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.084 2.523 . . . . 0.0 112.656 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.2 tt -89.41 121.41 31.63 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -107.85 147.22 31.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 111.527 -175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.529 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 1.5 m-85 -143.12 141.94 31.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.146 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.5 m -72.42 -28.73 63.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.43 0.633 . . . . 0.0 109.487 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.532 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 17.1 mt-30 -86.84 109.39 19.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.92 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.767 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 17.2 t -63.54 -51.17 73.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.294 0.569 . . . . 0.0 109.909 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.634 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.33 -29.07 60.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.843 -1.072 . . . . 0.0 112.111 -179.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.634 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 8.8 t70 -76.21 -47.27 24.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.532 -176.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -72.31 -36.08 68.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.485 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.518 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 22.8 pt -68.23 -35.24 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.436 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.31 -40.96 81.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.03 0.443 . . . . 0.0 110.338 172.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.47 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 33.2 t80 -62.29 -28.31 69.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.686 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.1 -15.9 61.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.288 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 60' ' ' ARG . 40.6 mtp-105 -98.19 11.71 36.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -172.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 177.96 -60.97 0.09 OUTLIER Glycine 0 CA--C 1.52 0.404 0 C-N-CA 119.274 -1.441 . . . . 0.0 114.469 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 58' ' ' TYR . 37.5 Cg_exo -59.81 -7.6 6.24 Favored 'Trans proline' 0 CA--C 1.536 0.619 0 C-N-CA 123.265 2.643 . . . . 0.0 115.149 -176.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.861 ' HG3' HG23 ' A' ' 68' ' ' ILE . 3.2 pm0 -77.41 89.61 3.8 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.41 1.1 . . . . 0.0 109.604 175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -106.78 -24.64 12.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.045 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.2 tp -68.6 -40.21 81.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.12 0.486 . . . . 0.0 110.275 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.596 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.24 152.65 29.8 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.538 177.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.819 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 59.8 Cg_endo -72.65 160.03 47.37 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.259 1.973 . . . . 0.0 111.447 176.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.861 HG23 ' HG3' ' A' ' 63' ' ' GLU . 29.1 pt -80.35 132.52 31.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.05 0.452 . . . . 0.0 111.035 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -99.08 -51.89 3.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -161.23 138.56 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.469 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.55 HG22 ' HB2' ' A' ' 95' ' ' ASP . 2.7 tt -108.15 134.64 49.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.153 177.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -111.88 130.07 55.95 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.95 145.61 27.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 121.026 0.441 . . . . 0.0 109.877 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 17.0 m120 -85.56 100.87 12.22 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.246 176.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -56.24 109.21 0.56 Allowed 'General case' 0 C--O 1.238 0.48 0 O-C-N 125.292 1.62 . . . . 0.0 110.136 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.495 ' SD ' ' HG2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -159.73 107.23 1.7 Allowed 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.291 -179.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 75.21 -68.3 2.05 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.399 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.582 ' HB1' HG13 ' A' ' 115' ' ' VAL . . . 67.42 -50.85 0.5 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.72 0.808 . . . . 0.0 112.51 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.85 -36.3 69.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.066 0.46 . . . . 0.0 110.547 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -93.31 -71.3 1.16 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 171.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.517 ' HB2' ' HA ' ' A' ' 78' ' ' ALA . . . 51.41 54.49 11.0 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 124.176 0.574 . . . . 0.0 112.052 174.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.5 p -83.82 175.94 9.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.532 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 28.0 p-90 -66.53 -20.0 65.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.152 0.501 . . . . 0.0 110.254 177.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -84.76 -26.28 27.69 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.655 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 63.76 171.49 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.604 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.951 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.495 ' HG2' ' SD ' ' A' ' 76' ' ' MET . 38.4 Cg_endo -92.16 0.77 4.16 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.636 1.557 . . . . 0.0 112.06 172.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 129.3 -168.55 20.88 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.097 -0.573 . . . . 0.0 111.869 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -77.16 146.45 37.09 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.22 -166.55 12.15 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.159 -1.019 . . . . 0.0 113.277 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.3 t-20 -77.65 152.34 33.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.133 -0.534 . . . . 0.0 110.087 -175.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.5 p-90 -98.05 128.7 44.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.436 -178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.3 pt -140.57 143.59 28.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.77 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.92 102.44 4.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.177 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.91 78.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.237 0.542 . . . . 0.0 111.066 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.55 ' HB2' HG22 ' A' ' 71' ' ' ILE . 21.8 t70 -61.85 -24.63 67.03 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.64 178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.6 mmtm -115.97 27.56 9.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.995 -176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.35 178.84 5.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.651 -173.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -92.67 136.02 33.59 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.431 0.634 . . . . 0.0 110.592 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.479 ' HE2' HD12 ' A' ' 56' ' ' ILE . 8.7 m-85 -120.54 136.22 54.85 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.739 178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.736 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.7 p -113.9 125.98 71.3 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 CA-C-O 121.835 0.826 . . . . 0.0 110.423 173.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.681 ' HA ' HH11 ' A' ' 106' ' ' ARG . 40.8 t -102.03 113.4 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 CA-C-N 114.021 -1.445 . . . . 0.0 108.461 174.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.66 122.57 7.2 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 119.975 -1.107 . . . . 0.0 111.553 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t -89.03 -28.46 20.15 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -85.34 -44.25 12.98 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.861 178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.673 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 60.9 mtp180 -146.01 127.16 14.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.322 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.681 HH11 ' HA ' ' A' ' 101' ' ' VAL . 7.6 ttt180 -176.58 -53.37 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.626 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . 151.39 26.33 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.375 -0.829 . . . . 0.0 112.28 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -59.26 -38.15 92.86 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.919 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 67.4 mtt -109.36 21.34 17.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.73 0.3 . . . . 0.0 110.637 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -155.55 -125.5 0.93 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.816 -178.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.42 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.32 101.7 24.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.942 0.401 . . . . 0.0 110.375 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.547 ' HA ' ' HA3' ' A' ' 107' ' ' GLY . 43.0 Cg_endo -66.94 123.4 10.93 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 123.229 2.619 . . . . 0.0 113.301 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -114.38 131.13 56.67 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.79 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.591 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -98.13 131.77 44.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.85 -177.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.736 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 93.3 t -98.04 104.54 22.87 Favored Pre-proline 0 C--N 1.324 -0.502 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.826 174.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.0 Cg_endo -96.53 127.18 0.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.975 3.117 . . . . 0.0 112.064 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.546 ' HD2' ' H ' ' A' ' 119' ' ' SER . 1.1 t80 -147.06 148.78 32.0 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.4 m -86.87 -17.54 33.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.938 0.399 . . . . 0.0 110.759 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.546 ' H ' ' HD2' ' A' ' 117' ' ' PHE . 43.9 m -92.3 107.56 19.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.922 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -54.5 -44.62 72.84 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.782 -178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -63.42 -28.03 69.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.311 -173.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.524 ' HG3' ' CE2' ' A' ' 117' ' ' PHE . 40.9 mm-40 -66.4 -44.64 82.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.067 0.46 . . . . 0.0 110.242 174.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.92 -36.05 77.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.364 0.602 . . . . 0.0 109.707 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.67 95.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.571 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -59.8 -33.85 72.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.295 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -64.37 -43.75 93.54 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.702 HG22 ' H ' ' A' ' 132' ' ' GLY . 40.5 t -72.95 -28.62 27.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.277 0.561 . . . . 0.0 110.397 177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 9.3 tp -57.6 -38.64 75.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.921 177.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.02 -46.46 11.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.419 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.765 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.5 pt-20 -156.58 -80.05 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.621 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.765 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.36 -133.43 10.85 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 114.249 0.46 . . . . 0.0 114.249 174.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.702 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -178.39 -85.47 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.475 ' HG3' ' SD ' ' A' ' 144' ' ' MET . 0.0 OUTLIER -130.16 139.5 50.87 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.629 0.252 . . . . 0.0 110.975 178.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 67.2 t -103.72 112.85 38.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.522 172.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.791 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -139.7 165.5 27.1 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.016 -175.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.81 161.29 14.92 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.666 ' HA ' HG12 ' A' ' 140' ' ' ILE . 1.6 tt -60.77 -31.03 70.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.188 0.518 . . . . 0.0 110.086 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.59 -22.91 67.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.645 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.28 26.01 9.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.043 -174.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.791 HD13 HD13 ' A' ' 135' ' ' LEU . 31.1 mm -71.69 119.48 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.397 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.498 ' CG2' ' HG2' ' A' ' 144' ' ' MET . 5.6 t -119.49 149.48 41.82 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.068 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.439 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 15.7 p-10 -68.99 -27.45 65.72 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.93 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.94 -28.67 70.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.667 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.498 ' HG2' ' CG2' ' A' ' 141' ' ' THR . 12.8 mmt -75.73 -37.66 59.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.968 0.413 . . . . 0.0 110.699 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.69 -23.44 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.48 -171.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.5 pp -153.0 142.42 21.69 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.669 -0.413 . . . . 0.0 111.209 -174.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 28.4 p -122.75 150.33 58.26 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.589 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -59.07 -59.75 0.42 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.293 1.995 . . . . 0.0 109.592 171.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 28.7 t -119.73 -71.79 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 166.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 149' ' ' VAL . 11.4 mt-10 172.28 -76.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.625 1.57 . . . . 0.0 107.569 177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 150' ' ' GLU . 0.6 OUTLIER 64.35 -31.17 0.12 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.878 1.271 . . . . 0.0 113.973 173.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 97.41 54.99 1.2 Allowed Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 10.2 t -102.66 144.68 30.74 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.667 ' HG2' ' HB3' ' A' ' 158' ' ' ASP . 2.2 mp0 -57.71 126.26 75.43 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 110.66 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.511 ' HD2' ' O ' ' A' ' 157' ' ' ALA . 59.8 Cg_endo -73.85 -85.22 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.029 2.486 . . . . 0.0 113.236 -177.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.425 ' HD2' ' HB3' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -75.5 -27.23 58.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 122.419 1.104 . . . . 0.0 108.089 174.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.511 ' O ' ' HD2' ' A' ' 155' ' ' PRO . . . 165.73 -162.9 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 112.563 -2.108 . . . . 0.0 105.448 -170.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.667 ' HB3' ' HG2' ' A' ' 154' ' ' GLU . 4.0 p30 -106.26 17.45 23.44 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 177.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 36.1 t70 -66.26 -83.81 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.475 -1.238 . . . . 0.0 111.358 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.558 176.557 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 50' ' ' SER . 88.0 tttt . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.645 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -132.89 145.05 50.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.713 0.292 . . . . 0.0 111.226 -176.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 10.4 pt20 -149.13 134.55 18.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.413 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.728 HG21 ' HB2' ' A' ' 59' ' ' ALA . 22.3 pt -115.58 135.69 54.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.183 0.516 . . . . 0.0 110.923 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -104.73 119.64 39.47 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.5 mp -81.16 151.66 28.13 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.38 -175.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.34 125.53 28.69 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.374 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.7 -36.75 3.22 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.634 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 41.5 t -81.6 125.45 78.36 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-O 120.932 0.396 . . . . 0.0 110.359 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.5 Cg_exo -78.74 -1.42 11.58 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.179 2.586 . . . . 0.0 112.289 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -114.63 134.01 22.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.69 0.281 . . . . 0.0 111.106 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 98.5 Cg_endo -93.37 162.25 2.45 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.331 2.687 . . . . 0.0 112.69 177.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.5 tt -115.21 116.27 28.07 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 20.6 p90 -119.62 146.04 45.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.286 0.565 . . . . 0.0 111.732 -175.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.407 ' HD1' ' H ' ' A' ' 51' ' ' GLN . 3.5 t80 -149.96 143.84 25.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.068 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 16.4 m -60.24 -45.61 92.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.096 0.475 . . . . 0.0 110.76 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.588 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 66.8 mt-30 -69.7 111.1 5.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.493 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 8.9 t -61.95 -52.42 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.948 0.404 . . . . 0.0 110.456 -177.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.566 HH11 ' HB2' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.86 -29.9 56.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.411 178.59 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.566 ' HB2' HH11 ' A' ' 53' ' ' ARG . 29.0 t70 -76.16 -51.56 11.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.953 0.406 . . . . 0.0 110.234 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.746 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -68.02 -38.3 82.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.676 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 28.3 pt -65.82 -30.24 49.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.66 96.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.678 173.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.746 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 70.2 m-85 -60.4 -44.97 95.17 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.712 0.292 . . . . 0.0 110.847 176.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.728 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -61.01 -18.18 56.25 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -105.05 12.5 32.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.824 0.345 . . . . 0.0 111.396 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.91 -85.4 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.34 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -48.05 -55.3 4.15 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.672 2.914 . . . . 0.0 113.858 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 57.21 -89.21 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.775 0.672 . . . . 0.0 110.43 -173.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.541 ' HB3' HD21 ' A' ' 40' ' ' LEU . 58.7 tt0 -178.97 -59.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.9 tp -165.87 -40.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.048 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -94.12 152.16 40.15 Favored Pre-proline 0 N--CA 1.446 -0.675 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.007 173.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.59 161.38 46.25 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.768 1.645 . . . . 0.0 111.305 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 41.5 pt -73.79 136.98 24.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.196 0.522 . . . . 0.0 110.786 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tt -98.37 -47.89 5.25 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.01 138.75 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.8 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' A' ' 95' ' ' ASP . 2.8 tt -111.08 133.23 57.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.079 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -112.86 145.06 41.35 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 36' ' ' ALA . 18.8 m -136.35 155.88 35.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-O 121.231 0.538 . . . . 0.0 110.912 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -91.21 102.65 15.37 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 171.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 21.2 t70 -57.0 108.53 0.52 Allowed 'General case' 0 CA--C 1.514 -0.426 0 O-C-N 125.034 1.459 . . . . 0.0 111.252 -175.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.599 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 1.6 mmt -161.12 62.02 0.29 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.409 -1.269 . . . . 0.0 108.555 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.937 ' HA2' ' HB2' ' A' ' 81' ' ' ALA . . . -100.15 27.02 22.28 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.78 -178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.44 97.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.94 0.435 . . . . 0.0 111.067 -175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 56.4 33.97 23.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.398 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.56 -59.7 0.22 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 119.148 -1.501 . . . . 0.0 114.566 176.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.937 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . . . 60.64 56.55 2.99 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.364 0.602 . . . . 0.0 110.375 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.6 p -83.99 177.18 8.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.069 -175.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.588 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 24.5 p90 -66.71 -24.21 66.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.267 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.85 -31.89 27.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 66.59 157.36 0.13 Allowed Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.059 174.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 76' ' ' MET . 21.8 Cg_exo -70.76 -22.02 28.05 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.532 2.155 . . . . 0.0 111.1 170.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . 146.87 -162.99 28.61 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.515 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.74 141.95 42.51 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 76' ' ' MET . . . -131.11 -156.14 8.42 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.179 -1.01 . . . . 0.0 113.484 -173.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -96.66 155.72 16.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.442 -175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -97.53 127.39 43.45 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.694 -174.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.803 HD13 ' HB2' ' A' ' 118' ' ' SER . 26.6 pt -145.3 166.97 10.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.33 -177.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.73 117.32 29.94 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.86 -35.54 74.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.737 -174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.754 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.3 OUTLIER -70.63 -18.22 62.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.932 0.872 . . . . 0.0 109.718 -178.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.468 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 41.1 mmtm -107.12 21.06 18.12 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.678 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.21 177.59 4.83 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.797 0.332 . . . . 0.0 110.87 -171.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -92.02 133.36 35.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.966 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -120.66 135.76 55.03 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.465 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.447 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.7 p -112.16 127.84 69.11 Favored 'Isoleucine or valine' 0 C--O 1.25 1.107 0 CA-C-O 121.695 0.759 . . . . 0.0 110.422 174.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.542 ' HA ' HH11 ' A' ' 106' ' ' ARG . 43.8 t -102.89 103.92 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.119 174.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.45 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -70.35 125.02 14.01 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.453 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.6 m -92.21 -14.42 29.04 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.186 0.517 . . . . 0.0 110.032 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -91.88 -43.57 9.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.008 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.664 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 54.1 mtp180 -121.41 -107.9 0.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 119.292 -0.385 . . . . 0.0 109.988 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.542 HH11 ' HA ' ' A' ' 101' ' ' VAL . 5.0 tpt180 68.26 -60.66 0.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 176.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.645 ' HA3' ' HA ' ' A' ' 112' ' ' PRO . . . -178.62 -61.11 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 58.56 -94.34 0.05 OUTLIER Glycine 0 C--N 1.332 0.319 0 O-C-N 123.92 0.424 . . . . 0.0 113.159 174.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.9 ptt? -83.05 -3.97 57.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.986 0.422 . . . . 0.0 110.94 -178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -118.98 -135.89 5.24 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -102.36 108.16 56.2 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.803 0.301 . . . . 0.0 110.342 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.645 ' HA ' ' HA3' ' A' ' 107' ' ' GLY . 18.4 Cg_endo -59.88 128.06 25.49 Favored 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 123.185 2.59 . . . . 0.0 112.99 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.414 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 43.1 mt-10 -114.52 135.35 54.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.904 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.544 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.77 131.62 38.95 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.827 -174.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.447 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 8.8 t -101.31 105.39 39.38 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 119.296 -0.962 . . . . 0.0 109.625 177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.4 Cg_exo -86.97 136.84 4.33 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 123.713 2.942 . . . . 0.0 112.341 177.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -129.27 149.01 51.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.049 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.803 ' HB2' HD13 ' A' ' 92' ' ' ILE . 30.9 t -85.2 -35.61 21.53 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.9 m -91.59 118.7 30.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.763 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -59.74 -42.55 93.42 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.429 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -65.9 -31.7 72.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.892 -173.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -64.55 -40.44 95.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.746 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.03 -42.54 84.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.51 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.26 -41.19 99.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.855 177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -65.42 -31.27 72.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.91 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -64.95 -36.52 84.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.916 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 62.1 t -73.02 -27.83 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.649 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mp -61.73 -46.23 90.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.086 0.469 . . . . 0.0 110.809 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.91 -49.92 26.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.485 177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.669 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 0.7 OUTLIER -145.96 -86.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.757 178.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.916 ' HA3' ' HA ' ' A' ' 127' ' ' VAL . . . 50.44 -148.68 6.94 Favored Glycine 0 N--CA 1.444 -0.792 0 O-C-N 123.642 0.588 . . . . 0.0 113.702 172.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.588 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -179.96 -84.77 0.06 OUTLIER Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -130.22 141.17 50.66 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 38.4 t -104.63 113.96 43.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.643 178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.765 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.28 164.17 29.92 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.699 -178.328 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.72 166.3 17.13 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.754 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 4.7 tt -62.22 -33.44 74.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.351 0.596 . . . . 0.0 109.611 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.44 -11.02 60.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.168 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -117.44 17.47 14.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.292 0.568 . . . . 0.0 110.073 -176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.765 HD13 HD13 ' A' ' 135' ' ' LEU . 31.9 mm -71.93 120.28 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.312 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.6 t -119.1 147.82 43.73 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.978 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -69.26 -31.32 69.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.891 -177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.77 -28.82 66.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.798 -178.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.617 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 8.2 mmt -87.18 -26.45 23.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.494 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.421 ' HA ' HG11 ' A' ' 101' ' ' VAL . 16.4 t -85.56 -24.2 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.207 0.527 . . . . 0.0 110.521 -177.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -160.3 151.88 19.75 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.566 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.44 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 4.0 p -94.59 120.06 65.43 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-O 120.829 0.347 . . . . 0.0 111.214 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 36.8 Cg_endo -66.6 -67.57 0.04 OUTLIER 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 122.73 2.287 . . . . 0.0 111.511 175.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.408 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 2.4 t -118.66 5.39 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' A' ' 152' ' ' GLY . 22.4 mt-10 66.58 -81.77 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.699 -170.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.1 t 43.31 -59.99 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.134 1.774 . . . . 0.0 114.999 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 150' ' ' GLU . . . 118.34 63.37 0.3 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 -175.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.1 m -116.91 161.58 19.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.545 0.212 . . . . 0.0 110.467 -177.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 158' ' ' ASP . 1.6 mp0 -66.54 135.17 94.53 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.712 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 154' ' ' GLU . 74.1 Cg_endo -81.21 -89.07 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 123.037 2.491 . . . . 0.0 114.583 -169.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.443 ' HD2' ' HB3' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -66.21 -25.71 67.04 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.001 0.429 . . . . 0.0 111.393 -173.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -171.03 -82.34 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 6.3 p-10 -171.18 20.67 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 171.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.443 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 30.5 t70 -78.11 -83.02 0.09 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.339 -177.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.695 -0.669 . . . . 0.0 110.186 173.73 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 22.1 ttmm . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -131.4 148.48 52.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 117.83 0.286 . . . . 0.0 111.275 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.543 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 1.7 pt20 -149.04 134.47 18.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.473 177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 36.1 pt -115.94 137.82 48.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.821 -0.549 . . . . 0.0 110.892 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -108.95 126.52 53.18 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.572 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.8 mp -97.51 150.52 21.0 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.931 0.396 . . . . 0.0 111.502 -175.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.719 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 38.2 tt0 -74.15 129.15 37.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.591 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.34 -34.7 4.05 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.842 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.471 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 33.2 t -81.9 129.99 62.49 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.1 Cg_endo -85.44 2.36 7.78 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.966 2.444 . . . . 0.0 112.439 -179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -122.43 134.54 24.93 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 120.845 0.355 . . . . 0.0 111.41 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 10.3 Cg_endo -91.1 145.05 3.48 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.488 2.792 . . . . 0.0 112.051 174.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 2.8 tm? -93.21 114.53 27.03 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -95.49 135.37 37.23 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.465 ' HB3' ' HB2' ' A' ' 55' ' ' ALA . 5.6 t80 -147.26 131.24 17.19 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.65 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 70.1 m -57.82 -49.02 78.06 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.056 -177.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -71.21 108.47 4.73 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.543 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 10.6 t -56.53 -50.18 74.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.65 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.88 -33.56 66.98 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.785 -177.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.65 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 11.8 t70 -76.52 -43.01 41.13 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.901 0.381 . . . . 0.0 110.848 -175.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -72.8 -39.51 66.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.277 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.592 HD12 ' HB3' ' A' ' 114' ' ' ALA . 12.0 pt -65.36 -29.95 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.942 0.401 . . . . 0.0 110.014 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.577 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -63.32 -41.79 98.95 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.823 173.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.431 ' CD2' ' HA ' ' A' ' 55' ' ' ALA . 21.1 m-30 -55.66 -43.8 76.61 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.126 0.489 . . . . 0.0 110.469 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HA ' HG21 ' A' ' 68' ' ' ILE . . . -61.2 -17.11 51.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.824 -177.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 60' ' ' ARG . 37.5 mtp180 -101.62 12.06 37.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 155.98 -60.33 0.36 Allowed Glycine 0 CA--C 1.518 0.239 0 C-N-CA 119.705 -1.236 . . . . 0.0 113.549 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 33.4 Cg_exo -63.36 51.18 0.14 Allowed 'Trans proline' 0 N--CA 1.48 0.694 0 C-N-CA 123.874 3.049 . . . . 0.0 114.242 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -104.1 -175.34 2.77 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 173.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -106.52 -161.76 0.81 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.103 -177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.0 tt -53.42 -34.85 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.671 -179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.572 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -85.06 140.49 37.06 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.668 0.27 . . . . 0.0 110.53 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.719 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 73.9 Cg_endo -78.17 159.68 29.96 Favored 'Trans proline' 0 CA--C 1.521 -0.137 0 C-N-CA 122.975 2.45 . . . . 0.0 112.559 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.419 HG21 ' HA ' ' A' ' 59' ' ' ALA . 45.1 pt -74.29 131.94 34.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 41' ' ' GLU . 6.1 tt -97.91 -49.5 4.77 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -161.15 138.03 2.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.876 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.535 HD11 HG22 ' A' ' 56' ' ' ILE . 2.8 tt -108.33 133.41 53.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.661 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.472 ' HB2' ' HG3' ' A' ' 37' ' ' GLN . 93.9 m-85 -113.7 143.21 44.99 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 94' ' ' ALA . 20.6 m -133.31 156.93 42.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.584 0.707 . . . . 0.0 110.392 175.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 11.3 m120 -93.67 106.16 18.14 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 171.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 90' ' ' ASN . 18.2 t70 -46.37 97.75 0.01 OUTLIER 'General case' 0 C--O 1.233 0.232 0 O-C-N 125.384 1.677 . . . . 0.0 110.719 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.565 ' HB3' ' HG2' ' A' ' 86' ' ' PRO . 65.5 mtt -147.86 51.2 1.04 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.19 -174.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 80' ' ' GLY . . . -91.86 27.07 10.52 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.035 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.506 ' HB3' ' HB3' ' A' ' 86' ' ' PRO . . . -71.42 96.82 1.53 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -175.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 68.98 22.93 6.8 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.93 0.769 . . . . 0.0 110.515 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.511 ' O ' ' HA2' ' A' ' 77' ' ' GLY . . . 146.66 -116.6 0.87 Allowed Glycine 0 N--CA 1.44 -1.065 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 175.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 80' ' ' GLY . . . 158.21 62.13 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -171.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 18.0 p -83.64 175.37 9.77 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.572 -169.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.457 ' H ' ' HD1' ' A' ' 83' ' ' TRP . 1.4 p-90 -71.55 -30.41 65.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.452 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -84.88 -24.33 28.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.316 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 69.03 154.39 0.14 Allowed Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.508 174.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.565 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 14.9 Cg_exo -50.04 -38.2 48.99 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.173 1.916 . . . . 0.0 112.132 171.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.25 -84.51 0.33 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.351 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -77.59 148.61 35.06 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.4 157.51 29.87 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 119.784 -1.198 . . . . 0.0 113.741 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 14.9 m-80 -92.58 151.84 19.93 Favored 'General case' 0 C--O 1.216 -0.675 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 25.1 p-90 -98.6 128.61 44.97 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 118.917 -1.113 . . . . 0.0 109.891 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.844 HG21 ' HB2' ' A' ' 118' ' ' SER . 23.3 pt -145.6 167.03 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.291 -176.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.83 116.04 23.84 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 171.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.56 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -69.92 -42.26 73.55 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -171.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.738 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -67.87 -23.11 65.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.777 0.798 . . . . 0.0 109.684 -177.027 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -101.06 32.55 3.18 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.816 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.41 178.47 7.04 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.662 -172.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -92.64 135.11 34.37 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.271 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.598 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 7.2 m-85 -120.73 135.9 55.01 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.417 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.92 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.4 p -114.96 120.32 64.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.639 0.733 . . . . 0.0 109.869 171.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.808 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 95.5 t -101.95 119.05 49.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.584 177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.504 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -82.62 121.1 5.34 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.808 -1.187 . . . . 0.0 112.412 -175.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.4 m -92.59 -28.92 16.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.003 0.43 . . . . 0.0 110.231 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.91 -44.16 64.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.158 -176.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 70.6 mtt180 -138.07 118.11 13.43 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.678 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 1.3 tpp180 175.27 -170.65 0.06 Allowed 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.499 0.499 . . . . 0.0 109.682 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.466 ' H ' ' HG3' ' A' ' 106' ' ' ARG . . . -51.83 -70.8 0.78 Allowed Glycine 0 C--N 1.335 0.527 0 O-C-N 123.623 0.577 . . . . 0.0 112.883 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.95 -78.16 0.65 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.138 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -89.91 -4.23 57.63 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.187 0.518 . . . . 0.0 110.076 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -121.55 -128.67 3.53 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.381 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.481 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -102.94 99.27 13.39 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.93 0.395 . . . . 0.0 111.163 177.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.481 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 35.6 Cg_endo -64.66 151.64 84.88 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 123.191 2.594 . . . . 0.0 112.229 176.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.678 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 41.3 mt-10 -118.21 146.36 44.29 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.42 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 99' ' ' TYR . . . -106.63 130.91 54.3 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.031 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.92 ' HB ' HG13 ' A' ' 100' ' ' VAL . 57.3 t -98.05 105.19 26.47 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 175.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.9 Cg_exo -86.76 132.52 3.46 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.751 2.967 . . . . 0.0 112.989 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -136.51 149.47 48.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.714 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.844 ' HB2' HG21 ' A' ' 92' ' ' ILE . 42.0 t -84.54 -19.75 32.68 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 170.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.454 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 15.7 m -105.59 115.51 30.37 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.3 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.48 -44.78 80.96 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 121.158 0.504 . . . . 0.0 110.979 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.454 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 20.4 p-10 -62.46 -29.34 70.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.121 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -71.29 -40.41 70.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.688 175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -66.63 -37.38 84.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.143 0.497 . . . . 0.0 109.986 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.31 -35.11 78.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.659 176.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.422 ' HA ' HD12 ' A' ' 128' ' ' LEU . . . -63.93 -34.81 78.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.776 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -63.18 -36.46 83.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.799 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.653 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 44.4 t -71.91 -31.75 41.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.486 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 125' ' ' ALA . 67.7 mt -60.54 -35.39 75.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.726 176.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.24 -50.22 7.13 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.75 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.813 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.8 pt-20 -148.32 -85.18 0.1 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.842 175.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.813 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 52.05 -146.84 13.54 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 114.656 0.622 . . . . 0.0 114.656 170.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.601 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -171.33 -89.06 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.808 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.29 160.1 34.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 175.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.37 113.32 43.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.182 0.515 . . . . 0.0 110.246 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.939 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -134.57 165.13 25.92 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.902 -177.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -86.67 160.86 18.73 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.738 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 6.7 tt -61.66 -42.85 99.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.274 0.559 . . . . 0.0 109.624 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.59 -18.51 62.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.943 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.26 20.71 13.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.576 -172.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.939 HD13 HD13 ' A' ' 135' ' ' LEU . 22.6 mm -71.87 120.86 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.896 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 t -107.05 147.7 29.64 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.433 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.19 -33.27 73.09 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.65 -28.79 68.84 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.744 0.653 . . . . 0.0 112.07 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.481 ' CE ' ' HB3' ' A' ' 155' ' ' PRO . 11.9 mmt -82.94 -26.84 31.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.769 -177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.483 ' HA ' HG11 ' A' ' 101' ' ' VAL . 2.2 t -92.68 -23.01 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.949 0.404 . . . . 0.0 110.514 -175.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.6 pp -170.04 164.79 9.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.131 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.448 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 19.6 p -113.66 118.66 42.82 Favored Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.622 174.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 32.9 Cg_endo -65.92 -82.44 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.747 2.298 . . . . 0.0 112.287 175.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.688 ' HB ' ' OG1' ' A' ' 151' ' ' THR . 5.2 t -109.64 -6.58 11.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 176.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 37.9 mt-10 89.69 -73.52 0.01 OUTLIER 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 -175.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.688 ' OG1' ' HB ' ' A' ' 149' ' ' VAL . 44.4 m 53.79 21.9 2.95 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 163.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 64.4 50.65 58.3 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.56 -175.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 9.7 p -64.11 125.45 24.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.207 0.527 . . . . 0.0 111.731 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -93.73 153.94 41.04 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.81 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.556 ' HG2' ' HA ' ' A' ' 158' ' ' ASP . 6.2 Cg_exo -64.65 -163.9 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.205 1.937 . . . . 0.0 111.975 173.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -32.23 50.51 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -175.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.45 37.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.556 ' HA ' ' HG2' ' A' ' 155' ' ' PRO . 34.8 t0 59.0 72.49 0.53 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.862 -167.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.418 ' H ' ' HG2' ' A' ' 155' ' ' PRO . 12.2 t70 -168.95 -143.11 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -172.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.351 172.448 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 37.2 ttpt . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -137.07 144.38 43.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.552 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 4.4 pt20 -147.11 132.17 18.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.952 0.406 . . . . 0.0 110.665 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 59' ' ' ALA . 30.1 pt -116.13 136.34 53.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.15 0.5 . . . . 0.0 110.985 -178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -105.2 132.17 51.75 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 43' ' ' SER . 11.1 mp -99.37 157.08 16.66 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.173 0.511 . . . . 0.0 111.527 -174.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 26.4 tt0 -74.22 124.32 26.16 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.224 175.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.85 -42.64 3.12 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.244 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 40' ' ' LEU . 15.7 t -82.13 123.83 79.22 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.0 Cg_exo -79.46 -11.6 14.3 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.983 2.455 . . . . 0.0 112.628 -176.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -97.98 131.97 25.61 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-O 120.981 0.419 . . . . 0.0 110.881 -176.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 59.7 Cg_endo -93.37 137.45 1.33 Allowed 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 123.184 2.589 . . . . 0.0 112.355 177.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 8.1 tt -88.06 119.68 28.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -129.68 135.63 48.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.138 0.494 . . . . 0.0 111.42 -177.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.518 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 44.2 m-85 -142.04 153.2 44.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.038 178.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.3 t -64.51 -49.32 71.78 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.082 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 81' ' ' ALA . 24.3 mt-30 -67.79 119.27 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.778 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.963 HG23 ' HB1' ' A' ' 81' ' ' ALA . 60.1 t -71.98 -50.23 38.96 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.516 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.661 ' HB3' ' HG3' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -53.99 -30.01 45.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.612 -1.176 . . . . 0.0 112.156 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.456 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 33.8 t70 -76.05 -50.08 15.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.7 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -68.77 -39.25 80.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.585 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.615 HD12 ' HE2' ' A' ' 99' ' ' TYR . 11.1 pt -68.11 -31.47 51.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.795 0.331 . . . . 0.0 110.283 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.78 -46.1 91.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.32 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -57.6 -41.9 82.15 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.747 177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -61.16 -17.44 52.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.096 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 45.5 mtm180 -102.79 7.39 39.56 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.414 -175.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.86 -82.47 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.081 -1.057 . . . . 0.0 112.77 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -50.49 -56.83 2.71 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.361 2.708 . . . . 0.0 113.56 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 52.22 -102.97 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.045 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.464 HE21 ' HB2' ' A' ' 47' ' ' LEU . 74.3 mt-30 -152.6 -86.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.1 tt -142.93 4.58 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 122.028 0.918 . . . . 0.0 109.346 174.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.442 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -138.29 161.65 58.03 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.143 -173.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.456 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 72.0 Cg_endo -76.77 157.4 35.36 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.273 1.982 . . . . 0.0 111.714 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.1 pt -74.05 151.47 7.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.095 0.474 . . . . 0.0 111.357 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.44 -48.1 3.04 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -158.07 143.96 8.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.415 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.551 HD11 HG22 ' A' ' 56' ' ' ILE . 3.3 tt -123.48 131.98 72.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.055 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -111.65 132.06 54.85 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.597 HG23 HG13 ' A' ' 92' ' ' ILE . 17.1 m -126.25 140.89 47.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-O 121.499 0.666 . . . . 0.0 110.63 178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -95.56 110.46 22.54 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 171.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -67.54 79.87 0.17 Allowed 'General case' 0 C--O 1.222 -0.374 0 O-C-N 124.367 1.042 . . . . 0.0 108.737 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.901 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 23.7 ptm 178.76 179.53 0.38 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.255 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.429 ' HA3' ' HB2' ' A' ' 81' ' ' ALA . . . 140.34 -33.59 2.06 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.416 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 80' ' ' GLY . . . 48.11 78.86 0.07 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.822 0.449 . . . . 0.0 111.26 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 73.78 -28.89 0.19 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.36 0.664 . . . . 0.0 111.819 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 78' ' ' ALA . . . -78.17 -5.54 87.31 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.238 -0.506 . . . . 0.0 112.884 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.963 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -113.22 -74.43 0.63 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.281 0.562 . . . . 0.0 110.274 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.3 p -104.26 152.56 22.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 169.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -76.1 -25.29 55.3 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.261 0.553 . . . . 0.0 110.188 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -84.05 -13.95 51.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 38.8 mt-30 72.16 139.29 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.22 0 CA-C-N 113.826 -1.533 . . . . 0.0 112.337 175.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 85' ' ' GLN . 28.9 Cg_endo -86.78 -83.93 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.196 2.597 . . . . 0.0 113.007 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.31 -137.21 4.57 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.586 -0.816 . . . . 0.0 113.385 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.99 136.84 38.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.58 0.352 . . . . 0.0 111.459 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.901 ' HA2' ' HB3' ' A' ' 76' ' ' MET . . . -66.39 87.52 0.12 Allowed Glycine 0 C--N 1.333 0.408 0 O-C-N 124.091 0.869 . . . . 0.0 115.205 -168.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -100.59 146.76 26.74 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -99.6 130.51 45.84 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.472 -0.768 . . . . 0.0 109.891 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.597 HG13 HG23 ' A' ' 73' ' ' VAL . 2.5 pt -145.28 158.27 13.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.187 0.518 . . . . 0.0 112.316 -177.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.03 117.66 25.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 170.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.577 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -65.77 -39.63 91.21 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -169.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.723 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.1 OUTLIER -68.69 -24.36 64.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.724 0.773 . . . . 0.0 109.393 -177.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.407 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 44.2 mmtm -100.83 26.36 6.97 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.246 -1.343 . . . . 0.0 111.522 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.46 176.48 7.43 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.363 -0.21 . . . . 0.0 110.474 -173.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -94.54 135.79 35.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.414 0.626 . . . . 0.0 110.418 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.615 ' HE2' HD12 ' A' ' 56' ' ' ILE . 8.1 m-85 -120.55 136.23 54.85 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.228 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.538 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -113.22 128.55 69.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.381 0.61 . . . . 0.0 110.112 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.0 t -101.68 109.24 25.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.404 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.532 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -80.68 126.21 7.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.643 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.3 m -92.54 -30.98 15.38 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -80.5 -47.02 14.89 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -163.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -129.12 12.59 6.12 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.022 -0.424 . . . . 0.0 111.281 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.648 ' HD3' ' HB3' ' A' ' 113' ' ' GLU . 1.4 tpm_? -89.5 -91.68 0.13 Allowed 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.95 -169.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -170.93 40.25 0.19 Allowed Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.502 -176.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -65.37 -29.88 76.31 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 119.908 -1.139 . . . . 0.0 111.174 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 88.4 mmm -109.12 20.87 17.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.395 -0.402 . . . . 0.0 110.692 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -160.32 -124.22 0.72 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.401 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -102.98 100.98 18.51 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.295 0.569 . . . . 0.0 110.844 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.4 146.41 50.24 Favored 'Trans proline' 0 C--N 1.331 -0.382 0 C-N-CA 123.61 2.874 . . . . 0.0 113.407 177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.661 ' HG3' ' HB3' ' A' ' 53' ' ' ARG . 27.5 tt0 -114.88 127.48 55.73 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.75 172.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.52 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.91 129.99 40.14 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.538 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 48.8 t -102.16 105.29 41.81 Favored Pre-proline 0 C--N 1.321 -0.671 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.312 174.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -89.35 110.98 0.5 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 123.821 3.014 . . . . 0.0 111.218 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.73 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.6 t80 -119.62 149.03 42.62 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.965 -0.384 . . . . 0.0 109.965 -176.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.517 ' HB2' HD13 ' A' ' 92' ' ' ILE . 44.1 t -71.6 -32.77 68.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.925 0.393 . . . . 0.0 111.06 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.73 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 66.9 m -99.24 124.16 44.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.848 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.91 -45.41 82.06 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.212 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -65.58 -28.7 69.33 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.349 -173.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -68.8 -42.08 77.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.465 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -65.55 -35.09 79.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.305 0.574 . . . . 0.0 110.1 177.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.65 -32.31 69.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.744 177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -65.19 -32.38 74.03 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.077 0.465 . . . . 0.0 110.703 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.467 ' HD2' HG21 ' A' ' 100' ' ' VAL . 79.6 t80 -61.71 -39.61 92.09 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 173.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.714 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 42.1 t -73.14 -28.82 26.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.658 176.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 6.7 tp -56.32 -43.99 79.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.957 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.64 -50.75 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.255 174.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.911 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.5 pt-20 -152.7 -76.16 0.13 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.486 177.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.911 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.48 -130.87 11.69 Favored Glycine 0 C--N 1.334 0.424 0 O-C-N 123.543 0.527 . . . . 0.0 112.974 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.65 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -179.84 -89.64 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.36 139.47 50.66 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 177.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.73 119.66 51.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.757 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -147.04 165.65 29.25 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.111 -177.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.05 162.73 15.2 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.791 ' HA ' HG12 ' A' ' 140' ' ' ILE . 1.1 tt -62.59 -32.64 73.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.133 0.492 . . . . 0.0 109.675 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.8 -11.65 58.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.252 176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -125.53 21.5 7.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.791 HG12 ' HA ' ' A' ' 137' ' ' LEU . 30.4 mm -71.63 118.18 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -119.28 147.68 44.01 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.238 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.557 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 13.4 p-10 -69.37 -26.92 64.9 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.72 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.83 -28.74 69.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.772 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 15.4 mmt -83.9 -26.2 29.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.412 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.3 -22.8 5.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.824 0.345 . . . . 0.0 111.357 -172.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.4 pp -143.61 142.81 31.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.581 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 32.4 p -113.12 122.8 34.86 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.093 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 22.4 Cg_endo -64.81 -75.75 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.314 2.009 . . . . 0.0 111.51 174.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.1 t -128.37 11.23 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' A' ' 152' ' ' GLY . 37.6 mt-10 67.51 -79.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.326 -173.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.445 HG23 ' N ' ' A' ' 152' ' ' GLY . 12.4 t 43.76 -62.57 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.931 1.692 . . . . 0.0 113.928 -171.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 150' ' ' GLU . . . 150.28 55.25 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.474 -0.65 . . . . 0.0 111.474 -177.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 32.3 t -89.95 148.68 22.97 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 157' ' ' ALA . 20.4 mm-40 -71.06 136.01 84.9 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.213 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 157' ' ' ALA . 98.3 Cg_endo -78.36 -118.29 0.01 OUTLIER 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.819 2.346 . . . . 0.0 112.239 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.435 ' H ' ' HB2' ' A' ' 155' ' ' PRO . 0.0 OUTLIER -60.46 -27.19 67.34 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.052 0.453 . . . . 0.0 109.784 177.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.513 ' O ' ' HD2' ' A' ' 155' ' ' PRO . . . -179.84 -118.26 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.808 177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -123.55 14.87 9.53 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 122.543 1.163 . . . . 0.0 108.564 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.29 30.89 1.82 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.475 -1.239 . . . . 0.0 112.251 -167.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.397 -0.811 . . . . 0.0 111.203 -177.806 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 50' ' ' SER . 37.2 ttmt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -144.55 144.29 31.24 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.918 0.39 . . . . 0.0 112.024 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -149.17 135.28 19.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.101 176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.608 HG21 ' HB2' ' A' ' 59' ' ' ALA . 33.7 pt -115.93 138.84 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.024 0.44 . . . . 0.0 111.103 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -107.57 121.15 44.07 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.581 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.5 mp -87.58 147.86 25.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.006 0.432 . . . . 0.0 110.912 -177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.534 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 27.6 tt0 -74.06 124.3 26.0 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.659 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.03 -38.4 3.2 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.884 -177.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 28.0 t -82.1 125.06 78.09 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.2 Cg_exo -80.44 1.77 9.01 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.998 2.465 . . . . 0.0 112.786 -176.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -107.28 132.86 20.63 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 9.4 Cg_endo -92.66 115.76 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.611 2.874 . . . . 0.0 111.702 174.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 tt -74.61 108.33 7.3 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -113.23 137.97 50.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.19 0.519 . . . . 0.0 111.318 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.577 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 36.6 m-85 -139.58 143.95 37.55 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.223 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 33.9 m -56.37 -54.43 45.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.561 ' HG2' ' HA ' ' A' ' 83' ' ' TRP . 48.4 mt-30 -63.62 125.58 24.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.148 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.5 t -65.28 -50.62 72.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.613 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -58.1 -28.27 64.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.376 -178.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.613 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 11.5 t70 -75.95 -51.6 12.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.824 0.345 . . . . 0.0 110.184 -176.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.577 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -64.93 -39.93 94.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.336 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 71' ' ' ILE . 28.7 pt -69.31 -31.88 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.951 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.05 82.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.319 . . . . 0.0 110.791 177.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -62.3 -32.04 72.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.481 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.608 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -70.75 -18.27 62.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 23.9 mtm180 -94.41 3.73 54.78 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -174.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.43 -60.49 0.23 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 119.412 -1.375 . . . . 0.0 114.414 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -40.47 -44.25 4.3 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.799 2.999 . . . . 0.0 114.781 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -82.26 99.7 9.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.148 0.499 . . . . 0.0 111.364 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -106.45 111.06 23.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.632 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -176.68 -42.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.079 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.581 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -151.78 151.25 28.01 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.534 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.5 Cg_endo -72.22 158.12 52.48 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.056 1.837 . . . . 0.0 111.741 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.0 pt -81.54 117.59 27.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.067 0.461 . . . . 0.0 110.434 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.6 tt -77.82 -48.05 17.44 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -161.19 138.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.218 177.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' A' ' 95' ' ' ASP . 3.6 tt -107.99 129.76 61.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.947 177.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.533 ' HA ' ' O ' ' A' ' 92' ' ' ILE . 79.6 m-85 -111.71 127.25 55.72 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.583 HG22 ' HB2' ' A' ' 94' ' ' ALA . 27.7 m -123.03 151.7 27.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-O 121.045 0.45 . . . . 0.0 110.061 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.535 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 15.6 m120 -86.03 97.03 10.05 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 90' ' ' ASN . 10.3 t70 -45.08 106.6 0.08 Allowed 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 125.581 1.801 . . . . 0.0 110.449 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -179.71 87.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 O-C-N 125.46 1.725 . . . . 0.0 109.16 178.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.611 ' HA3' HG13 ' A' ' 115' ' ' VAL . . . -126.93 28.94 4.51 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.541 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.53 ' H ' ' HG3' ' A' ' 86' ' ' PRO . . . -79.55 43.76 0.58 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.427 0.632 . . . . 0.0 110.509 -174.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -175.05 9.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.194 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.68 7.32 55.71 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.038 -177.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 55.3 53.1 10.43 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 110.047 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.609 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 26.4 p -83.67 177.55 8.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.625 -169.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.561 ' HA ' ' HG2' ' A' ' 51' ' ' GLN . 35.5 p90 -66.39 -25.05 66.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.189 0.519 . . . . 0.0 110.149 174.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -82.91 -35.14 26.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.702 176.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 82' ' ' THR . 0.9 OUTLIER 66.75 165.24 0.12 Allowed Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.49 175.054 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.53 ' HG3' ' H ' ' A' ' 78' ' ' ALA . 87.6 Cg_endo -90.31 5.66 4.3 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.054 1.836 . . . . 0.0 111.997 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.94 -179.68 16.05 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.038 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.96 146.12 51.36 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.64 -172.81 13.17 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.319 -0.943 . . . . 0.0 113.205 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 36.8 m-80 -95.18 151.6 19.08 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -97.51 129.75 44.65 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.076 -1.015 . . . . 0.0 111.121 -170.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.71 HD13 ' HB2' ' A' ' 118' ' ' SER . 24.9 pt -144.0 166.2 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.594 -173.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.09 106.3 14.78 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 173.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.583 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -69.84 -32.5 70.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.923 -173.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.735 ' HA ' HD13 ' A' ' 137' ' ' LEU . 1.0 OUTLIER -71.45 -23.87 61.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.72 0.771 . . . . 0.0 109.889 -177.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -99.45 29.6 3.94 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.07 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -137.21 -176.37 4.36 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -95.72 138.05 33.92 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.546 0.689 . . . . 0.0 110.621 -176.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.537 ' CE1' HD12 ' A' ' 137' ' ' LEU . 2.3 m-85 -120.53 136.62 54.72 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.028 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.797 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -114.46 123.14 69.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.438 0.637 . . . . 0.0 110.41 173.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 42.8 t -101.56 127.6 54.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.439 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -86.71 121.37 5.75 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.967 -1.111 . . . . 0.0 113.116 -173.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.4 m -92.48 -37.15 12.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.688 0.28 . . . . 0.0 110.79 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.14 -44.71 16.11 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.042 0.449 . . . . 0.0 110.9 -175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.522 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 50.8 mtp180 -134.62 121.6 21.11 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.562 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 165.55 -175.01 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.548 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -79.23 42.3 2.35 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.066 175.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.78 -24.69 70.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.6 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 53.8 ttp -103.57 -3.49 25.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.853 0.359 . . . . 0.0 110.474 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -153.91 -110.14 0.39 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.972 -175.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.548 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.47 99.32 14.84 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.676 0.274 . . . . 0.0 111.208 -179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.519 ' HA ' ' H ' ' A' ' 107' ' ' GLY . 49.6 Cg_endo -67.68 147.01 75.04 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.64 2.893 . . . . 0.0 113.659 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.562 ' CD ' ' HE ' ' A' ' 106' ' ' ARG . 1.6 mp0 -114.68 142.34 46.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 174.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.54 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -107.68 130.8 54.89 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.613 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.797 ' HB ' HG13 ' A' ' 100' ' ' VAL . 96.5 t -100.97 105.55 39.17 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 120.969 0.414 . . . . 0.0 110.38 175.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.3 Cg_exo -87.91 127.52 2.23 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.645 2.897 . . . . 0.0 112.387 174.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -134.07 148.82 51.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.487 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.71 ' HB2' HD13 ' A' ' 92' ' ' ILE . 33.0 t -80.48 -16.73 53.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.139 0.495 . . . . 0.0 109.947 174.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.8 m -108.58 131.9 54.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.523 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.5 OUTLIER -68.15 -48.67 64.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.073 0.463 . . . . 0.0 110.921 179.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -63.64 -28.5 69.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.888 -173.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.59 -40.2 76.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.385 175.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.37 -35.78 71.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 110.121 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.96 88.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.785 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -63.28 -30.07 71.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.001 176.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -66.06 -40.45 90.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.741 HG22 ' H ' ' A' ' 132' ' ' GLY . 59.5 t -72.25 -29.11 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.415 0.626 . . . . 0.0 110.395 175.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 7.7 tp -58.04 -43.7 86.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.122 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.83 -50.97 8.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.666 176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.688 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.8 pt-20 -141.6 -92.91 0.14 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.468 178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.688 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 47.98 -145.41 5.58 Favored Glycine 0 C--N 1.333 0.398 0 O-C-N 123.517 0.511 . . . . 0.0 113.984 174.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.741 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -172.62 -81.49 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.06 139.27 51.0 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.847 0.356 . . . . 0.0 110.793 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.13 115.21 43.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.215 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.779 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -140.04 159.82 41.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.786 179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.66 157.48 24.64 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.735 HD13 ' HA ' ' A' ' 95' ' ' ASP . 6.3 tt -60.95 -34.95 75.53 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 177.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.35 -13.8 59.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.759 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -127.66 29.64 5.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.126 0.488 . . . . 0.0 110.635 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.779 HD13 HD13 ' A' ' 135' ' ' LEU . 36.1 mm -71.58 121.42 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.5 t -108.95 147.87 31.59 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.154 177.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.6 p-10 -69.27 -32.84 72.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.877 -176.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.67 -29.77 66.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.019 -175.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.544 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 6.2 mmt -87.19 -33.86 19.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.457 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 141' ' ' THR . 3.9 t -78.99 -23.51 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 121.359 0.599 . . . . 0.0 109.915 -177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 1.8 pp -150.18 106.76 3.51 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.77 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.426 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 23.7 p -80.06 120.1 78.68 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.555 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 9.8 Cg_endo -55.76 -72.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.768 2.312 . . . . 0.0 111.671 177.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 1.7 t -129.27 10.25 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.467 ' O ' HG22 ' A' ' 151' ' ' THR . 42.4 mt-10 67.47 -77.92 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.326 -173.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 150' ' ' GLU . 5.8 t 53.07 -41.4 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.899 1.679 . . . . 0.0 114.936 -177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 122.37 15.6 4.09 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.3 p -70.55 142.37 51.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.598 0.237 . . . . 0.0 111.264 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.602 ' HG2' ' HB2' ' A' ' 158' ' ' ASP . 2.8 mp0 -56.61 126.07 69.33 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.274 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.436 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 27.1 Cg_endo -62.85 -86.7 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.334 2.689 . . . . 0.0 113.601 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.82 -28.36 15.92 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.029 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 177.2 19.57 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.344 0.402 . . . . 0.0 111.385 178.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.602 ' HB2' ' HG2' ' A' ' 154' ' ' GLU . 32.2 t70 53.42 84.9 0.05 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.398 0.618 . . . . 0.0 109.571 -171.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -163.91 -43.31 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.582 -165.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.815 179.735 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.677 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 69.6 tttt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.774 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -143.78 143.77 31.51 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.438 -0.505 . . . . 0.0 112.027 -175.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 3.4 pt20 -149.31 129.64 13.77 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.586 174.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.469 HG22 ' CG1' ' A' ' 71' ' ' ILE . 29.9 pt -116.11 135.29 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -103.24 121.45 42.73 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 176.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.4 mp -86.1 141.28 29.52 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.088 -176.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.653 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 32.7 tt0 -74.0 124.35 26.05 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.599 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.18 -14.21 64.24 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.269 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.44 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 34.7 t -105.86 125.47 33.13 Favored Pre-proline 0 C--N 1.324 -0.516 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.6 Cg_exo -78.0 5.99 4.95 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.944 2.429 . . . . 0.0 112.733 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -129.69 132.74 24.39 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.773 0.321 . . . . 0.0 111.182 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 7.6 Cg_endo -89.92 165.45 4.88 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.593 2.862 . . . . 0.0 112.133 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 7.1 tt -107.68 118.71 37.46 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -101.91 134.69 44.7 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -178.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.24 146.83 27.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.155 0.502 . . . . 0.0 110.85 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.5 m -69.27 -36.36 77.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.298 0.57 . . . . 0.0 110.63 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.92 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 51.8 mt-30 -84.94 122.7 29.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.834 -175.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.774 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 2.6 t -67.6 -51.7 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.577 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -52.62 -41.17 63.48 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.179 -178.73 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.577 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 29.8 t0 -76.34 -43.05 42.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.754 0.311 . . . . 0.0 111.105 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.2 -37.66 75.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.704 0.288 . . . . 0.0 111.443 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.763 HD12 ' HB3' ' A' ' 114' ' ' ALA . 24.4 pt -68.19 -31.29 51.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.419 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -64.37 -42.44 96.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.295 174.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 21.2 m-30 -57.17 -37.75 72.57 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.155 0.502 . . . . 0.0 110.438 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.568 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -64.63 -18.89 65.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.111 -177.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -94.66 -6.69 42.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -179.48 -58.98 0.08 OUTLIER Glycine 0 CA--C 1.519 0.309 0 C-N-CA 119.604 -1.284 . . . . 0.0 113.998 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 26.4 Cg_exo -65.56 46.3 0.18 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.527 2.818 . . . . 0.0 114.555 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -96.26 165.7 12.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.731 ' HG3' HG22 ' A' ' 65' ' ' ILE . 10.4 pt20 -92.86 -18.85 22.32 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -169.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.731 HG22 ' HG3' ' A' ' 64' ' ' GLN . 6.5 tt 179.32 -39.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.382 . . . . 0.0 111.976 -174.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.545 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -104.99 146.76 33.29 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.58 -171.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.653 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 55.9 Cg_endo -71.8 163.77 37.81 Favored 'Trans proline' 0 C--O 1.224 -0.183 0 C-N-CA 123.159 2.573 . . . . 0.0 111.73 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.568 HD13 ' HB1' ' A' ' 59' ' ' ALA . 27.6 pt -79.3 127.19 39.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.149 0.499 . . . . 0.0 110.737 177.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.2 tt -91.78 -48.13 6.97 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -159.17 138.75 3.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.84 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.469 ' CG1' HG22 ' A' ' 38' ' ' ILE . 3.0 tt -117.07 131.53 69.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.215 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -111.85 128.34 56.1 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.458 HG22 ' HB2' ' A' ' 94' ' ' ALA . 29.6 m -127.83 139.49 51.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-O 120.834 0.35 . . . . 0.0 110.096 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.677 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 2.2 m-20 -84.64 107.04 16.64 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -69.6 142.35 53.55 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 124.371 1.045 . . . . 0.0 109.494 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.783 ' O ' ' HG2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER 168.28 -29.13 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.648 0 O-C-N 124.511 1.132 . . . . 0.0 109.039 -170.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.601 ' HA3' ' HB2' ' A' ' 81' ' ' ALA . . . -69.47 68.49 0.54 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.364 -0.835 . . . . 0.0 113.622 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.97 106.78 2.87 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.589 -0.306 . . . . 0.0 110.445 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.22 26.49 15.94 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.539 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.9 -72.38 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.73 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.601 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . . . 57.19 52.35 9.05 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.309 0.576 . . . . 0.0 110.338 -177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.46 175.75 9.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.178 -173.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.92 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 31.7 p90 -68.8 -20.68 64.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.369 0.604 . . . . 0.0 110.162 175.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.85 -31.8 31.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.838 173.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 62.36 171.38 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.327 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.353 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.783 ' HG2' ' O ' ' A' ' 76' ' ' MET . 5.7 Cg_exo -83.88 -5.06 10.62 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.929 1.753 . . . . 0.0 110.372 166.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.09 174.06 13.22 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 -174.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -77.14 146.07 37.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.607 0.704 . . . . 0.0 109.468 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.433 ' HA3' ' HG2' ' A' ' 76' ' ' MET . . . -136.91 -140.18 4.05 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.655 -175.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 19.2 m120 -100.31 145.44 28.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 74' ' ' ASN . 37.3 p90 -98.52 130.94 45.1 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.549 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.694 HD13 ' HB2' ' A' ' 118' ' ' SER . 1.8 pt -133.6 151.92 34.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.656 -176.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.85 102.67 4.13 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.559 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . . . -61.02 -31.59 71.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.153 0.501 . . . . 0.0 110.935 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 1.0 OUTLIER -58.03 -31.05 66.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.165 176.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -111.39 27.7 9.43 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.868 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.559 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -122.52 178.59 4.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.529 0.204 . . . . 0.0 110.775 -174.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -92.74 131.61 37.66 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.251 0.548 . . . . 0.0 110.779 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -120.49 136.12 54.86 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.338 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.463 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 4.2 p -113.71 129.48 69.48 Favored 'Isoleucine or valine' 0 C--O 1.246 0.876 0 CA-C-O 121.866 0.841 . . . . 0.0 110.571 172.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.551 ' HA ' HH11 ' A' ' 106' ' ' ARG . 38.1 t -104.01 111.84 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.282 172.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.695 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -74.67 124.07 7.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.314 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.0 p -86.71 -31.23 21.12 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.957 0.408 . . . . 0.0 110.564 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -78.41 -35.04 47.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.714 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.62 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 60.2 mtp180 -121.13 -140.84 0.33 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.369 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.551 HH11 ' HA ' ' A' ' 101' ' ' VAL . 22.4 ttt180 72.25 176.57 0.27 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.478 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -71.94 -48.96 24.52 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.894 -0.67 . . . . 0.0 113.096 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.08 -96.89 0.33 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.339 -0.934 . . . . 0.0 110.832 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.0 mtt -99.48 -3.8 32.76 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.281 0.562 . . . . 0.0 109.735 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -90.78 -123.37 2.72 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.717 175.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.478 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.19 94.66 5.84 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 117.077 0.439 . . . . 0.0 110.663 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -68.92 113.18 3.15 Favored 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.74 2.293 . . . . 0.0 113.125 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -114.65 130.53 56.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.836 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.763 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -100.16 132.8 45.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.456 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.463 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 14.3 t -99.38 105.87 35.74 Favored Pre-proline 0 C--N 1.323 -0.557 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.674 176.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.548 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -90.73 131.45 1.58 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 124.2 3.267 . . . . 0.0 112.329 177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -128.82 153.27 47.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.694 ' HB2' HD13 ' A' ' 92' ' ' ILE . 38.4 t -85.08 -27.76 26.08 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 170.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.4 m -96.02 115.99 28.27 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.142 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -57.8 -45.75 85.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.315 0.578 . . . . 0.0 111.139 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -63.38 -28.54 70.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.368 -172.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -64.48 -42.45 95.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.075 0.464 . . . . 0.0 110.296 174.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -68.45 -37.34 80.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.283 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.3 98.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.709 176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.28 -36.42 83.6 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.12 0.486 . . . . 0.0 110.447 177.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -61.88 -40.7 96.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.762 176.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.631 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 78.6 t -66.19 -40.17 86.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.017 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 66.4 mt -56.86 -34.62 68.01 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.599 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.04 -41.86 13.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.231 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.62 ' OE1' ' HD3' ' A' ' 105' ' ' ARG . 7.6 pt-20 -161.12 -35.18 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -172.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.695 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -53.61 163.88 2.59 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.945 -0.571 . . . . 0.0 113.232 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -111.41 -66.26 0.52 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.705 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.424 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.13 141.56 50.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.829 0.347 . . . . 0.0 110.675 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.3 t -103.34 113.75 41.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.188 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.704 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -138.65 164.87 28.39 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.987 -176.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.27 170.07 13.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.541 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 3.6 tt -66.36 -30.52 70.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.304 0.573 . . . . 0.0 109.629 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.22 -12.1 60.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.587 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -109.43 12.82 24.4 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.959 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.704 HD13 HD13 ' A' ' 135' ' ' LEU . 41.8 mm -71.88 119.12 17.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 C-N-CA 120.235 -0.586 . . . . 0.0 110.082 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.3 t -119.37 147.12 44.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.849 175.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.426 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.1 p-10 -69.41 -25.49 64.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.053 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.27 -28.8 69.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.669 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.637 ' HA ' ' CE ' ' A' ' 144' ' ' MET . 3.9 mmt -87.1 -28.96 22.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.037 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 141' ' ' THR . 8.6 t -79.16 -23.56 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 CA-C-O 121.263 0.554 . . . . 0.0 110.476 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.2 pp -155.9 139.75 16.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.77 -177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.1 p -95.97 120.58 62.73 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.832 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -62.36 -78.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.175 1.917 . . . . 0.0 111.285 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.62 6.28 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 65.91 -74.94 0.05 Allowed 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.308 -167.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.0 t 43.32 31.06 0.35 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.626 1.17 . . . . 0.0 114.062 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 71.97 23.59 77.78 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.012 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 22.3 t -96.38 124.51 40.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.018 0.437 . . . . 0.0 109.824 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -80.0 149.62 70.43 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.333 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.428 ' HG2' ' O ' ' A' ' 159' ' ' ASP . 10.8 Cg_endo -55.82 -33.53 88.54 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.164 2.576 . . . . 0.0 112.445 -176.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.543 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 3.3 ptp85 -155.35 -69.25 0.12 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.318 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.543 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -145.93 69.65 1.22 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.23 31.66 0.39 Allowed 'General case' 0 N--CA 1.478 0.972 0 O-C-N 124.31 1.006 . . . . 0.0 111.81 -175.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.428 ' O ' ' HG2' ' A' ' 155' ' ' PRO . 11.9 t70 -130.49 -166.02 1.63 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.731 179.35 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 40.1 ttmt . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.584 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -126.54 144.35 50.9 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.978 0.418 . . . . 0.0 111.448 -175.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.472 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . 11.7 pt20 -148.84 136.76 20.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.963 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.707 HG21 ' HB2' ' A' ' 59' ' ' ALA . 30.3 pt -115.9 134.82 57.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.103 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -98.83 116.9 32.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' A' ' 66' ' ' ALA . 3.0 mp -92.26 142.34 27.58 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.964 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.796 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 34.7 tt0 -74.0 132.43 42.37 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.23 -36.46 3.19 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.5 -175.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.517 ' HB2' ' CB ' ' A' ' 40' ' ' LEU . 68.8 m -82.14 124.5 78.58 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.014 0.435 . . . . 0.0 110.332 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 2.5 Cg_endo -82.86 -3.47 11.16 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.134 2.556 . . . . 0.0 112.884 -176.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -125.39 133.98 25.37 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.719 -177.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 5.9 Cg_exo -79.1 141.88 16.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.999 2.466 . . . . 0.0 111.847 178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.516 ' HB3' HG12 ' A' ' 38' ' ' ILE . 6.3 tt -91.48 107.23 19.06 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . 38.4 p90 -116.81 137.68 52.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.173 0.511 . . . . 0.0 111.14 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -138.58 143.15 39.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.516 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 5.3 p -55.69 -40.7 72.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.224 0.535 . . . . 0.0 110.982 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.523 ' HG2' ' CB ' ' A' ' 83' ' ' TRP . 68.4 mt-30 -82.1 114.85 20.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.396 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.686 HG23 HE22 ' A' ' 85' ' ' GLN . 45.4 t -58.53 -47.89 87.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.298 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -58.68 -28.43 65.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.626 -178.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.459 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 22.5 t70 -75.99 -51.12 13.05 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.022 0.439 . . . . 0.0 110.257 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.66 -39.71 95.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.344 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.705 HG22 HD11 ' A' ' 71' ' ' ILE . 28.4 pt -69.08 -31.92 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.765 0.316 . . . . 0.0 110.546 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.95 82.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.707 0.289 . . . . 0.0 110.339 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.492 ' HA ' ' HB2' ' A' ' 62' ' ' PRO . 10.1 m-85 -62.12 -35.63 79.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.244 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -63.19 -18.1 63.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.707 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -81.71 -3.26 53.21 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.72 -42.64 0.96 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 119.63 -1.272 . . . . 0.0 114.68 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.492 ' HB2' ' HA ' ' A' ' 58' ' ' TYR . 93.2 Cg_exo -49.32 -16.68 1.21 Allowed 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 123.515 2.81 . . . . 0.0 115.367 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -68.38 -30.84 69.87 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.522 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 41.9 35.41 0.53 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.826 1.25 . . . . 0.0 114.059 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.2 tt -132.51 -47.55 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.594 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.2 151.84 28.37 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.623 0.249 . . . . 0.0 110.917 -175.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.796 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 74.5 Cg_endo -70.35 148.88 62.2 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 122.366 2.044 . . . . 0.0 111.805 -179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 68' ' ' ILE . 27.5 pt -84.4 105.33 13.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.394 0.616 . . . . 0.0 110.335 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.8 tt -67.27 -47.36 70.92 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -161.16 138.38 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.119 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.705 HD11 HG22 ' A' ' 56' ' ' ILE . 2.8 tt -108.34 131.13 59.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.76 177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -112.03 128.21 56.12 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.228 0.537 . . . . 0.0 110.007 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 94' ' ' ALA . 30.7 m -126.21 136.64 60.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.069 0.461 . . . . 0.0 109.839 177.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 91' ' ' TRP . 0.2 OUTLIER -83.72 101.04 11.28 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.441 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 61.1 t0 -55.92 103.73 0.11 Allowed 'General case' 0 C--O 1.236 0.386 0 O-C-N 124.774 1.296 . . . . 0.0 110.058 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.829 ' O ' ' HG2' ' A' ' 86' ' ' PRO . 52.6 mtt -127.64 -26.21 3.02 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.07 -176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.735 ' HA3' ' HB2' ' A' ' 81' ' ' ALA . . . -70.66 58.07 0.94 Allowed Glycine 0 C--O 1.226 -0.348 0 O-C-N 123.951 0.782 . . . . 0.0 115.015 -165.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.38 33.9 0.69 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.381 0.61 . . . . 0.0 109.846 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -171.53 8.54 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.548 -171.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.43 ' HA2' ' HZ ' ' A' ' 126' ' ' PHE . . . 127.02 -26.13 5.1 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.568 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.735 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . . . 67.68 70.06 0.35 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.399 0.619 . . . . 0.0 110.315 -177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.2 p -83.97 175.06 9.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.359 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.523 ' CB ' ' HG2' ' A' ' 51' ' ' GLN . 21.1 p-90 -70.2 -20.86 63.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.213 0.53 . . . . 0.0 110.321 174.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -83.08 -35.88 25.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.005 177.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.686 HE22 HG23 ' A' ' 52' ' ' VAL . 0.6 OUTLIER 68.1 140.74 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.144 173.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.829 ' HG2' ' O ' ' A' ' 76' ' ' MET . 52.1 Cg_exo -57.46 -48.38 17.62 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.925 2.416 . . . . 0.0 113.032 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 154.99 -141.65 8.32 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.682 -177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -67.1 139.67 57.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.973 0.415 . . . . 0.0 111.521 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -150.99 -165.05 12.47 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.535 -0.626 . . . . 0.0 111.535 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -100.15 138.45 37.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 117.08 0.44 . . . . 0.0 110.116 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.573 ' HA ' ' HA ' ' A' ' 74' ' ' ASN . 15.4 p-90 -98.61 131.08 45.09 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.416 -177.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.48 HD13 ' CA ' ' A' ' 118' ' ' SER . 3.7 pt -141.88 163.19 19.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.247 -170.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.39 107.31 10.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.384 171.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.493 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -62.61 -35.28 79.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.004 0.43 . . . . 0.0 111.229 -176.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.706 ' HA ' HD13 ' A' ' 137' ' ' LEU . 8.9 t70 -59.78 -26.82 66.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.88 0.848 . . . . 0.0 110.27 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -116.4 36.06 4.27 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.646 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.27 178.96 6.5 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.796 0.331 . . . . 0.0 110.55 -171.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -97.51 138.11 35.44 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-O 121.426 0.631 . . . . 0.0 109.924 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.413 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 5.6 m-85 -120.09 135.65 54.87 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.029 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.946 HG13 HG13 ' A' ' 115' ' ' VAL . 2.2 p -115.3 120.6 65.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.717 0.77 . . . . 0.0 109.473 170.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 64.4 t -101.74 115.94 44.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.57 -1.196 . . . . 0.0 108.58 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.48 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -77.61 120.87 5.64 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 119.83 -1.176 . . . . 0.0 112.263 -176.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 m -92.5 -29.16 16.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.926 0.394 . . . . 0.0 110.382 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -81.98 -43.97 17.32 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.133 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.497 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 46.6 mtp180 -130.93 121.19 24.72 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.577 HH22 ' HZ ' ' A' ' 126' ' ' PHE . 0.0 OUTLIER 172.84 175.21 0.1 Allowed 'General case' 0 N--CA 1.465 0.309 0 O-C-N 123.804 0.69 . . . . 0.0 109.863 177.387 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -49.88 -78.47 0.09 OUTLIER Glycine 0 C--N 1.337 0.587 0 O-C-N 123.363 0.414 . . . . 0.0 113.402 177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.37 -76.9 0.76 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.329 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -83.63 -3.67 57.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.155 0.503 . . . . 0.0 110.749 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -130.55 -124.0 2.56 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.426 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.42 96.99 9.36 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 110.545 -0.169 . . . . 0.0 110.545 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 28.3 Cg_endo -64.5 147.64 90.45 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.765 2.31 . . . . 0.0 112.695 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.493 ' O ' ' HD2' ' A' ' 106' ' ' ARG . 1.6 mp0 -115.0 121.83 44.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.709 -176.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . . . -94.08 131.51 39.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 175.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.946 HG13 HG13 ' A' ' 100' ' ' VAL . 1.4 p -108.8 106.77 59.35 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-O 121.783 0.802 . . . . 0.0 110.352 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.465 ' HB2' HG21 ' A' ' 73' ' ' VAL . 7.6 Cg_exo -81.86 119.99 3.35 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 124.414 3.409 . . . . 0.0 112.65 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -108.05 153.39 23.18 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.956 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.48 ' CA ' HD13 ' A' ' 92' ' ' ILE . 48.1 t -81.01 -43.06 20.15 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.184 174.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.401 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 19.6 m -100.65 131.09 46.73 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.292 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.577 ' HD2' ' N ' ' A' ' 121' ' ' ASP . 0.0 OUTLIER -65.32 -33.71 76.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.347 -177.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.577 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 10.8 p-10 -68.17 -28.51 67.35 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.196 0.522 . . . . 0.0 110.072 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -69.41 -39.28 78.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.788 173.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.08 -38.6 82.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.226 177.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.49 94.28 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.687 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.07 73.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.031 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.577 ' HZ ' HH22 ' A' ' 106' ' ' ARG . 44.6 t80 -66.02 -40.34 90.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.07 177.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.709 HG22 ' H ' ' A' ' 132' ' ' GLY . 65.0 t -73.05 -29.07 27.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.452 0.644 . . . . 0.0 110.255 176.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.7 tt -62.36 -36.23 81.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.929 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.19 -50.6 7.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.627 174.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.742 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 1.9 pt-20 -146.64 -88.92 0.09 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.298 176.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.742 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 49.85 -142.9 11.81 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 123.412 0.445 . . . . 0.0 113.794 174.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.709 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -175.62 -82.86 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -130.0 139.44 51.04 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.839 0.352 . . . . 0.0 110.381 176.507 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.8 t -101.1 113.95 38.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.955 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.629 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -139.85 165.7 26.6 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.068 -176.619 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -88.68 168.2 12.71 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.706 HD13 ' HA ' ' A' ' 95' ' ' ASP . 3.6 tt -63.4 -32.46 73.9 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.83 -16.07 63.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.028 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -111.88 12.39 20.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.488 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.629 HD13 HD13 ' A' ' 135' ' ' LEU . 16.4 mm -71.87 119.71 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 145' ' ' VAL . 5.2 t -119.29 145.5 46.07 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.958 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.405 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 14.9 p-10 -69.57 -27.52 65.2 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.082 0.239 . . . . 0.0 110.406 178.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.64 -28.98 68.98 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.885 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.736 ' HG2' ' HB3' ' A' ' 155' ' ' PRO . 3.9 mmt -84.72 -33.97 23.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.728 0.299 . . . . 0.0 111.425 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 141' ' ' THR . 3.5 t -79.81 -23.77 11.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.341 0.591 . . . . 0.0 110.275 -177.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.8 pp -159.88 143.3 14.15 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.773 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' A' ' 150' ' ' GLU . 16.7 p -106.51 120.42 48.55 Favored Pre-proline 0 C--N 1.318 -0.774 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.887 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 14.7 Cg_endo -58.9 -53.17 4.02 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.676 2.251 . . . . 0.0 111.83 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 1.4 t -135.62 20.28 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.597 ' HA ' ' HB ' ' A' ' 147' ' ' THR . 5.2 mm-40 64.81 -83.6 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.3 -168.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 t 44.83 7.45 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 176.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 57.38 46.36 91.93 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.297 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 25.4 m -71.08 144.75 50.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.776 0.288 . . . . 0.0 110.563 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 158' ' ' ASP . 45.2 mt-10 -75.8 122.88 87.91 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.736 ' HB3' ' HG2' ' A' ' 144' ' ' MET . 6.8 Cg_endo -48.53 -85.4 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 124.228 3.286 . . . . 0.0 114.299 -173.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.93 -22.3 12.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.216 0.532 . . . . 0.0 109.904 175.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -175.9 21.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.241 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 29.8 t0 53.81 71.88 0.48 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.307 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -126.65 -39.83 1.97 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.323 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 160' ' ' GLU . 1.7 pm0 . . . . . 0 C--O 1.25 1.079 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.503 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.716 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -132.45 144.12 50.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.68 0.276 . . . . 0.0 110.645 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 20.3 pt20 -149.16 131.63 15.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.092 176.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.751 HG22 ' HB ' ' A' ' 71' ' ' ILE . 29.8 pt -115.78 133.23 62.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.148 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -103.99 123.9 48.04 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.568 ' CB ' ' HB2' ' A' ' 43' ' ' SER . 6.4 mp -90.35 148.52 22.79 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.33 -175.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.633 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 35.7 tt0 -74.16 124.06 25.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.31 -28.8 4.57 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.066 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.568 ' HB2' ' CB ' ' A' ' 40' ' ' LEU . 59.7 m -81.72 124.51 79.57 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.923 0.392 . . . . 0.0 110.347 177.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 4.2 Cg_exo -78.12 -13.34 15.6 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.373 2.715 . . . . 0.0 113.298 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.63 133.62 24.09 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-O 120.876 0.369 . . . . 0.0 111.266 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.435 ' HG2' ' CE2' ' A' ' 48' ' ' PHE . 96.8 Cg_endo -85.98 168.51 9.26 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.873 2.382 . . . . 0.0 112.472 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 8.0 tt -111.75 116.21 30.34 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.435 ' CE2' ' HG2' ' A' ' 46' ' ' PRO . 98.6 m-85 -96.08 136.19 36.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.355 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.411 ' HD1' ' H ' ' A' ' 51' ' ' GLN . 0.8 OUTLIER -148.01 133.15 18.32 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 177.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.2 m -66.23 -40.48 90.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.395 0.617 . . . . 0.0 109.613 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.829 ' HG2' ' HB2' ' A' ' 83' ' ' TRP . 50.3 mt-30 -77.31 102.22 6.64 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.316 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.716 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 13.8 t -56.73 -50.05 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.177 0.513 . . . . 0.0 110.129 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.572 ' HA ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -55.44 -33.89 64.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.812 -1.086 . . . . 0.0 112.782 -178.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.433 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 7.8 t70 -76.34 -43.55 40.54 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.138 0.494 . . . . 0.0 110.084 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 58' ' ' TYR . . . -71.52 -34.75 70.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.746 -178.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.572 ' CD1' ' HA ' ' A' ' 53' ' ' ARG . 10.4 pt -68.56 -31.67 52.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.62 -38.76 88.83 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.542 173.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 55' ' ' ALA . 19.6 m-85 -60.29 -44.89 94.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.97 0.414 . . . . 0.0 111.356 175.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.46 -17.88 63.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.478 -174.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -105.04 12.63 31.99 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 179.21 -71.94 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.118 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -65.74 37.94 0.13 Allowed 'Trans proline' 0 N--CA 1.482 0.829 0 C-N-CA 124.189 3.26 . . . . 0.0 114.994 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' H ' ' HG2' ' A' ' 63' ' ' GLU . 15.1 pt-20 -68.57 144.14 54.65 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 173.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -53.83 -82.25 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -169.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.406 ' O ' HG12 ' A' ' 65' ' ' ILE . 12.8 tt -137.5 4.3 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 122.065 0.936 . . . . 0.0 109.559 -177.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 41' ' ' GLU . . . -141.33 156.45 67.33 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.52 -174.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.6 Cg_endo -72.62 160.26 46.91 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.184 1.923 . . . . 0.0 111.045 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.7 pt -77.19 134.81 27.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.333 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.4 tt -89.98 -52.64 4.87 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 p -161.34 141.26 3.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.761 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.751 ' HB ' HG22 ' A' ' 38' ' ' ILE . 1.7 tt -107.72 134.08 50.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.606 174.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.84 145.42 39.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 94' ' ' ALA . 31.1 m -137.77 143.21 34.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.392 0.615 . . . . 0.0 110.642 177.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.665 ' O ' ' HG3' ' A' ' 76' ' ' MET . 93.3 m-20 -78.39 105.46 9.66 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 168.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 1.072 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 31.5 t0 -58.78 121.46 11.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.368 -175.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.843 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -154.37 48.59 0.61 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.622 -179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.833 ' HA2' ' HB2' ' A' ' 81' ' ' ALA . . . -101.25 49.49 1.05 Allowed Glycine 0 C--N 1.314 -0.694 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.507 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.04 79.15 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.765 0.317 . . . . 0.0 110.561 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 57.94 25.7 12.49 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.763 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -162.6 -74.25 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.049 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.833 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . . . 59.33 62.17 1.86 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.406 0.622 . . . . 0.0 110.869 -178.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 77.6 p -83.82 176.14 9.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.882 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.829 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 46.6 p90 -69.25 -22.58 63.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 0.0 110.496 177.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -85.19 -24.59 27.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.616 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 71.68 158.86 0.16 Allowed Pre-proline 0 N--CA 1.468 0.471 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.433 173.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.843 ' HD2' ' HB2' ' A' ' 76' ' ' MET . 19.6 Cg_endo -88.16 8.16 4.22 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.801 2.334 . . . . 0.0 111.476 169.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 108.66 130.8 6.23 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.797 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -72.44 126.79 30.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.732 0.266 . . . . 0.0 110.457 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.49 -65.8 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.505 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 1.072 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 61.9 t30 -85.6 153.17 22.58 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -177.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 18.5 p90 -122.57 128.8 51.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.953 HG21 ' HB2' ' A' ' 118' ' ' SER . 21.7 pt -145.64 166.14 9.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.282 0.563 . . . . 0.0 112.354 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -85.24 101.59 12.64 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.217 -0.902 . . . . 0.0 108.852 168.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.685 ' O ' ' HG ' ' A' ' 137' ' ' LEU . . . -59.03 -40.01 83.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.029 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.725 ' HB2' HG22 ' A' ' 71' ' ' ILE . 24.0 t70 -63.3 -11.05 19.02 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.458 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -130.35 50.7 2.17 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.594 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -149.5 -169.2 3.31 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 120.469 0.176 . . . . 0.0 110.709 -173.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -94.82 142.25 27.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.52 0.676 . . . . 0.0 111.147 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -120.5 135.7 54.99 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.853 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.613 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.2 p -115.16 124.01 71.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.622 0.725 . . . . 0.0 110.007 169.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.569 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 43.8 t -101.65 106.92 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.753 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.901 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -72.62 141.16 30.35 Favored Glycine 0 C--O 1.223 -0.536 0 CA-C-N 116.057 -0.52 . . . . 0.0 114.219 -170.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.3 m -92.13 -32.77 15.0 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.625 -0.338 . . . . 0.0 111.207 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -88.29 -46.18 9.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -173.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.614 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 35.7 mtp-105 -104.73 -92.64 0.36 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.145 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 145' ' ' VAL . 37.2 ttp85 51.41 -87.87 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.78 23.75 0.02 OUTLIER Glycine 0 C--O 1.222 -0.652 0 C-N-CA 121.246 -0.502 . . . . 0.0 112.207 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -57.78 -26.82 58.28 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.283 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 70.7 mtm -105.68 15.98 26.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.66 0.267 . . . . 0.0 110.553 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -165.52 -120.92 0.54 Allowed Glycine 0 N--CA 1.453 -0.225 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.484 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.3 104.33 40.33 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.621 0.211 . . . . 0.0 110.743 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.484 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 6.8 Cg_endo -51.28 124.1 13.39 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.544 2.829 . . . . 0.0 113.124 177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.73 146.14 41.28 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.962 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -125.05 132.82 53.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.916 -175.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.721 HG22 ' HB3' ' A' ' 81' ' ' ALA . 67.6 t -96.7 106.36 29.6 Favored Pre-proline 0 C--N 1.322 -0.611 0 C-N-CA 120.523 -0.471 . . . . 0.0 109.879 174.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 1.2 Cg_endo -90.44 105.75 0.32 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.702 2.935 . . . . 0.0 111.056 175.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.92 ' HD1' ' H ' ' A' ' 119' ' ' SER . 2.2 t80 -117.95 149.07 41.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.911 -175.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.953 ' HB2' HG21 ' A' ' 92' ' ' ILE . 47.9 t -71.01 -35.73 72.17 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.915 0.388 . . . . 0.0 110.488 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.92 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 7.3 m -97.85 127.14 43.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.764 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.26 -43.16 98.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.155 0.502 . . . . 0.0 110.584 177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -60.75 -32.63 71.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.856 -176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -74.66 -37.99 62.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.733 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.83 -34.36 76.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.21 0.528 . . . . 0.0 110.12 176.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.86 -32.18 70.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.832 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.2 89.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.145 0.498 . . . . 0.0 110.042 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.96 -40.27 94.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.694 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.668 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 93.0 t -63.55 -38.2 81.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.695 176.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.38 -36.85 74.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.575 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.71 -45.75 16.62 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.254 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.686 ' HB2' ' HB3' ' A' ' 104' ' ' ALA . 0.1 OUTLIER -161.4 -36.03 0.05 OUTLIER 'General case' 0 C--O 1.236 0.353 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -172.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.901 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -46.71 163.09 0.17 Allowed Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.075 -0.966 . . . . 0.0 114.034 -178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.94 -72.63 0.71 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.82 -175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.59 ' HB3' ' CB ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -124.73 144.47 50.21 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.821 0.343 . . . . 0.0 111.078 -178.501 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 48.7 t -105.32 113.47 42.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.379 173.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.784 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -134.86 148.91 50.24 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.782 -179.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.85 161.02 23.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.614 0.245 . . . . 0.0 110.456 -178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -57.92 -27.29 63.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.037 -178.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.03 -16.06 60.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.779 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -123.7 20.48 9.37 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.945 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.784 HD13 HD13 ' A' ' 135' ' ' LEU . 19.6 mm -71.76 121.52 22.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.528 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.533 HG23 ' HG2' ' A' ' 144' ' ' MET . 4.0 t -114.68 145.77 41.65 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 175.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.554 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 9.2 p-10 -69.75 -24.48 63.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.381 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.85 -29.02 68.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.795 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.66 ' SD ' ' HB3' ' A' ' 155' ' ' PRO . 19.9 mmt -77.96 -40.28 39.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.952 0.406 . . . . 0.0 110.794 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.411 ' O ' ' NH1' ' A' ' 106' ' ' ARG . 2.4 t -85.73 -21.31 7.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.173 0.511 . . . . 0.0 111.33 -174.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.0 pp -144.56 127.67 16.6 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.343 0.592 . . . . 0.0 110.543 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 21.2 p -102.73 120.45 52.72 Favored Pre-proline 0 C--N 1.315 -0.893 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.486 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.35 -58.39 1.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.799 2.333 . . . . 0.0 112.354 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.96 3.68 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.009 0.433 . . . . 0.0 110.209 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.455 ' O ' HG22 ' A' ' 151' ' ' THR . 35.8 mt-10 65.95 -73.42 0.07 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.211 -166.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 150' ' ' GLU . 0.6 OUTLIER 57.8 -4.52 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.974 1.309 . . . . 0.0 114.181 172.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 92.36 25.58 20.87 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.005 -176.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 56.3 p -97.16 125.36 41.62 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.65 145.41 95.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.66 ' HB3' ' SD ' ' A' ' 144' ' ' MET . 37.4 Cg_exo -35.1 -58.67 0.38 Allowed 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.998 3.132 . . . . 0.0 113.495 -176.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.8 ptp180 -141.81 -42.55 0.35 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.66 174.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -165.22 25.81 0.05 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.825 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.4 t0 53.91 77.09 0.2 Allowed 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -165.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -136.96 24.25 3.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.563 -167.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.59 ' CB ' ' HB3' ' A' ' 133' ' ' GLN . 2.8 pt-20 . . . . . 0 C--O 1.246 0.918 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.269 -175.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' SER . 27.2 ttpp . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -126.96 143.88 51.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.914 0.388 . . . . 0.0 111.21 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 1.7 pm0 -149.06 136.28 20.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.934 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.89 HG21 ' HB2' ' A' ' 59' ' ' ALA . 37.1 pt -115.82 132.67 64.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.114 0.483 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -99.19 126.36 44.97 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.571 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.0 mp -91.75 151.98 20.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.006 -175.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.552 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 26.9 tt0 -74.01 125.44 28.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.958 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.62 -30.9 5.12 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.213 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.53 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 14.7 t -92.16 124.23 60.39 Favored Pre-proline 0 N--CA 1.448 -0.556 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.53 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 0.9 OUTLIER -84.73 19.62 1.36 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.168 2.579 . . . . 0.0 112.109 -178.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.91 133.58 24.56 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.527 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -91.51 138.08 2.1 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.659 2.239 . . . . 0.0 112.732 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.468 ' HB3' HG12 ' A' ' 38' ' ' ILE . 3.6 tt -89.28 104.16 16.73 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 47.3 p90 -113.21 151.06 31.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.335 -175.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' HE2' HE21 ' A' ' 51' ' ' GLN . 14.5 t80 -149.8 149.6 30.75 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 1.0 OUTLIER -53.65 -59.47 4.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.122 0.487 . . . . 0.0 110.482 179.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.656 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 32.7 mt-30 -65.4 121.96 16.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.459 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.598 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 12.6 t -59.92 -49.99 81.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.58 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -55.06 -30.28 59.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.482 179.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.656 ' HB2' ' HB2' ' A' ' 51' ' ' GLN . 5.2 t0 -76.13 -51.17 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.843 0.354 . . . . 0.0 110.805 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.743 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -67.89 -35.54 78.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.456 -177.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.826 HD12 ' HB3' ' A' ' 114' ' ' ALA . 20.9 pt -67.79 -31.68 53.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.305 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.15 -40.17 95.08 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.411 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.834 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 36.1 m-85 -57.97 -42.23 84.59 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.198 0.523 . . . . 0.0 110.77 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.89 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -63.36 -19.79 64.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.387 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -105.26 12.23 32.04 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.863 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -174.41 -72.59 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.656 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.834 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 25.9 Cg_exo -67.79 47.61 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.823 3.015 . . . . 0.0 113.606 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.561 ' OE1' ' HA ' ' A' ' 67' ' ' PRO . 9.4 pt-20 -81.37 -3.27 52.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.268 0.556 . . . . 0.0 110.217 177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 72.45 -78.67 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.844 171.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.1 tt -129.67 -52.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -171.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -97.31 148.49 34.49 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.432 0.158 . . . . 0.0 110.713 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.561 ' HA ' ' OE1' ' A' ' 63' ' ' GLU . 59.4 Cg_endo -71.81 157.72 54.59 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.447 2.098 . . . . 0.0 111.936 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 68' ' ' ILE . 47.5 pt -75.1 122.16 28.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.263 0.554 . . . . 0.0 110.261 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 41' ' ' GLU . 5.6 tt -88.22 -47.96 8.05 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.46 138.72 2.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.547 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.776 HD11 HG22 ' A' ' 56' ' ' ILE . 2.6 tt -110.19 131.58 60.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.315 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -111.94 142.16 44.69 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.881 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.0 m -138.66 143.66 31.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.968 0.414 . . . . 0.0 110.773 178.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.521 HD21 ' HA ' ' A' ' 88' ' ' ASP . 33.7 t30 -79.57 101.11 8.1 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 167.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 76' ' ' MET . 54.5 t0 -63.63 106.99 1.05 Allowed 'General case' 0 C--O 1.242 0.707 0 O-C-N 124.47 1.107 . . . . 0.0 110.628 -174.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.601 ' HG3' ' O ' ' A' ' 87' ' ' GLY . 3.6 mmt -152.29 58.95 0.83 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 113.442 -1.708 . . . . 0.0 107.86 172.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -96.28 26.46 21.2 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.042 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.15 39.45 0.82 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.979 0.419 . . . . 0.0 110.953 -172.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' A' ' 80' ' ' GLY . . . -179.43 -11.84 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.238 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.429 ' H ' ' H ' ' A' ' 79' ' ' ALA . . . 126.14 -4.32 7.82 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.997 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.27 65.39 1.09 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.622 0.725 . . . . 0.0 109.956 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.7 p -83.81 177.1 8.48 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.419 -171.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.409 ' HA ' ' HG2' ' A' ' 51' ' ' GLN . 68.8 t90 -59.43 -40.6 87.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.075 0.464 . . . . 0.0 110.026 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.32 -34.15 48.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.089 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 54.08 159.79 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 124.983 1.313 . . . . 0.0 112.935 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.532 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 8.2 Cg_exo -58.47 -25.93 75.97 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.67 1.58 . . . . 0.0 112.188 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.601 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . 135.39 -149.51 19.98 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.966 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.521 ' HA ' HD21 ' A' ' 74' ' ' ASN . 7.6 p-10 -77.55 137.52 38.65 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.999 0.428 . . . . 0.0 110.285 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.81 -141.85 3.99 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.549 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -100.6 133.65 44.73 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.0 p90 -98.16 130.25 44.92 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.13 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.688 HD13 ' HB2' ' A' ' 118' ' ' SER . 6.9 pt -145.04 166.42 11.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.934 -173.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.26 107.16 15.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.05 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 97' ' ' ALA . . . -62.1 -27.78 69.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.136 0.493 . . . . 0.0 110.479 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.548 ' HA ' HD13 ' A' ' 137' ' ' LEU . 22.7 t70 -59.54 -25.19 64.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.413 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.3 mmtm -123.65 43.14 3.05 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.384 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -139.86 -177.93 5.2 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -173.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -97.95 138.04 35.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.394 0.616 . . . . 0.0 110.646 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 116' ' ' PRO . 3.1 m-85 -120.46 135.33 55.09 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.104 -177.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.9 p -113.66 124.82 70.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.514 0.673 . . . . 0.0 109.816 173.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.6 t -101.59 113.87 39.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.433 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -79.44 121.84 5.63 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.011 -1.09 . . . . 0.0 112.774 -172.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.8 m -92.68 -41.02 10.4 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.854 0.359 . . . . 0.0 110.313 175.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.21 -43.84 63.85 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 -174.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -133.84 114.72 13.65 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.523 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER 176.0 -168.88 0.05 Allowed 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.554 0.534 . . . . 0.0 110.086 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.478 ' HA3' ' C ' ' A' ' 111' ' ' ALA . . . -65.56 -50.99 51.73 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.925 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 66.06 -102.15 0.68 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.272 -175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 23.3 mmt -86.46 -3.92 59.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 110.757 174.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -98.49 -124.53 5.08 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.478 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.35 96.13 8.01 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.56 0.18 . . . . 0.0 111.084 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.37 141.89 70.15 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.552 2.168 . . . . 0.0 111.9 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.523 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 36.5 mt-10 -125.94 140.63 52.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.605 -176.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.826 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -105.95 131.47 53.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.859 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.678 ' HB ' HG13 ' A' ' 100' ' ' VAL . 59.4 t -100.59 106.14 41.37 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 173.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.6 Cg_endo -87.75 122.92 1.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.695 2.93 . . . . 0.0 111.552 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.631 ' HD1' ' H ' ' A' ' 119' ' ' SER . 3.6 t80 -130.43 151.11 51.27 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.688 ' HB2' HD13 ' A' ' 92' ' ' ILE . 33.8 t -73.47 -35.79 65.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.631 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 15.2 m -105.96 128.83 54.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.798 0.332 . . . . 0.0 110.846 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.24 -49.85 57.9 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.787 -176.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -67.14 -28.38 68.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.29 0.567 . . . . 0.0 109.74 -174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 66.3 mm-40 -71.46 -34.84 70.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.594 172.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.64 -35.09 76.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.338 0.59 . . . . 0.0 109.69 174.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.81 -33.43 75.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.695 173.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.1 -32.3 73.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.918 0.39 . . . . 0.0 110.444 175.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -63.79 -37.49 87.58 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.65 HG22 ' H ' ' A' ' 132' ' ' GLY . 58.9 t -69.57 -30.48 45.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.447 176.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 tp -59.5 -39.6 84.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.949 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.44 -47.85 13.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.686 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.811 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.6 pt-20 -149.94 -89.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.459 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.811 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 44.88 -143.33 2.95 Favored Glycine 0 C--N 1.334 0.453 0 O-C-N 123.588 0.555 . . . . 0.0 114.297 174.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.65 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -176.08 -81.26 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -130.21 145.97 51.78 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.586 0.231 . . . . 0.0 110.568 175.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.21 116.31 52.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.149 0.499 . . . . 0.0 110.682 178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.854 HD13 HD13 ' A' ' 140' ' ' ILE . 0.4 OUTLIER -141.0 164.13 31.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.955 -178.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.31 163.3 18.68 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.548 HD13 ' HA ' ' A' ' 95' ' ' ASP . 0.6 OUTLIER -66.4 -31.57 72.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.399 0.618 . . . . 0.0 109.505 178.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -72.87 -9.12 58.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.878 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.27 17.9 11.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.23 -173.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.854 HD13 HD13 ' A' ' 135' ' ' LEU . 26.3 mm -71.87 121.99 23.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.147 0.499 . . . . 0.0 110.627 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.8 t -112.23 149.56 32.13 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.261 175.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.474 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 2.2 p-10 -68.92 -29.86 68.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.556 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.14 -27.43 68.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.66 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.548 ' HE3' ' HA ' ' A' ' 160' ' ' GLU . 13.4 mmt -87.11 -36.95 17.81 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.16 -22.73 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 121.09 0.471 . . . . 0.0 110.672 -174.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.3 pp -148.64 141.25 24.44 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.014 -177.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 18.3 p -126.0 135.55 27.24 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.053 0.454 . . . . 0.0 111.132 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -83.8 -49.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.822 2.348 . . . . 0.0 111.809 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 151' ' ' THR . 8.0 t -159.23 85.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -176.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -50.82 74.6 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.226 168.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.428 ' N ' ' O ' ' A' ' 149' ' ' VAL . 10.2 t -106.92 21.21 17.9 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.935 -1.029 . . . . 0.0 108.756 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.73 78.0 0.8 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.132 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.2 m -129.96 139.33 51.1 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -69.54 125.67 92.12 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.726 0.298 . . . . 0.0 110.294 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.55 -73.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.85 2.367 . . . . 0.0 112.253 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.596 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -108.67 -54.07 2.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.144 0.497 . . . . 0.0 110.786 176.633 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.596 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -151.84 37.76 0.58 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -174.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 157' ' ' ALA . 32.9 t70 73.74 -30.01 0.2 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.235 -175.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 157' ' ' ALA . 6.2 t70 -73.72 -168.8 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.362 177.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.548 ' HA ' ' HE3' ' A' ' 144' ' ' MET . 39.2 mt-10 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.595 -0.717 . . . . 0.0 109.926 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.593 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -126.71 142.54 51.51 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 9.0 pt20 -149.39 133.66 17.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.474 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.538 HG21 ' HB2' ' A' ' 59' ' ' ALA . 39.0 pt -115.63 136.21 53.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.957 0.408 . . . . 0.0 110.946 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -105.77 131.84 52.63 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 175.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.949 HD21 ' HB3' ' A' ' 64' ' ' GLN . 8.7 mp -89.19 152.57 21.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.113 0.482 . . . . 0.0 111.672 -173.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.859 ' HG3' HD13 ' A' ' 69' ' ' LEU . 32.0 tt0 -74.22 124.78 27.04 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 177.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.62 -41.1 2.29 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.238 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.534 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 31.2 t -81.92 123.96 79.6 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.038 0.447 . . . . 0.0 110.446 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.534 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.0 Cg_exo -81.74 5.63 6.18 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.322 2.682 . . . . 0.0 112.455 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.489 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -100.37 131.18 24.35 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.574 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 97.8 Cg_endo -101.41 161.08 0.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.573 2.848 . . . . 0.0 112.984 177.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.446 ' HB3' HG12 ' A' ' 38' ' ' ILE . 7.6 tt -117.73 114.93 24.05 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 173.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -118.24 135.77 54.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.61 0.719 . . . . 0.0 111.582 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -140.42 135.17 31.78 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.624 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.9 m -63.93 -29.49 70.66 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.579 0.704 . . . . 0.0 109.171 175.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.645 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 14.3 mt-30 -75.97 95.98 3.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.702 175.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.593 HG13 ' HB2' ' A' ' 36' ' ' ALA . 10.8 t -57.65 -52.03 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 121.058 0.456 . . . . 0.0 111.019 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' HA ' HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -54.15 -30.11 47.91 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.364 -178.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.511 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 1.2 m-20 -73.98 -53.47 9.99 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.761 0.315 . . . . 0.0 111.189 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.579 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -67.21 -35.97 80.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.256 -175.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.609 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 17.7 pt -70.35 -32.52 50.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.521 178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.17 -44.97 74.74 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.567 174.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.458 ' HD1' ' HG2' ' A' ' 62' ' ' PRO . 22.1 m-85 -62.39 -35.11 78.18 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -61.04 -17.8 54.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.896 0.379 . . . . 0.0 112.017 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -84.8 -15.57 44.43 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -157.35 -73.02 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.016 -1.088 . . . . 0.0 113.264 -175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.458 ' HG2' ' HD1' ' A' ' 58' ' ' TYR . 84.8 Cg_exo -48.67 -47.01 22.17 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.329 2.686 . . . . 0.0 113.205 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.433 ' OE2' ' HA ' ' A' ' 67' ' ' PRO . 44.9 mt-10 54.76 -91.08 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.564 0.746 . . . . 0.0 111.723 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.949 ' HB3' HD21 ' A' ' 40' ' ' LEU . 5.7 tp-100 -174.27 -61.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.186 0.517 . . . . 0.0 109.672 -178.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.0 tt -168.42 -38.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -106.63 165.3 13.17 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.519 ' HD2' ' HB1' ' A' ' 66' ' ' ALA . 73.0 Cg_endo -74.53 156.59 45.14 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 121.649 1.566 . . . . 0.0 111.628 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 48.3 pt -69.87 128.15 32.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.219 0.533 . . . . 0.0 110.909 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.859 HD13 ' HG3' ' A' ' 41' ' ' GLU . 42.6 tp -89.32 -48.95 7.01 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -160.99 138.45 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.631 178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.544 HD11 HG22 ' A' ' 56' ' ' ILE . 2.7 tt -110.89 135.42 50.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.429 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -112.91 138.81 49.2 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 94' ' ' ALA . 19.7 m -128.94 137.88 56.03 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-O 121.289 0.566 . . . . 0.0 110.551 175.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.492 ' O ' ' HG3' ' A' ' 76' ' ' MET . 27.9 t-20 -78.63 104.17 9.07 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 173.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -72.49 121.54 19.79 Favored 'General case' 0 C--O 1.237 0.445 0 O-C-N 124.256 0.973 . . . . 0.0 109.73 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.519 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -151.84 92.37 1.73 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.611 -176.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.7 -56.84 3.84 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.886 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HA ' ' HB2' ' A' ' 81' ' ' ALA . . . 70.99 -52.07 0.68 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.984 0.914 . . . . 0.0 112.49 175.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.91 -34.07 58.45 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.99 0.424 . . . . 0.0 110.791 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -97.29 -65.33 0.9 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 172.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 78' ' ' ALA . . . 44.06 64.54 1.26 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.59 0.756 . . . . 0.0 112.908 175.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.9 p -84.0 176.14 9.05 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.645 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 26.1 p90 -73.32 -12.83 60.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.164 0.507 . . . . 0.0 110.287 175.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -84.82 -35.15 22.49 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 68.02 161.04 0.14 Allowed Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.768 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 76' ' ' MET . 69.9 Cg_endo -93.52 29.35 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.195 1.93 . . . . 0.0 111.634 176.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.15 161.92 18.64 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.721 -176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -77.35 123.23 26.22 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -106.56 -139.18 9.32 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.145 -178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -100.04 149.45 23.47 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 67.2 p-90 -98.44 134.72 41.03 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.232 0.539 . . . . 0.0 110.639 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.737 HD13 ' HB2' ' A' ' 118' ' ' SER . 4.3 pt -133.78 151.91 33.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.543 -179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.04 102.54 4.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.54 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -61.16 -34.81 75.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.337 -176.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.615 ' HA ' HD13 ' A' ' 137' ' ' LEU . 16.7 t70 -57.81 -30.34 65.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.707 0.765 . . . . 0.0 110.354 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.3 mmtm -111.24 26.79 10.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.826 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -120.17 177.39 5.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.718 0.294 . . . . 0.0 111.06 -173.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -90.44 131.34 36.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.453 0.644 . . . . 0.0 110.535 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -120.62 135.33 55.13 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.071 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.697 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.8 p -112.82 125.46 70.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.745 0.783 . . . . 0.0 110.334 174.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.7 ' HA ' HH11 ' A' ' 106' ' ' ARG . 47.9 t -101.81 107.87 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.998 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.449 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -69.6 124.27 15.11 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.547 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.4 m -88.6 -31.01 18.81 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.77 -44.33 11.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.738 178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -133.59 109.52 9.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.755 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.797 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 13.7 ttt180 -168.64 -72.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.601 176.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 154.67 46.04 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.523 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -61.8 -39.49 97.54 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.699 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 45.2 tpp -109.39 -4.21 16.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.559 0.695 . . . . 0.0 110.1 174.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -115.88 -132.87 5.17 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.208 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.3 102.6 29.96 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 178.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 34.0 Cg_endo -63.74 129.47 24.95 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 123.253 2.636 . . . . 0.0 114.01 -175.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.797 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 47.9 mm-40 -114.21 129.33 56.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.364 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.609 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . . . -102.22 131.06 49.0 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.824 -0.171 . . . . 0.0 111.263 -177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.697 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 85.7 t -101.61 105.74 42.41 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.772 173.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.5 Cg_endo -90.09 127.04 1.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 123.762 2.975 . . . . 0.0 111.795 175.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.26 149.81 52.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.195 -176.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.737 ' HB2' HD13 ' A' ' 92' ' ' ILE . 47.9 t -79.1 -18.25 53.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.893 0.378 . . . . 0.0 110.758 176.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.7 m -119.85 134.24 55.31 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.77 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -67.48 -49.52 63.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -60.13 -28.99 68.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.452 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -70.23 -43.28 70.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.268 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.7 -30.2 69.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.148 176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.1 -38.09 72.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.639 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.57 74.79 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.264 0.554 . . . . 0.0 110.272 176.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -61.69 -39.64 92.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.847 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.829 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 94.6 t -70.78 -34.81 57.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.929 178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 67.6 mt -56.36 -40.94 75.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.62 177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.53 -48.97 11.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.699 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.751 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.5 pt-20 -145.4 -82.72 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.101 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.829 ' HA3' ' HA ' ' A' ' 127' ' ' VAL . . . 38.23 -142.24 0.35 Allowed Glycine 0 C--N 1.337 0.606 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 174.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.784 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -179.73 -87.28 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.491 HE21 ' HB ' ' A' ' 101' ' ' VAL . 1.9 pm0 -129.86 141.46 50.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.675 0.274 . . . . 0.0 110.863 175.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.48 113.22 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.04 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.73 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.41 165.05 27.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.656 -178.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.31 161.79 19.36 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.69 ' HA ' HG12 ' A' ' 140' ' ' ILE . 5.9 tt -61.75 -36.78 82.0 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -63.85 -11.48 27.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.487 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -126.0 23.15 7.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.012 0.434 . . . . 0.0 110.895 -176.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.73 HD13 HD13 ' A' ' 135' ' ' LEU . 34.4 mm -71.82 119.12 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 145' ' ' VAL . 14.1 t -119.26 148.65 42.9 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.681 -176.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.528 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 1.5 p30 -66.07 -41.73 90.35 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -171.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 155' ' ' PRO . . . -57.03 -28.6 62.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.523 ' SD ' ' HB2' ' A' ' 155' ' ' PRO . 19.2 mmt -82.19 -26.83 33.0 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 141' ' ' THR . 10.9 t -97.88 -23.19 4.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -170.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.6 pp -136.33 156.4 48.69 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.969 -172.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.5 p -111.99 119.52 44.08 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.044 0.449 . . . . 0.0 110.779 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.19 -81.83 0.01 OUTLIER 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 122.581 2.187 . . . . 0.0 111.976 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.557 ' HB ' ' OG1' ' A' ' 151' ' ' THR . 4.1 t -129.35 -2.48 2.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 15.0 mm-40 87.83 -77.78 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -169.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.557 ' OG1' ' HB ' ' A' ' 149' ' ' VAL . 13.0 m 68.46 -42.33 0.47 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 163.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 113.83 20.91 5.88 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.506 -0.637 . . . . 0.0 111.506 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 49.9 m -84.02 126.55 33.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.585 0.231 . . . . 0.0 110.438 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.718 ' HB3' ' HB2' ' A' ' 158' ' ' ASP . 4.3 mp0 -71.14 126.57 91.98 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.157 177.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.523 ' HB2' ' SD ' ' A' ' 144' ' ' MET . 61.8 Cg_endo -72.94 126.94 11.7 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.633 2.222 . . . . 0.0 111.325 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.462 ' HB3' ' O ' ' A' ' 155' ' ' PRO . 18.5 tpp85 69.66 -63.07 0.4 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.527 0.517 . . . . 0.0 110.471 -175.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.406 ' H ' ' H ' ' A' ' 158' ' ' ASP . . . -179.07 13.96 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.275 0.63 . . . . 0.0 109.92 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.718 ' HB2' ' HB3' ' A' ' 154' ' ' GLU . 14.0 t70 57.59 30.88 19.49 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -169.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.01 -68.22 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.679 -172.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.751 179.643 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.573 ' HB3' ' OD1' ' A' ' 74' ' ' ASN . 43.7 tttp . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.769 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -144.72 144.75 31.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.763 0.316 . . . . 0.0 111.671 -177.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 22.3 pt20 -145.56 134.8 22.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.874 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.722 HG12 ' HB3' ' A' ' 47' ' ' LEU . 3.9 pt -119.81 143.24 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.248 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -116.82 127.88 54.74 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.3 mp -92.07 142.42 27.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.068 0.461 . . . . 0.0 111.082 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.783 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 44.8 tt0 -73.83 124.69 26.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.866 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.05 -27.29 11.58 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.146 -178.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.3 t -92.0 125.56 56.45 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.1 Cg_exo -80.5 12.12 2.67 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.132 2.554 . . . . 0.0 112.833 -177.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -130.15 133.25 24.73 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 120.876 0.369 . . . . 0.0 110.961 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 55.6 Cg_endo -97.42 170.83 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 123.388 2.725 . . . . 0.0 112.782 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.722 ' HB3' HG12 ' A' ' 38' ' ' ILE . 14.4 tp -107.04 130.64 54.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.94 177.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -114.45 134.47 54.98 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.1 147.6 27.97 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.869 0.366 . . . . 0.0 110.688 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 55.3 m -70.38 -52.58 21.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.143 173.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.5 HE21 ' HB3' ' A' ' 83' ' ' TRP . 39.8 mt-30 -67.37 113.09 4.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.718 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.769 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 6.2 t -60.48 -50.48 80.17 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-O 121.565 0.697 . . . . 0.0 109.444 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.631 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -60.21 -28.79 68.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.692 -1.14 . . . . 0.0 112.548 -176.765 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.631 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 14.2 t70 -76.14 -45.5 33.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.781 0.324 . . . . 0.0 110.482 -177.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -70.45 -34.52 72.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.275 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.617 ' CD1' ' HB3' ' A' ' 114' ' ' ALA . 16.4 pt -71.19 -32.51 47.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.959 0.409 . . . . 0.0 110.179 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.26 -36.34 79.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.16 0.505 . . . . 0.0 110.302 172.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.456 ' CD1' HD22 ' A' ' 47' ' ' LEU . 33.8 t80 -60.62 -33.23 72.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.279 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.653 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -72.37 -18.1 61.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.605 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.55 ' NH2' ' HG ' ' A' ' 137' ' ' LEU . 75.1 mtt85 -105.62 13.14 30.33 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -152.36 -78.63 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.538 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -43.37 -35.54 5.71 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 124.041 3.161 . . . . 0.0 114.774 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -67.61 128.66 37.28 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.759 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -169.68 -36.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.122 -177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.9 -27.46 33.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.542 0.687 . . . . 0.0 109.644 174.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.748 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.1 141.2 14.08 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.309 175.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.783 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 70.4 Cg_endo -74.23 155.12 46.81 Favored 'Trans proline' 0 CA--C 1.52 -0.185 0 C-N-CA 122.679 2.253 . . . . 0.0 112.282 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.653 HD13 ' HB1' ' A' ' 59' ' ' ALA . 27.5 pt -75.74 116.92 19.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-O 121.373 0.606 . . . . 0.0 110.484 174.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 tt -79.12 -47.84 15.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 p -161.08 150.16 5.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.775 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.572 HD11 HG22 ' A' ' 56' ' ' ILE . 5.7 tt -128.0 128.61 69.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.448 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -111.99 133.46 54.15 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 94' ' ' ALA . 34.6 m -132.2 156.6 42.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.108 0.48 . . . . 0.0 110.668 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.573 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 12.3 m120 -92.34 104.56 16.89 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.459 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 10.3 t0 -49.56 103.9 0.06 Allowed 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 125.35 1.656 . . . . 0.0 109.525 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.58 ' SD ' ' HB3' ' A' ' 85' ' ' GLN . 3.3 ttm -144.69 41.04 1.31 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.038 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 79' ' ' ALA . . . -89.62 18.1 48.53 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.644 -175.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.06 22.17 0.11 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.216 0.532 . . . . 0.0 111.474 -175.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -172.89 20.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.493 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.401 ' HA2' ' CG2' ' A' ' 115' ' ' VAL . . . 91.51 -2.29 77.32 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.347 -176.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . . . 60.47 66.82 0.89 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.688 0.756 . . . . 0.0 110.315 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.7 p -83.73 175.59 9.57 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.445 -176.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.5 ' HB3' HE21 ' A' ' 51' ' ' GLN . 59.8 p-90 -67.26 -23.92 65.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.981 0.42 . . . . 0.0 110.767 176.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.03 -35.55 42.52 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.58 ' HB3' ' SD ' ' A' ' 76' ' ' MET . 24.2 mt-30 66.8 142.97 0.08 OUTLIER Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.578 176.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -57.61 -42.22 62.76 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.015 1.81 . . . . 0.0 112.07 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 133.2 -64.56 0.6 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.247 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.32 131.79 38.29 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.7 0.286 . . . . 0.0 110.619 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 75' ' ' ASP . . . -147.47 139.74 8.04 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.178 -1.011 . . . . 0.0 113.401 -177.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 27.3 t30 -100.13 149.14 23.83 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -98.48 129.74 45.08 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.705 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.747 HG21 ' HB2' ' A' ' 118' ' ' SER . 20.3 pt -145.02 166.17 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.967 -174.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.69 114.1 23.1 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 171.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -69.46 -38.07 77.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.263 -0.426 . . . . 0.0 112.036 -171.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.73 ' HA ' HD13 ' A' ' 137' ' ' LEU . 0.6 OUTLIER -68.03 -25.24 65.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.738 0.78 . . . . 0.0 109.752 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -98.9 37.35 1.53 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.262 177.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 117' ' ' PHE . . . -145.48 179.24 7.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.35 -171.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -93.59 141.8 28.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.304 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.406 ' CE1' HD12 ' A' ' 137' ' ' LEU . 2.9 m-85 -120.67 137.08 54.64 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.558 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.848 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.6 p -115.16 123.21 70.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.504 0.669 . . . . 0.0 109.368 172.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.482 ' HB ' ' HG2' ' A' ' 133' ' ' GLN . 56.4 t -101.53 107.13 20.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.31 123.25 7.7 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.793 -174.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.4 t -92.42 -35.4 13.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.893 0.378 . . . . 0.0 110.146 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -79.39 -45.08 20.21 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.943 0.401 . . . . 0.0 111.568 -175.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.437 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 48.9 mtp180 -129.58 111.72 13.01 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.633 ' NE ' ' HA ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -177.81 -170.74 0.27 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -54.54 -37.56 61.01 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.67 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.45 -105.26 1.09 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.041 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 86.7 mtp -92.94 -4.0 53.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.979 0.419 . . . . 0.0 110.374 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -95.15 -129.51 5.8 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.984 -0.626 . . . . 0.0 111.782 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.27 96.58 8.52 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 176.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 18.1 Cg_endo -59.72 151.51 69.78 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 123.401 2.734 . . . . 0.0 113.314 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.514 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 2.5 mp0 -117.1 146.13 43.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.54 175.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.617 ' HB3' ' CD1' ' A' ' 56' ' ' ILE . . . -103.98 131.13 51.53 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 177.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.848 ' HB ' HG13 ' A' ' 100' ' ' VAL . 5.7 t -99.19 105.22 31.07 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.545 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.3 Cg_exo -87.07 133.35 3.4 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.556 2.837 . . . . 0.0 112.89 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.4 ' O ' ' HB1' ' A' ' 97' ' ' ALA . 35.8 m-85 -129.26 149.67 50.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.46 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.747 ' HB2' HG21 ' A' ' 92' ' ' ILE . 32.5 t -78.05 -38.19 45.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.064 0.459 . . . . 0.0 109.837 172.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.3 m -96.28 135.33 38.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.818 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -46.2 84.85 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.978 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -64.73 -28.46 69.6 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.875 -172.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -64.98 -38.66 91.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.95 0.405 . . . . 0.0 110.677 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -73.02 -36.16 66.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.077 176.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.0 -44.99 83.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.065 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.65 -34.14 75.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.918 0.389 . . . . 0.0 110.9 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -62.78 -40.51 97.53 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.85 HG22 ' H ' ' A' ' 132' ' ' GLY . 91.7 t -72.43 -32.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.603 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 5.4 tp -57.75 -43.67 85.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.1 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.44 -44.64 15.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.164 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.653 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.2 pt-20 -150.69 -93.29 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.403 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.653 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.27 -138.12 7.73 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 114.438 0.535 . . . . 0.0 114.438 173.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.85 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -176.95 -83.09 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.482 ' HG2' ' HB ' ' A' ' 101' ' ' VAL . 13.2 pm0 -130.07 142.16 50.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.645 0.259 . . . . 0.0 110.937 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 90.5 t -109.45 120.14 60.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.046 0.451 . . . . 0.0 110.729 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.791 HD13 HD13 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -147.2 165.69 29.25 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.547 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.91 164.05 18.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.73 HD13 ' HA ' ' A' ' 95' ' ' ASP . 8.6 tt -63.88 -35.52 80.91 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.02 -10.14 59.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.975 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -117.85 20.27 13.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.493 0.663 . . . . 0.0 110.043 -174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.791 HD13 HD13 ' A' ' 135' ' ' LEU . 35.8 mm -76.58 121.69 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.895 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.478 HG23 ' HB2' ' A' ' 144' ' ' MET . 0.5 OUTLIER -106.08 145.85 30.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.858 171.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -69.96 -33.17 71.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.018 179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -62.19 -27.37 68.92 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.406 -177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.478 ' HB2' HG23 ' A' ' 141' ' ' THR . 1.7 mmt -73.45 -38.8 65.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.871 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.9 t -83.67 -22.61 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.275 -172.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.0 pp -151.08 133.44 15.42 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.594 -0.443 . . . . 0.0 111.406 -174.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 8.8 p -125.93 120.85 24.15 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.305 174.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.4 -59.59 0.41 Allowed 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.898 2.399 . . . . 0.0 113.392 -175.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 4.3 t -125.21 6.62 4.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.93 0.395 . . . . 0.0 110.68 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 60.91 47.62 7.46 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.82 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 t -71.9 -3.33 21.87 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 82.8 28.92 36.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.912 -0.661 . . . . 0.0 111.868 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 p -70.49 141.08 52.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.661 0.267 . . . . 0.0 111.231 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.507 ' OE2' ' HB2' ' A' ' 158' ' ' ASP . 37.9 mt-10 -59.73 125.84 81.26 Favored Pre-proline 0 C--N 1.332 -0.16 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.204 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.74 -72.29 0.03 OUTLIER 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 123.146 2.564 . . . . 0.0 112.723 -176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -117.66 -33.57 4.5 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.476 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 159' ' ' ASP . . . -171.05 39.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.895 -173.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.507 ' HB2' ' OE2' ' A' ' 154' ' ' GLU . 14.6 t70 71.99 -37.26 0.38 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.292 0.637 . . . . 0.0 110.659 -174.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 157' ' ' ALA . 1.9 t70 -65.24 -163.38 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.249 175.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.835 177.072 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.623 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 36.6 ttpt . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -134.16 144.54 48.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.149 0.431 . . . . 0.0 111.859 -177.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 28.9 pt20 -147.02 136.83 23.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.872 174.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.631 HG22 ' HB ' ' A' ' 71' ' ' ILE . 35.5 pt -120.06 132.75 68.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.2 0.524 . . . . 0.0 111.495 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -105.75 119.06 38.2 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.9 mp -92.94 142.78 26.92 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.039 0.447 . . . . 0.0 110.738 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.718 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 31.4 tt0 -71.34 124.2 24.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.702 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.67 -17.16 58.45 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.594 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 37.5 t -92.38 125.96 54.29 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 1.4 Cg_endo -83.56 10.07 3.83 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.08 2.52 . . . . 0.0 112.678 -178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -134.3 134.2 22.45 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.786 0.327 . . . . 0.0 111.35 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 9.1 Cg_endo -89.2 125.36 1.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 123.484 2.789 . . . . 0.0 111.422 173.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.36 102.97 13.85 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 44.5 p90 -103.14 139.57 38.47 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.732 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -144.59 142.88 30.49 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.705 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.623 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 4.8 m -57.15 -44.1 83.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.077 0.465 . . . . 0.0 111.426 -178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.652 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 46.1 mt-30 -78.46 119.89 22.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.163 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.573 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 9.9 t -64.49 -50.39 76.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.602 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.01 -29.84 45.07 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.512 179.159 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.602 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 22.2 t70 -76.34 -51.55 11.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.828 0.347 . . . . 0.0 110.691 -176.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -68.04 -37.51 81.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.283 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 114' ' ' ALA . 31.0 pt -67.6 -30.79 49.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.428 ' O ' ' HD2' ' A' ' 62' ' ' PRO . . . -62.58 -46.11 89.83 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.547 175.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.407 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 30.1 m-85 -62.14 -40.88 97.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.888 0.375 . . . . 0.0 110.839 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -60.83 -20.67 62.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.732 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 48.6 mtm105 -95.43 12.36 29.61 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -174.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.18 -62.35 0.32 Allowed Glycine 0 C--O 1.226 -0.354 0 C-N-CA 119.779 -1.201 . . . . 0.0 113.645 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 57' ' ' ALA . 18.1 Cg_exo -70.8 49.46 0.94 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.441 2.761 . . . . 0.0 114.323 -178.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.595 ' CD ' ' H ' ' A' ' 64' ' ' GLN . 0.2 OUTLIER -84.26 -89.23 0.1 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.601 179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.595 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 22.1 tp60 -164.23 -51.7 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.499 0.591 . . . . 0.0 112.018 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.516 HG22 ' HG3' ' A' ' 64' ' ' GLN . 14.6 tt 177.52 -27.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.258 0.551 . . . . 0.0 110.703 -170.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.474 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -99.41 144.56 28.51 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.455 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.718 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 53.5 Cg_endo -68.62 152.69 74.46 Favored 'Trans proline' 0 CA--C 1.517 -0.332 0 C-N-CA 122.383 2.055 . . . . 0.0 111.371 176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.521 HD13 ' O ' ' A' ' 59' ' ' ALA . 29.5 pt -81.58 107.17 13.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.498 0.666 . . . . 0.0 110.059 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -69.86 -49.42 52.5 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.0 p -161.22 138.94 2.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.927 177.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.631 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.6 tt -112.87 128.58 69.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.754 174.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -111.84 128.87 56.25 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 94' ' ' ALA . 35.4 m -128.28 153.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.212 0.529 . . . . 0.0 110.565 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.605 ' O ' ' HG2' ' A' ' 76' ' ' MET . 15.2 m120 -87.65 103.88 16.0 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 172.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -47.36 113.99 0.79 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 125.684 1.865 . . . . 0.0 110.7 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.605 ' HG2' ' O ' ' A' ' 74' ' ' ASN . 11.6 ptp -158.97 117.58 2.94 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.794 0.684 . . . . 0.0 110.074 -176.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.776 ' HA3' ' CZ ' ' A' ' 117' ' ' PHE . . . -151.12 44.89 0.66 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 119.656 -1.259 . . . . 0.0 113.941 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -97.79 26.42 5.13 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 174.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -176.95 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.674 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.546 ' HA2' ' CG2' ' A' ' 115' ' ' VAL . . . 131.03 20.67 1.14 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.281 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.403 ' HB1' ' CG2' ' A' ' 52' ' ' VAL . . . 55.83 54.52 8.05 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.421 0.629 . . . . 0.0 110.908 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.7 p -83.57 176.6 8.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.196 -174.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.652 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 44.5 p90 -64.66 -28.51 69.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.041 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -80.35 -33.07 37.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 70.37 138.1 0.06 OUTLIER Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.951 175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.454 ' CG ' ' HB2' ' A' ' 76' ' ' MET . 36.5 Cg_endo -65.78 -60.08 0.12 Allowed 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.292 1.995 . . . . 0.0 112.808 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.24 -38.21 0.41 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.794 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 76' ' ' MET . 10.9 p-10 -72.41 146.75 46.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 176.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.93 94.23 0.11 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.023 -1.085 . . . . 0.0 113.67 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 49.9 m-80 -100.29 151.83 21.02 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 172.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.5 p90 -98.13 126.95 43.81 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 118.916 -1.114 . . . . 0.0 110.268 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.901 HG21 ' HB2' ' A' ' 118' ' ' SER . 34.5 pt -145.62 166.73 9.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.083 -174.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -95.12 103.5 15.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 172.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.484 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -63.59 -30.52 71.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.25 -175.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.736 ' HA ' HD13 ' A' ' 137' ' ' LEU . 21.8 t70 -59.43 -24.26 63.36 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.697 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 mmtm -120.51 33.97 5.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.329 -178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.425 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -133.41 -177.64 4.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.293 -171.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -93.94 137.4 33.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.545 0.688 . . . . 0.0 110.422 -177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.61 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 6.0 m-85 -120.65 135.69 55.04 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.372 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.577 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 6.3 p -112.24 120.92 63.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.462 0.649 . . . . 0.0 109.643 170.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.442 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 96.9 t -101.61 107.35 21.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 176.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 131' ' ' GLY . . . -70.25 122.33 11.03 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.389 -175.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 m -92.31 -20.55 20.99 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.737 0.303 . . . . 0.0 110.821 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -96.99 -19.08 19.02 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.27 0.557 . . . . 0.0 110.453 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.404 HH11 ' CD ' ' A' ' 130' ' ' GLU . 23.3 mmm-85 -112.53 -30.63 7.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.416 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.864 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 5.4 mpt_? -120.88 -161.71 0.91 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.512 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.807 ' HA2' ' HD3' ' A' ' 112' ' ' PRO . . . 70.11 51.02 25.08 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -171.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.45 -127.04 0.16 Allowed Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 114.483 -0.858 . . . . 0.0 113.068 -173.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 66.2 mtt -97.93 21.32 10.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.665 0.745 . . . . 0.0 109.493 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -166.22 -114.07 0.29 Allowed Glycine 0 N--CA 1.441 -0.999 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.167 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.538 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.19 115.91 63.17 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.885 ' HG2' ' HA ' ' A' ' 145' ' ' VAL . 1.9 Cg_endo -44.09 157.15 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.905 3.07 . . . . 0.0 113.212 164.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.864 ' H ' ' HG2' ' A' ' 106' ' ' ARG . 43.3 mt-10 -113.47 125.97 54.81 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -177.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.61 ' HB1' ' HD2' ' A' ' 99' ' ' TYR . . . -93.76 131.97 38.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.873 -168.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.577 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 2.4 t -97.41 106.07 29.87 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 173.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 5.7 Cg_exo -85.91 131.07 3.72 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.225 2.617 . . . . 0.0 112.731 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.776 ' CZ ' ' HA3' ' A' ' 77' ' ' GLY . 81.6 m-85 -129.82 149.8 51.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.505 179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.901 ' HB2' HG21 ' A' ' 92' ' ' ILE . 16.6 t -87.23 -26.56 23.44 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.4 m -91.98 110.62 21.99 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.929 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -58.77 -46.82 86.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 0.0 111.245 -178.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -62.82 -28.74 70.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.214 -173.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.61 -44.82 81.05 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.891 0.377 . . . . 0.0 110.225 174.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.415 ' O ' HG23 ' A' ' 127' ' ' VAL . . . -65.85 -35.62 81.17 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.329 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.81 -41.49 62.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.477 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -63.0 -33.2 74.92 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.207 0.527 . . . . 0.0 110.529 177.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -59.84 -38.41 81.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.576 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.662 HG22 ' H ' ' A' ' 132' ' ' GLY . 61.7 t -73.17 -30.91 32.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.098 178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mp -56.82 -48.98 76.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.233 0.54 . . . . 0.0 110.72 176.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.73 -38.25 47.48 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.21 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.622 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 4.1 pt-20 -159.26 -90.92 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.708 -178.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.622 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 45.51 -139.05 6.0 Favored Glycine 0 C--N 1.336 0.537 0 O-C-N 123.827 0.704 . . . . 0.0 113.54 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.662 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -172.97 -89.54 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.497 ' HB2' ' HB3' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -128.44 139.15 52.5 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.809 0.337 . . . . 0.0 110.58 177.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 75.4 t -99.5 113.41 34.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.572 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.907 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.81 160.96 38.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.691 -179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.28 162.96 15.57 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.736 HD13 ' HA ' ' A' ' 95' ' ' ASP . 7.0 tt -64.3 -30.52 71.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.43 0.634 . . . . 0.0 109.495 177.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.91 -10.41 59.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.915 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -124.8 19.92 8.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.041 0.448 . . . . 0.0 110.407 -176.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.907 HD13 HD13 ' A' ' 135' ' ' LEU . 26.9 mm -72.1 119.76 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.498 ' O ' HG23 ' A' ' 145' ' ' VAL . 2.2 t -103.02 148.29 25.89 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.203 175.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.454 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 6.0 p-10 -68.94 -29.2 67.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.53 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.54 -32.29 66.93 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -175.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.456 ' HG3' ' HG3' ' A' ' 133' ' ' GLN . 18.0 mmt -86.99 -26.55 23.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.463 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.885 ' HA ' ' HG2' ' A' ' 112' ' ' PRO . 1.3 t -103.3 -3.22 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 0.0 111.405 -173.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.8 pp -169.64 132.87 1.23 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.822 178.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 1.8 p -94.0 118.69 67.26 Favored Pre-proline 0 C--N 1.319 -0.749 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.245 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 24.0 Cg_endo -62.47 -68.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.953 2.435 . . . . 0.0 112.917 -177.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 150' ' ' GLU . 64.6 t -114.7 -27.56 2.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.229 -0.441 . . . . 0.0 112.043 -173.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 149' ' ' VAL . 5.4 mm-40 68.99 46.15 0.86 Allowed 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.977 0.894 . . . . 0.0 108.791 -166.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.4 t -75.72 -13.98 60.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.636 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.13 50.27 6.92 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.61 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.2 t -130.14 161.42 31.13 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -57.16 132.57 80.69 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.49 -177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -47.9 -72.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.536 2.824 . . . . 0.0 112.801 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.22 -44.83 3.21 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.619 -0.432 . . . . 0.0 111.263 173.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -169.28 44.35 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.384 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.0 t70 56.59 32.78 21.55 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.321 1.058 . . . . 0.0 109.637 -176.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -142.07 -179.18 6.08 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 133' ' ' GLN . 9.9 mm-40 . . . . . 0 C--O 1.243 0.757 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.914 ' HG3' ' HA ' ' A' ' 50' ' ' SER . 34.6 ttmt . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.753 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -139.21 144.92 38.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.153 0.433 . . . . 0.0 111.754 -176.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 13.8 pt20 -149.19 134.49 18.35 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 173.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.619 HG22 ' HB ' ' A' ' 71' ' ' ILE . 23.1 pt -115.8 132.91 63.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.135 0.493 . . . . 0.0 111.403 -177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -98.99 116.97 32.45 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.692 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.5 mp -90.4 140.48 29.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.888 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.865 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 35.4 tt0 -71.91 124.9 25.88 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.317 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.35 -15.54 61.97 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.709 -176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.501 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 30.6 t -94.48 124.87 53.94 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 3.0 Cg_endo -81.47 2.95 8.2 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.091 2.527 . . . . 0.0 112.13 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -135.23 134.6 21.55 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.544 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 1.3 Cg_endo -83.68 147.63 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.21 2.607 . . . . 0.0 112.249 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 tt -99.15 112.58 24.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 33.9 p90 -108.62 143.85 37.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.984 0.421 . . . . 0.0 111.365 -177.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -150.03 139.65 21.63 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.914 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 17.2 m -63.21 -29.98 71.22 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -176.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.406 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 15.1 mt-30 -90.3 113.69 25.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.673 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.753 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 17.1 t -64.33 -50.66 75.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.007 0.432 . . . . 0.0 110.889 -177.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.649 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -56.79 -29.46 62.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.931 -177.375 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.649 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 5.1 t70 -76.12 -47.9 22.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.193 0.52 . . . . 0.0 109.828 -178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.23 80.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.459 -178.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.597 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 36.8 pt -69.16 -32.75 55.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.193 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.191 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.602 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . . . -68.22 -42.15 80.23 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 110.214 174.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -61.85 -31.31 71.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.721 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.469 ' HB1' HG21 ' A' ' 68' ' ' ILE . . . -73.23 -17.0 61.39 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.152 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.602 ' HE ' ' HA ' ' A' ' 57' ' ' ALA . 38.2 mtm105 -97.72 8.26 44.99 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.76 -67.69 0.03 OUTLIER Glycine 0 C--N 1.322 -0.198 0 C-N-CA 119.725 -1.226 . . . . 0.0 113.234 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.17 -0.85 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.844 3.03 . . . . 0.0 115.119 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -78.44 37.61 0.28 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.651 0.739 . . . . 0.0 110.595 174.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -79.91 -14.85 58.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.631 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tp -90.55 -38.62 11.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.212 0.53 . . . . 0.0 110.164 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.692 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -148.01 139.7 13.98 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.865 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 73.0 Cg_endo -74.17 150.73 42.96 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.328 2.019 . . . . 0.0 112.039 -177.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.469 HG21 ' HB1' ' A' ' 59' ' ' ALA . 37.8 pt -74.79 123.71 30.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.168 0.509 . . . . 0.0 110.303 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.9 tt -88.34 -53.07 4.86 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.8 142.36 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.287 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.619 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.6 tt -113.5 136.0 51.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.457 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -111.94 133.93 53.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.95 159.14 43.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-O 121.453 0.644 . . . . 0.0 111.72 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -95.52 106.98 19.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.141 171.197 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 90' ' ' ASN . 13.0 t70 -50.99 121.8 6.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 125.088 1.493 . . . . 0.0 109.816 175.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.48 ' SD ' ' N ' ' A' ' 35' ' ' LYS . 29.4 mtp -124.21 49.36 1.79 Allowed 'General case' 0 C--O 1.233 0.213 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -165.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 78' ' ' ALA . . . 73.45 -30.53 0.84 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.818 169.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.965 ' HA ' HG11 ' A' ' 115' ' ' VAL . . . 87.79 -64.44 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.986 0.915 . . . . 0.0 111.801 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.13 -38.34 24.74 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 123.548 0.53 . . . . 0.0 111.794 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.5 -81.82 1.27 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.554 173.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 56.41 22.32 6.32 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 36.1 p -84.38 175.44 9.36 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 121.169 -0.212 . . . . 0.0 110.478 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 2.6 p90 -63.26 -23.27 67.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.802 0.334 . . . . 0.0 110.546 172.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -81.75 -29.88 32.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.592 175.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.467 ' HB3' ' HE2' ' A' ' 76' ' ' MET . 0.0 OUTLIER 57.09 162.82 0.08 OUTLIER Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.782 1.233 . . . . 0.0 112.469 174.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -78.44 -9.96 16.1 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 121.36 1.374 . . . . 0.0 111.477 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 137.65 -177.57 19.8 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -77.11 140.14 40.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.438 0.619 . . . . 0.0 109.408 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -129.46 -126.74 2.87 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.989 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 35.4 m-80 -96.46 150.81 20.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.598 -0.301 . . . . 0.0 110.576 -173.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -99.0 126.14 44.63 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.466 173.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.734 HD13 ' HB2' ' A' ' 118' ' ' SER . 9.8 pt -145.72 166.54 9.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.137 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.58 106.44 18.49 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.427 ' C ' HD12 ' A' ' 137' ' ' LEU . . . -61.75 -33.2 73.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.121 0.486 . . . . 0.0 110.76 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.491 ' HB2' HG22 ' A' ' 71' ' ' ILE . 20.9 t70 -59.63 -24.96 64.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.41 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 mmtm -121.53 33.86 5.38 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.394 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.415 ' HB3' ' HA ' ' A' ' 94' ' ' ALA . . . -135.26 -172.77 3.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.318 -175.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.598 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 97.8 m-85 -95.36 139.16 32.05 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.521 0.676 . . . . 0.0 111.041 -176.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.616 ' CE1' HG22 ' A' ' 101' ' ' VAL . 17.9 t80 -120.34 131.04 54.69 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.659 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 2.9 p -109.52 123.07 65.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 C-N-CA 119.813 -0.755 . . . . 0.0 109.705 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.676 HG11 ' HB3' ' A' ' 144' ' ' MET . 4.0 t -101.74 103.01 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-N 113.895 -1.502 . . . . 0.0 108.394 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.662 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -69.26 134.49 26.82 Favored Glycine 0 N--CA 1.45 -0.432 0 O-C-N 123.574 0.546 . . . . 0.0 113.524 -173.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.5 m -92.08 -36.98 13.04 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.652 0.263 . . . . 0.0 110.317 175.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.08 -43.74 17.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.971 0.415 . . . . 0.0 110.385 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.567 ' HD3' ' OE1' ' A' ' 130' ' ' GLU . 41.3 mtp-105 -132.84 132.78 42.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.668 177.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 1.027 HH21 HG13 ' A' ' 145' ' ' VAL . 12.7 ttt85 -172.08 -62.63 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.814 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.83 -61.2 0.23 Allowed Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.83 -94.53 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.527 -0.368 . . . . 0.0 112.42 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.81 -4.49 59.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.981 0.42 . . . . 0.0 110.896 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -110.65 -129.84 5.66 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.623 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.439 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.17 102.2 26.91 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.718 0.259 . . . . 0.0 110.584 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 26.8 Cg_endo -61.86 128.06 23.26 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 123.745 2.964 . . . . 0.0 112.983 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.466 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 5.0 mm-40 -114.34 139.97 49.02 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.593 -177.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.552 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -123.59 134.59 53.79 Favored 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.64 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.965 HG11 ' HA ' ' A' ' 78' ' ' ALA . 46.1 t -98.13 106.68 36.56 Favored Pre-proline 0 C--N 1.314 -0.973 0 C-N-CA 119.259 -0.977 . . . . 0.0 109.983 172.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.598 ' HA ' ' O ' ' A' ' 98' ' ' PHE . 5.3 Cg_exo -84.55 110.17 1.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.157 2.571 . . . . 0.0 111.283 173.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.78 ' HD1' ' H ' ' A' ' 119' ' ' SER . 4.1 t80 -120.06 151.03 39.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.971 -174.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.734 ' HB2' HD13 ' A' ' 92' ' ' ILE . 33.1 t -74.89 -37.26 62.17 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.778 0.323 . . . . 0.0 110.953 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.78 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 9.6 m -95.95 128.22 42.65 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.608 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 98' ' ' PHE . 3.7 ttt180 -62.42 -48.97 77.33 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.133 0.492 . . . . 0.0 111.215 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -63.11 -31.59 72.76 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.786 -172.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -67.48 -40.44 85.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.731 174.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.17 -34.59 76.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.124 0.488 . . . . 0.0 109.747 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.09 74.72 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.865 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -62.76 -40.35 97.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.142 0.496 . . . . 0.0 109.964 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -60.11 -38.74 83.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.836 174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.689 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 60.8 t -64.57 -43.85 96.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.195 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 78.2 mt -52.46 -40.15 61.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.202 0.525 . . . . 0.0 110.678 177.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.86 -44.01 19.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.96 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.567 ' OE1' ' HD3' ' A' ' 105' ' ' ARG . 6.9 pt-20 -158.97 -33.49 0.06 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -172.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.689 ' CA ' ' HA ' ' A' ' 127' ' ' VAL . . . -52.76 167.01 1.12 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-N 116.257 -0.429 . . . . 0.0 113.907 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.64 -81.76 1.4 Allowed Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.269 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.619 ' HG2' ' HG3' ' A' ' 144' ' ' MET . 2.1 pt20 -125.99 144.39 50.72 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.958 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.415 HG23 HG21 ' A' ' 127' ' ' VAL . 61.1 t -98.88 113.15 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.325 176.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.603 ' H ' HD12 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -133.87 164.56 26.99 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.502 -178.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.86 163.84 22.01 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.444 HD23 HG13 ' A' ' 140' ' ' ILE . 0.8 OUTLIER -62.61 -24.81 67.78 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.864 0.364 . . . . 0.0 110.691 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -76.29 -19.97 57.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.949 0.404 . . . . 0.0 111.151 175.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -104.35 19.33 20.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.852 -173.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.592 HD13 HD13 ' A' ' 135' ' ' LEU . 48.8 mm -71.88 120.37 20.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.216 0.531 . . . . 0.0 111.084 -175.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.789 HG23 ' HB2' ' A' ' 144' ' ' MET . 0.8 OUTLIER -99.42 145.99 26.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.131 177.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.79 -32.21 70.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.045 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.23 -29.2 67.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.504 -175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.789 ' HB2' HG23 ' A' ' 141' ' ' THR . 0.0 OUTLIER -78.94 -35.48 43.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.343 175.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 1.027 HG13 HH21 ' A' ' 106' ' ' ARG . 55.9 t -78.27 -25.36 13.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.382 -167.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.4 pp -160.7 146.61 14.89 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.26 -174.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.4 p -109.01 119.15 49.66 Favored Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 121.057 0.456 . . . . 0.0 110.719 176.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.24 -67.86 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.913 2.408 . . . . 0.0 112.364 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.1 t -122.0 1.65 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.79 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 68.24 -76.73 0.05 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.341 -170.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.8 t 42.29 21.67 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.159 1.384 . . . . 0.0 114.643 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 66.29 26.91 72.69 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.17 -0.538 . . . . 0.0 113.885 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 48.9 m -76.33 152.67 36.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.052 0.426 . . . . 0.0 110.573 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.472 ' HG2' ' HB2' ' A' ' 158' ' ' ASP . 2.5 mp0 -70.63 142.32 88.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 178.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.423 ' HB2' ' HE2' ' A' ' 144' ' ' MET . 69.4 Cg_endo -80.55 19.91 1.03 Allowed 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.72 2.28 . . . . 0.0 112.799 -172.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.449 ' HE ' ' CD ' ' A' ' 133' ' ' GLN . 11.9 ptp85 177.06 -45.68 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.423 -177.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 162.54 -16.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.11 -161.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.472 ' HB2' ' HG2' ' A' ' 154' ' ' GLU . 25.1 t0 59.14 31.24 21.11 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 122.283 1.039 . . . . 0.0 108.761 -168.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.37 -49.58 22.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.665 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 5.0 pt-20 . . . . . 0 C--O 1.254 1.323 0 CA-C-O 118.651 -0.69 . . . . 0.0 110.362 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 50' ' ' SER . 40.0 ttmt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.738 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -132.19 144.21 50.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.675 ' HB3' ' HB3' ' A' ' 48' ' ' PHE . 11.9 pt20 -145.06 144.71 31.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.967 0.413 . . . . 0.0 110.574 177.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.705 HG21 ' HB2' ' A' ' 59' ' ' ALA . 23.2 pt -115.94 134.24 59.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 120.969 0.414 . . . . 0.0 110.415 177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -98.67 116.87 31.86 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.592 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.3 mp -89.16 139.0 30.92 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.234 -174.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.856 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 40.8 tt0 -73.89 122.39 22.45 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.51 -4.18 66.43 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.568 -173.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.472 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 46.9 t -120.02 128.28 25.93 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 5.7 Cg_exo -79.1 -12.8 14.3 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.105 2.537 . . . . 0.0 111.704 176.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -115.39 133.8 22.69 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.62 -176.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 2.2 Cg_endo -86.06 149.88 9.47 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.365 2.71 . . . . 0.0 112.149 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.9 tt -94.7 109.77 21.68 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.675 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . 31.1 p90 -115.54 147.87 40.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.374 0.607 . . . . 0.0 111.834 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -139.24 154.08 47.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.015 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 35' ' ' LYS . 6.2 m -56.42 -50.98 70.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.155 0.502 . . . . 0.0 110.917 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.402 ' HB2' ' CB ' ' A' ' 54' ' ' ASP . 55.2 mt-30 -77.38 136.06 38.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.397 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.738 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 48.4 t -73.17 -50.7 29.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' H ' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -52.78 -32.96 46.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.522 177.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.442 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 15.9 t70 -76.13 -50.0 15.8 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.864 0.364 . . . . 0.0 110.72 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 36' ' ' ALA . . . -67.93 -36.09 79.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.682 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.726 HG22 HD11 ' A' ' 71' ' ' ILE . 31.1 pt -66.02 -31.24 52.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.7 -0.4 . . . . 0.0 109.925 176.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 54' ' ' ASP . . . -61.27 -41.3 96.7 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.744 174.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.541 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 54.4 m-85 -58.1 -41.19 82.99 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.967 0.413 . . . . 0.0 111.046 176.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.705 ' HB2' HG21 ' A' ' 38' ' ' ILE . . . -63.61 -17.63 63.08 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.128 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.04 12.24 32.45 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 175.56 -68.22 0.09 OUTLIER Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.25 -0.976 . . . . 0.0 113.268 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.422 ' HB2' ' CD1' ' A' ' 58' ' ' TYR . 23.9 Cg_exo -68.14 46.47 0.34 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.586 2.858 . . . . 0.0 113.642 178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.96 172.96 13.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.752 0.311 . . . . 0.0 110.285 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.454 ' HB2' ' CD2' ' A' ' 40' ' ' LEU . 84.1 mm-40 -96.81 -164.58 1.16 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.843 0.354 . . . . 0.0 110.91 -176.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 11.3 tt -62.12 -19.4 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 121.379 0.609 . . . . 0.0 111.17 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.592 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -105.97 141.01 21.81 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.899 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.856 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 42.1 Cg_endo -69.36 162.79 40.46 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.967 2.445 . . . . 0.0 112.122 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 17.9 pt -84.38 116.57 28.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.1 0.476 . . . . 0.0 110.674 177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.6 tt -84.08 -52.58 6.18 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.11 139.86 7.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.662 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.726 HD11 HG22 ' A' ' 56' ' ' ILE . 4.1 tt -108.92 126.89 65.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.133 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -111.55 128.76 56.13 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.954 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.562 HG23 HG13 ' A' ' 92' ' ' ILE . 31.2 m -123.43 134.25 66.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.118 0.485 . . . . 0.0 110.101 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -89.5 99.44 12.44 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.607 ' O ' ' HA2' ' A' ' 89' ' ' GLY . 25.6 t70 -68.82 85.94 0.33 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.778 -176.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.745 ' HB3' ' HA2' ' A' ' 89' ' ' GLY . 21.7 ptm -165.17 -168.12 1.33 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.349 0.595 . . . . 0.0 112.268 -174.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.26 -42.9 2.42 Favored Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.787 ' HA ' ' HD2' ' A' ' 86' ' ' PRO . . . 51.88 28.33 5.01 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.111 0.536 . . . . 0.0 112.124 179.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -165.06 -62.19 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -104.97 -11.31 30.38 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.321 -0.942 . . . . 0.0 114.389 -170.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.687 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -61.38 -52.62 63.86 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.953 0.883 . . . . 0.0 109.325 178.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.0 p -129.62 152.75 48.8 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 114.001 -1.454 . . . . 0.0 107.497 168.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -72.22 -19.59 61.7 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.439 0.637 . . . . 0.0 110.054 179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -85.14 -18.48 34.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.776 175.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.436 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 10.4 mt-30 69.75 141.35 0.08 OUTLIER Pre-proline 0 N--CA 1.465 0.299 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.358 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.787 ' HD2' ' HA ' ' A' ' 78' ' ' ALA . 73.7 Cg_endo -91.49 -82.17 0.0 OUTLIER 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.918 2.412 . . . . 0.0 112.929 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.15 -126.2 1.67 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.378 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.68 146.62 48.11 Favored 'General case' 0 C--O 1.221 -0.395 0 C-N-CA 122.013 0.125 . . . . 0.0 110.957 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.745 ' HA2' ' HB3' ' A' ' 76' ' ' MET . . . -70.78 90.01 0.39 Allowed Glycine 0 CA--C 1.518 0.278 0 O-C-N 123.66 0.6 . . . . 0.0 113.964 -175.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -100.16 149.5 23.47 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -100.17 127.8 46.36 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 173.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.562 HG13 HG23 ' A' ' 73' ' ' VAL . 1.4 pt -145.51 156.65 13.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.59 117.99 30.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 164.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.61 -34.93 79.41 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -169.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.658 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 9.4 p-10 -66.9 -28.01 67.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.009 0.909 . . . . 0.0 109.789 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -105.32 33.33 3.74 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.177 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.58 171.48 12.55 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.215 -0.303 . . . . 0.0 110.351 -174.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -89.54 136.15 33.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.314 0.578 . . . . 0.0 110.013 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 7.6 m-85 -120.39 136.95 54.55 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.983 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.416 ' CG1' HG13 ' A' ' 115' ' ' VAL . 2.2 p -120.9 125.47 74.08 Favored 'Isoleucine or valine' 0 C--O 1.251 1.146 0 CA-C-O 121.691 0.758 . . . . 0.0 109.428 170.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.57 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 59.1 t -108.57 117.16 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.117 175.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -75.8 124.49 7.48 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.155 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.5 m -90.43 -23.45 21.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.013 0.435 . . . . 0.0 110.172 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -82.35 -45.17 15.24 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.224 -174.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.617 ' HD3' ' OE2' ' A' ' 130' ' ' GLU . 47.2 mtp180 -139.23 93.75 2.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.029 178.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.567 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -147.84 169.45 19.77 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.451 176.744 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.687 ' H ' ' HA ' ' A' ' 112' ' ' PRO . . . -79.51 45.85 2.95 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.836 178.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.8 -25.26 63.51 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.502 171.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.8 ptm -108.36 21.21 17.64 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 114.746 -0.727 . . . . 0.0 110.213 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -176.3 -116.7 0.47 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.013 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.589 ' C ' ' HA3' ' A' ' 107' ' ' GLY . . . -103.45 102.5 29.95 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.949 0.404 . . . . 0.0 111.378 177.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.687 ' HA ' ' H ' ' A' ' 107' ' ' GLY . 88.0 Cg_endo -74.54 151.83 42.45 Favored 'Trans proline' 0 N--CA 1.467 -0.078 0 C-N-CA 123.253 2.635 . . . . 0.0 111.948 177.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.567 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 1.7 tp10 -118.94 123.24 44.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.308 -177.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.501 ' HB3' HD11 ' A' ' 56' ' ' ILE . . . -99.88 121.43 41.3 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.488 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 6.4 p -110.81 106.63 57.77 Favored Pre-proline 0 C--N 1.316 -0.856 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.235 176.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.528 ' HG3' ' CE2' ' A' ' 99' ' ' TYR . 5.1 Cg_exo -84.98 112.21 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 124.379 3.386 . . . . 0.0 111.872 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -103.98 149.42 25.16 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.337 0.589 . . . . 0.0 111.015 -177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 43.0 t -79.68 -43.78 22.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 18.3 m -83.61 111.31 19.0 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.087 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -56.93 -45.0 83.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.741 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.8 -28.17 69.81 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.973 -173.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -67.47 -43.99 79.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.811 0.338 . . . . 0.0 110.521 174.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.8 92.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.243 0.544 . . . . 0.0 110.208 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.16 74.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.107 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 128' ' ' LEU . . . -61.63 -39.9 92.94 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.974 0.416 . . . . 0.0 111.186 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -57.63 -40.29 78.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.758 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.589 HG22 ' H ' ' A' ' 132' ' ' GLY . 42.4 t -71.79 -28.39 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.843 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 54.2 mt -57.85 -49.82 75.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.451 175.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.55 -48.66 54.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.176 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.918 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.5 pt-20 -157.81 -75.97 0.08 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.566 175.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.918 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.0 -136.85 8.1 Favored Glycine 0 N--CA 1.448 -0.546 0 O-C-N 123.601 0.563 . . . . 0.0 112.914 178.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.589 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -166.31 -91.91 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.15 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.57 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.48 139.7 50.53 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 176.393 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 12.0 t -95.61 118.19 41.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.781 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -138.27 164.37 29.42 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.464 -176.727 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.02 165.57 13.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.685 ' HA ' HG12 ' A' ' 140' ' ' ILE . 4.2 tt -64.55 -30.15 71.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.122 0.486 . . . . 0.0 109.95 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -74.19 -10.68 59.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.011 177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -118.99 15.59 13.33 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.41 0.624 . . . . 0.0 110.262 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.781 HD13 HD13 ' A' ' 135' ' ' LEU . 28.3 mm -72.07 121.52 22.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.923 178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.497 HG23 ' HG2' ' A' ' 144' ' ' MET . 1.2 t -115.39 147.03 41.01 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -69.4 -31.71 70.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.947 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.93 -29.36 60.0 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.367 0.417 . . . . 0.0 112.076 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.497 ' HG2' HG23 ' A' ' 141' ' ' THR . 12.5 mmt -75.74 -34.88 60.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.14 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.549 ' HB ' HD12 ' A' ' 146' ' ' LEU . 2.7 t -86.12 -25.28 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.049 -172.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.549 HD12 ' HB ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -179.65 149.2 0.36 Allowed 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.444 -176.012 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.415 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 43.0 p -103.07 120.18 53.05 Favored Pre-proline 0 C--N 1.317 -0.842 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.557 -178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 37.3 Cg_endo -68.39 -77.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.499 2.133 . . . . 0.0 111.483 173.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.6 t -128.86 -27.44 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 73.45 31.54 1.33 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.268 -177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.9 t -86.27 16.28 4.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.791 0.805 . . . . 0.0 109.407 175.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -113.91 -149.04 10.07 Favored Glycine 0 N--CA 1.437 -1.259 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.716 -176.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 39.1 m -99.89 162.66 12.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.275 -0.462 . . . . 0.0 110.351 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.31 143.43 85.25 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 175.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.9 -29.52 82.2 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.878 2.385 . . . . 0.0 113.213 -173.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.549 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 3.2 ptp180 -166.25 -54.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.549 175.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.549 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -160.19 28.3 0.17 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.867 -177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.8 t70 55.0 75.66 0.3 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.962 0.887 . . . . 0.0 108.92 -168.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.453 ' HB3' ' HD2' ' A' ' 156' ' ' ARG . 26.0 t0 -128.97 25.13 5.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 122.739 1.257 . . . . 0.0 107.863 -173.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.428 ' HA ' ' NE2' ' A' ' 133' ' ' GLN . 3.1 pt-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-N 113.221 -1.809 . . . . 0.0 111.137 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.589 ' HB3' ' OD1' ' A' ' 74' ' ' ASN . 30.0 ttpt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 55' ' ' ALA . . . -139.99 142.64 36.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.815 0.34 . . . . 0.0 111.052 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 12.8 pt20 -149.58 137.45 20.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.599 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.473 HG22 ' HB ' ' A' ' 71' ' ' ILE . 23.9 pt -115.88 142.91 27.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.847 0.356 . . . . 0.0 111.111 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -118.72 129.84 55.49 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 66' ' ' ALA . 10.3 mp -95.7 146.54 24.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.853 0.358 . . . . 0.0 111.167 -175.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.672 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 22.1 tt0 -74.05 125.37 28.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.722 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.09 -13.34 61.72 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.201 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 24.3 t -104.3 125.29 34.65 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 4.2 Cg_exo -80.83 10.47 3.34 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.057 2.505 . . . . 0.0 112.733 -177.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -124.15 133.23 24.52 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.812 0.339 . . . . 0.0 111.455 -177.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 70.8 Cg_endo -98.11 153.69 0.83 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.744 2.963 . . . . 0.0 112.382 173.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 37' ' ' GLN . 3.0 tm? -110.76 105.54 14.43 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 177.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -112.61 136.77 51.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.16 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.461 ' HE2' HE21 ' A' ' 51' ' ' GLN . 10.7 t80 -149.98 154.97 39.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.144 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.6 m -64.04 -38.78 92.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.298 -178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.92 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 45.4 mt-30 -72.42 108.69 5.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.571 178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.581 HG13 ' HB2' ' A' ' 36' ' ' ALA . 12.3 t -62.55 -51.52 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.621 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -53.95 -34.53 59.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.577 179.577 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.621 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 28.3 t70 -76.31 -46.69 26.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.767 0.317 . . . . 0.0 110.6 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.821 ' HA ' ' HD2' ' A' ' 58' ' ' TYR . . . -71.23 -39.03 71.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.426 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.538 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 27.3 pt -63.75 -30.81 50.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 175.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 54' ' ' ASP . . . -61.6 -42.66 99.18 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 174.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.821 ' HD2' ' HA ' ' A' ' 55' ' ' ALA . 61.6 m-85 -56.91 -39.16 73.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.979 0.418 . . . . 0.0 110.799 177.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HA ' HG21 ' A' ' 68' ' ' ILE . . . -65.86 -17.8 64.9 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.894 -179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 56' ' ' ILE . 15.3 mtm180 -102.37 12.61 36.32 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -173.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 169.57 -60.31 0.19 Allowed Glycine 0 CA--C 1.524 0.604 0 C-N-CA 119.616 -1.278 . . . . 0.0 114.303 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 23.6 Cg_exo -66.57 35.19 0.13 Allowed 'Trans proline' 0 N--CA 1.48 0.686 0 C-N-CA 123.774 2.983 . . . . 0.0 114.959 -177.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.442 ' OE2' ' HA ' ' A' ' 67' ' ' PRO . 4.6 pt-20 -83.42 128.03 34.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 170.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -47.58 -92.74 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -170.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 13.4 tt -125.85 -5.49 5.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.077 0.941 . . . . 0.0 109.516 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 41' ' ' GLU . . . -113.13 141.92 26.48 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.988 -176.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.672 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 60.0 Cg_endo -70.1 155.06 65.71 Favored 'Trans proline' 0 CA--C 1.516 -0.383 0 C-N-CA 122.413 2.076 . . . . 0.0 111.786 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 68' ' ' ILE . 22.8 pt -71.08 109.54 3.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.17 0.51 . . . . 0.0 110.287 175.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tt -71.7 -52.01 19.98 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 p -161.23 138.81 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.443 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.56 HG22 ' HB2' ' A' ' 95' ' ' ASP . 1.4 tt -111.39 135.85 49.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.465 174.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 92' ' ' ILE . 87.0 m-85 -115.23 134.64 54.96 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.118 178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.55 HG22 ' HB2' ' A' ' 94' ' ' ALA . 27.1 m -126.53 150.11 32.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.92 0.39 . . . . 0.0 110.086 176.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.589 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 14.0 m120 -83.71 104.9 14.2 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 173.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.55 ' O ' ' HA3' ' A' ' 89' ' ' GLY . 18.7 t70 -55.37 120.66 7.46 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 125.476 1.735 . . . . 0.0 110.29 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.574 ' HG3' ' O ' ' A' ' 74' ' ' ASN . 22.3 mtm -128.63 -165.25 1.48 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.303 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -55.33 -35.79 61.49 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 166.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.595 ' HB1' HG13 ' A' ' 115' ' ' VAL . . . 74.31 -32.27 0.23 Allowed 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.789 0.836 . . . . 0.0 112.881 169.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.71 -32.9 63.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.047 0.451 . . . . 0.0 110.581 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.28 -68.47 1.17 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.234 172.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 53.14 34.87 18.34 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.265 0.555 . . . . 0.0 112.135 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.5 p -83.59 177.61 8.34 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.227 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.92 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 47.0 p90 -64.13 -24.83 67.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.174 0.511 . . . . 0.0 111.081 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.74 -27.24 27.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 64.55 173.79 0.07 OUTLIER Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 114.524 -1.217 . . . . 0.0 110.746 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.573 ' HG2' ' HB3' ' A' ' 76' ' ' MET . 59.6 Cg_endo -97.04 6.08 1.54 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.399 2.066 . . . . 0.0 111.264 173.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.32 157.56 7.81 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.364 -175.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.94 126.71 31.43 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.842 0.353 . . . . 0.0 110.417 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 75' ' ' ASP . . . -118.6 -159.13 11.03 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.487 -174.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 76.9 m-20 -81.39 151.98 27.67 Favored 'General case' 0 C--O 1.212 -0.875 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -98.08 129.83 44.9 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 121.318 -0.864 . . . . 0.0 110.209 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.753 HD13 ' HB2' ' A' ' 118' ' ' SER . 20.3 pt -138.54 161.23 30.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.985 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.25 100.57 7.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.431 176.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -66.28 -34.97 79.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.798 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.613 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 31.3 t70 -61.06 -24.88 66.54 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.618 0.723 . . . . 0.0 110.138 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.1 mmtt -111.64 22.01 15.48 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.839 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -115.92 178.79 4.18 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 120.961 0.41 . . . . 0.0 111.156 -170.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -96.32 130.48 43.41 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.099 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.554 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 11.2 m-85 -120.48 136.56 54.72 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.918 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.867 HG13 ' HB ' ' A' ' 115' ' ' VAL . 1.5 p -121.06 125.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.216 0.531 . . . . 0.0 110.226 172.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.732 ' HB ' ' OE1' ' A' ' 133' ' ' GLN . 55.6 t -101.75 125.47 55.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.652 ' O ' ' HB3' ' A' ' 106' ' ' ARG . . . -87.55 126.84 8.2 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.753 -174.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.7 m -92.66 -21.27 20.11 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 120.551 0.215 . . . . 0.0 111.084 177.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 130' ' ' GLU . . . -89.02 -46.46 8.84 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -170.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.5 mtm180 -129.89 19.71 5.52 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.351 -178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.665 ' HG3' ' H ' ' A' ' 107' ' ' GLY . 8.9 tpp180 -112.0 -161.65 0.76 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.858 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.665 ' H ' ' HG3' ' A' ' 106' ' ' ARG . . . 66.58 46.17 78.78 Favored Glycine 0 CA--C 1.508 -0.397 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -163.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -56.95 -98.22 0.01 OUTLIER Glycine 0 CA--C 1.517 0.161 0 CA-C-N 113.78 -1.21 . . . . 0.0 115.771 -164.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 21.1 ttt -87.95 21.6 2.64 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.568 0.699 . . . . 0.0 110.957 -169.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 135.53 -57.69 0.68 Allowed Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 -177.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.459 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.29 122.68 44.36 Favored Pre-proline 0 N--CA 1.448 -0.566 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 175.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.47 ' CA ' ' HA2' ' A' ' 107' ' ' GLY . 5.2 Cg_endo -47.42 152.35 2.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.884 2.389 . . . . 0.0 112.372 173.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.548 ' H ' ' HG3' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -114.01 131.81 56.22 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -172.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.602 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -93.8 130.16 39.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.442 -174.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.867 ' HB ' HG13 ' A' ' 100' ' ' VAL . 93.1 t -94.85 103.94 13.1 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 174.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 3.4 Cg_exo -91.23 120.38 0.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.548 2.832 . . . . 0.0 112.171 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.36 148.81 50.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.375 -179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.753 ' HB2' HD13 ' A' ' 92' ' ' ILE . 42.2 t -80.26 -26.86 38.8 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 173.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 15.0 m -101.17 121.26 41.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.538 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -59.21 -46.66 87.86 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.618 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -62.76 -28.97 70.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.272 -173.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -69.63 -38.13 77.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.64 -36.93 81.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.302 0.572 . . . . 0.0 109.755 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -64.85 -35.85 82.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.573 175.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -64.41 -34.73 78.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.056 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.461 ' HZ ' HH21 ' A' ' 106' ' ' ARG . 63.8 t80 -63.48 -41.01 98.58 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.803 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 41.3 t -72.95 -30.86 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 121.202 0.525 . . . . 0.0 110.251 177.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 tt -59.2 -36.87 76.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.084 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.08 -50.94 7.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.15 175.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.88 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 1.3 pt-20 -146.94 -81.61 0.14 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.093 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.88 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 52.52 -146.82 15.46 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.809 -0.632 . . . . 0.0 113.669 173.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -172.53 -84.18 0.06 OUTLIER Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.732 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -130.43 145.23 51.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.728 0.299 . . . . 0.0 110.509 174.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 98.7 t -101.23 113.3 36.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.267 0.556 . . . . 0.0 109.535 175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.809 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -130.48 164.86 23.88 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.918 -178.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.476 ' H ' ' HB3' ' A' ' 139' ' ' ASP . . . -90.66 166.18 13.3 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.613 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 5.8 tt -64.38 -38.64 91.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.76 -10.24 57.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.26 175.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 136' ' ' ALA . 31.3 t70 -120.24 18.58 12.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.413 0.625 . . . . 0.0 110.389 -175.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.809 HD13 HD13 ' A' ' 135' ' ' LEU . 25.2 mm -72.02 121.35 22.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 145' ' ' VAL . 2.5 t -116.67 148.88 40.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.093 176.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.538 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 4.3 p30 -68.96 -26.36 65.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.605 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.16 -29.29 69.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.995 0.426 . . . . 0.0 111.324 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.722 ' HE2' ' HB2' ' A' ' 155' ' ' PRO . 11.5 mmt -86.96 -32.23 20.22 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.401 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 141' ' ' THR . 4.2 t -86.75 -23.7 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.13 0.49 . . . . 0.0 110.726 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 3.4 pp -153.4 125.5 7.93 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.324 -176.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.2 p -102.85 131.68 21.99 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.656 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -70.31 -99.25 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.661 2.241 . . . . 0.0 111.386 172.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.634 ' HB ' HG22 ' A' ' 151' ' ' THR . 4.8 t -115.21 -5.78 11.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 174.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 70.19 7.84 6.39 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.573 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.634 HG22 ' HB ' ' A' ' 149' ' ' VAL . 7.6 t -82.18 73.5 9.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 122.195 0.998 . . . . 0.0 109.035 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.83 -140.46 2.99 Favored Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.72 -173.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -102.34 161.32 13.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 177.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.06 132.08 93.72 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.722 ' HB2' ' HE2' ' A' ' 144' ' ' MET . 14.3 Cg_exo -46.45 -75.67 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 123.641 2.894 . . . . 0.0 114.465 -167.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.614 ' HG3' ' OD1' ' A' ' 159' ' ' ASP . 0.0 OUTLIER -92.87 -36.69 12.68 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.649 -176.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . 173.16 38.95 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.8 t70 62.7 97.47 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -164.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.614 ' OD1' ' HG3' ' A' ' 156' ' ' ARG . 8.3 m-20 -63.55 161.36 14.77 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.386 -157.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 C--O 1.252 1.194 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.329 -176.292 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 28.6 ttpp . . . . . 0 N--CA 1.484 1.229 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.639 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -147.62 144.54 28.49 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.633 ' HA ' ' O ' ' A' ' 47' ' ' LEU . 14.5 pt20 -147.31 126.82 13.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.898 0.38 . . . . 0.0 110.558 -178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.886 HG12 ' HB3' ' A' ' 47' ' ' LEU . 7.8 pt -117.3 138.13 48.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.12 0.486 . . . . 0.0 111.113 -176.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -103.95 126.97 51.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.518 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.828 HD23 ' HB3' ' A' ' 66' ' ' ALA . 9.0 mp -92.18 139.87 30.19 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.068 0.461 . . . . 0.0 111.286 -177.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.763 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 36.8 tt0 -74.54 124.33 26.43 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.429 176.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.0 -15.7 62.57 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.533 -177.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.483 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 33.4 t -120.0 124.09 28.04 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 120.957 0.408 . . . . 0.0 110.202 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 2.8 Cg_exo -77.31 7.71 3.61 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.055 2.503 . . . . 0.0 112.487 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.496 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -102.56 131.2 22.65 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.871 0.367 . . . . 0.0 111.254 -178.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 37.5 Cg_endo -98.88 136.89 0.31 Allowed 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.803 3.002 . . . . 0.0 112.69 174.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.886 ' HB3' HG12 ' A' ' 38' ' ' ILE . 13.8 tp -82.99 129.84 35.08 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.701 176.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.422 ' HE1' ' HG2' ' A' ' 46' ' ' PRO . 51.6 m-85 -118.38 133.12 56.14 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.96 0.41 . . . . 0.0 111.162 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.67 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 11.4 m-85 -150.2 148.96 29.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.477 174.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.6 m -77.32 -32.04 54.99 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.056 0.455 . . . . 0.0 110.488 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.741 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 41.5 mt-30 -88.14 122.53 31.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.682 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.639 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 6.2 t -63.77 -51.04 74.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.638 ' HD3' ' N ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -51.25 -36.44 42.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.867 179.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.638 ' N ' ' HD3' ' A' ' 53' ' ' ARG . 36.0 t70 -76.39 -49.22 17.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.823 0.344 . . . . 0.0 110.604 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.67 ' HB2' ' HB2' ' A' ' 49' ' ' PHE . . . -62.53 -42.49 99.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.446 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.003 HD12 ' HB3' ' A' ' 114' ' ' ALA . 21.9 pt -65.42 -31.48 54.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.284 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.579 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . . . -60.87 -43.62 98.17 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 120.591 0.234 . . . . 0.0 110.487 174.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.64 ' HA ' ' HG2' ' A' ' 62' ' ' PRO . 11.8 m-85 -61.1 -40.11 92.49 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.285 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.44 ' HB1' HG21 ' A' ' 68' ' ' ILE . . . -67.05 -27.03 67.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.432 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.579 ' HE ' ' HA ' ' A' ' 57' ' ' ALA . 83.4 mtm180 -88.57 -1.48 58.08 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.019 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.06 -75.75 0.03 OUTLIER Glycine 0 CA--C 1.52 0.348 0 C-N-CA 119.581 -1.295 . . . . 0.0 114.045 -176.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.64 ' HG2' ' HA ' ' A' ' 58' ' ' TYR . 30.7 Cg_exo -37.96 -51.31 1.93 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 124.314 3.343 . . . . 0.0 114.665 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -76.94 98.34 4.89 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -117.09 -23.11 8.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.208 -173.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.5 tp -67.45 -29.32 45.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-O 121.009 0.433 . . . . 0.0 111.244 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.828 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -141.5 141.45 22.96 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.763 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 57.8 Cg_endo -73.38 163.21 38.36 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.43 2.086 . . . . 0.0 111.993 179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.44 HG21 ' HB1' ' A' ' 59' ' ' ALA . 14.3 pt -85.49 121.02 36.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.337 0.589 . . . . 0.0 110.882 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.8 tt -85.81 -59.43 2.31 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.252 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.16 138.54 20.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.203 0.525 . . . . 0.0 110.298 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.506 HG13 HG22 ' A' ' 38' ' ' ILE . 2.3 tt -122.52 129.25 75.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.399 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -111.73 130.69 55.7 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.4 m -127.4 139.63 51.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.77 0.795 . . . . 0.0 111.25 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -87.58 101.67 13.86 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 170.338 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.944 ' HB3' ' HB2' ' A' ' 90' ' ' ASN . 12.5 t0 -46.95 108.34 0.14 Allowed 'General case' 0 C--N 1.331 -0.231 0 O-C-N 124.846 1.341 . . . . 0.0 109.267 175.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.572 ' C ' ' HG3' ' A' ' 86' ' ' PRO . 14.0 ttt -162.65 -101.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.591 -165.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.469 ' H ' ' HB3' ' A' ' 76' ' ' MET . . . -79.7 63.1 4.06 Favored Glycine 0 CA--C 1.499 -0.965 0 CA-C-O 122.112 0.84 . . . . 0.0 111.978 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 115' ' ' VAL . . . -142.75 -55.05 0.42 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.176 -1.512 . . . . 0.0 107.018 174.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.81 -20.76 65.21 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.039 166.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.643 ' HA3' ' HD3' ' A' ' 86' ' ' PRO . . . -89.37 -96.65 1.07 Allowed Glycine 0 C--N 1.342 0.878 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.158 175.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -178.88 -51.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 174.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 85' ' ' GLN . 71.9 p -107.7 175.75 5.38 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.741 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 10.9 p90 -70.45 -31.13 68.16 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.273 0.559 . . . . 0.0 110.125 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -84.87 -28.69 25.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.036 -174.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.509 ' HB2' ' OG1' ' A' ' 82' ' ' THR . 0.9 OUTLIER -61.71 -60.19 11.07 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -167.669 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.643 ' HD3' ' HA3' ' A' ' 80' ' ' GLY . 7.0 Cg_endo -44.75 -57.57 1.98 Allowed 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 123.298 2.665 . . . . 0.0 113.523 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 92.49 -45.7 2.57 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 76' ' ' MET . 11.4 m-20 -77.01 146.85 37.15 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 122.407 0.283 . . . . 0.0 110.474 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.96 100.65 0.29 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.857 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' A' ' 75' ' ' ASP . 91.7 m-20 -95.85 150.26 20.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 175.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -109.6 128.08 54.97 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.194 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.3 pt -145.52 163.45 11.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.635 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.7 109.13 21.15 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.62 -33.03 74.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.792 -174.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.87 ' HA ' HD13 ' A' ' 137' ' ' LEU . 12.7 t70 -58.66 -31.46 68.18 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.83 0.824 . . . . 0.0 110.566 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -111.31 38.29 2.61 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.207 -177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' A' ' 117' ' ' PHE . . . -140.09 169.81 17.01 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.535 -168.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -90.25 143.28 26.91 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.096 176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.478 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 3.2 m-85 -119.81 134.3 55.29 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.828 -178.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.642 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.2 p -113.17 121.54 65.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 170.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.624 HG12 HH11 ' A' ' 106' ' ' ARG . 19.7 t -101.79 103.06 14.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.755 ' O ' ' HB2' ' A' ' 106' ' ' ARG . . . -68.75 133.11 27.12 Favored Glycine 0 N--CA 1.439 -1.1 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.777 -173.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 26.9 t -92.11 -21.99 20.14 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 174.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.64 -43.81 68.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.608 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.519 ' HB2' ' OE1' ' A' ' 113' ' ' GLU . 77.1 mtt180 -100.97 -85.84 0.41 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.672 176.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.755 ' HB2' ' O ' ' A' ' 102' ' ' GLY . 3.7 ttp180 58.42 -96.6 0.07 Allowed 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 115.52 -0.763 . . . . 0.0 112.484 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 167.6 -60.56 0.21 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 -170.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 61.73 -84.83 0.03 OUTLIER Glycine 0 C--N 1.332 0.341 0 O-C-N 123.823 0.366 . . . . 0.0 113.034 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 11.2 tpt -82.99 -4.36 58.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.023 0.44 . . . . 0.0 110.381 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.79 -128.98 3.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.474 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.444 ' HA ' ' HD2' ' A' ' 112' ' ' PRO . . . -103.1 102.97 31.49 Favored Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 122.918 -0.166 . . . . 0.0 111.137 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 111' ' ' ALA . 2.4 Cg_endo -47.31 150.51 3.36 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.413 3.409 . . . . 0.0 113.936 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.704 ' HB3' ' HA ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -114.42 138.11 50.98 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.293 -172.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.003 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -128.77 130.33 46.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.649 172.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.642 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 14.5 t -106.97 104.85 53.63 Favored Pre-proline 0 C--N 1.315 -0.933 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.553 172.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 115' ' ' VAL . 2.7 Cg_exo -84.76 123.75 2.9 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.79 2.994 . . . . 0.0 112.697 178.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.469 ' O ' ' HB1' ' A' ' 97' ' ' ALA . 43.1 m-85 -127.0 149.18 50.01 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.266 -0.424 . . . . 0.0 109.879 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 41.9 t -79.68 -26.63 40.92 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.588 ' HB3' ' OD1' ' A' ' 121' ' ' ASP . 19.3 m -100.51 124.11 45.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.957 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -37.24 84.55 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.283 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.588 ' OD1' ' HB3' ' A' ' 119' ' ' SER . 19.5 p-10 -63.65 -32.37 73.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.661 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 119' ' ' SER . 43.7 mm-40 -64.28 -42.7 96.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.998 0.428 . . . . 0.0 110.259 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.85 -37.88 79.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.718 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.03 -41.86 94.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.67 177.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.426 ' HA ' HD12 ' A' ' 128' ' ' LEU . . . -59.92 -35.65 75.36 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 110.943 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -65.24 -37.37 87.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.204 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.488 ' HA ' ' HA3' ' A' ' 131' ' ' GLY . 46.9 t -72.24 -32.21 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.561 178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 125' ' ' ALA . 69.5 mt -58.33 -40.38 81.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.926 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.84 -49.63 9.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.549 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.647 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 5.6 pt-20 -149.65 -90.14 0.07 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.944 177.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.647 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 51.4 -149.76 7.66 Favored Glycine 0 C--N 1.331 0.267 0 N-CA-C 114.203 0.441 . . . . 0.0 114.203 173.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.427 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -163.86 -96.73 0.11 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.541 ' OE1' ' HB ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -123.32 144.33 49.51 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.941 0.37 . . . . 0.0 110.513 176.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 64.5 t -101.17 122.4 53.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.346 0.593 . . . . 0.0 110.646 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 140' ' ' ILE . 0.4 OUTLIER -147.11 154.7 41.44 Favored 'General case' 0 C--O 1.213 -0.822 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.669 178.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.411 ' H ' ' HB3' ' A' ' 139' ' ' ASP . . . -79.48 168.61 19.21 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.87 HD13 ' HA ' ' A' ' 95' ' ' ASP . 7.0 tt -67.71 -34.13 76.27 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 176.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.99 -15.33 60.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.254 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 136' ' ' ALA . 36.2 t70 -111.23 0.69 16.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.24 0.543 . . . . 0.0 110.861 -174.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.588 ' HA ' HD22 ' A' ' 135' ' ' LEU . 1.4 tt -71.64 144.79 12.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.514 0.673 . . . . 0.0 110.902 -176.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.32 148.16 43.49 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.421 176.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -69.05 -30.41 68.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.006 -176.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.841 ' HB3' ' HB3' ' A' ' 155' ' ' PRO . . . -65.29 -28.55 69.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.701 -178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.1 mmt -78.34 -26.23 46.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.672 0.272 . . . . 0.0 111.279 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.462 HG11 ' HD2' ' A' ' 60' ' ' ARG . 4.0 t -86.58 -23.54 6.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.059 0.457 . . . . 0.0 110.763 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.9 pp -157.04 132.42 9.17 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.18 -175.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 34.7 p -107.04 135.65 19.56 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-O 121.586 0.708 . . . . 0.0 111.642 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.472 ' HG2' ' H ' ' A' ' 150' ' ' GLU . 51.7 Cg_endo -93.04 -131.67 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.804 3.002 . . . . 0.0 111.47 175.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.434 ' H ' ' HB2' ' A' ' 148' ' ' PRO . 6.8 t -97.78 2.85 10.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.743 0.782 . . . . 0.0 109.123 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.472 ' H ' ' HG2' ' A' ' 148' ' ' PRO . 42.0 mt-10 59.98 22.1 11.2 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.579 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.6 t -87.28 26.72 1.16 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.102 0.953 . . . . 0.0 109.03 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -118.48 -124.46 3.36 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.273 -172.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 15.1 p -129.39 161.77 29.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.642 0.258 . . . . 0.0 110.651 -176.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.499 ' HB3' ' HA ' ' A' ' 158' ' ' ASP . 2.0 mp0 -71.6 139.96 84.01 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.727 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.841 ' HB3' ' HB3' ' A' ' 143' ' ' ALA . 52.6 Cg_endo -72.93 -29.91 11.64 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.816 2.344 . . . . 0.0 111.86 176.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 159' ' ' ASP . 6.8 ptp180 -144.55 -141.72 0.12 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.614 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.417 ' H ' ' HB2' ' A' ' 156' ' ' ARG . . . -71.1 72.7 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 170.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 155' ' ' PRO . 9.8 t70 62.27 -79.0 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -164.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.577 ' HA ' ' HG3' ' A' ' 156' ' ' ARG . 5.0 p-10 -171.81 -166.67 0.44 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.573 0.225 . . . . 0.0 110.552 167.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 . . . . . 0 C--O 1.251 1.182 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.845 -175.898 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 74' ' ' ASN . 37.0 tttp . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.491 ' HB2' HG13 ' A' ' 52' ' ' VAL . . . -141.49 143.08 33.64 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 118.699 0.681 . . . . 0.0 112.135 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.622 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 10.7 pt20 -149.29 139.26 22.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.538 173.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.564 HG22 ' HB ' ' A' ' 71' ' ' ILE . 17.1 pt -122.33 138.14 53.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.163 0.506 . . . . 0.0 111.622 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -98.86 116.39 31.0 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 173.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.814 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.4 mp -92.17 134.24 35.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.98 0.419 . . . . 0.0 110.765 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.896 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 39.9 tt0 -71.75 125.82 28.11 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.516 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.67 -26.63 23.89 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 23.1 t -97.79 126.08 42.11 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.3 Cg_exo -74.2 -9.59 22.0 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.878 2.385 . . . . 0.0 113.177 -174.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.25 146.55 49.58 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.821 0.343 . . . . 0.0 111.587 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -78.24 151.45 26.58 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.824 2.349 . . . . 0.0 112.389 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tt -108.77 101.18 10.32 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.622 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 53.9 p90 -101.62 151.98 21.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.819 0.342 . . . . 0.0 110.592 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -148.04 149.74 32.65 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.656 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 p -64.28 -48.65 74.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.339 0.59 . . . . 0.0 110.764 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.725 ' HG2' ' HB3' ' A' ' 83' ' ' TRP . 35.0 mt-30 -78.63 113.99 17.16 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.391 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 36' ' ' ALA . 9.1 t -57.58 -48.83 82.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.639 HH11 ' HB2' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -54.34 -30.99 53.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.156 -0.929 . . . . 0.0 112.702 -178.409 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.639 ' HB2' HH11 ' A' ' 53' ' ' ARG . 14.1 t70 -76.37 -48.48 19.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.804 0.335 . . . . 0.0 110.683 -177.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.77 83.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.333 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.855 HD12 ' HB3' ' A' ' 114' ' ' ALA . 23.3 pt -67.47 -30.24 48.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.728 0.299 . . . . 0.0 110.676 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.07 88.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.861 0.362 . . . . 0.0 110.309 174.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -59.66 -37.32 78.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.434 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -70.58 -18.28 62.9 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.905 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.572 HH12 HG11 ' A' ' 145' ' ' VAL . 48.9 mtm180 -105.07 12.38 32.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -174.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -172.57 -72.42 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.317 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_exo -55.24 -2.01 0.22 Allowed 'Trans proline' 0 N--CA 1.48 0.724 0 C-N-CA 123.905 3.07 . . . . 0.0 115.145 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.481 ' OE1' HG12 ' A' ' 68' ' ' ILE . 1.1 pt-20 -74.4 53.63 0.54 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.578 0.704 . . . . 0.0 110.033 171.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -92.33 -39.93 11.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.725 -176.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.5 tt -75.79 -30.22 21.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.074 0.464 . . . . 0.0 110.545 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.814 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.06 140.41 13.45 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.347 176.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.896 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 80.4 Cg_endo -77.9 153.77 29.43 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.546 2.164 . . . . 0.0 112.134 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.709 HD13 ' HB1' ' A' ' 59' ' ' ALA . 46.6 pt -77.96 125.47 37.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-O 121.304 0.573 . . . . 0.0 110.188 174.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tt -86.0 -52.5 5.67 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -156.66 141.12 8.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.129 176.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.564 ' HB ' HG22 ' A' ' 38' ' ' ILE . 2.9 tt -114.6 129.19 71.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.322 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.462 ' O ' ' HG2' ' A' ' 37' ' ' GLN . 87.1 m-85 -111.96 128.24 56.1 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.501 HG22 ' HB2' ' A' ' 94' ' ' ALA . 28.2 m -126.05 157.02 36.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.455 177.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 0.9 OUTLIER -86.95 110.3 19.93 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 171.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 15.8 t70 -52.8 98.06 0.02 OUTLIER 'General case' 0 C--O 1.239 0.542 0 O-C-N 125.338 1.649 . . . . 0.0 109.503 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.633 ' SD ' ' HB2' ' A' ' 86' ' ' PRO . 2.0 mmt -179.71 87.74 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 113.585 -1.643 . . . . 0.0 108.548 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 79' ' ' ALA . . . -146.57 36.87 1.23 Allowed Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 177.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.89 16.88 0.1 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -167.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 77' ' ' GLY . . . -156.04 7.09 0.21 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.893 0.378 . . . . 0.0 110.537 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA3' ' NH1' ' A' ' 106' ' ' ARG . . . 130.0 -12.18 5.86 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.259 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.29 63.74 0.76 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.604 0.716 . . . . 0.0 109.945 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 46.3 p -83.81 176.71 8.73 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.409 -172.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.725 ' HB3' ' HG2' ' A' ' 51' ' ' GLN . 41.3 p-90 -66.62 -25.08 66.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.155 0.502 . . . . 0.0 110.275 172.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -77.5 -36.16 52.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.24 175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 67.93 150.64 0.12 Allowed Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.889 173.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.633 ' HB2' ' SD ' ' A' ' 76' ' ' MET . 17.1 Cg_exo -72.7 0.2 7.98 Favored 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 122.701 2.267 . . . . 0.0 111.568 169.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.46 176.26 15.64 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.055 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.34 135.76 38.4 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 173.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.77 -136.6 3.59 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.073 -174.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.599 ' O ' ' HA ' ' A' ' 74' ' ' ASN . 53.7 t30 -89.91 151.34 21.78 Favored 'General case' 0 C--O 1.215 -0.744 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -173.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -98.8 128.91 45.16 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 121.354 -0.841 . . . . 0.0 109.896 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.714 HG21 ' HB2' ' A' ' 118' ' ' SER . 25.9 pt -145.17 162.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.185 -175.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.29 110.7 19.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.501 ' HB2' HG22 ' A' ' 73' ' ' VAL . . . -69.51 -35.25 75.34 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -172.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.656 ' HA ' ' HB3' ' A' ' 137' ' ' LEU . 0.2 OUTLIER -68.35 -22.73 64.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.797 0.808 . . . . 0.0 109.791 -178.394 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HG2' ' OD1' ' A' ' 95' ' ' ASP . 43.2 mmtm -102.68 26.5 7.92 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.767 175.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.09 176.69 7.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.475 -171.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -91.36 134.48 34.57 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.035 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.514 ' HD2' ' HB1' ' A' ' 114' ' ' ALA . 7.8 m-85 -120.39 136.16 54.81 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.946 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.897 HG13 ' HB ' ' A' ' 115' ' ' VAL . 2.1 p -115.62 122.39 69.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.445 0.64 . . . . 0.0 109.639 173.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.683 HG23 HD11 ' A' ' 135' ' ' LEU . 48.1 t -101.59 109.78 26.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.765 ' HA2' ' HA2' ' A' ' 131' ' ' GLY . . . -69.69 125.05 16.15 Favored Glycine 0 N--CA 1.448 -0.531 0 O-C-N 123.986 0.804 . . . . 0.0 113.263 -173.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.0 t -90.13 -38.58 13.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.839 0.352 . . . . 0.0 110.227 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -80.29 -43.72 20.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.821 0.343 . . . . 0.0 111.466 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 79.8 mtt180 -125.65 107.08 10.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.014 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.731 ' HD2' ' HB2' ' A' ' 113' ' ' GLU . 1.2 tpp180 173.93 -177.28 0.08 Allowed 'General case' 0 C--O 1.232 0.165 0 O-C-N 123.941 0.776 . . . . 0.0 109.68 171.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -60.02 -57.33 19.82 Favored Glycine 0 N--CA 1.451 -0.33 0 O-C-N 123.368 0.417 . . . . 0.0 113.615 -176.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.63 -98.26 0.59 Allowed Glycine 0 N--CA 1.451 -0.301 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -174.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.428 ' CE ' ' HA ' ' A' ' 148' ' ' PRO . 4.1 mmt -86.99 -3.35 59.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.952 0.406 . . . . 0.0 110.733 173.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.7 -127.93 6.12 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 175.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.24 96.17 7.9 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.787 0.327 . . . . 0.0 110.598 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.475 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . 72.6 Cg_endo -76.51 147.64 28.72 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.384 2.056 . . . . 0.0 112.498 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.731 ' HB2' ' HD2' ' A' ' 106' ' ' ARG . 32.1 mt-10 -129.33 131.68 46.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.462 -176.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.855 ' HB3' HD12 ' A' ' 56' ' ' ILE . . . -93.87 131.1 39.62 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.499 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.897 ' HB ' HG13 ' A' ' 100' ' ' VAL . 87.0 t -95.94 106.28 26.96 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-O 120.89 0.376 . . . . 0.0 110.227 176.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 2.3 Cg_endo -91.55 123.68 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.586 2.857 . . . . 0.0 112.677 177.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -132.97 150.42 52.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.092 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.714 ' HB2' HG21 ' A' ' 92' ' ' ILE . 9.7 t -86.9 -21.92 26.01 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.1 m -93.77 119.48 32.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.873 177.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -61.62 -48.01 82.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.096 0.474 . . . . 0.0 111.202 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -62.59 -29.57 70.69 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.618 -174.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -62.15 -41.58 98.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.946 0.403 . . . . 0.0 110.578 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 100' ' ' VAL . . . -69.87 -37.02 75.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.131 178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.44 -44.68 86.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.048 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.95 82.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.105 0.479 . . . . 0.0 110.452 176.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -60.66 -42.86 97.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.736 175.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.631 ' HA ' ' CA ' ' A' ' 131' ' ' GLY . 55.1 t -61.97 -42.33 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.158 177.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tp -54.36 -36.16 63.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.784 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.06 -40.1 15.0 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.29 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -164.52 -35.13 0.03 OUTLIER 'General case' 0 C--O 1.236 0.393 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -172.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.765 ' HA2' ' HA2' ' A' ' 102' ' ' GLY . . . -49.39 156.07 1.81 Allowed Glycine 0 CA--C 1.518 0.245 0 CA-C-N 115.867 -0.606 . . . . 0.0 113.45 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.443 ' N ' ' HA2' ' A' ' 102' ' ' GLY . . . -94.03 -82.67 1.56 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.949 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.609 HE21 HD23 ' A' ' 135' ' ' LEU . 12.6 pt20 -130.36 150.42 51.6 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.835 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.34 113.34 32.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.366 0.603 . . . . 0.0 110.214 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.683 HD11 HG23 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -133.89 159.97 39.07 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.759 -179.047 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.434 ' H ' ' HB3' ' A' ' 139' ' ' ASP . . . -84.69 168.63 15.07 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.656 ' HB3' ' HA ' ' A' ' 95' ' ' ASP . 6.0 tt -65.2 -32.08 73.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.312 0.577 . . . . 0.0 109.497 178.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.91 -10.26 59.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.735 176.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 136' ' ' ALA . 18.0 t70 -116.4 14.92 15.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.297 -174.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.644 HD13 HD13 ' A' ' 135' ' ' LEU . 36.6 mm -71.49 121.41 21.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.76 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 145' ' ' VAL . 1.5 t -108.36 147.82 30.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.126 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -69.41 -22.87 63.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.122 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 155' ' ' PRO . . . -67.4 -30.07 69.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.654 -175.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.445 ' HG3' ' HG2' ' A' ' 133' ' ' GLN . 78.1 mmm -86.44 -37.78 17.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.832 0.348 . . . . 0.0 111.189 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.572 HG11 HH12 ' A' ' 60' ' ' ARG . 13.3 t -78.81 -21.86 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-O 121.522 0.677 . . . . 0.0 110.44 -174.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -147.31 104.82 3.68 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.119 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.5 ' HB ' ' OE2' ' A' ' 150' ' ' GLU . 20.0 p -102.06 123.91 41.86 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.613 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.499 ' O ' HG22 ' A' ' 151' ' ' THR . 71.9 Cg_endo -74.51 44.42 1.07 Allowed 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 123.405 2.737 . . . . 0.0 112.251 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.458 ' O ' HG12 ' A' ' 149' ' ' VAL . 6.5 t 54.79 28.11 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 122.067 0.937 . . . . 0.0 109.869 -174.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.5 ' OE2' ' HB ' ' A' ' 147' ' ' THR . 1.8 mp0 59.28 23.06 11.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.575 -1.193 . . . . 0.0 112.214 175.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 148' ' ' PRO . 6.9 t -81.57 13.77 2.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.792 0.806 . . . . 0.0 109.539 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . -119.55 -142.59 6.78 Favored Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.788 -173.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 37.4 t -96.61 163.23 13.11 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -57.11 151.88 32.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.511 ' HA ' ' HB1' ' A' ' 143' ' ' ALA . 11.4 Cg_endo -54.39 -22.99 29.06 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.07 2.513 . . . . 0.0 113.087 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.53 ' HG3' ' H ' ' A' ' 157' ' ' ALA . 2.1 ptp180 -174.96 -54.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.256 176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.53 ' H ' ' HG3' ' A' ' 156' ' ' ARG . . . -163.21 30.39 0.09 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.761 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.5 t70 54.22 68.25 0.88 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.845 0.831 . . . . 0.0 109.465 -170.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -100.51 -6.14 25.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.397 -172.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 C--O 1.25 1.105 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.076 -179.608 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.604 ' N ' ' HB3' ' A' ' 74' ' ' ASN . 79.8 tttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.737 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . . . -143.15 144.75 32.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 118.046 0.385 . . . . 0.0 111.401 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.612 ' HA ' ' HA ' ' A' ' 48' ' ' PHE . 3.9 pt20 -149.2 140.1 22.84 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 172.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.615 HG22 ' HB ' ' A' ' 71' ' ' ILE . 24.2 pt -115.77 131.15 69.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.112 0.482 . . . . 0.0 110.19 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -98.75 118.22 34.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.848 HD23 ' HB3' ' A' ' 66' ' ' ALA . 8.4 mp -84.04 153.24 23.93 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.375 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.545 ' HB3' ' HG2' ' A' ' 67' ' ' PRO . 28.9 tt0 -74.12 126.84 31.45 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.962 177.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.82 -41.46 3.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.561 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 22.9 t -81.93 125.28 77.97 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 43' ' ' SER . 6.1 Cg_exo -79.09 -3.97 13.53 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.14 2.56 . . . . 0.0 112.493 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . . . -101.82 133.54 20.69 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.59 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 45' ' ' ALA . 61.2 Cg_endo -92.03 133.44 1.31 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 123.01 2.473 . . . . 0.0 112.315 176.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.9 tt -86.96 105.62 17.25 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 37' ' ' GLN . 40.2 p90 -111.79 143.73 42.25 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.183 0.516 . . . . 0.0 111.468 -175.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -150.01 138.92 20.97 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.422 ' HA ' ' HG3' ' A' ' 35' ' ' LYS . 15.1 m -58.91 -37.0 75.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.95 0.405 . . . . 0.0 111.342 -177.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.539 ' HB3' ' HD2' ' A' ' 53' ' ' ARG . 51.2 mt-30 -81.86 109.29 16.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.432 -178.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.737 ' HA ' ' HB2' ' A' ' 36' ' ' ALA . 39.8 t -59.31 -46.77 92.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.147 0.499 . . . . 0.0 110.661 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.539 ' HD2' ' HB3' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -57.15 -30.29 64.32 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.113 -0.949 . . . . 0.0 112.469 -178.375 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -74.6 -48.64 25.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.118 0.485 . . . . 0.0 110.28 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.97 -41.81 90.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.75 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' A' ' 53' ' ' ARG . 35.1 pt -66.05 -31.74 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.545 0.212 . . . . 0.0 110.579 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.3 90.76 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.781 176.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.629 ' HD1' ' HB2' ' A' ' 62' ' ' PRO . 54.5 m-85 -62.74 -37.49 86.79 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 111.444 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.733 ' HB1' HD13 ' A' ' 68' ' ' ILE . . . -63.99 -17.87 63.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.229 -175.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.9 mtp-105 -100.31 12.66 36.61 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -173.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.48 -56.41 0.34 Allowed Glycine 0 CA--C 1.518 0.269 0 C-N-CA 119.457 -1.354 . . . . 0.0 113.863 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.629 ' HB2' ' HD1' ' A' ' 58' ' ' TYR . 34.2 Cg_exo -60.62 6.53 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.346 2.698 . . . . 0.0 114.458 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -66.89 105.54 1.64 Allowed 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 170.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -128.68 77.82 1.81 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.39 0.614 . . . . 0.0 110.864 -177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 66' ' ' ALA . 5.4 tp 177.42 -52.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.723 176.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.848 ' HB3' HD23 ' A' ' 40' ' ' LEU . . . -152.28 146.33 18.34 Favored Pre-proline 0 N--CA 1.448 -0.551 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.545 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 66.7 Cg_endo -72.41 156.71 54.23 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.109 1.873 . . . . 0.0 111.994 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.733 HD13 ' HB1' ' A' ' 59' ' ' ALA . 46.1 pt -73.47 129.94 36.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.08 0.467 . . . . 0.0 110.577 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tt -88.86 -49.67 6.67 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -160.46 139.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 114.682 -1.144 . . . . 0.0 109.067 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.615 ' HB ' HG22 ' A' ' 38' ' ' ILE . 4.4 tt -108.94 129.87 62.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 120.912 0.387 . . . . 0.0 110.115 179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -111.84 127.29 55.78 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.6 m -124.63 153.72 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.007 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.604 ' HB3' ' N ' ' A' ' 35' ' ' LYS . 25.7 t-20 -80.17 102.0 9.15 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 90' ' ' ASN . 25.5 t70 -49.66 107.1 0.13 Allowed 'General case' 0 C--O 1.243 0.72 0 O-C-N 125.808 1.943 . . . . 0.0 110.973 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.534 ' HG3' ' O ' ' A' ' 74' ' ' ASN . 0.0 OUTLIER -171.36 151.56 3.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.377 -179.419 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 155.5 50.3 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.598 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.68 88.83 3.95 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . 60.19 32.04 20.72 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.485 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.15 -90.87 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.991 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.496 ' HB3' HG22 ' A' ' 115' ' ' VAL . . . 61.86 33.15 17.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.541 0.686 . . . . 0.0 110.278 -173.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.558 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 20.4 p -83.74 177.08 8.51 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.721 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 17.2 t90 -55.51 -35.64 65.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.811 0.339 . . . . 0.0 111.288 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -77.24 -30.37 54.45 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 177.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.558 ' HG2' ' O ' ' A' ' 82' ' ' THR . 22.8 mt-30 63.88 170.28 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.498 175.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -94.44 9.73 1.96 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.547 2.165 . . . . 0.0 111.468 171.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 109.24 130.08 5.97 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.018 -177.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -64.65 135.09 55.56 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.696 0.284 . . . . 0.0 110.769 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -136.27 -79.0 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.172 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.774 ' HB3' ' HB3' ' A' ' 75' ' ' ASP . 43.9 t30 -100.07 153.49 19.18 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -120.02 131.35 55.11 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 121.691 -0.631 . . . . 0.0 110.676 173.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.78 HG21 ' HB2' ' A' ' 118' ' ' SER . 42.1 pt -141.98 167.37 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.839 -175.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 96' ' ' LYS . . . -84.64 116.99 23.49 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 171.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.457 ' O ' HD11 ' A' ' 137' ' ' LEU . . . -69.18 -39.63 78.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.596 -174.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.863 ' O ' ' HG ' ' A' ' 137' ' ' LEU . 2.4 p-10 -78.13 0.58 24.29 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.939 0.876 . . . . 0.0 110.645 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 40.3 mmtm -127.18 56.49 1.52 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.348 -1.296 . . . . 0.0 111.235 169.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.647 ' H ' HD21 ' A' ' 137' ' ' LEU . . . -156.76 -170.12 3.21 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 121.738 -0.601 . . . . 0.0 112.101 -172.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -97.97 140.96 31.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.023 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 116' ' ' PRO . 2.2 m-85 -120.68 136.75 54.76 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.09 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.511 ' CG1' ' HB ' ' A' ' 115' ' ' VAL . 3.0 p -113.08 120.49 63.21 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.773 0.797 . . . . 0.0 109.614 168.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.608 HG23 HD11 ' A' ' 135' ' ' LEU . 99.7 t -101.87 106.77 20.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.757 -1.11 . . . . 0.0 108.556 176.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.7 130.74 28.48 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.745 -176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 34.2 t -92.37 -28.91 16.61 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -87.26 -45.46 10.6 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 120.973 0.416 . . . . 0.0 110.133 -178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -128.93 129.8 45.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.482 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.952 HH21 HG13 ' A' ' 145' ' ' VAL . 36.6 ttt85 -170.07 -64.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.085 -177.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 164.26 -44.63 0.31 Allowed Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 -177.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.19 -111.41 4.08 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.318 -0.467 . . . . 0.0 111.995 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 82.6 mtp -86.22 -3.78 59.04 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.178 0.514 . . . . 0.0 110.198 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -92.43 -126.28 3.91 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.473 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -103.39 92.85 4.28 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.938 0.369 . . . . 0.0 111.03 175.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.24 121.89 10.31 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.228 2.619 . . . . 0.0 112.715 176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -114.48 139.27 49.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.026 0.441 . . . . 0.0 110.576 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.585 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -120.46 133.89 55.35 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.238 -172.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.511 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 39.9 t -100.84 105.02 35.56 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.541 -0.464 . . . . 0.0 109.942 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 4.9 Cg_exo -89.1 124.82 1.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.758 2.972 . . . . 0.0 111.356 171.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.644 ' HD1' ' H ' ' A' ' 119' ' ' SER . 1.7 t80 -135.73 149.13 49.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -176.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.78 ' HB2' HG21 ' A' ' 92' ' ' ILE . 24.1 t -80.35 -31.11 38.0 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.258 0.551 . . . . 0.0 110.273 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.644 ' H ' ' HD1' ' A' ' 117' ' ' PHE . 16.3 m -90.08 113.37 25.08 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.346 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.57 -43.04 75.54 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.402 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -63.83 -31.51 72.72 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.682 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.49 ' HG3' ' CE1' ' A' ' 117' ' ' PHE . 43.3 mm-40 -66.23 -43.0 87.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.84 175.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.63 -38.1 80.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.111 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.43 79.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.874 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' A' ' 128' ' ' LEU . . . -59.7 -31.36 69.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.251 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -62.68 -44.02 97.33 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.677 HG22 ' H ' ' A' ' 132' ' ' GLY . 56.5 t -72.91 -29.21 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.469 176.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.485 ' HB2' ' HA ' ' A' ' 125' ' ' ALA . 9.0 tp -58.22 -35.84 72.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.016 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.68 -50.11 7.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.988 175.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.784 ' HG3' ' H ' ' A' ' 131' ' ' GLY . 6.9 pt-20 -156.26 -79.95 0.08 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.39 175.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.784 ' H ' ' HG3' ' A' ' 130' ' ' GLU . . . 46.55 -129.7 11.41 Favored Glycine 0 C--N 1.335 0.502 0 O-C-N 123.522 0.514 . . . . 0.0 112.753 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.677 ' H ' HG22 ' A' ' 127' ' ' VAL . . . -174.67 -83.01 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.606 HE21 ' HB ' ' A' ' 101' ' ' VAL . 2.8 pm0 -130.22 139.28 50.82 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.819 0.342 . . . . 0.0 110.516 174.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.422 HG23 HG21 ' A' ' 127' ' ' VAL . 76.4 t -98.1 124.13 50.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 172.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.798 HD13 HD13 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -146.99 152.52 38.74 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.815 -177.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 140' ' ' ILE . . . -92.47 173.3 7.86 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.568 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.946 HD22 ' H ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -48.4 -40.73 26.8 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.305 178.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.61 -29.76 67.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.676 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.404 ' OD2' ' HB3' ' A' ' 135' ' ' LEU . 13.4 t70 -95.52 3.9 53.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.309 0.576 . . . . 0.0 110.33 -175.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.798 HD13 HD13 ' A' ' 135' ' ' LEU . 26.2 mm -71.37 119.43 17.72 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-O 121.279 0.561 . . . . 0.0 109.842 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.417 ' CG2' ' HG2' ' A' ' 144' ' ' MET . 3.5 t -119.39 148.43 43.22 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.003 173.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.448 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.1 p-10 -69.05 -25.81 64.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.729 0.3 . . . . 0.0 110.41 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.69 70.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.217 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.572 ' HE2' ' HG2' ' A' ' 156' ' ' ARG . 10.6 mmt -83.51 -34.11 25.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.07 0.462 . . . . 0.0 110.596 177.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.952 HG13 HH21 ' A' ' 106' ' ' ARG . 38.8 t -78.99 -25.21 13.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.488 -173.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 142' ' ' ASP . 4.4 pp -158.07 151.82 23.76 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.276 -174.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.431 ' HA ' ' HD2' ' A' ' 148' ' ' PRO . 16.0 p -101.87 120.08 55.07 Favored Pre-proline 0 C--N 1.316 -0.874 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.663 177.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 147' ' ' THR . 19.9 Cg_endo -62.87 -71.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.364 2.043 . . . . 0.0 111.213 175.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 2.2 t -128.13 12.63 3.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.462 ' O ' HG22 ' A' ' 151' ' ' THR . 39.4 mt-10 65.84 -76.87 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.798 -169.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 150' ' ' GLU . 1.1 t 53.71 -0.94 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.986 1.314 . . . . 0.0 114.348 176.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 150' ' ' GLU . . . 71.86 30.24 66.14 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.027 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.6 p -86.05 141.62 29.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.82 0.31 . . . . 0.0 110.509 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.0 125.33 91.31 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 0.0 110.577 179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.17 -95.38 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.062 2.508 . . . . 0.0 112.647 -179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.718 HH21 ' HB3' ' A' ' 135' ' ' LEU . 1.9 ptp180 -67.89 -32.4 72.86 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 172.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.55 ' N ' ' HG3' ' A' ' 156' ' ' ARG . . . 172.67 -175.1 0.05 Allowed 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 112.981 -1.918 . . . . 0.0 106.483 -174.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -82.59 60.72 5.34 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 122.013 0.911 . . . . 0.0 109.368 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -99.19 -15.88 18.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.196 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 . . . . . 0 C--O 1.253 1.251 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.999 -176.791 . . . . . . . . 0 0 . 1 stop_ save_